Clustering O 0 0.3759795129299164
of O 0 0.047573864459991455
missense O 1 0.868311882019043
mutations O 1 0.9087741374969482
in O 0 0.0533183254301548
the O 0 0.1300121247768402
ataxia B-Disease 1 0.973246693611145
- I-Disease 1 0.8705645203590393
telangiectasia I-Disease 1 0.9658534526824951
gene O 1 0.8852941393852234
in O 0 0.050642650574445724
a O 0 0.07862362265586853
sporadic B-Disease 1 0.6919426321983337
T I-Disease 1 0.9011643528938293
- I-Disease 1 0.7779852151870728
cell I-Disease 1 0.906486988067627
leukaemia I-Disease 1 0.9496811628341675
. O 0 0.13432030379772186

Ataxia B-Disease 1 0.9224488735198975
- I-Disease 1 0.7917338013648987
telangiectasia I-Disease 1 0.9253457188606262
( O 0 0.1958949714899063
A B-Disease 0 0.10384567826986313
- I-Disease 0 0.42846423387527466
T I-Disease 1 0.7430240511894226
) O 0 0.060793373733758926
is O 0 0.021802987903356552
a O 0 0.09603481739759445
recessive B-Disease 1 0.9771709442138672
multi I-Disease 1 0.8177728652954102
- I-Disease 1 0.792535662651062
system I-Disease 1 0.7193617224693298
disorder I-Disease 1 0.9820137619972229
caused O 1 0.7005525231361389
by O 0 0.07525745034217834
mutations O 1 0.881963312625885
in O 0 0.015048147179186344
the O 0 0.018261123448610306
ATM O 0 0.4704304337501526
gene O 1 0.7971857786178589
at O 0 0.04126863181591034
11q22 O 1 0.5924736261367798
- O 0 0.3527642786502838
q23 O 1 0.5369720458984375
( O 0 0.10994921624660492
ref O 0 0.29215922951698303
. O 0 0.012189159169793129
3 O 0 0.02098882757127285
) O 0 0.031288065016269684
. O 0 0.019695837050676346

The O 0 0.04220839962363243
risk O 1 0.5700936913490295
of O 0 0.0378216952085495
cancer B-Disease 1 0.9486555457115173
, O 0 0.024017224088311195
especially O 0 0.11147945374250412
lymphoid B-Disease 1 0.8227407336235046
neoplasias I-Disease 0 0.34351295232772827
, O 0 0.010776165872812271
is O 0 0.00914352759718895
substantially O 0 0.11007487773895264
elevated O 0 0.18231076002120972
in O 0 0.01430466677993536
A B-Disease 0 0.08263005316257477
- I-Disease 1 0.5265752673149109
T I-Disease 1 0.8922064304351807
patients O 1 0.8748419880867004
and O 0 0.009123713709414005
has O 0 0.01110236905515194
long O 0 0.04590965434908867
been O 0 0.016080256551504135
associated O 0 0.1279304027557373
with O 0 0.09014425426721573
chromosomal O 1 0.9505599737167358
instability O 1 0.8466870784759521
. O 0 0.09127342700958252

By O 0 0.06778982281684875
analysing O 1 0.5104036927223206
tumour B-Disease 1 0.931580662727356
DNA O 1 0.6356009244918823
from O 0 0.08912590146064758
patients O 1 0.8717889785766602
with O 0 0.10676385462284088
sporadic B-Disease 1 0.7646535038948059
T I-Disease 1 0.9297052621841431
- I-Disease 1 0.8324245810508728
cell I-Disease 1 0.9287600517272949
prolymphocytic I-Disease 1 0.9421214461326599
leukaemia I-Disease 1 0.9786937236785889
( O 1 0.584248960018158
T B-Disease 1 0.8721038103103638
- I-Disease 1 0.5333389043807983
PLL I-Disease 1 0.8436506986618042
) O 0 0.0354452021420002
, O 0 0.00783721636980772
a O 0 0.0135393301025033
rare O 0 0.2129453867673874
clonal B-Disease 1 0.7866845726966858
malignancy I-Disease 1 0.8730886578559875
with O 0 0.01185612566769123
similarities O 0 0.05539392679929733
to O 0 0.0068534910678863525
a O 0 0.036116987466812134
mature B-Disease 1 0.7223485112190247
T I-Disease 1 0.8852065205574036
- I-Disease 1 0.7626533508300781
cell I-Disease 1 0.8870298862457275
leukaemia I-Disease 1 0.9554570317268372
seen O 0 0.041440632194280624
in O 0 0.012410290539264679
A B-Disease 0 0.029196318238973618
- I-Disease 0 0.14957325160503387
T I-Disease 0 0.3004072308540344
, O 0 0.004837768152356148
we O 0 0.003204351756721735
demonstrate O 0 0.006748095154762268
a O 0 0.004835803061723709
high O 0 0.00792298000305891
frequency O 0 0.033794231712818146
of O 0 0.01352139562368393
ATM O 0 0.46425938606262207
mutations O 1 0.9370789527893066
in O 0 0.08001191169023514
T B-Disease 1 0.7806956768035889
- I-Disease 0 0.4543837606906891
PLL I-Disease 1 0.8261092305183411
. O 0 0.07327398657798767

In O 0 0.022402506321668625
marked O 0 0.021595848724246025
contrast O 0 0.01817993074655533
to O 0 0.006431215908378363
the O 0 0.008640616200864315
ATM O 0 0.27151045203208923
mutation O 1 0.8590944409370422
pattern O 0 0.2338940054178238
in O 0 0.013041672296822071
A B-Disease 0 0.03219971805810928
- I-Disease 0 0.16531993448734283
T I-Disease 0 0.3481658399105072
, O 0 0.004631638526916504
the O 0 0.0035957014188170433
most O 0 0.007339924573898315
frequent O 0 0.08940878510475159
nucleotide O 0 0.20855073630809784
changes O 0 0.03717615827918053
in O 0 0.01288091205060482
this O 0 0.031096111983060837
leukaemia B-Disease 1 0.9358134865760803
were O 0 0.04753169044852257
missense O 1 0.8972118496894836
mutations O 1 0.931450605392456
. O 0 0.10777569562196732

These O 0 0.021253252401947975
clustered O 0 0.028430914506316185
in O 0 0.008157976903021336
the O 0 0.005207551643252373
region O 0 0.007383815944194794
corresponding O 0 0.009006381034851074
to O 0 0.00353014818392694
the O 0 0.004753167275339365
kinase O 0 0.3623190224170685
domain O 0 0.02055410109460354
, O 0 0.0038571693003177643
which O 0 0.0029947746079415083
is O 0 0.0035444595851004124
highly O 0 0.014200921170413494
conserved O 0 0.05015797168016434
in O 0 0.010388127528131008
ATM O 0 0.25067463517189026
- O 0 0.203233540058136
related O 0 0.20445965230464935
proteins O 0 0.36877626180648804
in O 0 0.0344608798623085
mouse O 1 0.6998047232627869
, O 0 0.03461669012904167
yeast O 1 0.6592394113540649
and O 0 0.029869774356484413
Drosophila O 0 0.4792104959487915
. O 0 0.04675198718905449

The O 0 0.029957594349980354
resulting O 0 0.15057602524757385
amino O 0 0.22949180006980896
- O 0 0.12238907814025879
acid O 0 0.23715664446353912
substitutions O 0 0.026416251435875893
are O 0 0.005525563843548298
predicted O 0 0.013302521780133247
to O 0 0.00450680498033762
interfere O 0 0.03552445024251938
with O 0 0.009654401801526546
ATP O 0 0.17111164331436157
binding O 0 0.12202878296375275
or O 0 0.04082399234175682
substrate O 0 0.21840845048427582
recognition O 0 0.08959273248910904
. O 0 0.037238337099552155

Two O 0 0.02471846342086792
of O 0 0.017710549756884575
seventeen O 0 0.060433339327573776
mutated O 1 0.8735783696174622
T B-Disease 1 0.7780132293701172
- I-Disease 0 0.2953278720378876
PLL I-Disease 1 0.5997750163078308
samples O 0 0.04594818502664566
had O 0 0.009886341169476509
a O 0 0.010727857239544392
previously O 0 0.01601230911910534
reported O 0 0.04744083434343338
A B-Disease 0 0.0598982572555542
- I-Disease 0 0.3975341022014618
T I-Disease 1 0.8278462886810303
allele O 1 0.8398932218551636
. O 0 0.07507435977458954

In O 0 0.024190708994865417
contrast O 0 0.03067002445459366
, O 0 0.011080549098551273
no O 0 0.016462143510580063
mutations O 1 0.673026978969574
were O 0 0.006759514566510916
detected O 0 0.14184099435806274
in O 0 0.00779013941064477
the O 0 0.016919037327170372
p53 O 1 0.8896254897117615
gene O 1 0.7506457567214966
, O 0 0.014959145337343216
suggesting O 0 0.05774575099349022
that O 0 0.009753713384270668
this O 0 0.03187692165374756
tumour B-Disease 1 0.9647844433784485
suppressor O 1 0.8499037623405457
is O 0 0.014854189939796925
not O 0 0.006897083483636379
frequently O 0 0.020362069830298424
altered O 0 0.11166168749332428
in O 0 0.015657231211662292
this O 0 0.03397003933787346
leukaemia B-Disease 1 0.9287003874778748
. O 0 0.0679088607430458

Occasional O 0 0.3009793758392334
missense O 1 0.8096284866333008
mutations O 1 0.7640129923820496
in O 0 0.015231846831738949
ATM O 0 0.03820299729704857
were O 0 0.005422132555395365
also O 0 0.0053388322703540325
found O 0 0.020210348069667816
in O 0 0.04516855627298355
tumour B-Disease 1 0.9693194627761841
DNA O 1 0.6998749375343323
from O 0 0.1177653819322586
patients O 1 0.9279045462608337
with O 0 0.10293219238519669
B B-Disease 1 0.7131537199020386
- I-Disease 1 0.6512060165405273
cell I-Disease 1 0.8788175582885742
non I-Disease 1 0.7421319484710693
- I-Disease 1 0.9162445068359375
Hodgkins I-Disease 1 0.983998715877533
lymphomas I-Disease 1 0.9755334258079529
( O 0 0.33650094270706177
B B-Disease 0 0.41777488589286804
- I-Disease 0 0.2011593133211136
NHL I-Disease 0 0.08960004150867462
) O 0 0.016386408358812332
and O 0 0.005548275075852871
a O 0 0.012788905762135983
B B-Disease 0 0.20557238161563873
- I-Disease 0 0.18833597004413605
NHL I-Disease 0 0.178218275308609
cell O 0 0.43266937136650085
line O 0 0.04746526852250099
. O 0 0.033940307796001434

The O 0 0.014370071701705456
evidence O 0 0.009823109023272991
of O 0 0.005361996591091156
a O 0 0.005867640487849712
significant O 0 0.008284715935587883
proportion O 0 0.014569133520126343
of O 0 0.005971554666757584
loss O 0 0.0951533243060112
- O 0 0.08906245976686478
of O 0 0.010064742527902126
- O 0 0.14747834205627441
function O 0 0.18415911495685577
mutations O 1 0.7077327370643616
and O 0 0.00392534164711833
a O 0 0.003969344776123762
complete O 0 0.005782403517514467
absence O 0 0.007675877772271633
of O 0 0.0022897140588611364
the O 0 0.0026615264359861612
normal O 0 0.021364392712712288
copy O 0 0.009484543465077877
of O 0 0.003391703823581338
ATM O 0 0.03097488544881344
in O 0 0.004149202257394791
the O 0 0.003476862097159028
majority O 0 0.023374399170279503
of O 0 0.027704712003469467
mutated O 1 0.9561845660209656
tumours B-Disease 1 0.9759938716888428
establishes O 1 0.7134491801261902
somatic O 1 0.8148412108421326
inactivation O 0 0.3655063211917877
of O 0 0.0068274615332484245
this O 0 0.008741198107600212
gene O 0 0.462844580411911
in O 0 0.00869468692690134
the O 0 0.012519942596554756
pathogenesis O 1 0.8563873767852783
of O 0 0.03206583485007286
sporadic B-Disease 1 0.6127914786338806
T I-Disease 1 0.8214050531387329
- I-Disease 0 0.38737961649894714
PLL I-Disease 1 0.7411705851554871
and O 0 0.011017117649316788
suggests O 0 0.04221489280462265
that O 0 0.006956185679882765
ATM O 0 0.08198919147253036
acts O 0 0.019906535744667053
as O 0 0.012346056289970875
a O 0 0.07488392293453217
tumour B-Disease 1 0.9539315700531006
suppressor O 1 0.9026444554328918
. O 0 0.09746360778808594

As O 0 0.01852608285844326
constitutional O 0 0.02015599235892296
DNA O 0 0.0555538646876812
was O 0 0.006069675553590059
not O 0 0.003980619367212057
available O 0 0.004491165746003389
, O 0 0.004866180010139942
a O 0 0.012713342905044556
putative O 1 0.6319947838783264
hereditary O 1 0.9103192090988159
predisposition O 1 0.9006208777427673
to O 0 0.033370491117239
T B-Disease 1 0.7383362054824829
- I-Disease 0 0.3284457325935364
PLL I-Disease 1 0.63852858543396
will O 0 0.008784271776676178
require O 0 0.020350703969597816
further O 0 0.01147369109094143
investigation O 0 0.021781302988529205
. O 0 0.012005043216049671
. O 0 0.01829562336206436

Myotonic B-Disease 1 0.9333364963531494
dystrophy I-Disease 1 0.9526515007019043
protein O 1 0.7980164289474487
kinase O 1 0.5927553176879883
is O 0 0.01361011527478695
involved O 0 0.012323823757469654
in O 0 0.00629698159173131
the O 0 0.005619433708488941
modulation O 0 0.11247789859771729
of O 0 0.007220194675028324
the O 0 0.03250386193394661
Ca2 O 1 0.932056188583374
+ O 1 0.8781165480613708
homeostasis O 1 0.9283103942871094
in O 0 0.16669529676437378
skeletal O 1 0.9469953775405884
muscle O 1 0.949946403503418
cells O 1 0.909996509552002
. O 0 0.13783209025859833

Myotonic B-Disease 1 0.9307863712310791
dystrophy I-Disease 1 0.9521328210830688
( O 1 0.530151903629303
DM B-Disease 1 0.8881272673606873
) O 0 0.04757477715611458
, O 0 0.011224813759326935
the O 0 0.00882894266396761
most O 0 0.04365882650017738
prevalent O 1 0.8797658681869507
muscular B-Disease 1 0.9740357398986816
disorder I-Disease 1 0.980117917060852
in O 0 0.09416551142930984
adults O 1 0.5005190372467041
, O 0 0.014806345105171204
is O 0 0.012199279852211475
caused O 0 0.15997324883937836
by O 0 0.01573057286441326
( O 0 0.07495299726724625
CTG O 0 0.47024083137512207
) O 0 0.033270251005887985
n O 0 0.06815499812364578
- O 0 0.06820124387741089
repeat O 0 0.0715622529387474
expansion O 0 0.01807190477848053
in O 0 0.007616800721734762
a O 0 0.017131969332695007
gene O 1 0.6406031847000122
encoding O 0 0.3149961829185486
a O 0 0.06651152670383453
protein O 1 0.7813785076141357
kinase O 1 0.91595458984375
( O 0 0.4469679594039917
DM B-Disease 1 0.9608038067817688
protein O 1 0.8406134843826294
kinase O 1 0.8512442708015442
; O 0 0.07343213260173798
DMPK O 0 0.28619489073753357
) O 0 0.014741531573235989
and O 0 0.005534206982702017
involves O 0 0.036596063524484634
changes O 0 0.021713631227612495
in O 0 0.01241131778806448
cytoarchitecture O 0 0.22301742434501648
and O 0 0.020564815029501915
ion O 0 0.4491172134876251
homeostasis O 1 0.8097727298736572
. O 0 0.06493867933750153

To O 0 0.01635132171213627
obtain O 0 0.016219276934862137
clues O 0 0.01543731801211834
to O 0 0.005295747425407171
the O 0 0.0050944979302585125
normal O 0 0.03546341508626938
biological O 0 0.034124039113521576
role O 0 0.011472197249531746
of O 0 0.0062560285441577435
DMPK O 0 0.31843096017837524
in O 0 0.01763816736638546
cellular O 0 0.4882551431655884
ion O 0 0.35161834955215454
homeostasis O 1 0.5795066952705383
, O 0 0.004917321261018515
we O 0 0.002955595962703228
have O 0 0.003209644230082631
compared O 0 0.009261968545615673
the O 0 0.005543451756238937
resting O 0 0.10579823702573776
[ O 0 0.16280892491340637
Ca2 O 1 0.7862504124641418
+ O 0 0.29900872707366943
] O 0 0.033669207245111465
i O 0 0.0039597563445568085
, O 0 0.0030498842243105173
the O 0 0.0030678235925734043
amplitude O 0 0.02754397690296173
and O 0 0.004929377697408199
shape O 0 0.07243534177541733
of O 0 0.028108129277825356
depolarization O 1 0.9314420223236084
- O 1 0.751225471496582
induced O 1 0.9640756249427795
Ca2 O 1 0.940310537815094
+ O 1 0.5831829905509949
transients O 0 0.3275279104709625
, O 0 0.005446352530270815
and O 0 0.003108764300122857
the O 0 0.0031858603470027447
content O 0 0.0066307014785707
of O 0 0.00539692398160696
ATP O 0 0.17770268023014069
- O 0 0.08837854117155075
driven O 0 0.06742820143699646
ion O 0 0.37401628494262695
pumps O 0 0.27060389518737793
in O 0 0.06939103454351425
cultured O 1 0.8433456420898438
skeletal O 1 0.9572885036468506
muscle O 1 0.9535095691680908
cells O 1 0.8103653788566589
of O 0 0.022760257124900818
wild O 0 0.22395853698253632
- O 0 0.2959390878677368
type O 0 0.25070691108703613
and O 0 0.02937440574169159
DMPK O 1 0.6890144348144531
[ O 0 0.4147593677043915
- O 1 0.5086507201194763
/ O 1 0.667306661605835
- O 0 0.4229028820991516
] O 0 0.3330894410610199
knockout O 1 0.7259519100189209
mice O 1 0.896081805229187
. O 0 0.08763781189918518

In O 0 0.05522574856877327
vitro O 1 0.5447843670845032
- O 0 0.3509783446788788
differentiated O 1 0.6393634676933289
DMPK O 1 0.6291348934173584
[ O 0 0.23928231000900269
- O 0 0.36640244722366333
/ O 0 0.4913749098777771
- O 0 0.21998856961727142
] O 0 0.12261857092380524
myotubes O 0 0.20741339027881622
exhibit O 0 0.03698878735303879
a O 0 0.011208407580852509
higher O 0 0.03382713720202446
resting O 0 0.1590244024991989
[ O 0 0.2235093116760254
Ca2 O 1 0.8147954344749451
+ O 0 0.3355504870414734
] O 0 0.04146160930395126
i O 0 0.004763358272612095
than O 0 0.00418273638933897
do O 0 0.005600904114544392
wild O 0 0.048325784504413605
- O 0 0.09622784703969955
type O 0 0.12959671020507812
myotubes O 0 0.1556267887353897
because O 0 0.006712276488542557
of O 0 0.0031044213101267815
an O 0 0.004297159146517515
altered O 0 0.06792660057544708
open O 0 0.014988438226282597
probability O 0 0.037921153008937836
of O 0 0.007305235601961613
voltage O 0 0.233785480260849
- O 0 0.2729378938674927
dependent O 0 0.3783762454986572
l O 1 0.7158006429672241
- O 1 0.5064769387245178
type O 1 0.5492134094238281
Ca2 O 1 0.866474986076355
+ O 0 0.4268629252910614
and O 0 0.020591285079717636
Na O 1 0.5389678478240967
+ O 0 0.37410175800323486
channels O 0 0.0732380598783493
. O 0 0.027233632281422615

The O 0 0.03305443003773689
mutant O 0 0.3092813789844513
myotubes O 0 0.22670455276966095
exhibit O 0 0.04602377861738205
smaller O 0 0.023974841460585594
and O 0 0.011262577958405018
slower O 0 0.19478696584701538
Ca2 O 1 0.8219573497772217
+ O 0 0.40660402178764343
responses O 0 0.15874618291854858
upon O 0 0.017969727516174316
triggering O 0 0.32923242449760437
by O 0 0.02301398664712906
acetylcholine O 1 0.5754060745239258
or O 0 0.028117576614022255
high O 0 0.031186850741505623
external O 0 0.08113803714513779
K O 0 0.24429601430892944
+ O 0 0.33336758613586426
. O 0 0.03655516356229782

In O 0 0.019169531762599945
addition O 0 0.01390884444117546
, O 0 0.006604483816772699
we O 0 0.004391324706375599
observed O 0 0.009782610461115837
that O 0 0.004353617783635855
these O 0 0.010103230364620686
Ca2 O 1 0.7685903310775757
+ O 0 0.46132662892341614
transients O 1 0.505131185054779
partially O 0 0.10683710128068924
result O 0 0.021246450021862984
from O 0 0.006455340422689915
an O 0 0.006517177447676659
influx O 0 0.08528303354978561
of O 0 0.010623703710734844
extracellular O 1 0.5310968160629272
Ca2 O 1 0.8358415961265564
+ O 0 0.25770390033721924
through O 0 0.016383057460188866
the O 0 0.01460054237395525
l O 1 0.5813508033752441
- O 0 0.4449213743209839
type O 1 0.5019529461860657
Ca2 O 1 0.8654961585998535
+ O 0 0.41313350200653076
channel O 0 0.06597599387168884
. O 0 0.031067444011569023

Neither O 0 0.030092909932136536
the O 0 0.010848299600183964
content O 0 0.013825797475874424
nor O 0 0.010863629169762135
the O 0 0.00604684604331851
activity O 0 0.018742239102721214
of O 0 0.012537680566310883
Na O 1 0.6570316553115845
+ O 1 0.6379653215408325
/ O 1 0.6049596071243286
K O 0 0.48608288168907166
+ O 1 0.6824659705162048
ATPase O 1 0.8162407875061035
and O 0 0.07085985690355301
sarcoplasmic O 1 0.9316896796226501
reticulum O 1 0.9260097146034241
Ca2 O 1 0.926151692867279
+ O 1 0.7151763439178467
- O 0 0.38398393988609314
ATPase O 1 0.5586059093475342
are O 0 0.016387930139899254
affected O 0 0.12122231721878052
by O 0 0.02865499071776867
DMPK O 0 0.3631044626235962
absence O 0 0.164258673787117
. O 0 0.04090914875268936

In O 0 0.017980609089136124
conclusion O 0 0.01582958921790123
, O 0 0.006205045618116856
our O 0 0.005323328543454409
data O 0 0.006309118587523699
suggest O 0 0.008660406805574894
that O 0 0.004713230300694704
DMPK O 0 0.08253896236419678
is O 0 0.005228650290518999
involved O 0 0.010354137979447842
in O 0 0.005842771381139755
modulating O 0 0.20526008307933807
the O 0 0.00446954695507884
initial O 0 0.01727248914539814
events O 0 0.014939469285309315
of O 0 0.01147573534399271
excitation O 1 0.5907124876976013
- O 0 0.46110713481903076
contraction O 1 0.812465250492096
coupling O 1 0.7291877269744873
in O 0 0.15117423236370087
skeletal O 1 0.9416466355323792
muscle O 1 0.9154245257377625
. O 0 0.05836385115981102
. O 0 0.04082879424095154

Constitutional O 0 0.41768980026245117
RB1 O 1 0.8927049040794373
- O 1 0.7828089594841003
gene O 1 0.9223964214324951
mutations O 1 0.930732786655426
in O 0 0.1115538626909256
patients O 1 0.9090366363525391
with O 0 0.10031616687774658
isolated O 1 0.6203924417495728
unilateral B-Disease 1 0.6242271661758423
retinoblastoma I-Disease 1 0.8928513526916504
. O 0 0.09619361162185669

In O 0 0.03653978183865547
most O 0 0.048352744430303574
patients O 1 0.8107938766479492
with O 0 0.04053055867552757
isolated O 1 0.5062071084976196
unilateral B-Disease 1 0.5840986967086792
retinoblastoma I-Disease 1 0.943807065486908
, O 0 0.07258202135562897
tumor B-Disease 1 0.9212635159492493
development O 0 0.05210809037089348
is O 0 0.010550528764724731
initiated O 0 0.07045503705739975
by O 0 0.01705700159072876
somatic O 1 0.5242125391960144
inactivation O 0 0.20879368484020233
of O 0 0.006570377852767706
both O 0 0.012212147936224937
alleles O 1 0.5993538498878479
of O 0 0.013721113093197346
the O 0 0.05146985128521919
RB1 O 1 0.9167311787605286
gene O 1 0.8507781624794006
. O 0 0.07035968452692032

However O 0 0.01934322714805603
, O 0 0.009431610815227032
some O 0 0.006234156433492899
of O 0 0.006503884214907885
these O 0 0.01999414712190628
patients O 1 0.8693931102752686
can O 0 0.07725466042757034
transmit O 1 0.5881624221801758
retinoblastoma B-Disease 1 0.923329770565033
predisposition O 1 0.7992389798164368
to O 0 0.012972167693078518
their O 0 0.019398098811507225
offspring O 1 0.5721474885940552
. O 0 0.04805123060941696

To O 0 0.01677786558866501
determine O 0 0.014701900072395802
the O 0 0.007778136990964413
frequency O 0 0.014935077168047428
and O 0 0.005058248993009329
nature O 0 0.013472623191773891
of O 0 0.009563752450048923
constitutional O 0 0.20970410108566284
RB1 O 1 0.9561164379119873
- O 1 0.7884484529495239
gene O 1 0.9564654231071472
mutations O 1 0.9659940004348755
in O 0 0.14926068484783173
patients O 1 0.9321537017822266
with O 0 0.060792483389377594
isolated O 1 0.5242276191711426
unilateral B-Disease 0 0.4567539691925049
retinoblastoma I-Disease 1 0.8710576295852661
, O 0 0.014419890008866787
we O 0 0.006888910196721554
analyzed O 0 0.11572670191526413
DNA O 0 0.3549804091453552
from O 0 0.04832817241549492
peripheral O 1 0.8502005934715271
blood O 1 0.7727895379066467
and O 0 0.044126853346824646
from O 0 0.21044744551181793
tumor B-Disease 1 0.9693082571029663
tissue O 1 0.9327079057693481
. O 0 0.13909228146076202

The O 0 0.022731034085154533
analysis O 0 0.02704688347876072
of O 0 0.01469829399138689
tumors B-Disease 1 0.8694209456443787
from O 0 0.01644987426698208
54 O 0 0.03791472688317299
( O 0 0.03149820864200592
71 O 0 0.02962285466492176
% O 0 0.024071479216217995
) O 0 0.008001933805644512
of O 0 0.004555019550025463
76 O 0 0.04049469530582428
informative O 0 0.10869629681110382
patients O 1 0.7359238862991333
showed O 0 0.03686075657606125
loss O 0 0.0775490403175354
of O 0 0.01255782786756754
constitutional O 0 0.09448692202568054
heterozygosity O 1 0.8633743524551392
( O 0 0.3032912313938141
LOH O 1 0.8462031483650208
) O 0 0.06100904196500778
at O 0 0.031663306057453156
intragenic O 0 0.4988502860069275
loci O 1 0.7823155522346497
. O 0 0.07470808178186417

Three O 0 0.028934545814990997
of O 0 0.01918528787791729
13 O 0 0.0449104867875576
uninformative O 1 0.5714689493179321
patients O 1 0.7139474153518677
had O 0 0.020019937306642532
constitutional O 0 0.04757801443338394
deletions O 0 0.4083746373653412
. O 0 0.04002143815159798

For O 0 0.025475550442934036
39 O 0 0.028704270720481873
randomly O 0 0.03451087698340416
selected O 0 0.030963366851210594
tumors B-Disease 1 0.9277701377868652
, O 0 0.021000443026423454
SSCP O 0 0.4052686393260956
, O 0 0.02684674598276615
hetero O 1 0.7634978294372559
- O 0 0.27899518609046936
duplex O 1 0.5129530429840088
analysis O 0 0.03686610609292984
, O 0 0.006485854275524616
sequencing O 0 0.04661870747804642
, O 0 0.004399193916469812
and O 0 0.0033779763616621494
Southern O 0 0.008514530956745148
blot O 0 0.08241091668605804
analysis O 0 0.011110732331871986
were O 0 0.0033489842899143696
used O 0 0.006894814781844616
to O 0 0.01030845195055008
identify O 0 0.20184975862503052
mutations O 1 0.8892953991889954
. O 0 0.055486541241407394

Mutations O 1 0.6937974095344543
were O 0 0.016179196536540985
detected O 0 0.09327329695224762
in O 0 0.009250699542462826
21 O 0 0.018190898001194
( O 0 0.02605322375893593
91 O 0 0.033052101731300354
% O 0 0.02207087352871895
) O 0 0.013353300280869007
of O 0 0.008675617165863514
23 O 0 0.08953273296356201
tumors B-Disease 1 0.9403786063194275
with O 0 0.08173183351755142
LOH O 1 0.8274162411689758
. O 0 0.06418128311634064

In O 0 0.025352617725729942
6 O 0 0.02432316541671753
( O 0 0.021927043795585632
38 O 0 0.016040809452533722
% O 0 0.021530847996473312
) O 0 0.010556000284850597
of O 0 0.0058328500017523766
16 O 0 0.04880787804722786
tumors B-Disease 1 0.9485243558883667
without O 0 0.0632341206073761
LOH O 1 0.6666095852851868
, O 0 0.00955847930163145
one O 0 0.010129492729902267
mutation O 1 0.7462164163589478
was O 0 0.007215035613626242
detected O 0 0.09809686988592148
, O 0 0.0035756004508584738
and O 0 0.0024399675894528627
in O 0 0.0030919662676751614
9 O 0 0.008827573619782925
( O 0 0.012894154526293278
56 O 0 0.011257736943662167
% O 0 0.016290200874209404
) O 0 0.007317425683140755
of O 0 0.003576731774955988
the O 0 0.012031813152134418
tumors B-Disease 1 0.9427822828292847
without O 0 0.07574610412120819
LOH O 1 0.7260897159576416
, O 0 0.009420711547136307
both O 0 0.014870081096887589
mutations O 1 0.7204537987709045
were O 0 0.008924153633415699
found O 0 0.02917489968240261
. O 0 0.027689993381500244

Thus O 0 0.02904440276324749
, O 0 0.009806811809539795
a O 0 0.007041499018669128
total O 0 0.005883165169507265
of O 0 0.00637011369690299
45 O 0 0.02443712018430233
mutations O 1 0.6702590584754944
were O 0 0.0070818886160850525
identified O 0 0.04930060729384422
in O 0 0.03214764595031738
tumors B-Disease 1 0.9417223930358887
of O 0 0.04004989191889763
36 O 0 0.22671519219875336
patients O 1 0.9011961817741394
. O 0 0.07218668609857559

Thirty O 0 0.036122653633356094
- O 0 0.02870228700339794
nine O 0 0.010448191314935684
of O 0 0.0056637548841536045
the O 0 0.009862322360277176
mutations O 1 0.7890272736549377
- O 0 0.09174700826406479
including O 0 0.013704911805689335
34 O 0 0.02436196058988571
small O 0 0.02916252799332142
mutations O 1 0.7612081170082092
, O 0 0.006240460090339184
2 O 0 0.008020266890525818
large O 0 0.012454790063202381
structural O 0 0.14002512395381927
alterations O 0 0.10905171930789948
, O 0 0.005412220489233732
and O 0 0.006324203219264746
hypermethylation O 1 0.5100699067115784
in O 0 0.017413128167390823
3 O 0 0.08004039525985718
tumors O 1 0.9531406760215759
- O 0 0.09533005207777023
were O 0 0.004298265557736158
not O 0 0.004053822252899408
detected O 0 0.07068297266960144
in O 0 0.005275264848023653
the O 0 0.0074011883698403835
corresponding O 0 0.19223226606845856
peripheral O 1 0.8894849419593811
blood O 1 0.8814331293106079
DNA O 1 0.6687623262405396
. O 0 0.0719243586063385

In O 0 0.02267308346927166
6 O 0 0.021641474217176437
( O 0 0.01938595250248909
17 O 0 0.013266907073557377
% O 0 0.01266581378877163
) O 0 0.0054945433512330055
of O 0 0.002716297283768654
the O 0 0.00391408009454608
36 O 0 0.04372740536928177
patients O 1 0.6242628693580627
, O 0 0.007416270673274994
a O 0 0.012071923352777958
mutation O 1 0.6929798126220703
was O 0 0.0081273028627038
detected O 0 0.0756717398762703
in O 0 0.005195624195039272
constitutional O 0 0.01838330551981926
DNA O 0 0.12383733689785004
, O 0 0.003198721446096897
and O 0 0.002207139739766717
1 O 0 0.0033470431808382273
of O 0 0.00284832576289773
these O 0 0.009189126081764698
mutations O 1 0.7034550905227661
is O 0 0.006203846540302038
known O 0 0.007561791688203812
to O 0 0.003066773759201169
be O 0 0.004606665577739477
associated O 0 0.03237380459904671
with O 0 0.015043307095766068
reduced O 0 0.16241313517093658
expressivity O 1 0.7420698404312134
. O 0 0.0661420002579689

The O 0 0.01800936460494995
presence O 0 0.015538587234914303
of O 0 0.006860511377453804
a O 0 0.008572345599532127
constitutional O 0 0.030487744137644768
mutation O 1 0.5599945187568665
was O 0 0.005080249160528183
not O 0 0.003854235401377082
associated O 0 0.010128168389201164
with O 0 0.004272812511771917
an O 0 0.004880493972450495
early O 0 0.013319971039891243
age O 0 0.05426471680402756
at O 0 0.03560663387179375
treatment O 1 0.6659494042396545
. O 0 0.061364058405160904

In O 0 0.03370828926563263
1 O 0 0.04663718864321709
patient O 1 0.5594441890716553
, O 0 0.018403539434075356
somatic O 1 0.5302411317825317
mosaicism O 1 0.5845996737480164
was O 0 0.008551200851798058
demonstrated O 0 0.02417215332388878
by O 0 0.010376458056271076
molecular O 0 0.17783185839653015
analysis O 0 0.02143324911594391
of O 0 0.007796455640345812
DNA O 0 0.2636551260948181
and O 0 0.016315167769789696
RNA O 0 0.43405795097351074
from O 0 0.04534490406513214
peripheral O 1 0.8330222964286804
blood O 1 0.812749445438385
. O 0 0.08220880478620529

In O 0 0.03246236592531204
2 O 0 0.056025318801403046
patients O 1 0.7242186069488525
without O 0 0.024571750313043594
a O 0 0.03759552165865898
detectable O 1 0.811082124710083
mutation O 1 0.9371861815452576
in O 0 0.08035790175199509
peripheral O 1 0.9016900062561035
blood O 1 0.7998847961425781
, O 0 0.031217075884342194
mosaicism O 1 0.6815354228019714
was O 0 0.007030711509287357
suggested O 0 0.01657005213201046
because O 0 0.007843343541026115
1 O 0 0.006230139639228582
of O 0 0.0050723254680633545
the O 0 0.025395693257451057
patients O 1 0.9357845783233643
showed O 0 0.46490293741226196
multifocal O 1 0.9772015810012817
tumors B-Disease 1 0.9608168005943298
and O 0 0.010369814932346344
the O 0 0.006529743783175945
other O 0 0.008823649026453495
later O 0 0.015875302255153656
developed O 0 0.1995338350534439
bilateral B-Disease 0 0.18221834301948547
retinoblastoma I-Disease 1 0.8824177384376526
. O 0 0.06638158112764359

In O 0 0.019312215968966484
conclusion O 0 0.015943801030516624
, O 0 0.0064103445038199425
our O 0 0.004943939857184887
results O 0 0.007427345961332321
emphasize O 0 0.008496916852891445
that O 0 0.0028891742695122957
the O 0 0.0033038067631423473
manifestation O 0 0.08064410835504532
and O 0 0.006983042694628239
transmissibility O 0 0.41839131712913513
of O 0 0.010637374594807625
retinoblastoma B-Disease 1 0.5861716866493225
depend O 0 0.008280927315354347
on O 0 0.002518169116228819
the O 0 0.002630142495036125
nature O 0 0.004509409423917532
of O 0 0.0022078845649957657
the O 0 0.00253100274130702
first O 0 0.005307429935783148
mutation O 1 0.5028107762336731
, O 0 0.003686777548864484
its O 0 0.002564278431236744
time O 0 0.0024247420951724052
in O 0 0.0024917875416576862
development O 0 0.005200287327170372
, O 0 0.001963866874575615
and O 0 0.0014487386215478182
the O 0 0.0017737426096573472
number O 0 0.0029098920058459044
and O 0 0.0029186876490712166
types O 0 0.03182113915681839
of O 0 0.006374413147568703
cells O 0 0.4505128860473633
that O 0 0.005696473643183708
are O 0 0.008184928447008133
affected O 0 0.12763644754886627
. O 0 0.017761820927262306
. O 0 0.026087669655680656

Hereditary B-Disease 1 0.8927392363548279
deficiency I-Disease 1 0.9227533936500549
of I-Disease 0 0.012812236323952675
the I-Disease 0 0.008936239406466484
fifth I-Disease 0 0.012230693362653255
component I-Disease 0 0.019896704703569412
of I-Disease 0 0.0063050128519535065
complement I-Disease 0 0.027108192443847656
in O 0 0.011109261773526669
man O 0 0.030563000589609146
. O 0 0.026119759306311607

I O 0 0.08081711083650589
. O 0 0.06434857845306396

Clinical O 1 0.5490812659263611
, O 0 0.02732706628739834
immunochemical O 0 0.12780402600765228
, O 0 0.015298623591661453
and O 0 0.01192792784422636
family O 0 0.05079274624586105
studies O 0 0.09780439734458923
. O 0 0.03044404275715351

The O 0 0.021125029772520065
first O 0 0.01536535657942295
recognized O 0 0.042696863412857056
human O 0 0.13038302958011627
kindred O 1 0.6220122575759888
with O 0 0.09486329555511475
hereditary B-Disease 1 0.9213995933532715
deficiency I-Disease 1 0.9589504599571228
of I-Disease 0 0.007326637394726276
the I-Disease 0 0.005427488591521978
fifth I-Disease 0 0.014494204893708229
component I-Disease 0 0.03248381242156029
of I-Disease 0 0.006941385101526976
complement I-Disease 0 0.10223264247179031
( O 0 0.07752136886119843
C5 O 0 0.471856951713562
) O 0 0.030425142496824265
is O 0 0.012773058377206326
described O 0 0.03103949874639511
. O 0 0.023226222023367882

The O 0 0.027706749737262726
proband O 0 0.07291993498802185
, O 0 0.01310718897730112
a O 0 0.011976136825978756
20 O 0 0.015331241302192211
- O 0 0.06458447128534317
year O 0 0.02213781140744686
- O 0 0.14114221930503845
old O 0 0.08412016928195953
black O 0 0.31199103593826294
female O 1 0.6779180765151978
with O 1 0.7352359294891357
systemic B-Disease 1 0.9892354607582092
lupus I-Disease 1 0.9903059005737305
erythematosus I-Disease 1 0.9815102815628052
since O 0 0.20622114837169647
age O 0 0.1604013442993164
11 O 0 0.062459658831357956
, O 0 0.0358763113617897
lacked O 0 0.3164174556732178
serum O 1 0.9439781308174133
hemolytic O 1 0.9795830845832825
complement O 0 0.3317953944206238
activity O 0 0.09565277397632599
, O 0 0.012719149701297283
even O 0 0.018059097230434418
during O 0 0.0458686538040638
remission O 1 0.8113341927528381
. O 0 0.06688208132982254

C5 O 0 0.3417215943336487
was O 0 0.03027731366455555
undetectable O 0 0.3476383686065674
in O 0 0.01555287279188633
her O 0 0.020806115120649338
serum O 0 0.3819255828857422
by O 0 0.01739831082522869
both O 0 0.028027307242155075
immunodiffusion O 1 0.5795137286186218
and O 0 0.13303391635417938
hemolytic O 1 0.9613771438598633
assays O 1 0.6349050402641296
. O 0 0.09412536025047302

Other O 0 0.02065405063331127
complement O 0 0.026540685445070267
components O 0 0.01716863550245762
were O 0 0.007768324110656977
normal O 0 0.06341098994016647
during O 0 0.06176065653562546
remission O 1 0.8413423299789429
of O 0 0.07140862196683884
lupus O 1 0.9758152961730957
, O 0 0.025054264813661575
but O 0 0.016607720404863358
C1 O 1 0.6048423647880554
, O 0 0.020224301144480705
C4 O 0 0.31338274478912354
, O 0 0.01766839064657688
C2 O 1 0.5672526955604553
, O 0 0.010471438057720661
and O 0 0.010579428635537624
C3 O 1 0.5321502685546875
levels O 0 0.13634465634822845
fell O 0 0.07605075091123581
during O 0 0.12067310512065887
exacerbations O 1 0.9023467302322388
. O 0 0.09618376940488815

A O 0 0.03405415639281273
younger O 0 0.05099663510918617
half O 0 0.021220088005065918
- O 0 0.08581344038248062
sister O 0 0.03807264193892479
, O 0 0.005291488952934742
who O 0 0.005150926765054464
had O 0 0.006503770127892494
no O 0 0.01943405345082283
underlying O 0 0.4955710172653198
disease O 1 0.9615845680236816
, O 0 0.0067612724378705025
was O 0 0.0037399709690362215
also O 0 0.003993582911789417
found O 0 0.007600605487823486
to O 0 0.006875538267195225
lack O 0 0.08213649690151215
immunochemically O 1 0.5943607687950134
detectable O 1 0.8131554126739502
C5 O 1 0.7613775134086609
. O 0 0.06924504786729813

By O 0 0.12710705399513245
hemolytic O 1 0.9344348907470703
assay O 0 0.17175644636154175
, O 0 0.011981560848653316
she O 0 0.008656752295792103
exhibited O 0 0.016792070120573044
1 O 0 0.009685983881354332
- O 0 0.02190147340297699
2 O 0 0.005567851942032576
% O 0 0.005705634132027626
of O 0 0.0029713260009884834
the O 0 0.004366814624518156
normal O 0 0.0906282439827919
serum O 1 0.5000063180923462
C5 O 0 0.3818938434123993
level O 0 0.016200629994273186
and O 0 0.005533304531127214
normal O 0 0.039135511964559555
concentrations O 0 0.07563859224319458
of O 0 0.005571094807237387
other O 0 0.008183667436242104
complement O 0 0.04728657007217407
components O 0 0.04585551470518112
. O 0 0.02596054971218109

C5 O 0 0.19750531017780304
levels O 0 0.03262612968683243
of O 0 0.008198270574212074
other O 0 0.005922660697251558
family O 0 0.008238817565143108
members O 0 0.0038381002377718687
were O 0 0.0025306381285190582
either O 0 0.004523398354649544
normal O 0 0.02021542564034462
or O 0 0.007322733290493488
approximately O 0 0.009123731404542923
half O 0 0.01697084866464138
- O 0 0.09069234132766724
normal O 0 0.09674492478370667
, O 0 0.011065870523452759
consistent O 0 0.07121389359235764
with O 0 0.07258876413106918
autosomal O 1 0.9729433059692383
codominant O 1 0.6595126390457153
inheritance O 0 0.48424428701400757
of O 0 0.01793668605387211
the O 0 0.0543045699596405
gene O 1 0.9108184576034546
determining O 1 0.6615004539489746
C5 B-Disease 1 0.9356750249862671
deficiency I-Disease 1 0.9704293012619019
. O 0 0.17939411103725433

Normal O 1 0.5648378133773804
hemolytic O 1 0.9139344692230225
titers O 0 0.38332220911979675
were O 0 0.0184423066675663
restored O 0 0.022840768098831177
to O 0 0.010106774978339672
both O 0 0.0260528065264225
homozygous O 1 0.8869141936302185
C5 B-Disease 1 0.9211528301239014
- I-Disease 1 0.6839077472686768
deficient I-Disease 1 0.9316716194152832
( O 0 0.18943285942077637
C5D B-Disease 1 0.653761625289917
) O 0 0.03981481119990349
sera O 0 0.05838298797607422
by O 0 0.007577499374747276
addition O 0 0.00962034985423088
of O 0 0.007416470441967249
highly O 0 0.0706304982304573
purified O 0 0.36490774154663086
human O 0 0.29255804419517517
C5 O 1 0.6395789980888367
. O 0 0.057955726981163025

In O 0 0.028667638078331947
specific O 0 0.04363027960062027
C5 O 0 0.35211071372032166
titrations O 0 0.4384253919124603
, O 0 0.007486640475690365
however O 0 0.005054894834756851
, O 0 0.002888984512537718
it O 0 0.00198559882119298
was O 0 0.0020967856980860233
noted O 0 0.0031406765338033438
that O 0 0.0018156800651922822
when O 0 0.00224675121717155
limited O 0 0.003639104077592492
amounts O 0 0.00892607681453228
of O 0 0.0034525340888649225
C5 O 0 0.13560619950294495
were O 0 0.0034009036608040333
assayed O 0 0.03528334200382233
in O 0 0.003792667994275689
the O 0 0.003183256834745407
presence O 0 0.009788302704691887
of O 0 0.004410519264638424
low O 0 0.05262376368045807
dilutions O 0 0.45574551820755005
of O 0 0.009660362266004086
either O 0 0.04105014353990555
C5D B-Disease 1 0.610358715057373
serum O 1 0.5857096314430237
, O 0 0.012370401993393898
curving O 0 0.09442199021577835
rather O 0 0.016216199845075607
than O 0 0.018564162775874138
linear O 0 0.3883536458015442
dose O 1 0.7272654175758362
- O 0 0.15239892899990082
response O 0 0.042964592576026917
plots O 0 0.019887130707502365
were O 0 0.004702936392277479
consistently O 0 0.00866206455975771
obtained O 0 0.008360073901712894
, O 0 0.006247567478567362
suggesting O 0 0.02486523613333702
some O 0 0.010915873572230339
inhibitory O 0 0.39195770025253296
effect O 0 0.14995069801807404
. O 0 0.034941937774419785

Further O 0 0.031266216188669205
studies O 0 0.031106742098927498
suggested O 0 0.01593620702624321
that O 0 0.007723535411059856
low O 0 0.04249940440058708
dilutions O 0 0.4686790704727173
of O 0 0.016029516234993935
C5D B-Disease 1 0.7123908400535583
serum O 1 0.7215234041213989
contain O 0 0.1399051398038864
a O 0 0.038181405514478683
factor O 0 0.2864316999912262
( O 0 0.0767413079738617
or O 0 0.028288213536143303
factors O 0 0.1487049162387848
) O 0 0.025318186730146408
interfering O 0 0.021724823862314224
at O 0 0.003734329016879201
some O 0 0.003398037748411298
step O 0 0.009549661539494991
in O 0 0.006387954577803612
the O 0 0.01896669901907444
hemolytic O 1 0.9723666310310364
assay O 0 0.1950913667678833
of O 0 0.009335445240139961
C5 O 0 0.2769392132759094
, O 0 0.0061529455706477165
rather O 0 0.007100474555045366
than O 0 0.005761813838034868
a O 0 0.011754610575735569
true O 0 0.08308477699756622
C5 O 1 0.7429536581039429
inhibitor O 1 0.8372951149940491
or O 0 0.07397740334272385
inactivator O 0 0.4336918890476227
. O 0 0.04944678768515587

Of O 0 0.02181323803961277
clinical O 0 0.20019058883190155
interest O 0 0.011330652981996536
are O 0 0.0057370965369045734
( O 0 0.010219443589448929
a O 0 0.004927240777760744
) O 0 0.005643567070364952
the O 0 0.003706842428073287
documentation O 0 0.025366099551320076
of O 0 0.018974602222442627
membranous O 1 0.9372327327728271
glomerulonephritis B-Disease 1 0.9708914756774902
, O 0 0.13807673752307892
vasculitis B-Disease 1 0.9574353098869324
, O 0 0.03015602007508278
and O 0 0.03434253856539726
arthritis B-Disease 1 0.9710975885391235
in O 0 0.013851912692189217
an O 0 0.009896344505250454
individual O 0 0.05502462387084961
lacking O 0 0.17563821375370026
C5 O 1 0.5070619583129883
( O 0 0.02761967107653618
and O 0 0.003720593173056841
its O 0 0.005535626783967018
biologic O 0 0.3216308653354645
functions O 0 0.028261657804250717
) O 0 0.016583027318120003
, O 0 0.0046773008070886135
and O 0 0.0044845701195299625
( O 0 0.03132505342364311
b O 0 0.07218408584594727
) O 0 0.010129005648195744
a O 0 0.007496553473174572
remarkable O 0 0.06675636768341064
propensity O 1 0.6403159499168396
to O 0 0.10232122242450714
bacterial B-Disease 1 0.9843846559524536
infections I-Disease 1 0.9788170456886292
in O 0 0.01702069491147995
the O 0 0.009754699654877186
proband O 0 0.20999297499656677
, O 0 0.005216888152062893
even O 0 0.005741513334214687
during O 0 0.00842958502471447
periods O 0 0.037354860454797745
of O 0 0.006995867006480694
low O 0 0.14496122300624847
- O 0 0.24975447356700897
dose O 1 0.6067967414855957
or O 0 0.04674521088600159
alternate O 0 0.07442548125982285
- O 0 0.2553654611110687
day O 0 0.08944278955459595
corticosteroid O 1 0.914971113204956
therapy O 1 0.9049264192581177
. O 0 0.1106228306889534

Other O 0 0.01979883387684822
observations O 0 0.021197523921728134
indicate O 0 0.014913751743733883
that O 0 0.0061302524991333485
the O 0 0.005348975770175457
C5D B-Disease 0 0.08641593903303146
state O 0 0.0062308902852237225
is O 0 0.00589362159371376
compatible O 0 0.028304753825068474
with O 0 0.010466734878718853
normal O 0 0.1745000034570694
coagulation O 1 0.829615592956543
function O 0 0.03946075960993767
and O 0 0.003614630550146103
the O 0 0.003878847463056445
capacity O 0 0.00651923380792141
to O 0 0.0053976248018443584
mount O 0 0.050760332494974136
a O 0 0.08491667360067368
neutrophilic O 1 0.9401137828826904
leukocytosis O 1 0.9403205513954163
during O 1 0.5375470519065857
pyogenic B-Disease 1 0.9545506238937378
infection I-Disease 1 0.9662178754806519
. O 0 0.07552121579647064
. O 0 0.05406896024942398

Susceptibility O 1 0.8703593611717224
to O 0 0.12575313448905945
ankylosing B-Disease 1 0.9410049915313721
spondylitis I-Disease 1 0.9323006272315979
in O 0 0.03731945529580116
twins O 0 0.26697608828544617
: O 0 0.012101525440812111
the O 0 0.006022913847118616
role O 0 0.017471617087721825
of O 0 0.012277535162866116
genes O 1 0.7151220440864563
, O 0 0.02649354375898838
HLA O 1 0.6651630401611328
, O 0 0.007843028753995895
and O 0 0.005416549742221832
the O 0 0.00803397037088871
environment O 0 0.04984571039676666
. O 0 0.026229195296764374

OBJECTIVE O 0 0.03275502100586891
To O 0 0.011050398461520672
determine O 0 0.010088109411299229
the O 0 0.0059890104457736015
relative O 0 0.023143846541643143
effects O 0 0.20953430235385895
of O 0 0.012948243878781796
genetic O 1 0.7028131484985352
and O 0 0.01344346720725298
environmental O 0 0.11246157437562943
factors O 0 0.3346814811229706
in O 0 0.09458553045988083
susceptibility O 1 0.9511243104934692
to O 0 0.24424682557582855
ankylosing B-Disease 1 0.9757559299468994
spondylitis I-Disease 1 0.9678437113761902
( O 0 0.22466206550598145
AS B-Disease 0 0.05686406046152115
) O 0 0.06176164373755455
. O 0 0.030799536034464836

METHODS O 0 0.059432219713926315
Twins O 0 0.1367824524641037
with O 0 0.010030857287347317
AS B-Disease 0 0.006994155235588551
were O 0 0.004542774986475706
identified O 0 0.008947327733039856
from O 0 0.00477056298404932
the O 0 0.005445432849228382
Royal O 0 0.039273377507925034
National O 0 0.12446814775466919
Hospital O 1 0.8817011713981628
for O 0 0.4352371096611023
Rheumatic B-Disease 1 0.9842897057533264
Diseases I-Disease 1 0.9792628884315491
database O 1 0.6041221618652344
. O 0 0.11045362800359726

Clinical O 1 0.546963632106781
and O 0 0.02304200641810894
radiographic O 0 0.28619205951690674
examinations O 0 0.038815177977085114
were O 0 0.0065835751593112946
performed O 0 0.012987221591174603
to O 0 0.006554424297064543
establish O 0 0.09316756576299667
diagnoses O 1 0.9006413817405701
, O 0 0.054529979825019836
and O 0 0.0944446250796318
disease O 1 0.9776073098182678
severity O 1 0.6552077531814575
was O 0 0.010793641209602356
assessed O 0 0.025179944932460785
using O 0 0.006765734404325485
a O 0 0.006290584336966276
combination O 0 0.04014567285776138
of O 0 0.0064284102991223335
validated O 0 0.042387668043375015
scoring O 0 0.02434743568301201
systems O 0 0.11259658634662628
. O 0 0.03612945228815079

HLA O 1 0.8551298379898071
typing O 0 0.43905332684516907
for O 0 0.06194469332695007
HLA O 1 0.8943824768066406
- O 0 0.40857428312301636
B27 O 1 0.5685108304023743
, O 0 0.060003384947776794
HLA O 1 0.8662185072898865
- O 0 0.274921715259552
B60 O 0 0.3479129672050476
, O 0 0.017585285007953644
and O 0 0.021524203941226006
HLA O 1 0.8517834544181824
- O 0 0.24614498019218445
DR1 O 1 0.5826195478439331
was O 0 0.008628261275589466
performed O 0 0.017124870792031288
by O 0 0.011689339764416218
polymerase O 0 0.46497535705566406
chain O 0 0.15429379045963287
reaction O 0 0.09686936438083649
with O 0 0.010152441449463367
sequence O 0 0.08459143340587616
- O 0 0.09655095636844635
specific O 0 0.03145480528473854
primers O 0 0.1598583608865738
, O 0 0.007040165364742279
and O 0 0.006425341125577688
zygosity O 0 0.13902223110198975
was O 0 0.010501579381525517
assessed O 0 0.06072253733873367
using O 0 0.034995630383491516
microsatellite O 1 0.680974006652832
markers O 0 0.32504093647003174
. O 0 0.05112042278051376

Genetic O 0 0.40945112705230713
and O 0 0.015330476686358452
environmental O 0 0.024830346927046776
variance O 0 0.025000683963298798
components O 0 0.010020559653639793
were O 0 0.004095510113984346
assessed O 0 0.008082081563770771
with O 0 0.0038421277422457933
the O 0 0.0033771933522075415
program O 0 0.011308794841170311
Mx O 0 0.10942880064249039
, O 0 0.0033250560518354177
using O 0 0.0033708116970956326
data O 0 0.0032610746566206217
from O 0 0.0027601304464042187
this O 0 0.0020032150205224752
and O 0 0.0022359956055879593
previous O 0 0.005246841814368963
studies O 0 0.022203339263796806
of O 0 0.006695967633277178
twins O 0 0.23359152674674988
with O 0 0.013638000935316086
AS B-Disease 0 0.023346077650785446
. O 0 0.03143282234668732

RESULTS O 0 0.0407445915043354
Six O 0 0.022394612431526184
of O 0 0.0149232754483819
8 O 0 0.046595994383096695
monozygotic O 1 0.8441754579544067
( O 0 0.23169554769992828
MZ O 1 0.9151272177696228
) O 0 0.09038827568292618
twin O 0 0.3269956409931183
pairs O 0 0.3242669701576233
were O 0 0.038406290113925934
disease O 1 0.9655556082725525
concordant O 1 0.548163115978241
, O 0 0.010022114962339401
compared O 0 0.01947978511452675
with O 0 0.006593699567019939
4 O 0 0.009028539061546326
of O 0 0.005246608052402735
15 O 0 0.0197947695851326
B27 O 0 0.2936265766620636
- O 0 0.21408915519714355
positive O 0 0.28085121512413025
dizygotic O 1 0.8579872846603394
( O 0 0.20325513184070587
DZ O 1 0.7560983300209045
) O 0 0.053762633353471756
twin O 0 0.17153891921043396
pairs O 0 0.1263999342918396
( O 0 0.03466358035802841
27 O 0 0.014958322048187256
% O 0 0.015936821699142456
) O 0 0.006565306335687637
and O 0 0.003029964631423354
4 O 0 0.004706149455159903
of O 0 0.003756903577595949
32 O 0 0.018336761742830276
DZ O 0 0.4587290287017822
twin O 0 0.20353730022907257
pairs O 0 0.11813555657863617
overall O 0 0.0449703224003315
( O 0 0.029713449999690056
12 O 0 0.009682174772024155
. O 0 0.007104853168129921
5 O 0 0.013623756356537342
% O 0 0.028041068464517593
) O 0 0.023887135088443756
. O 0 0.020313233137130737

Nonsignificant O 0 0.20291770994663239
increases O 0 0.05248706787824631
in O 0 0.013519742526113987
similarity O 0 0.040857747197151184
with O 0 0.00804541353136301
regard O 0 0.014185123145580292
to O 0 0.0060963197611272335
age O 0 0.12713474035263062
at O 0 0.1229933425784111
disease O 1 0.9816770553588867
onset O 1 0.9202892780303955
and O 0 0.008181464858353138
all O 0 0.004525516182184219
of O 0 0.014009632170200348
the O 0 0.1056043729186058
disease O 1 0.9834603667259216
severity O 1 0.7968258261680603
scores O 0 0.11115013062953949
assessed O 0 0.09126821905374527
were O 0 0.008822767995297909
noted O 0 0.08296704292297363
in O 0 0.14110098779201508
disease O 1 0.9810373187065125
- O 1 0.7778365015983582
concordant O 1 0.9257202744483948
MZ O 1 0.9527785181999207
twins O 1 0.799126148223877
compared O 0 0.24841265380382538
with O 0 0.11417380720376968
concordant O 1 0.8471881747245789
DZ O 1 0.8752871155738831
twins O 1 0.668687641620636
. O 0 0.07867354899644852

HLA O 1 0.8297982215881348
- O 0 0.20797130465507507
B27 O 0 0.21220329403877258
and O 0 0.01301934290677309
B60 O 0 0.10124687105417252
were O 0 0.007004703860729933
associated O 0 0.02575342170894146
with O 0 0.00818934291601181
the O 0 0.018073705956339836
disease O 1 0.9493401646614075
in O 0 0.01423479150980711
probands O 0 0.16660644114017487
, O 0 0.0047769262455403805
and O 0 0.003062022151425481
the O 0 0.0037460948806256056
rate O 0 0.06564831733703613
of O 0 0.03464807942509651
disease O 1 0.9713488221168518
concordance O 0 0.4032839834690094
was O 0 0.011940152384340763
significantly O 0 0.11445096880197525
increased O 0 0.03881312906742096
among O 0 0.03695175424218178
DZ O 1 0.6093831658363342
twin O 0 0.1910586655139923
pairs O 0 0.07490269094705582
in O 0 0.0058157178573310375
which O 0 0.004393437877297401
the O 0 0.006061846856027842
co O 0 0.09991563111543655
- O 0 0.08538396656513214
twin O 0 0.11789020150899887
was O 0 0.005740453954786062
positive O 0 0.02657279744744301
for O 0 0.006527911406010389
both O 0 0.00988934375345707
B27 O 0 0.1730380356311798
and O 0 0.02268710732460022
DR1 O 1 0.7051533460617065
. O 0 0.05338544026017189

Additive O 1 0.6319189667701721
genetic O 1 0.6996543407440186
effects O 0 0.1544034630060196
were O 0 0.008968244306743145
estimated O 0 0.011993849650025368
to O 0 0.005479815416038036
contribute O 0 0.020529041066765785
97 O 0 0.011188967153429985
% O 0 0.007266360800713301
of O 0 0.005095082800835371
the O 0 0.006541095674037933
population O 0 0.03976728022098541
variance O 0 0.13645143806934357
. O 0 0.030880775302648544

CONCLUSION O 0 0.06537073850631714
Susceptibility O 0 0.3955363929271698
to O 0 0.008857572451233864
AS B-Disease 0 0.008057248778641224
is O 0 0.005778742488473654
largely O 0 0.012818087823688984
genetically O 0 0.1944950520992279
determined O 0 0.011004584841430187
, O 0 0.0035176784731447697
and O 0 0.0027284743264317513
the O 0 0.0036062337458133698
environmental O 0 0.05854053050279617
trigger O 0 0.3446508049964905
for O 0 0.012656569480895996
the O 0 0.042628027498722076
disease O 1 0.9637405872344971
is O 0 0.02886025235056877
probably O 0 0.05928358808159828
ubiquitous O 0 0.21771304309368134
. O 0 0.03785096853971481

HLA O 1 0.8308598399162292
- O 0 0.13836348056793213
B27 O 0 0.11273264139890671
accounts O 0 0.015350774861872196
for O 0 0.007081968244165182
a O 0 0.006791063584387302
minority O 0 0.014204908162355423
of O 0 0.004334830213338137
the O 0 0.007809114176779985
overall O 0 0.13269942998886108
genetic O 1 0.878186047077179
susceptibility O 1 0.8214445114135742
to O 0 0.013027366250753403
AS B-Disease 0 0.02686094120144844
. O 0 0.02893173322081566

Cell O 1 0.5232776403427124
cycle O 0 0.30455487966537476
- O 0 0.18598391115665436
dependent O 0 0.14199066162109375
colocalization O 0 0.26261189579963684
of O 0 0.015654990449547768
BARD1 O 0 0.4312078654766083
and O 0 0.029938573017716408
BRCA1 O 1 0.9394030570983887
proteins O 0 0.4984543025493622
in O 0 0.02215839922428131
discrete O 0 0.1704292595386505
nuclear O 0 0.06789322942495346
domains O 0 0.2139427810907364
. O 0 0.037488214671611786

Germ O 1 0.6589653491973877
- O 0 0.18557186424732208
line O 0 0.0589941032230854
mutations O 1 0.8079819083213806
of O 0 0.021282846108078957
the O 0 0.09191250056028366
BRCA1 O 1 0.9736089706420898
gene O 1 0.9475793242454529
predispose O 1 0.9188223481178284
women O 0 0.23948854207992554
to O 0 0.046105705201625824
early O 0 0.43875837326049805
- O 1 0.9308082461357117
onset O 1 0.986510694026947
breast B-Disease 1 0.9883559942245483
and I-Disease 1 0.7557328939437866
ovarian I-Disease 1 0.9914101958274841
cancer I-Disease 1 0.9842770099639893
by O 0 0.11350956559181213
compromising O 0 0.4120086133480072
the O 0 0.03741275519132614
genes O 1 0.8712802529335022
presumptive O 1 0.7752609252929688
function O 0 0.23521988093852997
as O 0 0.04039658233523369
a O 0 0.18524052202701569
tumor B-Disease 1 0.9601821303367615
suppressor O 1 0.9122616648674011
. O 0 0.12255362421274185

Although O 0 0.027068622410297394
the O 0 0.015979032963514328
biochemical O 0 0.17071418464183807
properties O 0 0.031539104878902435
of O 0 0.011463840492069721
BRCA1 O 1 0.897000789642334
polypeptides O 0 0.16902221739292145
are O 0 0.004742092918604612
not O 0 0.003292401786893606
understood O 0 0.00647377735003829
, O 0 0.002965527353808284
their O 0 0.00361289968714118
expression O 0 0.028796611353754997
pattern O 0 0.06400089710950851
and O 0 0.006958780810236931
subcellular O 0 0.21078656613826752
localization O 0 0.16628317534923553
suggest O 0 0.03906736895442009
a O 0 0.011883793398737907
role O 0 0.030650213360786438
in O 0 0.023875027894973755
cell O 1 0.5146191120147705
- O 0 0.2970249056816101
cycle O 0 0.48335322737693787
regulation O 0 0.28334948420524597
. O 0 0.049386437982320786

When O 0 0.041997216641902924
resting O 0 0.16343310475349426
cells O 0 0.4846532940864563
are O 0 0.012606730684638023
induced O 0 0.4846642017364502
to O 0 0.007174330297857523
proliferate O 0 0.09308062493801117
, O 0 0.004315974656492472
the O 0 0.004089316353201866
steady O 0 0.02629080042243004
- O 0 0.0367499403655529
state O 0 0.006530525628477335
levels O 0 0.041791997849941254
of O 0 0.011266881600022316
BRCA1 O 1 0.9001880884170532
increase O 0 0.039216119796037674
in O 0 0.008001146838068962
late O 0 0.015287823043763638
G1 O 0 0.33523428440093994
and O 0 0.004811969120055437
reach O 0 0.007434467785060406
a O 0 0.007816273719072342
maximum O 0 0.014688672497868538
during O 0 0.02131376788020134
S O 0 0.12121487408876419
phase O 0 0.15465041995048523
. O 0 0.036174554377794266

Moreover O 0 0.07198237627744675
, O 0 0.01691289246082306
in O 0 0.014257517643272877
S O 0 0.16880184412002563
phase O 0 0.2717670202255249
cells O 1 0.8131918907165527
, O 0 0.05736641585826874
BRCA1 O 1 0.9362977743148804
polypeptides O 0 0.3856191337108612
are O 0 0.01363713014870882
hyperphosphorylated O 0 0.26649415493011475
and O 0 0.010671091265976429
accumulate O 0 0.15470100939273834
into O 0 0.015631627291440964
discrete O 0 0.2324310541152954
subnuclear O 1 0.6401075124740601
foci O 1 0.7731083035469055
termed O 0 0.4852282702922821
" O 0 0.07849252969026566
BRCA1 O 1 0.9222633838653564
nuclear O 0 0.166970357298851
dots O 0 0.497130423784256
. O 0 0.053937673568725586

" O 0 0.07604622095823288
BRCA1 O 1 0.8915897607803345
associates O 0 0.17732246220111847
in O 0 0.0188045185059309
vivo O 0 0.20870673656463623
with O 0 0.013897483237087727
a O 0 0.021882642060518265
structurally O 0 0.44680055975914
related O 0 0.30501484870910645
protein O 1 0.5852887630462646
termed O 0 0.44900205731391907
BARD1 O 1 0.563279926776886
. O 0 0.05695708468556404

Here O 0 0.01324331946671009
we O 0 0.005619461182504892
show O 0 0.005777438171207905
that O 0 0.0033107984345406294
the O 0 0.0034428087528795004
steady O 0 0.014370963908731937
- O 0 0.021974850445985794
state O 0 0.00492819445207715
levels O 0 0.018839510157704353
of O 0 0.0052618300542235374
BARD1 O 0 0.18292079865932465
, O 0 0.00563224358484149
unlike O 0 0.015249989926815033
those O 0 0.005651699844747782
of O 0 0.010397530160844326
BRCA1 O 1 0.9041673541069031
, O 0 0.013823676854372025
remain O 0 0.019798986613750458
relatively O 0 0.04991411790251732
constant O 0 0.08525227755308151
during O 0 0.08094405382871628
cell O 1 0.6832079291343689
cycle O 1 0.7263054251670837
progression O 1 0.8940866589546204
. O 0 0.1055060550570488

However O 0 0.028102684766054153
, O 0 0.017522109672427177
immunostaining O 0 0.08922462165355682
revealed O 0 0.025978464633226395
that O 0 0.01066645048558712
BARD1 O 0 0.30597060918807983
resides O 0 0.09848619252443314
within O 0 0.03766544163227081
BRCA1 O 1 0.8972670435905457
nuclear O 0 0.0442090667784214
dots O 0 0.14833228290081024
during O 0 0.014703406020998955
S O 0 0.05592352896928787
phase O 0 0.03787587955594063
of O 0 0.00477204192429781
the O 0 0.006537405773997307
cell O 0 0.1984494924545288
cycle O 0 0.11481551080942154
, O 0 0.005633258260786533
but O 0 0.003939191810786724
not O 0 0.0037701784167438745
during O 0 0.006738048046827316
the O 0 0.009360695257782936
G1 O 1 0.5164304375648499
phase O 0 0.2042870968580246
. O 0 0.044148560613393784

Nevertheless O 0 0.04806343838572502
, O 0 0.019650503993034363
BARD1 O 0 0.11538838595151901
polypeptides O 0 0.060067519545555115
are O 0 0.0061089699156582355
found O 0 0.005629821680486202
exclusively O 0 0.005075770430266857
in O 0 0.003081662580370903
the O 0 0.003014039248228073
nuclear O 0 0.006372449919581413
fractions O 0 0.009104249067604542
of O 0 0.004178673028945923
both O 0 0.008904773741960526
G1 O 1 0.5635008215904236
- O 0 0.11941400170326233
and O 0 0.015966664999723434
S O 0 0.2881435751914978
- O 0 0.35821688175201416
phase O 1 0.5035313367843628
cells O 1 0.8424733877182007
. O 0 0.08647876977920532

Therefore O 0 0.03245949000120163
, O 0 0.015088285319507122
progression O 0 0.22465208172798157
to O 0 0.006638004910200834
S O 0 0.03832462802529335
phase O 0 0.025825537741184235
is O 0 0.005123179405927658
accompanied O 0 0.007167375180870295
by O 0 0.004041390493512154
the O 0 0.004001039545983076
aggregation O 0 0.07123694568872452
of O 0 0.006944745779037476
nuclear O 0 0.03611241653561592
BARD1 O 0 0.29733651876449585
polypeptides O 0 0.35384541749954224
into O 0 0.07320234179496765
BRCA1 O 1 0.9313475489616394
nuclear O 0 0.1657344251871109
dots O 0 0.4815042018890381
. O 0 0.05740146338939667

This O 0 0.03786154463887215
cell O 0 0.32508161664009094
cycle O 0 0.2701079845428467
- O 0 0.14775265753269196
dependent O 0 0.10521498322486877
colocalization O 0 0.2019573450088501
of O 0 0.014136960729956627
BARD1 O 0 0.4348700940608978
and O 0 0.027058899402618408
BRCA1 O 1 0.9248778820037842
indicates O 0 0.08329571038484573
a O 0 0.012269742786884308
role O 0 0.028413621708750725
for O 0 0.01735522598028183
BARD1 O 1 0.621205747127533
in O 0 0.1868440955877304
BRCA1 O 1 0.973461389541626
- O 1 0.8655504584312439
mediated O 1 0.9443303346633911
tumor B-Disease 1 0.9626506567001343
suppression O 1 0.739824116230011
. O 0 0.1031336635351181

Ethnic O 0 0.05308404937386513
differences O 0 0.04088110476732254
in O 0 0.017953375354409218
the O 0 0.022085022181272507
HFE O 1 0.8007776737213135
codon O 1 0.5544760823249817
282 O 1 0.5085464119911194
( O 0 0.3475966155529022
Cys O 1 0.9066105484962463
/ O 1 0.7881776094436646
Tyr O 1 0.8517771363258362
) O 0 0.1744915246963501
polymorphism O 1 0.5780938863754272
. O 0 0.04639318957924843

Recent O 0 0.050229642540216446
studies O 0 0.04829461872577667
have O 0 0.013199808076024055
shown O 0 0.049081772565841675
that O 0 0.06179942563176155
hereditary B-Disease 1 0.9661741256713867
hemochromatosis I-Disease 1 0.9806561470031738
( O 0 0.46264731884002686
HH B-Disease 1 0.9094519019126892
) O 0 0.03150790557265282
is O 0 0.0046704597771167755
likely O 0 0.008051804266870022
to O 0 0.0029795505106449127
be O 0 0.003868545638397336
caused O 0 0.09615767002105713
by O 0 0.009779313579201698
homozygosity O 0 0.16159850358963013
for O 0 0.008450508117675781
a O 0 0.02734357863664627
Cys282Tyr O 1 0.5847491025924683
mutation O 1 0.8986589908599854
in O 0 0.026098931208252907
the O 0 0.02641860581934452
HFE O 1 0.9089714884757996
gene O 1 0.7435832023620605
located O 0 0.022622788324952126
4 O 0 0.028304340317845345
. O 0 0.022440273314714432

5 O 0 0.09430642426013947
Mb O 0 0.43398305773735046
telomeric O 1 0.6374703049659729
to O 0 0.03788842260837555
HLA O 1 0.8197201490402222
- O 0 0.19030259549617767
A O 0 0.04280165955424309
. O 0 0.037645258009433746

Population O 0 0.03561003506183624
studies O 0 0.02252078615128994
of O 0 0.006690587382763624
this O 0 0.005711162928491831
polymorphism O 0 0.11168551445007324
are O 0 0.004413592163473368
facilitated O 0 0.02191859856247902
by O 0 0.00420573353767395
the O 0 0.0033409802708774805
fact O 0 0.005396588705480099
that O 0 0.00423605227842927
the O 0 0.008350236341357231
Cys282Tyr O 1 0.5119447112083435
mutation O 1 0.899488091468811
creates O 0 0.24742209911346436
a O 0 0.03438310697674751
Rsal O 0 0.38104838132858276
restriction O 0 0.1074303686618805
site O 0 0.02819778211414814
. O 0 0.026579398661851883

We O 0 0.019274268299341202
have O 0 0.01159624569118023
studied O 0 0.01475053746253252
the O 0 0.008648429065942764
codon O 0 0.23199363052845
282 O 0 0.3061734735965729
( O 0 0.23731417953968048
Cys O 1 0.9138338565826416
/ O 1 0.6785844564437866
Tyr O 1 0.7500349879264832
) O 0 0.04969625174999237
polymorphism O 0 0.19552916288375854
in O 0 0.008242678828537464
different O 0 0.010727861896157265
ethnic O 0 0.025890491902828217
groups O 0 0.031555887311697006
. O 0 0.030220817774534225

In O 0 0.01972128637135029
agreement O 0 0.014190451242029667
with O 0 0.007522359024733305
previous O 0 0.00916325580328703
observations O 0 0.01280943863093853
the O 0 0.008502486161887646
Tyr O 1 0.5781306624412537
allele O 1 0.569756805896759
appeared O 0 0.012410517781972885
to O 0 0.0037428648211061954
be O 0 0.004513802006840706
rare O 0 0.05173768848180771
or O 0 0.015096900053322315
absent O 0 0.07888428121805191
in O 0 0.012651986442506313
Asiatic O 0 0.24658820033073425
( O 0 0.04116364195942879
Indian O 0 0.015041201375424862
, O 0 0.007792977150529623
Chinese O 0 0.0184730626642704
) O 0 0.03763657063245773
populations O 0 0.3221314549446106
. O 0 0.036204077303409576

The O 0 0.02261441759765148
highest O 0 0.031014785170555115
allele O 0 0.49056077003479004
frequency O 0 0.06354233622550964
( O 0 0.019037563353776932
7 O 0 0.009723726660013199
. O 0 0.005335422698408365
5 O 0 0.007943478412926197
% O 0 0.015582439489662647
) O 0 0.008440524339675903
was O 0 0.004240525886416435
found O 0 0.006984974257647991
in O 0 0.007637156173586845
Swedes O 0 0.04643702879548073
. O 0 0.023680534213781357

Saamis O 0 0.27048882842063904
( O 0 0.04105104133486748
2 O 0 0.016932811588048935
% O 0 0.016380999237298965
) O 0 0.010433167219161987
and O 0 0.005861843936145306
Mordvinians O 0 0.11462828516960144
( O 0 0.012637151405215263
1 O 0 0.0055083963088691235
. O 0 0.004007603041827679
8 O 0 0.006768254097551107
% O 0 0.013525504618883133
) O 0 0.007293950766324997
had O 0 0.004153231158852577
significantly O 0 0.025806335732340813
lower O 0 0.014868166297674179
frequencies O 0 0.016568560153245926
of O 0 0.0070035201497375965
the O 0 0.01802149787545204
Tyr O 1 0.7561189532279968
allele O 1 0.827497661113739
. O 0 0.07351882755756378

Comparisons O 0 0.05917826667428017
with O 0 0.025527212768793106
allele O 0 0.46127307415008545
frequencies O 0 0.03321247547864914
based O 0 0.011414377950131893
on O 0 0.006620172876864672
prevalence O 1 0.5833002924919128
estimates O 0 0.036618463695049286
of O 0 0.008601401932537556
HH B-Disease 1 0.569907009601593
showed O 0 0.01190764270722866
some O 0 0.005305740982294083
disagreements O 0 0.013608423992991447
with O 0 0.004935771226882935
the O 0 0.00513136200606823
RFLP O 0 0.324779212474823
data O 0 0.011393814347684383
, O 0 0.005832786671817303
particularly O 0 0.01295019593089819
in O 0 0.010193146765232086
Finns O 0 0.10689477622509003
. O 0 0.03617759048938751

The O 0 0.024345824494957924
newly O 0 0.028838636353611946
described O 0 0.04738473519682884
HFE O 1 0.5342112183570862
marker O 0 0.057083386927843094
provides O 0 0.012613179162144661
a O 0 0.0057716998271644115
new O 0 0.003963700961321592
approach O 0 0.0054905530996620655
to O 0 0.0027242815122008324
the O 0 0.0034250987228006124
screening O 0 0.0434148833155632
of O 0 0.0043953051790595055
HH B-Disease 0 0.3739865720272064
as O 0 0.00408936059102416
well O 0 0.0035224156454205513
as O 0 0.0029698447324335575
studies O 0 0.012594959698617458
of O 0 0.0031070983968675137
the O 0 0.005613037850707769
relationship O 0 0.08605043590068817
between O 0 0.02970980294048786
the O 0 0.06371431052684784
HFE O 1 0.9452178478240967
Tyr O 1 0.9283878207206726
allele O 1 0.9131260514259338
and O 0 0.06652333587408066
different O 0 0.2640068531036377
disorders O 1 0.9705426692962646
including O 0 0.47280919551849365
cancer B-Disease 1 0.9585641622543335

Autosomal B-Disease 1 0.933325469493866
dominant I-Disease 1 0.8689233064651489
neurohypophyseal I-Disease 1 0.922855019569397
diabetes I-Disease 1 0.9721865653991699
insipidus I-Disease 1 0.9406964778900146
associated O 0 0.2505001127719879
with O 0 0.03795763477683067
a O 0 0.06022288277745247
missense O 1 0.90171879529953
mutation O 1 0.9437448382377625
encoding O 1 0.7823203206062317
Gly23 O 1 0.8210754990577698
- O 1 0.5579209923744202
- O 1 0.5467014908790588
> O 1 0.7516182065010071
Val O 1 0.6963858008384705
in O 0 0.04860815033316612
neurophysin O 1 0.5249142050743103
II O 0 0.20518021285533905
. O 0 0.04512106627225876

Autosomal B-Disease 1 0.9395434260368347
dominant I-Disease 1 0.8837273716926575
neurohypophyseal I-Disease 1 0.9252254962921143
diabetes I-Disease 1 0.9765052795410156
insipidus I-Disease 1 0.9504066109657288
( O 0 0.43511122465133667
ADNDI B-Disease 1 0.7495678067207336
) O 0 0.09179792553186417
is O 0 0.028566399589180946
an O 0 0.10019448399543762
inherited B-Disease 1 0.9699766039848328
disease I-Disease 1 0.9885522127151489
caused O 1 0.7583438158035278
by O 0 0.08063659071922302
progressive O 1 0.6542441844940186
degeneration O 1 0.9127960205078125
of O 0 0.010124660097062588
the O 0 0.014196102507412434
magnocellular O 1 0.7544816136360168
neurons O 0 0.451973557472229
of O 0 0.006669029127806425
the O 0 0.009439262561500072
hypothalamus O 0 0.44929155707359314
leading O 0 0.024904070422053337
to O 0 0.006012862082570791
decreased O 0 0.12349355965852737
ability O 0 0.026575110852718353
to O 0 0.0054044900462031364
produce O 0 0.03491676598787308
the O 0 0.0199452992528677
hormone O 1 0.8970114588737488
arginine O 1 0.8078628778457642
vasopressin O 1 0.8781865835189819
( O 0 0.23641017079353333
AVP O 1 0.6111341118812561
) O 0 0.07262793183326721
. O 0 0.03803354129195213

Affected O 0 0.13478535413742065
individuals O 0 0.03722938522696495
are O 0 0.009173501282930374
not O 0 0.009401729330420494
symptomatic O 1 0.5252394676208496
at O 0 0.012847929261624813
birth O 0 0.1954774409532547
, O 0 0.011203822679817677
but O 0 0.017979076132178307
usually O 0 0.19588498771190643
develop O 1 0.8232677578926086
diabetes B-Disease 1 0.9854767918586731
insipidus I-Disease 1 0.9555966854095459
at O 0 0.050562288612127304
1 O 0 0.05637591704726219
- O 0 0.18483445048332214
6 O 0 0.04254007712006569
yr O 1 0.5152868032455444
of O 0 0.014069347642362118
age O 0 0.07901754230260849
. O 0 0.036882996559143066

The O 0 0.03486226499080658
genetic O 1 0.6386544704437256
locus O 0 0.3253360986709595
of O 0 0.011480945162475109
the O 0 0.028389757499098778
disease O 1 0.9517408013343811
is O 0 0.017640596255660057
the O 0 0.015169432386755943
AVP O 1 0.6866047978401184
- O 0 0.4470566213130951
neurophysin O 1 0.7111955285072327
II O 0 0.37433376908302307
( O 0 0.19488921761512756
NPII O 1 0.6567755341529846
) O 0 0.11209768056869507
gene O 1 0.6014699935913086
, O 0 0.010680971667170525
and O 0 0.009791621007025242
mutations O 1 0.7794155478477478
that O 0 0.009163178503513336
cause O 0 0.272548645734787
ADNDI B-Disease 0 0.13047221302986145
have O 0 0.0037323336582630873
been O 0 0.0026167957112193108
found O 0 0.0036354961339384317
in O 0 0.002588903531432152
both O 0 0.0028454046696424484
the O 0 0.0031669829040765762
signal O 0 0.02124243788421154
peptide O 0 0.13299725949764252
of O 0 0.004633727949112654
the O 0 0.00897339079529047
prepro O 0 0.4344097673892975
- O 0 0.335970938205719
AVP O 1 0.7269526720046997
- O 0 0.3364484906196594
NPII O 1 0.5667718648910522
precursor O 0 0.34606611728668213
and O 0 0.01243489421904087
within O 0 0.023858897387981415
NPII O 0 0.2909983694553375
itself O 0 0.05436905473470688
. O 0 0.03040362149477005

An O 0 0.028849860653281212
affected O 0 0.06801611930131912
girl O 0 0.0286253709346056
who O 0 0.007524159736931324
presented O 0 0.006686240900307894
at O 0 0.004241544753313065
9 O 0 0.005869301501661539
months O 0 0.006279901601374149
of O 0 0.003253703471273184
age O 0 0.014795713126659393
and O 0 0.004362547770142555
her O 0 0.01215986255556345
similarly O 0 0.09154901653528214
affected O 0 0.1824103146791458
younger O 0 0.08480842411518097
brother O 0 0.01810573600232601
and O 0 0.0030928892083466053
father O 0 0.005336746573448181
were O 0 0.002192938467487693
all O 0 0.0019818234723061323
found O 0 0.0037401115987449884
to O 0 0.0027825692668557167
have O 0 0.00405910424888134
a O 0 0.01775459386408329
novel O 0 0.2988811135292053
missense O 1 0.9253460764884949
mutation O 1 0.9560734033584595
( O 0 0.2395506352186203
G1758 O 1 0.67511385679245
- O 0 0.4219357371330261
- O 0 0.4684896767139435
> O 1 0.752302885055542
T O 1 0.6374629139900208
) O 0 0.03351996839046478
encoding O 0 0.09792637079954147
the O 0 0.010620451532304287
amino O 0 0.377379834651947
acid O 1 0.7235917448997498
substitution O 0 0.4021480679512024
Gly23 O 1 0.7355821132659912
- O 1 0.559173583984375
- O 1 0.5311492085456848
> O 1 0.7476325631141663
Val O 1 0.6652444005012512
within O 0 0.06133868172764778
NPII O 0 0.4249706566333771
. O 0 0.0478743314743042

The O 0 0.041399821639060974
mutation O 1 0.7189157009124756
was O 0 0.0168079175055027
confirmed O 0 0.03095136396586895
by O 0 0.02043602429330349
restriction O 0 0.16143986582756042
endonuclease O 1 0.5747576951980591
analysis O 0 0.0807643011212349
. O 0 0.03160383552312851

A O 0 0.057096000760793686
T1 O 0 0.32626739144325256
- O 0 0.0725892186164856
weighted O 0 0.03180055692791939
magnetic O 0 0.04433747008442879
resonance O 0 0.1010700985789299
imaging O 0 0.11298192292451859
of O 0 0.009081143885850906
the O 0 0.015383104793727398
fathers O 1 0.5482664108276367
pituitary O 1 0.9584593772888184
gland O 1 0.94000244140625
demonstrates O 0 0.46766260266304016
an O 0 0.1589042842388153
attenuated O 1 0.922762930393219
posterior O 1 0.9202857613563538
pituitary O 1 0.9267792701721191
bright O 0 0.29562392830848694
spot O 0 0.11122241616249084
. O 0 0.05149044468998909

This O 0 0.028499500826001167
mutation O 1 0.6030764579772949
may O 0 0.01601216197013855
be O 0 0.005279690958559513
valuable O 0 0.007360413670539856
for O 0 0.005016739945858717
developing O 0 0.030504627153277397
models O 0 0.02287249080836773
of O 0 0.012334962375462055
dominantly B-Disease 1 0.7299308776855469
inherited I-Disease 1 0.8985604643821716
neurodegeneration I-Disease 1 0.9252633452415466
, O 0 0.007784693501889706
as O 0 0.004068257752805948
the O 0 0.0038177836686372757
early O 0 0.014912273734807968
age O 0 0.05260381102561951
of O 0 0.030758580192923546
onset O 1 0.9465872645378113
of O 0 0.0751374214887619
symptoms O 1 0.9708369374275208
suggests O 0 0.22645694017410278
that O 0 0.01301022432744503
this O 0 0.023477278649806976
mutation O 1 0.8699849247932434
may O 0 0.03846737742424011
be O 0 0.005485329311341047
particularly O 0 0.02742120437324047
deleterious O 0 0.40764930844306946
to O 0 0.007979203015565872
the O 0 0.018500356003642082
magnocellular O 1 0.8163307309150696
neuron O 1 0.7000765204429626
. O 0 0.03283822908997536
. O 0 0.03765402361750603

Frequent O 0 0.3466522991657257
inactivation O 0 0.4611639976501465
of O 0 0.053135793656110764
PTEN O 1 0.8756539225578308
/ O 1 0.6251640915870667
MMAC1 O 1 0.6212841868400574
in O 0 0.1302877515554428
primary O 1 0.7762106657028198
prostate B-Disease 1 0.9752904772758484
cancer I-Disease 1 0.9620431065559387
. O 0 0.21327629685401917

Sporadic B-Disease 1 0.8734344840049744
prostate I-Disease 1 0.9600070714950562
carcinoma I-Disease 1 0.949478268623352
is O 0 0.020129868760704994
the O 0 0.00986021850258112
most O 0 0.012796071358025074
common O 0 0.1654684841632843
male B-Disease 0 0.4489009380340576
cancer I-Disease 1 0.9159438014030457
in O 0 0.00603809067979455
the O 0 0.0033804818522185087
Western O 0 0.005583138670772314
world O 0 0.004257052205502987
, O 0 0.002779777394607663
yet O 0 0.003029653336852789
many O 0 0.002108044922351837
of O 0 0.001971486257389188
the O 0 0.003136387327685952
major O 0 0.028886714950203896
genetic O 1 0.5102120637893677
events O 0 0.020862707868218422
involved O 0 0.015039633959531784
in O 0 0.004970704670995474
the O 0 0.006759982090443373
progression O 1 0.5910202860832214
of O 0 0.010384820401668549
this O 0 0.024749161675572395
often O 0 0.20647917687892914
fatal O 1 0.9666570425033569
cancer B-Disease 1 0.9707902073860168
remain O 0 0.03808964416384697
to O 0 0.010119372047483921
be O 0 0.01250525377690792
elucidated O 0 0.29508915543556213
. O 0 0.035768236964941025

Numerous O 0 0.06629981100559235
cytogenetic O 0 0.4878898859024048
and O 0 0.021352244541049004
allelotype O 0 0.28654536604881287
studies O 0 0.05013947933912277
have O 0 0.010159040801227093
reported O 0 0.03235810250043869
frequent O 0 0.07891397923231125
loss O 0 0.07050842046737671
of O 0 0.017311595380306244
heterozygosity O 1 0.7439947128295898
on O 0 0.04078947380185127
chromosomal O 1 0.9471750259399414
arm O 1 0.662605881690979
10q O 1 0.8075695037841797
in O 0 0.29364344477653503
sporadic B-Disease 1 0.9404264688491821
prostate I-Disease 1 0.9840199947357178
cancer I-Disease 1 0.9748163819313049
. O 0 0.2522311806678772

Deletion O 0 0.45343679189682007
mapping O 0 0.06833120435476303
studies O 0 0.03418395295739174
have O 0 0.00798393040895462
unambiguously O 0 0.031110281124711037
identified O 0 0.013505681417882442
a O 0 0.006938098929822445
region O 0 0.013433877378702164
of O 0 0.0063014645129442215
chromosome O 1 0.509959876537323
10q23 O 0 0.07012612372636795
to O 0 0.00415523536503315
be O 0 0.0031116921454668045
the O 0 0.003818137338384986
minimal O 0 0.033984314650297165
area O 0 0.008572624996304512
of O 0 0.008960478939116001
loss O 0 0.09862365573644638
. O 0 0.03863057494163513

A O 0 0.08503982424736023
new O 0 0.194503515958786
tumor B-Disease 1 0.9601669311523438
suppressor O 1 0.9401570558547974
gene O 1 0.903148353099823
, O 0 0.09052114933729172
PTEN O 1 0.9042969942092896
/ O 0 0.3825864791870117
MMAC1 O 0 0.2111111730337143
, O 0 0.007078113500028849
was O 0 0.005030614323914051
isolated O 0 0.035205043852329254
recently O 0 0.0065073114819824696
at O 0 0.0034627995919436216
this O 0 0.002921512583270669
region O 0 0.010473394766449928
of O 0 0.007760271895676851
chromosome O 1 0.7118142247200012
10q23 O 0 0.14122027158737183
and O 0 0.00482597341760993
found O 0 0.006923159584403038
to O 0 0.00344222504645586
be O 0 0.005962750408798456
inactivated O 0 0.23249292373657227
by O 0 0.04966836795210838
mutation O 1 0.93425452709198
in O 0 0.10204026848077774
three O 0 0.42054906487464905
prostate B-Disease 1 0.9880349040031433
cancer I-Disease 1 0.9833735227584839
cell O 1 0.8825949430465698
lines O 0 0.28626593947410583
. O 0 0.07894501835107803

We O 0 0.03523894399404526
screened O 0 0.21317990124225616
80 O 0 0.33978843688964844
prostate B-Disease 1 0.9689578413963318
tumors I-Disease 1 0.9531678557395935
by O 0 0.0518370121717453
microsatellite O 1 0.6611060500144958
analysis O 0 0.046068571507930756
and O 0 0.008059878833591938
found O 0 0.032483335584402084
chromosome O 1 0.6369614005088806
10q23 O 0 0.10253602266311646
to O 0 0.005529975052922964
be O 0 0.005069814156740904
deleted O 0 0.030229736119508743
in O 0 0.01006934605538845
23 O 0 0.03131674975156784
cases O 0 0.18815138936042786
. O 0 0.03634493052959442

We O 0 0.014369479380548
then O 0 0.007800997234880924
proceeded O 0 0.009766743518412113
with O 0 0.005947442725300789
sequence O 0 0.015079651959240437
analysis O 0 0.008918726816773415
of O 0 0.003952755592763424
the O 0 0.005486208479851484
entire O 0 0.06318094581365585
PTEN O 1 0.9075106978416443
/ O 1 0.5087175965309143
MMAC1 O 1 0.5918461680412292
coding O 0 0.409450501203537
region O 0 0.02598186396062374
and O 0 0.0062062726356089115
tested O 0 0.07685466855764389
for O 0 0.011984054930508137
homozygous O 1 0.6666716933250427
deletion O 0 0.49010953307151794
with O 0 0.011231018230319023
new O 0 0.01097422931343317
intragenic O 0 0.2321816384792328
markers O 0 0.09661500155925751
in O 0 0.006304531823843718
these O 0 0.007022254168987274
23 O 0 0.02184545248746872
cases O 0 0.08823166787624359
with O 0 0.01754351705312729
10q23 O 0 0.2790760397911072
loss O 0 0.1351431906223297
of O 0 0.029591653496026993
heterozygosity O 1 0.7454676032066345
. O 0 0.06496409326791763

The O 0 0.014973456971347332
identification O 0 0.013491706922650337
of O 0 0.005971079226583242
the O 0 0.0053116935305297375
second O 0 0.009824900887906551
mutational O 0 0.43195733428001404
event O 0 0.022924238815903664
in O 0 0.008392858318984509
10 O 0 0.013004432432353497
( O 0 0.037899449467659
43 O 0 0.0382210910320282
% O 0 0.12834948301315308
) O 0 0.1894693374633789
tumors B-Disease 1 0.9747985005378723
establishes O 1 0.7921538352966309
PTEN O 1 0.9352140426635742
/ O 0 0.4427719712257385
MMAC1 O 0 0.20367389917373657
as O 0 0.0060324473306536674
a O 0 0.00639387359842658
main O 0 0.011973140761256218
inactivation O 0 0.22886808216571808
target O 0 0.021903730928897858
of O 0 0.012299974448978901
10q O 1 0.558955192565918
loss O 0 0.4792809784412384
in O 0 0.2527996301651001
sporadic B-Disease 1 0.9412611722946167
prostate I-Disease 1 0.9884741902351379
cancer I-Disease 1 0.9810413718223572
. O 0 0.1465817093849182
. O 0 0.07523904740810394

Risk O 1 0.6390780806541443
reversals O 0 0.35767409205436707
in O 0 0.04545769467949867
predictive O 1 0.6996039152145386
testing O 0 0.48150476813316345
for O 0 0.22778186202049255
Huntington B-Disease 1 0.9518125653266907
disease I-Disease 1 0.9694417119026184
. O 0 0.15592820942401886

The O 0 0.026189101859927177
first O 0 0.021609485149383545
predictive O 0 0.48109251260757446
testing O 0 0.31174030900001526
for O 0 0.14156240224838257
Huntington B-Disease 1 0.9644662141799927
disease I-Disease 1 0.9808128476142883
( O 0 0.15447723865509033
HD B-Disease 0 0.21430626511573792
) O 0 0.009981208480894566
was O 0 0.0035080790985375643
based O 0 0.0036815509665757418
on O 0 0.002514132298529148
analysis O 0 0.008289786987006664
of O 0 0.0055290814489126205
linked O 0 0.36648502945899963
polymorphic O 1 0.8373411297798157
DNA O 0 0.4126809537410736
markers O 0 0.0892297774553299
to O 0 0.004718454089015722
estimate O 0 0.014133306220173836
the O 0 0.005203261040151119
likelihood O 0 0.06389079988002777
of O 0 0.00839716475456953
inheriting O 0 0.2986072897911072
the O 0 0.02049868181347847
mutation O 1 0.8486158847808838
for O 0 0.02588740363717079
HD B-Disease 0 0.292924165725708
. O 0 0.035400208085775375

Limits O 0 0.030360816046595573
to O 0 0.011083208955824375
accuracy O 0 0.014141886495053768
included O 0 0.008620986714959145
recombination O 0 0.15112286806106567
between O 0 0.00899430736899376
the O 0 0.006308431271463633
DNA O 0 0.1539427638053894
markers O 0 0.07865071296691895
and O 0 0.005683985538780689
the O 0 0.009671193547546864
mutation O 1 0.8210054636001587
, O 0 0.0112993735820055
pedigree O 0 0.16552598774433136
structure O 0 0.018342314288020134
, O 0 0.004111899062991142
and O 0 0.0035151508636772633
whether O 0 0.008783454075455666
DNA O 0 0.09575902670621872
samples O 0 0.01682695746421814
were O 0 0.003815671894699335
available O 0 0.005486976355314255
from O 0 0.006700792815536261
family O 0 0.02361501194536686
members O 0 0.014123847708106041
. O 0 0.023254647850990295

With O 0 0.017966629937291145
direct O 0 0.016578709706664085
tests O 0 0.014753545634448528
for O 0 0.005997350439429283
the O 0 0.00585287855938077
HD B-Disease 0 0.1686282604932785
mutation O 0 0.4682200849056244
, O 0 0.003360769711434841
we O 0 0.0019391976529732347
have O 0 0.002087113680317998
assessed O 0 0.0044970135204494
the O 0 0.0019315663957968354
accuracy O 0 0.004322081338614225
of O 0 0.0025687830056995153
results O 0 0.010514847934246063
obtained O 0 0.007562066428363323
by O 0 0.005311152432113886
linkage O 0 0.11924003809690475
approaches O 0 0.020847031846642494
when O 0 0.004082096740603447
requested O 0 0.00447988323867321
to O 0 0.0026277194265276194
do O 0 0.0029397655744105577
so O 0 0.0029709122609347105
by O 0 0.003492050338536501
the O 0 0.004711141809821129
test O 0 0.0363839752972126
individuals O 0 0.08263922482728958
. O 0 0.025880103930830956

For O 0 0.015417905524373055
six O 0 0.0107297133654356
such O 0 0.007096136454492807
individuals O 0 0.01108646485954523
, O 0 0.003982617985457182
there O 0 0.003401057096198201
was O 0 0.0039984737522900105
significant O 0 0.013790018856525421
disparity O 0 0.09266392141580582
between O 0 0.010952885262668133
the O 0 0.010777238756418228
tests O 0 0.09813526272773743
. O 0 0.032928742468357086

Three O 0 0.01935463212430477
went O 0 0.012382140383124352
from O 0 0.008656342513859272
a O 0 0.01175101101398468
decreased O 0 0.19265587627887726
risk O 0 0.22846993803977966
to O 0 0.004099300596863031
an O 0 0.007263781037181616
increased O 0 0.044432252645492554
risk O 0 0.30895063281059265
, O 0 0.0038159892428666353
while O 0 0.0028667903970927
in O 0 0.0029170974157750607
another O 0 0.003951251972466707
three O 0 0.0045946030877530575
the O 0 0.009592358022928238
risk O 0 0.4269177317619324
was O 0 0.0193636417388916
decreased O 0 0.31493625044822693
. O 0 0.04189136624336243

Knowledge O 0 0.021496979519724846
of O 0 0.008392274379730225
the O 0 0.006117791868746281
potential O 0 0.010838352143764496
reasons O 0 0.006491796113550663
for O 0 0.002774217864498496
these O 0 0.0028433948755264282
changes O 0 0.0050562042742967606
in O 0 0.0027407724410295486
results O 0 0.00547790015116334
and O 0 0.0024560322053730488
impact O 0 0.008499388583004475
of O 0 0.0035850431304425
these O 0 0.011162088252604008
risk O 0 0.42291370034217834
reversals O 0 0.14046038687229156
on O 0 0.004565604496747255
both O 0 0.01616849936544895
patients O 1 0.581198513507843
and O 0 0.004569961689412594
the O 0 0.004762906115502119
counseling O 0 0.13042685389518738
team O 0 0.004158567171543837
can O 0 0.004110679030418396
assist O 0 0.005994309205561876
in O 0 0.002229575300589204
the O 0 0.002148184459656477
development O 0 0.005132603459060192
of O 0 0.0024961624294519424
strategies O 0 0.023736918345093727
for O 0 0.0031006280332803726
the O 0 0.004295295104384422
prevention O 0 0.2712273895740509
and O 0 0.002983126789331436
, O 0 0.0026508651208132505
where O 0 0.002422560006380081
necessary O 0 0.004178351256996393
, O 0 0.0031229020096361637
management O 0 0.010991559363901615
of O 0 0.0033886784221976995
a O 0 0.012002973817288876
risk O 0 0.3522396385669708
reversal O 0 0.11124584823846817
in O 0 0.008530018851161003
any O 0 0.013403563760221004
predictive O 0 0.38236692547798157
testing O 0 0.10999466478824615
program O 0 0.032411955296993256
. O 0 0.015166467987000942
. O 0 0.023741215467453003

A O 0 0.049770839512348175
novel O 0 0.1264229416847229
common O 0 0.22348472476005554
missense O 1 0.8402615189552307
mutation O 1 0.8625189065933228
G301C O 0 0.20290221273899078
in O 0 0.012773004360496998
the O 0 0.010880968533456326
N O 0 0.12741388380527496
- O 0 0.2861483693122864
acetylgalactosamine O 1 0.6042482852935791
- O 0 0.39935216307640076
6 O 0 0.18605457246303558
- O 1 0.6135184168815613
sulfate O 1 0.942268431186676
sulfatase O 1 0.9434269666671753
gene O 1 0.9081949591636658
in O 0 0.10803671926259995
mucopolysaccharidosis B-Disease 1 0.7299985289573669
IVA I-Disease 1 0.8438411355018616
. O 0 0.08984038233757019

Mucopolysaccharidosis B-Disease 1 0.7711969017982483
IVA I-Disease 1 0.8379606008529663
( O 0 0.21392306685447693
MPS B-Disease 0 0.3083111643791199
IVA I-Disease 1 0.8915364146232605
) O 0 0.14251136779785156
is O 0 0.075318343937397
an O 0 0.3031521439552307
autosomal B-Disease 1 0.9881048202514648
recessive I-Disease 1 0.9864016175270081
lysosomal I-Disease 1 0.9736652374267578
storage I-Disease 1 0.8148720264434814
disorder I-Disease 1 0.9796751737594604
caused O 1 0.6750609278678894
by O 0 0.05596393719315529
a O 0 0.10197845846414566
genetic B-Disease 1 0.9436748623847961
defect I-Disease 1 0.8946852087974548
in O 0 0.051655836403369904
N O 0 0.3201885223388672
- O 0 0.3590470552444458
acetylgalactosamine O 1 0.6212575435638428
- O 0 0.368233859539032
6 O 0 0.16298459470272064
- O 1 0.581149697303772
sulfate O 1 0.9407291412353516
sulfatase O 1 0.9340867400169373
( O 0 0.24077634513378143
GALNS O 0 0.49869436025619507
) O 0 0.057575833052396774
. O 0 0.033058080822229385

In O 0 0.020075388252735138
previous O 0 0.015945089980959892
studies O 0 0.018712520599365234
, O 0 0.004055158235132694
we O 0 0.002491358434781432
have O 0 0.0028624865226447582
found O 0 0.004937383346259594
two O 0 0.005878994707018137
common O 0 0.10590258240699768
mutations O 1 0.8254322409629822
in O 0 0.016882475465536118
Caucasians O 0 0.2909848093986511
and O 0 0.0074852099642157555
Japanese O 0 0.013105573132634163
, O 0 0.010265398770570755
respectively O 0 0.025346608832478523
. O 0 0.024828065186738968

To O 0 0.02484748139977455
characterize O 0 0.05934559553861618
the O 0 0.014089090749621391
mutational O 0 0.4179750084877014
spectrum O 0 0.04777529463171959
in O 0 0.006962674204260111
various O 0 0.007234801538288593
ethnic O 0 0.022869916632771492
groups O 0 0.01981177367269993
, O 0 0.013004211708903313
mutations O 1 0.6985422968864441
in O 0 0.009418941102921963
the O 0 0.012445016764104366
GALNS O 1 0.5141496658325195
gene O 1 0.7195901870727539
in O 0 0.02657235413789749
Colombian O 0 0.13907335698604584
MPS B-Disease 0 0.3899492919445038
IVA I-Disease 1 0.9406136870384216
patients O 1 0.8542650938034058
were O 0 0.008045352064073086
investigated O 0 0.0434982031583786
, O 0 0.004924220498651266
and O 0 0.005376710556447506
genetic O 0 0.35172533988952637
backgrounds O 0 0.017623353749513626
were O 0 0.0034197550266981125
extensively O 0 0.011055463925004005
analyzed O 0 0.013767074793577194
to O 0 0.003475250443443656
identify O 0 0.017064277082681656
racial O 0 0.028867490589618683
origin O 0 0.01863281987607479
, O 0 0.004948985762894154
based O 0 0.007254885043948889
on O 0 0.0077268504537642
mitochondrial O 1 0.733189046382904
DNA O 1 0.6246348023414612
( O 0 0.15479178726673126
mtDNA O 1 0.6752017736434937
) O 0 0.08131847530603409
lineages O 1 0.577627420425415
. O 0 0.04361528158187866

Three O 0 0.04190346226096153
novel O 0 0.2374073565006256
missense O 1 0.833271324634552
mutations O 1 0.8265132904052734
never O 0 0.018209613859653473
identified O 0 0.018643975257873535
previously O 0 0.006626023445278406
in O 0 0.003377307439222932
other O 0 0.0035311346873641014
populations O 0 0.03621014580130577
and O 0 0.0028380530420690775
found O 0 0.0038286640774458647
in O 0 0.003019115887582302
16 O 0 0.0045512523502111435
out O 0 0.003633125452324748
of O 0 0.0048294696025550365
19 O 0 0.019302301108837128
Colombian O 0 0.07100114226341248
MPS B-Disease 0 0.3164237439632416
IVA I-Disease 1 0.9221218824386597
unrelated O 1 0.6330224871635437
alleles O 1 0.79291170835495
account O 0 0.03469724953174591
for O 0 0.018039381131529808
84 O 0 0.07857023179531097
. O 0 0.037175726145505905

2 O 0 0.0280347540974617
% O 0 0.017300264909863472
of O 0 0.008099340833723545
the O 0 0.008541409857571125
alleles O 0 0.425505667924881
in O 0 0.01010570116341114
this O 0 0.010085044428706169
study O 0 0.05397995561361313
. O 0 0.029028115794062614

The O 0 0.03563593700528145
G301C O 0 0.2401205152273178
and O 0 0.024849342182278633
S162F O 0 0.39982151985168457
mutations O 1 0.7433637976646423
account O 0 0.02550451271235943
for O 0 0.015083646401762962
68 O 0 0.04640443995594978
. O 0 0.029072659090161324

4 O 0 0.049253180623054504
% O 0 0.03343735262751579
and O 0 0.01900656893849373
10 O 0 0.025319281965494156
. O 0 0.026497315615415573

5 O 0 0.030399389564990997
% O 0 0.02360776625573635
of O 0 0.012417689897119999
mutations O 1 0.632634162902832
, O 0 0.007290119770914316
respectively O 0 0.00810982845723629
, O 0 0.004003418143838644
whereas O 0 0.009767609648406506
the O 0 0.0034798244014382362
remaining O 0 0.006279901601374149
F69V O 0 0.08018257468938828
is O 0 0.004567702766507864
limited O 0 0.006146265659481287
to O 0 0.0048652649857103825
a O 0 0.009501940570771694
single O 0 0.04403696209192276
allele O 1 0.6826042532920837
. O 0 0.04888053610920906

The O 0 0.029029419645667076
skewed O 0 0.23212574422359467
prevalence O 1 0.5226548910140991
of O 0 0.011193985119462013
G301C O 0 0.13337257504463196
in O 0 0.008853729814291
only O 0 0.008180818520486355
Colombian O 0 0.10598359256982803
patients O 1 0.8198046684265137
and O 0 0.02349843643605709
haplotype O 1 0.7850971817970276
analysis O 0 0.048397768288850784
by O 0 0.014017617329955101
restriction O 0 0.0914619117975235
fragment O 0 0.17852889001369476
length O 0 0.10370183736085892
polymorphisms O 1 0.6874487400054932
in O 0 0.008603732101619244
the O 0 0.01211844477802515
GALNS O 1 0.545793890953064
gene O 1 0.6723029613494873
suggest O 0 0.05448698252439499
that O 0 0.008815199136734009
G301C O 0 0.21105091273784637
originated O 0 0.05520706996321678
from O 0 0.010164896957576275
a O 0 0.018077386543154716
common O 0 0.1093023344874382
ancestor O 0 0.3401029407978058
. O 0 0.053330011665821075

Investigation O 0 0.03525444120168686
of O 0 0.010424288921058178
the O 0 0.009624752216041088
genetic O 0 0.33109286427497864
background O 0 0.015740612521767616
by O 0 0.0060087768360972404
means O 0 0.007927617989480495
of O 0 0.0060795326717197895
mtDNA O 0 0.48364415764808655
lineages O 0 0.31323450803756714
indicate O 0 0.01970045268535614
that O 0 0.0036142747849226
all O 0 0.0031255881767719984
our O 0 0.007084822282195091
patients O 0 0.4932878613471985
are O 0 0.0047949692234396935
probably O 0 0.00843135453760624
of O 0 0.006139779929071665
native O 0 0.02903934195637703
American O 0 0.03611183166503906
descent O 0 0.21446086466312408

Low O 0 0.12200066447257996
frequency O 0 0.13289673626422882
of O 0 0.06263827532529831
BRCA1 O 1 0.9477343559265137
germline O 1 0.9460648894309998
mutations O 1 0.9331077337265015
in O 0 0.0967627689242363
45 O 0 0.22642916440963745
German O 1 0.7164361476898193
breast B-Disease 1 0.9812703132629395
/ I-Disease 1 0.9601089358329773
ovarian I-Disease 1 0.984391450881958
cancer I-Disease 1 0.9736957550048828
families O 0 0.447494775056839
. O 0 0.12208518385887146

In O 0 0.023172888904809952
this O 0 0.012675800360739231
study O 0 0.018189895898103714
we O 0 0.009030080400407314
investigated O 0 0.08023270219564438
45 O 0 0.1091260239481926
German O 1 0.6156920194625854
breast B-Disease 1 0.9868440628051758
/ I-Disease 1 0.9714349508285522
ovarian I-Disease 1 0.9907281398773193
cancer I-Disease 1 0.9854685664176941
families O 1 0.5107026696205139
for O 0 0.15095378458499908
germline O 1 0.9605637192726135
mutations O 1 0.9540107846260071
in O 0 0.0675245076417923
the O 0 0.08366521447896957
BRCA1 O 1 0.9582919478416443
gene O 1 0.9068984985351562
. O 0 0.12329506874084473

We O 0 0.024828242138028145
identified O 0 0.04779191315174103
four O 0 0.04229869693517685
germline O 1 0.94035404920578
mutations O 1 0.9460415244102478
in O 0 0.10487142950296402
three O 0 0.34005486965179443
breast B-Disease 1 0.9872352480888367
cancer I-Disease 1 0.9812699556350708
families O 0 0.20404988527297974
and O 0 0.024825770407915115
in O 0 0.08951164036989212
one O 0 0.3736768960952759
breast B-Disease 1 0.9912433624267578
- I-Disease 1 0.97138512134552
ovarian I-Disease 1 0.993556797504425
cancer I-Disease 1 0.9877365827560425
family O 0 0.22837187349796295
. O 0 0.008984943851828575
among O 0 0.008404882624745369
these O 0 0.004378423094749451
were O 0 0.0037846912164241076
one O 0 0.010755132883787155
frameshift O 1 0.8577553629875183
mutation O 1 0.8381305932998657
, O 0 0.009592413902282715
one O 0 0.009495825506746769
nonsense O 0 0.13483144342899323
mutation O 1 0.7329256534576416
, O 0 0.007650726940482855
one O 0 0.006602854002267122
novel O 0 0.0870932936668396
splice O 1 0.541775643825531
site O 0 0.07282288372516632
mutation O 1 0.8224007487297058
, O 0 0.010366386733949184
and O 0 0.008210198022425175
one O 0 0.02187960594892502
missense O 1 0.8536838889122009
mutation O 1 0.9138527512550354
. O 0 0.08312047272920609

The O 0 0.039730772376060486
missense O 1 0.7394614815711975
mutation O 1 0.722798228263855
was O 0 0.011280753649771214
also O 0 0.007487909402698278
found O 0 0.010065088048577309
in O 0 0.009960426948964596
2 O 0 0.018427357077598572
. O 0 0.020796747878193855

8 O 0 0.028998130932450294
% O 0 0.016051694750785828
of O 0 0.005731817334890366
the O 0 0.004239100497215986
general O 0 0.005195664241909981
population O 0 0.009276783093810081
, O 0 0.004146515857428312
suggesting O 0 0.01194339245557785
that O 0 0.0038297793362289667
it O 0 0.004423144273459911
is O 0 0.00949971005320549
not O 0 0.024009784683585167
disease O 1 0.9528511166572571
associated O 0 0.1994647979736328
. O 0 0.0421370305120945

The O 0 0.024718524888157845
average O 0 0.0502975732088089
age O 0 0.13425683975219727
of O 0 0.12249496579170227
disease O 1 0.9803428053855896
onset O 1 0.9507953524589539
in O 0 0.038501374423503876
those O 0 0.05335545167326927
families O 0 0.3382228910923004
harbouring O 1 0.8758648633956909
causative O 1 0.9268143773078918
mutations O 1 0.916560173034668
was O 0 0.02085076831281185
between O 0 0.030572718009352684
32 O 0 0.04885508492588997
. O 0 0.03311040624976158

3 O 0 0.05518173426389694
and O 0 0.027429688721895218
37 O 0 0.04365445300936699
. O 0 0.030841602012515068

4 O 0 0.02920130267739296
years O 0 0.015697887167334557
, O 0 0.008143490180373192
whereas O 0 0.01464285422116518
the O 0 0.0063099623657763
family O 0 0.0343620665371418
harbouring O 0 0.21930646896362305
the O 0 0.020403467118740082
missense O 1 0.8475800156593323
mutation O 1 0.8313730955123901
had O 0 0.010232904925942421
an O 0 0.006602319423109293
average O 0 0.015471519902348518
age O 0 0.030454767867922783
of O 0 0.01041912566870451
onset O 1 0.8022107481956482
of O 0 0.013145112432539463
51 O 0 0.06650113314390182
. O 0 0.032280609011650085

2 O 0 0.06281892210245132
years O 0 0.04840657114982605
. O 0 0.04635023698210716

These O 0 0.020451586693525314
findings O 0 0.02652117796242237
show O 0 0.015848008915781975
that O 0 0.013845836743712425
BRCA1 O 1 0.8541024923324585
is O 0 0.014253806322813034
implicated O 0 0.12531986832618713
in O 0 0.00843798741698265
a O 0 0.010978500358760357
small O 0 0.02468285895884037
fraction O 0 0.24708712100982666
of O 0 0.2891903519630432
breast B-Disease 1 0.9891546368598938
/ I-Disease 1 0.9723319411277771
ovarian I-Disease 1 0.992219865322113
cancer I-Disease 1 0.9834994673728943
families O 0 0.2059020698070526
suggesting O 0 0.10393725335597992
the O 0 0.011197802610695362
involvement O 0 0.10227523744106293
of O 0 0.013942946679890156
another O 0 0.14769867062568665
susceptibility O 1 0.9580680131912231
gene O 1 0.928602933883667
( O 0 0.23136784136295319
s O 0 0.3463221490383148
) O 0 0.13285750150680542

Paternal O 1 0.822513997554779
transmission O 1 0.8583532571792603
of O 1 0.5390840172767639
congenital B-Disease 1 0.9734141826629639
myotonic I-Disease 1 0.9547850489616394
dystrophy I-Disease 1 0.9474441409111023
. O 0 0.26043257117271423

We O 0 0.021352391690015793
report O 0 0.01873684488236904
a O 0 0.01779940351843834
rare O 0 0.1296902447938919
case O 0 0.06333047151565552
of O 0 0.07148399204015732
paternally O 1 0.9494946002960205
transmitted O 1 0.9759477972984314
congenital B-Disease 1 0.9898973703384399
myotonic I-Disease 1 0.9824935793876648
dystrophy I-Disease 1 0.9801082015037537
( O 1 0.8210778832435608
DM B-Disease 1 0.9322341084480286
) O 0 0.243922621011734
. O 0 0.06153089553117752

The O 0 0.02533675730228424
proband O 0 0.08596959710121155
is O 0 0.011983242817223072
a O 0 0.0110092144459486
23 O 0 0.01284189522266388
year O 0 0.012048634700477123
old O 0 0.034630075097084045
, O 0 0.03994927182793617
mentally B-Disease 1 0.7810949087142944
retarded I-Disease 1 0.893139123916626
male O 1 0.7950961589813232
who O 0 0.4019944667816162
suffers O 1 0.9622219800949097
severe O 1 0.9592382907867432
muscular B-Disease 1 0.9505795836448669
weakness I-Disease 1 0.8338116407394409
. O 0 0.1437167078256607

He O 0 0.025225523859262466
presented O 0 0.03211360424757004
with O 0 0.06527335196733475
respiratory O 1 0.9568424224853516
and O 0 0.022574758157134056
feeding O 0 0.3864900469779968
difficulties O 0 0.2611636519432068
at O 0 0.03873619809746742
birth O 0 0.4197428524494171
. O 0 0.06168597564101219

His O 0 0.04471588134765625
two O 0 0.041414808481931686
sibs O 1 0.8380478024482727
suffer O 1 0.8062304258346558
from O 0 0.19633786380290985
childhood O 1 0.9096659421920776
onset O 1 0.9510469436645508
DM B-Disease 1 0.9202166795730591
. O 0 0.1872149109840393

Their O 0 0.019418135285377502
late O 0 0.017450788989663124
father O 0 0.01346132718026638
had O 0 0.006731563247740269
the O 0 0.006176447961479425
adult O 0 0.1029093787074089
type O 0 0.13771334290504456
of O 0 0.02093023806810379
DM B-Disease 1 0.8920300602912903
, O 0 0.0176237802952528
with O 0 0.024868836626410484
onset O 1 0.8288132548332214
around O 0 0.015043477527797222
30 O 0 0.022196859121322632
years O 0 0.022402683272957802
. O 0 0.02717285044491291

Only O 0 0.017672240734100342
six O 0 0.013939039781689644
other O 0 0.00926424004137516
cases O 0 0.055117275565862656
of O 0 0.016366131603717804
paternal O 1 0.7701685428619385
transmission O 1 0.8763129115104675
of O 0 0.2491658627986908
congenital B-Disease 1 0.9856675267219543
DM I-Disease 1 0.9411344528198242
have O 0 0.026349762454628944
been O 0 0.018530916422605515
reported O 0 0.057636842131614685
recently O 0 0.047540370374917984
. O 0 0.03266172856092453

We O 0 0.01738191954791546
review O 0 0.017819728702306747
the O 0 0.010270346887409687
sex O 0 0.13883139193058014
related O 0 0.1533856838941574
effects O 0 0.3604050278663635
on O 0 0.02117488719522953
transmission O 1 0.7132411003112793
of O 0 0.19468806684017181
congenital B-Disease 1 0.9776297807693481
DM I-Disease 1 0.9419334530830383
. O 0 0.20363622903823853

Decreased O 0 0.36940711736679077
fertility O 0 0.4933668076992035
of O 0 0.021003885194659233
males O 0 0.3093574047088623
with O 0 0.06215843930840492
adult O 1 0.6643105745315552
onset O 1 0.9596513509750366
DM B-Disease 1 0.9109811782836914
and O 0 0.01381809450685978
contraction O 0 0.205475315451622
of O 0 0.005952039267867804
the O 0 0.005539752077311277
repeat O 0 0.09094561636447906
upon O 0 0.01054040901362896
male O 0 0.16206182539463043
transmission O 0 0.2928076982498169
contribute O 0 0.038597188889980316
to O 0 0.004297094419598579
the O 0 0.004510265775024891
almost O 0 0.013559476472437382
absent O 0 0.17248161137104034
occurrence O 0 0.4136199653148651
of O 0 0.03529855236411095
paternal O 1 0.8487465977668762
transmission O 1 0.8994138240814209
of O 0 0.34682461619377136
congenital B-Disease 1 0.9814452528953552
DM I-Disease 1 0.9489750266075134
. O 0 0.2258707582950592

Also O 0 0.01628923788666725
the O 0 0.009370251558721066
fathers O 0 0.019147345796227455
of O 0 0.005416698753833771
the O 0 0.006802381481975317
reported O 0 0.06776147335767746
congenitally O 1 0.6826684474945068
affected O 0 0.23200909793376923
children O 0 0.041593484580516815
showed O 0 0.011543428525328636
, O 0 0.0042517599649727345
on O 0 0.003476556856185198
average O 0 0.012373216450214386
, O 0 0.008642837405204773
shorter O 0 0.1371944546699524
CTG O 1 0.5639945268630981
repeat O 0 0.27138641476631165
lengths O 0 0.14008381962776184
and O 0 0.02070830576121807
hence O 0 0.2624819278717041
less O 0 0.39415499567985535
severe O 1 0.9695134162902832
clinical O 1 0.9667379856109619
symptoms O 1 0.9655492901802063
than O 0 0.031502872705459595
the O 0 0.020080406218767166
mothers O 1 0.531170129776001
of O 0 0.03854532912373543
children O 1 0.5145425200462341
with O 0 0.4834541082382202
congenital B-Disease 1 0.9805650115013123
DM I-Disease 1 0.9451795220375061
. O 0 0.23446331918239594

We O 0 0.024000000208616257
conclude O 0 0.03693901374936104
that O 0 0.01571274735033512
paternal O 1 0.5615139007568359
transmission O 1 0.7613089084625244
of O 0 0.19878120720386505
congenital B-Disease 1 0.9870145320892334
DM I-Disease 1 0.9520713090896606
is O 0 0.05798472836613655
rare O 0 0.19384939968585968
and O 0 0.015131359919905663
preferentially O 0 0.3789549171924591
occurs O 0 0.3584650158882141
with O 0 0.04093132168054581
onset O 1 0.9072593450546265
of O 0 0.026074571534991264
DM B-Disease 1 0.8496522903442383
past O 0 0.016096055507659912
30 O 0 0.011755331419408321
years O 0 0.008054455742239952
in O 0 0.006135006435215473
the O 0 0.006173574831336737
father O 0 0.021134689450263977
. O 0 0.012229323387145996
. O 0 0.02058866247534752

The O 0 0.11316671222448349
RB1 O 1 0.9008822441101074
gene O 1 0.8900446891784668
mutation O 1 0.8653391599655151
in O 0 0.030680593103170395
a O 0 0.04496670514345169
child O 0 0.4070074260234833
with O 0 0.21444536745548248
ectopic B-Disease 1 0.9562696814537048
intracranial I-Disease 1 0.9542968273162842
retinoblastoma I-Disease 1 0.918993353843689
. O 0 0.1285398155450821

The O 0 0.11078167706727982
RB1 O 1 0.9036498665809631
gene O 1 0.868373453617096
mutation O 1 0.7648587226867676
was O 0 0.013711190782487392
investigated O 0 0.02440693974494934
in O 0 0.00870443694293499
a O 0 0.013639016076922417
child O 0 0.21086454391479492
with O 0 0.11961261183023453
ectopic B-Disease 1 0.9699137210845947
intracranial I-Disease 1 0.9659309387207031
retinoblastoma I-Disease 1 0.9233866930007935
using O 0 0.04568776115775108
DNA O 0 0.20837733149528503
obtained O 0 0.01168200932443142
from O 0 0.005830409005284309
both O 0 0.007110795471817255
the O 0 0.012864788994193077
pineal B-Disease 1 0.7911078929901123
and I-Disease 0 0.08818111568689346
retinal I-Disease 1 0.9616613984107971
tumours I-Disease 1 0.950577974319458
of O 0 0.031800735741853714
the O 0 0.037758007645606995
patient O 1 0.8091912865638733
. O 0 0.07904484868049622

A O 0 0.04446697607636452
nonsense O 0 0.12307427078485489
mutation O 1 0.6618024110794067
in O 0 0.02087501809000969
exon O 0 0.21736891567707062
17 O 0 0.03320886567234993
( O 0 0.039060190320014954
codon O 0 0.16054196655750275
556 O 0 0.10282513499259949
) O 0 0.010847681201994419
of O 0 0.005102504510432482
the O 0 0.009998181834816933
RB1 O 1 0.8431742191314697
gene O 0 0.4516163766384125
was O 0 0.005098552443087101
found O 0 0.00446910597383976
to O 0 0.0024504074826836586
be O 0 0.0025941256899386644
present O 0 0.006738625932484865
homozygously O 0 0.07463902235031128
in O 0 0.004785776138305664
both O 0 0.006950973533093929
the O 0 0.014687850140035152
retinal B-Disease 1 0.8669673800468445
and I-Disease 0 0.021725624799728394
the I-Disease 0 0.04290120676159859
pineal I-Disease 1 0.8979729413986206
tumours I-Disease 1 0.9396747350692749
. O 0 0.11944372951984406

The O 0 0.0195967648178339
same O 0 0.01863349974155426
mutation O 0 0.41790470480918884
was O 0 0.00792508665472269
present O 0 0.009763570502400398
heterozygously O 0 0.061100609600543976
in O 0 0.004864729940891266
the O 0 0.004332254640758038
DNA O 0 0.07719875872135162
from O 0 0.004314829595386982
the O 0 0.003585244296118617
constitutional O 0 0.019853366538882256
cells O 0 0.29008105397224426
of O 0 0.00433135824277997
the O 0 0.0071228849701583385
patient O 0 0.33041203022003174
, O 0 0.005758482497185469
proving O 0 0.0169694647192955
it O 0 0.0030125551857054234
to O 0 0.003123354399576783
be O 0 0.004020042717456818
of O 0 0.007762107532471418
germline O 1 0.7371900081634521
origin O 0 0.102824866771698
. O 0 0.0437639057636261

The O 0 0.023280145600438118
initial O 0 0.05076930299401283
mutation O 1 0.5290331840515137
was O 0 0.008118167519569397
shown O 0 0.007716981694102287
to O 0 0.004259882960468531
have O 0 0.0048502725549042225
occurred O 0 0.015292518772184849
in O 0 0.007931924425065517
the O 0 0.013785247690975666
paternally O 1 0.7352318167686462
derived O 1 0.5406086444854736
RB1 O 1 0.9167899489402771
allele O 1 0.8726438879966736
. O 0 0.10355032980442047

The O 0 0.026857202872633934
mutation O 0 0.48662638664245605
is O 0 0.008166322484612465
in O 0 0.004640914034098387
an O 0 0.0032818815670907497
area O 0 0.003361073322594166
of O 0 0.0026294493582099676
the O 0 0.004232577979564667
gene O 0 0.3391995131969452
that O 0 0.005707874428480864
encodes O 0 0.0916864275932312
the O 0 0.006610725075006485
protein O 0 0.25563812255859375
- O 0 0.07679649442434311
binding O 0 0.0606662891805172
region O 0 0.012165446765720844
known O 0 0.006730915978550911
as O 0 0.003069924423471093
the O 0 0.0036737166810780764
pocket O 0 0.03969639912247658
region O 0 0.008408857509493828
and O 0 0.002646746812388301
has O 0 0.0036797919310629368
been O 0 0.004370398819446564
detected O 0 0.07405306398868561
in O 0 0.00524843530729413
other O 0 0.008602171204984188
cases O 0 0.09802952408790588
of O 0 0.023039981722831726
retinoblastoma B-Disease 1 0.8780944347381592
. O 0 0.04104141891002655
. O 0 0.03925008326768875

Low O 0 0.05935414507985115
levels O 0 0.03732774779200554
of O 0 0.0122541394084692
beta O 0 0.12934452295303345
hexosaminidase O 0 0.18229928612709045
A O 0 0.01895972713828087
in O 0 0.016869641840457916
healthy O 0 0.4168374836444855
individuals O 0 0.08423864841461182
with O 0 0.03553064912557602
apparent O 1 0.5311325788497925
deficiency O 1 0.9622938632965088
of O 0 0.01873696781694889
this O 0 0.026750244200229645
enzyme O 1 0.6411712765693665
. O 0 0.05259153991937637

Appreciable O 0 0.3054148554801941
beta O 0 0.20697034895420074
hexosaminidase O 0 0.13550300896167755
A O 0 0.022059857845306396
( O 0 0.020753033459186554
hex O 0 0.026334594935178757
A O 0 0.011261303909122944
) O 0 0.011201181448996067
activity O 0 0.01377849467098713
has O 0 0.005812751594930887
been O 0 0.008652182295918465
detected O 0 0.2929444909095764
in O 0 0.06699807941913605
cultured O 1 0.8980975151062012
skin O 1 0.9788984060287476
fibroblasts O 1 0.965683102607727
and O 0 0.3579866886138916
melanoma B-Disease 1 0.9857300519943237
tissue O 1 0.9354553818702698
from O 0 0.09279144555330276
healthy O 1 0.6305115222930908
individuals O 0 0.11150339990854263
previously O 0 0.027851145714521408
reported O 0 0.03750370442867279
as O 0 0.008111745119094849
having O 0 0.06156670302152634
deficiency B-Disease 1 0.9476136565208435
of I-Disease 0 0.007560298778116703
hex I-Disease 0 0.06208305060863495
A I-Disease 0 0.01500899437814951
activity O 0 0.03297404572367668
indistinguishable O 0 0.09158041328191757
from O 0 0.010320098139345646
that O 0 0.010294944979250431
of O 0 0.04740423709154129
patients O 1 0.9546186327934265
with O 0 0.4645547568798065
Tay B-Disease 1 0.9801585078239441
- I-Disease 1 0.9505894780158997
Sachs I-Disease 1 0.9728547930717468
disease I-Disease 1 0.9835548996925354
( O 1 0.5653775930404663
TSD B-Disease 1 0.9159275889396667
) O 0 0.14500784873962402
. O 0 0.04627217724919319

Identification O 0 0.044784095138311386
and O 0 0.016689296811819077
quantitation O 0 0.0829877182841301
of O 0 0.010335671715438366
hex O 0 0.0268720556050539
A O 0 0.011474442668259144
, O 0 0.009330542758107185
amounting O 0 0.020227311179041862
to O 0 0.009690897539258003
3 O 0 0.02120462991297245
. O 0 0.023625187575817108

5 O 0 0.05755871534347534
% O 0 0.051265545189380646
- O 0 0.09097988903522491
6 O 0 0.040010932832956314
. O 0 0.03080120123922825

9 O 0 0.02855905517935753
% O 0 0.016294604167342186
of O 0 0.007835419848561287
total O 0 0.009572817012667656
beta O 0 0.1107463389635086
hexosaminidase O 0 0.14255891740322113
activity O 0 0.016899283975362778
, O 0 0.0044609494507312775
has O 0 0.003658907487988472
been O 0 0.0036831009201705456
obtained O 0 0.007055692840367556
by O 0 0.013688492588698864
cellulose O 1 0.5781635046005249
acetate O 1 0.7652588486671448
gel O 1 0.8331761956214905
electrophoresis O 1 0.8085457682609558
, O 0 0.0533643513917923
DEAE O 1 0.6367097496986389
- O 0 0.4340902268886566
cellulose O 1 0.7216763496398926
ion O 0 0.4947732985019684
- O 0 0.26329636573791504
exchange O 0 0.054913479834795
chromatography O 0 0.39607569575309753
, O 0 0.02407112717628479
radial O 1 0.5650583505630493
immunodiffusion O 0 0.32034802436828613
, O 0 0.014862671494483948
and O 0 0.014617374166846275
radioimmunoassay O 0 0.2638549506664276
. O 0 0.031847063452005386

Previous O 0 0.03541135415434837
family O 0 0.034338995814323425
studies O 0 0.024176346138119698
suggested O 0 0.011180846020579338
that O 0 0.0046266913414001465
these O 0 0.004320091102272272
individuals O 0 0.01776006445288658
may O 0 0.010670507326722145
be O 0 0.0040980312041938305
compound O 0 0.05108597129583359
heterozygotes O 0 0.41341811418533325
for O 0 0.006920780520886183
the O 0 0.008323642425239086
common O 0 0.20736046135425568
mutant O 1 0.8289667367935181
TSD B-Disease 1 0.9395961165428162
gene O 1 0.8215548992156982
and O 0 0.015581810846924782
a O 0 0.033803362399339676
rare O 0 0.34774649143218994
( O 0 0.2158810943365097
allelic O 1 0.8331582546234131
) O 0 0.19614098966121674
mutant O 1 0.8122945427894592
gene O 1 0.8613766431808472
. O 0 0.06370794773101807

Thus O 0 0.03095250204205513
, O 0 0.01295207254588604
the O 0 0.009265263564884663
postulated O 0 0.17205004394054413
rate O 0 0.10898178070783615
mutant O 1 0.539244532585144
gene O 0 0.4479658305644989
appears O 0 0.019143562763929367
to O 0 0.0038371158298105
code O 0 0.005975026171654463
for O 0 0.002892524003982544
the O 0 0.002820770489051938
expression O 0 0.010366933420300484
of O 0 0.0035439510829746723
low O 0 0.01599074713885784
amounts O 0 0.016420487314462662
of O 0 0.007098108064383268
hex O 0 0.05708810314536095
A O 0 0.023692263290286064
. O 0 0.027543537318706512

Heterozygotes O 0 0.2746107876300812
for O 0 0.015938937664031982
the O 0 0.011483640410006046
rare O 0 0.08869367837905884
mutant O 0 0.30017635226249695
may O 0 0.020955927670001984
be O 0 0.005975278094410896
indistinguishable O 0 0.10496588796377182
from O 0 0.01667698286473751
heterozygotes O 1 0.5156196355819702
for O 0 0.01199328526854515
the O 0 0.01668766885995865
common O 0 0.31253287196159363
TSD B-Disease 1 0.8942945599555969
mutant O 1 0.7904140949249268
. O 0 0.09099148958921432

However O 0 0.023260673508048058
, O 0 0.011988652870059013
direct O 0 0.014044570736587048
visualization O 0 0.031026877462863922
and O 0 0.005833344999700785
quantitation O 0 0.07668719440698624
of O 0 0.005288428161293268
hex O 0 0.016496704891324043
A O 0 0.0063509345054626465
by O 0 0.004436634946614504
the O 0 0.003249906236305833
methods O 0 0.01948201283812523
described O 0 0.05751965939998627
may O 0 0.09524668753147125
prevent O 0 0.3262658417224884
false O 0 0.15091878175735474
- O 0 0.41838693618774414
positive O 1 0.6150715351104736
prenatal O 1 0.9749423861503601
diagnosis O 1 0.9577108025550842
of O 0 0.04092838242650032
TSD B-Disease 1 0.8540398478507996
in O 0 0.027790183201432228
fetuses O 1 0.6185934543609619
having O 0 0.018394986167550087
the O 0 0.00734204426407814
incomplete O 0 0.0689035952091217
hex B-Disease 0 0.15354706346988678
A I-Disease 0 0.05916091054677963
deficiency I-Disease 1 0.9493404030799866
of O 0 0.005552857182919979
the O 0 0.007092729676514864
type O 0 0.07656516879796982
described O 0 0.016950948163866997
in O 0 0.00559604587033391
the O 0 0.007318221963942051
four O 0 0.019239025190472603
healthy O 1 0.562178373336792
individuals O 0 0.2795383632183075

The O 0 0.18044747412204742
tumor B-Disease 1 0.9454125761985779
suppressor O 1 0.9193071722984314
gene O 1 0.9022310972213745
Smad4 O 1 0.7207556962966919
/ O 0 0.4161268174648285
Dpc4 O 0 0.1852210909128189
is O 0 0.008341760374605656
required O 0 0.008757607080042362
for O 0 0.0058618891052901745
gastrulation O 0 0.24079908430576324
and O 0 0.005537309683859348
later O 0 0.005941187962889671
for O 0 0.007122608833014965
anterior O 0 0.4665715992450714
development O 0 0.0235541220754385
of O 0 0.008940493687987328
the O 0 0.025046331807971
mouse O 1 0.7866613268852234
embryo O 1 0.8192805051803589
. O 0 0.08501681685447693

Mutations O 1 0.7955102920532227
in O 0 0.030305789783596992
the O 0 0.036625321954488754
SMAD4 O 1 0.8416240811347961
/ O 1 0.8436765670776367
DPC4 O 1 0.9329317808151245
tumor B-Disease 1 0.9748183488845825
suppressor O 1 0.9328503012657166
gene O 1 0.6584237813949585
, O 0 0.008115922100841999
a O 0 0.007427384611219168
key O 0 0.010670890100300312
signal O 0 0.028669754043221474
transducer O 0 0.13393206894397736
in O 0 0.008660939522087574
most O 0 0.015244081616401672
TGFbeta O 1 0.5762205123901367
- O 0 0.2880321443080902
related O 0 0.213477224111557
pathways O 0 0.4569258689880371
, O 0 0.0057630157098174095
are O 0 0.00383130949921906
involved O 0 0.007739547174423933
in O 0 0.0051998598501086235
50 O 0 0.014735314063727856
% O 0 0.08134384453296661
of O 0 0.07643196731805801
pancreatic B-Disease 1 0.9729675650596619
cancers I-Disease 1 0.9681085348129272
. O 0 0.13246773183345795

Homozygous O 1 0.7982203960418701
Smad4 O 1 0.766606330871582
mutant O 1 0.8280779719352722
mice O 1 0.8659318089485168
die O 0 0.3340303897857666
before O 0 0.022987915202975273
day O 0 0.02205142192542553
7 O 0 0.03177812322974205
. O 0 0.029350679367780685

5 O 0 0.06887805461883545
of O 0 0.04435737058520317
embryogenesis O 0 0.3808189332485199
. O 0 0.05828336253762245

Mutant O 0 0.3353744447231293
embryos O 0 0.11534945666790009
have O 0 0.013783718459308147
reduced O 0 0.018975451588630676
size O 0 0.010974938981235027
, O 0 0.005766076967120171
fail O 0 0.03001401200890541
to O 0 0.005074184387922287
gastrulate O 0 0.09339171648025513
or O 0 0.011227608658373356
express O 0 0.01711122691631317
a O 0 0.014171759597957134
mesodermal O 1 0.6124929785728455
marker O 0 0.11763665825128555
, O 0 0.009711116552352905
and O 0 0.007551145274192095
show O 0 0.03491595387458801
abnormal O 1 0.8515591621398926
visceral O 1 0.7383568286895752
endoderm O 1 0.7661219835281372
development O 0 0.13505037128925323
. O 0 0.05413196608424187

Growth B-Disease 0 0.45833322405815125
retardation I-Disease 1 0.8161721229553223
of O 0 0.019715595990419388
the O 0 0.019998716190457344
Smad4 O 1 0.618287205696106
- O 0 0.4363253712654114
deficient O 1 0.8221887946128845
embryos O 0 0.46133658289909363
results O 0 0.08192469924688339
from O 0 0.02108948491513729
reduced O 0 0.17481708526611328
cell O 1 0.5095570683479309
proliferation O 0 0.31168001890182495
rather O 0 0.020310139283537865
than O 0 0.019534882158041
increased O 0 0.14781714975833893
apoptosis O 1 0.7847377061843872
. O 0 0.053037986159324646

Aggregation O 0 0.25671613216400146
of O 0 0.03435856103897095
mutant O 1 0.6524815559387207
Smad4 O 1 0.6916804909706116
ES O 1 0.5769358277320862
cells O 1 0.5630285739898682
with O 0 0.03042336367070675
wild O 0 0.19141212105751038
- O 0 0.38188058137893677
type O 0 0.4534105658531189
tetraploid O 1 0.765745997428894
morulae O 1 0.6003679633140564
rescues O 0 0.45911699533462524
the O 0 0.057513926178216934
gastrulation B-Disease 1 0.8767561912536621
defect I-Disease 1 0.8709983825683594
. O 0 0.08847378194332123

These O 0 0.017975114285945892
results O 0 0.01767430268228054
indicate O 0 0.013960474170744419
that O 0 0.005193796008825302
Smad4 O 0 0.04134013503789902
is O 0 0.004536518827080727
initially O 0 0.004563611000776291
required O 0 0.003813725896179676
for O 0 0.002417796291410923
the O 0 0.00294955144636333
differentiation O 0 0.054089561104774475
of O 0 0.003204822540283203
the O 0 0.005104838404804468
visceral O 0 0.2857416570186615
endoderm O 0 0.4166783094406128
and O 0 0.004871788900345564
that O 0 0.004532563034445047
the O 0 0.00925805326551199
gastrulation B-Disease 1 0.7902425527572632
defect I-Disease 1 0.6925529837608337
in O 0 0.01228165440261364
the O 0 0.012111859396100044
epiblast O 1 0.6448462009429932
is O 0 0.015775807201862335
secondary O 0 0.07088683545589447
and O 0 0.00995497964322567
non O 0 0.08830996602773666
- O 0 0.2592873275279999
cell O 0 0.446615070104599
autonomous O 0 0.10065452754497528
. O 0 0.04160745069384575

Rescued O 0 0.1797010898590088
embryos O 0 0.4097605347633362
show O 0 0.09035805612802505
severe O 1 0.8526371121406555
anterior O 1 0.7662924528121948
truncations O 0 0.31890544295310974
, O 0 0.010971905663609505
indicating O 0 0.017287321388721466
a O 0 0.006043124012649059
second O 0 0.0056785522028803825
important O 0 0.006197640206664801
role O 0 0.011928558349609375
for O 0 0.009404287673532963
Smad4 O 0 0.3363214135169983
in O 0 0.0451529398560524
anterior O 1 0.8758378624916077
patterning O 1 0.797792375087738
during O 0 0.1341700702905655
embryogenesis O 1 0.7089725136756897
. O 0 0.07830528914928436

Prevalence O 1 0.7661495208740234
of O 0 0.04480867460370064
p16 O 1 0.806369423866272
and O 0 0.06611616164445877
CDK4 O 1 0.8404638767242432
germline O 1 0.9390431642532349
mutations O 1 0.9343348741531372
in O 0 0.10981616377830505
48 O 0 0.43457481265068054
melanoma B-Disease 1 0.9736320376396179
- O 1 0.6366240382194519
prone O 1 0.6322756409645081
families O 0 0.08534030616283417
in O 0 0.022098759189248085
France O 0 0.07144071906805038
. O 0 0.0327727310359478

The O 0 0.06346780806779861
French O 0 0.4545823335647583
Familial B-Disease 1 0.9448641538619995
Melanoma I-Disease 1 0.947964608669281
Study O 0 0.29682523012161255
Group O 0 0.09150570631027222
. O 0 0.04634437710046768

Germline O 1 0.8456282615661621
mutations O 1 0.7289368510246277
in O 0 0.01890752650797367
the O 0 0.012279768474400043
p16 O 1 0.5216278433799744
and O 0 0.013873168267309666
CDK4 O 0 0.3800371289253235
genes O 0 0.35705551505088806
have O 0 0.006541712675243616
been O 0 0.004890433978289366
reported O 0 0.011327928863465786
in O 0 0.003617049427703023
a O 0 0.007190873846411705
subset O 0 0.12122685462236404
of O 0 0.032261621206998825
melanoma B-Disease 1 0.9737244844436646
pedigrees O 0 0.4386984407901764
, O 0 0.00857350043952465
but O 0 0.004843676928430796
their O 0 0.0060977814719080925
prevalence O 1 0.6354624629020691
is O 0 0.007291165180504322
not O 0 0.0050367130897939205
well O 0 0.007584103848785162
known O 0 0.02596161887049675
. O 0 0.025565797463059425

We O 0 0.020835069939494133
searched O 0 0.02488577365875244
for O 0 0.012960500083863735
such O 0 0.02942844107747078
germline O 1 0.9023978114128113
mutations O 1 0.8744443655014038
in O 0 0.02222370356321335
48 O 0 0.08982759714126587
French O 0 0.29510432481765747
melanoma B-Disease 1 0.9733101725578308
- O 0 0.3853335678577423
prone O 0 0.3620811998844147
families O 0 0.018235627561807632
selected O 0 0.005690939724445343
according O 0 0.004037937615066767
to O 0 0.0026307229418307543
two O 0 0.0028450964018702507
major O 0 0.006474688183516264
criteria O 0 0.011174796149134636
families O 0 0.00899876281619072
with O 0 0.0032932059839367867
at O 0 0.0030887858010828495
least O 0 0.0041741374880075455
three O 0 0.005016801878809929
affected O 0 0.0760161355137825
members O 0 0.007634612265974283
( O 0 0.03740905970335007
n O 0 0.06525705009698868
= O 0 0.10777709633111954
20 O 0 0.01050472166389227
) O 0 0.009729541838169098
or O 0 0.005544083192944527
families O 0 0.007199651096016169
with O 0 0.002657799981534481
two O 0 0.0027901676949113607
affected O 0 0.024404384195804596
members O 0 0.002689572051167488
, O 0 0.0018724484834820032
one O 0 0.001549632172100246
of O 0 0.0017000229563564062
them O 0 0.002274650614708662
affected O 0 0.02154531702399254
before O 0 0.002506871009245515
the O 0 0.0024575861170887947
age O 0 0.008156070485711098
of O 0 0.0033574888948351145
50 O 0 0.012343271635472775
( O 0 0.03077080100774765
n O 0 0.0609709769487381
= O 0 0.1437372863292694
28 O 0 0.015455670654773712
) O 0 0.008090534247457981
, O 0 0.0031654315534979105
and O 0 0.0029590334743261337
one O 0 0.004356895107775927
additional O 0 0.013216800056397915
minor O 0 0.11673448979854584
criterion O 0 0.15405137836933136
. O 0 0.027828367426991463

Sixteen O 0 0.05876452848315239
different O 0 0.056916847825050354
p16 O 1 0.8604967594146729
germline O 1 0.898044228553772
mutations O 1 0.69190514087677
were O 0 0.008191728964447975
found O 0 0.008590851910412312
in O 0 0.005382930394262075
21 O 0 0.008730408735573292
families O 0 0.01495606079697609
, O 0 0.005427113268524408
while O 0 0.0073316567577421665
one O 0 0.019918667152523994
germline O 1 0.9402101039886475
mutation O 1 0.9208233952522278
, O 0 0.017562182620167732
Arg24His O 0 0.21802662312984467
, O 0 0.006711183115839958
was O 0 0.00606396421790123
detected O 0 0.09860004484653473
in O 0 0.008197813294827938
the O 0 0.014839420095086098
CDK4 O 1 0.6173924803733826
gene O 1 0.8455523252487183
. O 0 0.0642121434211731

The O 0 0.024802958592772484
frequency O 0 0.04689386114478111
of O 0 0.01874518394470215
p16 O 1 0.8795565366744995
gene O 1 0.8673781156539917
mutation O 1 0.6961249113082886
in O 0 0.008004017174243927
our O 0 0.005599910859018564
sample O 0 0.017645016312599182
( O 0 0.01554544921964407
44 O 0 0.010363861918449402
% O 0 0.012809282168745995
) O 0 0.005619036965072155
is O 0 0.0023323092609643936
among O 0 0.0029514888301491737
the O 0 0.0022775016259402037
highest O 0 0.006168784108012915
rates O 0 0.02409514971077442
yet O 0 0.0074828327633440495
reported O 0 0.011824257671833038
and O 0 0.0035004799719899893
the O 0 0.0070282225497066975
CDK4 O 1 0.5443407297134399
mutation O 1 0.8101518750190735
is O 0 0.009673723950982094
the O 0 0.005854776594787836
second O 0 0.04085410758852959
mutation O 1 0.9114053845405579
detected O 0 0.37710773944854736
in O 0 0.015594681724905968
this O 0 0.021469883620738983
gene O 1 0.7259584665298462
worldwide O 0 0.1825764775276184
. O 0 0.04003426060080528

In O 0 0.020165514200925827
summary O 0 0.019863154739141464
, O 0 0.0066065238788723946
our O 0 0.005355489905923605
results O 0 0.008396191522479057
show O 0 0.00821253564208746
frequent O 0 0.030459076166152954
involvement O 0 0.02172980085015297
of O 0 0.005642727017402649
the O 0 0.021106848493218422
p16 O 1 0.9305433034896851
gene O 1 0.9315354228019714
in O 0 0.19562897086143494
familial B-Disease 1 0.9728479385375977
melanoma I-Disease 1 0.9696685075759888
and O 0 0.011417267844080925
confirm O 0 0.012428290210664272
the O 0 0.0046429079957306385
role O 0 0.00969931110739708
of O 0 0.005016290117055178
the O 0 0.011470289900898933
CDK4 O 1 0.6944780945777893
gene O 1 0.8547918200492859
as O 0 0.0491916723549366
a O 0 0.3007809817790985
melanoma B-Disease 1 0.9805245399475098
- O 1 0.8239728212356567
predisposing O 1 0.9390602111816406
gene O 1 0.8875197172164917
. O 0 0.04841938242316246
. O 0 0.043932605534791946

Progression O 1 0.548402726650238
of O 0 0.03364242985844612
somatic O 1 0.6791619658470154
CTG O 1 0.5950703024864197
repeat O 0 0.2954966425895691
length O 0 0.08639413118362427
heterogeneity O 0 0.41629543900489807
in O 0 0.02092435397207737
the O 0 0.039952490478754044
blood O 1 0.8941207528114319
cells O 1 0.9282128810882568
of O 0 0.3877376914024353
myotonic B-Disease 1 0.9732289910316467
dystrophy I-Disease 1 0.9792408347129822
patients O 1 0.9497237801551819
. O 0 0.2650628685951233

The O 0 0.03872767463326454
genetic O 1 0.6084844470024109
basis O 0 0.046281229704618454
of O 0 0.10775309056043625
myotonic B-Disease 1 0.9682320952415466
dystrophy I-Disease 1 0.9762778878211975
( O 0 0.4149773120880127
DM B-Disease 1 0.9040643572807312
) O 0 0.02264847420156002
is O 0 0.005112126003950834
the O 0 0.004218725953251123
expansion O 0 0.008826980367302895
of O 0 0.004370242822915316
an O 0 0.008521554060280323
unstable O 0 0.4077500104904175
CTG O 0 0.4076681435108185
repeat O 0 0.07427565008401871
in O 0 0.005395857151597738
the O 0 0.005174560472369194
34 O 0 0.016707194969058037
UTR O 0 0.21057084202766418
of O 0 0.008646441623568535
the O 0 0.03555014729499817
DM B-Disease 1 0.9516496658325195
protein O 1 0.8916609287261963
kinase O 1 0.9054484963417053
gene O 1 0.7920127511024475
on O 0 0.024232830852270126
chromosome O 1 0.8018602132797241
19 O 0 0.061816319823265076
. O 0 0.04215075448155403

One O 0 0.013233478181064129
of O 0 0.0069237276911735535
the O 0 0.005039449781179428
principal O 0 0.007523636799305677
features O 0 0.006821738090366125
of O 0 0.003947874065488577
the O 0 0.013359470292925835
DM B-Disease 1 0.941556990146637
mutation O 1 0.8478643298149109
is O 0 0.010189673863351345
an O 0 0.006119424942880869
extraordinarily O 0 0.04639175906777382
high O 0 0.009854521602392197
level O 0 0.010265011340379715
of O 0 0.007600994314998388
somatic O 1 0.7244715094566345
mosaicism O 1 0.7352226972579956
, O 0 0.008688761852681637
due O 0 0.008994418196380138
to O 0 0.0029308954253792763
an O 0 0.0037205067928880453
extremely O 0 0.012545700185000896
high O 0 0.008609037846326828
degree O 0 0.018246563151478767
of O 0 0.007060879375785589
somatic O 1 0.5814622640609741
instability O 0 0.2925598919391632
both O 0 0.007085845340043306
within O 0 0.007037559058517218
and O 0 0.0049772607162594795
between O 0 0.011711561121046543
different O 0 0.03142407163977623
tissues O 1 0.7106242775917053
. O 0 0.06518996506929398

This O 0 0.022131484001874924
instability O 0 0.10754335671663284
appears O 0 0.015795210376381874
to O 0 0.004674551077187061
be O 0 0.0031805129256099463
biased O 0 0.0072160703130066395
towards O 0 0.004136420786380768
further O 0 0.0036747725680470467
expansion O 0 0.005419623106718063
and O 0 0.002508175792172551
continuous O 0 0.006321938242763281
throughout O 0 0.0031201906967908144
the O 0 0.002015068894252181
life O 0 0.0036491998471319675
of O 0 0.0021949491929262877
an O 0 0.002876364393159747
individual O 0 0.0074064903892576694
, O 0 0.0027230926789343357
features O 0 0.0037056857254356146
that O 0 0.0019505973905324936
could O 0 0.0024205888621509075
be O 0 0.0019944438245147467
associated O 0 0.007775248493999243
with O 0 0.003115384839475155
the O 0 0.004050285089761019
progressive O 0 0.15913383662700653
nature O 0 0.04906969889998436
of O 0 0.018249597400426865
the O 0 0.08227013051509857
disease O 1 0.9688283205032349
. O 0 0.11260565370321274

Although O 0 0.039198003709316254
increasing O 0 0.050299130380153656
measured O 0 0.06083115190267563
allele O 1 0.6067367792129517
size O 0 0.04043141007423401
between O 0 0.051713354885578156
patients O 1 0.7128675580024719
clearly O 0 0.025807274505496025
correlates O 0 0.16058997809886932
with O 0 0.01012173667550087
an O 0 0.012430878356099129
increased O 0 0.12034367769956589
severity O 1 0.6429170370101929
of O 0 0.025555497035384178
symptoms O 1 0.909981906414032
and O 0 0.006987974047660828
an O 0 0.006210909225046635
earlier O 0 0.010306651704013348
age O 0 0.023999013006687164
of O 0 0.010168765671551228
onset O 1 0.7978038191795349
, O 0 0.00586118595674634
this O 0 0.004158977419137955
correlation O 0 0.06308366358280182
is O 0 0.0036930092610418797
not O 0 0.0027469461783766747
precise O 0 0.008913793601095676
and O 0 0.0037958291359245777
measured O 0 0.02969440445303917
allele O 0 0.346976637840271
length O 0 0.015444625169038773
cannot O 0 0.005634017288684845
be O 0 0.0023874330800026655
used O 0 0.002707024337723851
as O 0 0.0026836846955120564
an O 0 0.00368291512131691
accurate O 0 0.01478575635701418
predictor O 0 0.27468419075012207
of O 0 0.00856591947376728
age O 0 0.07311990112066269
of O 0 0.02772635780274868
onset O 1 0.9210829138755798
. O 0 0.09896393120288849

In O 0 0.01839444413781166
order O 0 0.01116715744137764
to O 0 0.006304791662842035
further O 0 0.008659088984131813
characterize O 0 0.03818601369857788
the O 0 0.0078263645991683
dynamics O 0 0.14044195413589478
of O 0 0.03093438781797886
DM B-Disease 1 0.9399147033691406
CTG O 1 0.7670516967773438
repeat O 0 0.4716254472732544
somatic O 1 0.6992434859275818
instability O 0 0.29728347063064575
, O 0 0.005931153427809477
we O 0 0.0033885205630213022
have O 0 0.003899906063452363
studied O 0 0.010277275927364826
repeat O 0 0.06349852681159973
length O 0 0.020103996619582176
changes O 0 0.01630677655339241
over O 0 0.007236764300614595
time O 0 0.013200603425502777
in O 0 0.06536159664392471
111 O 1 0.7596022486686707
myotonic B-Disease 1 0.9841606020927429
dystrophy I-Disease 1 0.9888871312141418
patients O 1 0.9666240215301514
with O 0 0.15673458576202393
varying O 1 0.5187374353408813
clinical O 1 0.9256236553192139
severity O 1 0.7438966035842896
and O 0 0.02056182362139225
CTG O 0 0.38927507400512695
repeat O 0 0.08241063356399536
size O 0 0.011137028224766254
over O 0 0.005905786529183388
time O 0 0.005356290377676487
intervals O 0 0.018189506605267525
of O 0 0.005046043545007706
1 O 0 0.014595597051084042
- O 0 0.06090090796351433
7 O 0 0.021312236785888672
years O 0 0.025098105892539024
. O 0 0.02632729336619377

We O 0 0.014286115765571594
have O 0 0.007160869427025318
found O 0 0.007390731945633888
a O 0 0.005634738598018885
direct O 0 0.010569257661700249
progression O 0 0.1860681176185608
of O 0 0.0037930714897811413
the O 0 0.0038461044896394014
size O 0 0.010905207134783268
heterogeneity O 0 0.11102355271577835
over O 0 0.005594135727733374
time O 0 0.004966729786247015
related O 0 0.021731264889240265
to O 0 0.00393309211358428
initial O 0 0.02513614483177662
CTG O 0 0.295579731464386
repeat O 0 0.06280798465013504
size O 0 0.007824595086276531
and O 0 0.0031544696539640427
the O 0 0.002838170388713479
time O 0 0.003826547646895051
interval O 0 0.016199961304664612
and O 0 0.003724554320797324
always O 0 0.005605991929769516
biased O 0 0.013009550981223583
towards O 0 0.009265613742172718
further O 0 0.014887680299580097
expansion O 0 0.03381120041012764
. O 0 0.02735103666782379

Attempts O 0 0.0365881621837616
to O 0 0.01139612402766943
mathematically O 0 0.018979281187057495
model O 0 0.01134976465255022
the O 0 0.005188890732824802
dynamics O 0 0.019274616613984108
have O 0 0.004098004661500454
proved O 0 0.00806254893541336
only O 0 0.00354669033549726
partially O 0 0.03721996024250984
successful O 0 0.018944915384054184
suggesting O 0 0.03383229672908783
that O 0 0.0046033188700675964
individual O 0 0.035313524305820465
specific O 0 0.06964091211557388
genetic O 1 0.7488703727722168
and O 0 0.01377058494836092
/ O 0 0.19241414964199066
or O 0 0.012339221313595772
environmental O 0 0.027115143835544586
factors O 0 0.05146319791674614
also O 0 0.003959347028285265
play O 0 0.005192384589463472
a O 0 0.008205807767808437
role O 0 0.023886464536190033
in O 0 0.024835757911205292
somatic O 1 0.755325436592102
mosaicism O 1 0.869134783744812
. O 0 0.03567073494195938
. O 0 0.03335626795887947

Aspartylglucosaminuria B-Disease 0 0.329194575548172
among O 0 0.05802709236741066
Palestinian O 0 0.06356598436832428
Arabs O 0 0.07455507665872574
. O 0 0.04207713529467583

Aspartylglucosaminuria B-Disease 1 0.7230358123779297
( O 0 0.2059493064880371
AGU B-Disease 1 0.8248220682144165
) O 0 0.04039602726697922
is O 0 0.013318239711225033
a O 0 0.021087074652314186
rare O 0 0.41329145431518555
disorder B-Disease 1 0.9592365622520447
of I-Disease 0 0.055131684988737106
glycoprotein I-Disease 1 0.8657737970352173
metabolism I-Disease 1 0.8919280171394348
caused O 1 0.5337236523628235
by O 0 0.04187430068850517
the O 0 0.037461813539266586
deficiency B-Disease 1 0.9679107069969177
of I-Disease 0 0.020717382431030273
the I-Disease 0 0.061585936695337296
lysosomal I-Disease 1 0.9388818740844727
enzyme I-Disease 1 0.8964682221412659
aspartylglucosaminidase I-Disease 1 0.7404980659484863
( O 0 0.17828772962093353
AGA O 0 0.4081369638442993
) O 0 0.0556219220161438
. O 0 0.030258554965257645

AGU B-Disease 1 0.8260655403137207
is O 0 0.06931964308023453
inherited O 1 0.6607500910758972
as O 0 0.049798645079135895
an O 0 0.2547633945941925
autosomal O 1 0.9821165204048157
recessive O 1 0.9787418842315674
trait O 1 0.8031278252601624
and O 0 0.012417186051607132
occurs O 0 0.08715196698904037
with O 0 0.005822415463626385
a O 0 0.005898898467421532
high O 0 0.00984740536659956
frequency O 0 0.018970772624015808
in O 0 0.004023634362965822
Finland O 0 0.009343020617961884
because O 0 0.0064562358893454075
of O 0 0.004665662534534931
a O 0 0.011109547689557076
founder O 0 0.06538772583007812
effect O 0 0.1312297284603119
. O 0 0.03346777334809303

While O 0 0.024622304365038872
very O 0 0.0196684543043375
few O 0 0.027937276288866997
patients O 1 0.677152693271637
with O 0 0.01984276995062828
AGU B-Disease 1 0.7165728807449341
have O 0 0.0063367681577801704
been O 0 0.004939463920891285
reported O 0 0.010609829798340797
from O 0 0.006760039832442999
non O 0 0.04354562610387802
- O 0 0.07724981755018234
Finnish O 0 0.06628116965293884
origin O 0 0.0742373988032341
, O 0 0.020254401490092278
we O 0 0.025223305448889732
diagnosed O 1 0.9722121357917786
the O 0 0.08835616707801819
disorder O 1 0.9734932780265808
in O 0 0.05670629441738129
8 O 0 0.17911396920681
patients O 1 0.9025299549102783
originating O 0 0.14684569835662842
from O 0 0.015579121187329292
3 O 0 0.03231583535671234
unrelated O 0 0.165638729929924
families O 0 0.01468584779649973
, O 0 0.003523567458614707
all O 0 0.003005625680088997
Palestinian O 0 0.009013070724904537
Arabs O 0 0.013385006226599216
from O 0 0.004668753128498793
the O 0 0.004133638925850391
region O 0 0.01061549223959446
of O 0 0.006666243076324463
Jerusalem O 0 0.02443505823612213
. O 0 0.021389368921518326

The O 0 0.07607799768447876
clinical O 1 0.8382694721221924
diagnosis O 1 0.8480976223945618
of O 0 0.023195777088403702
AGU B-Disease 1 0.8250601887702942
is O 0 0.010975026525557041
often O 0 0.009057271294295788
difficult O 0 0.00847749225795269
, O 0 0.0029070982709527016
in O 0 0.002615832956507802
particular O 0 0.004073830787092447
early O 0 0.003575603710487485
in O 0 0.0021820985712110996
the O 0 0.0022340924479067326
course O 0 0.007266127038747072
of O 0 0.00420427368953824
the O 0 0.018842415884137154
disease O 1 0.9463996291160583
, O 0 0.006812200881540775
and O 0 0.002676650183275342
most O 0 0.003661394352093339
of O 0 0.004459230229258537
the O 0 0.01933748833835125
patients O 1 0.9067233204841614
are O 0 0.04646077752113342
diagnosed O 1 0.9481040835380554
after O 0 0.014904038980603218
the O 0 0.005608661565929651
age O 0 0.021244831383228302
of O 0 0.007217959966510534
5 O 0 0.020549967885017395
years O 0 0.026272933930158615
. O 0 0.03080383501946926

However O 0 0.023779021576046944
, O 0 0.010897694155573845
since O 0 0.011970896273851395
these O 0 0.011170907877385616
patients O 1 0.651028037071228
excrete O 0 0.24167877435684204
early O 0 0.011197463609278202
large O 0 0.007910351268947124
amounts O 0 0.014912974089384079
of O 0 0.005881308112293482
aspartylglucosamine O 0 0.21649791300296783
in O 0 0.0173657163977623
urine O 0 0.38719478249549866
, O 0 0.02483450435101986
biochemical O 0 0.42581307888031006
screening O 0 0.15680241584777832
is O 0 0.009265895001590252
easy O 0 0.0189653467386961
by O 0 0.017062406986951828
urine O 0 0.43200957775115967
chromatography O 0 0.49605751037597656
. O 0 0.027415139600634575
. O 0 0.03089713305234909

Detection O 0 0.1630098670721054
of O 0 0.02277732826769352
heterozygous O 1 0.506172239780426
carriers O 0 0.25476932525634766
of O 0 0.02400616556406021
the O 0 0.12867002189159393
ataxia B-Disease 1 0.9758815765380859
- I-Disease 1 0.8556029200553894
telangiectasia I-Disease 1 0.9647495150566101
( O 0 0.3304329514503479
ATM O 1 0.5048419237136841
) O 0 0.14457036554813385
gene O 1 0.7544772028923035
by O 0 0.06199106201529503
G2 O 1 0.8904480934143066
phase O 1 0.6123205423355103
chromosomal O 1 0.9376220107078552
radiosensitivity O 1 0.656618058681488
of O 0 0.07437673211097717
peripheral O 1 0.9246620535850525
blood O 1 0.93081134557724
lymphocytes O 1 0.9284210205078125
. O 0 0.1260288953781128

In O 0 0.3473602533340454
ataxia B-Disease 1 0.9530104994773865
- I-Disease 1 0.8353583812713623
telangiectasia I-Disease 1 0.9462574124336243
( O 0 0.31049492955207825
A B-Disease 0 0.1952524334192276
- I-Disease 1 0.6563050746917725
T I-Disease 1 0.9105758666992188
) O 0 0.2726263999938965
patients O 1 0.9129683375358582
, O 0 0.043509162962436676
mutations O 1 0.8045715093612671
in O 0 0.008900894783437252
a O 0 0.011583170853555202
single O 0 0.04245579615235329
gene O 1 0.708746075630188
, O 0 0.015421627089381218
ATM O 0 0.14445799589157104
, O 0 0.010130603797733784
result O 0 0.10099229961633682
in O 0 0.07766231149435043
an O 0 0.45207083225250244
autosomal B-Disease 1 0.9926626682281494
recessive I-Disease 1 0.9909886717796326
syndrome I-Disease 1 0.9860697984695435
that O 0 0.020330118015408516
embraces O 0 0.06448136270046234
a O 0 0.008505374193191528
variety O 0 0.014685606583952904
of O 0 0.007338034920394421
clinical O 0 0.4560606777667999
features O 0 0.021387971937656403
and O 0 0.007455998566001654
manifests O 0 0.19648589193820953
extreme O 0 0.13324470818042755
radiosensitivity O 0 0.2511790096759796
and O 0 0.006480402313172817
a O 0 0.010288679040968418
strong O 0 0.028054021298885345
pre O 0 0.14380012452602386
- O 0 0.26084038615226746
disposition O 0 0.2760184705257416
to O 0 0.03150543197989464
malignancy B-Disease 1 0.8845095634460449
. O 0 0.062072187662124634

Heterozygotes O 0 0.28292447328567505
for O 0 0.01704864203929901
the O 0 0.013805502094328403
ATM O 0 0.15692618489265442
gene O 0 0.40383800864219666
have O 0 0.00819801539182663
no O 0 0.010927767492830753
clinical O 0 0.33253127336502075
expression O 0 0.055721215903759
of O 0 0.007728203199803829
A B-Disease 0 0.06508580595254898
- I-Disease 0 0.34577566385269165
T I-Disease 1 0.7084495425224304
but O 0 0.0184215996414423
may O 0 0.0846981406211853
be O 0 0.0433511845767498
cancer B-Disease 1 0.9641108512878418
prone O 0 0.4089207351207733
with O 0 0.014251374639570713
a O 0 0.013195808045566082
moderate O 0 0.10171905159950256
increase O 0 0.03987579792737961
in O 0 0.01287571806460619
in O 0 0.025792481377720833
vitro O 1 0.6870662569999695
radiosensitivity O 1 0.6333869099617004
. O 0 0.06932394951581955

We O 0 0.025301679968833923
performed O 0 0.029397398233413696
a O 0 0.02210238017141819
blind O 0 0.28035011887550354
chromosomal O 1 0.8178780674934387
analysis O 0 0.06669005751609802
on O 0 0.015561738982796669
G2 O 1 0.7893232107162476
- O 0 0.3562098443508148
phase O 0 0.4337577223777771
lymphocytes O 1 0.8855212926864624
from O 0 0.03221117705106735
7 O 0 0.07801036536693573
unrelated O 0 0.45048555731773376
A B-Disease 0 0.13334447145462036
- I-Disease 1 0.6075637936592102
T I-Disease 1 0.9044945240020752
patients O 1 0.893267035484314
, O 0 0.018831225112080574
13 O 0 0.03479241207242012
obligate O 0 0.36203476786613464
A B-Disease 0 0.10961028933525085
- I-Disease 1 0.5119019150733948
T I-Disease 1 0.8626114130020142
heterozygotes O 1 0.8126972317695618
( O 0 0.04225064069032669
parents O 0 0.025718707591295242
of O 0 0.005321313627064228
the O 0 0.012164302170276642
patients O 1 0.7521750926971436
) O 0 0.010689213871955872
, O 0 0.003008502069860697
and O 0 0.0025818641297519207
14 O 0 0.006374657619744539
normal O 0 0.029562214389443398
controls O 0 0.02721785381436348
following O 0 0.01973962038755417
X O 0 0.0931987538933754
- O 0 0.09619569778442383
irradiation O 0 0.12427734583616257
with O 0 0.008501088246703148
1 O 0 0.012833048589527607
Gy O 0 0.2469523400068283
in O 0 0.004741222131997347
order O 0 0.0045975432731211185
to O 0 0.003227149834856391
evaluate O 0 0.022124746814370155
this O 0 0.004658005200326443
cytogenetic O 0 0.2558461129665375
method O 0 0.012324695475399494
as O 0 0.003999072127044201
a O 0 0.0059061176143586636
tool O 0 0.017142103984951973
for O 0 0.00706485565751791
detection O 0 0.1367274671792984
of O 0 0.01199511531740427
ATM O 0 0.2283613234758377
carriers O 0 0.29418694972991943
. O 0 0.0456940196454525

Both O 0 0.038359370082616806
A B-Disease 0 0.07193829119205475
- I-Disease 0 0.3927188813686371
T I-Disease 1 0.82177734375
homozygotes O 1 0.7721573710441589
and O 0 0.019968142732977867
heterozygotes O 1 0.5304556488990784
showed O 0 0.040787093341350555
significantly O 0 0.1767086386680603
increased O 0 0.07846283912658691
levels O 0 0.14354975521564484
of O 0 0.05394846573472023
radiation O 1 0.9143563508987427
- O 1 0.7187349200248718
induced O 1 0.9560959339141846
chromatid O 1 0.9026302695274353
damage O 0 0.39073681831359863
relative O 0 0.026196539402008057
to O 0 0.005541964899748564
that O 0 0.004867167677730322
of O 0 0.006714698858559132
normal O 0 0.0762925073504448
controls O 0 0.07982710748910904
. O 0 0.029570840299129486

These O 0 0.017393063753843307
results O 0 0.016335299238562584
show O 0 0.009928672574460506
that O 0 0.00658067874610424
the O 0 0.01011922862380743
G2 O 1 0.7675450444221497
- O 0 0.31318986415863037
phase O 0 0.46336498856544495
chromosomal O 1 0.9320976138114929
radiosensitivity O 1 0.5160539746284485
assay O 0 0.13508141040802002
can O 0 0.005660944152623415
be O 0 0.0026800576597452164
used O 0 0.002999017247930169
for O 0 0.0030913434457033873
the O 0 0.004358552396297455
detection O 0 0.08020138740539551
of O 0 0.00840897299349308
A B-Disease 0 0.0615103580057621
- I-Disease 0 0.4404749572277069
T I-Disease 1 0.8630856275558472
heterozygotes O 1 0.8341633677482605
. O 0 0.08739492297172546

In O 0 0.029566900804638863
combination O 0 0.1339842826128006
with O 0 0.026709938421845436
molecular O 0 0.4710249900817871
genetic O 1 0.5949622392654419
analyses O 0 0.037721116095781326
, O 0 0.004867333918809891
this O 0 0.0031052124686539173
test O 0 0.007250178139656782
may O 0 0.00424021203070879
be O 0 0.0015617262106388807
of O 0 0.0017491307808086276
value O 0 0.003148175310343504
in O 0 0.0041908398270606995
studies O 0 0.0386173389852047
of O 0 0.014590569771826267
familial B-Disease 1 0.8976905941963196
and I-Disease 0 0.02901328168809414
sporadic I-Disease 1 0.5510517358779907
cancers I-Disease 1 0.9582532048225403
aimed O 0 0.04136747121810913
at O 0 0.0055973120033741
determination O 0 0.008738711476325989
of O 0 0.003090919926762581
the O 0 0.004427595529705286
potential O 0 0.05974143370985985
involvement O 0 0.0871780514717102
of O 0 0.024713221937417984
ATM O 1 0.693301796913147
mutations O 1 0.9656197428703308
in O 0 0.20532603561878204
tumor B-Disease 1 0.9748103022575378
risk O 1 0.7898306250572205
or O 0 0.06198122352361679
development O 0 0.06004766374826431
. O 0 0.018953640013933182
. O 0 0.023965910077095032

Ataxia B-Disease 1 0.9405213594436646
- I-Disease 1 0.6837007999420166
telangiectasia I-Disease 1 0.9003198742866516
: O 0 0.03269445151090622
identification O 0 0.02566511183977127
and O 0 0.009549855254590511
detection O 0 0.07599394023418427
of O 0 0.008378108963370323
founder O 0 0.10678353905677795
- O 0 0.22265943884849548
effect O 0 0.27053526043891907
mutations O 1 0.8526760339736938
in O 0 0.011726725846529007
the O 0 0.01443688478320837
ATM O 0 0.3520866930484772
gene O 1 0.6501461863517761
in O 0 0.018436133861541748
ethnic O 0 0.0862036868929863
populations O 0 0.46418464183807373
. O 0 0.04909048229455948

To O 0 0.017291441559791565
facilitate O 0 0.020771773532032967
the O 0 0.008806887082755566
evaluation O 0 0.022387005388736725
of O 0 0.007927171885967255
ATM O 0 0.23377232253551483
heterozygotes O 1 0.6030722260475159
for O 0 0.021250704303383827
susceptibility O 1 0.8088315725326538
to O 0 0.015988413244485855
other O 0 0.06242445856332779
diseases O 1 0.9690835475921631
, O 0 0.023900985717773438
such O 0 0.04438019543886185
as O 0 0.09810859709978104
breast B-Disease 1 0.9810606241226196
cancer I-Disease 1 0.9541782140731812
, O 0 0.006000179331749678
we O 0 0.0024524875916540623
have O 0 0.002363265724852681
attempted O 0 0.004370087292045355
to O 0 0.002158980816602707
define O 0 0.008095748722553253
the O 0 0.003681015456095338
most O 0 0.009966584853827953
common O 0 0.12167161703109741
mutations O 1 0.7603511810302734
and O 0 0.006133140064775944
their O 0 0.007542595267295837
frequencies O 0 0.13939683139324188
in O 0 0.13519775867462158
ataxia B-Disease 1 0.9816064238548279
- I-Disease 1 0.8504710793495178
telangiectasia I-Disease 1 0.9709789752960205
( O 0 0.29293614625930786
A B-Disease 0 0.11423040926456451
- I-Disease 0 0.49947628378868103
T I-Disease 1 0.8079913854598999
) O 0 0.11096103489398956
homozygotes O 1 0.5958394408226013
from O 0 0.017172973603010178
10 O 0 0.021388160064816475
ethnic O 0 0.08056922256946564
populations O 0 0.3832990229129791
. O 0 0.045134879648685455

Both O 0 0.041617501527071
genomic O 1 0.6252092719078064
mutations O 1 0.7042869329452515
and O 0 0.009972792118787766
their O 0 0.007500997744500637
effects O 0 0.10109630972146988
on O 0 0.008641236461699009
cDNA O 0 0.19536322355270386
were O 0 0.01495281606912613
characterized O 0 0.3622432351112366
. O 0 0.03995786979794502

Protein O 0 0.3590678572654724
- O 0 0.09007342159748077
truncation O 0 0.10635774582624435
testing O 0 0.02192072384059429
of O 0 0.006674164440482855
the O 0 0.006165832281112671
entire O 0 0.016914641484618187
ATM O 0 0.12786859273910522
cDNA O 0 0.3050185739994049
detected O 0 0.2787867784500122
92 O 0 0.07086799293756485
( O 0 0.03777403011918068
66 O 0 0.04870610311627388
% O 0 0.06625424325466156
) O 0 0.07776609808206558
truncating O 1 0.7026939988136292
mutations O 1 0.8801828026771545
in O 0 0.034665245562791824
140 O 0 0.15259335935115814
mutant O 1 0.7851936221122742
alleles O 1 0.9051228761672974
screened O 0 0.35050249099731445
. O 0 0.058070920407772064

The O 0 0.024759499356150627
haplotyping O 0 0.14260731637477875
of O 0 0.015951963141560555
patients O 1 0.7022222280502319
with O 0 0.019821738824248314
identical O 0 0.22034768760204315
mutations O 1 0.8200016617774963
indicates O 0 0.029756002128124237
that O 0 0.0032102270051836967
almost O 0 0.0028501495253294706
all O 0 0.001659597735852003
of O 0 0.0018605570076033473
these O 0 0.0023186071775853634
represent O 0 0.005869290325790644
common O 0 0.039172541350126266
ancestry O 0 0.07955071330070496
and O 0 0.003690229030326009
that O 0 0.004099625628441572
very O 0 0.011033454909920692
few O 0 0.02241736650466919
spontaneously O 1 0.6010428071022034
recurring O 1 0.8131150007247925
ATM O 1 0.7895169258117676
mutations O 1 0.9433634877204895
exist O 0 0.18568706512451172
. O 0 0.04861355200409889

Assays O 0 0.15751521289348602
requiring O 0 0.053176186978816986
minimal O 0 0.035037845373153687
amounts O 0 0.019725225865840912
of O 0 0.009880933910608292
genomic O 0 0.30754995346069336
DNA O 0 0.06693191081285477
were O 0 0.0047667184844613075
designed O 0 0.0069070556201040745
to O 0 0.0036909272894263268
allow O 0 0.007999194785952568
rapid O 0 0.09779413044452667
screening O 0 0.10858559608459473
for O 0 0.010004754178225994
common O 0 0.1576036512851715
ethnic O 0 0.24300329387187958
mutations O 1 0.9330152869224548
. O 0 0.1108604371547699

These O 0 0.03659569099545479
rapid O 0 0.2005896419286728
assays O 0 0.3968406617641449
detected O 0 0.4486919045448303
mutations O 1 0.6951868534088135
in O 0 0.01055017951875925
76 O 0 0.022006429731845856
% O 0 0.014140396378934383
of O 0 0.0061591207049787045
Costa O 0 0.05336896702647209
Rican O 0 0.10710293799638748
patients O 1 0.8148425221443176
( O 0 0.03442207723855972
3 O 0 0.012929841876029968
) O 0 0.008051457814872265
, O 0 0.002722574397921562
50 O 0 0.004040559753775597
% O 0 0.007888535037636757
of O 0 0.0040630619041621685
Norwegian O 0 0.04136109724640846
patients O 1 0.7714645266532898
( O 0 0.03954440355300903
1 O 0 0.007911628112196922
) O 0 0.005667502526193857
, O 0 0.00264963717199862
25 O 0 0.0037380103021860123
% O 0 0.009502699598670006
of O 0 0.004605886992067099
Polish O 0 0.13348248600959778
patients O 1 0.8686842322349548
( O 0 0.03560972586274147
4 O 0 0.012192036025226116
) O 0 0.0071292445063591
, O 0 0.0023438693024218082
and O 0 0.00192865205463022
14 O 0 0.004543660674244165
% O 0 0.01439264789223671
of O 0 0.00628209812566638
Italian O 0 0.13547557592391968
patients O 1 0.830120861530304
( O 0 0.040802229195833206
1 O 0 0.01203469280153513
) O 0 0.007349158171564341
, O 0 0.0024462544824928045
as O 0 0.001970465062186122
well O 0 0.002460468327626586
as O 0 0.0031756912358105183
in O 0 0.008579866029322147
patients O 1 0.5770987868309021
of O 0 0.011028971523046494
Amish O 0 0.2851102352142334
/ O 0 0.40099552273750305
Mennonite O 0 0.15869760513305664
and O 0 0.008822067640721798
Irish O 0 0.06506370007991791
English O 0 0.03852327540516853
backgrounds O 0 0.09122464805841446
. O 0 0.034633785486221313

Additional O 0 0.05183107405900955
mutations O 0 0.44824254512786865
were O 0 0.010000118054449558
observed O 0 0.015184582211077213
in O 0 0.00662062456831336
Japanese O 0 0.007609076797962189
, O 0 0.004876723047345877
Utah O 0 0.010385220870375633
Mormon O 0 0.019904090091586113
, O 0 0.006523466669023037
and O 0 0.006544638425111771
African O 0 0.09094337373971939
American O 0 0.10966610163450241
patients O 1 0.8927331566810608
. O 0 0.07876083254814148

These O 0 0.02830437757074833
assays O 0 0.06146284192800522
should O 0 0.011527198366820812
facilitate O 0 0.02171962708234787
screening O 0 0.05809955671429634
for O 0 0.00833867210894823
A B-Disease 0 0.03556009382009506
- I-Disease 0 0.28372088074684143
T I-Disease 1 0.7511885166168213
heterozygotes O 1 0.5830844640731812
in O 0 0.011456023901700974
the O 0 0.009889086708426476
populations O 0 0.252246230840683
studied O 0 0.04516542702913284
. O 0 0.018428664654493332
. O 0 0.02528906986117363

The O 0 0.09106352180242538
von B-Disease 1 0.806940495967865
Hippel I-Disease 1 0.9226648807525635
- I-Disease 1 0.8896439075469971
Lindau I-Disease 1 0.9529902338981628
tumor I-Disease 1 0.9684777855873108
suppressor O 1 0.9381913542747498
gene O 1 0.7974652051925659
is O 0 0.017051981762051582
required O 0 0.016221901401877403
for O 0 0.012510187923908234
cell O 0 0.3131839632987976
cycle O 0 0.19745872914791107
exit O 0 0.0903579369187355
upon O 0 0.03952005133032799
serum O 1 0.7028526663780212
withdrawal O 0 0.2889403998851776
. O 0 0.05100933089852333

The O 0 0.03003096953034401
inactivation O 0 0.12635742127895355
of O 0 0.015766169875860214
the O 0 0.030160177499055862
von B-Disease 1 0.7659426927566528
Hippel I-Disease 1 0.9508998990058899
- I-Disease 1 0.8675417900085449
Lindau I-Disease 1 0.9608423113822937
( I-Disease 1 0.7914796471595764
VHL I-Disease 1 0.9713179469108582
) I-Disease 1 0.8131084442138672
tumor I-Disease 1 0.9799797534942627
suppressor O 1 0.9693847894668579
gene O 1 0.9630187749862671
predisposes O 1 0.9443637132644653
affected O 1 0.57668536901474
individuals O 0 0.11353152245283127
to O 0 0.013808962889015675
the O 0 0.06291481107473373
human O 1 0.8660467267036438
VHL B-Disease 1 0.9855014681816101
cancer I-Disease 1 0.9911929965019226
syndrome I-Disease 1 0.9872146844863892
and O 0 0.054091598838567734
is O 0 0.052449170500040054
associated O 0 0.2808091640472412
with O 0 0.19092822074890137
sporadic B-Disease 1 0.9278541803359985
renal I-Disease 1 0.9881402254104614
cell I-Disease 1 0.9701647162437439
carcinomas I-Disease 1 0.9802605509757996
( O 1 0.6288920640945435
RCC B-Disease 1 0.8956359624862671
) O 0 0.14987528324127197
and O 0 0.04579562693834305
brain B-Disease 1 0.8844347596168518
hemangioblastomas I-Disease 1 0.6118676662445068
. O 0 0.06732625514268875

VHL O 1 0.8509790897369385
- O 0 0.39089083671569824
negative O 0 0.3582339584827423
786 O 1 0.6827526688575745
- O 0 0.3341842591762543
0 O 0 0.20822928845882416
RCC B-Disease 1 0.8210615515708923
cells O 1 0.5630234479904175
are O 0 0.010159376077353954
tumorigenic O 0 0.1644229292869568
in O 0 0.013868017122149467
nude O 0 0.397752970457077
mice O 1 0.7947189211845398
which O 0 0.010390941984951496
is O 0 0.008418286219239235
suppressed O 0 0.06854324787855148
by O 0 0.007251725997775793
the O 0 0.00820149015635252
reintroduction O 0 0.2716640532016754
of O 0 0.02844051830470562
VHL B-Disease 1 0.8986910581588745
. O 0 0.08398408442735672

Remarkably O 0 0.09524921327829361
, O 0 0.018179209902882576
this O 0 0.010032828897237778
occurs O 0 0.07746171951293945
without O 0 0.010200360789895058
affecting O 0 0.06817347556352615
the O 0 0.006321686320006847
growth O 0 0.05680347606539726
rate O 0 0.04407018423080444
and O 0 0.008065775036811829
cell O 0 0.30347034335136414
cycle O 0 0.2554376721382141
profile O 0 0.09236603230237961
of O 0 0.006933858618140221
these O 0 0.015646571293473244
cells O 0 0.45644545555114746
in O 0 0.015609754249453545
culture O 0 0.054164186120033264
. O 0 0.036743827164173126

The O 0 0.03804557025432587
786 O 0 0.4644996225833893
- O 0 0.1484854817390442
0 O 0 0.06449583172798157
cell O 0 0.21103087067604065
line O 0 0.01567123830318451
, O 0 0.008729224093258381
like O 0 0.02105427347123623
many O 0 0.06300176680088043
cancer B-Disease 1 0.973461389541626
cells O 1 0.7255709767341614
, O 0 0.010603814385831356
fails O 0 0.036200352013111115
to O 0 0.004739271942526102
exit O 0 0.018903236836194992
the O 0 0.009092194959521294
cell O 0 0.3675297498703003
cycle O 0 0.27931705117225647
upon O 0 0.0407625213265419
serum O 1 0.65142422914505
withdrawal O 0 0.2587805688381195
. O 0 0.05019771680235863

Here O 0 0.01638418808579445
, O 0 0.007770169526338577
it O 0 0.0043945531360805035
is O 0 0.0037063402123749256
shown O 0 0.004493769723922014
that O 0 0.00309923873282969
reintroduction O 0 0.037868745625019073
of O 0 0.0039954232051968575
the O 0 0.006745778489857912
wild O 0 0.13561631739139557
- O 0 0.38035228848457336
type O 1 0.6036308407783508
VHL B-Disease 1 0.9530350565910339
gene O 1 0.8401116132736206
restores O 0 0.29378047585487366
the O 0 0.012775510549545288
ability O 0 0.08070121705532074
of O 0 0.05381021276116371
VHL O 1 0.9583157300949097
- O 1 0.7600303888320923
negative O 1 0.850249707698822
RCC B-Disease 1 0.9665133357048035
cancer I-Disease 1 0.9795716404914856
cells O 1 0.7080735564231873
to O 0 0.008450644090771675
exit O 0 0.03879467025399208
the O 0 0.010676548816263676
cell O 0 0.34723982214927673
cycle O 0 0.21621376276016235
and O 0 0.012709501199424267
enter O 0 0.09351986646652222
G0 O 1 0.8634020686149597
/ O 1 0.633300244808197
quiescence O 1 0.6623204946517944
in O 0 0.030826985836029053
low O 0 0.22474953532218933
serum O 1 0.7758027911186218
. O 0 0.07551100850105286

Both O 0 0.07909314334392548
VHL O 1 0.8839359879493713
- O 0 0.26747745275497437
positive O 0 0.1597682386636734
and O 0 0.04686959460377693
VHL O 1 0.9396914839744568
- O 1 0.6003174781799316
negative O 1 0.6035342216491699
RCC B-Disease 1 0.8751463890075684
cells O 1 0.7618576884269714
exit O 0 0.08842568099498749
the O 0 0.0174641702324152
cell O 1 0.5016027688980103
cycle O 0 0.34053438901901245
by O 0 0.04008461534976959
contact O 0 0.2832931876182556
inhibition O 1 0.7069464921951294
. O 0 0.05122649297118187

The O 0 0.05624094977974892
cyclin O 1 0.8561490178108215
- O 0 0.37826108932495117
dependent O 0 0.37167608737945557
kinase O 1 0.8298162221908569
inhibitor O 1 0.8509246706962585
, O 0 0.025606919080018997
p27 O 1 0.6707689166069031
, O 0 0.013551467098295689
accumulates O 0 0.17120862007141113
upon O 0 0.01501026377081871
serum O 0 0.4131443500518799
withdrawal O 0 0.04189252108335495
, O 0 0.003640442620962858
only O 0 0.002372568938881159
in O 0 0.0021935345139354467
the O 0 0.002398718846961856
presence O 0 0.009519939310848713
of O 0 0.004703820217400789
VHL B-Disease 1 0.6405844688415527
, O 0 0.0042225997895002365
as O 0 0.0030828742310404778
a O 0 0.004136187024414539
result O 0 0.007958854548633099
of O 0 0.003179010469466448
the O 0 0.004383264575153589
stabilization O 0 0.040916599333286285
of O 0 0.005467521958053112
the O 0 0.010806779377162457
protein O 0 0.33427324891090393
. O 0 0.035041749477386475

We O 0 0.01636226288974285
propose O 0 0.01948312297463417
that O 0 0.006301595829427242
the O 0 0.005114976316690445
loss O 0 0.023237286135554314
of O 0 0.007282207254320383
wild O 0 0.15127596259117126
- O 0 0.3805910348892212
type O 1 0.6361547708511353
VHL B-Disease 1 0.9555593729019165
gene O 1 0.7701448798179626
results O 0 0.056596774607896805
in O 0 0.008490857668220997
a O 0 0.015447886660695076
specific O 0 0.07533484697341919
cellular O 1 0.637485682964325
defect O 1 0.8263512253761292
in O 0 0.046109069138765335
serum O 1 0.8344506621360779
- O 0 0.33417922258377075
dependent O 0 0.2638844847679138
growth O 0 0.161446213722229
control O 0 0.07230052351951599
, O 0 0.008811295963823795
which O 0 0.012763718143105507
may O 0 0.09506513178348541
initiate O 0 0.4894736409187317
tumor B-Disease 1 0.9519790410995483
formation O 0 0.47850653529167175
. O 0 0.06975148618221283

This O 0 0.019562194123864174
is O 0 0.011669079773128033
corrected O 0 0.03150046989321709
by O 0 0.007895322516560555
the O 0 0.005857602693140507
reintroduction O 0 0.09900491684675217
of O 0 0.010113751515746117
wild O 0 0.16008976101875305
- O 0 0.37225964665412903
type O 1 0.5254201292991638
VHL B-Disease 1 0.9313538074493408
, O 0 0.047775816172361374
implicating O 1 0.544562816619873
VHL B-Disease 1 0.8408091068267822
as O 0 0.009795764461159706
the O 0 0.009787850081920624
first O 0 0.0389287993311882
tumor B-Disease 1 0.9655646085739136
suppressor O 1 0.7985846400260925
involved O 0 0.027043845504522324
in O 0 0.004717693198472261
the O 0 0.004110666923224926
regulation O 0 0.031346023082733154
of O 0 0.006948656402528286
cell O 0 0.27351921796798706
cycle O 0 0.14460887014865875
exit O 0 0.02403818815946579
, O 0 0.0038612685166299343
which O 0 0.0026139861438423395
is O 0 0.0027360517997294664
consistent O 0 0.007731436286121607
with O 0 0.00421454943716526
its O 0 0.005200440064072609
gatekeeper O 0 0.2964989244937897
function O 0 0.08931399136781693
in O 0 0.015681907534599304
the O 0 0.040960900485515594
kidney O 1 0.9595659375190735
. O 0 0.05033017322421074
. O 0 0.04805460572242737

Piebaldism B-Disease 1 0.630098819732666
with O 0 0.09542357921600342
deafness B-Disease 1 0.9300405979156494
: O 0 0.06451298296451569
molecular O 0 0.29750311374664307
evidence O 0 0.01854732073843479
for O 0 0.010540473274886608
an O 0 0.026183653622865677
expanded O 0 0.19885680079460144
syndrome O 1 0.9658411741256714
. O 0 0.12205599248409271

In O 0 0.019348809495568275
a O 0 0.012027041055262089
South O 0 0.011996425688266754
African O 0 0.03446490690112114
girl O 0 0.056320853531360626
of O 0 0.013310774229466915
Xhosa O 1 0.6527147889137268
stock O 0 0.21700724959373474
with O 0 0.13519231975078583
severe O 1 0.931005597114563
piebaldism B-Disease 1 0.8313812017440796
and O 0 0.17549669742584229
profound O 1 0.9291048645973206
congenital O 1 0.9901087284088135
sensorineural B-Disease 1 0.9775397777557373
deafness I-Disease 1 0.9676966667175293
we O 0 0.016686871647834778
identified O 0 0.053964994847774506
a O 0 0.01438058540225029
novel O 0 0.08412735909223557
missense O 0 0.49560266733169556
substitution O 0 0.05982806533575058
at O 0 0.006872940342873335
a O 0 0.0077921077609062195
highly O 0 0.027133002877235413
conserved O 0 0.05593305081129074
residue O 0 0.046548932790756226
in O 0 0.005709539167582989
the O 0 0.009208508767187595
intracellular O 1 0.628423273563385
kinase O 1 0.5718157887458801
domain O 0 0.04995174705982208
of O 0 0.007817014120519161
the O 0 0.014643225818872452
KIT O 0 0.41532307863235474
proto O 1 0.7607914209365845
- O 1 0.5281952023506165
oncogene O 1 0.8961658477783203
, O 0 0.0443091094493866
R796G O 0 0.34787431359291077
. O 0 0.04102036729454994

Though O 0 0.06800444424152374
auditory B-Disease 1 0.5132389068603516
anomalies I-Disease 0 0.2213107794523239
have O 0 0.010908483527600765
been O 0 0.008875242434442043
observed O 0 0.0353093184530735
in O 0 0.013983296230435371
mice O 1 0.7245590090751648
with O 0 0.03200653940439224
dominant O 0 0.41198626160621643
white O 0 0.3174566924571991
spotting O 1 0.7660112977027893
( O 0 0.27602657675743103
W O 1 0.629197359085083
) O 0 0.03296095132827759
due O 0 0.031424298882484436
to O 0 0.01460703369230032
KIT O 1 0.6040514707565308
mutations O 1 0.9573388695716858
, O 0 0.08624272793531418
deafness B-Disease 1 0.9599748849868774
is O 0 0.013417399488389492
not O 0 0.006827743258327246
typical O 0 0.04039501026272774
in O 0 0.012901999987661839
human O 0 0.12711217999458313
piebaldism B-Disease 0 0.4276484549045563
. O 0 0.050403892993927

Thus O 0 0.031218115240335464
, O 0 0.012881876900792122
the O 0 0.010043962858617306
occurrence O 0 0.26314184069633484
of O 0 0.035943564027547836
sensorineural B-Disease 1 0.9492585062980652
deafness I-Disease 1 0.9616789221763611
in O 0 0.026972338557243347
this O 0 0.013281078077852726
patient O 0 0.47557497024536133
extends O 0 0.048980750143527985
considerably O 0 0.0381256639957428
the O 0 0.0069075231440365314
phenotypic O 0 0.26146769523620605
range O 0 0.014231640845537186
of O 0 0.007183459121733904
piebaldism B-Disease 0 0.3100517690181732
due O 0 0.07335812598466873
to O 0 0.02192910574376583
KIT O 1 0.6432071328163147
gene O 1 0.922508955001831
mutation O 1 0.9121864438056946
in O 0 0.027019616216421127
humans O 0 0.3327055871486664
and O 0 0.011754699982702732
tightens O 0 0.3210764527320862
the O 0 0.01274872850626707
clinical O 1 0.5267114639282227
similarity O 0 0.11255212873220444
between O 0 0.01804741658270359
piebaldism B-Disease 0 0.13422800600528717
and O 0 0.004708647262305021
the O 0 0.0053390758112072945
various O 0 0.010749254375696182
forms O 0 0.13648547232151031
of O 0 0.13526909053325653
Waardenburg B-Disease 1 0.9728469252586365
syndrome I-Disease 1 0.9802539944648743
. O 0 0.11627603322267532
. O 0 0.06113722547888756

Cycloheximide O 0 0.21177266538143158
facilitates O 0 0.07656627893447876
the O 0 0.012996111065149307
identification O 0 0.015615243464708328
of O 0 0.008623309433460236
aberrant O 0 0.250380277633667
transcripts O 0 0.04148735851049423
resulting O 0 0.06304716318845749
from O 0 0.010536560788750648
a O 0 0.013666755519807339
novel O 0 0.1309886872768402
splice O 1 0.6696455478668213
- O 0 0.31555408239364624
site O 0 0.06810007244348526
mutation O 1 0.8414871096611023
in O 0 0.03624923154711723
COL17A1 O 1 0.533983588218689
in O 0 0.028412433341145515
a O 0 0.08044987171888351
patient O 1 0.8771675229072571
with O 0 0.21563208103179932
generalized O 1 0.9410474300384521
atrophic B-Disease 1 0.9606193900108337
benign I-Disease 1 0.9565207958221436
epidermolysis I-Disease 1 0.9468740224838257
bullosa I-Disease 1 0.9075872302055359
. O 0 0.1995241940021515

Patients O 1 0.8704969882965088
with O 0 0.23479107022285461
generalized O 1 0.9133548140525818
atrophic B-Disease 1 0.9491029977798462
benign I-Disease 1 0.9492703676223755
epidermolysis I-Disease 1 0.9439897537231445
bullosa I-Disease 1 0.9067579507827759
often O 0 0.05655192211270332
show O 0 0.028319688513875008
decreased O 0 0.19999827444553375
expression O 0 0.11706943809986115
of O 0 0.0196582842618227
type O 0 0.37037691473960876
XVII O 1 0.7503287196159363
collagen O 1 0.843108057975769
, O 0 0.023796038702130318
a O 0 0.026454949751496315
transmembrane O 0 0.47476649284362793
hemidesmosomal O 1 0.5307105779647827
protein O 0 0.4358937740325928
encoded O 0 0.12502062320709229
by O 0 0.031293511390686035
COL17A1 O 0 0.33718064427375793
. O 0 0.03562752902507782

This O 0 0.016380729153752327
report O 0 0.013924228958785534
documents O 0 0.011659069918096066
a O 0 0.01112874411046505
novel O 0 0.07046964764595032
splice O 1 0.5620186924934387
- O 0 0.2884421944618225
site O 0 0.0697576031088829
mutation O 1 0.8320905566215515
in O 0 0.0251952912658453
COL17A1 O 0 0.44169172644615173
in O 0 0.022631267085671425
a O 0 0.06086226925253868
patient O 1 0.8635105490684509
with O 0 0.20488612353801727
generalized O 1 0.9529163241386414
atrophic B-Disease 1 0.9786770343780518
benign I-Disease 1 0.9767888784408569
epidermolysis I-Disease 1 0.9698006510734558
bullosa I-Disease 1 0.9384422898292542
, O 0 0.01715645007789135
and O 0 0.005936052650213242
applies O 0 0.012535939924418926
a O 0 0.004881197586655617
new O 0 0.0048757134936749935
methodology O 0 0.010295636020600796
to O 0 0.004209685139358044
define O 0 0.013185195624828339
and O 0 0.005334721878170967
characterize O 0 0.06732962280511856
the O 0 0.010701781138777733
resulting O 0 0.25699669122695923
mRNA O 0 0.4272879362106323
splice O 1 0.6804089546203613
variants O 1 0.5443021655082703
. O 0 0.06454920768737793

Mutational O 0 0.4762093424797058
analysis O 0 0.043990619480609894
of O 0 0.017536254599690437
COL17A1 O 0 0.2089628279209137
identified O 0 0.03811417147517204
a O 0 0.030799388885498047
maternally O 1 0.7567417025566101
inherited O 1 0.8402345180511475
G O 0 0.48235368728637695
- O 0 0.1618763655424118
to O 0 0.01375487633049488
- O 0 0.2076965570449829
T O 1 0.5058324933052063
transversion O 0 0.1643061488866806
at O 0 0.007774095982313156
the O 0 0.006269670091569424
- O 0 0.03663169965147972
1 O 0 0.008223784156143665
position O 0 0.006903158500790596
of O 0 0.008525712415575981
exon O 0 0.20291127264499664
32 O 0 0.04569953680038452
. O 0 0.03216756507754326

This O 0 0.033991213887929916
acceptor O 0 0.4166824221611023
splice O 0 0.47375914454460144
- O 0 0.11954568326473236
site O 0 0.023604556918144226
mutation O 0 0.49547117948532104
led O 0 0.011194434016942978
to O 0 0.004478598944842815
the O 0 0.004520350135862827
formation O 0 0.035989657044410706
of O 0 0.005856572184711695
aberrant O 0 0.3263297975063324
transcripts O 0 0.03232549875974655
present O 0 0.015283114276826382
at O 0 0.012136336416006088
extremely O 0 0.05517302453517914
low O 0 0.07236270606517792
levels O 0 0.13791656494140625
. O 0 0.0362379364669323

Based O 0 0.02271018922328949
on O 0 0.009831628762185574
our O 0 0.009267965331673622
recent O 0 0.011921771802008152
finding O 0 0.01416486594825983
that O 0 0.009357530623674393
cycloheximide O 0 0.3046587109565735
stabilized O 0 0.47280335426330566
mutant O 1 0.5781310200691223
COL17A1 O 0 0.4395294189453125
transcripts O 0 0.07351578027009964
in O 0 0.02173839882016182
keratinocytes O 1 0.6298749446868896
homozygous O 1 0.5714558362960815
for O 0 0.015141261741518974
a O 0 0.0355689600110054
frameshift O 1 0.8591827154159546
mutation O 1 0.8084121942520142
, O 0 0.007550238166004419
the O 0 0.004590106196701527
effects O 0 0.06874652951955795
of O 0 0.004452685359865427
the O 0 0.006679601036012173
splice O 0 0.38759660720825195
- O 0 0.11266648769378662
site O 0 0.02227679453790188
mutation O 1 0.5557172894477844
on O 0 0.006447393912822008
splicing O 0 0.1697021871805191
of O 0 0.008384060114622116
COL17A1 O 0 0.14301389455795288
transcripts O 0 0.017479198053479195
were O 0 0.0052945963107049465
determined O 0 0.013242595829069614
using O 0 0.016653472557663918
reverse O 0 0.24551214277744293
transcriptase O 1 0.8878457546234131
polymerase O 1 0.6075554490089417
chain O 0 0.15727655589580536
reaction O 0 0.04797399789094925
of O 0 0.006046679336577654
total O 0 0.014039296656847
RNA O 0 0.39749887585639954
from O 0 0.02574029378592968
keratinocytes O 1 0.5020248889923096
incubated O 0 0.18597224354743958
for O 0 0.014142564497888088
2 O 0 0.025852639228105545
. O 0 0.026065802201628685

5 O 0 0.036698851734399796
h O 0 0.042885880917310715
in O 0 0.009019945748150349
the O 0 0.00597973819822073
presence O 0 0.013624346815049648
or O 0 0.0077521358616650105
absence O 0 0.02075355313718319
of O 0 0.007177826948463917
10 O 0 0.021097451448440552
microg O 0 0.33989575505256653
cycloheximide O 0 0.297603577375412
per O 0 0.04363739490509033
ml O 1 0.52443528175354
. O 0 0.05216937139630318

Using O 0 0.02555619366466999
this O 0 0.010836715810000896
approach O 0 0.014722222462296486
, O 0 0.0072066932916641235
an O 0 0.009598740376532078
abnormally O 1 0.5816762447357178
spliced O 0 0.4681168794631958
transcript O 0 0.0716581866145134
was O 0 0.005167196039110422
identified O 0 0.006962275132536888
that O 0 0.002752340165898204
contains O 0 0.00420921528711915
an O 0 0.0034355507232248783
extra O 0 0.006117484997957945
264 O 0 0.01547105424106121
bases O 0 0.00779191916808486
upstream O 0 0.023932630196213722
from O 0 0.007738909684121609
exon O 0 0.15886259078979492
32 O 0 0.01820395328104496
, O 0 0.007253349758684635
resulting O 0 0.05815303325653076
in O 0 0.007271598093211651
a O 0 0.01733947917819023
premature O 1 0.5976349711418152
termination O 1 0.5002773404121399
codon O 0 0.27936452627182007
27 O 0 0.035238683223724365
bp O 0 0.05408691614866257
downstream O 0 0.05436405539512634
from O 0 0.012325809337198734
the O 0 0.013275310397148132
cryptic O 0 0.336849570274353
splice O 0 0.4654504656791687
site O 0 0.04560426250100136
. O 0 0.039467260241508484

Three O 0 0.02293003723025322
other O 0 0.013844851404428482
splice O 0 0.2365204095840454
variants O 0 0.09468423575162888
, O 0 0.005845374893397093
including O 0 0.004537083674222231
one O 0 0.00339966407045722
derived O 0 0.009380951523780823
from O 0 0.0038724837359040976
the O 0 0.003609970910474658
skipping O 0 0.03677096962928772
of O 0 0.006487587466835976
exon O 0 0.16293112933635712
32 O 0 0.011589542962610722
, O 0 0.004785648547112942
were O 0 0.0040358914993703365
also O 0 0.006546973716467619
identified O 0 0.029198553413152695
. O 0 0.0195323396474123

These O 0 0.018732735887169838
results O 0 0.018859965726733208
indicate O 0 0.016521403566002846
the O 0 0.006845621392130852
usefulness O 0 0.0426580086350441
of O 0 0.008318028412759304
cycloheximide O 0 0.289951354265213
treatment O 0 0.29683810472488403
in O 0 0.00845240242779255
evaluating O 0 0.031042037531733513
the O 0 0.005893582012504339
abnormal O 0 0.4346614480018616
processing O 0 0.015090029686689377
of O 0 0.005677803419530392
mRNA O 0 0.12658220529556274
due O 0 0.02203703112900257
to O 0 0.007439229637384415
splice O 1 0.5872136950492859
- O 0 0.2362244725227356
site O 0 0.053038813173770905
mutations O 1 0.8457292914390564
, O 0 0.008785891346633434
because O 0 0.011939152143895626
( O 0 0.017081722617149353
i O 0 0.00591569347307086
) O 0 0.01911819539964199
aberrant O 0 0.3637194037437439
splicing O 0 0.3525928258895874
often O 0 0.02912292256951332
generates O 0 0.07373080402612686
a O 0 0.03638458624482155
premature O 1 0.7823561429977417
termination O 1 0.652432918548584
codon O 0 0.3775097131729126
, O 0 0.014221047051250935
( O 0 0.028711088001728058
ii O 0 0.031386759132146835
) O 0 0.015419237315654755
transcripts O 0 0.031465671956539154
with O 0 0.017649175599217415
premature O 1 0.6510908007621765
termination O 1 0.5884478092193604
codons O 0 0.4722726047039032
can O 0 0.02942325733602047
occur O 0 0.1441182941198349
at O 0 0.011272714473307133
low O 0 0.0771479606628418
or O 0 0.04260437190532684
undetectable O 1 0.6323512196540833
levels O 0 0.13153356313705444
due O 0 0.04220645874738693
to O 0 0.008184069767594337
nonsense O 0 0.13421384990215302
- O 0 0.23897035419940948
mediated O 1 0.662760853767395
mRNA O 0 0.3797518312931061
decay O 0 0.20103244483470917
, O 0 0.007617334369570017
and O 0 0.004931520204991102
( O 0 0.020832989364862442
iii O 0 0.03806903958320618
) O 0 0.005766088142991066
the O 0 0.00233621709048748
levels O 0 0.007394329644739628
of O 0 0.0023057623766362667
these O 0 0.0034786202013492584
transcripts O 0 0.01533812377601862
can O 0 0.0048843142576515675
be O 0 0.003807520493865013
increased O 0 0.015195883810520172
by O 0 0.013486039824783802
cycloheximide O 0 0.2772071063518524
. O 0 0.039757244288921356

A O 0 0.07192575931549072
deletion O 1 0.7309423685073853
mutation O 1 0.7519227266311646
in O 0 0.02061665989458561
COL17A1 O 0 0.13578462600708008
in O 0 0.011732363142073154
five O 0 0.014610094018280506
Austrian O 0 0.16458383202552795
families O 0 0.1761767715215683
with O 0 0.1430301070213318
generalized O 1 0.9314704537391663
atrophic B-Disease 1 0.9621622562408447
benign I-Disease 1 0.9595842957496643
epidermolysis I-Disease 1 0.9498012065887451
bullosa I-Disease 1 0.9237579703330994
represents O 0 0.13386477530002594
propagation O 0 0.14352859556674957
of O 0 0.014991000294685364
an O 0 0.019374681636691093
ancestral O 0 0.29554837942123413
allele O 1 0.7643327713012695
. O 0 0.07582417130470276

Patients O 1 0.8910263180732727
with O 0 0.26779985427856445
generalized O 1 0.9164423942565918
atrophic B-Disease 1 0.9463356733322144
benign I-Disease 1 0.9504318833351135
epidermolysis I-Disease 1 0.9386443495750427
bullosa I-Disease 1 0.8987438082695007
, O 0 0.02470562793314457
a O 0 0.019473662599921227
usually O 0 0.031151095405220985
nonlethal O 0 0.2021263688802719
form O 0 0.08854261785745621
of O 0 0.05892478674650192
junctional B-Disease 1 0.9452762007713318
epidermolysis I-Disease 1 0.963229775428772
bullosa I-Disease 1 0.9445362687110901
, O 0 0.05033167824149132
have O 0 0.038524329662323
generalized O 1 0.7701877355575562
blistering B-Disease 1 0.728386402130127
, O 0 0.18656675517559052
nail B-Disease 1 0.9207261800765991
dystrophy I-Disease 1 0.97682124376297
, O 0 0.2884727716445923
patchy B-Disease 1 0.920607328414917
alopecia I-Disease 1 0.9661301970481873
, O 0 0.10118100047111511
and O 0 0.09907855838537216
dental B-Disease 1 0.9262445569038391
abnormalities I-Disease 1 0.9491752982139587
. O 0 0.1499614417552948

Skin B-Disease 1 0.877983570098877
fragility I-Disease 0 0.39987465739250183
in O 0 0.017966948449611664
most O 0 0.014450174756348133
cases O 0 0.06899670511484146
is O 0 0.0078037031926214695
due O 0 0.019471576437354088
to O 0 0.009901209734380245
mutations O 1 0.8107813596725464
in O 0 0.017940199002623558
the O 0 0.025213420391082764
gene O 1 0.8397315144538879
encoding O 1 0.6588356494903564
type O 1 0.7080015540122986
XVII O 1 0.8896489143371582
collagen O 1 0.9248261451721191
( O 0 0.2948240339756012
COL17A1 O 1 0.663172721862793
) O 0 0.08574666827917099
. O 0 0.03350333869457245

Recently O 0 0.04276900738477707
, O 0 0.014509269967675209
we O 0 0.008774608373641968
reported O 0 0.014363913796842098
five O 0 0.011181024834513664
Austrian O 0 0.1246650293469429
families O 0 0.14521145820617676
with O 0 0.1425658017396927
generalized O 1 0.9368680715560913
atrophic B-Disease 1 0.9693979024887085
benign I-Disease 1 0.965444028377533
epidermolysis I-Disease 1 0.9542808532714844
bullosa I-Disease 1 0.9166505336761475
who O 0 0.03273356333374977
share O 0 0.02626798115670681
the O 0 0.015355496667325497
same O 0 0.042550623416900635
COL17A1 O 1 0.705720067024231
mutation O 1 0.9147505164146423
. O 0 0.08213247358798981

Affected O 0 0.15936718881130219
individuals O 0 0.02865966409444809
in O 0 0.009608735330402851
three O 0 0.007701941765844822
families O 0 0.014087109826505184
are O 0 0.005168858449906111
homozygous O 0 0.2467295527458191
for O 0 0.008855964988470078
4003delTC O 0 0.13686886429786682
, O 0 0.005349732004106045
whereas O 0 0.012403862550854683
those O 0 0.004351950250566006
in O 0 0.0037303445860743523
two O 0 0.0047859619371593
others O 0 0.010204799473285675
are O 0 0.008625377900898457
compound O 0 0.1203174963593483
heterozygotes O 1 0.676368236541748
. O 0 0.04713770002126694

To O 0 0.01658625528216362
determine O 0 0.014366614632308483
if O 0 0.0072595602832734585
the O 0 0.005295174662023783
occurrence O 0 0.04929595813155174
of O 0 0.0053527625277638435
4003delTC O 0 0.0960918739438057
in O 0 0.006012742407619953
these O 0 0.00660553527995944
unrelated O 0 0.12334533780813217
families O 0 0.03582244738936424
signifies O 0 0.07900162041187286
propagation O 0 0.060400329530239105
of O 0 0.005016233306378126
an O 0 0.010266483761370182
ancestral O 0 0.24754096567630768
allele O 1 0.6624003648757935
or O 0 0.02521413378417492
a O 0 0.020985811948776245
mutational O 1 0.6305556893348694
hot O 0 0.04177650809288025
spot O 0 0.02000357210636139
, O 0 0.010116701945662498
haplotypes O 0 0.42226675152778625
were O 0 0.0038855797611176968
determined O 0 0.009583587758243084
for O 0 0.006309558171778917
polymorphisms O 0 0.48750048875808716
both O 0 0.008837654255330563
within O 0 0.011705005541443825
and O 0 0.010921090841293335
flanking O 0 0.2453867644071579
COL17A1 O 1 0.5541975498199463
. O 0 0.05519169941544533

Five O 0 0.0386565625667572
intragenic O 0 0.24806764721870422
polymorphisms O 0 0.32582899928092957
were O 0 0.010308494791388512
chosen O 0 0.009844490326941013
based O 0 0.008654088713228703
on O 0 0.0075426241382956505
their O 0 0.010732954367995262
informativeness O 0 0.17232808470726013
. O 0 0.03209937736392021

One O 0 0.01284232921898365
of O 0 0.007146861404180527
these O 0 0.00455919886007905
, O 0 0.00333788082934916
not O 0 0.002481736009940505
previously O 0 0.004701483529061079
reported O 0 0.007291023153811693
, O 0 0.0029842727817595005
was O 0 0.0030618298333138227
2988 O 0 0.044677335768938065
A O 0 0.006277486216276884
or O 0 0.006647932808846235
C O 0 0.023842263966798782
that O 0 0.0027174237184226513
introduces O 0 0.012121127918362617
a O 0 0.0047909594140946865
new O 0 0.004983683116734028
restriction O 0 0.022881392389535904
site O 0 0.007960427552461624
for O 0 0.006893227808177471
Eco0109 O 0 0.11216219514608383
I O 0 0.01621220074594021
. O 0 0.022708933800458908

All O 0 0.01797015592455864
the O 0 0.01367152575403452
4003delTC O 0 0.30724218487739563
alleles O 1 0.5689737200737
showed O 0 0.017420154064893723
the O 0 0.007326196879148483
same O 0 0.011696982197463512
haplotype O 1 0.5197591185569763
for O 0 0.007835282012820244
these O 0 0.009234077297151089
five O 0 0.01962616667151451
polymorphic O 1 0.7523206472396851
markers O 0 0.3789328634738922
. O 0 0.052727047353982925

Fourteen O 0 0.06470979750156403
microsatellite O 0 0.4502592980861664
polymorphisms O 0 0.22409141063690186
were O 0 0.008569030091166496
selected O 0 0.007077517453581095
based O 0 0.005780402570962906
on O 0 0.0033236704766750336
their O 0 0.0038347800727933645
high O 0 0.007775105070322752
heterozygosity O 0 0.1857367902994156
and O 0 0.004098665434867144
their O 0 0.00399233540520072
location O 0 0.008031543344259262
within O 0 0.011083162389695644
10q23 O 0 0.22871296107769012
- O 0 0.1674051433801651
q25 O 0 0.3558860719203949
near O 0 0.06372915953397751
COL17A1 O 0 0.42746078968048096
. O 0 0.04612709954380989

Three O 0 0.03375712037086487
families O 0 0.04246939346194267
shared O 0 0.0538952499628067
microsatellite O 1 0.695711612701416
polymorphisms O 1 0.558883547782898
covering O 0 0.020439419895410538
at O 0 0.007733338512480259
most O 0 0.006569312885403633
19 O 0 0.01101431343704462
cM O 0 0.04013006016612053
, O 0 0.004036110360175371
whereas O 0 0.008796694688498974
the O 0 0.003344157012179494
others O 0 0.0049696811474859715
shared O 0 0.007528971880674362
smaller O 0 0.012937790714204311
regions O 0 0.027078848332166672
consistent O 0 0.019825389608740807
with O 0 0.005368790589272976
cross O 0 0.017759867012500763
- O 0 0.01797741837799549
over O 0 0.004105474334210157
events O 0 0.007706464733928442
during O 0 0.007185047492384911
passage O 0 0.01029697060585022
of O 0 0.005480384454131126
this O 0 0.008962258696556091
mutation O 1 0.6373482346534729
through O 0 0.012750925496220589
several O 0 0.01536099798977375
generations O 0 0.12208602577447891
. O 0 0.0384298600256443

These O 0 0.02180325798690319
results O 0 0.02236163802444935
indicate O 0 0.01938973367214203
that O 0 0.00915366318076849
4003delTC O 0 0.15084725618362427
occurs O 0 0.07699983566999435
on O 0 0.005650126840919256
a O 0 0.008418134413659573
single O 0 0.025877056643366814
ancestral O 0 0.2900804579257965
allele O 1 0.7285017967224121
. O 0 0.02738197334110737
. O 0 0.02803909406065941

The O 0 0.059600792825222015
haptoglobin O 1 0.7331463694572449
- O 0 0.4832404851913452
gene O 1 0.839905321598053
deletion O 1 0.6737967729568481
responsible O 0 0.0653911605477333
for O 0 0.025737913325428963
anhaptoglobinemia B-Disease 0 0.31111371517181396
. O 0 0.03958539664745331

We O 0 0.01465526595711708
have O 0 0.00896227452903986
found O 0 0.010978510603308678
an O 0 0.00924723967909813
allelic O 0 0.4127790033817291
deletion O 0 0.39425528049468994
of O 0 0.008488263934850693
the O 0 0.015472768805921078
haptoglobin O 1 0.6730916500091553
( O 0 0.1101495623588562
Hp O 0 0.26879921555519104
) O 0 0.04060408100485802
gene O 0 0.3309839069843292
from O 0 0.006740177050232887
an O 0 0.007628887891769409
individual O 0 0.03294460102915764
with O 0 0.02486957423388958
anhaptoglobinemia B-Disease 0 0.43759864568710327
. O 0 0.04858897998929024

The O 0 0.030806727707386017
Hp O 0 0.2519646883010864
gene O 1 0.5097590684890747
cluster O 0 0.07507295161485672
consists O 0 0.009901756420731544
of O 0 0.005957887973636389
coding O 0 0.09328994899988174
regions O 0 0.013562186621129513
of O 0 0.004021809436380863
the O 0 0.0045881373807787895
alpha O 0 0.034139540046453476
chain O 0 0.056991539895534515
and O 0 0.005944508593529463
beta O 0 0.09704339504241943
chain O 0 0.05155206099152565
of O 0 0.005511821713298559
the O 0 0.01459081657230854
haptoglobin O 1 0.817607581615448
gene O 1 0.8366402983665466
( O 0 0.06788711994886398
Hp O 0 0.09440164268016815
) O 0 0.0060238903388381
and O 0 0.002166650490835309
of O 0 0.0021249831188470125
the O 0 0.0031031952239573
alpha O 0 0.018279042094945908
chain O 0 0.04282315447926521
and O 0 0.0056970492005348206
beta O 0 0.11646374315023422
chain O 0 0.05966220796108246
of O 0 0.006253567989915609
the O 0 0.016791801899671555
haptoglobin O 1 0.8258423209190369
- O 1 0.5965133309364319
related O 1 0.6311948299407959
gene O 1 0.9104328155517578
( O 0 0.23684439063072205
Hpr O 1 0.7750587463378906
) O 0 0.018202150240540504
, O 0 0.004153273068368435
in O 0 0.00399853615090251
tandem O 0 0.027012910693883896
from O 0 0.004948114976286888
the O 0 0.005147032905369997
5 O 0 0.011246995069086552
side O 0 0.01849552057683468
. O 0 0.02409193105995655

Southern O 0 0.050999414175748825
blot O 0 0.10502587258815765
and O 0 0.014982834458351135
PCR O 0 0.11925946176052094
analyses O 0 0.018577435985207558
have O 0 0.005157949402928352
indicated O 0 0.0062389736995100975
that O 0 0.002758994232863188
the O 0 0.00293366820551455
individual O 0 0.006986306514590979
with O 0 0.006157983094453812
anhaptoglobinemia B-Disease 0 0.137987419962883
was O 0 0.0068617528304457664
homozygous O 0 0.32675614953041077
for O 0 0.006434235721826553
the O 0 0.009682325646281242
gene O 1 0.6463973522186279
deletion O 0 0.39081981778144836
and O 0 0.004397379234433174
that O 0 0.003957209177315235
the O 0 0.0058937277644872665
gene O 1 0.514888346195221
deletion O 0 0.26546773314476013
was O 0 0.0038367637898772955
included O 0 0.0035890634171664715
at O 0 0.0029802988283336163
least O 0 0.0037462031468749046
from O 0 0.003810263704508543
the O 0 0.004130133893340826
promoter O 0 0.10219737887382507
region O 0 0.011274139396846294
of O 0 0.0052707502618432045
Hp O 0 0.08971771597862244
to O 0 0.008540679700672626
Hpr O 0 0.49127644300460815
alpha O 0 0.03638412058353424
but O 0 0.0062256804667413235
not O 0 0.005326252896338701
to O 0 0.009754915721714497
Hpr O 1 0.7107142210006714
beta O 0 0.433704137802124
( O 0 0.13878090679645538
Hpdel O 0 0.43768149614334106
) O 0 0.054674308747053146
. O 0 0.028735514730215073

In O 0 0.016847899183630943
addition O 0 0.01132217887789011
, O 0 0.005153590813279152
we O 0 0.003160216147080064
found O 0 0.0037347974721342325
seven O 0 0.004185009282082319
individuals O 0 0.014643633738160133
with O 0 0.005303210113197565
hypohaptoglobinemia B-Disease 0 0.06362423300743103
in O 0 0.0036651480477303267
three O 0 0.0037187642883509398
families O 0 0.011072076857089996
, O 0 0.002743133809417486
and O 0 0.002005926100537181
the O 0 0.0027242894284427166
genotypes O 0 0.16708624362945557
of O 0 0.00244355876930058
six O 0 0.003154880367219448
of O 0 0.0021964088082313538
the O 0 0.002478962065652013
seven O 0 0.004430508241057396
individuals O 0 0.013607962988317013
were O 0 0.002623799489811063
found O 0 0.005823187995702028
to O 0 0.004431938752532005
be O 0 0.01047668606042862
Hp2 O 0 0.48734650015830994
/ O 0 0.4516928195953369
Hpdel O 0 0.4386724531650543
. O 0 0.04573347046971321

The O 0 0.02812108024954796
phenotypes O 0 0.41138768196105957
and O 0 0.011418655514717102
genotypes O 0 0.310254842042923
in O 0 0.005445453803986311
one O 0 0.0034556707832962275
of O 0 0.002612616401165724
these O 0 0.0025229500606656075
three O 0 0.002740445313975215
families O 0 0.0065348390489816666
showed O 0 0.00521748187020421
the O 0 0.002733782632276416
father O 0 0.00853843055665493
to O 0 0.003554383059963584
be O 0 0.005636042449623346
hypohaptoglobinemic B-Disease 0 0.25218403339385986
( O 0 0.07139450311660767
Hp2 O 0 0.39237460494041443
) O 0 0.032721031457185745
and O 0 0.009516973979771137
Hp2 O 0 0.38924410939216614
/ O 0 0.24908120930194855
Hpdel O 0 0.16985182464122772
, O 0 0.005353465676307678
the O 0 0.004115790594369173
mother O 0 0.015984175726771355
to O 0 0.0037116757594048977
be O 0 0.0045745181851089
Hp2 O 0 0.16706964373588562
- O 0 0.06041904538869858
1 O 0 0.011815730482339859
and O 0 0.00723223714157939
Hp1 O 0 0.3394503593444824
/ O 0 0.2004079669713974
Hp2 O 0 0.0986410453915596
, O 0 0.0029173402581363916
one O 0 0.0018883626908063889
of O 0 0.0017891413299366832
the O 0 0.0018703751266002655
two O 0 0.0026944971177726984
children O 0 0.012070359662175179
to O 0 0.00327484798617661
be O 0 0.00502507109194994
hypohaptoglobinemic B-Disease 0 0.262669175863266
( O 0 0.07867071777582169
Hp2 O 0 0.32833075523376465
) O 0 0.0214875228703022
and O 0 0.008043350651860237
Hp2 O 0 0.3649251163005829
/ O 0 0.2269304394721985
Hpdel O 0 0.11921001225709915
, O 0 0.0032234189566224813
and O 0 0.002236817264929414
the O 0 0.002354412106797099
other O 0 0.0031463410705327988
child O 0 0.020191965624690056
to O 0 0.003271976485848427
be O 0 0.003991189878433943
Hp1 O 0 0.14047788083553314
and O 0 0.010931752622127533
Hp1 O 1 0.519697904586792
/ O 0 0.38527053594589233
Hpdel O 0 0.2944459319114685
, O 0 0.008090664632618427
showing O 0 0.017946045845746994
an O 0 0.010963593609631062
anomalous O 0 0.33446043729782104
inheritance O 0 0.408468097448349
of O 0 0.015995489433407784
Hp O 0 0.38970518112182617
phenotypes O 1 0.7175208926200867
in O 0 0.014932054094970226
the O 0 0.012156397104263306
child O 0 0.17572994530200958
with O 0 0.02676970325410366
Hp1 O 0 0.43710315227508545
. O 0 0.054891787469387054

The O 0 0.041313573718070984
Hp2 O 1 0.5312076210975647
/ O 0 0.33025702834129333
Hpdel O 0 0.25319957733154297
individuals O 0 0.02697787806391716
had O 0 0.007526251021772623
an O 0 0.006775366608053446
extremely O 0 0.019194258376955986
low O 0 0.02232930064201355
level O 0 0.00952863972634077
of O 0 0.00735522760078311
Hp O 0 0.19174550473690033
( O 0 0.07006688416004181
mean O 0 0.10589595139026642
+ O 1 0.5143964290618896
/ O 0 0.4303310811519623
- O 0 0.18739396333694458
SD O 0 0.3623742163181305
= O 0 0.24792702496051788
0 O 0 0.06215878203511238
. O 0 0.028905153274536133
049 O 1 0.8204213976860046
+ O 1 0.5383127927780151
/ O 0 0.3994413912296295
- O 0 0.10896212607622147
0 O 0 0.04751310497522354
. O 0 0.017740745097398758
043 O 1 0.6434256434440613
mg O 1 0.6956850290298462
/ O 1 0.5656164884567261
ml O 1 0.6473168730735779
; O 0 0.0518987812101841
n O 0 0.06401070952415466
= O 0 0.10860860347747803
6 O 0 0.013782473281025887
) O 0 0.00669717276468873
, O 0 0.0027602592017501593
compared O 0 0.004700229503214359
with O 0 0.002626570174470544
the O 0 0.0025294756051152945
level O 0 0.006294591818004847
( O 0 0.012675811536610126
1 O 0 0.007102075032889843
. O 0 0.0052507007494568825
64 O 0 0.027193939313292503
+ O 0 0.2922268509864807
/ O 0 0.2187320441007614
- O 0 0.07093797624111176
1 O 0 0.014419999904930592
. O 0 0.012127067893743515
07 O 0 0.20512117445468903
mg O 1 0.6744491457939148
/ O 1 0.5057198405265808
ml O 1 0.5035805106163025
) O 0 0.018484190106391907
obtained O 0 0.007281880360096693
from O 0 0.005970038007944822
52 O 0 0.026274429634213448
healthy O 0 0.3594733476638794
volunteers O 0 0.0815197005867958
having O 0 0.06972984969615936
phenotype O 1 0.919900119304657
Hp2 O 0 0.37834927439689636
, O 0 0.008048580028116703
whereas O 0 0.0326446034014225
the O 0 0.007176851388067007
serum O 0 0.4758323132991791
Hp O 0 0.08400736004114151
level O 0 0.00827865395694971
of O 0 0.004196389578282833
an O 0 0.005713015794754028
individual O 0 0.028639625757932663
with O 0 0.023398082703351974
Hp1 O 1 0.5617204308509827
/ O 0 0.38265037536621094
Hpdel O 0 0.29130062460899353
was O 0 0.014756450429558754
0 O 0 0.046729397028684616
. O 0 0.02887118048965931

50 O 0 0.057991333305835724
mg O 0 0.44582584500312805
/ O 0 0.3035762906074524
ml O 0 0.17615385353565216
, O 0 0.006508248392492533
which O 0 0.0033722887746989727
was O 0 0.002661779522895813
approximately O 0 0.003410424804314971
half O 0 0.003187256632372737
the O 0 0.002524210372939706
level O 0 0.004027559421956539
of O 0 0.003148773917928338
Hp O 0 0.053597718477249146
in O 0 0.0066264597699046135
control O 0 0.03755789250135422
sera O 0 0.07865533977746964
from O 0 0.009265298955142498
the O 0 0.015058709308505058
Hp1 O 1 0.6680524349212646
phenotype O 1 0.9366391897201538
( O 0 0.052790794521570206
1 O 0 0.012602346017956734
. O 0 0.007628523278981447
26 O 0 0.02921804040670395
+ O 0 0.329607754945755
/ O 0 0.24859099090099335
- O 0 0.0740961879491806
0 O 0 0.030259106308221817
. O 0 0.008848645724356174
33 O 0 0.04697410762310028
mg O 1 0.5669316053390503
/ O 1 0.5182462930679321
ml O 1 0.5980269908905029
; O 0 0.053781621158123016
n O 0 0.07003069669008255
= O 0 0.09455899894237518
9 O 0 0.012107547372579575
) O 0 0.009314073249697685
, O 0 0.004645464941859245
showing O 0 0.01653261110186577
a O 0 0.04078643023967743
gene O 1 0.8528690934181213
- O 0 0.38360729813575745
dosage O 1 0.7236194014549255
effect O 0 0.30253422260284424
. O 0 0.058564458042383194

The O 0 0.024254370480775833
other O 0 0.022655591368675232
allele O 1 0.6552658081054688
( O 0 0.05968184769153595
Hp2 O 0 0.22741812467575073
) O 0 0.011516032740473747
of O 0 0.004488551057875156
individuals O 0 0.031985167413949966
with O 0 0.0149852205067873
Hp2 O 0 0.36095842719078064
/ O 0 0.2045557200908661
Hpdel O 0 0.12201434373855591
was O 0 0.0035463296808302402
found O 0 0.0036705678794533014
to O 0 0.0023361158091574907
have O 0 0.002188818994909525
, O 0 0.002135401125997305
in O 0 0.002406349405646324
all O 0 0.0028087422251701355
exons O 0 0.1661490947008133
, O 0 0.007603655569255352
no O 0 0.012896740809082985
mutation O 1 0.7723610997200012
, O 0 0.012738901190459728
by O 0 0.01856580376625061
DNA O 0 0.38434886932373047
sequencing O 0 0.3214256465435028
. O 0 0.03711066395044327

On O 0 0.012922004796564579
the O 0 0.007210904266685247
basis O 0 0.005811578128486872
of O 0 0.003373148152604699
the O 0 0.0031461017206311226
present O 0 0.00458528520539403
study O 0 0.005844560917466879
, O 0 0.002279458334669471
the O 0 0.002537432126700878
mechanism O 0 0.02905343659222126
of O 0 0.003623010590672493
anhaptoglobinemia B-Disease 0 0.08989249169826508
and O 0 0.0032771958503872156
the O 0 0.003749798284843564
mechanism O 0 0.05516867712140083
of O 0 0.006634371355175972
anomalous O 0 0.34092065691947937
inheritance O 0 0.44524699449539185
of O 0 0.02024458348751068
Hp O 0 0.3883918225765228
phenotypes O 1 0.6673807501792908
were O 0 0.008218714036047459
well O 0 0.013154630549252033
explained O 0 0.04580586031079292
. O 0 0.02551543153822422

However O 0 0.02784678526222706
, O 0 0.013753252103924751
the O 0 0.009769325144588947
mechanism O 0 0.04694214090704918
of O 0 0.013419791124761105
hypohaptoglobinemia B-Disease 0 0.30302539467811584
remains O 0 0.06496388465166092
unknown O 0 0.12624888122081757

ATM O 1 0.6091587543487549
mutations O 1 0.8897384405136108
and O 0 0.05772802606225014
phenotypes O 1 0.9099655747413635
in O 0 0.2376781404018402
ataxia B-Disease 1 0.9744184017181396
- I-Disease 1 0.7210655212402344
telangiectasia I-Disease 1 0.9358677864074707
families O 0 0.04376924782991409
in O 0 0.006765516474843025
the O 0 0.005028609652072191
British O 0 0.01503816433250904
Isles O 0 0.057565800845623016
: O 0 0.011285885237157345
expression O 0 0.04798978939652443
of O 0 0.008218029513955116
mutant O 0 0.48391926288604736
ATM O 0 0.21230965852737427
and O 0 0.009410757571458817
the O 0 0.028975719586014748
risk O 1 0.8392008543014526
of O 0 0.25212758779525757
leukemia B-Disease 1 0.9881814122200012
, O 1 0.5068259835243225
lymphoma B-Disease 1 0.9862620830535889
, O 0 0.23924283683300018
and O 0 0.3280867338180542
breast B-Disease 1 0.9813176989555359
cancer I-Disease 1 0.9718011617660522
. O 0 0.22700278460979462

We O 0 0.01578795537352562
report O 0 0.012269159778952599
the O 0 0.008497246541082859
spectrum O 0 0.029223568737506866
of O 0 0.010892967693507671
59 O 0 0.12049026787281036
ATM O 1 0.6177378296852112
mutations O 1 0.9469287395477295
observed O 0 0.4088022708892822
in O 0 0.2618813216686249
ataxia B-Disease 1 0.9804257750511169
- I-Disease 1 0.891738772392273
telangiectasia I-Disease 1 0.9684509634971619
( O 0 0.2524537146091461
A B-Disease 0 0.15835262835025787
- I-Disease 1 0.535922110080719
T I-Disease 1 0.8809051513671875
) O 0 0.16567416489124298
patients O 1 0.7626721262931824
in O 0 0.010608158074319363
the O 0 0.00984986498951912
British O 0 0.03820023685693741
Isles O 0 0.18634498119354248
. O 0 0.037273455411195755

Of O 0 0.024493537843227386
51 O 0 0.0771469995379448
ATM O 0 0.32186633348464966
mutations O 1 0.7654507756233215
identified O 0 0.02305707149207592
in O 0 0.005910307168960571
families O 0 0.008139331825077534
native O 0 0.005509540904313326
to O 0 0.0027257108595222235
the O 0 0.0030562325846403837
British O 0 0.0075162602588534355
Isles O 0 0.02559814229607582
, O 0 0.003862666431814432
11 O 0 0.005723436828702688
were O 0 0.004006074741482735
founder O 0 0.06460665166378021
mutations O 1 0.5754178166389465
, O 0 0.003935149405151606
and O 0 0.002688440727069974
2 O 0 0.0039037035312503576
of O 0 0.0029821183998137712
these O 0 0.004264690913259983
11 O 0 0.011229990050196648
conferred O 0 0.07122248411178589
a O 0 0.03997999429702759
milder O 1 0.8440055251121521
clinical O 1 0.8755097389221191
phenotype O 1 0.9061012864112854
with O 0 0.014803465455770493
respect O 0 0.010521716438233852
to O 0 0.0081779258325696
both O 0 0.04522423446178436
cerebellar B-Disease 1 0.9508703947067261
degeneration I-Disease 1 0.9586727619171143
and O 0 0.05948290973901749
cellular O 0 0.4922209084033966
features O 0 0.07488223165273666
. O 0 0.04540757089853287

We O 0 0.012414976954460144
report O 0 0.00996560137718916
, O 0 0.005174108315259218
in O 0 0.004765709396451712
two O 0 0.004741566255688667
A B-Disease 0 0.02266695350408554
- I-Disease 0 0.19025062024593353
T I-Disease 1 0.5539262890815735
families O 0 0.04530112072825432
, O 0 0.008552396669983864
an O 0 0.017464080825448036
ATM O 0 0.4861834943294525
mutation O 1 0.9418536424636841
( O 0 0.22356016933918
7271T O 1 0.6254205107688904
- O 0 0.3338489830493927
- O 0 0.36892181634902954
> O 1 0.6066982746124268
G O 0 0.32293501496315
) O 0 0.01383217703551054
that O 0 0.0032662972807884216
may O 0 0.008532015606760979
be O 0 0.003005742793902755
associated O 0 0.017456969246268272
with O 0 0.005464714020490646
an O 0 0.01073385588824749
increased O 0 0.15468426048755646
risk O 1 0.7613552808761597
of O 0 0.16938886046409607
breast B-Disease 1 0.9874910116195679
cancer I-Disease 1 0.976704478263855
in O 0 0.03114742413163185
both O 0 0.04462754353880882
homozygotes O 1 0.8236510157585144
and O 0 0.029903991147875786
heterozygotes O 1 0.8236691355705261
( O 0 0.1126079186797142
relative O 0 0.11677498370409012
risk O 0 0.41328591108322144
12 O 0 0.0151231549680233
. O 0 0.00681179529055953
7 O 0 0.017658818513154984
; O 0 0.029672225937247276
P O 0 0.18351653218269348
= O 0 0.17694887518882751
. O 0 0.014537982642650604
0025 O 1 0.5899618268013
) O 0 0.01021133828908205
, O 0 0.0032379000913351774
although O 0 0.003299265867099166
there O 0 0.002344664419069886
is O 0 0.0027734371833503246
a O 0 0.006675219628959894
less O 0 0.04514347016811371
severe O 1 0.7847138047218323
A B-Disease 0 0.11604109406471252
- I-Disease 1 0.5009194612503052
T I-Disease 1 0.8731601238250732
phenotype O 1 0.8669692277908325
in O 0 0.008393961004912853
terms O 0 0.006534254644066095
of O 0 0.00382542097941041
the O 0 0.006554125342518091
degree O 0 0.04646008834242821
of O 0 0.04771196469664574
cerebellar B-Disease 1 0.9460648894309998
degeneration I-Disease 1 0.9542936086654663
. O 0 0.1966712921857834

This O 0 0.05082251504063606
mutation O 1 0.8876131176948547
( O 0 0.1409364640712738
7271T O 1 0.5458874702453613
- O 0 0.3118200898170471
- O 0 0.27174192667007446
> O 0 0.4861864447593689
G O 0 0.17169566452503204
) O 0 0.011509543284773827
also O 0 0.0037082440685480833
allows O 0 0.006836220622062683
expression O 0 0.009380853734910488
of O 0 0.00357551546767354
full O 0 0.006034182850271463
- O 0 0.03853558003902435
length O 0 0.03126012906432152
ATM O 0 0.10691040754318237
protein O 0 0.07161054015159607
at O 0 0.004866186995059252
a O 0 0.005007361527532339
level O 0 0.006592294666916132
comparable O 0 0.021037185564637184
with O 0 0.005932173691689968
that O 0 0.005241423845291138
in O 0 0.011315936222672462
unaffected O 0 0.3473561704158783
individuals O 0 0.15843233466148376
. O 0 0.0393284447491169

In O 0 0.01578059047460556
addition O 0 0.010720355436205864
, O 0 0.005666912067681551
we O 0 0.0035861299838870764
have O 0 0.0034757950343191624
studied O 0 0.00853858795017004
18 O 0 0.014847256243228912
A B-Disease 0 0.05282798781991005
- I-Disease 0 0.477191686630249
T I-Disease 1 0.9091026186943054
patients O 1 0.8740402460098267
, O 0 0.009774775244295597
in O 0 0.008097440004348755
15 O 0 0.022010330110788345
families O 0 0.06582000851631165
, O 0 0.01813661865890026
who O 0 0.08159530162811279
developed O 1 0.8091376423835754
leukemia B-Disease 1 0.9878557324409485
, O 0 0.4339270293712616
lymphoma B-Disease 1 0.9870447516441345
, O 0 0.21359151601791382
preleukemic O 1 0.8871090412139893
T O 1 0.9342755675315857
- O 1 0.7989395260810852
cell O 1 0.9064464569091797
proliferation O 1 0.8623411655426025
, O 0 0.14046670496463776
or O 1 0.598646879196167
Hodgkin B-Disease 1 0.9869297742843628
lymphoma I-Disease 1 0.9841804504394531
, O 0 0.040168315172195435
mostly O 0 0.036530669778585434
in O 0 0.03463921323418617
childhood O 1 0.6300370097160339
. O 0 0.07642775774002075

A O 0 0.03209850192070007
wide O 0 0.024158695712685585
variety O 0 0.02047467790544033
of O 0 0.012294507585465908
ATM O 0 0.3584980070590973
mutation O 1 0.8748084902763367
types O 0 0.12055101990699768
, O 0 0.011359385214745998
including O 0 0.02955629862844944
missense O 1 0.7956579327583313
mutations O 1 0.8564924597740173
and O 0 0.009909247979521751
in O 0 0.009854945354163647
- O 0 0.07079185545444489
frame O 0 0.06473180651664734
deletions O 0 0.20204581320285797
, O 0 0.004583926871418953
were O 0 0.003841335652396083
seen O 0 0.010252481326460838
in O 0 0.009500734508037567
these O 0 0.03427448496222496
patients O 1 0.8424474596977234
. O 0 0.05288003757596016

We O 0 0.011731347069144249
also O 0 0.006049256306141615
show O 0 0.005502193234860897
that O 0 0.0031254279892891645
25 O 0 0.003997279331088066
% O 0 0.00468367850407958
of O 0 0.0028731985948979855
all O 0 0.00375026511028409
A B-Disease 0 0.045563820749521255
- I-Disease 0 0.42523813247680664
T I-Disease 1 0.8666998147964478
patients O 1 0.8362888693809509
carried O 0 0.021573506295681
in O 0 0.013803086243569851
- O 0 0.19644032418727875
frame O 0 0.17303098738193512
deletions O 1 0.6216329336166382
or O 0 0.10936351120471954
missense O 1 0.8537582755088806
mutations O 1 0.8252067565917969
, O 0 0.005116869695484638
many O 0 0.003008783794939518
of O 0 0.002437079092487693
which O 0 0.002453172579407692
were O 0 0.001944030518643558
also O 0 0.002720881486311555
associated O 0 0.011812068521976471
with O 0 0.005489719565957785
expression O 0 0.05949384719133377
of O 0 0.011548925191164017
mutant O 1 0.5805988907814026
ATM O 0 0.4196171760559082
protein O 1 0.509579598903656
. O 0 0.05141107738018036

The O 0 0.05425688251852989
DMPK O 1 0.6910921931266785
gene O 1 0.8181379437446594
of O 0 0.09721395373344421
severely O 1 0.8850688934326172
affected O 1 0.9338211417198181
myotonic B-Disease 1 0.9774262309074402
dystrophy I-Disease 1 0.9834989905357361
patients O 1 0.9551548361778259
is O 0 0.07213596999645233
hypermethylated O 0 0.47364550828933716
proximal O 0 0.46461954712867737
to O 0 0.008742040954530239
the O 0 0.0077965110540390015
largely O 0 0.023569796234369278
expanded O 0 0.03618832305073738
CTG O 0 0.4775819480419159
repeat O 0 0.3237646818161011
. O 0 0.04813303053379059

Using O 0 0.05470883473753929
methylation O 0 0.3375667631626129
- O 0 0.09632209688425064
sensitive O 0 0.041020624339580536
restriction O 0 0.05654320865869522
enzymes O 0 0.14553377032279968
, O 0 0.006491584237664938
we O 0 0.0044251903891563416
characterized O 0 0.043675124645233154
the O 0 0.005307208746671677
methylation O 0 0.12975317239761353
pattern O 0 0.022864075377583504
on O 0 0.002541669411584735
the O 0 0.002330941613763571
5 O 0 0.0037960130721330643
side O 0 0.00309921195730567
of O 0 0.0025007533840835094
the O 0 0.004025514703243971
CTG O 0 0.2629045844078064
repeat O 0 0.09767044335603714
in O 0 0.008230227045714855
the O 0 0.01288588996976614
DMPK O 1 0.6079520583152771
gene O 1 0.6718572378158569
of O 0 0.013249426148831844
normal O 0 0.14917804300785065
individuals O 0 0.08041644841432571
and O 0 0.011276806704699993
of O 0 0.0361056923866272
patients O 1 0.9467383027076721
affected O 1 0.6687660217285156
with O 0 0.2928149700164795
myotonic B-Disease 1 0.9777766466140747
dystrophy I-Disease 1 0.9748862981796265
, O 0 0.02399255521595478
showing O 0 0.037035584449768066
expansions O 0 0.08663839101791382
of O 0 0.010463051497936249
the O 0 0.016927067190408707
repetitive O 1 0.6591916680335999
sequence O 0 0.22526411712169647
. O 0 0.058641400188207626

The O 0 0.031662717461586
gene O 0 0.3642858862876892
segment O 0 0.037380874156951904
analyzed O 0 0.026915157213807106
corresponds O 0 0.01856689341366291
to O 0 0.007201017811894417
the O 0 0.01091200951486826
genomic O 1 0.6092420816421509
SacI O 1 0.6405172944068909
- O 0 0.24179118871688843
HindIII O 0 0.4161223769187927
fragment O 0 0.12978923320770264
carrying O 0 0.026582838967442513
exons O 0 0.3313163220882416
11 O 0 0.03871356323361397
- O 0 0.1068408414721489
15 O 0 0.03301875665783882
. O 0 0.026115015149116516

There O 0 0.020614493638277054
is O 0 0.013260235078632832
constitutive O 0 0.19178509712219238
methylation O 0 0.234566792845726
in O 0 0.014459699392318726
intron O 0 0.4141349196434021
12 O 0 0.010026388801634312
at O 0 0.005820375867187977
restriction O 0 0.014522314071655273
sites O 0 0.006359835620969534
of O 0 0.00428912416100502
SacII O 0 0.12013304978609085
and O 0 0.007284562103450298
HhaI O 0 0.24702022969722748
, O 0 0.011979810893535614
localized O 0 0.33928871154785156
1 O 0 0.010224465280771255
, O 0 0.00575815187767148
159 O 0 0.03389625996351242
- O 0 0.03886060416698456
1 O 0 0.006872526835650206
, O 0 0.0044348896481096745
232 O 0 0.02086336351931095
bp O 0 0.016854235902428627
upstream O 0 0.01357010006904602
of O 0 0.0036421865224838257
the O 0 0.005220715422183275
CTG O 0 0.27075067162513733
repeat O 0 0.09147688746452332
, O 0 0.004972207359969616
whereas O 0 0.010578560642898083
most O 0 0.0031771191861480474
, O 0 0.001958792796358466
if O 0 0.0017037515062838793
not O 0 0.0011077182134613395
all O 0 0.0010800688760355115
, O 0 0.001216998789459467
of O 0 0.0012030670186504722
the O 0 0.0013849970418959856
other O 0 0.0017930235480889678
sites O 0 0.0031526542734354734
of O 0 0.0031945928931236267
SacII O 0 0.1112726554274559
, O 0 0.005777671467512846
HhaI O 0 0.12361180782318115
, O 0 0.004655830096453428
and O 0 0.003947359509766102
HpaII O 0 0.07483462989330292
in O 0 0.004027869086712599
this O 0 0.0033652514684945345
region O 0 0.010402284562587738
are O 0 0.0041357590816915035
unmethylated O 0 0.24936996400356293
, O 0 0.005231706891208887
in O 0 0.005880171433091164
normal O 0 0.05715816468000412
individuals O 0 0.02374599128961563
and O 0 0.0035631032660603523
most O 0 0.004278426058590412
of O 0 0.005465841386467218
the O 0 0.023322125896811485
patients O 1 0.8791720867156982
. O 0 0.06938137114048004

In O 0 0.016380660235881805
a O 0 0.009815094992518425
number O 0 0.0066230930387973785
of O 0 0.005878000054508448
young O 0 0.050017718225717545
and O 0 0.018002355471253395
severely O 1 0.6217283010482788
affected O 1 0.5124845504760742
patients O 1 0.8395508527755737
, O 0 0.007418629713356495
however O 0 0.005397345870733261
, O 0 0.003430089447647333
complete O 0 0.006434905808418989
methylation O 0 0.04550584405660629
of O 0 0.0024440123233944178
these O 0 0.0032292120158672333
restriction O 0 0.01612842082977295
sites O 0 0.004744749050587416
was O 0 0.0037317839451134205
found O 0 0.006446844432502985
in O 0 0.006407229229807854
the O 0 0.013949151150882244
mutated O 1 0.8790450096130371
allele O 1 0.8531903028488159
. O 0 0.07266789674758911

In O 0 0.01752699539065361
most O 0 0.010318847373127937
of O 0 0.007679154630750418
these O 0 0.016558075323700905
patients O 1 0.772373616695404
, O 0 0.011927765794098377
the O 0 0.017173325642943382
onset O 1 0.9033613204956055
of O 0 0.03784608840942383
the O 0 0.1357753574848175
disease O 1 0.979439914226532
was O 0 0.26337486505508423
congenital O 1 0.9732561707496643
. O 0 0.18672838807106018

Preliminary O 0 0.04174485057592392
in O 0 0.022104917094111443
vivo O 0 0.3328908085823059
footprinting O 1 0.5106337666511536
data O 0 0.014467678964138031
gave O 0 0.00982280820608139
evidence O 0 0.009529589675366879
for O 0 0.008214078843593597
protein O 0 0.3813723623752594
- O 0 0.20003458857536316
DNA O 0 0.3778059184551239
contact O 0 0.06683505326509476
in O 0 0.008577014319598675
normal O 0 0.06225159391760826
genes O 0 0.2659003436565399
at O 0 0.006433772388845682
an O 0 0.0067452131770551205
Sp1 O 0 0.3378590941429138
consensus O 0 0.01245906576514244
binding O 0 0.019335122779011726
site O 0 0.005385326221585274
upstream O 0 0.011116953566670418
of O 0 0.0035715934354811907
the O 0 0.004198693670332432
CTG O 0 0.17935679852962494
repeat O 0 0.042379122227430344
and O 0 0.002774128457531333
for O 0 0.002393195638433099
a O 0 0.003785335225984454
significant O 0 0.009836950339376926
reduction O 0 0.02860492281615734
of O 0 0.003163782646879554
this O 0 0.004034868441522121
interaction O 0 0.05360265448689461
in O 0 0.010887852869927883
cells O 0 0.49940750002861023
with O 0 0.018841633573174477
a O 0 0.043410904705524445
hypermethylated O 1 0.6369170546531677
DMPK O 1 0.7431622743606567
gene O 1 0.8117657899856567
. O 0 0.033268727362155914
. O 0 0.033371228724718094

The O 0 0.07519861310720444
hemochromatosis B-Disease 1 0.9187437295913696
gene O 1 0.6234568953514099
product O 0 0.05185418576002121
complexes O 0 0.07481855154037476
with O 0 0.009400109760463238
the O 0 0.008613129146397114
transferrin O 0 0.3987140357494354
receptor O 0 0.4573352336883545
and O 0 0.012036483734846115
lowers O 0 0.3165684640407562
its O 0 0.011756201274693012
affinity O 0 0.1441582292318344
for O 0 0.013663413003087044
ligand O 0 0.28338009119033813
binding O 0 0.1389526128768921
. O 0 0.030717553570866585

We O 0 0.020822644233703613
recently O 0 0.02215847559273243
reported O 0 0.01662280410528183
the O 0 0.008934462442994118
positional O 0 0.058727458119392395
cloning O 0 0.13243888318538666
of O 0 0.009024444967508316
a O 0 0.016876325011253357
candidate O 0 0.08154943585395813
gene O 1 0.8082210421562195
for O 0 0.11256596446037292
hereditary B-Disease 1 0.9500851631164551
hemochromatosis I-Disease 1 0.9598874449729919
called O 0 0.3717157244682312
HFE O 1 0.8846234083175659
. O 0 0.10455778241157532

The O 0 0.026328936219215393
gene O 0 0.2997947037220001
product O 0 0.01918712630867958
, O 0 0.005595717113465071
a O 0 0.0047248066402971745
member O 0 0.004475954454392195
of O 0 0.0032753164414316416
the O 0 0.004592315759509802
major O 0 0.03073790855705738
histocompatibility O 1 0.7500076293945312
complex O 0 0.06456892937421799
class O 0 0.028940802440047264
I O 0 0.008919178508222103
- O 0 0.035228047519922256
like O 0 0.008306177332997322
family O 0 0.01691117137670517
, O 0 0.0031076385639607906
was O 0 0.002466003643348813
found O 0 0.003395038889721036
to O 0 0.002635174198076129
have O 0 0.004272896330803633
a O 0 0.020570898428559303
mutation O 1 0.8865853548049927
, O 0 0.04762912169098854
Cys O 1 0.8661906719207764
- O 0 0.43301236629486084
282 O 1 0.5551676154136658
- O 1 0.5759702920913696
- O 1 0.5943390130996704
> O 1 0.8075411915779114
Tyr O 1 0.8085386753082275
( O 0 0.12090199440717697
C282Y O 0 0.2656915485858917
) O 0 0.01898009702563286
, O 0 0.005142278969287872
in O 0 0.005177968181669712
85 O 0 0.020636990666389465
% O 0 0.0265467818826437
of O 0 0.01841859519481659
patient O 1 0.7438727021217346
chromosomes O 1 0.6186218857765198
. O 0 0.059528086334466934

This O 0 0.03315719589591026
mutation O 1 0.6422767043113708
eliminates O 0 0.07256100326776505
the O 0 0.009351886808872223
ability O 0 0.017316941171884537
of O 0 0.008058254607021809
HFE O 1 0.5235916972160339
to O 0 0.008204881101846695
associate O 0 0.025392672047019005
with O 0 0.01879541017115116
beta2 O 1 0.5176210403442383
- O 0 0.34067302942276
microglobulin O 1 0.5861989855766296
( O 0 0.12887132167816162
beta2m O 0 0.4714418351650238
) O 0 0.04810872673988342
and O 0 0.015146567486226559
prevents O 1 0.5514683127403259
cell O 1 0.5102395415306091
- O 0 0.18887914717197418
surface O 0 0.10493847727775574
expression O 0 0.21420903503894806
. O 0 0.042832985520362854

A O 0 0.030255166813731194
second O 0 0.02329331636428833
mutation O 0 0.49674999713897705
that O 0 0.006438166368752718
has O 0 0.005268103908747435
no O 0 0.004956282675266266
effect O 0 0.015877740457654
on O 0 0.004313741344958544
beta2m O 0 0.19233670830726624
association O 0 0.031366169452667236
, O 0 0.006321731489151716
H63D O 0 0.10076871514320374
, O 0 0.0032732579857110977
was O 0 0.002330212155357003
found O 0 0.00282233371399343
in O 0 0.002370163332670927
eight O 0 0.003344370285049081
out O 0 0.0029139756225049496
of O 0 0.004368983209133148
nine O 0 0.02411598153412342
patients O 1 0.8416278958320618
heterozygous O 1 0.5283691883087158
for O 0 0.013097519986331463
the O 0 0.016384311020374298
C282Y O 0 0.4449153244495392
mutant O 1 0.6436882019042969
. O 0 0.06942782551050186

In O 0 0.018280452117323875
this O 0 0.010015252977609634
report O 0 0.009273921139538288
, O 0 0.005296081770211458
we O 0 0.004520161543041468
demonstrate O 0 0.010149067267775536
in O 0 0.01065127458423376
cultured O 0 0.344789981842041
293 O 1 0.5425552725791931
cells O 1 0.8879209160804749
overexpressing O 1 0.8996437191963196
wild O 0 0.26306453347206116
- O 0 0.32417523860931396
type O 0 0.26206591725349426
or O 0 0.06896314769983292
mutant O 1 0.6782006025314331
HFE O 1 0.8521841764450073
proteins O 0 0.22342753410339355
that O 0 0.006062361411750317
both O 0 0.005664584692567587
the O 0 0.00617228215560317
wild O 0 0.09899229556322098
- O 0 0.18741478025913239
type O 0 0.21175529062747955
and O 0 0.0277416855096817
H63D O 1 0.7279333472251892
HFE O 1 0.9168274402618408
proteins O 1 0.603517472743988
form O 0 0.2088174968957901
stable O 0 0.26835134625434875
complexes O 0 0.2536047399044037
with O 0 0.016248898580670357
the O 0 0.026623107492923737
transferrin O 1 0.8394107818603516
receptor O 1 0.8792252540588379
( O 0 0.32360318303108215
TfR O 1 0.8485490083694458
) O 0 0.09024474769830704
. O 0 0.032706987112760544

The O 0 0.03110453300178051
C282Y O 0 0.3538326323032379
mutation O 1 0.6936964392662048
nearly O 0 0.029351437464356422
completely O 0 0.023140447214245796
prevents O 0 0.061316028237342834
the O 0 0.00553508335724473
association O 0 0.012603056617081165
of O 0 0.005604987498372793
the O 0 0.013161434791982174
mutant O 1 0.6637244820594788
HFE O 1 0.8831049799919128
protein O 0 0.4777083694934845
with O 0 0.024400003254413605
the O 0 0.02640487439930439
TfR O 1 0.7452986240386963
. O 0 0.05415579676628113

Studies O 0 0.07110975682735443
on O 0 0.020473537966609
cell O 0 0.36478936672210693
- O 0 0.13447895646095276
associated O 0 0.08012804388999939
transferrin O 0 0.21024756133556366
at O 0 0.009152663871645927
37 O 0 0.015777168795466423
degrees O 0 0.018135908991098404
C O 0 0.03849073126912117
suggest O 0 0.011965782381594181
that O 0 0.003914228640496731
the O 0 0.00828312523663044
overexpressed O 1 0.7225387096405029
wild O 0 0.277156263589859
- O 0 0.42060235142707825
type O 1 0.5218210220336914
HFE O 1 0.8806767463684082
protein O 0 0.44277021288871765
decreases O 0 0.1562497317790985
the O 0 0.0074365935288369656
affinity O 0 0.0671924576163292
of O 0 0.006516769994050264
the O 0 0.012337053194642067
TfR O 1 0.6196539998054504
for O 0 0.02353065460920334
transferrin O 1 0.5885461568832397
. O 0 0.06666222214698792

The O 0 0.03716190531849861
overexpressed O 1 0.665363609790802
H63D O 0 0.31016165018081665
protein O 0 0.13962788879871368
does O 0 0.010317016392946243
not O 0 0.004035855643451214
have O 0 0.0029082458931952715
this O 0 0.002518715336918831
effect O 0 0.007086362224072218
, O 0 0.002688016276806593
providing O 0 0.003858560463413596
the O 0 0.0020643470343202353
first O 0 0.0023396702017635107
direct O 0 0.004613853525370359
evidence O 0 0.003778551472350955
for O 0 0.0031442795880138874
a O 0 0.005606058519333601
functional O 0 0.06690558791160583
consequence O 0 0.06656800210475922
of O 0 0.009011081419885159
the O 0 0.021785765886306763
H63D O 1 0.7096221446990967
mutation O 1 0.9277845025062561
. O 0 0.08709792792797089

Addition O 0 0.03458350896835327
of O 0 0.017746111378073692
soluble O 1 0.5150434970855713
wild O 0 0.2476346343755722
- O 0 0.49841824173927307
type O 1 0.6426860690116882
HFE O 1 0.9418649673461914
/ O 1 0.6769751906394958
beta2m O 1 0.6119558811187744
heterodimers O 1 0.776360273361206
to O 0 0.022880099713802338
cultured O 1 0.5182422399520874
cells O 1 0.5389925837516785
also O 0 0.006971324328333139
decreased O 0 0.06011524051427841
the O 0 0.0048068794421851635
apparent O 0 0.05261576920747757
affinity O 0 0.059648144990205765
of O 0 0.004119257442653179
the O 0 0.0049508605152368546
TfR O 0 0.2915005087852478
for O 0 0.004361466970294714
its O 0 0.00511031411588192
ligand O 0 0.08055602759122849
under O 0 0.006967776454985142
steady O 0 0.027783872559666634
- O 0 0.033642109483480453
state O 0 0.005762341432273388
conditions O 0 0.02647770754992962
, O 0 0.004243208561092615
both O 0 0.005644562654197216
in O 0 0.010945897549390793
293 O 0 0.3534923493862152
cells O 1 0.6572381854057312
and O 0 0.016984084621071815
in O 0 0.045633479952812195
HeLa O 1 0.9057121276855469
cells O 1 0.8835972547531128
. O 0 0.10355699062347412

Furthermore O 0 0.04351547360420227
, O 0 0.012231499888002872
at O 0 0.007870151661336422
4 O 0 0.01046126987785101
degrees O 0 0.013201050460338593
C O 0 0.03185074031352997
, O 0 0.0038125428836792707
the O 0 0.0037000265438109636
added O 0 0.008982219733297825
soluble O 0 0.24048657715320587
complex O 0 0.04723616689443588
of O 0 0.018582239747047424
HFE O 1 0.8971855640411377
/ O 1 0.5357024073600769
beta2m O 0 0.48756492137908936
inhibited O 0 0.3730481266975403
binding O 0 0.060301341116428375
of O 0 0.009676356799900532
transferrin O 0 0.40046799182891846
to O 0 0.020161455497145653
HeLa O 1 0.839302122592926
cell O 1 0.6764987707138062
TfR O 1 0.6798425912857056
in O 0 0.014603766612708569
a O 0 0.023513423278927803
concentration O 0 0.2074793577194214
- O 0 0.20847709476947784
dependent O 0 0.1981448084115982
manner O 0 0.09789565205574036
. O 0 0.03624618425965309

Scatchard O 0 0.119385726749897
plots O 0 0.027229592204093933
of O 0 0.007946116849780083
these O 0 0.005961555056273937
data O 0 0.006747827399522066
indicate O 0 0.008173084817826748
that O 0 0.0033289080020040274
the O 0 0.0037934426218271255
added O 0 0.008953706361353397
heterodimer O 0 0.26642516255378723
substantially O 0 0.0704684630036354
reduced O 0 0.028896626085042953
the O 0 0.006981713697314262
affinity O 0 0.09214164316654205
of O 0 0.014545254409313202
TfR O 1 0.6516084671020508
for O 0 0.028202718123793602
transferrin O 1 0.547193706035614
. O 0 0.04594527930021286

These O 0 0.0199709702283144
results O 0 0.022078489884734154
establish O 0 0.019897356629371643
a O 0 0.013522221706807613
molecular O 0 0.22361379861831665
link O 0 0.11560279130935669
between O 0 0.01855301298201084
HFE O 1 0.5374678373336792
and O 0 0.005763447377830744
a O 0 0.006209953222423792
key O 0 0.012144045904278755
protein O 0 0.14040003716945648
involved O 0 0.012249638326466084
in O 0 0.00486376229673624
iron O 0 0.02791222184896469
transport O 0 0.010909924283623695
, O 0 0.003725026734173298
the O 0 0.00391033012419939
TfR O 0 0.3551955223083496
, O 0 0.0036898262333124876
and O 0 0.002437910297885537
raise O 0 0.0060880184173583984
the O 0 0.0027149051893502474
possibility O 0 0.011425279080867767
that O 0 0.003212518058717251
alterations O 0 0.04040847718715668
in O 0 0.004351631738245487
this O 0 0.005130147095769644
regulatory O 0 0.1008753776550293
mechanism O 0 0.07924795895814896
may O 0 0.009608258493244648
play O 0 0.004212688654661179
a O 0 0.005761147476732731
role O 0 0.012692687101662159
in O 0 0.006031075492501259
the O 0 0.0156873632222414
pathogenesis O 1 0.8961961269378662
of O 0 0.10468960553407669
hereditary B-Disease 1 0.9568930864334106
hemochromatosis I-Disease 1 0.965320348739624
. O 0 0.09749089181423187
. O 0 0.0556006133556366

Genomic O 0 0.3660435974597931
organization O 0 0.03230619430541992
of O 0 0.014776422642171383
the O 0 0.019913548603653908
UBE3A O 1 0.8497514724731445
/ O 1 0.5947703123092651
E6 O 1 0.6346371173858643
- O 0 0.4073691964149475
AP O 0 0.327756404876709
gene O 1 0.682702898979187
and O 0 0.01961398497223854
related O 0 0.20604021847248077
pseudogenes O 1 0.6197245717048645
. O 0 0.05661039054393768

The O 0 0.05317861586809158
UBE3A O 1 0.7351437211036682
gene O 1 0.6218292117118835
encodes O 0 0.13683098554611206
the O 0 0.0184472668915987
E6 O 0 0.3656235933303833
- O 0 0.25633662939071655
AP O 0 0.19380410015583038
ubiquitin O 0 0.4026182293891907
- O 0 0.16226427257061005
protein O 0 0.30188390612602234
ligase O 0 0.08431928604841232
and O 0 0.004845789168030024
has O 0 0.004540642723441124
recently O 0 0.008241225965321064
been O 0 0.004268844611942768
shown O 0 0.010637706145644188
to O 0 0.006312803365290165
be O 0 0.026867881417274475
mutated O 1 0.9450573921203613
in O 1 0.6564888954162598
Angelman B-Disease 1 0.9887979626655579
syndrome I-Disease 1 0.9919918179512024
patients O 1 0.9611364006996155
who O 0 0.12246774137020111
lack O 0 0.2865406572818756
15q11 O 1 0.7082635760307312
- O 1 0.513744056224823
q13 O 1 0.7274001836776733
deletions O 1 0.8180025815963745
or O 0 0.2775624990463257
chromosome O 1 0.902887225151062
15 O 0 0.17304357886314392
paternal O 1 0.7754228115081787
uniparental B-Disease 1 0.8985077738761902
disomy I-Disease 1 0.6903206706047058
. O 0 0.09310615062713623

Previous O 0 0.06807850301265717
UBE3A O 0 0.4612058699131012
cDNA O 0 0.1314418464899063
analysis O 0 0.02738475427031517
has O 0 0.010711378417909145
shown O 0 0.012316310778260231
a O 0 0.01032554917037487
coding O 0 0.18849729001522064
region O 0 0.015016735531389713
of O 0 0.008077159523963928
approximately O 0 0.017891310155391693
2 O 0 0.022875478491187096
. O 0 0.027707207947969437

6 O 0 0.04042745381593704
kb O 0 0.04961305111646652
and O 0 0.01093387696892023
a O 0 0.011397135443985462
3 O 0 0.017642347142100334
- O 0 0.1123117059469223
untranslated O 0 0.41991451382637024
region O 0 0.0575871579349041
( O 0 0.04081456735730171
UTR O 0 0.2524859309196472
) O 0 0.011097157374024391
of O 0 0.0054846275597810745
< O 0 0.09674953669309616
50 O 0 0.008241256698966026
bp O 0 0.01857924833893776
, O 0 0.005131585989147425
whereas O 0 0.012363022193312645
Northern O 0 0.00758151663467288
analysis O 0 0.008518681861460209
has O 0 0.004499549977481365
indicated O 0 0.010383893735706806
mRNA O 0 0.04122414439916611
sizes O 0 0.012264711782336235
of O 0 0.006027651485055685
5 O 0 0.018232133239507675
- O 0 0.0649837777018547
8 O 0 0.03224438428878784
kb O 0 0.1657545566558838
. O 0 0.03190561756491661

We O 0 0.015749841928482056
have O 0 0.010218782350420952
analyzed O 0 0.021099697798490524
additional O 0 0.013028532266616821
cDNA O 0 0.09882952272891998
clones O 0 0.18299005925655365
and O 0 0.006176547612994909
provide O 0 0.007176895625889301
evidence O 0 0.0063909972086548805
for O 0 0.005299159791320562
an O 0 0.00634149881079793
additional O 0 0.013380806893110275
0 O 0 0.03302169218659401
. O 0 0.02142450213432312

5 O 0 0.03860526531934738
kb O 0 0.04947614669799805
of O 0 0.01278864685446024
5 O 0 0.018601475283503532
- O 0 0.0676945298910141
UTR O 0 0.21079136431217194
and O 0 0.011009316891431808
> O 0 0.15153862535953522
2 O 0 0.013101601973176003
kb O 0 0.05338842421770096
of O 0 0.009088132530450821
3 O 0 0.027496786788105965
- O 0 0.16560503840446472
UTR O 0 0.41415539383888245
. O 0 0.043354324996471405

We O 0 0.013520085252821445
have O 0 0.008111653849482536
established O 0 0.008533604443073273
the O 0 0.006034120451658964
genomic O 0 0.19523167610168457
organization O 0 0.012036687694489956
of O 0 0.006065016146749258
UBE3A O 0 0.2030119001865387
and O 0 0.005198854021728039
the O 0 0.0058121345937252045
sequence O 0 0.038502562791109085
of O 0 0.01701044850051403
intron O 1 0.8230783343315125
- O 0 0.3416805565357208
exon O 1 0.5230340957641602
borders O 0 0.1544996052980423
. O 0 0.04241006448864937

We O 0 0.012241136282682419
have O 0 0.007286249194294214
also O 0 0.00544664217159152
mapped O 0 0.010330893099308014
two O 0 0.006556951906532049
highly O 0 0.03193402290344238
homologous O 1 0.5086378455162048
processed O 0 0.0695587694644928
pseudogenes O 0 0.49405205249786377
, O 0 0.013739282265305519
UBE3AP1 O 0 0.14253775775432587
and O 0 0.005995406303554773
UBE3AP2 O 0 0.12709622085094452
, O 0 0.004737722221761942
to O 0 0.0036220536567270756
chromosomes O 0 0.11790255457162857
2 O 0 0.00700979633256793
and O 0 0.003213646588847041
21 O 0 0.005513842683285475
, O 0 0.003027112688869238
respectively O 0 0.0044991206377744675
, O 0 0.002803283743560314
and O 0 0.0033707190304994583
determined O 0 0.009324797429144382
their O 0 0.008515702560544014
genomic O 0 0.44223764538764954
organization O 0 0.061957620084285736
. O 0 0.03331928700208664

These O 0 0.01647997461259365
results O 0 0.013557212427258492
will O 0 0.005084203090518713
form O 0 0.006742044817656279
the O 0 0.003105833660811186
basis O 0 0.004375218413770199
for O 0 0.0043373918160796165
studies O 0 0.031205078586935997
of O 0 0.010633707046508789
mutation O 1 0.78748619556427
and O 0 0.015565246343612671
imprinting O 1 0.5642878413200378
of O 0 0.03318410366773605
UBE3A O 1 0.8404375314712524
. O 0 0.07807206362485886

Mutation O 1 0.8691232204437256
spectrum O 0 0.33426329493522644
and O 0 0.06621737778186798
genotype O 1 0.9090363383293152
- O 1 0.7105711102485657
phenotype O 1 0.9460622072219849
analyses O 1 0.5560898780822754
in O 0 0.29817578196525574
Cowden B-Disease 1 0.9609153270721436
disease I-Disease 1 0.9769516587257385
and O 0 0.21181665360927582
Bannayan B-Disease 1 0.9250442385673523
- I-Disease 1 0.9190507531166077
Zonana I-Disease 1 0.9651694297790527
syndrome I-Disease 1 0.9812790155410767
, O 0 0.17237505316734314
two O 0 0.2653408944606781
hamartoma B-Disease 1 0.9638479948043823
syndromes I-Disease 1 0.9737398624420166
with O 1 0.5315937399864197
germline O 1 0.9514856934547424
PTEN O 1 0.9380979537963867
mutation O 1 0.9204714298248291
. O 0 0.12510256469249725

The O 0 0.16913819313049316
tumour B-Disease 1 0.9394392371177673
suppressor O 1 0.9209535121917725
gene O 1 0.8903008699417114
PTEN O 1 0.7224459052085876
, O 0 0.01622132956981659
which O 0 0.008689997717738152
maps O 0 0.014512292109429836
to O 0 0.011276382021605968
10q23 O 0 0.15952810645103455
. O 0 0.0268744807690382

3 O 0 0.0372784361243248
and O 0 0.016301093623042107
encodes O 0 0.04502890631556511
a O 0 0.015336287207901478
403 O 0 0.07449270039796829
amino O 0 0.20542572438716888
acid O 1 0.5133934617042542
dual O 0 0.25048935413360596
specificity O 0 0.4801313281059265
phosphatase O 1 0.8558675646781921
( O 0 0.18312732875347137
protein O 1 0.6953085660934448
tyrosine O 1 0.7591143846511841
phosphatase O 1 0.8525141477584839
; O 0 0.0714467465877533
PTPase O 0 0.21640656888484955
) O 0 0.010057739913463593
, O 0 0.0033615108113735914
was O 0 0.0024548338260501623
shown O 0 0.004094586241990328
recently O 0 0.004052216652780771
to O 0 0.0023834286257624626
play O 0 0.003119351575151086
a O 0 0.00486565288156271
broad O 0 0.030137354508042336
role O 0 0.02651403285562992
in O 0 0.026759861037135124
human O 0 0.39719632267951965
malignancy B-Disease 1 0.930649995803833
. O 0 0.09397002309560776

Somatic O 1 0.8459784984588623
PTEN O 1 0.8628222346305847
deletions O 0 0.48944470286369324
and O 0 0.0275704488158226
mutations O 1 0.7409933805465698
were O 0 0.011689616367220879
observed O 0 0.133563831448555
in O 0 0.07772813737392426
sporadic B-Disease 1 0.8760610818862915
breast I-Disease 1 0.9835618138313293
, I-Disease 0 0.42825987935066223
brain I-Disease 1 0.9768236875534058
, I-Disease 1 0.5051760077476501
prostate I-Disease 1 0.9892277717590332
and I-Disease 1 0.5892981886863708
kidney I-Disease 1 0.9915738701820374
cancer I-Disease 1 0.9875120520591736
cell O 1 0.7837182283401489
lines O 0 0.06889843195676804
and O 0 0.007344536483287811
in O 0 0.009293810464441776
several O 0 0.01944006234407425
primary O 0 0.3585202693939209
tumours B-Disease 1 0.9647418856620789
such O 0 0.17701712250709534
as O 0 0.3410065770149231
endometrial B-Disease 1 0.9857943058013916
carcinomas I-Disease 1 0.9855886101722717
, O 1 0.8660117387771606
malignant B-Disease 1 0.9891617298126221
melanoma I-Disease 1 0.9878988862037659
and O 1 0.7420310974121094
thyroid B-Disease 1 0.9766155481338501
tumours I-Disease 1 0.9601927995681763
. O 0 0.2624456286430359

In O 0 0.028114669024944305
addition O 0 0.024872785434126854
, O 0 0.014563369564712048
PTEN O 0 0.4549853205680847
was O 0 0.010147989727556705
identified O 0 0.01925116963684559
as O 0 0.007621520198881626
the O 0 0.019736040383577347
susceptibility O 1 0.9332553744316101
gene O 1 0.87637859582901
for O 0 0.06651359051465988
two O 0 0.3564089238643646
hamartoma B-Disease 1 0.9782229661941528
syndromes I-Disease 1 0.9893129467964172
Cowden B-Disease 1 0.9807155132293701
disease I-Disease 1 0.9836154580116272
( O 0 0.28582584857940674
CD B-Disease 0 0.1890077143907547
; O 0 0.1226559579372406
MIM O 1 0.6800737977027893
158350 O 0 0.3996597230434418
) O 0 0.034469764679670334
and O 0 0.013521025888621807
Bannayan B-Disease 1 0.5368883609771729
- I-Disease 0 0.4403403401374817
Zonana I-Disease 1 0.8921252489089966
( I-Disease 0 0.23615601658821106
BZS I-Disease 1 0.7535197138786316
) I-Disease 0 0.0863003060221672
or I-Disease 0 0.09132927656173706
Ruvalcaba I-Disease 1 0.8958958387374878
- I-Disease 1 0.6567289233207703
Riley I-Disease 1 0.736399233341217
- I-Disease 1 0.7840551733970642
Smith I-Disease 1 0.8086631894111633
syndrome I-Disease 1 0.9814062118530273
( O 1 0.5552918314933777
MIM O 1 0.8596615195274353
153480 O 1 0.5587157607078552
) O 0 0.07036346197128296
. O 0 0.035220224410295486

Constitutive O 0 0.2847483158111572
DNA O 0 0.11619514971971512
from O 0 0.020002778619527817
37 O 0 0.022477129474282265
CD B-Disease 0 0.02061775140464306
families O 0 0.015400534495711327
and O 0 0.0072542703710496426
seven O 0 0.0110103664919734
BZS B-Disease 0 0.33053791522979736
families O 0 0.04925432428717613
was O 0 0.012127354741096497
screened O 0 0.09774719178676605
for O 0 0.052779942750930786
germline O 1 0.9391463994979858
PTEN O 1 0.9221904873847961
mutations O 1 0.9125110507011414
. O 0 0.11268192529678345

PTEN O 1 0.8234835863113403
mutations O 1 0.6084771752357483
were O 0 0.01217174157500267
identified O 0 0.01413120049983263
in O 0 0.00535166310146451
30 O 0 0.0062590171582996845
of O 0 0.004088339861482382
37 O 0 0.010567217133939266
( O 0 0.01481323130428791
81 O 0 0.022088710218667984
% O 0 0.022297076880931854
) O 0 0.009009666740894318
CD B-Disease 0 0.010514733381569386
families O 0 0.010637635365128517
, O 0 0.003845538478344679
including O 0 0.007106931880116463
missense O 0 0.4392775595188141
and O 0 0.006188838742673397
nonsense O 0 0.07819288223981857
point O 0 0.028214355930685997
mutations O 1 0.8729044198989868
, O 0 0.01672724448144436
deletions O 0 0.3324817717075348
, O 0 0.013697179965674877
insertions O 0 0.2561517655849457
, O 0 0.011588226072490215
a O 0 0.028562627732753754
deletion O 1 0.7849360704421997
/ O 0 0.42727088928222656
insertion O 0 0.2978664040565491
and O 0 0.016476834192872047
splice O 1 0.5155131816864014
site O 0 0.07842379808425903
mutations O 1 0.8698237538337708
. O 0 0.0668148472905159

These O 0 0.026580149307847023
mutations O 0 0.2661525309085846
were O 0 0.0069000995717942715
scattered O 0 0.007783651351928711
over O 0 0.004025810863822699
the O 0 0.0035935344640165567
entire O 0 0.006903586443513632
length O 0 0.009432430379092693
of O 0 0.004946403205394745
PTEN O 0 0.405799001455307
, O 0 0.003360277973115444
with O 0 0.0025254422798752785
the O 0 0.0020190232899039984
exception O 0 0.004212908912450075
of O 0 0.0020093340426683426
the O 0 0.002165647689253092
first O 0 0.003098904388025403
, O 0 0.003483362728729844
fourth O 0 0.007141216658055782
and O 0 0.0059197330847382545
last O 0 0.01570238173007965
exons O 0 0.34178081154823303
. O 0 0.036549102514982224

A O 0 0.03239017352461815
hot O 0 0.030100183561444283
spot O 0 0.02134195901453495
for O 0 0.017384245991706848
PTEN O 1 0.8396744728088379
mutation O 1 0.7287168502807617
in O 0 0.010667416267096996
CD B-Disease 0 0.01579604670405388
was O 0 0.004857200663536787
identified O 0 0.011257858946919441
in O 0 0.0045310421846807
exon O 0 0.06508583575487137
5 O 0 0.005913386587053537
that O 0 0.0027471070643514395
contains O 0 0.0041597564704716206
the O 0 0.003201553365215659
PTPase O 0 0.05743579939007759
core O 0 0.013926860876381397
motif O 0 0.05272532254457474
, O 0 0.0037676463834941387
with O 0 0.00392860546708107
13 O 0 0.005450264550745487
of O 0 0.003217940218746662
30 O 0 0.007306377869099379
( O 0 0.014347625896334648
43 O 0 0.01793910562992096
% O 0 0.05317654833197594
) O 0 0.03922692686319351
CD B-Disease 0 0.0753031075000763
mutations O 1 0.8259994983673096
identified O 0 0.03747187554836273
in O 0 0.00903112068772316
this O 0 0.012486176565289497
exon O 0 0.28522011637687683
. O 0 0.030680805444717407

Seven O 0 0.021246811375021935
of O 0 0.01066669262945652
30 O 0 0.011734161525964737
( O 0 0.010550280101597309
23 O 0 0.008578475564718246
% O 0 0.008099746890366077
) O 0 0.003852063324302435
were O 0 0.0017429935978725553
within O 0 0.002562297508120537
the O 0 0.0022235328797250986
core O 0 0.006776108406484127
motif O 0 0.029552193358540535
, O 0 0.002400569152086973
the O 0 0.0023490998428314924
majority O 0 0.006163249723613262
( O 0 0.004933057818561792
five O 0 0.002194554079324007
of O 0 0.0018232844304293394
seven O 0 0.003380910726264119
) O 0 0.004124250262975693
of O 0 0.0021351377945393324
which O 0 0.0030404587741941214
were O 0 0.004984603729099035
missense O 1 0.7166656851768494
mutations O 1 0.8330612778663635
, O 0 0.00711215240880847
possibly O 0 0.012269483879208565
pointing O 0 0.006755011156201363
to O 0 0.0027017504908144474
the O 0 0.00301217008382082
functional O 0 0.023341529071331024
significance O 0 0.007827790454030037
of O 0 0.004610144998878241
this O 0 0.007194771897047758
region O 0 0.024784287437796593
. O 0 0.022810133174061775

Germline O 1 0.8887239098548889
PTEN O 1 0.8474264144897461
mutations O 1 0.620713472366333
were O 0 0.011700929142534733
identified O 0 0.013563985005021095
in O 0 0.00521044060587883
four O 0 0.004262055270373821
of O 0 0.00400100601837039
seven O 0 0.006950219161808491
( O 0 0.018183309584856033
57 O 0 0.03061511181294918
% O 0 0.050575174391269684
) O 0 0.03418292850255966
BZS B-Disease 0 0.34065866470336914
families O 0 0.061780378222465515
studied O 0 0.04199281334877014
. O 0 0.024575956165790558

Interestingly O 0 0.06398536264896393
, O 0 0.012759554199874401
none O 0 0.01010232511907816
of O 0 0.006057571154087782
these O 0 0.009448349475860596
mutations O 1 0.6710695028305054
was O 0 0.007004083599895239
observed O 0 0.017642710357904434
in O 0 0.005486934445798397
the O 0 0.007164647337049246
PTPase O 0 0.20008225739002228
core O 0 0.051188837736845016
motif O 0 0.29737865924835205
. O 0 0.051050666719675064

It O 0 0.012332046404480934
is O 0 0.007325125392526388
also O 0 0.00427892804145813
worthy O 0 0.007510428316891193
of O 0 0.0028987121768295765
note O 0 0.006187363527715206
that O 0 0.002559028333052993
a O 0 0.004251341801136732
single O 0 0.009198577143251896
nonsense O 0 0.036336954683065414
point O 0 0.011773187667131424
mutation O 1 0.7352445721626282
, O 0 0.008177392184734344
R233X O 0 0.09887242317199707
, O 0 0.004725688602775335
was O 0 0.003738991916179657
observed O 0 0.012974478304386139
in O 0 0.0049303933046758175
the O 0 0.009443486109375954
germline O 1 0.8436087965965271
DNA O 0 0.19200940430164337
from O 0 0.007236449047923088
two O 0 0.008625964634120464
unrelated O 0 0.16351640224456787
CD B-Disease 0 0.029985757544636726
families O 0 0.018604034557938576
and O 0 0.007264874875545502
one O 0 0.01188905630260706
BZS B-Disease 0 0.44195857644081116
family O 0 0.10179776698350906
. O 0 0.03417469561100006

Genotype O 1 0.8452939987182617
- O 0 0.41503599286079407
phenotype O 1 0.7896213531494141
studies O 0 0.026199590414762497
were O 0 0.00576917827129364
not O 0 0.0037517049349844456
performed O 0 0.004991558846086264
on O 0 0.0027915409300476313
this O 0 0.003318848554044962
small O 0 0.00606295932084322
group O 0 0.009879108518362045
of O 0 0.009695162996649742
BZS B-Disease 0 0.4636758863925934
families O 0 0.08080623298883438
. O 0 0.03607308119535446

However O 0 0.04252761974930763
, O 0 0.03808057680726051
genotype O 1 0.8246617913246155
- O 0 0.4758090674877167
phenotype O 1 0.899224579334259
analysis O 0 0.09427409619092941
inthe O 0 0.25848281383514404
group O 0 0.011455904692411423
of O 0 0.00529738562181592
CD B-Disease 0 0.02131832018494606
families O 0 0.016113657504320145
revealed O 0 0.010592129081487656
two O 0 0.004036882892251015
possible O 0 0.009197838604450226
associations O 0 0.01584082655608654
worthy O 0 0.012976052239537239
of O 0 0.004356545861810446
follow O 0 0.0104604447260499
- O 0 0.028907733038067818
up O 0 0.006370907183736563
in O 0 0.008019334636628628
independent O 0 0.017277631908655167
analyses O 0 0.08370798826217651
. O 0 0.025981275364756584

The O 0 0.01605999656021595
first O 0 0.00826492439955473
was O 0 0.0059282719157636166
an O 0 0.004490488208830357
association O 0 0.010137776844203472
noted O 0 0.005047800950706005
in O 0 0.0031241681426763535
the O 0 0.0031631242018193007
group O 0 0.00702559994533658
of O 0 0.0065124500542879105
CD B-Disease 0 0.07118838280439377
families O 0 0.20645231008529663
with O 0 0.34798434376716614
breast B-Disease 1 0.9815234541893005
disease I-Disease 1 0.9756805896759033
. O 0 0.20877650380134583

A O 0 0.02882516384124756
correlation O 0 0.055475153028964996
was O 0 0.009990887716412544
observed O 0 0.01493323314934969
between O 0 0.007549198344349861
the O 0 0.00599656580016017
presence O 0 0.0367298498749733
/ O 0 0.11559618264436722
absence O 0 0.027254022657871246
of O 0 0.0063597033731639385
a O 0 0.03415160998702049
PTEN O 1 0.8972617983818054
mutation O 1 0.8039056658744812
and O 0 0.008023974485695362
the O 0 0.00930111575871706
type O 0 0.21276028454303741
of O 0 0.07250544428825378
breast O 1 0.9741597175598145
involvement O 1 0.6528000235557556
( O 0 0.48051905632019043
unaffected O 1 0.8842722773551941
versus O 1 0.7648475766181946
benign O 1 0.946293294429779
versus O 1 0.8312803506851196
malignant O 1 0.9599141478538513
) O 0 0.21417966485023499
. O 0 0.06188701465725899

Specifically O 0 0.02553068846464157
and O 0 0.008152658119797707
more O 0 0.005750543437898159
directly O 0 0.005566938780248165
, O 0 0.003537353128194809
an O 0 0.0032085487619042397
association O 0 0.007176776882261038
was O 0 0.003095897613093257
also O 0 0.00301743415184319
observed O 0 0.010358816012740135
between O 0 0.004903189837932587
the O 0 0.004069507587701082
presence O 0 0.025926314294338226
of O 0 0.013464829884469509
a O 0 0.1635497361421585
PTEN O 1 0.9665421843528748
mutation O 1 0.9763097763061523
and O 1 0.7340757846832275
malignant B-Disease 1 0.987949013710022
breast I-Disease 1 0.9853522181510925
disease I-Disease 1 0.976325273513794
. O 0 0.3277301788330078

Secondly O 0 0.04544805362820625
, O 0 0.010683446191251278
there O 0 0.00589389493688941
appeared O 0 0.006019404157996178
to O 0 0.0029916109051555395
be O 0 0.002801301423460245
an O 0 0.004590755328536034
interdependent O 0 0.20476534962654114
association O 0 0.03533037379384041
between O 0 0.02744639478623867
mutations O 1 0.802979052066803
upstream O 0 0.04426529258489609
and O 0 0.003882871475070715
within O 0 0.004859257489442825
the O 0 0.004085769411176443
PTPase O 0 0.16063255071640015
core O 0 0.022600684314966202
motif O 0 0.07858752459287643
, O 0 0.003621137933805585
the O 0 0.0029454806353896856
core O 0 0.011220416985452175
motif O 0 0.06073826923966408
containing O 0 0.00903690978884697
the O 0 0.0035524414852261543
majority O 0 0.021236328408122063
of O 0 0.010757612995803356
missense O 1 0.8279549479484558
mutations O 1 0.8198564648628235
, O 0 0.004861422348767519
and O 0 0.002306954003870487
the O 0 0.0023492842447012663
involvement O 0 0.01031404733657837
of O 0 0.0027995582204312086
all O 0 0.003233513794839382
major O 0 0.043980758637189865
organ O 1 0.5919285416603088
systems O 0 0.29096490144729614
( O 0 0.09736519306898117
central O 0 0.0634685754776001
nervous O 1 0.823442280292511
system O 0 0.38800719380378723
, O 0 0.19589313864707947
thyroid O 1 0.9853973984718323
, O 0 0.36829864978790283
breast O 1 0.9835482239723206
, O 0 0.3678882420063019
skin O 1 0.9738031625747681
and O 0 0.4558872878551483
gastrointestinal O 1 0.9814786911010742
tract O 1 0.9581766724586487
) O 0 0.24786268174648285
. O 0 0.06430044025182724

However O 0 0.017753247171640396
, O 0 0.00781540758907795
these O 0 0.004740058910101652
observations O 0 0.00649677449837327
would O 0 0.0026548770256340504
need O 0 0.0028326334431767464
to O 0 0.0018391754711046815
be O 0 0.001856885734014213
confirmed O 0 0.0039579295553267
by O 0 0.002578429412096739
studying O 0 0.0044883848167955875
a O 0 0.003572368761524558
larger O 0 0.0062113539315760136
number O 0 0.004217814654111862
of O 0 0.005499563179910183
CD B-Disease 0 0.03400375321507454
families O 0 0.04247770085930824
. O 0 0.023108607158064842

Molecular O 1 0.6529629230499268
defects O 1 0.8026355504989624
leading O 0 0.03488941118121147
to O 0 0.013458388857543468
human O 0 0.13626615703105927
complement B-Disease 0 0.3422457277774811
component I-Disease 1 0.6487200856208801
C6 I-Disease 1 0.9536218643188477
deficiency I-Disease 1 0.9777445197105408
in O 0 0.025347355753183365
an O 0 0.01645425520837307
African O 0 0.09462536871433258
- O 0 0.13625505566596985
American O 0 0.05186489224433899
family O 0 0.0954432487487793
. O 0 0.03522421047091484

Complement B-Disease 0 0.4595126807689667
component I-Disease 1 0.7130914330482483
C6 I-Disease 1 0.941100001335144
deficiency I-Disease 1 0.9745962023735046
( O 0 0.29526928067207336
C6D B-Disease 1 0.6567369103431702
) O 0 0.08545630425214767
was O 0 0.019658200442790985
diagnosed O 1 0.8619511723518372
in O 0 0.007454512175172567
a O 0 0.008852289989590645
16 O 0 0.02032557688653469
- O 0 0.08259781450033188
year O 0 0.025330906733870506
- O 0 0.14060834050178528
old O 0 0.05145098641514778
African O 0 0.17694459855556488
- O 0 0.27813956141471863
American O 0 0.11510846763849258
male O 1 0.6469120383262634
with O 0 0.43901941180229187
meningococcal B-Disease 1 0.9757289290428162
meningitis I-Disease 1 0.9694778919219971
. O 0 0.2613200843334198

The O 0 0.03228602185845375
patients O 1 0.5420528054237366
father O 0 0.02024087868630886
and O 0 0.005577912554144859
two O 0 0.00504816509783268
brothers O 0 0.01901371031999588
also O 0 0.004286282230168581
had O 0 0.00529774185270071
C6D B-Disease 0 0.07526018470525742
, O 0 0.0034352706279605627
but O 0 0.0030019041150808334
gave O 0 0.005379016976803541
no O 0 0.004986214451491833
history O 0 0.011089183390140533
of O 0 0.036453984677791595
meningitis B-Disease 1 0.971802830696106
or O 0 0.14848096668720245
other O 0 0.12091492861509323
neisserial B-Disease 1 0.8930308818817139
infection I-Disease 1 0.9662812948226929
. O 0 0.14242444932460785

By O 0 0.03495468944311142
using O 0 0.031126653775572777
exon O 0 0.2892759442329407
- O 0 0.13627639412879944
specific O 0 0.0795147567987442
polymerase O 1 0.5434704422950745
chain O 0 0.3011796176433563
reaction O 0 0.2337190806865692
( O 0 0.08066195249557495
PCR O 0 0.44338345527648926
) O 0 0.041641879826784134
/ O 0 0.11192136257886887
single O 0 0.022177888080477715
- O 0 0.11252786219120026
strand O 0 0.24583807587623596
conformation O 0 0.20218762755393982
polymorphism O 0 0.2873404622077942
as O 0 0.006009298376739025
a O 0 0.006704171188175678
screening O 0 0.03062916174530983
step O 0 0.008288783952593803
and O 0 0.0049096583388745785
nucleotide O 0 0.09689855575561523
sequencing O 0 0.0440233051776886
of O 0 0.004263694863766432
target O 0 0.010156835429370403
exons O 0 0.0751853883266449
, O 0 0.003837297670543194
we O 0 0.0025549009442329407
determined O 0 0.004639101680368185
that O 0 0.0025122780352830887
the O 0 0.0032828126568347216
proband O 0 0.06052367016673088
was O 0 0.004964892752468586
a O 0 0.007720261346548796
compound O 0 0.061635106801986694
heterozygote O 1 0.5146810412406921
for O 0 0.01689058728516102
two O 0 0.05788767710328102
C6 O 1 0.9052874445915222
gene O 1 0.9207428097724915
mutations O 1 0.9252882599830627
. O 0 0.10994156450033188

The O 0 0.016951706260442734
first O 0 0.011109879240393639
, O 0 0.008852730505168438
1195delC O 0 0.047500744462013245
located O 0 0.007946804165840149
in O 0 0.006432474125176668
exon O 0 0.11000842601060867
7 O 0 0.01015931461006403
, O 0 0.004332411102950573
is O 0 0.003616376081481576
a O 0 0.006201924290508032
novel O 0 0.0841536819934845
mutation O 1 0.6159048676490784
, O 0 0.004434794653207064
while O 0 0.003001386532559991
the O 0 0.0026186162140220404
second O 0 0.004347585141658783
, O 0 0.005363919772207737
1936delG O 0 0.11196679621934891
in O 0 0.007077879272401333
exon O 0 0.1585116684436798
12 O 0 0.007756153121590614
, O 0 0.003845863277092576
has O 0 0.0028563453815877438
been O 0 0.002986604580655694
described O 0 0.007254074793308973
before O 0 0.004074477590620518
to O 0 0.00596901960670948
cause O 0 0.34263870120048523
C6D B-Disease 0 0.3078608810901642
in O 0 0.011305835098028183
an O 0 0.017454132437705994
unrelated O 0 0.30630022287368774
African O 0 0.15033361315727234
- O 0 0.1602434515953064
American O 0 0.03645068034529686
individual O 0 0.07598597556352615
. O 0 0.03937239572405815

Both O 0 0.07298007607460022
mutations O 1 0.8488317131996155
result O 0 0.13624432682991028
in O 0 0.05369288846850395
premature O 1 0.8296566009521484
termination O 1 0.700313150882721
codons O 1 0.5804020762443542
and O 0 0.04840988665819168
C6 O 1 0.7543146014213562
null O 1 0.5612351894378662
alleles O 1 0.8739650845527649
. O 0 0.07909052819013596

Allele O 1 0.7302945256233215
- O 0 0.13838455080986023
specific O 0 0.03741690516471863
PCR O 0 0.15606366097927094
indicated O 0 0.013054695911705494
that O 0 0.004629998933523893
the O 0 0.004493428394198418
probands O 0 0.08527005463838577
two O 0 0.00680416589602828
brothers O 0 0.05848928168416023
also O 0 0.010433451272547245
inherited O 0 0.38168591260910034
the O 0 0.01252248976379633
1195delC O 0 0.4920937120914459
mutation O 1 0.775073766708374
from O 0 0.012827981263399124
their O 0 0.009558126330375671
heterozygous O 0 0.497331440448761
mother O 0 0.050098028033971786
and O 0 0.005653005093336105
the O 0 0.009999767877161503
1936delG O 1 0.5014033913612366
mutation O 1 0.8217007517814636
from O 0 0.01943475939333439
their O 0 0.017986727878451347
homozygous O 1 0.6693799495697021
father O 0 0.06966819614171982
. O 0 0.02224847860634327
. O 0 0.029326003044843674

PAX6 O 1 0.7949438095092773
mutations O 1 0.8397476673126221
reviewed O 0 0.12976382672786713
. O 0 0.07283882051706314

Mutations O 1 0.8247160315513611
in O 0 0.02967550978064537
PAX6 O 0 0.4387728273868561
are O 0 0.009333823807537556
responsible O 0 0.016167040914297104
for O 0 0.006003049202263355
human O 0 0.033631909638643265
aniridia B-Disease 0 0.1067783311009407
and O 0 0.003909626509994268
have O 0 0.0036440440453588963
also O 0 0.0033218374010175467
been O 0 0.004707219544798136
found O 0 0.01776522397994995
in O 0 0.02624913491308689
patients O 1 0.8802114725112915
with O 0 0.0819060355424881
Peters B-Disease 1 0.7255022525787354
anomaly I-Disease 1 0.8846428394317627
, O 0 0.11872132122516632
with O 0 0.47802355885505676
congenital B-Disease 1 0.9913132786750793
cataracts I-Disease 1 0.9831010699272156
, O 0 0.2081592082977295
with O 0 0.39552241563796997
autosomal B-Disease 1 0.9855018854141235
dominant I-Disease 1 0.8859450817108154
keratitis I-Disease 1 0.9647183418273926
, O 0 0.027519192546606064
and O 0 0.012869707308709621
with O 0 0.046271611005067825
isolated B-Disease 1 0.6061387062072754
foveal I-Disease 1 0.8728695511817932
hypoplasia I-Disease 1 0.9340930581092834
. O 0 0.13144737482070923

No O 0 0.029895955696702003
locus O 0 0.1624450385570526
other O 0 0.015097339637577534
than O 0 0.01927950605750084
chromosome O 1 0.6555268168449402
11p13 O 0 0.13628992438316345
has O 0 0.008445806801319122
been O 0 0.0074319662526249886
implicated O 0 0.10791097581386566
in O 0 0.008827706798911095
aniridia B-Disease 0 0.18665657937526703
, O 0 0.006206604652106762
and O 0 0.005811919458210468
PAX6 O 0 0.377297580242157
is O 0 0.005222458858042955
clearly O 0 0.005613828543573618
the O 0 0.0031481392215937376
major O 0 0.00600323174148798
, O 0 0.003727986942976713
if O 0 0.003456403035670519
not O 0 0.002957480726763606
only O 0 0.004449129570275545
, O 0 0.009598643518984318
gene O 0 0.447605162858963
responsible O 0 0.0525350458920002
. O 0 0.025238119065761566

Twenty O 0 0.038392167538404465
- O 0 0.035126250237226486
eight O 0 0.012559104710817337
percent O 0 0.017350638285279274
of O 0 0.011825255118310452
identified O 0 0.1737869679927826
PAX6 O 1 0.909275233745575
mutations O 1 0.9113293290138245
are O 0 0.028735684230923653
C O 0 0.35133835673332214
- O 0 0.2499980330467224
T O 0 0.47025933861732483
changes O 0 0.038792092353105545
at O 0 0.012723241001367569
CpG O 0 0.4809150695800781
dinucleotides O 0 0.18221677839756012
, O 0 0.005753854289650917
20 O 0 0.006604245863854885
% O 0 0.01150291133671999
are O 0 0.004207858815789223
splicing O 0 0.15726083517074585
errors O 0 0.022215206176042557
, O 0 0.0032420121133327484
and O 0 0.0023128471802920103
more O 0 0.0027226521633565426
than O 0 0.003592875087633729
30 O 0 0.007165891584008932
% O 0 0.016910996288061142
are O 0 0.006260788068175316
deletion O 0 0.36839035153388977
or O 0 0.02917598932981491
insertion O 0 0.2589980959892273
events O 0 0.057453759014606476
. O 0 0.038736481219530106

There O 0 0.01948162540793419
is O 0 0.010354886762797832
a O 0 0.009444691240787506
noticeably O 0 0.044921886175870895
elevated O 0 0.06257785111665726
level O 0 0.010550329461693764
of O 0 0.0068544913083314896
mutation O 1 0.5832154750823975
in O 0 0.0056349895894527435
the O 0 0.005203363951295614
paired O 0 0.06856008619070053
domain O 0 0.027411170303821564
compared O 0 0.013151041232049465
with O 0 0.004191132262349129
the O 0 0.003450111486017704
rest O 0 0.006050856783986092
of O 0 0.005006147548556328
the O 0 0.011383481323719025
gene O 1 0.631649911403656
. O 0 0.04112057387828827

Increased O 0 0.10828440636396408
mutation O 1 0.5286892652511597
in O 0 0.014370894990861416
the O 0 0.010056735016405582
homeodomain O 0 0.16893506050109863
is O 0 0.00827851239591837
accounted O 0 0.01276491954922676
for O 0 0.006041646469384432
by O 0 0.006978699471801519
the O 0 0.00919583160430193
hypermutable O 0 0.26675617694854736
CpG O 1 0.5278812050819397
dinucleotide O 0 0.398479700088501
in O 0 0.023915089666843414
codon O 0 0.29676327109336853
240 O 0 0.0857686921954155
. O 0 0.041160304099321365

Very O 0 0.026314709335565567
nearly O 0 0.01883235201239586
all O 0 0.011106238700449467
mutations O 1 0.7059376835823059
appear O 0 0.028164595365524292
to O 0 0.007265428546816111
cause O 0 0.17577014863491058
loss O 0 0.03488391637802124
of O 0 0.0039427620358765125
function O 0 0.018053000792860985
of O 0 0.0041855559684336185
the O 0 0.007444605231285095
mutant O 0 0.4963519871234894
allele O 0 0.47630971670150757
, O 0 0.0043174950405955315
and O 0 0.0025091543793678284
more O 0 0.0026180308777838945
than O 0 0.0031846670899540186
80 O 0 0.007633159402757883
% O 0 0.010375900194048882
of O 0 0.005614097695797682
exonic O 0 0.14162416756153107
substitutions O 0 0.059542667120695114
result O 0 0.05144403129816055
in O 0 0.018584344536066055
nonsense O 0 0.16165876388549805
codons O 0 0.4737507998943329
. O 0 0.05319133773446083

In O 0 0.024777676910161972
a O 0 0.02070656605064869
gene O 0 0.279935747385025
with O 0 0.007750195916742086
such O 0 0.006661531049758196
extraordinarily O 0 0.036882370710372925
high O 0 0.009935771115124226
sequence O 0 0.02291143126785755
conservation O 0 0.014361665584146976
throughout O 0 0.006476907059550285
evolution O 0 0.014811490662395954
, O 0 0.003707027295604348
there O 0 0.0030348156578838825
are O 0 0.0037353187799453735
presumed O 0 0.07789573818445206
undiscovered O 0 0.4259795546531677
missense O 1 0.8634749054908752
mutations O 1 0.8641728758811951
, O 0 0.007626339327543974
these O 0 0.004378153011202812
are O 0 0.003778237383812666
hypothesized O 0 0.07557886093854904
to O 0 0.0033174168784171343
exist O 0 0.00751096848398447
in O 0 0.004077020566910505
as O 0 0.0061804126016795635
- O 0 0.07580167055130005
yet O 0 0.03392980247735977
unidentified O 0 0.1804414540529251
phenotypes O 1 0.8062917590141296
. O 0 0.027916887775063515
. O 0 0.028148867189884186

Genetic O 1 0.7973721623420715
heterogeneity O 0 0.3690278232097626
and O 0 0.019615033641457558
penetrance O 0 0.47073549032211304
analysis O 0 0.029192572459578514
of O 0 0.010131855495274067
the O 0 0.031228262931108475
BRCA1 O 1 0.9528496265411377
and O 0 0.20273582637310028
BRCA2 O 1 0.9764205813407898
genes O 1 0.9558008313179016
in O 1 0.628439724445343
breast B-Disease 1 0.982778012752533
cancer I-Disease 1 0.9748556017875671
families O 0 0.4025844633579254
. O 0 0.10045009106397629

The O 0 0.3608405888080597
Breast B-Disease 1 0.9491233229637146
Cancer I-Disease 1 0.9508644342422485
Linkage O 1 0.8298808336257935
Consortium O 0 0.4378412961959839
. O 0 0.06785828620195389

The O 0 0.026060117408633232
contribution O 0 0.04048500210046768
of O 0 0.03036727011203766
BRCA1 O 1 0.9316586852073669
and O 0 0.11998967826366425
BRCA2 O 1 0.9625167846679688
to O 0 0.2990933656692505
inherited B-Disease 1 0.9763638973236084
breast I-Disease 1 0.9857951402664185
cancer I-Disease 1 0.9751660823822021
was O 0 0.022983195260167122
assessed O 0 0.06363274902105331
by O 0 0.01623835228383541
linkage O 0 0.3169335722923279
and O 0 0.01765214465558529
mutation O 1 0.7642635107040405
analysis O 0 0.02477145567536354
in O 0 0.005548159126192331
237 O 0 0.033286917954683304
families O 0 0.014933660626411438
, O 0 0.003175817895680666
each O 0 0.0026902714744210243
with O 0 0.0029822885990142822
at O 0 0.003100744681432843
least O 0 0.007542913313955069
four O 0 0.013158951885998249
cases O 0 0.283645361661911
of O 0 0.125258669257164
breast B-Disease 1 0.9874460697174072
cancer I-Disease 1 0.9772657752037048
, O 0 0.030261024832725525
collected O 0 0.030153818428516388
by O 0 0.05250443518161774
the O 0 0.2247316688299179
Breast B-Disease 1 0.9862440228462219
Cancer I-Disease 1 0.9826027154922485
Linkage O 1 0.9003527164459229
Consortium O 1 0.5957565307617188
. O 0 0.07862676680088043

Families O 0 0.03296215087175369
were O 0 0.010525589808821678
included O 0 0.00923875905573368
without O 0 0.0063972859643399715
regard O 0 0.007216016296297312
to O 0 0.004153365269303322
the O 0 0.006256834603846073
occurrence O 0 0.31729474663734436
of O 0 0.04940199851989746
ovarian B-Disease 1 0.9744268655776978
or I-Disease 0 0.16387106478214264
other I-Disease 0 0.13658514618873596
cancers I-Disease 1 0.9631028771400452
. O 0 0.1474151760339737

Overall O 0 0.14543648064136505
, O 0 0.07669594138860703
disease O 1 0.9411570429801941
was O 0 0.013359076343476772
linked O 0 0.1278354674577713
to O 0 0.009003253653645515
BRCA1 O 1 0.8066318035125732
in O 0 0.007152486592531204
an O 0 0.004342216998338699
estimated O 0 0.009604493156075478
52 O 0 0.009320899844169617
% O 0 0.00762310391291976
of O 0 0.002911207964643836
families O 0 0.01482800580561161
, O 0 0.003703237744048238
to O 0 0.004014184232801199
BRCA2 O 1 0.7871959209442139
in O 0 0.00574321998283267
32 O 0 0.0072402325458824635
% O 0 0.009123758412897587
of O 0 0.002798037137836218
families O 0 0.010419223457574844
, O 0 0.0028994055464863777
and O 0 0.0022365334443747997
to O 0 0.0024920746218413115
neither O 0 0.01622598059475422
gene O 0 0.2657639980316162
in O 0 0.004879442509263754
16 O 0 0.010606005787849426
% O 0 0.01797904446721077
( O 0 0.013956419192254543
95 O 0 0.009732937440276146
% O 0 0.016836415976285934
confidence O 0 0.015661045908927917
interval O 0 0.10518033057451248
[ O 0 0.13316254317760468
CI O 0 0.4123169779777527
] O 0 0.062346894294023514
6 O 0 0.019705453887581825
% O 0 0.0322464182972908
- O 0 0.060939181596040726
28 O 0 0.020104117691516876
% O 0 0.028106974437832832
) O 0 0.014502529986202717
, O 0 0.0068712541833519936
suggesting O 0 0.047947924584150314
other O 0 0.03215082734823227
predisposition O 1 0.8738403916358948
genes O 1 0.7821900844573975
. O 0 0.07827846705913544

The O 0 0.022341908887028694
majority O 0 0.031017333269119263
( O 0 0.0272771455347538
81 O 0 0.03366070240736008
% O 0 0.026139773428440094
) O 0 0.01597597263753414
of O 0 0.010312830097973347
the O 0 0.11841423809528351
breast B-Disease 1 0.9866200685501099
- I-Disease 1 0.954537034034729
ovarian I-Disease 1 0.9915392994880676
cancer I-Disease 1 0.9842984676361084
families O 0 0.14647161960601807
were O 0 0.007329030893743038
due O 0 0.04045156016945839
to O 0 0.010450189933180809
BRCA1 O 1 0.88435959815979
, O 0 0.006102996878325939
with O 0 0.004606278613209724
most O 0 0.0051261382177472115
others O 0 0.011774634942412376
( O 0 0.02758583426475525
14 O 0 0.01926598697900772
% O 0 0.054519739001989365
) O 0 0.02748972736299038
due O 0 0.04157044738531113
to O 0 0.02581927552819252
BRCA2 O 1 0.9275059700012207
. O 0 0.0778668224811554

Conversely O 0 0.06643455475568771
, O 0 0.012887710705399513
the O 0 0.006542555522173643
majority O 0 0.008352593518793583
of O 0 0.004499230068176985
families O 0 0.02011207304894924
with O 0 0.01592792570590973
male B-Disease 0 0.3101864457130432
and I-Disease 0 0.06193438917398453
female I-Disease 1 0.8269624710083008
breast I-Disease 1 0.9875550866127014
cancer I-Disease 1 0.9785429239273071
were O 0 0.022143973037600517
due O 0 0.09061950445175171
to O 0 0.03224234655499458
BRCA2 O 1 0.9514702558517456
( O 0 0.14370518922805786
76 O 0 0.1242799162864685
% O 0 0.07903420925140381
) O 0 0.03801880031824112
. O 0 0.02689489722251892

The O 0 0.01852348819375038
largest O 0 0.01950235851109028
proportion O 0 0.034754857420921326
( O 0 0.018219634890556335
67 O 0 0.0135676683858037
% O 0 0.010438533499836922
) O 0 0.0052063860930502415
of O 0 0.0024994700215756893
families O 0 0.008139023557305336
due O 0 0.00732329161837697
to O 0 0.0026155479717999697
other O 0 0.005235433578491211
genes O 0 0.2914479076862335
was O 0 0.003975990228354931
found O 0 0.0051650842651724815
in O 0 0.003786180866882205
families O 0 0.01036736462265253
with O 0 0.0037821070291101933
four O 0 0.004825790412724018
or O 0 0.011274367570877075
five O 0 0.015455177053809166
cases O 0 0.1650773286819458
of O 0 0.05530068278312683
female O 1 0.801281750202179
breast B-Disease 1 0.9842097759246826
cancer I-Disease 1 0.9731906056404114
only O 0 0.06329390406608582
. O 0 0.06628359854221344

These O 0 0.018255464732646942
estimates O 0 0.018308404833078384
were O 0 0.006811588536947966
not O 0 0.00534858787432313
substantially O 0 0.040711671113967896
affected O 0 0.0402974933385849
either O 0 0.006067618262022734
by O 0 0.004939810372889042
changing O 0 0.010647893883287907
the O 0 0.005987431388348341
assumed O 0 0.0561409592628479
penetrance O 1 0.6782670021057129
model O 0 0.06416003406047821
for O 0 0.019644303247332573
BRCA1 O 1 0.9052038192749023
or O 0 0.024755189195275307
by O 0 0.010465327650308609
including O 0 0.017046993598341942
or O 0 0.05665312707424164
excluding O 0 0.2642555832862854
BRCA1 O 1 0.9659314155578613
mutation O 1 0.9355406165122986
data O 0 0.0875287801027298
. O 0 0.04690409451723099

Among O 0 0.03452659025788307
those O 0 0.01850828342139721
families O 0 0.06875753402709961
with O 0 0.06658516079187393
disease O 1 0.96341872215271
due O 0 0.07685690373182297
to O 0 0.011796454899013042
BRCA1 O 1 0.7905241250991821
that O 0 0.00444144569337368
were O 0 0.002585176844149828
tested O 0 0.01427453849464655
by O 0 0.002857751213014126
one O 0 0.002139501739293337
of O 0 0.002084898529574275
the O 0 0.0032310299575328827
standard O 0 0.026500841602683067
screening O 0 0.10414399206638336
methods O 0 0.027657367289066315
, O 0 0.010164618492126465
mutations O 1 0.6455973982810974
were O 0 0.00452169356867671
detected O 0 0.06962215900421143
in O 0 0.00450338376685977
the O 0 0.004752675537019968
coding O 0 0.19303055107593536
sequence O 0 0.047510452568531036
or O 0 0.015390757471323013
splice O 0 0.16908298432826996
sites O 0 0.007503851316869259
in O 0 0.003924849443137646
an O 0 0.003808982204645872
estimated O 0 0.014515252783894539
63 O 0 0.02449806220829487
% O 0 0.02728801779448986
( O 0 0.021172596141695976
95 O 0 0.01844519004225731
% O 0 0.037056729197502136
CI O 0 0.30639931559562683
51 O 0 0.03238477185368538
% O 0 0.036486390978097916
- O 0 0.07192111760377884
77 O 0 0.0460398904979229
% O 0 0.04514174163341522
) O 0 0.02515460178256035
. O 0 0.019075581803917885

The O 0 0.021519603207707405
estimated O 0 0.02573540434241295
sensitivity O 0 0.037369582802057266
was O 0 0.007303175516426563
identical O 0 0.014779116027057171
for O 0 0.005334382876753807
direct O 0 0.011184293776750565
sequencing O 0 0.05181630700826645
and O 0 0.006841939873993397
other O 0 0.008428425528109074
techniques O 0 0.05005535110831261
. O 0 0.024958034977316856

The O 0 0.029559431597590446
penetrance O 0 0.37044042348861694
of O 0 0.01728382520377636
BRCA2 O 1 0.7656177282333374
was O 0 0.009525218978524208
estimated O 0 0.012694159522652626
by O 0 0.00731539586558938
maximizing O 0 0.02969839982688427
the O 0 0.007594446651637554
LOD O 0 0.18516971170902252
score O 0 0.015070879831910133
in O 0 0.036079924553632736
BRCA2 O 1 0.95828777551651
- O 1 0.5121554732322693
mutation O 1 0.8476896286010742
families O 0 0.0457884706556797
, O 0 0.007016066461801529
over O 0 0.0058335051871836185
all O 0 0.00636290991678834
possible O 0 0.0382232628762722
penetrance O 1 0.670815646648407
functions O 0 0.06844029575586319
. O 0 0.039979878813028336

The O 0 0.028308387845754623
estimated O 0 0.08605209738016129
cumulative O 0 0.4973725378513336
risk O 1 0.720999002456665
of O 0 0.11867007613182068
breast B-Disease 1 0.9776594042778015
cancer I-Disease 1 0.967892050743103
reached O 0 0.03163428232073784
28 O 0 0.031867366284132004
% O 0 0.03214085474610329
( O 0 0.02477726712822914
95 O 0 0.016815466806292534
% O 0 0.029937200248241425
CI O 0 0.2206418216228485
9 O 0 0.011766858398914337
% O 0 0.01656302995979786
- O 0 0.023512836545705795
44 O 0 0.00989394262433052
% O 0 0.015933210030198097
) O 0 0.0065816049464046955
by O 0 0.0032414523884654045
age O 0 0.008229362778365612
50 O 0 0.004977624397724867
years O 0 0.004497083369642496
and O 0 0.0033049562480300665
84 O 0 0.018411852419376373
% O 0 0.021173939108848572
( O 0 0.01724057085812092
95 O 0 0.013259368017315865
% O 0 0.03520495444536209
CI O 0 0.26521602272987366
43 O 0 0.025732234120368958
% O 0 0.026802994310855865
- O 0 0.037624623626470566
95 O 0 0.015024391934275627
% O 0 0.017760997638106346
) O 0 0.007429793477058411
by O 0 0.005277905613183975
age O 0 0.016531627625226974
70 O 0 0.015934348106384277
years O 0 0.01912042312324047
. O 0 0.019350409507751465

The O 0 0.07843542844057083
corresponding O 1 0.7417842149734497
ovarian B-Disease 1 0.9723562598228455
cancer I-Disease 1 0.9675571322441101
risks O 1 0.6026633381843567
were O 0 0.024094196036458015
0 O 0 0.07075309753417969
. O 0 0.03472535312175751

4 O 0 0.04135625436902046
% O 0 0.0313265323638916
( O 0 0.021217167377471924
95 O 0 0.015458093956112862
% O 0 0.029513603076338768
CI O 0 0.2150016725063324
0 O 0 0.023997368291020393
% O 0 0.020975058898329735
- O 0 0.03667903691530228
1 O 0 0.007390983868390322
% O 0 0.013165498152375221
) O 0 0.006256371736526489
by O 0 0.0031414423137903214
age O 0 0.005627422593533993
50 O 0 0.003993544261902571
years O 0 0.0042777047492563725
and O 0 0.0026988571044057608
27 O 0 0.006891373544931412
% O 0 0.017146660014986992
( O 0 0.012996691279113293
95 O 0 0.012798154726624489
% O 0 0.031448062509298325
CI O 0 0.2983819544315338
0 O 0 0.03253413364291191
% O 0 0.025423308834433556
- O 0 0.043133821338415146
47 O 0 0.02140493504703045
% O 0 0.023943159729242325
) O 0 0.011584305204451084
by O 0 0.005805019289255142
age O 0 0.019166920334100723
70 O 0 0.01864766702055931
years O 0 0.02167770452797413
. O 0 0.024862010031938553

The O 0 0.04511209577322006
lifetime O 0 0.44702231884002686
risk O 1 0.7868208885192871
of O 0 0.1730974018573761
breast B-Disease 1 0.977540135383606
cancer I-Disease 1 0.9697957634925842
appears O 0 0.133246049284935
similar O 0 0.025637052953243256
to O 0 0.005868069361895323
the O 0 0.01227041520178318
risk O 1 0.5591562390327454
in O 0 0.0397309735417366
BRCA1 O 1 0.9482333660125732
carriers O 0 0.2402830272912979
, O 0 0.004835206549614668
but O 0 0.0026947034057229757
there O 0 0.0019396113930270076
was O 0 0.0017904029227793217
some O 0 0.002184045035392046
suggestion O 0 0.00495906313881278
of O 0 0.003130691358819604
a O 0 0.013264546170830727
lower O 0 0.11417974531650543
risk O 1 0.6697768568992615
in O 0 0.07059484720230103
BRCA2 O 1 0.963513195514679
carriers O 1 0.5815841555595398
< O 1 0.510053813457489
50 O 0 0.016821807250380516
years O 0 0.0118752745911479
of O 0 0.009599491953849792
age O 0 0.05342821031808853
. O 0 0.0293604526668787

Eye B-Disease 1 0.7616071105003357
movement I-Disease 0 0.3604646623134613
abnormalities I-Disease 1 0.9341477751731873
correlate O 1 0.659595787525177
with O 0 0.15274156630039215
genotype O 1 0.9318243265151978
in O 0 0.40419214963912964
autosomal O 1 0.9787632822990417
dominant O 1 0.9251506328582764
cerebellar B-Disease 1 0.9659595489501953
ataxia I-Disease 1 0.9609633088111877
type I-Disease 1 0.6129763126373291
I I-Disease 0 0.0578748844563961
. O 0 0.042811308056116104

We O 0 0.027895865961909294
compared O 0 0.04632360488176346
horizontal O 0 0.14486053586006165
eye O 0 0.3637508749961853
movements O 0 0.06330136209726334
( O 0 0.041780829429626465
visually O 0 0.11466236412525177
guided O 0 0.045916665345430374
saccades O 1 0.6873611807823181
, O 0 0.014216803945600986
antisaccades O 0 0.17415548861026764
, O 0 0.00615585595369339
and O 0 0.004481427371501923
smooth O 0 0.05678537115454674
pursuit O 0 0.0769365206360817
) O 0 0.015640851110219955
in O 0 0.006695393472909927
control O 0 0.02815936878323555
subjects O 0 0.05665533244609833
( O 0 0.04684392362833023
n O 0 0.07906151562929153
= O 0 0.14109469950199127
14 O 0 0.018156059086322784
) O 0 0.014234859496355057
and O 0 0.005955078639090061
patients O 0 0.4930155575275421
with O 0 0.007866030558943748
three O 0 0.010170982219278812
forms O 0 0.11121808737516403
of O 0 0.07583034783601761
autosomal O 1 0.9828610420227051
dominant O 1 0.8331019282341003
cerebellar B-Disease 1 0.9673835039138794
ataxias I-Disease 1 0.8572116494178772
type I-Disease 0 0.4881029427051544
I I-Disease 0 0.06033647432923317
spinocerebellar B-Disease 1 0.9123942255973816
ataxias I-Disease 0 0.3557296693325043
1 I-Disease 0 0.015011588111519814
and I-Disease 0 0.006285707466304302
2 I-Disease 0 0.012004573829472065
( O 0 0.024289948865771294
SCA1 B-Disease 0 0.17326714098453522
, O 0 0.007442139554768801
n O 0 0.04450627416372299
= O 0 0.10558211803436279
11 O 0 0.016664836555719376
; O 0 0.02357679046690464
SCA2 B-Disease 0 0.18965324759483337
, O 0 0.007375276181846857
n O 0 0.046698521822690964
= O 0 0.09341641515493393
10 O 0 0.010248142294585705
) O 0 0.017159612849354744
and O 0 0.012069279327988625
SCA3 B-Disease 1 0.750351071357727
/ O 1 0.7108128666877747
Machado B-Disease 1 0.7742565870285034
- I-Disease 1 0.7609242796897888
Joseph I-Disease 1 0.7742118835449219
disease I-Disease 1 0.9830242395401001
( O 0 0.33866509795188904
MJD B-Disease 1 0.7819832563400269
) O 0 0.07729264348745346
( O 0 0.06041816249489784
n O 0 0.07440163195133209
= O 0 0.11624231189489365
16 O 0 0.022288702428340912
) O 0 0.023251688107848167
. O 0 0.02127145789563656

In O 0 0.0382767990231514
SCA1 B-Disease 0 0.1848825365304947
, O 0 0.023587554693222046
saccade O 0 0.3446866273880005
amplitude O 0 0.09221679717302322
was O 0 0.013118875212967396
significantly O 0 0.06318072229623795
increased O 0 0.032470617443323135
, O 0 0.01174920704215765
resulting O 0 0.09093738347291946
in O 0 0.02146550640463829
hypermetria B-Disease 0 0.3690083920955658
. O 0 0.04146320000290871

The O 0 0.032062653452157974
smooth O 0 0.05739716440439224
pursuit O 0 0.04835119470953941
gain O 0 0.031039517372846603
was O 0 0.0181256290525198
decreased O 0 0.20314155519008636
. O 0 0.035299934446811676

In O 0 0.04153130576014519
SCA2 B-Disease 0 0.2607981860637665
, O 0 0.025648703798651695
saccade O 0 0.32629385590553284
velocity O 0 0.06357406079769135
was O 0 0.019499249756336212
markedly O 0 0.3550260365009308
decreased O 0 0.3604401648044586
. O 0 0.046166300773620605

The O 0 0.01830466464161873
percentage O 0 0.01681477390229702
of O 0 0.007785968016833067
errors O 0 0.02354712039232254
in O 0 0.007639837916940451
antisaccades O 0 0.10653803497552872
was O 0 0.006037982180714607
greatly O 0 0.025636380538344383
increased O 0 0.01767854019999504
and O 0 0.00530271464958787
was O 0 0.009908096864819527
significantly O 0 0.22442004084587097
correlated O 0 0.45277518033981323
with O 0 0.05242110788822174
age O 0 0.35829320549964905
at O 0 0.3102285861968994
disease O 1 0.9804266691207886
onset O 1 0.9573717713356018
. O 0 0.20534180104732513

In O 0 0.022568605840206146
addition O 0 0.017116840928792953
, O 0 0.008150309324264526
a O 0 0.008135017938911915
correlation O 0 0.04230509325861931
between O 0 0.010570388287305832
smooth O 0 0.039868779480457306
pursuit O 0 0.026880018413066864
gain O 0 0.010168620385229588
and O 0 0.003420004853978753
the O 0 0.004002484492957592
number O 0 0.005404018331319094
of O 0 0.008836722932755947
trinucleotide O 1 0.5399077534675598
repeats O 0 0.1559624969959259
was O 0 0.01279856450855732
found O 0 0.02557452954351902
. O 0 0.025106312707066536

In O 0 0.038605913519859314
SCA3 B-Disease 0 0.33545565605163574
, O 0 0.023950228467583656
gaze B-Disease 0 0.13057629764080048
- I-Disease 0 0.16315117478370667
evoked I-Disease 0 0.33078721165657043
nystagmus I-Disease 1 0.7769240736961365
was O 0 0.009350760839879513
often O 0 0.009313651360571384
present O 0 0.007825471460819244
as O 0 0.006078006234019995
was O 0 0.008051755838096142
saccade O 0 0.3500562012195587
hypometria O 0 0.23708802461624146
and O 0 0.00951693207025528
smooth O 0 0.06375300139188766
pursuit O 0 0.0525641143321991
gain O 0 0.03860320523381233
was O 0 0.02029302529990673
markedly O 0 0.41286060214042664
decreased O 0 0.3979463279247284
. O 0 0.053143445402383804

Three O 0 0.026730364188551903
major O 0 0.02664491906762123
criteria O 0 0.03520110994577408
, O 0 0.01570213958621025
saccade O 0 0.37780389189720154
amplitude O 0 0.12614165246486664
, O 0 0.013337591663002968
saccade O 0 0.26181113719940186
velocity O 0 0.023723721504211426
, O 0 0.005078080575913191
and O 0 0.0036144929472357035
presence O 0 0.009563697502017021
of O 0 0.0053634559735655785
gaze B-Disease 0 0.12043628096580505
- I-Disease 0 0.15081854164600372
evoked I-Disease 0 0.28661811351776123
nystagmus I-Disease 1 0.7481036186218262
, O 0 0.0061004385352134705
permitted O 0 0.005830638110637665
the O 0 0.0033869461622089148
correct O 0 0.01600603014230728
assignment O 0 0.0074305287562310696
of O 0 0.0024723727256059647
90 O 0 0.004178730305284262
% O 0 0.0037703735288232565
of O 0 0.001979029970243573
the O 0 0.0028370502404868603
SCA1 B-Disease 0 0.07534486800432205
, O 0 0.002952190348878503
90 O 0 0.00436594570055604
% O 0 0.005304072983562946
of O 0 0.0021901524160057306
the O 0 0.0027060655411332846
SCA2 B-Disease 0 0.06872089952230453
, O 0 0.0027472989168018103
and O 0 0.0022047185339033604
93 O 0 0.006769850384443998
% O 0 0.0067644789814949036
of O 0 0.0031477652955800295
the O 0 0.006700863130390644
patients O 1 0.631018340587616
with O 0 0.01259206049144268
SCA3 B-Disease 0 0.2640160918235779
to O 0 0.005602960009127855
their O 0 0.01295334193855524
genetically O 1 0.7231560945510864
confirmed O 0 0.1916235238313675
patient O 1 0.5066568851470947
group O 0 0.01711966283619404
and O 0 0.004293755162507296
, O 0 0.003872781293466687
therefore O 0 0.006817494053393602
, O 0 0.004217237699776888
may O 0 0.012957547791302204
help O 0 0.018852047622203827
orient O 0 0.06838066875934601
diagnoses O 1 0.7878952622413635
of O 0 0.013611280359327793
SCA1 B-Disease 0 0.39570391178131104
, O 0 0.011144507676362991
SCA2 B-Disease 0 0.19572049379348755
, O 0 0.0070095486007630825
and O 0 0.006542759947478771
SCA3 B-Disease 0 0.2520414888858795
at O 0 0.011345609091222286
early O 0 0.03587329015135765
clinical O 1 0.5757774114608765
stages O 0 0.15700621902942657
of O 0 0.014218253083527088
the O 0 0.04807829484343529
diseases O 1 0.9552029967308044
. O 0 0.04318293556571007
. O 0 0.04566378518939018

Genetic O 1 0.5871529579162598
basis O 0 0.03643100708723068
and O 0 0.023508518934249878
molecular O 1 0.5060691237449646
mechanism O 1 0.5690305829048157
for O 0 0.21965578198432922
idiopathic B-Disease 1 0.9617670178413391
ventricular I-Disease 1 0.9465330839157104
fibrillation I-Disease 1 0.9414423108100891
. O 0 0.21986447274684906

Ventricular B-Disease 1 0.9105879068374634
fibrillation I-Disease 1 0.9228039383888245
causes O 0 0.4255989193916321
more O 0 0.014754877425730228
than O 0 0.010687333531677723
300 O 0 0.013155044987797737
, O 0 0.00819906685501337
000 O 0 0.044176194816827774
sudden O 0 0.22464372217655182
deaths O 0 0.115115687251091
each O 0 0.006502349860966206
year O 0 0.006900053005665541
in O 0 0.004980761557817459
the O 0 0.007080748677253723
USA O 0 0.03173549845814705
alone O 0 0.03701382130384445
. O 0 0.026137860491871834

In O 0 0.018053526058793068
approximately O 0 0.015532204881310463
5 O 0 0.012308558449149132
- O 0 0.01992255449295044
12 O 0 0.006340068764984608
% O 0 0.007158580701798201
of O 0 0.0029845053795725107
these O 0 0.004638744983822107
cases O 0 0.02683459222316742
, O 0 0.002792676445096731
there O 0 0.0027196062728762627
are O 0 0.0039003484416753054
no O 0 0.02453489415347576
demonstrable O 1 0.7880515456199646
cardiac O 1 0.9670393466949463
or O 0 0.22397637367248535
non O 0 0.48392942547798157
- O 1 0.7385000586509705
cardiac O 1 0.9697859883308411
causes O 1 0.5794976353645325
to O 0 0.005366728641092777
account O 0 0.007224656641483307
for O 0 0.003024433972314
the O 0 0.0034548528492450714
episode O 0 0.015897519886493683
, O 0 0.004085119813680649
which O 0 0.0042786975391209126
is O 0 0.00645963242277503
therefore O 0 0.03084387816488743
classified O 0 0.22549696266651154
as O 0 0.22809411585330963
idiopathic B-Disease 1 0.9844999313354492
ventricular I-Disease 1 0.976223349571228
fibrillation I-Disease 1 0.9791961312294006
( O 1 0.6809033155441284
IVF B-Disease 1 0.9373369216918945
) O 0 0.16427752375602722
. O 0 0.04475811496376991

A O 0 0.03520577400922775
distinct O 0 0.06164269894361496
group O 0 0.028951644897460938
of O 0 0.021815422922372818
IVF B-Disease 1 0.9265017509460449
patients O 1 0.7960593700408936
has O 0 0.008647467941045761
been O 0 0.004395275376737118
found O 0 0.004750966560095549
to O 0 0.002867872826755047
present O 0 0.005490099545568228
with O 0 0.006569776684045792
a O 0 0.012454702518880367
characteristic O 0 0.2681182324886322
electrocardiographic O 1 0.5260171294212341
pattern O 0 0.47619470953941345
. O 0 0.05581662431359291

Because O 0 0.017989015206694603
of O 0 0.007051711902022362
the O 0 0.0047189537435770035
small O 0 0.005089806858450174
size O 0 0.004499255213886499
of O 0 0.002801283961161971
most O 0 0.003521081991493702
pedigrees O 0 0.0576537661254406
and O 0 0.0033693830482661724
the O 0 0.0045968517661094666
high O 0 0.044064346700906754
incidence O 1 0.7959868907928467
of O 0 0.015389353968203068
sudden B-Disease 0 0.4808395802974701
death I-Disease 0 0.14376099407672882
, O 0 0.009758740663528442
however O 0 0.014629692770540714
, O 0 0.019813086837530136
molecular O 1 0.5909637212753296
genetic O 1 0.8301628232002258
studies O 0 0.11460719257593155
of O 0 0.01384812779724598
IVF B-Disease 1 0.6960889101028442
have O 0 0.006797680165618658
not O 0 0.004569986369460821
yet O 0 0.006858241278678179
been O 0 0.006951681338250637
done O 0 0.014206049032509327
. O 0 0.01744191162288189

Because O 1 0.5107636451721191
IVF B-Disease 1 0.9351509809494019
causes O 1 0.9461057782173157
cardiac O 1 0.9601369500160217
rhythm O 1 0.6460748910903931
disturbance O 0 0.4895230531692505
, O 0 0.009934571571648121
we O 0 0.005226027686148882
investigated O 0 0.022361574694514275
whether O 0 0.010633967816829681
malfunction O 0 0.22974561154842377
of O 0 0.007290350738912821
ion O 0 0.18263407051563263
channels O 0 0.06830315291881561
could O 0 0.025492602959275246
cause O 0 0.45940184593200684
the O 0 0.05497455596923828
disorder O 1 0.9724332690238953
by O 0 0.05158059671521187
studying O 0 0.1439061164855957
mutations O 1 0.9038588404655457
in O 0 0.03484443575143814
the O 0 0.057297155261039734
cardiac O 1 0.9641971588134766
sodium O 1 0.8181082010269165
channel O 0 0.2988898456096649
gene O 1 0.876434326171875
SCN5A O 1 0.6740650534629822
. O 0 0.060206662863492966

We O 0 0.014476963318884373
have O 0 0.010014298371970654
now O 0 0.008404664695262909
identified O 0 0.019277768209576607
a O 0 0.0181797556579113
missense O 1 0.7952274084091187
mutation O 1 0.8510327935218811
, O 0 0.013285721652209759
a O 0 0.023005228489637375
splice O 1 0.7731385827064514
- O 1 0.6203858256340027
donor O 1 0.8139694333076477
mutation O 1 0.8897911906242371
, O 0 0.011239228770136833
and O 0 0.006021107081323862
a O 0 0.02269044518470764
frameshift O 1 0.8843572735786438
mutation O 1 0.8610042929649353
in O 0 0.010176620446145535
the O 0 0.007674614433199167
coding O 0 0.29203149676322937
region O 0 0.018905065953731537
of O 0 0.007783120963722467
SCN5A O 0 0.2572304308414459
in O 0 0.01730715110898018
three O 0 0.04650451987981796
IVF B-Disease 1 0.9020525813102722
families O 0 0.2065485268831253
. O 0 0.06078134477138519

We O 0 0.01477879099547863
show O 0 0.011067107319831848
that O 0 0.006753255147486925
sodium O 0 0.05627664923667908
channels O 0 0.01640053279697895
with O 0 0.007473362144082785
the O 0 0.011655488051474094
missense O 1 0.8566361665725708
mutation O 1 0.9102596640586853
recover O 0 0.24513189494609833
from O 0 0.01622878760099411
inactivation O 0 0.18647316098213196
more O 0 0.006581439170986414
rapidly O 0 0.03965701535344124
than O 0 0.007429852616041899
normal O 0 0.046782832592725754
and O 0 0.0038890475407242775
that O 0 0.0041358452290296555
the O 0 0.012731725350022316
frameshift O 1 0.8955256342887878
mutation O 1 0.9292815923690796
causes O 1 0.5576871037483215
the O 0 0.009414234198629856
sodium O 0 0.18876685202121735
channel O 0 0.014692122116684914
to O 0 0.0053703621961176395
be O 0 0.00578438863158226
non O 0 0.04315321147441864
- O 0 0.12596113979816437
functional O 0 0.23282641172409058
. O 0 0.049312081187963486

Our O 0 0.027390584349632263
results O 0 0.03764231130480766
indicate O 0 0.04389595985412598
that O 0 0.021676674485206604
mutations O 1 0.9023164510726929
in O 0 0.10059773921966553
cardiac O 1 0.9530009627342224
ion O 0 0.4559876322746277
- O 0 0.20507510006427765
channel O 0 0.07988099753856659
genes O 1 0.5718267560005188
contribute O 0 0.06089514121413231
to O 0 0.006082477979362011
the O 0 0.010571465827524662
risk O 0 0.4173332452774048
of O 0 0.021517476066946983
developing O 0 0.4359002411365509
IVF B-Disease 1 0.8746477961540222
. O 0 0.03944231942296028
. O 0 0.03295288607478142

Molecular O 0 0.4126676321029663
heterogeneity O 0 0.27168190479278564
in O 0 0.022187530994415283
mucopolysaccharidosis B-Disease 0 0.1920781433582306
IVA I-Disease 0 0.2990575432777405
in O 0 0.008460546843707561
Australia O 0 0.006607838906347752
and O 0 0.004077969118952751
Northern O 0 0.008054117672145367
Ireland O 0 0.011789252981543541
: O 0 0.010449512861669064
nine O 0 0.01924317516386509
novel O 0 0.1962021440267563
mutations O 1 0.8668984770774841
including O 0 0.02987661212682724
T312S O 0 0.2291889190673828
, O 0 0.00893933605402708
a O 0 0.014713584445416927
common O 0 0.16733811795711517
allele O 1 0.7573675513267517
that O 0 0.03297983482480049
confers O 1 0.5642842650413513
a O 0 0.13446541130542755
mild O 1 0.9044682383537292
phenotype O 1 0.9315499067306519
. O 0 0.11659250408411026

Mucopolysaccharidosis B-Disease 1 0.7224177718162537
IVA I-Disease 1 0.8144369125366211
( O 0 0.1895512193441391
MPS B-Disease 0 0.25361767411231995
IVA I-Disease 1 0.8414342403411865
) O 0 0.10384577512741089
is O 0 0.06461910903453827
an O 0 0.30584925413131714
autosomal B-Disease 1 0.9845374822616577
recessive I-Disease 1 0.9832859635353088
lysosomal I-Disease 1 0.9684352278709412
storage I-Disease 1 0.8140430450439453
disorder I-Disease 1 0.9786418676376343
caused O 1 0.6089545488357544
by O 0 0.04156523197889328
a O 0 0.10204239189624786
genetic B-Disease 1 0.9554832577705383
defect I-Disease 1 0.9046468138694763
in O 0 0.04984988644719124
N O 0 0.29364755749702454
- O 0 0.38308385014533997
acetylgalactosamine O 1 0.5787609219551086
- O 0 0.34613466262817383
6 O 0 0.1422235667705536
- O 1 0.571660041809082
sulfate O 1 0.9301071763038635
sulfatase O 1 0.9411990642547607
( O 0 0.30091652274131775
GALNS O 1 0.6388936638832092
) O 0 0.08003953844308853
. O 0 0.03795773908495903

Previous O 0 0.03860151395201683
studies O 0 0.041237398982048035
of O 0 0.011696001514792442
patients O 0 0.4928486943244934
from O 0 0.008614562451839447
a O 0 0.01009040605276823
British O 0 0.016092104837298393
- O 0 0.049619875848293304
Irish O 0 0.0420331209897995
population O 0 0.01574927754700184
showed O 0 0.00885778944939375
that O 0 0.003807404777035117
the O 0 0.005875930655747652
I113F O 0 0.3772440552711487
mutation O 1 0.7378081679344177
is O 0 0.005554853472858667
the O 0 0.004147208295762539
most O 0 0.008232204243540764
common O 0 0.10458987951278687
single O 0 0.12689030170440674
mutation O 1 0.9412173628807068
among O 0 0.19691112637519836
MPS B-Disease 1 0.6562212109565735
IVA I-Disease 1 0.9611397981643677
patients O 1 0.939213216304779
and O 0 0.04787589982151985
produces O 1 0.5199924111366272
a O 0 0.2687343657016754
severe O 1 0.9553413987159729
clinical O 1 0.9448550939559937
phenotype O 1 0.94217848777771
. O 0 0.16093839704990387

We O 0 0.023219630122184753
studied O 0 0.04564549773931503
mutations O 1 0.573441207408905
in O 0 0.010265137068927288
the O 0 0.009454871527850628
GALNS O 0 0.4240364134311676
gene O 1 0.513806164264679
from O 0 0.010462972335517406
23 O 0 0.021255988627672195
additional O 0 0.036311257630586624
MPS B-Disease 0 0.3448593318462372
IVA I-Disease 1 0.9463230967521667
patients O 1 0.9101418256759644
( O 0 0.03919884189963341
15 O 0 0.008031804114580154
from O 0 0.004174807108938694
Australia O 0 0.0039315312169492245
, O 0 0.002977607771754265
8 O 0 0.00436169421300292
from O 0 0.003894544905051589
Northern O 0 0.007669778540730476
Ireland O 0 0.013515093363821507
) O 0 0.009576416574418545
, O 0 0.00399984885007143
with O 0 0.008200294338166714
various O 0 0.041002657264471054
clinical O 1 0.9078195691108704
phenotypes O 1 0.9435871839523315
( O 0 0.34196823835372925
severe O 1 0.8488687872886658
, O 0 0.017143527045845985
16 O 0 0.03971027582883835
cases O 0 0.20351047813892365
; O 0 0.033556196838617325
intermediate O 0 0.08549023419618607
, O 0 0.01235003862529993
4 O 0 0.04566665366292
cases O 0 0.36800023913383484
; O 0 0.09423987567424774
mild O 1 0.5889766812324524
, O 0 0.016194991767406464
3 O 0 0.04023916646838188
cases O 0 0.17179568111896515
) O 0 0.045064907521009445
. O 0 0.028155334293842316

We O 0 0.016866406425833702
found O 0 0.012746904976665974
two O 0 0.008217765018343925
common O 0 0.048084557056427
mutations O 1 0.5504952073097229
that O 0 0.003965005744248629
together O 0 0.004750964231789112
accounted O 0 0.009332888759672642
for O 0 0.003240956226363778
32 O 0 0.0063224053010344505
% O 0 0.00799553282558918
of O 0 0.003471569623798132
the O 0 0.005945117212831974
44 O 0 0.0528256893157959
unrelated O 0 0.4681350886821747
alleles O 1 0.8358882069587708
in O 0 0.035145778208971024
these O 0 0.07302682101726532
patients O 1 0.901032567024231
. O 0 0.07349836081266403

One O 0 0.022339746356010437
is O 0 0.012694492936134338
the O 0 0.012214378453791142
T312S O 0 0.3975878357887268
mutation O 1 0.8067989945411682
, O 0 0.013750646263360977
a O 0 0.017307531088590622
novel O 0 0.21441498398780823
mutation O 1 0.8599509000778198
found O 0 0.038237523287534714
exclusively O 0 0.0487072616815567
in O 0 0.05616841837763786
milder O 1 0.8821529746055603
patients O 1 0.9211527109146118
. O 0 0.09379510581493378

The O 0 0.016070745885372162
other O 0 0.00923808291554451
is O 0 0.006207051686942577
the O 0 0.005543704144656658
previously O 0 0.010721645317971706
described O 0 0.028368806466460228
I113F O 0 0.19401131570339203
that O 0 0.013209494762122631
produces O 0 0.25270938873291016
a O 0 0.13430067896842957
severe O 1 0.9273106455802917
phenotype O 1 0.9382621645927429
. O 0 0.12028814852237701

The O 0 0.031885839998722076
I113F O 0 0.13203708827495575
and O 0 0.018555622547864914
T312S O 0 0.3772149980068207
mutations O 1 0.7683344483375549
accounted O 0 0.03412503004074097
for O 0 0.007906113751232624
8 O 0 0.012203464284539223
( O 0 0.01346233393996954
18 O 0 0.008022763766348362
% O 0 0.01617118902504444
) O 0 0.007831624709069729
and O 0 0.002985403873026371
6 O 0 0.008798349648714066
( O 0 0.012050888501107693
14 O 0 0.007332076784223318
% O 0 0.013563909567892551
) O 0 0.006473385263234377
of O 0 0.004307027440518141
44 O 0 0.03429749980568886
unrelated O 0 0.4142240881919861
alleles O 1 0.8345291018486023
, O 0 0.015032303519546986
respectively O 0 0.03222177177667618
. O 0 0.026461118832230568

The O 0 0.024252664297819138
relatively O 0 0.033217836171388626
high O 0 0.02543770708143711
residual O 0 0.16596338152885437
GALNS O 0 0.21653185784816742
activity O 0 0.02495228312909603
seen O 0 0.011207942850887775
when O 0 0.007167700678110123
the O 0 0.006759729236364365
T312S O 0 0.23114663362503052
mutant O 0 0.42119425535202026
cDNA O 0 0.31885021924972534
is O 0 0.0284355990588665
overexpressed O 1 0.669009804725647
in O 0 0.028185764327645302
mutant O 1 0.7662529945373535
cells O 1 0.7816669940948486
provides O 0 0.039555516093969345
an O 0 0.006874574348330498
explanation O 0 0.021985400468111038
for O 0 0.008673984557390213
the O 0 0.026377759873867035
mild O 1 0.9164364337921143
phenotype O 1 0.9601578116416931
in O 0 0.10418082773685455
patients O 1 0.8982393741607666
with O 0 0.04699787497520447
this O 0 0.046183355152606964
mutation O 1 0.9163042902946472
. O 0 0.08326388150453568

The O 0 0.017756687477231026
distribution O 0 0.01780840940773487
and O 0 0.007578316610306501
relative O 0 0.010434336960315704
frequencies O 0 0.009913969784975052
of O 0 0.0044230311177670956
the O 0 0.0050645689480006695
I113F O 0 0.13349033892154694
and O 0 0.00937709677964449
T312S O 0 0.3692501187324524
mutations O 1 0.737555742263794
in O 0 0.007219046354293823
Australia O 0 0.0060275401920080185
corresponded O 0 0.015423060394823551
to O 0 0.0026258183643221855
those O 0 0.0031904520001262426
observed O 0 0.009512689895927906
in O 0 0.0031042033806443214
Northern O 0 0.005537554156035185
Ireland O 0 0.006738188676536083
and O 0 0.0022287683095782995
are O 0 0.0020256484858691692
unique O 0 0.004319195169955492
to O 0 0.001846848288550973
these O 0 0.0025124442763626575
two O 0 0.0035374874714761972
populations O 0 0.0930415466427803
, O 0 0.0036859693937003613
suggesting O 0 0.018435703590512276
that O 0 0.0032852194271981716
both O 0 0.005498835816979408
mutations O 0 0.4240473210811615
were O 0 0.002608028007671237
probably O 0 0.004787574987858534
introduced O 0 0.004290668293833733
to O 0 0.002303250366821885
Australia O 0 0.00339051173068583
by O 0 0.0038758874870836735
Irish O 0 0.023738840594887733
migrants O 0 0.012338017113506794
during O 0 0.006624561734497547
the O 0 0.0062910886481404305
19th O 0 0.022304043173789978
century O 0 0.02768230065703392
. O 0 0.024452846497297287

Haplotype O 1 0.6297383308410645
analysis O 0 0.037269774824380875
using O 0 0.018828565254807472
6 O 0 0.014614323154091835
RFLPs O 0 0.08248770982027054
provides O 0 0.010847962461411953
additional O 0 0.00586573826149106
data O 0 0.004664192907512188
that O 0 0.0035389168187975883
the O 0 0.0062534441240131855
I113F O 0 0.40863969922065735
mutation O 1 0.8403367400169373
originated O 0 0.10112754255533218
from O 0 0.012593946419656277
a O 0 0.020407037809491158
common O 0 0.10983172804117203
ancestor O 0 0.2667667269706726
. O 0 0.04564577341079712

The O 0 0.021599235013127327
other O 0 0.014158622361719608
9 O 0 0.026965949684381485
novel O 0 0.19474540650844574
mutations O 1 0.8465644717216492
identified O 0 0.036687348037958145
in O 0 0.005805845372378826
these O 0 0.005367843434214592
23 O 0 0.0130445072427392
patients O 0 0.3207637667655945
were O 0 0.0028304478619247675
each O 0 0.0033779575023800135
limited O 0 0.0052138944156467915
to O 0 0.0034998543560504913
a O 0 0.007618877571076155
single O 0 0.022565724328160286
family O 0 0.06226540729403496
. O 0 0.0297313891351223

These O 0 0.01744934357702732
data O 0 0.012908018194139004
provide O 0 0.008689644746482372
further O 0 0.00618224311619997
evidence O 0 0.006205234210938215
for O 0 0.0047673992812633514
extensive O 0 0.029884301126003265
allelic O 0 0.4751194417476654
heterogeneity O 0 0.37339216470718384
in O 0 0.018857089802622795
MPS B-Disease 0 0.16476668417453766
IVA I-Disease 1 0.7369585633277893
in O 0 0.02214582823216915
British O 0 0.05963781476020813
- O 0 0.16934096813201904
Irish O 0 0.18509328365325928
patients O 1 0.6514591574668884
and O 0 0.004592773504555225
provide O 0 0.005626664962619543
evidence O 0 0.004384781699627638
for O 0 0.0029279428999871016
their O 0 0.003400127636268735
transmission O 0 0.07652878016233444
to O 0 0.003409013384953141
Australia O 0 0.006248028948903084
by O 0 0.007609808351844549
British O 0 0.023653488606214523
- O 0 0.08555858582258224
Irish O 0 0.08471815288066864
migrants O 0 0.05456775799393654
. O 0 0.020235462114214897
. O 0 0.02351258508861065

Identification O 0 0.059671539813280106
of O 0 0.028608093038201332
constitutional O 0 0.12696051597595215
WT1 O 1 0.9023666381835938
mutations O 1 0.9178770780563354
, O 0 0.04542170837521553
in O 0 0.06022863835096359
patients O 1 0.9229514598846436
with O 0 0.2258937805891037
isolated O 1 0.922503650188446
diffuse B-Disease 1 0.9752775430679321
mesangial I-Disease 1 0.9782243371009827
sclerosis I-Disease 1 0.980663001537323
, O 0 0.03232460841536522
and O 0 0.01201950665563345
analysis O 0 0.052285123616456985
of O 0 0.03143017366528511
genotype O 1 0.9342493414878845
/ O 1 0.7681463956832886
phenotype O 1 0.9155836701393127
correlations O 0 0.3189260959625244
by O 0 0.00923540722578764
use O 0 0.007239223923534155
of O 0 0.0066238208673894405
a O 0 0.027334898710250854
computerized O 1 0.5320629477500916
mutation O 1 0.9106974601745605
database O 0 0.2332439422607422
. O 0 0.046489764004945755

Constitutional O 0 0.0730772390961647
mutations O 1 0.5465094447135925
of O 0 0.015932057052850723
the O 0 0.019594939425587654
WT1 O 1 0.8523103594779968
gene O 1 0.6618965864181519
, O 0 0.01613425649702549
encoding O 0 0.14601680636405945
a O 0 0.03522041067481041
zinc O 1 0.6641839146614075
- O 1 0.5170059204101562
finger O 1 0.6322727799415588
transcription O 1 0.816246509552002
factor O 0 0.43440499901771545
involved O 0 0.1145123690366745
in O 0 0.058628346771001816
renal O 1 0.9690206050872803
and O 0 0.028674321249127388
gonadal O 1 0.7673912644386292
development O 0 0.031246159225702286
, O 0 0.005535162054002285
are O 0 0.003885698039084673
found O 0 0.01131430920213461
in O 0 0.010915272869169712
most O 0 0.06274992227554321
patients O 1 0.9469224810600281
with O 0 0.2855278551578522
Denys B-Disease 1 0.9633001089096069
- I-Disease 1 0.9348569512367249
Drash I-Disease 1 0.9727216958999634
syndrome I-Disease 1 0.990557074546814
( O 1 0.7070472836494446
DDS B-Disease 1 0.9458184838294983
) O 0 0.17564448714256287
, O 0 0.06584405153989792
or O 0 0.29804956912994385
diffuse B-Disease 1 0.9652876257896423
mesangial I-Disease 1 0.9816670417785645
sclerosis I-Disease 1 0.989795982837677
( O 1 0.6982154846191406
DMS B-Disease 1 0.9288759231567383
) O 0 0.10226742178201675
associated O 0 0.1055656224489212
with O 0 0.026175906881690025
pseudohermaphroditism B-Disease 1 0.5484017133712769
and O 0 0.04904062673449516
/ O 1 0.714523196220398
or O 0 0.4536527097225189
Wilms B-Disease 1 0.9694240093231201
tumor I-Disease 1 0.9681470394134521
( O 0 0.39867475628852844
WT B-Disease 1 0.8432466387748718
) O 0 0.09824260324239731
. O 0 0.04136374592781067

Most O 0 0.0775325745344162
mutations O 1 0.8882013559341431
in O 0 0.10515458881855011
DDS B-Disease 1 0.8977466225624084
patients O 1 0.8234550356864929
lie O 0 0.03665442764759064
in O 0 0.013241799548268318
exon O 0 0.22242842614650726
8 O 0 0.017864694818854332
or O 0 0.01639561727643013
exon O 0 0.15321345627307892
9 O 0 0.015266344882547855
, O 0 0.007600303739309311
encoding O 0 0.1532018482685089
zinc O 0 0.36678317189216614
finger O 0 0.21553350985050201
2 O 0 0.022944144904613495
or O 0 0.029014568775892258
zinc O 0 0.36027687788009644
finger O 0 0.13214434683322906
3 O 0 0.010999566875398159
, O 0 0.004241137765347958
respectively O 0 0.005327634513378143
, O 0 0.0032954984344542027
with O 0 0.00348895532079041
a O 0 0.005296812858432531
hot O 0 0.016335269436240196
spot O 0 0.021148238331079483
( O 0 0.050460316240787506
R394W O 0 0.2773081064224243
) O 0 0.027199605479836464
in O 0 0.01257784478366375
exon O 0 0.2263336330652237
9 O 0 0.032773926854133606
. O 0 0.02812134101986885

We O 0 0.017556769773364067
analyzed O 0 0.020759716629981995
a O 0 0.009114997461438179
series O 0 0.00875846017152071
of O 0 0.0054806312546133995
24 O 0 0.033225543797016144
patients O 1 0.6928894519805908
, O 0 0.008001329377293587
10 O 0 0.009538546204566956
with O 0 0.01677273027598858
isolated B-Disease 0 0.49603578448295593
DMS I-Disease 1 0.8971721529960632
( O 0 0.2145826369524002
IDMS B-Disease 1 0.876121461391449
) O 0 0.02398083545267582
, O 0 0.005298900883644819
10 O 0 0.006941724102944136
with O 0 0.012067625299096107
DDS B-Disease 1 0.5843973755836487
, O 0 0.006470367778092623
and O 0 0.005423737224191427
4 O 0 0.01552974060177803
with O 0 0.038601234555244446
urogenital B-Disease 1 0.9122263193130493
abnormalities I-Disease 1 0.9563624262809753
and O 0 0.05867719650268555
/ O 1 0.5487067103385925
or O 0 0.10932449996471405
WT B-Disease 1 0.7812836170196533
. O 0 0.07193352282047272

We O 0 0.02742975577712059
report O 0 0.062402382493019104
WT1 O 1 0.8631730079650879
heterozygous O 1 0.8127244114875793
mutations O 1 0.8619170188903809
in O 0 0.02021648734807968
16 O 0 0.047588810324668884
patients O 1 0.6513825058937073
, O 0 0.007060253992676735
4 O 0 0.007995699532330036
of O 0 0.005290640983730555
whom O 0 0.01288655772805214
presented O 0 0.01515605952590704
with O 0 0.02804490365087986
IDMS B-Disease 1 0.810662567615509
. O 0 0.05444667488336563

One O 0 0.027720632031559944
male O 0 0.07868556678295135
and O 0 0.014382382854819298
two O 0 0.030957570299506187
female O 1 0.5880149006843567
IDMS B-Disease 1 0.9543266892433167
patients O 1 0.9562183618545532
with O 0 0.3943231403827667
WT1 O 1 0.9490708708763123
mutations O 1 0.9609594345092773
underwent O 1 0.9082945585250854
normal O 1 0.6856302618980408
puberty O 1 0.8851291537284851
. O 0 0.11547884345054626

Two O 0 0.059191010892391205
mutations O 1 0.8613047003746033
associated O 0 0.09790554642677307
with O 0 0.018299365416169167
IDMS B-Disease 1 0.5433333516120911
are O 0 0.00766177661716938
different O 0 0.008246863260865211
from O 0 0.007986502721905708
those O 0 0.012079482898116112
described O 0 0.0849321186542511
in O 0 0.10208380967378616
DDS B-Disease 1 0.927869439125061
patients O 1 0.9365125298500061
. O 0 0.1033100038766861

No O 0 0.06567811220884323
WT1 O 1 0.8261821866035461
mutations O 1 0.7725864052772522
were O 0 0.011420260183513165
detected O 0 0.08129116147756577
in O 0 0.007085037417709827
the O 0 0.006056830286979675
six O 0 0.018862104043364525
other O 0 0.06474926322698593
IDMS B-Disease 1 0.9544318914413452
patients O 1 0.938788652420044
, O 0 0.05141348019242287
suggesting O 0 0.37073156237602234
genetic O 1 0.8802111148834229
heterogeneity O 1 0.6090983748435974
of O 0 0.03397151082754135
this O 0 0.11598760634660721
disease O 1 0.9597844481468201
. O 0 0.08076759427785873

We O 0 0.0319947674870491
analyzed O 0 0.2705878019332886
genotype O 1 0.8941299319267273
/ O 1 0.6208881139755249
phenotype O 1 0.8799944519996643
correlations O 0 0.1345171183347702
, O 0 0.005150125361979008
on O 0 0.0027062136214226484
the O 0 0.0023881064262241125
basis O 0 0.002729930682107806
of O 0 0.0017961746780201793
the O 0 0.0021283875685185194
constitution O 0 0.004976717289537191
of O 0 0.003937331028282642
a O 0 0.020280595868825912
WT1 O 1 0.8861745595932007
mutation O 1 0.8657453060150146
database O 0 0.07718643546104431
of O 0 0.010197858326137066
84 O 0 0.13855959475040436
germ O 1 0.6962065696716309
- O 0 0.15787537395954132
line O 0 0.034639179706573486
mutations O 1 0.6588910818099976
, O 0 0.004311620257794857
to O 0 0.0028274510987102985
compare O 0 0.014291387982666492
the O 0 0.0035469988361001015
distribution O 0 0.014110634103417397
and O 0 0.004354988224804401
type O 0 0.054564449936151505
of O 0 0.007470264565199614
mutations O 1 0.7668439745903015
, O 0 0.0063804020173847675
according O 0 0.0057296897284686565
to O 0 0.0038758493028581142
the O 0 0.007904079742729664
different O 0 0.06519432365894318
symptoms O 1 0.9408794045448303
. O 0 0.08499845117330551

This O 0 0.020939821377396584
demonstrated O 0 0.02819257788360119
( O 0 0.01825866661965847
1 O 0 0.009204259142279625
) O 0 0.006856880150735378
the O 0 0.004134828690439463
association O 0 0.016327381134033203
between O 0 0.02362198196351528
mutations O 1 0.6994978785514832
in O 0 0.009925457648932934
exons O 0 0.24460652470588684
8 O 0 0.010550274513661861
and O 0 0.0044787004590034485
9 O 0 0.009353507310152054
and O 0 0.009915963746607304
DMS B-Disease 1 0.621408224105835
; O 0 0.0244327150285244
( O 0 0.026944195851683617
2 O 0 0.016572151333093643
) O 0 0.028111055493354797
among O 0 0.03449816256761551
patients O 1 0.7324196100234985
with O 0 0.02064957469701767
DMS B-Disease 0 0.4637046456336975
, O 0 0.004273058380931616
a O 0 0.005073671229183674
higher O 0 0.01078310701996088
frequency O 0 0.028902286663651466
of O 0 0.007823573425412178
exon O 0 0.40058478713035583
8 O 0 0.0817267894744873
mutations O 1 0.8732048869132996
among O 0 0.04878724738955498
46 O 0 0.08625414967536926
, O 0 0.05627048388123512
XY O 1 0.9154200553894043
patients O 1 0.9031437635421753
with O 0 0.041779518127441406
female O 0 0.35274574160575867
phenotype O 1 0.8944306969642639
than O 0 0.019512563943862915
among O 0 0.031080886721611023
46 O 0 0.07436694949865341
, O 0 0.05892781913280487
XY O 1 0.909298837184906
patients O 1 0.9122304916381836
with O 0 0.044654905796051025
sexual O 0 0.3651334345340729
ambiguity O 0 0.28270524740219116
or O 0 0.09332488477230072
male O 1 0.6406213045120239
phenotype O 1 0.9512932896614075
; O 0 0.045601628720760345
and O 0 0.006133506074547768
( O 0 0.020477939397096634
3 O 0 0.011852801777422428
) O 0 0.01132902316749096
statistically O 0 0.025916241109371185
significant O 0 0.013230222277343273
evidence O 0 0.010583373717963696
that O 0 0.007492283824831247
mutations O 1 0.6875457167625427
in O 0 0.01098980288952589
exons O 0 0.210574671626091
8 O 0 0.012503404170274734
and O 0 0.0049029020592570305
9 O 0 0.015495199710130692
preferentially O 0 0.22076091170310974
affect O 0 0.16223448514938354
amino O 0 0.258647620677948
acids O 0 0.2680716812610626
with O 0 0.007909520529210567
different O 0 0.00913031306117773
functions O 0 0.017397448420524597
. O 0 0.011201931163668633
. O 0 0.015828030183911324

The O 0 0.05125708505511284
185delAG O 1 0.6669485569000244
BRCA1 O 1 0.9191123843193054
mutation O 1 0.7808820009231567
originated O 0 0.035351213067770004
before O 0 0.008368253707885742
the O 0 0.004946485627442598
dispersion O 0 0.02660435624420643
of O 0 0.0035368655808269978
Jews O 0 0.006219688802957535
in O 0 0.0032645913306623697
the O 0 0.0029370817355811596
diaspora O 0 0.01619148999452591
and O 0 0.00334104523062706
is O 0 0.004035256337374449
not O 0 0.0042763096280395985
limited O 0 0.009093670174479485
to O 0 0.009503722190856934
Ashkenazim O 0 0.3140797019004822
. O 0 0.0358889102935791

The O 0 0.04337017610669136
185delAG O 1 0.625584602355957
mutation O 1 0.8843754529953003
in O 0 0.07174833118915558
BRCA1 O 1 0.926673173904419
is O 0 0.027226494625210762
detected O 0 0.22352097928524017
in O 0 0.01457187905907631
Ashkenazi O 0 0.33086398243904114
Jews O 0 0.05609294772148132
both O 0 0.04578239470720291
in O 0 0.1974128782749176
familial B-Disease 1 0.983555018901825
breast I-Disease 1 0.9881828427314758
and I-Disease 1 0.6228423714637756
ovarian I-Disease 1 0.9905208349227905
cancer I-Disease 1 0.9794624447822571
and O 0 0.018694661557674408
in O 0 0.009940998628735542
the O 0 0.007826598361134529
general O 0 0.017769435420632362
population O 0 0.05441881716251373
. O 0 0.033737435936927795

All O 0 0.03593328595161438
tested O 0 0.3500281274318695
Ashkenazi O 1 0.6678377985954285
mutation O 1 0.8429208993911743
carriers O 0 0.14994944632053375
share O 0 0.017926057800650597
the O 0 0.010474951937794685
same O 0 0.016115713864564896
allelic O 1 0.5786572694778442
pattern O 0 0.23744937777519226
at O 0 0.022678613662719727
the O 0 0.04707644134759903
BRCA1 O 1 0.9299380779266357
locus O 1 0.7443715333938599
. O 0 0.07674836367368698

Our O 0 0.019576000049710274
previous O 0 0.01586311310529709
study O 0 0.01581411622464657
showed O 0 0.010363294743001461
that O 0 0.0052987802773714066
this O 0 0.008785244077444077
Ashkenazi O 0 0.48440343141555786
mutation O 1 0.7551974058151245
also O 0 0.009807497262954712
occurs O 0 0.07083380222320557
in O 0 0.005203512031584978
Iraqi O 0 0.009042377583682537
Jews O 0 0.009421286173164845
with O 0 0.006212661042809486
a O 0 0.01058043260127306
similar O 0 0.07355991005897522
allelic O 1 0.7309374213218689
pattern O 1 0.5043879747390747
. O 0 0.07146381586790085

We O 0 0.017145268619060516
extended O 0 0.014506619423627853
our O 0 0.00794462114572525
analysis O 0 0.009199146181344986
to O 0 0.00407316954806447
other O 0 0.004965812899172306
non O 0 0.02540212869644165
- O 0 0.09542640298604965
Ashkenazi O 0 0.18987852334976196
subsets O 0 0.06484287977218628
354 O 0 0.03137198090553284
of O 0 0.006231442093849182
Moroccan O 0 0.02158586122095585
origin O 0 0.013023491948843002
, O 0 0.005671370774507523
200 O 0 0.008238068781793118
Yemenites O 0 0.10393530875444412
and O 0 0.006121785379946232
150 O 0 0.01295376755297184
Iranian O 0 0.015355936251580715
Jews O 0 0.025591537356376648
. O 0 0.023125099018216133

Heteroduplex O 0 0.22180598974227905
analysis O 0 0.04001409560441971
complemented O 0 0.03996172547340393
by O 0 0.013315508142113686
direct O 0 0.02271641232073307
DNA O 0 0.1556987315416336
sequencing O 0 0.1038288027048111
of O 0 0.013943785801529884
abnormally O 1 0.5945632457733154
migrating O 0 0.18065908551216125
bands O 0 0.027489038184285164
were O 0 0.011134980246424675
employed O 0 0.03263459727168083
. O 0 0.02758217230439186

Four O 0 0.018372897058725357
of O 0 0.010369437746703625
Moroccan O 0 0.024131303653120995
origin O 0 0.01871434971690178
( O 0 0.014077194966375828
1 O 0 0.006114611867815256
. O 0 0.0035126616712659597
1 O 0 0.004322752356529236
% O 0 0.00892818532884121
) O 0 0.004273709841072559
and O 0 0.0019609390292316675
none O 0 0.0030573909170925617
of O 0 0.0022133050952106714
the O 0 0.0032692961394786835
Yemenites O 0 0.09967727959156036
or O 0 0.006590020842850208
Iranians O 0 0.006239419337362051
was O 0 0.004136780742555857
a O 0 0.00548331905156374
carrier O 0 0.023176301270723343
of O 0 0.007190777454525232
the O 0 0.017045842483639717
185delAG O 1 0.5629279613494873
mutation O 1 0.9057344198226929
. O 0 0.07441937923431396

BRCA1 O 1 0.863286018371582
allelic O 0 0.4573042094707489
patterns O 0 0.055446427315473557
were O 0 0.008550028316676617
determined O 0 0.007894146256148815
for O 0 0.0035881907679140568
four O 0 0.003049153834581375
of O 0 0.002447608159855008
these O 0 0.002903600689023733
individuals O 0 0.008430271409451962
and O 0 0.002469143131747842
for O 0 0.0031505106016993523
12 O 0 0.008144576102495193
additional O 0 0.02187223732471466
non O 0 0.1817014515399933
- O 1 0.5244163274765015
Ashkenazi O 1 0.8921648859977722
185delAG O 1 0.9230083227157593
mutation O 1 0.9697415828704834
carriers O 1 0.7986226081848145
who O 0 0.18491391837596893
had O 0 0.4245404899120331
breast B-Disease 1 0.9853002429008484
/ I-Disease 1 0.9658876657485962
ovarian I-Disease 1 0.9862659573554993
cancer I-Disease 1 0.9755233526229858
. O 0 0.31580641865730286

Six O 0 0.03534942492842674
non O 0 0.08345667272806168
- O 0 0.16234621405601501
Ashkenazi O 0 0.31863224506378174
individuals O 0 0.03331582620739937
shared O 0 0.012336118146777153
the O 0 0.0069669815711677074
common O 0 0.13438726961612701
Ashkenazi O 1 0.5276017785072327
haplotype O 1 0.6522546410560608
, O 0 0.0055246674455702305
four O 0 0.003793621202930808
had O 0 0.003706750925630331
a O 0 0.006338656879961491
closely O 0 0.019935401156544685
related O 0 0.06999347358942032
pattern O 0 0.06371044367551804
, O 0 0.0037622186355292797
and O 0 0.0026999006513506174
the O 0 0.0032208519987761974
rest O 0 0.010095909237861633
( O 0 0.03313547372817993
n O 0 0.06609144806861877
= O 0 0.11399604380130768
6 O 0 0.015322346240282059
) O 0 0.010304398834705353
displayed O 0 0.011372045613825321
a O 0 0.02079005539417267
distinct O 0 0.3913649618625641
BRCA1 O 1 0.9552994966506958
allelic O 1 0.8752338290214539
pattern O 1 0.6514822840690613
. O 0 0.10010061413049698

We O 0 0.018420187756419182
conclude O 0 0.02602049708366394
that O 0 0.010442759841680527
the O 0 0.01641101762652397
185delAG O 1 0.7408323287963867
BRCA1 O 1 0.9661777019500732
mutation O 1 0.9299079775810242
occurs O 0 0.20405569672584534
in O 0 0.008461938239634037
some O 0 0.006979810073971748
non O 0 0.06954939663410187
- O 0 0.16813243925571442
Ashkenazi O 0 0.4096069931983948
populations O 0 0.21028460562229156
at O 0 0.009128729812800884
rates O 0 0.04804319143295288
comparable O 0 0.029856085777282715
with O 0 0.007443101145327091
that O 0 0.006869774777442217
of O 0 0.011368594132363796
Ashkenazim O 0 0.3923550248146057
. O 0 0.042574454098939896

The O 0 0.019937211647629738
majority O 0 0.021983982995152473
of O 0 0.01123633049428463
Jewish O 0 0.05734877660870552
185delAG O 1 0.5123558640480042
mutation O 1 0.8684691786766052
carriers O 0 0.16061145067214966
have O 0 0.00790004525333643
a O 0 0.009738494642078876
common O 0 0.08270296454429626
allelic O 1 0.529897153377533
pattern O 0 0.15050162374973297
, O 0 0.005958952941000462
supporting O 0 0.011179991066455841
the O 0 0.004588581155985594
founder O 0 0.028088772669434547
effect O 0 0.0339336171746254
notion O 0 0.01680159755051136
, O 0 0.003994978964328766
but O 0 0.0036089555360376835
dating O 0 0.01732875034213066
the O 0 0.0059057921171188354
mutations O 1 0.6388790607452393
origin O 0 0.013415083289146423
to O 0 0.00293465587310493
an O 0 0.0033769106958061457
earlier O 0 0.005018646828830242
date O 0 0.00565464049577713
than O 0 0.005283105652779341
currently O 0 0.009635668247938156
estimated O 0 0.03249940648674965
. O 0 0.026097726076841354

However O 0 0.022876180708408356
, O 0 0.011364264413714409
the O 0 0.007523687090724707
different O 0 0.01029243879020214
allelic O 0 0.35417553782463074
pattern O 0 0.11115361750125885
at O 0 0.009435513988137245
the O 0 0.01524615939706564
BRCA1 O 1 0.9411231279373169
locus O 0 0.4695935547351837
even O 0 0.011005569249391556
in O 0 0.007270176894962788
some O 0 0.00874910969287157
Jewish O 0 0.10748646408319473
mutation O 1 0.8950774669647217
carriers O 0 0.28159299492836
, O 0 0.0075447880662977695
might O 0 0.00910523533821106
suggest O 0 0.01536967046558857
that O 0 0.0044359611347317696
the O 0 0.011465396732091904
mutation O 1 0.8776575922966003
arose O 0 0.1826845407485962
independently O 0 0.046710651367902756
. O 0 0.016837161034345627
. O 0 0.02269473671913147

Crystal O 0 0.0882248803973198
structure O 0 0.030627679079771042
of O 0 0.012683404609560966
the O 0 0.021074868738651276
hemochromatosis B-Disease 1 0.9512084126472473
protein O 1 0.6369159817695618
HFE O 1 0.6763731837272644
and O 0 0.009115949273109436
characterization O 0 0.03198271989822388
of O 0 0.005684542935341597
its O 0 0.007816762663424015
interaction O 0 0.06759409606456757
with O 0 0.026090186089277267
transferrin O 1 0.628983736038208
receptor O 1 0.7435031533241272
. O 0 0.05492910370230675

HFE O 1 0.7048271894454956
is O 0 0.030649617314338684
an O 0 0.031125282868742943
MHC O 1 0.770206868648529
- O 0 0.24266137182712555
related O 0 0.2050660103559494
protein O 0 0.2813883423805237
that O 0 0.008913040161132812
is O 0 0.015372976660728455
mutated O 1 0.62270587682724
in O 0 0.012103680521249771
the O 0 0.02178080566227436
iron B-Disease 1 0.5903924703598022
- I-Disease 1 0.8833009004592896
overload I-Disease 1 0.9692392945289612
disease I-Disease 1 0.9861698150634766
hereditary B-Disease 1 0.9706836342811584
hemochromatosis I-Disease 1 0.9602124691009521
. O 0 0.3180970251560211

HFE O 1 0.7352559566497803
binds O 0 0.23557403683662415
to O 0 0.028110064566135406
transferrin O 1 0.6912350058555603
receptor O 1 0.7252275943756104
( O 0 0.1308823525905609
TfR O 1 0.6459411978721619
) O 0 0.01850239746272564
and O 0 0.00649864599108696
reduces O 0 0.0748085156083107
its O 0 0.006378322374075651
affinity O 0 0.07183950394392014
for O 0 0.00742873502895236
iron O 0 0.07226917892694473
- O 0 0.08303450047969818
loaded O 0 0.02937520109117031
transferrin O 0 0.4721728563308716
, O 0 0.02566869743168354
implicating O 0 0.44116008281707764
HFE O 1 0.7788437008857727
in O 0 0.03997410461306572
iron O 0 0.31844764947891235
metabolism O 1 0.8160560131072998
. O 0 0.06751011312007904

The O 0 0.05769803375005722
2 O 0 0.060780614614486694
. O 0 0.04824486002326012

6 O 0 0.03456061705946922
A O 0 0.01919698156416416
crystal O 0 0.038053471595048904
structure O 0 0.019721848890185356
of O 0 0.009573409333825111
HFE O 1 0.5665184259414673
reveals O 0 0.04327915981411934
the O 0 0.006639939267188311
locations O 0 0.016034066677093506
of O 0 0.0215230043977499
hemochromatosis B-Disease 1 0.965310275554657
mutations O 1 0.8513553738594055
and O 0 0.009245028719305992
a O 0 0.012275142595171928
patch O 0 0.22959092259407043
of O 0 0.005958636291325092
histidines O 0 0.1066310703754425
that O 0 0.0037194958422333
could O 0 0.004388661589473486
be O 0 0.0035276145208626986
involved O 0 0.01533414889127016
in O 0 0.019146831706166267
pH O 1 0.7596604824066162
- O 0 0.3090718388557434
dependent O 0 0.24693399667739868
interactions O 0 0.35706692934036255
. O 0 0.05148904770612717

We O 0 0.01792019046843052
also O 0 0.010818086564540863
demonstrate O 0 0.014762835577130318
that O 0 0.00974361877888441
soluble O 0 0.4751301109790802
TfR O 1 0.6399917602539062
and O 0 0.019557271152734756
HFE O 1 0.754814863204956
bind O 0 0.22956357896327972
tightly O 0 0.026135815307497978
at O 0 0.004518655128777027
the O 0 0.003669931087642908
basic O 0 0.013222957029938698
pH O 0 0.23498548567295074
of O 0 0.0036798547953367233
the O 0 0.005086452234536409
cell O 0 0.1734132319688797
surface O 0 0.014348396100103855
, O 0 0.003296733135357499
but O 0 0.0026314149145036936
not O 0 0.0022634840570390224
at O 0 0.0035251115914434195
the O 0 0.006946113426238298
acidic O 1 0.5282920598983765
pH O 1 0.6717243194580078
of O 0 0.028925569728016853
intracellular O 1 0.7439339756965637
vesicles O 1 0.7100440263748169
. O 0 0.08013390004634857

TfR O 1 0.8030881881713867
HFE O 1 0.81009441614151
stoichiometry O 0 0.4523555338382721
( O 0 0.04476240649819374
2 O 0 0.019173957407474518
1 O 0 0.014514549635350704
) O 0 0.01486239954829216
differs O 0 0.04322376102209091
from O 0 0.015437585301697254
TfR O 1 0.6974732875823975
transferrin O 1 0.6717439293861389
stoichiometry O 1 0.5728629231452942
( O 0 0.04277511686086655
2 O 0 0.009564113803207874
2 O 0 0.007810698822140694
) O 0 0.006706766318529844
, O 0 0.003030956955626607
implying O 0 0.008797629736363888
a O 0 0.003606458194553852
different O 0 0.003976078703999519
mode O 0 0.010281617753207684
of O 0 0.003174872836098075
binding O 0 0.02470986172556877
for O 0 0.0068685575388371944
HFE O 0 0.4920969009399414
and O 0 0.007232818752527237
transferrin O 0 0.2756968140602112
to O 0 0.007965642027556896
TfR O 1 0.5000114440917969
, O 0 0.005451073404401541
consistent O 0 0.008861318230628967
with O 0 0.00418879883363843
our O 0 0.00380305596627295
demonstration O 0 0.0133500462397933
that O 0 0.007549873553216457
HFE O 1 0.6279717087745667
, O 0 0.010430517606437206
transferrin O 0 0.2651369273662567
, O 0 0.008198019117116928
and O 0 0.009203415364027023
TfR O 1 0.6002829074859619
form O 0 0.08241122961044312
a O 0 0.02662682719528675
ternary O 0 0.3590894937515259
complex O 0 0.1081782802939415
. O 0 0.03707070276141167

Identification O 0 0.03267412632703781
of O 0 0.012614194303750992
three O 0 0.011958764865994453
novel O 0 0.1389652043581009
mutations O 1 0.6988489031791687
and O 0 0.00518999295309186
a O 0 0.0055474513210356236
high O 0 0.008475195616483688
frequency O 0 0.018208490684628487
of O 0 0.006052342243492603
the O 0 0.014345090836286545
Arg778Leu O 1 0.6825475692749023
mutation O 1 0.927494466304779
in O 0 0.09232866764068604
Korean O 0 0.48456013202667236
patients O 1 0.9504215717315674
with O 0 0.2539803981781006
Wilson B-Disease 1 0.8210793137550354
disease I-Disease 1 0.9693592190742493
. O 0 0.1600857526063919

Four O 0 0.06770841777324677
mutations O 1 0.8896186947822571
- O 0 0.20432868599891663
- O 0 0.13814231753349304
R778L O 0 0.24174611270427704
, O 0 0.01315353438258171
A874V O 0 0.1437951624393463
, O 0 0.008358215913176537
L1083F O 0 0.07556776702404022
, O 0 0.005666298791766167
and O 0 0.005416786298155785
2304delC O 0 0.15412668883800507
- O 0 0.0651567354798317
- O 0 0.027411507442593575
in O 0 0.004899929277598858
the O 0 0.004745970014482737
copper O 0 0.061756033450365067
- O 0 0.15194323658943176
transporting O 0 0.14691534638404846
enzyme O 1 0.7286607623100281
, O 0 0.040138401091098785
P O 0 0.4305092692375183
- O 0 0.39884087443351746
type O 0 0.4542052745819092
ATPase O 1 0.7937152981758118
( O 0 0.08156496286392212
ATP7B O 0 0.2592742145061493
) O 0 0.011357124894857407
, O 0 0.00366322323679924
were O 0 0.0036434398498386145
identified O 0 0.020863935351371765
in O 0 0.014542916789650917
Korean O 0 0.25541216135025024
Patients O 1 0.9306069016456604
with O 0 0.16402621567249298
Wilson B-Disease 1 0.7430182695388794
disease I-Disease 1 0.9657791256904602
. O 0 0.14862991869449615

Arg778Leu O 0 0.13335879147052765
, O 0 0.013432981446385384
the O 0 0.00762201426550746
most O 0 0.007989082485437393
frequently O 0 0.02399710938334465
reported O 0 0.046184007078409195
mutation O 1 0.5249450206756592
of O 0 0.0044337990693748
this O 0 0.004922132473438978
enzyme O 0 0.167426198720932
, O 0 0.0029053876642137766
was O 0 0.002364416839554906
found O 0 0.0031902804039418697
in O 0 0.002403020625934005
six O 0 0.0038969507440924644
of O 0 0.004675331991165876
eight O 0 0.045105237513780594
unrelated O 1 0.6723978519439697
patients O 1 0.8983879685401917
studied O 0 0.061963893473148346
, O 0 0.009096949361264706
an O 0 0.00961381010711193
allele O 1 0.5139395594596863
frequency O 0 0.04794471710920334
of O 0 0.008639569394290447
37 O 0 0.03381410986185074
. O 0 0.027268406003713608

5 O 0 0.03149203956127167
% O 0 0.01731395535171032
, O 0 0.007356853689998388
which O 0 0.00465711485594511
is O 0 0.004924781620502472
considerably O 0 0.011237554252147675
higher O 0 0.005912470631301403
than O 0 0.0038749033119529486
those O 0 0.003901773365214467
in O 0 0.004923118278384209
other O 0 0.008316745050251484
Asian O 0 0.10281644761562347
populations O 0 0.4130812883377075
. O 0 0.048019472509622574

The O 0 0.027323182672262192
novel O 0 0.06311585009098053
single O 0 0.03551792353391647
nucleotide O 0 0.4127779006958008
deletion O 1 0.5418009757995605
, O 0 0.012731610797345638
2304delC O 0 0.1116047129034996
, O 0 0.00647880882024765
was O 0 0.00438464293256402
found O 0 0.007150590885430574
in O 0 0.007161615416407585
one O 0 0.016328129917383194
patient O 1 0.668181836605072
. O 0 0.05025020241737366

Since O 0 0.042234696447849274
a O 0 0.03232653811573982
mutation O 1 0.6401418447494507
at O 0 0.02589653618633747
cDNA O 0 0.43491098284721375
nucleotide O 1 0.6446337103843689
2302 O 1 0.8400025367736816
( O 0 0.05432959645986557
2302insC O 0 0.16680270433425903
) O 0 0.010008452460169792
had O 0 0.0038969656452536583
been O 0 0.0031037323642522097
previously O 0 0.0038805746007710695
described O 0 0.005410539451986551
, O 0 0.002540439134463668
this O 0 0.0023153540678322315
region O 0 0.004841906949877739
of O 0 0.0033094643149524927
the O 0 0.009267676621675491
ATP7B O 1 0.6121527552604675
gene O 1 0.835262656211853
may O 0 0.12296725064516068
be O 0 0.029263760894536972
susceptible O 1 0.8305555582046509
to O 0 0.07130981236696243
gene O 1 0.9445057511329651
rearrangements O 1 0.920318067073822
causing O 1 0.9219107627868652
Wilson B-Disease 1 0.8656153082847595
disease I-Disease 1 0.9680029153823853
. O 0 0.17302989959716797

Disruption O 0 0.14589011669158936
of O 0 0.023288561031222343
splicing O 0 0.2631010115146637
regulated O 0 0.07431826740503311
by O 0 0.0173882395029068
a O 0 0.02528260461986065
CUG O 1 0.5410721302032471
- O 0 0.29293346405029297
binding O 0 0.4001559913158417
protein O 1 0.7361500263214111
in O 0 0.2738569378852844
myotonic B-Disease 1 0.9569563865661621
dystrophy I-Disease 1 0.9604825973510742
. O 0 0.25616884231567383

Myotonic B-Disease 1 0.9346171021461487
dystrophy I-Disease 1 0.9544840455055237
( O 1 0.5433063507080078
DM B-Disease 1 0.9073441624641418
) O 0 0.047119565308094025
is O 0 0.010889372788369656
caused O 0 0.04661614075303078
by O 0 0.006407894194126129
a O 0 0.008318755775690079
CTG O 0 0.12571969628334045
expansion O 0 0.012462562881410122
in O 0 0.004629421513527632
the O 0 0.003970860969275236
3 O 0 0.011110370978713036
untranslated O 0 0.16624414920806885
region O 0 0.019608205184340477
of O 0 0.0089558782055974
the O 0 0.028355715796351433
DM B-Disease 1 0.9339606165885925
gene O 1 0.8735593557357788
. O 0 0.07751116901636124

One O 0 0.026893291622400284
model O 0 0.03813081234693527
of O 0 0.02821081317961216
DM B-Disease 1 0.9257522821426392
pathogenesis O 1 0.8892245888710022
suggests O 0 0.08625154942274094
that O 0 0.007620395161211491
RNAs O 0 0.09922220557928085
from O 0 0.005452389363199472
the O 0 0.004170840606093407
expanded O 0 0.011214635334908962
allele O 0 0.2977762520313263
create O 0 0.019322695210576057
a O 0 0.007421867921948433
gain O 0 0.01985226385295391
- O 0 0.05244002118706703
of O 0 0.008542384952306747
- O 0 0.1566319614648819
function O 0 0.2052399069070816
mutation O 1 0.7297990322113037
by O 0 0.007439853623509407
the O 0 0.00543034914880991
inappropriate O 0 0.04592044651508331
binding O 0 0.02982996217906475
of O 0 0.006241924595087767
proteins O 0 0.14197687804698944
to O 0 0.0069589195773005486
the O 0 0.011981965973973274
CUG O 0 0.47588542103767395
repeats O 0 0.3735664188861847
. O 0 0.05677938833832741

Data O 0 0.022685283794999123
presented O 0 0.013968858867883682
here O 0 0.007527134381234646
indicate O 0 0.008848459459841251
that O 0 0.004185347352176905
the O 0 0.005431598983705044
conserved O 0 0.06017749384045601
heterogeneous O 0 0.31726938486099243
nuclear O 0 0.06072206050157547
ribonucleoprotein O 1 0.6392390727996826
, O 0 0.01914280280470848
CUG O 0 0.423084557056427
- O 0 0.22060810029506683
binding O 0 0.18376199901103973
protein O 1 0.510587751865387
( O 0 0.11186166852712631
CUG O 1 0.5233502388000488
- O 0 0.20038479566574097
BP O 0 0.1284085512161255
) O 0 0.018232550472021103
, O 0 0.005607605446130037
may O 0 0.011309733614325523
mediate O 0 0.05905730649828911
the O 0 0.008433248847723007
trans O 0 0.3567616641521454
- O 0 0.1265474110841751
dominant O 0 0.125791534781456
effect O 0 0.03838973864912987
of O 0 0.007279529236257076
the O 0 0.01480847131460905
RNA O 0 0.39660707116127014
. O 0 0.030329158529639244

CUG O 0 0.3560831546783447
- O 0 0.08479014784097672
BP O 0 0.04387304186820984
was O 0 0.009655523113906384
found O 0 0.008511222898960114
to O 0 0.006023287773132324
bind O 0 0.07390499860048294
to O 0 0.006045848596841097
the O 0 0.01901848614215851
human O 1 0.5726540088653564
cardiac O 1 0.977612316608429
troponin O 1 0.9549748301506042
T O 1 0.899674117565155
( O 0 0.1984572857618332
cTNT O 0 0.42764750123023987
) O 0 0.05386609584093094
pre O 0 0.13276319205760956
- O 0 0.21869561076164246
messenger O 0 0.23560015857219696
RNA O 0 0.2654380202293396
and O 0 0.009700466878712177
regulate O 0 0.0787876546382904
its O 0 0.015089704655110836
alternative O 0 0.07237324863672256
splicing O 0 0.4910201132297516
. O 0 0.05215371772646904

Splicing O 0 0.20996823906898499
of O 0 0.024739807471632957
cTNT O 0 0.19377727806568146
was O 0 0.023294754326343536
disrupted O 0 0.33276110887527466
in O 0 0.09643492847681046
DM B-Disease 1 0.9500554800033569
striated O 1 0.9357870221138
muscle O 1 0.8721868991851807
and O 0 0.014157405123114586
in O 0 0.02541089802980423
normal O 0 0.3124809265136719
cells O 1 0.6929517984390259
expressing O 0 0.08594469726085663
transcripts O 0 0.05061115697026253
that O 0 0.010493645444512367
contain O 0 0.06799546629190445
CUG O 0 0.43540632724761963
repeats O 0 0.3000572919845581
. O 0 0.043605390936136246

Altered O 0 0.15531350672245026
expression O 0 0.06366756558418274
of O 0 0.01847207173705101
genes O 1 0.6778197884559631
regulated O 0 0.23486030101776123
posttranscriptionally O 0 0.3207975924015045
by O 0 0.02589249052107334
CUG O 0 0.4514693319797516
- O 0 0.1731390357017517
BP O 0 0.11348644644021988
therefore O 0 0.023222437128424644
may O 0 0.03256554529070854
contribute O 0 0.09904151409864426
to O 0 0.03599781170487404
DM B-Disease 1 0.9437583088874817
pathogenesis O 1 0.9173554182052612
. O 0 0.04039902985095978
. O 0 0.03772186487913132

Identification O 0 0.03576508164405823
of O 0 0.014638128690421581
a O 0 0.015002848580479622
novel O 0 0.054098181426525116
nonsense O 0 0.11292201280593872
mutation O 1 0.6951552629470825
and O 0 0.00891776941716671
a O 0 0.013523881323635578
missense O 1 0.5093008875846863
substitution O 0 0.09516967087984085
in O 0 0.01140748243778944
the O 0 0.014743455685675144
vasopressin O 1 0.723880410194397
- O 0 0.3576386868953705
neurophysin O 1 0.6069288849830627
II O 0 0.2846183776855469
gene O 1 0.5276857018470764
in O 0 0.010940417647361755
two O 0 0.011793514713644981
Spanish O 0 0.09109334647655487
kindreds O 1 0.8187969923019409
with O 0 0.31625789403915405
familial B-Disease 1 0.9632306098937988
neurohypophyseal I-Disease 1 0.9409914016723633
diabetes I-Disease 1 0.977075457572937
insipidus I-Disease 1 0.9324235320091248
. O 0 0.2658756375312805

Familial B-Disease 1 0.9278721213340759
neurohypophyseal I-Disease 1 0.9153811931610107
diabetes I-Disease 1 0.9657834768295288
insipidus I-Disease 1 0.9410118460655212
( O 0 0.458551287651062
FNDI B-Disease 1 0.7968103885650635
) O 0 0.1205974593758583
is O 0 0.06462782621383667
an O 0 0.2369232326745987
autosomal B-Disease 1 0.9859289526939392
dominant I-Disease 1 0.9463308453559875
disease I-Disease 1 0.9880695939064026
caused O 1 0.8775972127914429
by O 0 0.2977856993675232
deficiency O 1 0.9789076447486877
in O 0 0.06123724579811096
the O 0 0.09208115935325623
antidiuretic O 1 0.9505338668823242
hormone O 1 0.9519286751747131
arginine O 1 0.8390656113624573
vasopressin O 1 0.817298173904419
( O 0 0.14779570698738098
AVP O 0 0.36407753825187683
) O 0 0.019961712881922722
encoded O 0 0.02611393667757511
by O 0 0.007915900088846684
the O 0 0.009438767097890377
AVP O 1 0.5069718956947327
- O 0 0.3070381283760071
neurophysin O 1 0.6175865530967712
II O 0 0.30789801478385925
( O 0 0.15246595442295074
AVP O 1 0.6929879188537598
- O 0 0.3724951446056366
NPII O 1 0.6599560379981995
) O 0 0.1557074636220932
gene O 1 0.7424389719963074
on O 0 0.02302807942032814
chromosome O 1 0.8385387063026428
20p13 O 0 0.44855162501335144
. O 0 0.04768398404121399

In O 0 0.018477903679013252
this O 0 0.008800121024250984
study O 0 0.011157820001244545
, O 0 0.004809793550521135
we O 0 0.0030998443253338337
analyzed O 0 0.007181106600910425
two O 0 0.0038325125351548195
families O 0 0.01263098418712616
with O 0 0.006655491888523102
FNDI B-Disease 0 0.15008707344532013
using O 0 0.008865504525601864
direct O 0 0.012505942024290562
automated O 0 0.025394750759005547
fluorescent O 0 0.10612753033638
, O 0 0.00528979254886508
solid O 0 0.013726404868066311
phase O 0 0.06348837912082672
, O 0 0.006602210458368063
single O 0 0.02086680941283703
- O 0 0.12169554829597473
stranded O 0 0.20062974095344543
DNA O 0 0.29422232508659363
sequencing O 0 0.19722440838813782
of O 0 0.018307769671082497
PCR O 1 0.5990799069404602
- O 0 0.3374347388744354
amplified O 1 0.5286611318588257
AVP O 1 0.77825927734375
- O 1 0.511143684387207
NPII O 1 0.7137475609779358
DNA O 1 0.575052797794342
. O 0 0.05989500507712364

In O 0 0.016032259911298752
one O 0 0.00781551469117403
of O 0 0.00498447148129344
the O 0 0.005168464500457048
families O 0 0.018681559711694717
, O 0 0.006587093695998192
affected O 0 0.05845906585454941
individuals O 0 0.02139829285442829
presented O 0 0.010321213863790035
a O 0 0.010936347767710686
novel O 0 0.08425482362508774
nonsense O 0 0.1924453228712082
mutation O 1 0.812341570854187
in O 0 0.01092023029923439
exon O 0 0.15918368101119995
3 O 0 0.006837551016360521
of O 0 0.0029760675970464945
the O 0 0.004144676495343447
gene O 0 0.25390365719795227
, O 0 0.0034280854742974043
consisting O 0 0.005591078661382198
in O 0 0.002963423263281584
a O 0 0.005649379454553127
G O 0 0.08582545816898346
to O 0 0.005525936372578144
T O 0 0.24984605610370636
transition O 0 0.04152665287256241
at O 0 0.011575071141123772
nucleotide O 0 0.3158154785633087
2101 O 0 0.35876092314720154
, O 0 0.005197763908654451
which O 0 0.004269184544682503
produces O 0 0.025521142408251762
a O 0 0.006070368457585573
stop O 0 0.009700988419353962
signal O 0 0.016859063878655434
in O 0 0.0083070183172822
codon O 0 0.21910841763019562
82 O 0 0.07068867236375809
( O 0 0.09940982609987259
Glu O 1 0.6927839517593384
) O 0 0.028496364131569862
of O 0 0.015711922198534012
NPII O 0 0.3644813299179077
. O 0 0.04500298574566841

The O 0 0.03660516440868378
premature O 1 0.5107970237731934
termination O 0 0.227866992354393
eliminates O 0 0.054263170808553696
part O 0 0.009112969972193241
of O 0 0.0054057566449046135
the O 0 0.006427363026887178
C O 0 0.09683103114366531
- O 0 0.07499135285615921
terminal O 0 0.053395457565784454
domain O 0 0.016962889581918716
of O 0 0.004515018779784441
NPII O 0 0.08940389007329941
, O 0 0.0038722187746316195
including O 0 0.004166323225945234
a O 0 0.004907920490950346
cysteine O 0 0.0813107118010521
residue O 0 0.031947486102581024
in O 0 0.004088945686817169
position O 0 0.0037799912970513105
85 O 0 0.00711794663220644
, O 0 0.002305846894159913
which O 0 0.0017521322006359696
could O 0 0.0021517875138670206
be O 0 0.00183343596290797
involved O 0 0.0038534337654709816
in O 0 0.002689664252102375
the O 0 0.0035051684826612473
correct O 0 0.031825706362724304
folding O 0 0.06599219143390656
of O 0 0.009137234650552273
the O 0 0.021103404462337494
prohormone O 1 0.7173352241516113
. O 0 0.05408088117837906

In O 0 0.015795119106769562
the O 0 0.008137591183185577
second O 0 0.00822717510163784
family O 0 0.01113403495401144
, O 0 0.004839677829295397
a O 0 0.005628602579236031
G279A O 0 0.05857975408434868
substitution O 0 0.026858709752559662
at O 0 0.004898207727819681
position O 0 0.004220893606543541
- O 0 0.014215762726962566
1 O 0 0.003782588755711913
of O 0 0.0023824446834623814
the O 0 0.0030264260713011026
signal O 0 0.0238372590392828
peptide O 0 0.1683000922203064
was O 0 0.005115330684930086
observed O 0 0.0203949436545372
in O 0 0.005081473849713802
all O 0 0.005810313392430544
affected O 0 0.16271886229515076
individuals O 0 0.09385223686695099
. O 0 0.03365220129489899

This O 0 0.04103057086467743
missense O 1 0.7233723998069763
mutation O 1 0.7430300116539001
, O 0 0.015558474697172642
which O 0 0.011059260927140713
replaces O 0 0.16291242837905884
Ala O 0 0.3979586362838745
with O 0 0.036931902170181274
Thr O 1 0.7962383031845093
, O 0 0.00897660106420517
is O 0 0.010332832112908363
frequent O 0 0.08212406188249588
among O 0 0.04626260697841644
FNDI B-Disease 1 0.7432925701141357
patients O 1 0.7910488843917847
and O 0 0.0057069081813097
is O 0 0.004265441093593836
thought O 0 0.005313876084983349
to O 0 0.002794974483549595
reduce O 0 0.014825510792434216
the O 0 0.003607111284509301
efficiency O 0 0.013356705196201801
of O 0 0.006571028381586075
cleavage O 0 0.35350561141967773
by O 0 0.015862978994846344
signal O 0 0.07181966304779053
peptidases O 0 0.34393632411956787
. O 0 0.02097785659134388
. O 0 0.030264606699347496

Genetic O 1 0.8215905427932739
heterogeneity O 1 0.5008900165557861
of O 0 0.05195104703307152
Saethre B-Disease 1 0.8184988498687744
- I-Disease 1 0.7966907620429993
Chotzen I-Disease 1 0.9273388385772705
syndrome I-Disease 1 0.9749854207038879
, O 0 0.02866554819047451
due O 0 0.038236141204833984
to O 0 0.012373216450214386
TWIST O 0 0.2069113403558731
and O 0 0.03903881832957268
FGFR O 1 0.7488583326339722
mutations O 1 0.9177932143211365
. O 0 0.09450017660856247

Thirty O 0 0.05424879863858223
- O 0 0.09656877815723419
two O 0 0.02006828971207142
unrelated O 0 0.34754541516304016
patients O 1 0.6716254949569702
with O 0 0.013953781686723232
features O 0 0.0314604677259922
of O 0 0.026695484295487404
Saethre B-Disease 1 0.8621487021446228
- I-Disease 1 0.8146652579307556
Chotzen I-Disease 1 0.9543721079826355
syndrome I-Disease 1 0.9860070943832397
, O 0 0.07219288498163223
a O 0 0.10072771459817886
common O 1 0.7283766269683838
autosomal B-Disease 1 0.9829354286193848
dominant I-Disease 1 0.7425144910812378
condition I-Disease 1 0.656774640083313
of O 0 0.05926661938428879
craniosynostosis B-Disease 1 0.9492523074150085
and O 0 0.06359764188528061
limb B-Disease 1 0.922514021396637
anomalies I-Disease 0 0.46734151244163513
, O 0 0.008903651498258114
were O 0 0.005101241171360016
screened O 0 0.0483158715069294
for O 0 0.01169220358133316
mutations O 1 0.7937106490135193
in O 0 0.015542932786047459
TWIST O 0 0.17581966519355774
, O 0 0.013314531184732914
FGFR2 O 0 0.20905759930610657
, O 0 0.011891522444784641
and O 0 0.01325250044465065
FGFR3 O 0 0.31389379501342773
. O 0 0.034730181097984314

Nine O 0 0.038004592061042786
novel O 0 0.05124112218618393
and O 0 0.013131394051015377
three O 0 0.022391818463802338
recurrent O 1 0.8328254222869873
TWIST O 0 0.46512308716773987
mutations O 1 0.7810555100440979
were O 0 0.00722460588440299
found O 0 0.00965505838394165
in O 0 0.007975392043590546
12 O 0 0.016494501382112503
families O 0 0.06350240856409073
. O 0 0.03293747827410698

Seven O 0 0.02181231789290905
families O 0 0.01600206457078457
were O 0 0.005578898824751377
found O 0 0.004969155881553888
to O 0 0.003091954393312335
have O 0 0.0033327359706163406
the O 0 0.005704841576516628
FGFR3 O 0 0.46586450934410095
P250R O 0 0.44707807898521423
mutation O 1 0.718294620513916
, O 0 0.004659570753574371
and O 0 0.0026899981312453747
one O 0 0.0025600329972803593
individual O 0 0.006914838217198849
was O 0 0.003079791087657213
found O 0 0.004151856526732445
to O 0 0.003004864091053605
have O 0 0.005068902391940355
an O 0 0.012404096312820911
FGFR2 O 0 0.4838029742240906
VV269 O 1 0.5311822295188904
- O 0 0.3033825159072876
270 O 0 0.27586629986763
deletion O 1 0.7771931886672974
. O 0 0.05968848988413811

To O 0 0.015493476763367653
date O 0 0.013412433676421642
, O 0 0.007377929054200649
our O 0 0.006873795762658119
detection O 0 0.0712309330701828
rate O 0 0.02527548559010029
for O 0 0.009831485338509083
TWIST O 0 0.1815485954284668
or O 0 0.05953666940331459
FGFR O 1 0.5904877781867981
mutations O 1 0.8578511476516724
is O 0 0.01205143891274929
68 O 0 0.03266126662492752
% O 0 0.022527065128087997
in O 0 0.009196022525429726
our O 0 0.029283108189702034
Saethre B-Disease 1 0.8164418935775757
- I-Disease 1 0.8597487211227417
Chotzen I-Disease 1 0.967712938785553
syndrome I-Disease 1 0.989703357219696
patients O 1 0.9242011904716492
, O 0 0.014290932565927505
including O 0 0.01129484549164772
our O 0 0.008646111935377121
five O 0 0.03433135896921158
patients O 1 0.861640214920044
elsewhere O 0 0.07628262788057327
reported O 0 0.08207045495510101
with O 0 0.04468528926372528
TWIST O 1 0.5277807116508484
mutations O 1 0.9219180345535278
. O 0 0.10054806619882584

More O 0 0.019472891464829445
than O 0 0.012452560476958752
35 O 0 0.015811705961823463
different O 0 0.015347533859312534
TWIST O 0 0.26969844102859497
mutations O 1 0.7223106622695923
are O 0 0.005763393361121416
now O 0 0.0052312458865344524
known O 0 0.007121121510863304
in O 0 0.004396569449454546
the O 0 0.006513714790344238
literature O 0 0.02413969673216343
. O 0 0.024250278249382973

The O 0 0.018638839945197105
most O 0 0.012692592106759548
common O 0 0.026250828057527542
phenotypic O 0 0.15630771219730377
features O 0 0.011144702322781086
, O 0 0.003854217007756233
present O 0 0.0035658383276313543
in O 0 0.002257642336189747
more O 0 0.002230969723314047
than O 0 0.002474199514836073
a O 0 0.002980920486152172
third O 0 0.003854363691061735
of O 0 0.003982223104685545
our O 0 0.011552266776561737
patients O 1 0.8028284311294556
with O 0 0.04030168056488037
TWIST O 0 0.4887848198413849
mutations O 1 0.890625
, O 0 0.014786490239202976
are O 0 0.009812681004405022
coronal B-Disease 0 0.41952237486839294
synostosis I-Disease 0 0.4626031517982483
, O 0 0.026845822110772133
brachycephaly B-Disease 0 0.4074264466762543
, O 0 0.03689228743314743
low B-Disease 0 0.3848690390586853
frontal I-Disease 1 0.9320569038391113
hairline I-Disease 1 0.9598038792610168
, O 0 0.1859944760799408
facial B-Disease 1 0.9427235722541809
asymmetry I-Disease 1 0.8483366370201111
, O 0 0.11823993176221848
ptosis B-Disease 1 0.9514159560203552
, O 0 0.03346112743020058
hypertelorism B-Disease 1 0.6154946684837341
, O 0 0.01182569656521082
broad B-Disease 0 0.04226585477590561
great I-Disease 0 0.01766134798526764
toes I-Disease 0 0.14725133776664734
, O 0 0.011681107804179192
and O 0 0.01265700999647379
clinodactyly B-Disease 0 0.2719847559928894
. O 0 0.03699185699224472

Significant O 0 0.05941856652498245
intra O 0 0.18485751748085022
- O 0 0.10040511190891266
and O 0 0.017026757821440697
interfamilial O 0 0.39188116788864136
phenotypic O 1 0.6011849045753479
variability O 0 0.4206794202327728
is O 0 0.00962656270712614
present O 0 0.010586109012365341
for O 0 0.008451367728412151
either O 0 0.03778515011072159
TWIST O 1 0.5815202593803406
mutations O 1 0.9497185945510864
or O 0 0.2824079990386963
FGFR O 1 0.8349342942237854
mutations O 1 0.9247823357582092
. O 0 0.09155083447694778

The O 0 0.020517153665423393
overlap O 0 0.04414746165275574
in O 0 0.010694009251892567
clinical O 0 0.1556880623102188
features O 0 0.008595459163188934
and O 0 0.0031009700614959
the O 0 0.0028739378321915865
presence O 0 0.00716320239007473
, O 0 0.002677779644727707
in O 0 0.002390170469880104
the O 0 0.0025421553291380405
same O 0 0.007998627610504627
genes O 0 0.3167232871055603
, O 0 0.00428220396861434
of O 0 0.00480484077706933
mutations O 1 0.5517157912254333
for O 0 0.004193853586912155
more O 0 0.003635774366557598
than O 0 0.00568256014958024
one O 0 0.009230016730725765
craniosynostotic B-Disease 0 0.4921751916408539
condition I-Disease 0 0.40265756845474243
- O 0 0.07848132401704788
such O 0 0.008917070925235748
as O 0 0.013316354714334011
Saethre B-Disease 0 0.4776102602481842
- I-Disease 0 0.24879388511180878
Chotzen I-Disease 0 0.41955190896987915
, I-Disease 0 0.015464969910681248
Crouzon I-Disease 0 0.28901436924934387
, I-Disease 0 0.013317938894033432
and I-Disease 0 0.02205648273229599
Pfeiffer I-Disease 1 0.8874213695526123
syndromes I-Disease 1 0.9682954549789429
- O 0 0.09783761948347092
support O 0 0.008468803018331528
the O 0 0.004751856904476881
hypothesis O 0 0.06338878720998764
that O 0 0.005112055689096451
TWIST O 0 0.055614545941352844
and O 0 0.004233293700963259
FGFRs O 0 0.06425689905881882
are O 0 0.002700486220419407
components O 0 0.005252066068351269
of O 0 0.002195624867454171
the O 0 0.0026980785187333822
same O 0 0.009999003261327744
molecular O 0 0.3046466112136841
pathway O 0 0.3681569993495941
involved O 0 0.01989496685564518
in O 0 0.005598383955657482
the O 0 0.007297729142010212
modulation O 0 0.36742129921913147
of O 0 0.028709731996059418
craniofacial O 1 0.9040965437889099
and O 0 0.034420326352119446
limb O 1 0.8806902170181274
development O 0 0.09532639384269714
in O 0 0.03154201805591583
humans O 0 0.42934542894363403
. O 0 0.027007654309272766
. O 0 0.029026636853814125

Mutation O 1 0.8170233368873596
analysis O 0 0.12277175486087799
of O 0 0.06984814256429672
UBE3A O 1 0.8690373301506042
in O 1 0.5954079031944275
Angelman B-Disease 1 0.9621065258979797
syndrome I-Disease 1 0.9762582182884216
patients O 1 0.9319252967834473
. O 0 0.2037183940410614

Angelman B-Disease 1 0.9517425298690796
syndrome I-Disease 1 0.9647142291069031
( O 0 0.13696441054344177
AS B-Disease 0 0.02417001686990261
) O 0 0.029355378821492195
is O 0 0.01581324078142643
caused O 0 0.2926040589809418
by O 0 0.0434606708586216
chromosome O 1 0.8957707285881042
15q11 O 1 0.6512030959129333
- O 0 0.3253089487552643
q13 O 0 0.4908241033554077
deletions O 0 0.3745698630809784
of O 0 0.013163980096578598
maternal O 1 0.5201265215873718
origin O 0 0.0658571794629097
, O 0 0.014266588725149632
by O 0 0.030051589012145996
paternal O 1 0.7623552083969116
uniparental B-Disease 1 0.9472192525863647
disomy I-Disease 1 0.8404570817947388
( O 0 0.3456627130508423
UPD B-Disease 1 0.8737746477127075
) O 0 0.03772839531302452
15 O 0 0.018064584583044052
, O 0 0.010164465755224228
by O 0 0.02996082231402397
imprinting O 1 0.8486077189445496
defects O 1 0.8786088824272156
, O 0 0.014394222758710384
and O 0 0.0074370368383824825
by O 0 0.028160450980067253
mutations O 1 0.8542232513427734
in O 0 0.02144312672317028
the O 0 0.03254643827676773
UBE3A O 1 0.8710102438926697
gene O 1 0.8691205978393555
. O 0 0.08011352270841599

UBE3A O 1 0.5767402052879333
encodes O 0 0.16917940974235535
a O 0 0.04535228759050369
ubiquitin O 0 0.4086821973323822
- O 0 0.20621544122695923
protein O 0 0.3474215269088745
ligase O 0 0.17752483487129211
and O 0 0.014133286662399769
shows O 0 0.09951545298099518
brain O 1 0.9150460958480835
- O 0 0.2906423807144165
specific O 0 0.1576109677553177
imprinting O 1 0.7430007457733154
. O 0 0.06951246410608292

Here O 0 0.03248056769371033
we O 0 0.019673258066177368
describe O 0 0.09951342642307281
UBE3A O 1 0.8218601942062378
coding O 1 0.773321807384491
- O 0 0.4663006067276001
region O 0 0.2724250257015228
mutations O 1 0.942467451095581
detected O 0 0.42974933981895447
by O 0 0.02307412400841713
SSCP O 0 0.252490371465683
analysis O 0 0.022678079083561897
in O 0 0.006429972592741251
13 O 0 0.010712985880672932
AS B-Disease 0 0.010648089461028576
individuals O 0 0.05394790694117546
or O 0 0.03589965030550957
families O 0 0.07025858014822006
. O 0 0.039218928664922714

Two O 0 0.02670043148100376
identical O 0 0.04530099406838417
de O 0 0.06279287487268448
novo O 0 0.1486940234899521
5 O 0 0.02365971729159355
- O 0 0.05873541533946991
bp O 0 0.05664755776524544
duplications O 0 0.1913061887025833
in O 0 0.011743759736418724
exon O 0 0.12055815011262894
16 O 0 0.014228731393814087
were O 0 0.007935164496302605
found O 0 0.018447643145918846
. O 0 0.023239975795149803

Among O 0 0.018885405734181404
the O 0 0.009201398119330406
other O 0 0.0073385704308748245
11 O 0 0.01209869235754013
unique O 0 0.036013420671224594
mutations O 1 0.7208009362220764
, O 0 0.005379761103540659
8 O 0 0.006067684851586819
were O 0 0.0034310610499233007
small O 0 0.009894385933876038
deletions O 0 0.23067604005336761
or O 0 0.021409425884485245
insertions O 0 0.23634962737560272
predicted O 0 0.0663812905550003
to O 0 0.007442180998623371
cause O 0 0.32567742466926575
frameshifts O 0 0.19769498705863953
, O 0 0.0045364066027104855
1 O 0 0.004183793440461159
was O 0 0.0032554371282458305
a O 0 0.005183771252632141
mutation O 0 0.3330613970756531
to O 0 0.0032680968288332224
a O 0 0.004745271988213062
stop O 0 0.008400985039770603
codon O 0 0.08421645313501358
, O 0 0.005091055296361446
1 O 0 0.0058616530150175095
was O 0 0.003915076609700918
a O 0 0.01117582805454731
missense O 1 0.6745507717132568
mutation O 1 0.7143936157226562
, O 0 0.004923204425722361
and O 0 0.002751834923401475
1 O 0 0.004310437012463808
was O 0 0.003131166100502014
predicted O 0 0.016556506976485252
to O 0 0.004341955296695232
cause O 0 0.16851142048835754
insertion O 0 0.07523059844970703
of O 0 0.003788828616961837
an O 0 0.004955896642059088
isoleucine O 0 0.08722520619630814
in O 0 0.003915147390216589
the O 0 0.0041898624040186405
hect O 0 0.09741542488336563
domain O 0 0.02105960249900818
of O 0 0.004229787737131119
the O 0 0.0070436932146549225
UBE3A O 1 0.5909350514411926
protein O 0 0.23201090097427368
, O 0 0.006156343501061201
which O 0 0.004265408031642437
functions O 0 0.008463887497782707
in O 0 0.0068722371943295
E2 O 0 0.27880561351776123
binding O 0 0.08344638347625732
and O 0 0.012030486017465591
ubiquitin O 0 0.2204975038766861
transfer O 0 0.035594597458839417
. O 0 0.025750067085027695

Eight O 0 0.020004520192742348
of O 0 0.009490679018199444
the O 0 0.00751474080607295
cases O 0 0.04690324142575264
were O 0 0.006681701634079218
familial O 1 0.718734860420227
, O 0 0.005609964951872826
and O 0 0.0042609767988324165
five O 0 0.006940320134162903
were O 0 0.007518628612160683
sporadic O 0 0.12055066227912903
. O 0 0.025072671473026276

In O 0 0.028750672936439514
two O 0 0.02712124027311802
familial O 1 0.858944833278656
cases O 0 0.09614119678735733
and O 0 0.006218545604497194
one O 0 0.007449875120073557
sporadic O 0 0.1815500259399414
case O 0 0.039077553898096085
, O 0 0.015555938705801964
mosaicism O 1 0.7110645174980164
for O 0 0.03285584598779678
UBE3A O 1 0.8851661682128906
mutations O 1 0.8749985098838806
was O 0 0.01147009339183569
detected O 0 0.09447231143712997
in O 0 0.004456366878002882
the O 0 0.002963910810649395
mother O 0 0.008605362847447395
of O 0 0.002490569604560733
three O 0 0.003665017895400524
AS B-Disease 0 0.006468834821134806
sons O 0 0.025611259043216705
, O 0 0.0032315088901668787
in O 0 0.003377934917807579
the O 0 0.0036677662283182144
maternal O 0 0.2889896035194397
grandfather O 0 0.023687873035669327
of O 0 0.0028462002519518137
two O 0 0.003081934992223978
AS B-Disease 0 0.003946870099753141
first O 0 0.0038643069565296173
cousins O 0 0.05401940271258354
, O 0 0.002916156081482768
and O 0 0.002088937209919095
in O 0 0.0022624472621828318
the O 0 0.002958895405754447
mother O 0 0.016981026157736778
of O 0 0.004307971801608801
an O 0 0.00790836475789547
AS B-Disease 0 0.01937226951122284
daughter O 0 0.15542063117027283
. O 0 0.03581097349524498

The O 0 0.018285254016518593
frequencies O 0 0.019056709483265877
with O 0 0.006954680196940899
which O 0 0.004524265415966511
we O 0 0.004503458272665739
detected O 0 0.1849002093076706
mutations O 1 0.5674946308135986
were O 0 0.0038527713622897863
5 O 0 0.00893525592982769
( O 0 0.011879214085638523
14 O 0 0.0067357695661485195
% O 0 0.010467766784131527
) O 0 0.004019567742943764
of O 0 0.002263238886371255
35 O 0 0.006294580176472664
in O 0 0.004549328237771988
sporadic O 0 0.10892734676599503
cases O 0 0.035069309175014496
and O 0 0.0037754185032099485
8 O 0 0.00985290203243494
( O 0 0.015826396644115448
80 O 0 0.009182051755487919
% O 0 0.015669722110033035
) O 0 0.007528858724981546
of O 0 0.003885797690600157
10 O 0 0.011954573914408684
in O 0 0.02520635910332203
familial O 1 0.9104560613632202
cases O 0 0.3053380846977234
. O 0 0.023125886917114258
. O 0 0.02701214700937271

The O 0 0.10378436744213104
hemochromatosis B-Disease 1 0.9232956171035767
845 O 1 0.7693357467651367
G O 1 0.5844435095787048
- O 0 0.2811989486217499
- O 0 0.2183026224374771
> O 0 0.24790063500404358
A O 0 0.014575068838894367
and O 0 0.00978664867579937
187 O 0 0.13468222320079803
C O 0 0.4250613749027252
- O 0 0.49195918440818787
- O 1 0.6168221235275269
> O 1 0.8596494197845459
G O 1 0.8226149678230286
mutations O 1 0.9579567909240723
: O 0 0.1548442542552948
prevalence O 1 0.8830999732017517
in O 0 0.0309135802090168
non O 0 0.2128797322511673
- O 0 0.4069024622440338
Caucasian O 1 0.7657850980758667
populations O 1 0.6223018765449524
. O 0 0.07429789006710052

Hemochromatosis B-Disease 1 0.8912075757980347
, O 0 0.04433398321270943
the O 0 0.056146278977394104
inherited B-Disease 1 0.9269723892211914
disorder I-Disease 1 0.9597439169883728
of I-Disease 0 0.022972462698817253
iron I-Disease 0 0.293517142534256
metabolism I-Disease 1 0.7166714072227478
, O 0 0.013818180188536644
leads O 0 0.05840819329023361
, O 0 0.008367560803890228
if O 0 0.015243236906826496
untreated O 1 0.6166614890098572
, O 0 0.00998567696660757
to O 0 0.008284386247396469
progressive O 0 0.40491247177124023
iron B-Disease 0 0.3885475695133209
overload I-Disease 1 0.788569450378418
and O 0 0.04570719599723816
premature B-Disease 1 0.7961013913154602
death I-Disease 0 0.34335857629776
. O 0 0.08962968736886978

The O 0 0.10188500583171844
hemochromatosis B-Disease 1 0.9382039308547974
gene O 1 0.799321174621582
, O 0 0.034009262919425964
HFE O 1 0.5957427620887756
, O 0 0.009454899467527866
recently O 0 0.009349629282951355
has O 0 0.004191627725958824
been O 0 0.0032969960011541843
identified O 0 0.006697905715554953
, O 0 0.0023173808585852385
and O 0 0.0022403139155358076
characterization O 0 0.0139410849660635
of O 0 0.002604725770652294
this O 0 0.0036395383067429066
gene O 0 0.18440133333206177
has O 0 0.003211535979062319
shown O 0 0.004093102645128965
that O 0 0.0020560964476317167
it O 0 0.00227575795724988
contains O 0 0.004776344168931246
two O 0 0.0048291850835084915
mutations O 1 0.5844315886497498
that O 0 0.004746249411255121
result O 0 0.024102816358208656
in O 0 0.009990133345127106
amino O 0 0.25725045800209045
acid O 1 0.5840155482292175
substitutions O 0 0.23339733481407166
- O 0 0.3012586534023285
cDNA O 1 0.6119574904441833
nucleotides O 1 0.7271084189414978
845 O 1 0.7534540891647339
G O 1 0.529298722743988
- O 0 0.2871534824371338
- O 0 0.19838067889213562
> O 0 0.3529071807861328
A O 0 0.0265501718968153
( O 0 0.06652680039405823
C282Y O 0 0.23031871020793915
) O 0 0.016819629818201065
and O 0 0.007446638308465481
187 O 0 0.1553390771150589
C O 0 0.3836420774459839
- O 0 0.378662109375
- O 0 0.48519086837768555
> O 1 0.7421516180038452
G O 1 0.5161399841308594
( O 0 0.13011552393436432
H63D O 0 0.48690763115882874
) O 0 0.048238981515169144
. O 0 0.022341178730130196

Although O 0 0.10685715079307556
hemochromatosis B-Disease 1 0.8866860866546631
is O 0 0.023424556478857994
common O 0 0.05027548223733902
in O 0 0.016980523243546486
Caucasians O 0 0.49627384543418884
, O 0 0.02257535047829151
affecting O 0 0.3847985565662384
> O 1 0.5281175971031189
= O 0 0.18771439790725708
1 O 0 0.01961592771112919
/ O 0 0.07027706503868103
300 O 0 0.007068656384944916
individuals O 0 0.00812363252043724
of O 0 0.0026884290855377913
northern O 0 0.004693502560257912
European O 0 0.005120929330587387
origin O 0 0.00752525357529521
, O 0 0.0027747908607125282
it O 0 0.0019918365869671106
has O 0 0.0023292312398552895
not O 0 0.002130000153556466
been O 0 0.002992937108501792
recognized O 0 0.009204864501953125
in O 0 0.006342944223433733
other O 0 0.011800835840404034
populations O 0 0.2897169291973114
. O 0 0.03632838651537895

The O 0 0.02047671377658844
present O 0 0.0161267276853323
study O 0 0.01750330813229084
used O 0 0.011841229163110256
PCR O 0 0.16117645800113678
and O 0 0.008281958289444447
restriction O 0 0.10236835479736328
- O 0 0.2242703139781952
enzyme O 1 0.6079728603363037
digestion O 0 0.3699522912502289
to O 0 0.005142928101122379
analyze O 0 0.012212158180773258
the O 0 0.004181507509201765
frequency O 0 0.011895803734660149
of O 0 0.0042374106124043465
the O 0 0.009266157634556293
845 O 1 0.6053417325019836
G O 1 0.5376413464546204
- O 0 0.28789761662483215
- O 0 0.23716816306114197
> O 0 0.32035505771636963
A O 0 0.013292238116264343
and O 0 0.008034498430788517
187 O 0 0.10702535510063171
C O 0 0.35778921842575073
- O 0 0.388032466173172
- O 1 0.5408724546432495
> O 1 0.8293308615684509
G O 1 0.7686494588851929
mutations O 1 0.9486862421035767
in O 0 0.0703745111823082
HLA O 1 0.8937191367149353
- O 0 0.1860876977443695
typed O 0 0.08902816474437714
samples O 0 0.06968992948532104
from O 0 0.01793026179075241
non O 0 0.09392305463552475
- O 0 0.22274108231067657
Caucasian O 1 0.5241041779518127
populations O 0 0.2246050238609314
, O 0 0.007172343321144581
comprising O 0 0.011031337082386017
Australian O 0 0.010702620260417461
Aboriginal O 0 0.031406886875629425
, O 0 0.0060453214682638645
Chinese O 0 0.009144814684987068
, O 0 0.006419675424695015
and O 0 0.006525123026221991
Pacific O 0 0.03174012899398804
Islanders O 0 0.0764005184173584
. O 0 0.029293961822986603

Results O 0 0.03560144454240799
showed O 0 0.01878037303686142
that O 0 0.00932500883936882
the O 0 0.010251639410853386
845 O 0 0.45861563086509705
G O 0 0.4196169972419739
- O 0 0.30779412388801575
- O 0 0.2611292898654938
> O 0 0.4431129992008209
A O 0 0.038330648094415665
mutation O 1 0.6762364506721497
was O 0 0.005319186486303806
present O 0 0.008239397779107094
in O 0 0.004292863421142101
these O 0 0.009342600591480732
populations O 0 0.3037968873977661
( O 0 0.09407804906368256
allele O 1 0.6578060388565063
frequency O 0 0.0722428485751152
0 O 0 0.02136112004518509
. O 0 0.004211502615362406
32 O 0 0.007774442434310913
% O 0 0.012908602133393288
) O 0 0.005932632368057966
, O 0 0.0023789608385413885
and O 0 0.0017592892982065678
, O 0 0.002046859124675393
furthermore O 0 0.004629977513104677
, O 0 0.0018170191906392574
it O 0 0.001523590530268848
was O 0 0.0018366185249760747
always O 0 0.0028662467375397682
seen O 0 0.004857249557971954
in O 0 0.005074212793260813
conjunction O 0 0.08635961264371872
with O 0 0.04380963742733002
HLA O 1 0.9198741316795349
haplotypes O 1 0.8646647334098816
common O 0 0.12690423429012299
in O 0 0.01797957345843315
Caucasians O 0 0.4290710687637329
, O 0 0.011974354274570942
suggesting O 0 0.05526437237858772
that O 0 0.013032431714236736
845 O 0 0.497698038816452
G O 0 0.4596400856971741
- O 0 0.23412075638771057
- O 0 0.18118667602539062
> O 0 0.26177534461021423
A O 0 0.00885218195617199
may O 0 0.007302097510546446
have O 0 0.0029305443167686462
been O 0 0.0032101962715387344
introduced O 0 0.005723925773054361
into O 0 0.005115109961479902
these O 0 0.00895732082426548
populations O 0 0.28768613934516907
by O 0 0.045730192214250565
Caucasian O 1 0.7941052913665771
admixture O 1 0.8644645810127258
. O 0 0.10413442552089691

187 O 0 0.1745997965335846
C O 0 0.29822838306427
- O 0 0.22179044783115387
- O 0 0.2034701406955719
> O 0 0.3226950466632843
G O 0 0.07690783590078354
was O 0 0.007167201489210129
present O 0 0.007755434140563011
at O 0 0.006435248535126448
an O 0 0.008864338509738445
allele O 0 0.4068785011768341
frequency O 0 0.03950241208076477
of O 0 0.008898856118321419
2 O 0 0.022353101521730423
. O 0 0.022871917113661766

68 O 0 0.03921016678214073
% O 0 0.017895590513944626
in O 0 0.007162157911807299
the O 0 0.005351097323000431
two O 0 0.0073760198429226875
populations O 0 0.19366803765296936
analyzed O 0 0.051189202815294266
( O 0 0.024187924340367317
Australian O 0 0.015168500132858753
Aboriginal O 0 0.0399913564324379
and O 0 0.00882326066493988
Chinese O 0 0.020687595009803772
) O 0 0.03485368564724922
. O 0 0.02527286484837532

In O 0 0.018426716327667236
the O 0 0.010032681748270988
Australian O 0 0.01707751862704754
Aboriginal O 0 0.04009421169757843
samples O 0 0.04723501205444336
, O 0 0.01152331568300724
187 O 0 0.08919889479875565
C O 0 0.26253998279571533
- O 0 0.21034769713878632
- O 0 0.23046284914016724
> O 0 0.4059807062149048
G O 0 0.13410277664661407
was O 0 0.005271477624773979
found O 0 0.005430817604064941
to O 0 0.0030179291497915983
be O 0 0.004344501532614231
associated O 0 0.04578962177038193
with O 0 0.04292306303977966
HLA O 1 0.9234623312950134
haplotypes O 1 0.8952755928039551
common O 0 0.15744328498840332
in O 0 0.020655786618590355
Caucasians O 0 0.4461606740951538
, O 0 0.007962958887219429
suggesting O 0 0.01990640163421631
that O 0 0.003318460425361991
it O 0 0.0032350285910069942
was O 0 0.004122436977922916
introduced O 0 0.010386068373918533
by O 0 0.009684236720204353
recent O 0 0.036895934492349625
admixture O 1 0.6676565408706665
. O 0 0.045865003019571304

In O 0 0.01726371794939041
the O 0 0.01025885995477438
Chinese O 0 0.012776413932442665
samples O 0 0.03216484934091568
analyzed O 0 0.033806148916482925
, O 0 0.010363983921706676
187 O 0 0.11369473487138748
C O 0 0.3224664032459259
- O 0 0.2666170299053192
- O 0 0.22671838104724884
> O 0 0.372170090675354
G O 0 0.10124466568231583
was O 0 0.004049982875585556
present O 0 0.004865729250013828
in O 0 0.0036225321236997843
association O 0 0.007922905497252941
with O 0 0.0036795262712985277
a O 0 0.0045121461153030396
wide O 0 0.013666357845067978
variety O 0 0.030324671417474747
of O 0 0.022628627717494965
HLA O 1 0.9191078543663025
haplotypes O 1 0.8093172907829285
, O 0 0.008086161687970161
showing O 0 0.01845894753932953
this O 0 0.006572843063622713
mutation O 0 0.48710909485816956
to O 0 0.0039529260247945786
be O 0 0.0026042363606393337
widespread O 0 0.017799710854887962
and O 0 0.003299160860478878
likely O 0 0.008752575144171715
to O 0 0.0036188492085784674
predate O 0 0.10593803226947784
the O 0 0.006573640275746584
more O 0 0.017023999243974686
genetically O 1 0.6073582768440247
restricted O 0 0.233381986618042
845 O 1 0.7809994220733643
G O 1 0.7417986989021301
- O 1 0.5236818790435791
- O 1 0.5099743008613586
> O 1 0.6506913900375366
A O 0 0.10833898186683655
mutation O 1 0.9038316607475281
. O 0 0.07772941142320633

Genotype O 1 0.8458137512207031
- O 1 0.7899178266525269
phenotype O 1 0.9137505292892456
correlations O 1 0.8219130635261536
in O 0 0.44821956753730774
attenuated B-Disease 1 0.9339903593063354
adenomatous I-Disease 1 0.9578667283058167
polyposis I-Disease 1 0.9483348727226257
coli I-Disease 1 0.919696033000946
. O 0 0.23481667041778564

Germ O 1 0.7331558465957642
- O 0 0.19281204044818878
line O 0 0.0747353807091713
mutations O 1 0.8088991641998291
of O 0 0.023051850497722626
the O 0 0.09785886108875275
tumor B-Disease 1 0.9709040522575378
suppressor O 1 0.9467313885688782
APC O 1 0.858450710773468
are O 0 0.08868551254272461
implicated O 1 0.792584240436554
in O 0 0.4560956358909607
attenuated B-Disease 1 0.9699291586875916
adenomatous I-Disease 1 0.9820589423179626
polyposis I-Disease 1 0.983030378818512
coli I-Disease 1 0.9759753942489624
( O 1 0.6652189493179321
AAPC B-Disease 1 0.9122315645217896
) O 0 0.0701434537768364
, O 0 0.015016107819974422
a O 0 0.031488087028265
variant O 1 0.8491449356079102
of O 0 0.3051590919494629
familial B-Disease 1 0.9769061207771301
adenomatous I-Disease 1 0.9785506725311279
polyposis I-Disease 1 0.9676410555839539
( O 1 0.6633970737457275
FAP B-Disease 1 0.9004060626029968
) O 0 0.15819042921066284
. O 0 0.05402939021587372

AAPC B-Disease 1 0.5691572427749634
is O 0 0.02015734650194645
recognized O 0 0.018350351601839066
by O 0 0.009644385427236557
the O 0 0.007374099921435118
occurrence O 0 0.12250976264476776
of O 0 0.009957841597497463
< O 0 0.3350560665130615
100 O 0 0.051220234483480453
colonic B-Disease 1 0.8994572162628174
adenomas I-Disease 1 0.9087849855422974
and O 0 0.01631765626370907
a O 0 0.034240201115608215
later O 0 0.11610212922096252
onset O 1 0.9748534560203552
of O 1 0.5288261771202087
colorectal B-Disease 1 0.991174042224884
cancer I-Disease 1 0.9834888577461243
( O 0 0.37867486476898193
age O 0 0.2526998519897461
> O 0 0.4931619465351105
40 O 0 0.03094313107430935
years O 0 0.026534687727689743
) O 0 0.0368705578148365
. O 0 0.027010533958673477

The O 0 0.015377574600279331
aim O 0 0.015585262328386307
of O 0 0.006311768665909767
this O 0 0.0055763814598321915
study O 0 0.011157878674566746
was O 0 0.005789425689727068
to O 0 0.00841717142611742
assess O 0 0.29521679878234863
genotype O 1 0.9290361404418945
- O 1 0.7437402009963989
phenotype O 1 0.9539729952812195
correlations O 1 0.7204353213310242
in O 0 0.09343674033880234
AAPC B-Disease 1 0.8858896493911743
families O 0 0.1680404096841812
. O 0 0.05250248312950134

By O 0 0.0417628213763237
protein O 0 0.34634658694267273
- O 0 0.16784460842609406
truncation O 0 0.27459052205085754
test O 0 0.037928737699985504
( O 0 0.025975247845053673
PTT O 0 0.04489370435476303
) O 0 0.012233656831085682
assay O 0 0.025736762210726738
, O 0 0.0037455216515809298
the O 0 0.003325063968077302
entire O 0 0.009236385114490986
coding O 0 0.1620897650718689
region O 0 0.011895461939275265
of O 0 0.004255292005836964
the O 0 0.009720325469970703
APC B-Disease 1 0.6096630096435547
gene O 1 0.6274029016494751
was O 0 0.008419719524681568
screened O 0 0.04724857583642006
in O 0 0.009755639359354973
affected O 0 0.11318953335285187
individuals O 0 0.04357890412211418
from O 0 0.012326297350227833
11 O 0 0.05285736545920372
AAPC B-Disease 1 0.8652293682098389
kindreds O 1 0.5303894877433777
, O 0 0.007329238578677177
and O 0 0.004355797078460455
their O 0 0.006260007154196501
phenotypic O 0 0.2824432849884033
differences O 0 0.05849037319421768
were O 0 0.010474169626832008
examined O 0 0.10881482064723969
. O 0 0.031851835548877716

Five O 0 0.04535328224301338
novel O 0 0.2381945103406906
germ O 1 0.7056070566177368
- O 0 0.25719669461250305
line O 0 0.10134520381689072
APC B-Disease 1 0.756575345993042
mutations O 1 0.8259386420249939
were O 0 0.009662164375185966
identified O 0 0.030344730243086815
in O 0 0.010334348306059837
seven O 0 0.026195207610726357
kindreds O 1 0.5596519112586975
. O 0 0.04735400155186653

Mutations O 1 0.5250446796417236
were O 0 0.010782482102513313
located O 0 0.00888840202242136
in O 0 0.0051742782816290855
three O 0 0.003993632737547159
different O 0 0.004369157832115889
regions O 0 0.01371210627257824
of O 0 0.004253710154443979
the O 0 0.01093246415257454
APC B-Disease 1 0.6675217747688293
gene O 1 0.7470903992652893
( O 0 0.03550993278622627
1 O 0 0.009022888727486134
) O 0 0.006062137428671122
at O 0 0.0027914869133383036
the O 0 0.0025791076477617025
5 O 0 0.005417237989604473
end O 0 0.0065367999486625195
spanning O 0 0.03286631405353546
exons O 0 0.18311133980751038
4 O 0 0.00787406787276268
and O 0 0.0032719324808567762
5 O 0 0.007208515424281359
, O 0 0.004075055941939354
( O 0 0.009251371957361698
2 O 0 0.006044687703251839
) O 0 0.006655825302004814
within O 0 0.005331911612302065
exon O 0 0.07963335514068604
9 O 0 0.008866014890372753
, O 0 0.003559933276847005
and O 0 0.002934780204668641
( O 0 0.0066392445005476475
3 O 0 0.0057525779120624065
) O 0 0.00473916856572032
at O 0 0.003091746009886265
the O 0 0.003336006309837103
3 O 0 0.012309259735047817
distal O 0 0.38364970684051514
end O 0 0.01113416999578476
of O 0 0.007190685719251633
the O 0 0.016548169776797295
gene O 1 0.6602649688720703
. O 0 0.04630044102668762

Variability O 0 0.18903696537017822
in O 0 0.015781687572598457
the O 0 0.009443561546504498
number O 0 0.010959779843688011
of O 0 0.04092239961028099
colorectal B-Disease 1 0.9795984625816345
adenomas I-Disease 1 0.9356458783149719
was O 0 0.011523944325745106
most O 0 0.010181891731917858
apparent O 0 0.08394698798656464
in O 0 0.011886000633239746
individuals O 0 0.06976110488176346
with O 0 0.030028101056814194
mutations O 1 0.8414110541343689
in O 0 0.011207299306988716
region O 0 0.025038838386535645
1 O 0 0.013284546323120594
, O 0 0.006857412867248058
and O 0 0.009080659598112106
upper O 0 0.28478312492370605
- O 1 0.6866257786750793
gastrointestinal O 1 0.9713303446769714
manifestations O 0 0.47863122820854187
were O 0 0.009677283465862274
more O 0 0.021771851927042007
severe O 1 0.6353856325149536
in O 0 0.01358765084296465
them O 0 0.013305356726050377
. O 0 0.031162036582827568

In O 0 0.025244800373911858
individuals O 0 0.03692734241485596
with O 0 0.01687529683113098
mutations O 1 0.601586103439331
in O 0 0.008506491780281067
either O 0 0.008962682448327541
region O 0 0.010879803448915482
2 O 0 0.006702507380396128
or O 0 0.005917701870203018
region O 0 0.00601219804957509
3 O 0 0.004024744499474764
, O 0 0.002408781321719289
the O 0 0.0020409622229635715
average O 0 0.004547195043414831
number O 0 0.0033616721630096436
of O 0 0.004466702230274677
adenomas B-Disease 1 0.6056066751480103
tended O 0 0.02467380277812481
to O 0 0.00298138870857656
be O 0 0.002259965520352125
lower O 0 0.006609178148210049
than O 0 0.0030804381240159273
those O 0 0.003192284144461155
in O 0 0.004751103930175304
individuals O 0 0.047436293214559555
with O 0 0.016844723373651505
mutations O 1 0.7355934381484985
in O 0 0.009892288595438004
region O 0 0.0190664641559124
1 O 0 0.010426207445561886
, O 0 0.005841018632054329
although O 0 0.013093525543808937
age O 0 0.04765212535858154
at O 0 0.027032090350985527
diagnosis O 1 0.8333763480186462
was O 0 0.014901154674589634
similar O 0 0.05753747746348381
. O 0 0.030346665531396866

In O 0 0.03123176097869873
all O 0 0.021517733111977577
AAPC B-Disease 1 0.7337110638618469
kindreds O 0 0.394243985414505
, O 0 0.014871366322040558
a O 0 0.014598943293094635
predominance O 0 0.1403241604566574
of O 0 0.014178202487528324
right O 0 0.13115470111370087
- O 1 0.707206130027771
sided O 1 0.9263186454772949
colorectal B-Disease 1 0.9865925908088684
adenomas I-Disease 1 0.9738827347755432
and O 0 0.34576940536499023
rectal B-Disease 1 0.9649111032485962
polyp I-Disease 1 0.9561319351196289
sparing O 1 0.669556736946106
was O 0 0.036796197295188904
observed O 0 0.13742724061012268
. O 0 0.04000650346279144

No O 0 0.05977582558989525
desmoid B-Disease 1 0.5804598331451416
tumors I-Disease 1 0.8825221657752991
were O 0 0.014440860599279404
found O 0 0.016758330166339874
in O 0 0.012178708799183369
these O 0 0.016549061983823776
kindreds O 0 0.4396520256996155
. O 0 0.035799380391836166

Our O 0 0.019651196897029877
data O 0 0.013723460957407951
suggest O 0 0.012822258286178112
that O 0 0.005160234868526459
, O 0 0.00498324865475297
in O 0 0.007170035503804684
AAPC B-Disease 1 0.5494543313980103
families O 0 0.021613173186779022
, O 0 0.004189701750874519
the O 0 0.0034339725971221924
location O 0 0.005043473094701767
of O 0 0.004350532777607441
the O 0 0.010639261454343796
APC B-Disease 1 0.7599735856056213
mutation O 1 0.9241331815719604
may O 0 0.126076340675354
partially O 0 0.2385336309671402
predict O 0 0.20504163205623627
specific O 0 0.1226690262556076
phenotypic O 1 0.6327964067459106
expression O 0 0.31215494871139526
. O 0 0.05645795539021492

This O 0 0.013730310834944248
should O 0 0.007915031164884567
help O 0 0.006861940957605839
in O 0 0.0038879280909895897
the O 0 0.003278264543041587
design O 0 0.0077333939261734486
of O 0 0.007376288063824177
tailored O 0 0.39458560943603516
clinical O 1 0.7862266898155212
- O 0 0.3028366267681122
management O 0 0.144022598862648
protocols O 0 0.1055218055844307
in O 0 0.0073674703016877174
this O 0 0.007336319424211979
subset O 0 0.18068568408489227
of O 0 0.04873727634549141
FAP B-Disease 1 0.9506945013999939
patients O 1 0.9421231746673584
. O 0 0.049901705235242844
. O 0 0.03912179917097092

Wilms B-Disease 1 0.8399673700332642
' I-Disease 0 0.1951780617237091
tumor I-Disease 1 0.8264314532279968
1 O 0 0.02213061787188053
and O 0 0.012496587820351124
Dax O 0 0.10793641954660416
- O 0 0.08838041871786118
1 O 0 0.02385473996400833
modulate O 0 0.3342810571193695
the O 0 0.01582956686615944
orphan O 1 0.6968751549720764
nuclear O 0 0.1560344398021698
receptor O 1 0.8143855929374695
SF O 1 0.6972466707229614
- O 0 0.13445188105106354
1 O 0 0.019222766160964966
in O 0 0.01471488457173109
sex O 0 0.21667808294296265
- O 0 0.2579939067363739
specific O 0 0.15593773126602173
gene O 1 0.8246750831604004
expression O 0 0.3571719825267792
. O 0 0.051970224827528

Products O 0 0.06218443438410759
of O 0 0.028178535401821136
steroidogenic O 1 0.7898575663566589
factor O 0 0.2105899453163147
1 O 0 0.04293747991323471
( O 0 0.09836485981941223
SF O 1 0.5418106913566589
- O 0 0.1368703693151474
1 O 0 0.0242720115929842
) O 0 0.04130177199840546
and O 0 0.03780230134725571
Wilms B-Disease 1 0.9600037932395935
tumor I-Disease 1 0.9607192873954773
1 O 0 0.12273601442575455
( O 0 0.23127423226833344
WT1 O 1 0.8941124677658081
) O 0 0.053671471774578094
genes O 0 0.26561790704727173
are O 0 0.005858491640537977
essential O 0 0.014146791771054268
for O 0 0.008095008321106434
mammalian O 1 0.5338025689125061
gonadogenesis O 0 0.3252023756504059
prior O 0 0.029156683012843132
to O 0 0.016077127307653427
sexual O 0 0.28992438316345215
differentiation O 1 0.6205844879150391
. O 0 0.045752305537462234

In O 0 0.03271014615893364
males O 0 0.1305215209722519
, O 0 0.020327437669038773
SF O 0 0.39813607931137085
- O 0 0.0805218294262886
1 O 0 0.01516924612224102
participates O 0 0.056896720081567764
in O 0 0.006917749065905809
sexual O 0 0.06218704208731651
development O 0 0.013953295536339283
by O 0 0.00876501202583313
regulating O 0 0.10072216391563416
expression O 0 0.05584649741649628
of O 0 0.009123912081122398
the O 0 0.03312859311699867
polypeptide O 1 0.8951771259307861
hormone O 1 0.9619351029396057
Mullerian O 1 0.9578925371170044
inhibiting O 1 0.9477047920227051
substance O 1 0.8725721836090088
( O 0 0.41938793659210205
MIS O 1 0.8676182627677917
) O 0 0.09182368218898773
. O 0 0.036354824900627136

Here O 0 0.02176835387945175
, O 0 0.012730201706290245
we O 0 0.007602605037391186
show O 0 0.010003549978137016
that O 0 0.013710946775972843
WT1 O 1 0.8063523173332214
- O 0 0.3856141269207001
KTS O 1 0.8489351868629456
isoforms O 0 0.4850369095802307
associate O 0 0.0567927211523056
and O 0 0.011464813724160194
synergize O 1 0.5145102739334106
with O 0 0.025942014530301094
SF O 0 0.49818161129951477
- O 0 0.08897647261619568
1 O 0 0.015697253867983818
to O 0 0.008295799605548382
promote O 0 0.05046992748975754
MIS O 1 0.6901506781578064
expression O 0 0.22896844148635864
. O 0 0.04355303943157196

In O 0 0.040648914873600006
contrast O 0 0.08515945822000504
, O 0 0.05161900073289871
WT1 O 1 0.8953514695167542
missense O 1 0.9077566266059875
mutations O 1 0.9298020601272583
, O 0 0.029873188585042953
associated O 0 0.06622274219989777
with O 0 0.01658700965344906
male B-Disease 0 0.3469836711883545
pseudohermaphroditism I-Disease 1 0.7437065243721008
in O 0 0.146458238363266
Denys B-Disease 1 0.9390714764595032
- I-Disease 1 0.8501997590065002
Drash I-Disease 1 0.9386249780654907
syndrome I-Disease 1 0.9810319542884827
, O 0 0.056860703974962234
fail O 0 0.22817696630954742
to O 0 0.019563332200050354
synergize O 1 0.6577765941619873
with O 0 0.06095725670456886
SF O 1 0.6696309447288513
- O 0 0.186855748295784
1 O 0 0.037837594747543335
. O 0 0.03266501799225807

Additionally O 0 0.041158247739076614
, O 0 0.01477837935090065
the O 0 0.011667247861623764
X O 0 0.08640585839748383
- O 0 0.11418348550796509
linked O 0 0.1901201456785202
, O 0 0.010010606609284878
candidate O 0 0.05118383839726448
dosage O 1 0.6842650175094604
- O 0 0.2598431706428528
sensitive O 0 0.16579242050647736
sex O 0 0.3183937072753906
- O 0 0.32248619198799133
reversal O 1 0.5140937566757202
gene O 1 0.7914139628410339
, O 0 0.02001073956489563
Dax O 0 0.14455296099185944
- O 0 0.12947015464305878
1 O 0 0.022441068664193153
, O 0 0.012985387817025185
antagonizes O 1 0.5053545236587524
synergy O 0 0.3396539092063904
between O 0 0.04500311240553856
SF O 1 0.5794499516487122
- O 0 0.1113138198852539
1 O 0 0.013940193690359592
and O 0 0.007212140131741762
WT1 O 0 0.4817143678665161
, O 0 0.004808271303772926
most O 0 0.004268471151590347
likely O 0 0.007909506559371948
through O 0 0.005208629183471203
a O 0 0.006862819194793701
direct O 0 0.020387504249811172
interaction O 0 0.06322093307971954
with O 0 0.019037390127778053
SF O 1 0.5842978954315186
- O 0 0.18898852169513702
1 O 0 0.03984344005584717
. O 0 0.032992251217365265

We O 0 0.02002650871872902
propose O 0 0.03204665333032608
that O 0 0.012984861619770527
WT1 O 0 0.39975979924201965
and O 0 0.010115350596606731
Dax O 0 0.07778055220842361
- O 0 0.0663020983338356
1 O 0 0.014684973284602165
functionally O 0 0.11581134796142578
oppose O 0 0.012409985065460205
each O 0 0.005282887257635593
other O 0 0.005304402206093073
in O 0 0.01026966329663992
testis O 1 0.7016640305519104
development O 0 0.07237638533115387
by O 0 0.059579066932201385
modulating O 1 0.8826261758804321
SF O 1 0.8593385815620422
- O 0 0.39286795258522034
1 O 0 0.08616425842046738
- O 0 0.3713218867778778
mediated O 1 0.7483759522438049
transactivation O 1 0.7073559165000916
. O 0 0.03455100581049919
. O 0 0.03772810846567154

A O 0 0.07168568670749664
mouse O 1 0.5308176279067993
model O 0 0.13080672919750214
for O 0 0.12390565127134323
Prader B-Disease 1 0.9493269324302673
- I-Disease 1 0.9337140917778015
Willi I-Disease 1 0.967588484287262
syndrome I-Disease 1 0.9837693572044373
imprinting O 1 0.9334533214569092
- O 1 0.7369411587715149
centre O 0 0.47828948497772217
mutations O 1 0.92256098985672
. O 0 0.10962764918804169

Imprinting O 0 0.3063851296901703
in O 0 0.022785980254411697
the O 0 0.01579398475587368
15q11 O 0 0.2539352476596832
- O 0 0.10970404744148254
q13 O 0 0.2560006082057953
region O 0 0.04263550415635109
involves O 0 0.08790531754493713
an O 0 0.011783581227064133
imprinting O 1 0.5396159291267395
centre O 0 0.060851916670799255
( O 0 0.05920621380209923
IC O 0 0.21033865213394165
) O 0 0.01171876024454832
, O 0 0.0036623284686356783
mapping O 0 0.008035559207201004
in O 0 0.002936964388936758
part O 0 0.0032986216247081757
to O 0 0.0026511824689805508
the O 0 0.0034602582454681396
promoter O 0 0.042655378580093384
and O 0 0.004570535384118557
first O 0 0.007577588781714439
exon O 0 0.16252242028713226
of O 0 0.015502636320888996
SNRPN O 0 0.3440819978713989
. O 0 0.03670844808220863

Deletion O 0 0.1761813759803772
of O 0 0.018909161910414696
this O 0 0.01454073004424572
IC O 0 0.27118349075317383
abolishes O 0 0.42758819460868835
local O 0 0.03359377756714821
paternally O 1 0.5782835483551025
derived O 0 0.3002413809299469
gene O 1 0.7841001749038696
expression O 0 0.15324439108371735
and O 0 0.01483629085123539
results O 0 0.18495437502861023
in O 0 0.19635924696922302
Prader B-Disease 1 0.963361918926239
- I-Disease 1 0.9411630630493164
Willi I-Disease 1 0.9676576852798462
syndrome I-Disease 1 0.9821885228157043
( O 1 0.7279877066612244
PWS B-Disease 1 0.9236587882041931
) O 0 0.16560477018356323
. O 0 0.05230892077088356

We O 0 0.01563720405101776
have O 0 0.01110407616943121
created O 0 0.01831972599029541
two O 0 0.017382260411977768
deletion O 1 0.8195489645004272
mutations O 1 0.9034303426742554
in O 0 0.04877884313464165
mice O 1 0.7871096134185791
to O 0 0.011954259127378464
understand O 0 0.06568819284439087
PWS B-Disease 1 0.7244686484336853
and O 0 0.00732790632173419
the O 0 0.006354176439344883
mechanism O 0 0.04986511170864105
of O 0 0.007262695115059614
this O 0 0.01063163485378027
IC O 0 0.29782262444496155
. O 0 0.037792615592479706

Mice O 1 0.844173789024353
harbouring O 0 0.3725755512714386
an O 0 0.02987268753349781
intragenic O 0 0.3864036202430725
deletion O 0 0.47726964950561523
in O 0 0.01785310171544552
Snrpn O 0 0.24802792072296143
are O 0 0.011366904713213444
phenotypically O 0 0.4532022774219513
normal O 0 0.08158021420240402
, O 0 0.006851044483482838
suggesting O 0 0.03015061654150486
that O 0 0.007986517623066902
mutations O 1 0.6623206734657288
of O 0 0.006438587326556444
SNRPN O 0 0.16068506240844727
are O 0 0.004986784420907497
not O 0 0.005339192226529121
sufficient O 0 0.017761096358299255
to O 0 0.015505877323448658
induce O 1 0.7154721617698669
PWS B-Disease 1 0.9047291278839111
. O 0 0.09286826848983765

Mice O 0 0.44849729537963867
with O 0 0.019243692979216576
a O 0 0.014747709967195988
larger O 0 0.03240722790360451
deletion O 0 0.3705182373523712
involving O 0 0.03932841867208481
both O 0 0.009398586116731167
Snrpn O 0 0.1010674461722374
and O 0 0.007107457146048546
the O 0 0.013031045906245708
putative O 1 0.7168704867362976
PWS O 1 0.9397048354148865
- O 0 0.294447124004364
IC O 0 0.37737032771110535
lack O 0 0.047379255294799805
expression O 0 0.036414146423339844
of O 0 0.006882874295115471
the O 0 0.011493426747620106
imprinted O 1 0.6941543221473694
genes O 1 0.9015219807624817
Zfp127 O 1 0.7860349416732788
( O 0 0.24015209078788757
mouse O 1 0.6857879757881165
homologue O 1 0.5479323863983154
of O 0 0.019487367942929268
ZNF127 O 0 0.4853304326534271
) O 0 0.033035460859537125
, O 0 0.009399065747857094
Ndn O 0 0.3064611852169037
and O 0 0.006567903328686953
Ipw O 0 0.14927425980567932
, O 0 0.007041993085294962
and O 0 0.006309944204986095
manifest O 0 0.06144541874527931
several O 0 0.02219870314002037
phenotypes O 1 0.8538908362388611
common O 0 0.290615439414978
to O 0 0.062117818742990494
PWS B-Disease 1 0.9350908994674683
infants O 1 0.9105706214904785
. O 0 0.1305493712425232

These O 0 0.013196554034948349
data O 0 0.008816591463983059
demonstrate O 0 0.00731100607663393
that O 0 0.0031547173857688904
both O 0 0.0026507568545639515
the O 0 0.0020994474180042744
position O 0 0.002368639688938856
of O 0 0.0021088249050080776
the O 0 0.002611250150948763
IC O 0 0.032916415482759476
and O 0 0.0022895410656929016
its O 0 0.002370142377912998
role O 0 0.0049874987453222275
in O 0 0.002824928844347596
the O 0 0.002943738829344511
coordinate O 0 0.022481271997094154
expression O 0 0.05598095804452896
of O 0 0.006759553216397762
genes O 0 0.4774288237094879
is O 0 0.011194898746907711
conserved O 0 0.08626376837491989
between O 0 0.026097171008586884
mouse O 0 0.37836316227912903
and O 0 0.006218274589627981
human O 0 0.03089452162384987
, O 0 0.0036704682279378176
and O 0 0.0025302856229245663
indicate O 0 0.006945485714823008
that O 0 0.002171969274058938
the O 0 0.0031524966470897198
mouse O 0 0.1495780348777771
is O 0 0.004542007111012936
a O 0 0.004291911143809557
suitable O 0 0.011145595461130142
model O 0 0.009095672518014908
system O 0 0.007181296590715647
in O 0 0.002598945749923587
which O 0 0.002048306167125702
to O 0 0.0019590763840824366
investigate O 0 0.005817785393446684
the O 0 0.0034875315614044666
molecular O 0 0.1456255167722702
mechanisms O 0 0.09477536380290985
of O 0 0.0049096629954874516
imprinting O 0 0.21515721082687378
in O 0 0.004516690503805876
this O 0 0.003207014873623848
region O 0 0.006444831844419241
of O 0 0.003901497460901737
the O 0 0.007832997478544712
genome O 0 0.3313091993331909
. O 0 0.018846934661269188
. O 0 0.025510083884000778

Mutations O 1 0.7052255272865295
of O 0 0.023787179961800575
the O 0 0.02787194959819317
ATM O 1 0.5610548257827759
gene O 1 0.8807405233383179
detected O 0 0.47551286220550537
in O 0 0.0497702918946743
Japanese O 0 0.3571731746196747
ataxia B-Disease 1 0.9810962080955505
- I-Disease 1 0.924137532711029
telangiectasia I-Disease 1 0.9796684384346008
patients O 1 0.9448645710945129
: O 0 0.03705698624253273
possible O 0 0.02891603484749794
preponderance O 0 0.10418780148029327
of O 0 0.0047622546553611755
the O 0 0.005682060960680246
two O 0 0.01432753074914217
founder O 0 0.2220950573682785
mutations O 1 0.9054775834083557
4612del165 O 0 0.46732836961746216
and O 0 0.033953722566366196
7883del5 O 0 0.41186490654945374
. O 0 0.047038111835718155

The O 0 0.033670537173748016
ATM O 0 0.14337754249572754
( O 0 0.05615098774433136
A O 0 0.04370883107185364
- O 0 0.3375966548919678
T O 1 0.766823947429657
, O 0 0.04954993352293968
mutated O 1 0.8676949739456177
) O 0 0.11462228745222092
gene O 1 0.6418451070785522
on O 0 0.015425334684550762
human O 0 0.3622480630874634
chromosome O 1 0.8986437916755676
11q22 O 1 0.5857495069503784
. O 0 0.05840260535478592

3 O 0 0.027282828465104103
has O 0 0.010639483109116554
recently O 0 0.01063691359013319
been O 0 0.005984114948660135
identified O 0 0.010546328499913216
as O 0 0.004369273781776428
the O 0 0.007607189938426018
gene O 1 0.5997734069824219
responsible O 0 0.05734967812895775
for O 0 0.018816346302628517
the O 0 0.11232040822505951
human O 1 0.936193585395813
recessive B-Disease 1 0.9914265871047974
disease I-Disease 1 0.9918422698974609
ataxia B-Disease 1 0.9866804480552673
- I-Disease 1 0.9396024346351624
telangiectasia I-Disease 1 0.9700853228569031
( O 0 0.36332401633262634
A B-Disease 0 0.2298804372549057
- I-Disease 1 0.5466615557670593
T I-Disease 1 0.8487589359283447
) O 0 0.11267374455928802
. O 0 0.04230940714478493

In O 0 0.019160421565175056
order O 0 0.01066613756120205
to O 0 0.005635940469801426
define O 0 0.013538319617509842
the O 0 0.007064159493893385
types O 0 0.1416446715593338
of O 0 0.10649294406175613
disease O 1 0.983061671257019
- O 1 0.6656637191772461
causing O 1 0.80945885181427
ATM O 1 0.6313666701316833
mutations O 1 0.8862668871879578
in O 0 0.01528538204729557
Japanese O 0 0.02627060003578663
A B-Disease 0 0.07999648153781891
- I-Disease 0 0.49745994806289673
T I-Disease 1 0.8623158931732178
patients O 1 0.7575477957725525
as O 0 0.004768152255564928
well O 0 0.0033776748459786177
as O 0 0.0025767902843654156
to O 0 0.002500350121408701
look O 0 0.005035349167883396
for O 0 0.00448026554659009
possible O 0 0.037981919944286346
mutational O 1 0.7255837917327881
hotspots O 0 0.38801881670951843
, O 0 0.017854491248726845
reverse O 0 0.28008952736854553
- O 0 0.2799057364463806
transcribed O 0 0.4292023479938507
RNA O 0 0.45265328884124756
derived O 0 0.06728272885084152
from O 0 0.00850145798176527
ten O 0 0.016664760187268257
patients O 1 0.6328093409538269
belonging O 0 0.014950779266655445
to O 0 0.004189108964055777
eight O 0 0.009197881445288658
unrelated O 0 0.12765134871006012
Japanese O 0 0.024141287431120872
A B-Disease 0 0.05368378013372421
- I-Disease 0 0.30698519945144653
T I-Disease 1 0.5930970311164856
families O 0 0.04017063230276108
was O 0 0.0069222161546349525
analyzed O 0 0.03660392388701439
for O 0 0.010171587578952312
mutations O 1 0.6522220373153687
by O 0 0.010523801669478416
the O 0 0.010425621643662453
restriction O 0 0.16300126910209656
endonuclease O 1 0.6295203566551208
fingerprinting O 0 0.20254725217819214
method O 0 0.0794675424695015
. O 0 0.039643850177526474

As O 0 0.015420266427099705
has O 0 0.009385693818330765
been O 0 0.007617824710905552
reported O 0 0.0108031602576375
by O 0 0.006429427769035101
others O 0 0.00985571276396513
, O 0 0.008773831650614738
mutations O 1 0.5700848698616028
that O 0 0.005081611219793558
lead O 0 0.016617143526673317
to O 0 0.006390827242285013
exon O 0 0.3074833154678345
skipping O 0 0.24946163594722748
or O 0 0.07348772138357162
premature O 1 0.713135302066803
protein O 0 0.369363933801651
truncation O 0 0.13711470365524292
were O 0 0.004939906299114227
also O 0 0.004865068942308426
predominant O 0 0.031855132430791855
in O 0 0.007631747517734766
our O 0 0.012002622708678246
mutants O 0 0.21183457970619202
. O 0 0.037913743406534195

Six O 0 0.03159351274371147
different O 0 0.02214418165385723
mutations O 0 0.46455660462379456
were O 0 0.006768267136067152
identified O 0 0.00942541565746069
on O 0 0.0038645050954073668
12 O 0 0.005662852432578802
of O 0 0.004184427205473185
the O 0 0.007242563180625439
16 O 0 0.048948023468256
alleles O 1 0.8813281059265137
examined O 0 0.3206014931201935
. O 0 0.0398423857986927

Four O 0 0.026241358369588852
were O 0 0.014147171750664711
deletions O 0 0.11337634176015854
involving O 0 0.02217220887541771
a O 0 0.008880143985152245
loss O 0 0.02050366997718811
of O 0 0.005708799697458744
a O 0 0.008320428431034088
single O 0 0.021603325381875038
exon O 0 0.28352850675582886
exon O 0 0.24613383412361145
7 O 0 0.018779408186674118
, O 0 0.009632469154894352
exon O 0 0.16846317052841187
16 O 0 0.016549725085496902
, O 0 0.010361172258853912
exon O 0 0.17409147322177887
33 O 0 0.02700207754969597
or O 0 0.028808891773223877
exon O 0 0.240722194314003
35 O 0 0.036442600190639496
. O 0 0.03039303608238697

The O 0 0.02037598192691803
others O 0 0.015560774132609367
were O 0 0.008884245529770851
minute O 0 0.015688546001911163
deletions O 0 0.1436212658882141
, O 0 0.009015633724629879
4649delA O 0 0.08223608881235123
in O 0 0.009476376697421074
exon O 0 0.11652319133281708
33 O 0 0.01919582299888134
and O 0 0.00851461198180914
7883del5 O 0 0.13079063594341278
in O 0 0.017975347116589546
exon O 0 0.3348965346813202
55 O 0 0.060973815619945526
. O 0 0.030976658686995506

The O 0 0.03308119997382164
mutations O 1 0.7322145700454712
4612del165 O 0 0.1381380707025528
and O 0 0.010035933926701546
7883del5 O 0 0.0493093766272068
were O 0 0.003791172755882144
found O 0 0.004459815099835396
in O 0 0.003063387470319867
more O 0 0.0029696905985474586
than O 0 0.003695604857057333
two O 0 0.004760899115353823
unrelated O 0 0.1119767352938652
families O 0 0.03638693317770958
; O 0 0.013902084901928902
44 O 0 0.012357976287603378
% O 0 0.020941035822033882
( O 0 0.009205302223563194
7 O 0 0.004486289341002703
of O 0 0.002504152711480856
16 O 0 0.0052312156185507774
) O 0 0.004686855711042881
of O 0 0.002536745509132743
the O 0 0.004915646277368069
mutant O 0 0.33896738290786743
alleles O 1 0.5722922682762146
had O 0 0.005114190746098757
one O 0 0.0036744147073477507
of O 0 0.003723636269569397
the O 0 0.005749935749918222
two O 0 0.023304687812924385
mutations O 1 0.8981600999832153
. O 0 0.057444747537374496

The O 0 0.02650596760213375
4612del165 O 0 0.252915620803833
mutations O 0 0.4504663050174713
in O 0 0.007065591402351856
three O 0 0.0050491830334067345
different O 0 0.004328448791056871
families O 0 0.0058931466192007065
were O 0 0.002516741631552577
all O 0 0.002397005446255207
ascribed O 0 0.01367727667093277
to O 0 0.002667524851858616
the O 0 0.003274790709838271
same O 0 0.01671871356666088
T O 1 0.6372021436691284
- O 0 0.27127569913864136
- O 0 0.23583225905895233
> O 0 0.2819947600364685
A O 0 0.011564896441996098
substitution O 0 0.03421363979578018
at O 0 0.006660600192844868
the O 0 0.00932949036359787
splice O 1 0.5543493628501892
donor O 0 0.4890115261077881
site O 0 0.026035042479634285
in O 0 0.024170810356736183
intron O 1 0.6812891960144043
33 O 0 0.09575721621513367
. O 0 0.037710387259721756

Microsatellite O 1 0.5264995098114014
genotyping O 0 0.1870998591184616
around O 0 0.021021967753767967
the O 0 0.013083468191325665
ATM O 0 0.08535359799861908
locus O 0 0.17521189153194427
also O 0 0.006740541197359562
indicated O 0 0.010095690377056599
that O 0 0.00377826951444149
a O 0 0.006106345448642969
common O 0 0.061798714101314545
haplotype O 0 0.4405685067176819
was O 0 0.00477994279935956
shared O 0 0.008309708908200264
by O 0 0.006238787434995174
the O 0 0.009197221137583256
mutant O 1 0.5700886845588684
alleles O 1 0.8581408262252808
in O 0 0.04013703763484955
both O 0 0.07247868925333023
mutations O 1 0.9208292365074158
. O 0 0.1001603975892067

This O 0 0.020015759393572807
suggests O 0 0.023464035242795944
that O 0 0.0077769034542143345
these O 0 0.0071990820579230785
two O 0 0.009465573355555534
founder O 0 0.1219966933131218
mutations O 1 0.8226285576820374
may O 0 0.033755287528038025
be O 0 0.007114156614989042
predominant O 0 0.0752093642950058
among O 0 0.023628689348697662
Japanese O 0 0.043924879282712936
ATM O 0 0.44361892342567444
mutant O 1 0.7709453105926514
alleles O 1 0.8958095908164978
. O 0 0.09429370611906052

W474C O 0 0.28477925062179565
amino O 0 0.2741186320781708
acid O 0 0.4681994318962097
substitution O 0 0.1372527927160263
affects O 0 0.23867571353912354
early O 0 0.012651522643864155
processing O 0 0.010784602724015713
of O 0 0.00498775253072381
the O 0 0.005777460057288408
alpha O 0 0.03460158407688141
- O 0 0.07429880648851395
subunit O 0 0.12069588154554367
of O 0 0.009202585555613041
beta O 0 0.17064404487609863
- O 0 0.1197545975446701
hexosaminidase O 0 0.1845570057630539
A O 0 0.013978983275592327
and O 0 0.0063535720109939575
is O 0 0.011604361236095428
associated O 0 0.05964218080043793
with O 0 0.048682138323783875
subacute O 1 0.9390501379966736
G B-Disease 1 0.6153967976570129
( I-Disease 0 0.19641178846359253
M2 I-Disease 1 0.5110974311828613
) I-Disease 0 0.0808953046798706
gangliosidosis I-Disease 0 0.3261164128780365
. O 0 0.037051063030958176

Mutations O 1 0.768944501876831
in O 0 0.023668933659791946
the O 0 0.02313314378261566
HEXA O 1 0.8493236303329468
gene O 1 0.5291306376457214
, O 0 0.010855481028556824
encoding O 0 0.04410097375512123
the O 0 0.007921511307358742
alpha O 0 0.04933662712574005
- O 0 0.08063473552465439
subunit O 0 0.13369320333003998
of O 0 0.009309612214565277
beta O 0 0.2278919368982315
- O 0 0.1326656937599182
hexosaminidase O 0 0.21214202046394348
A O 0 0.016047967597842216
( O 0 0.021921349689364433
Hex O 0 0.03751377388834953
A O 0 0.009178928099572659
) O 0 0.007858182303607464
, O 0 0.003373560030013323
that O 0 0.0038846794050186872
abolish O 0 0.03789385035634041
Hex O 0 0.10698334872722626
A O 0 0.09633897989988327
enzyme O 1 0.90940260887146
activity O 1 0.6689335703849792
cause O 1 0.9616641402244568
Tay B-Disease 1 0.9826349020004272
- I-Disease 1 0.9552897810935974
Sachs I-Disease 1 0.9810953140258789
disease I-Disease 1 0.9892908930778503
( O 1 0.592113733291626
TSD B-Disease 1 0.9336649775505066
) O 0 0.06827303767204285
, O 0 0.011978207156062126
the O 0 0.01915072649717331
fatal O 1 0.9361295104026794
infantile B-Disease 1 0.9520375728607178
form I-Disease 0 0.17013749480247498
of I-Disease 0 0.02834984101355076
G I-Disease 1 0.5206775665283203
( I-Disease 0 0.13405247032642365
M2 I-Disease 0 0.45960670709609985
) I-Disease 0 0.056941963732242584
gangliosidosis I-Disease 0 0.26578983664512634
, I-Disease 0 0.015870217233896255
Type I-Disease 0 0.08662732690572739
1 I-Disease 0 0.022313792258501053
. O 0 0.02431735210120678

Less O 0 0.2863979935646057
severe O 1 0.8851330876350403
, O 0 0.18626876175403595
subacute O 1 0.9531057476997375
( O 1 0.5728621482849121
juvenile O 1 0.9401715993881226
- O 1 0.8257687091827393
onset O 1 0.9691752195358276
) O 0 0.25789138674736023
and O 0 0.11772027611732483
chronic O 1 0.9816306233406067
( O 0 0.4500913918018341
adult O 1 0.7525484561920166
- O 1 0.741532564163208
onset O 1 0.9680746793746948
) O 0 0.09359809011220932
variants O 0 0.20899303257465363
are O 0 0.005980188958346844
characterized O 0 0.0977550745010376
by O 0 0.005349351558834314
a O 0 0.006313066463917494
broad O 0 0.041573841124773026
spectrum O 0 0.09169048070907593
of O 0 0.01516981516033411
clinical O 1 0.621194064617157
manifestations O 0 0.21860383450984955
and O 0 0.006707918830215931
are O 0 0.005373671650886536
associated O 0 0.02355843409895897
with O 0 0.0081082284450531
residual O 0 0.11687341332435608
levels O 0 0.051615916192531586
of O 0 0.009043854661285877
Hex O 0 0.11885975301265717
A O 0 0.046999070793390274
enzyme O 1 0.621594250202179
activity O 0 0.13398101925849915
. O 0 0.043677281588315964

We O 0 0.023389602079987526
identified O 0 0.03653381019830704
a O 0 0.030441584065556526
1422 O 1 0.7093248963356018
G O 1 0.5375380516052246
- O 0 0.41590040922164917
- O 0 0.41979098320007324
> O 1 0.6479665637016296
C O 0 0.30402445793151855
( O 0 0.09613664448261261
amino O 0 0.3011482059955597
acid O 1 0.5870148539543152
W474C O 0 0.26159927248954773
) O 0 0.014899265952408314
substitution O 0 0.018848245963454247
in O 0 0.0033402054104954004
the O 0 0.0026202143635600805
first O 0 0.0027582519687712193
position O 0 0.0027855965308845043
of O 0 0.0034162411466240883
exon O 0 0.09616662561893463
13 O 0 0.009496642276644707
of O 0 0.005597699899226427
HEXA O 0 0.4981643855571747
of O 0 0.006622261367738247
a O 0 0.011598574928939342
non O 0 0.0630914494395256
- O 0 0.13459551334381104
Jewish O 0 0.06031915172934532
proband O 0 0.2540762424468994
who O 0 0.021269775927066803
manifested O 0 0.40576469898223877
a O 0 0.06407652050256729
subacute O 1 0.9381349086761475
variant O 1 0.7222787737846375
of O 0 0.03420497849583626
G B-Disease 1 0.5070050358772278
( I-Disease 0 0.15832650661468506
M2 I-Disease 0 0.4439769387245178
) I-Disease 0 0.06987062841653824
gangliosidosis I-Disease 0 0.35744741559028625
. O 0 0.036863818764686584

On O 0 0.019036246463656425
the O 0 0.013051681220531464
second O 0 0.02428772859275341
maternally O 1 0.7114905714988708
inherited O 1 0.8206920623779297
allele O 1 0.6805755496025085
, O 0 0.01034020259976387
we O 0 0.006028726231306791
identified O 0 0.0328952930867672
the O 0 0.030008483678102493
common O 1 0.7339653968811035
infantile O 1 0.9827595949172974
disease O 1 0.9866594076156616
- O 1 0.7249017357826233
causing O 1 0.759488046169281
4 O 0 0.11360975354909897
- O 0 0.29013943672180176
bp O 0 0.18232586979866028
insertion O 0 0.4168270230293274
, O 0 0.023920437321066856
+ O 0 0.40849125385284424
TATC O 1 0.51777583360672
1278 O 0 0.466472327709198
, O 0 0.013453837484121323
in O 0 0.014334199018776417
exon O 0 0.2452603280544281
11 O 0 0.03838955610990524
. O 0 0.03543006628751755

Pulse O 0 0.25402557849884033
- O 0 0.11346571892499924
chase O 0 0.07890374958515167
analysis O 0 0.029009168967604637
using O 0 0.019769346341490746
proband O 0 0.23025783896446228
fibroblasts O 0 0.3714677691459656
revealed O 0 0.018675217404961586
that O 0 0.004918807186186314
the O 0 0.0061847553588449955
W474C O 0 0.21871018409729004
- O 0 0.08614244312047958
containing O 0 0.04623493552207947
alpha O 0 0.0949154794216156
- O 0 0.15917284786701202
subunit O 0 0.28891751170158386
precursor O 0 0.2005634605884552
was O 0 0.006226836703717709
normally O 0 0.012541034258902073
synthesized O 0 0.05638580769300461
, O 0 0.0036261482164263725
but O 0 0.0029541782569140196
not O 0 0.003768013557419181
phosphorylated O 0 0.07727959007024765
or O 0 0.013481257483363152
secreted O 0 0.16672897338867188
, O 0 0.005458671599626541
and O 0 0.0043084765784442425
the O 0 0.009586064144968987
mature O 0 0.4897283613681793
lysosomal O 1 0.876528263092041
alpha O 0 0.21922971308231354
- O 0 0.240739107131958
subunit O 0 0.2005588263273239
was O 0 0.011396382935345173
not O 0 0.012872179038822651
detected O 0 0.21660621464252472
. O 0 0.02922658994793892

When O 0 0.02909804880619049
the O 0 0.01593528315424919
W474C O 0 0.13912412524223328
- O 0 0.06539926677942276
containing O 0 0.02549837715923786
alpha O 0 0.06391127407550812
- O 0 0.11787168681621552
subunit O 0 0.20456933975219727
was O 0 0.012512498535215855
transiently O 0 0.373244971036911
co O 0 0.07949210703372955
- O 0 0.028950491920113564
expressed O 0 0.007916031405329704
with O 0 0.005285328254103661
the O 0 0.006407581269741058
beta O 0 0.16727927327156067
- O 0 0.07213811576366425
subunit O 0 0.0835689902305603
to O 0 0.004370939917862415
produce O 0 0.01812030002474785
Hex O 0 0.048442352563142776
A O 0 0.01753665693104267
( O 0 0.04114047437906265
alphabeta O 0 0.22133499383926392
) O 0 0.01966278627514839
in O 0 0.011064749211072922
COS O 0 0.354092001914978
- O 0 0.1195034459233284
7 O 0 0.03430749848484993
cells O 0 0.3680807948112488
, O 0 0.00550181744620204
the O 0 0.004967276472598314
mature O 0 0.19026201963424683
alpha O 0 0.04774577543139458
- O 0 0.07572431117296219
subunit O 0 0.08769117295742035
was O 0 0.003201528685167432
present O 0 0.0034317004028707743
, O 0 0.0019805091433227062
but O 0 0.0015732463216409087
its O 0 0.0016704313457012177
level O 0 0.0024684069212526083
was O 0 0.0016901957569643855
much O 0 0.0023833378218114376
lower O 0 0.0048780073411762714
than O 0 0.0027365698479115963
that O 0 0.002684684470295906
from O 0 0.006205231416970491
normal O 0 0.08672326803207397
alpha O 0 0.09176337718963623
- O 0 0.18155014514923096
subunit O 0 0.33538129925727844
transfections O 0 0.17364156246185303
, O 0 0.0052490620873868465
although O 0 0.0045947120524942875
higher O 0 0.005960642360150814
than O 0 0.004393965471535921
in O 0 0.0052890777587890625
those O 0 0.017259793356060982
cells O 1 0.6994983553886414
transfected O 1 0.7156038880348206
with O 0 0.016429532319307327
an O 0 0.017971206456422806
alpha O 0 0.17364393174648285
- O 0 0.3288438618183136
subunit O 1 0.5927649736404419
associated O 0 0.2849031686782837
with O 0 0.163417786359787
infantile O 1 0.9469081163406372
TSD B-Disease 1 0.902957022190094
. O 0 0.10189243406057358

Furthermore O 0 0.037702757865190506
, O 0 0.012235124595463276
the O 0 0.008191226050257683
precursor O 0 0.03530241549015045
level O 0 0.0076399752870202065
of O 0 0.004513497464358807
the O 0 0.005248113535344601
W474C O 0 0.15047962963581085
alpha O 0 0.05237046629190445
- O 0 0.06979472935199738
subunit O 0 0.08738302439451218
was O 0 0.004145796876400709
found O 0 0.004775200039148331
to O 0 0.002981819212436676
accumulate O 0 0.04772317036986351
in O 0 0.003593373578041792
comparison O 0 0.007475477643311024
to O 0 0.003177040722221136
the O 0 0.004701403435319662
normal O 0 0.0687427967786789
alpha O 0 0.10526861995458603
- O 0 0.2356056123971939
subunit O 0 0.4436962604522705
precursor O 0 0.4821043610572815
levels O 0 0.2266232818365097
. O 0 0.05144856870174408

We O 0 0.019336696714162827
conclude O 0 0.02530362270772457
that O 0 0.010474348440766335
the O 0 0.014683551155030727
1422 O 1 0.7764639854431152
G O 1 0.6212489008903503
- O 0 0.47255101799964905
- O 1 0.5580921769142151
> O 1 0.7361832857131958
C O 0 0.4046366810798645
mutation O 1 0.7299007773399353
is O 0 0.008294593542814255
the O 0 0.0069855921901762486
cause O 0 0.20055051147937775
of O 0 0.009640022180974483
Hex B-Disease 0 0.21648941934108734
A I-Disease 0 0.17772608995437622
enzyme I-Disease 1 0.9508266448974609
deficiency I-Disease 1 0.9771355390548706
in O 0 0.0302695594727993
the O 0 0.022839384153485298
proband O 0 0.41609951853752136
. O 0 0.0420159250497818

The O 0 0.02897520735859871
resulting O 0 0.10939444601535797
W474C O 0 0.18816658854484558
substitution O 0 0.07193267345428467
clearly O 0 0.02381162904202938
interferes O 0 0.1892741620540619
with O 0 0.012230083346366882
alpha O 0 0.04871772229671478
- O 0 0.08386195451021194
subunit O 0 0.11056282371282578
processing O 0 0.012032277882099152
, O 0 0.0034894163254648447
but O 0 0.0026026503182947636
because O 0 0.0031893630512058735
the O 0 0.0026628810446709394
base O 0 0.003997400868684053
substitution O 0 0.02278047613799572
falls O 0 0.01429382711648941
at O 0 0.0026678701397031546
the O 0 0.002300908090546727
first O 0 0.002645547967404127
position O 0 0.0033242502249777317
of O 0 0.003757383907213807
exon O 0 0.13683970272541046
13 O 0 0.01988038420677185
, O 0 0.010555732063949108
aberrant O 0 0.47954925894737244
splicing O 0 0.45262423157691956
may O 0 0.020743340253829956
also O 0 0.005230783950537443
contribute O 0 0.03058178536593914
to O 0 0.006007774733006954
Hex B-Disease 0 0.13535262644290924
A I-Disease 0 0.08726020157337189
deficiency I-Disease 1 0.96427321434021
in O 0 0.01431466918438673
this O 0 0.013952640816569328
proband O 0 0.3076510727405548
. O 0 0.01894317753612995
. O 0 0.020768404006958008

Two O 0 0.07183243334293365
frequent O 1 0.5183178186416626
missense O 1 0.8849089741706848
mutations O 1 0.9308478236198425
in O 0 0.3193683326244354
Pendred B-Disease 1 0.9139263033866882
syndrome I-Disease 1 0.9594387412071228
. O 0 0.19291234016418457

Pendred B-Disease 1 0.9054375290870667
syndrome I-Disease 1 0.9657059907913208
is O 0 0.41969457268714905
an O 1 0.7469143271446228
autosomal B-Disease 1 0.985171377658844
recessive I-Disease 1 0.9858922362327576
disorder I-Disease 1 0.9830883145332336
characterized O 1 0.892432451248169
by O 0 0.19479472935199738
early O 0 0.3955416679382324
childhood O 1 0.9369679093360901
deafness B-Disease 1 0.96568763256073
and O 0 0.2656249701976776
goiter B-Disease 1 0.9390077590942383
. O 0 0.140162855386734

A O 0 0.024649402126669884
century O 0 0.01554154697805643
after O 0 0.009589985013008118
its O 0 0.006565231829881668
recognition O 0 0.025833893567323685
as O 0 0.011772188358008862
a O 0 0.09781937301158905
syndrome O 1 0.9772524237632751
by O 0 0.04111280292272568
Vaughan O 0 0.2806953489780426
Pendred O 1 0.556336522102356
, O 0 0.047293197363615036
the O 0 0.13025902211666107
disease O 1 0.9860659241676331
gene O 1 0.9456241130828857
( O 0 0.25199639797210693
PDS O 1 0.5953007340431213
) O 0 0.029727796092629433
was O 0 0.00807126984000206
mapped O 0 0.0428224541246891
to O 0 0.0212959386408329
chromosome O 1 0.8561341762542725
7q22 O 1 0.5281322598457336
- O 0 0.2897648215293884
q31 O 0 0.46813952922821045
. O 0 0.05376195162534714

1 O 0 0.023133112117648125
and O 0 0.00831487774848938
, O 0 0.006028288044035435
recently O 0 0.008202974684536457
, O 0 0.00457411352545023
found O 0 0.0056894500739872456
to O 0 0.004790243227034807
encode O 0 0.05357734486460686
a O 0 0.03349083289504051
putative O 1 0.6175891160964966
sulfate O 1 0.8853738903999329
transporter O 1 0.7184854745864868
. O 0 0.06237049400806427

We O 0 0.02052840031683445
performed O 0 0.03106892667710781
mutation O 1 0.6110844612121582
analysis O 0 0.01903066411614418
of O 0 0.006478459108620882
the O 0 0.014013361185789108
PDS B-Disease 1 0.788037121295929
gene O 1 0.8627761006355286
in O 0 0.04378116503357887
patients O 1 0.8136224150657654
from O 0 0.018255800008773804
14 O 0 0.031064532697200775
Pendred B-Disease 0 0.29995283484458923
families O 0 0.05512312054634094
originating O 0 0.0519406683743
from O 0 0.00569940498098731
seven O 0 0.006417826283723116
countries O 0 0.0066384864039719105
and O 0 0.005951204802840948
identified O 0 0.02938173897564411
all O 0 0.014725791290402412
mutations O 1 0.8726767897605896
. O 0 0.06583616882562637

The O 0 0.030731046572327614
mutations O 1 0.5219222903251648
include O 0 0.01654970832169056
three O 0 0.008065194822847843
single O 0 0.01044430211186409
base O 0 0.009592870250344276
deletions O 0 0.10560458153486252
, O 0 0.0064185261726379395
one O 0 0.007141034118831158
splice O 0 0.40930068492889404
site O 0 0.05486666411161423
mutation O 1 0.8064489960670471
and O 0 0.019038697704672813
10 O 0 0.0614919438958168
missense O 1 0.8579197525978088
mutations O 1 0.9140260219573975
. O 0 0.07770485430955887

One O 0 0.06104063615202904
missense O 1 0.8700990080833435
mutation O 1 0.9172741770744324
( O 0 0.10735078901052475
L236P O 0 0.2115292102098465
) O 0 0.011296783573925495
was O 0 0.004019462503492832
found O 0 0.004390257876366377
in O 0 0.00323702790774405
a O 0 0.005192170850932598
homozygous O 0 0.15173602104187012
state O 0 0.00472360709682107
in O 0 0.0038145591970533133
two O 0 0.004782041534781456
consanguineous O 0 0.3840455412864685
families O 0 0.01797465793788433
and O 0 0.0036607300862669945
in O 0 0.00401772977784276
a O 0 0.005298177246004343
heterozygous O 0 0.15341441333293915
state O 0 0.004475684370845556
in O 0 0.004329904448240995
five O 0 0.006273394450545311
additional O 0 0.013588149100542068
non O 0 0.07616458088159561
- O 0 0.2398199588060379
consanguineous O 1 0.6645318865776062
families O 0 0.11167711764574051
. O 0 0.03733488917350769

Another O 0 0.1239984855055809
missense O 1 0.8705428838729858
mutation O 1 0.9070304036140442
( O 0 0.08744065463542938
T416P O 0 0.16565033793449402
) O 0 0.011411823332309723
was O 0 0.004074777010828257
found O 0 0.004732710774987936
in O 0 0.0033174604177474976
a O 0 0.0054980251006782055
homozygous O 0 0.1715974062681198
state O 0 0.0044833337888121605
in O 0 0.0032370032276958227
one O 0 0.003190368879586458
family O 0 0.009724934585392475
and O 0 0.002620397601276636
in O 0 0.0038320631720125675
a O 0 0.006145325489342213
heterozygous O 0 0.16499662399291992
state O 0 0.006139566656202078
in O 0 0.0060060033574700356
four O 0 0.01130540482699871
families O 0 0.05809098109602928
. O 0 0.03552018105983734

Pendred B-Disease 1 0.6244525909423828
patients O 1 0.5828625559806824
in O 0 0.015620887279510498
three O 0 0.011423771269619465
non O 0 0.05882354453206062
- O 0 0.13706453144550323
consanguineous O 0 0.43847015500068665
families O 0 0.015150650404393673
were O 0 0.003981318790465593
shown O 0 0.006220084149390459
to O 0 0.003247839631512761
be O 0 0.004325602203607559
compound O 0 0.057306915521621704
heterozygotes O 1 0.5199979543685913
for O 0 0.017641473561525345
L236P O 0 0.32279330492019653
and O 0 0.019089369103312492
T416P O 0 0.3266115188598633
. O 0 0.038713350892066956

In O 0 0.01608651876449585
total O 0 0.009007109329104424
, O 0 0.00496259331703186
one O 0 0.003402652684599161
or O 0 0.003637059358879924
both O 0 0.0027433319482952356
of O 0 0.0025604763068258762
these O 0 0.004640335217118263
mutations O 0 0.40173134207725525
were O 0 0.0023882428649812937
found O 0 0.003732055425643921
in O 0 0.002534804865717888
nine O 0 0.0034791233483701944
of O 0 0.002784698735922575
the O 0 0.004554066341370344
14 O 0 0.015164964832365513
families O 0 0.04494631662964821
analyzed O 0 0.08418118953704834
. O 0 0.033766377717256546

The O 0 0.01951504684984684
identification O 0 0.019922375679016113
of O 0 0.008764248341321945
two O 0 0.010800561867654324
frequent O 0 0.17169351875782013
PDS B-Disease 1 0.7227079272270203
mutations O 1 0.8613617420196533
will O 0 0.011194935068488121
facilitate O 0 0.07642102241516113
the O 0 0.03213603422045708
molecular O 1 0.8339707255363464
diagnosis O 1 0.9569085836410522
of O 0 0.1957072913646698
Pendred B-Disease 1 0.9442957639694214
syndrome I-Disease 1 0.9741541743278503
. O 0 0.21394886076450348

Insertional O 1 0.6565383076667786
mutation O 1 0.7492474913597107
by O 0 0.030815279111266136
transposable O 0 0.39863988757133484
element O 0 0.05370253324508667
, O 0 0.014992466196417809
L1 O 0 0.22200387716293335
, O 0 0.009062190540134907
in O 0 0.010604149661958218
the O 0 0.034256815910339355
DMD B-Disease 1 0.9621936082839966
gene O 1 0.8694013953208923
results O 0 0.20685657858848572
in O 0 0.058432821184396744
X B-Disease 1 0.5695769786834717
- I-Disease 1 0.7135933041572571
linked I-Disease 1 0.8968368172645569
dilated I-Disease 1 0.949023962020874
cardiomyopathy I-Disease 1 0.9595008492469788
. O 0 0.20134718716144562

X B-Disease 1 0.5538856983184814
- I-Disease 1 0.7218403816223145
linked I-Disease 1 0.8930501937866211
dilated I-Disease 1 0.9547030329704285
cardiomyopathy I-Disease 1 0.9717851877212524
( O 0 0.3206184208393097
XLDCM B-Disease 1 0.6286005973815918
) O 0 0.033968523144721985
is O 0 0.011127952486276627
a O 0 0.0309935100376606
clinical O 1 0.7631049156188965
phenotype O 1 0.836396336555481
of O 0 0.01068274024873972
dystrophinopathy B-Disease 0 0.29202067852020264
which O 0 0.008881423622369766
is O 0 0.014397491700947285
characterized O 0 0.301148921251297
by O 0 0.03584855794906616
preferential O 1 0.6182217001914978
myocardial B-Disease 1 0.9612628221511841
involvement I-Disease 0 0.20253396034240723
without O 0 0.02681397832930088
any O 0 0.020526034757494926
overt O 0 0.3730889856815338
clinical O 1 0.7533285021781921
signs O 0 0.24303889274597168
of O 0 0.08741460740566254
skeletal B-Disease 1 0.9550864100456238
myopathy I-Disease 1 0.9567457437515259
. O 0 0.14755086600780487

To O 0 0.019523467868566513
date O 0 0.018696725368499756
, O 0 0.011365759186446667
several O 0 0.020195994526147842
mutations O 1 0.8707237243652344
in O 0 0.04820135608315468
the O 0 0.16630615293979645
Duchenne B-Disease 1 0.9800674319267273
muscular I-Disease 1 0.983219563961029
dystrophy I-Disease 1 0.9866160154342651
gene O 1 0.9552099704742432
, O 0 0.14451931416988373
DMD O 1 0.9362876415252686
, O 0 0.010689652524888515
have O 0 0.005089473910629749
been O 0 0.005580761469900608
identified O 0 0.024415865540504456
in O 0 0.012925837188959122
patients O 1 0.6661801338195801
with O 0 0.016167065128684044
XLDCM B-Disease 0 0.2926696538925171
, O 0 0.0060003530234098434
but O 0 0.004911311902105808
a O 0 0.013236315920948982
pathogenic O 1 0.6618094444274902
correlation O 0 0.1371382772922516
of O 0 0.010323780588805676
these O 0 0.03578275814652443
cardiospecific O 1 0.7433758974075317
mutations O 1 0.9480478763580322
in O 0 0.10594987124204636
DMD O 1 0.951685905456543
with O 0 0.02895832434296608
the O 0 0.024428145959973335
XLDCM B-Disease 1 0.7096636891365051
phenotype O 1 0.8879434466362
has O 0 0.012112942524254322
remained O 0 0.010670476593077183
to O 0 0.005891018081456423
be O 0 0.008350852876901627
elucidated O 0 0.23287808895111084
. O 0 0.028956042602658272

We O 0 0.01538910809904337
report O 0 0.010500628501176834
here O 0 0.005285297986119986
the O 0 0.003942010924220085
identification O 0 0.006815567146986723
of O 0 0.0038242184091359377
a O 0 0.005540535319596529
unique O 0 0.013826148584485054
de O 0 0.049429476261138916
novo O 0 0.23421819508075714
L1 O 0 0.48103365302085876
insertion O 0 0.2625328600406647
in O 0 0.010563842952251434
the O 0 0.016964063048362732
muscle O 1 0.8218942880630493
exon O 0 0.46386271715164185
1 O 0 0.0343305729329586
in O 0 0.036340225487947464
DMD O 1 0.9327104091644287
in O 0 0.02143619954586029
three O 0 0.031444001942873
XLDCM B-Disease 1 0.7277169823646545
patients O 1 0.8464335203170776
from O 0 0.015812305733561516
two O 0 0.01606914773583412
unrelated O 0 0.21836893260478973
Japanese O 0 0.031431663781404495
families O 0 0.08212114870548248
. O 0 0.04492015391588211

The O 0 0.023927370086312294
insertion O 0 0.059809524565935135
was O 0 0.010822675190865993
a O 0 0.010550055652856827
5 O 0 0.013849249109625816
- O 0 0.04865723103284836
truncated O 0 0.07035363465547562
form O 0 0.022157620638608932
of O 0 0.006922763306647539
human O 0 0.0776853933930397
L1 O 0 0.368589848279953
inversely O 0 0.09988249093294144
integrated O 0 0.018506929278373718
in O 0 0.0044869021512568
the O 0 0.004058052320033312
5 O 0 0.013829647563397884
- O 0 0.0669088214635849
untranslated O 0 0.22383920848369598
region O 0 0.017076246440410614
in O 0 0.005937777925282717
the O 0 0.008548444136977196
muscle O 1 0.654207170009613
exon O 0 0.2395963817834854
1 O 0 0.010036134161055088
, O 0 0.0046286811120808125
which O 0 0.0034812414087355137
affected O 0 0.03536142036318779
the O 0 0.004252494778484106
transcription O 0 0.16085141897201538
or O 0 0.005411438178271055
the O 0 0.002891360782086849
stability O 0 0.011515463702380657
of O 0 0.0032720696181058884
the O 0 0.0064599174074828625
muscle O 1 0.6359548568725586
form O 0 0.04286011680960655
of O 0 0.008200202137231827
dystrophin O 1 0.6456072926521301
transcripts O 0 0.031760428100824356
but O 0 0.003466825233772397
not O 0 0.002372884890064597
that O 0 0.002198144095018506
of O 0 0.002763253403827548
the O 0 0.009371260181069374
brain O 1 0.8885869979858398
or O 0 0.12215999513864517
Purkinje O 1 0.8989203572273254
cell O 1 0.587171733379364
form O 0 0.05924263224005699
, O 0 0.0053058951161801815
probably O 0 0.006853504106402397
due O 0 0.005641977768391371
to O 0 0.002492455067113042
its O 0 0.0033429197501391172
unique O 0 0.007364063989371061
site O 0 0.006353399716317654
of O 0 0.0057126497849822044
integration O 0 0.03962540626525879
. O 0 0.022499777376651764

We O 0 0.014523345045745373
speculate O 0 0.01760738343000412
that O 0 0.005248893052339554
this O 0 0.004593501333147287
insertion O 0 0.03383728116750717
of O 0 0.0050117396749556065
an O 0 0.008559580892324448
L1 O 0 0.35025373101234436
sequence O 0 0.10114884376525879
in O 0 0.02754804491996765
DMD O 1 0.9066116213798523
is O 0 0.0066124689765274525
responsible O 0 0.008465823717415333
for O 0 0.0028686162550002337
some O 0 0.002469507046043873
of O 0 0.002455308800563216
the O 0 0.002951237605884671
population O 0 0.012153511866927147
of O 0 0.0057399640791118145
Japanese O 0 0.041727449744939804
patients O 1 0.7777296900749207
with O 0 0.03554008901119232
XLDCM B-Disease 0 0.39237526059150696
. O 0 0.022271882742643356
. O 0 0.027256306260824203

Severe O 1 0.8770381212234497
early O 1 0.5230711698532104
- O 1 0.893351674079895
onset O 1 0.9695109128952026
obesity B-Disease 1 0.9693631529808044
, O 0 0.4668603837490082
adrenal B-Disease 1 0.9654282331466675
insufficiency I-Disease 1 0.9567990303039551
and O 0 0.12178947031497955
red O 1 0.6524330377578735
hair O 1 0.9343726634979248
pigmentation O 1 0.9692519307136536
caused O 1 0.8696032762527466
by O 0 0.3068438470363617
POMC O 1 0.9461376667022705
mutations O 1 0.9398857355117798
in O 0 0.08621744066476822
humans O 1 0.6199499368667603
. O 0 0.0689040869474411

Sequential O 0 0.09375029057264328
cleavage O 0 0.13597950339317322
of O 0 0.012537315487861633
the O 0 0.012921628542244434
precursor O 0 0.32240018248558044
protein O 0 0.3552124500274658
pre O 0 0.16209329664707184
- O 0 0.1682054102420807
pro O 0 0.09952893108129501
- O 0 0.3712753653526306
opiomelanocortin O 1 0.6268347501754761
( O 0 0.1804627627134323
POMC O 1 0.8736395835876465
) O 0 0.03955618292093277
generates O 0 0.06719551980495453
the O 0 0.01822756603360176
melanocortin O 1 0.7947961091995239
peptides O 1 0.7118948698043823
adrenocorticotrophin O 1 0.7025064826011658
( O 0 0.21358594298362732
ACTH O 1 0.8220028281211853
) O 0 0.07499784231185913
, O 0 0.036492910236120224
melanocyte O 1 0.8806965351104736
- O 1 0.5197515487670898
stimulating O 1 0.8424158692359924
hormones O 1 0.9296506643295288
( O 0 0.3704807460308075
MSH O 1 0.9222032427787781
) O 0 0.03729340806603432
alpha O 0 0.034604255110025406
, O 0 0.006765571888536215
beta O 0 0.0536646731197834
and O 0 0.00434747664257884
gamma O 0 0.039150990545749664
as O 0 0.00370353483594954
well O 0 0.003755099605768919
as O 0 0.004590585827827454
the O 0 0.015378275886178017
opioid O 1 0.8616892099380493
- O 1 0.5918614268302917
receptor O 1 0.9077099561691284
ligand O 1 0.7689037322998047
beta O 1 0.6723955869674683
- O 1 0.540297269821167
endorphin O 1 0.8576658368110657
. O 0 0.08641308546066284

While O 0 0.02265855297446251
a O 0 0.01624286361038685
few O 0 0.014757808297872543
cases O 0 0.10102708637714386
of O 0 0.030142182484269142
isolated O 1 0.8145734071731567
ACTH B-Disease 1 0.9660082459449768
deficiency I-Disease 1 0.9799389839172363
have O 0 0.034519780427217484
been O 0 0.02933330647647381
reported O 0 0.13677167892456055
( O 0 0.21897496283054352
OMIM O 1 0.933403491973877
201400 O 1 0.5142295956611633
) O 0 0.040309254080057144
, O 0 0.009529323317110538
an O 0 0.025629281997680664
inherited O 1 0.8771474361419678
POMC O 1 0.9348344802856445
defect O 1 0.7202275991439819
has O 0 0.00818848330527544
not O 0 0.004777588881552219
been O 0 0.005061532370746136
described O 0 0.011630055494606495
so O 0 0.008483863435685635
far O 0 0.014424975030124187
. O 0 0.02081623300909996

Recent O 0 0.04290396347641945
studies O 0 0.03293034806847572
in O 0 0.012600268237292767
animal O 0 0.03686916083097458
models O 0 0.024911800399422646
elucidated O 0 0.09306732565164566
a O 0 0.0075491382740437984
central O 0 0.007703043054789305
role O 0 0.00955108180642128
of O 0 0.005653955973684788
alpha O 0 0.07141069322824478
- O 0 0.17230862379074097
MSH O 1 0.6742938756942749
in O 0 0.006544183008372784
the O 0 0.005124390125274658
regulation O 0 0.027782272547483444
of O 0 0.00564227532595396
food O 0 0.035406824201345444
intake O 0 0.23028340935707092
by O 0 0.01998179964721203
activation O 0 0.3083788752555847
of O 0 0.010861857794225216
the O 0 0.04246101155877113
brain O 1 0.9542760848999023
melanocortin O 1 0.9158644676208496
- O 0 0.44633716344833374
4 O 0 0.14030097424983978
- O 1 0.5174951553344727
receptor O 1 0.8765236139297485
( O 0 0.26149073243141174
MC4 O 1 0.8798038959503174
- O 0 0.28640031814575195
R O 0 0.21319837868213654
; O 0 0.022556262090802193
refs O 0 0.05856313928961754
3 O 0 0.014189711771905422
- O 0 0.03521641343832016
5 O 0 0.009614666923880577
) O 0 0.0062379660084843636
and O 0 0.002734574256464839
the O 0 0.0033567347563803196
linkage O 0 0.11520186066627502
of O 0 0.009545405395328999
human O 0 0.28890925645828247
obesity B-Disease 1 0.9454063773155212
to O 0 0.017107408493757248
chromosome O 1 0.6409381628036499
2 O 0 0.009318254888057709
in O 0 0.004201340023428202
close O 0 0.0056283301673829556
proximity O 0 0.01473961304873228
to O 0 0.003794279182329774
the O 0 0.006968997418880463
POMC O 1 0.7237860560417175
locus O 0 0.32142603397369385
, O 0 0.0046754940412938595
led O 0 0.005127103999257088
to O 0 0.0025496752932667732
the O 0 0.0026245745830237865
proposal O 0 0.005873412359505892
of O 0 0.0033233151771128178
an O 0 0.005210347007960081
association O 0 0.022342057898640633
of O 0 0.01568020135164261
POMC O 1 0.8691945672035217
with O 0 0.10771217197179794
human O 1 0.6224208474159241
obesity B-Disease 1 0.9546836018562317
. O 0 0.1251251995563507

The O 0 0.020398307591676712
dual O 0 0.027454081922769547
role O 0 0.015502032823860645
of O 0 0.008891661651432514
alpha O 0 0.07983268052339554
- O 0 0.22673316299915314
MSH O 1 0.8109586238861084
in O 0 0.017990125343203545
regulating O 0 0.25915688276290894
food O 0 0.0995270311832428
intake O 0 0.3721199035644531
and O 0 0.027987031266093254
influencing O 1 0.5292931795120239
hair O 1 0.8487822413444519
pigmentation O 1 0.9482403993606567
predicts O 0 0.34944504499435425
that O 0 0.011366540566086769
the O 0 0.024769429117441177
phenotype O 1 0.9353718161582947
associated O 0 0.11811831593513489
with O 0 0.016241636127233505
a O 0 0.025582822039723396
defect O 1 0.7797744870185852
in O 0 0.0472605936229229
POMC O 1 0.8843021988868713
function O 0 0.16995647549629211
would O 0 0.019896788522601128
include O 0 0.16306735575199127
obesity B-Disease 1 0.9626742005348206
, O 0 0.05122928321361542
alteration O 1 0.6731724739074707
in O 0 0.11294139176607132
pigmentation O 1 0.9516286253929138
and O 0 0.21463192999362946
ACTH B-Disease 1 0.9526523351669312
deficiency I-Disease 1 0.9690384268760681
. O 0 0.1450817584991455

The O 0 0.020158518105745316
observation O 0 0.021611999720335007
of O 0 0.009746885858476162
these O 0 0.01235254667699337
symptoms O 1 0.7097343802452087
in O 0 0.006775406189262867
two O 0 0.00738862669095397
probands O 0 0.13584351539611816
prompted O 0 0.02774425409734249
us O 0 0.007122982759028673
to O 0 0.003953431732952595
search O 0 0.008669549599289894
for O 0 0.00892438180744648
mutations O 1 0.7290897369384766
within O 0 0.019750839099287987
their O 0 0.027569886296987534
POMC O 1 0.8882260918617249
genes O 1 0.8187699317932129
. O 0 0.06637809425592422

Patient O 0 0.31544193625450134
1 O 0 0.015288984403014183
was O 0 0.007372075226157904
found O 0 0.005850570742040873
to O 0 0.0033299587666988373
be O 0 0.00296055618673563
a O 0 0.0048835426568984985
compound O 0 0.02536436729133129
heterozygote O 0 0.29240551590919495
for O 0 0.006104898173362017
two O 0 0.013714461587369442
mutations O 1 0.8473538160324097
in O 0 0.021365802735090256
exon O 0 0.40495163202285767
3 O 0 0.04615670442581177
( O 0 0.0569034218788147
G7013T O 0 0.1878366768360138
, O 0 0.008372919633984566
C7133delta O 0 0.21747086942195892
) O 0 0.011118951253592968
which O 0 0.004399075172841549
interfere O 0 0.019096821546554565
with O 0 0.005613032728433609
appropriate O 0 0.01714131608605385
synthesis O 0 0.13329292833805084
of O 0 0.013608686625957489
ACTH O 1 0.7177053689956665
and O 0 0.017397839576005936
alpha O 0 0.2027493566274643
- O 0 0.41859835386276245
MSH O 1 0.8881474137306213
. O 0 0.08336175978183746

Patient O 0 0.48887062072753906
2 O 0 0.02533235214650631
was O 0 0.01348192896693945
homozygous O 0 0.26317086815834045
for O 0 0.009608961641788483
a O 0 0.018945492804050446
mutation O 1 0.7887481451034546
in O 0 0.021079961210489273
exon O 0 0.35861384868621826
2 O 0 0.033909957855939865
( O 0 0.062035951763391495
C3804A O 0 0.2590157091617584
) O 0 0.03322168067097664
which O 0 0.017587723210453987
abolishes O 1 0.5536287426948547
POMC O 1 0.8037545084953308
translation O 0 0.09864619374275208
. O 0 0.04196743294596672

These O 0 0.016473805531859398
findings O 0 0.01688668504357338
represent O 0 0.008000961504876614
the O 0 0.004701206926256418
first O 0 0.004180810879915953
examples O 0 0.007136414293199778
of O 0 0.005279382690787315
a O 0 0.03412500396370888
genetic B-Disease 1 0.9172057509422302
defect I-Disease 1 0.803564190864563
within O 0 0.02819562330842018
the O 0 0.0247394647449255
POMC O 1 0.9208284616470337
gene O 1 0.6736775636672974
and O 0 0.009890533052384853
define O 0 0.06934475153684616
a O 0 0.04510676860809326
new O 0 0.19555824995040894
monogenic B-Disease 1 0.9718823432922363
endocrine I-Disease 1 0.9841480255126953
disorder I-Disease 1 0.9860082268714905
resulting O 1 0.7869343757629395
in O 0 0.16298547387123108
early O 1 0.5102462768554688
- O 1 0.9303982257843018
onset O 1 0.9832901954650879
obesity B-Disease 1 0.9846928119659424
, O 0 0.4883176386356354
adrenal B-Disease 1 0.9758481979370117
insufficiency I-Disease 1 0.9586832523345947
and O 0 0.09932201355695724
red O 1 0.5603311061859131
hair O 1 0.9017926454544067
pigmentation O 1 0.9425226449966431
. O 0 0.06530667096376419
. O 0 0.05114825814962387

A O 0 0.040113598108291626
European O 0 0.04437442496418953
multicenter O 1 0.6085159182548523
study O 0 0.06816064566373825
of O 0 0.034120894968509674
phenylalanine B-Disease 1 0.8853738307952881
hydroxylase I-Disease 1 0.9398549795150757
deficiency I-Disease 1 0.974380373954773
: O 0 0.04506094008684158
classification O 0 0.12674611806869507
of O 0 0.009749602526426315
105 O 0 0.06407519429922104
mutations O 1 0.7482069134712219
and O 0 0.005531688220798969
a O 0 0.006648584268987179
general O 0 0.007332542445510626
system O 0 0.027068009600043297
for O 0 0.014934397302567959
genotype O 1 0.8159477114677429
- O 0 0.22509853541851044
based O 0 0.03806291148066521
prediction O 0 0.23345062136650085
of O 0 0.0688314363360405
metabolic O 1 0.9586009979248047
phenotype O 1 0.9416443109512329
. O 0 0.13634563982486725

Phenylketonuria B-Disease 1 0.9140796065330505
( O 0 0.49465295672416687
PKU B-Disease 1 0.9255778193473816
) O 0 0.08423447608947754
and O 0 0.031608957797288895
mild B-Disease 1 0.8265238404273987
hyperphenylalaninemia I-Disease 1 0.8680225610733032
( O 0 0.4526972472667694
MHP B-Disease 1 0.9429227709770203
) O 0 0.16773565113544464
are O 0 0.08056388795375824
allelic B-Disease 1 0.9529768228530884
disorders I-Disease 1 0.9839497208595276
caused O 1 0.7978073954582214
by O 0 0.10521796345710754
mutations O 1 0.9161180257797241
in O 0 0.027424298226833344
the O 0 0.03344583138823509
gene O 1 0.8829158544540405
encoding O 1 0.7074072957038879
phenylalanine O 1 0.8733554482460022
hydroxylase O 1 0.8936512470245361
( O 0 0.4222151041030884
PAH O 1 0.9149128198623657
) O 0 0.10507136583328247
. O 0 0.04080614820122719

Previous O 0 0.032940223813056946
studies O 0 0.026776878163218498
have O 0 0.007178910542279482
suggested O 0 0.01111669559031725
that O 0 0.005582630634307861
the O 0 0.008583554066717625
highly O 0 0.18223275244235992
variable O 1 0.7719492316246033
metabolic O 1 0.9682149887084961
phenotypes O 1 0.9631263613700867
of O 0 0.49467846751213074
PAH B-Disease 1 0.9790274500846863
deficiency I-Disease 1 0.9817290902137756
correlate O 1 0.8857050538063049
with O 0 0.3885561525821686
PAH O 1 0.9477155804634094
genotypes O 1 0.9063578844070435
. O 0 0.1655096560716629

We O 0 0.025399165228009224
identified O 0 0.0424310564994812
both O 0 0.03321094065904617
causative O 1 0.8786339163780212
mutations O 1 0.9327749013900757
in O 0 0.06479804217815399
686 O 1 0.7381151914596558
patients O 1 0.8362188339233398
from O 0 0.01683744415640831
seven O 0 0.018912136554718018
European O 0 0.049972761422395706
centers O 0 0.16344279050827026
. O 0 0.03925170376896858

On O 0 0.013052785769104958
the O 0 0.007338583469390869
basis O 0 0.006597885861992836
of O 0 0.0043295943178236485
the O 0 0.00561795337125659
phenotypic O 0 0.18774893879890442
characteristics O 0 0.06419507414102554
of O 0 0.01271964143961668
297 O 0 0.48641112446784973
functionally O 1 0.835868239402771
hemizygous O 1 0.7557728886604309
patients O 1 0.8248764276504517
, O 0 0.008976121433079243
105 O 0 0.009409712627530098
of O 0 0.003731959732249379
the O 0 0.004582545720040798
mutations O 0 0.4784088432788849
were O 0 0.0026185549795627594
assigned O 0 0.003504545660689473
to O 0 0.002236997475847602
one O 0 0.0026799733750522137
of O 0 0.0034563946537673473
four O 0 0.008155450224876404
arbitrary O 0 0.06939633935689926
phenotype O 1 0.886178731918335
categories O 0 0.16639338433742523
. O 0 0.055441826581954956

We O 0 0.013392584398388863
proposed O 0 0.014013109728693962
and O 0 0.005865585990250111
tested O 0 0.01735483482480049
a O 0 0.006099773105233908
simple O 0 0.01059502363204956
model O 0 0.012607106007635593
for O 0 0.006906405091285706
correlation O 0 0.13796210289001465
between O 0 0.03921986743807793
genotype O 1 0.7407718896865845
and O 0 0.025165313854813576
phenotypic O 1 0.5564568638801575
outcome O 0 0.14191259443759918
. O 0 0.04785109683871269

The O 0 0.032611291855573654
observed O 0 0.1350354105234146
phenotype O 1 0.769531786441803
matched O 0 0.07438648492097855
the O 0 0.010899807326495647
predicted O 0 0.10347459465265274
phenotype O 1 0.6925396919250488
in O 0 0.007438044063746929
79 O 0 0.017907867208123207
% O 0 0.0072000534273684025
of O 0 0.0026900863740593195
the O 0 0.003012886270880699
cases O 0 0.0239386186003685
, O 0 0.002349423011764884
and O 0 0.0016630784375593066
in O 0 0.0018685617251321673
only O 0 0.002228050259873271
5 O 0 0.0049211629666388035
of O 0 0.0039062313735485077
184 O 0 0.09623763710260391
patients O 1 0.6526455879211426
was O 0 0.004767971578985453
the O 0 0.004846039693802595
observed O 0 0.06632926315069199
phenotype O 1 0.5943700075149536
more O 0 0.0046575628221035
than O 0 0.004380726721137762
one O 0 0.0038611306808888912
category O 0 0.009637328796088696
away O 0 0.006070003379136324
from O 0 0.0064050559885799885
that O 0 0.0066086892038583755
expected O 0 0.015689048916101456
. O 0 0.02078896015882492

Among O 0 0.02149048075079918
the O 0 0.010702251456677914
seven O 0 0.010593793354928493
contributing O 0 0.027117574587464333
centers O 0 0.016450917348265648
, O 0 0.004218835849314928
the O 0 0.003405836410820484
proportion O 0 0.028332697227597237
of O 0 0.007439860142767429
patients O 1 0.5895041227340698
for O 0 0.0064892955124378204
whom O 0 0.01742604747414589
the O 0 0.006964735221117735
observed O 0 0.12678313255310059
phenotype O 1 0.7021486759185791
did O 0 0.005500586237758398
not O 0 0.0029391800053417683
match O 0 0.004440005868673325
the O 0 0.004777675028890371
predicted O 0 0.1093955785036087
phenotype O 1 0.7890615463256836
was O 0 0.006758189294487238
4 O 0 0.013235514052212238
% O 0 0.03369549289345741
- O 0 0.0731184184551239
23 O 0 0.024917112663388252
% O 0 0.06412143260240555
( O 0 0.08006545156240463
P O 0 0.32212013006210327
< O 0 0.42351752519607544
. O 0 0.018018318340182304
0001 O 0 0.4940481185913086
) O 0 0.008943329565227032
, O 0 0.0031332417856901884
suggesting O 0 0.008554374799132347
that O 0 0.0030008500907570124
differences O 0 0.010208336636424065
in O 0 0.004356777295470238
methods O 0 0.015170094557106495
used O 0 0.013566629029810429
for O 0 0.03465975448489189
mutation O 1 0.9508865475654602
detection O 1 0.6902025938034058
or O 0 0.19207735359668732
phenotype O 1 0.9433801770210266
classification O 0 0.2824803292751312
may O 0 0.022292612120509148
account O 0 0.008738016709685326
for O 0 0.004844322334975004
a O 0 0.0077027431689202785
considerable O 0 0.0242135189473629
proportion O 0 0.10267791152000427
of O 0 0.038205720484256744
genotype O 1 0.9182658195495605
- O 1 0.6835199594497681
phenotype O 1 0.9322865605354309
inconsistencies O 1 0.5551475286483765
. O 0 0.08671846985816956

Our O 0 0.02266182191669941
data O 0 0.01830332912504673
indicate O 0 0.018235649913549423
that O 0 0.00928665790706873
the O 0 0.026257354766130447
PAH O 1 0.949536144733429
- O 1 0.6864941120147705
mutation O 1 0.9416511654853821
genotype O 1 0.7577995657920837
is O 0 0.010880147106945515
the O 0 0.006843112874776125
main O 0 0.015276248566806316
determinant O 0 0.36170870065689087
of O 0 0.07163228839635849
metabolic O 1 0.9670180678367615
phenotype O 1 0.9622882008552551
in O 0 0.11889251321554184
most O 0 0.24975384771823883
patients O 1 0.9629676938056946
with O 1 0.5714870691299438
PAH B-Disease 1 0.9669537544250488
deficiency I-Disease 1 0.9703108668327332
. O 0 0.2234732061624527

In O 0 0.017286285758018494
the O 0 0.00851473305374384
present O 0 0.007846762426197529
study O 0 0.010632658377289772
, O 0 0.003954039420932531
the O 0 0.0042082821018993855
classification O 0 0.05875110998749733
of O 0 0.011433225125074387
105 O 0 0.17086318135261536
PAH O 1 0.9572075605392456
mutations O 1 0.9093250036239624
may O 0 0.04029573127627373
allow O 0 0.007814787328243256
the O 0 0.0043541197665035725
prediction O 0 0.029508056119084358
of O 0 0.00475503271445632
the O 0 0.008940743282437325
biochemical O 1 0.6442408561706543
phenotype O 1 0.8987267017364502
in O 0 0.020340485498309135
> O 0 0.2965972125530243
10 O 0 0.013362878933548927
, O 0 0.006793707609176636
000 O 0 0.04331168904900551
genotypes O 0 0.491446316242218
, O 0 0.004259737674146891
which O 0 0.002495126100257039
may O 0 0.004414002876728773
be O 0 0.002071344293653965
useful O 0 0.004422537516802549
for O 0 0.0027235744055360556
the O 0 0.003573446534574032
management O 0 0.024765444919466972
of O 0 0.0073474436067044735
hyperphenylalaninemia B-Disease 0 0.4447861313819885
in O 0 0.05683265998959541
newborns O 1 0.884503185749054
. O 0 0.07962693274021149

Somatic O 1 0.5685710310935974
instability O 0 0.1481490433216095
of O 0 0.01401942316442728
the O 0 0.01353992335498333
CTG O 0 0.41937455534935
repeat O 0 0.19543878734111786
in O 0 0.03456705063581467
mice O 1 0.8686121702194214
transgenic O 1 0.603538990020752
for O 0 0.03530965372920036
the O 0 0.10324352234601974
myotonic B-Disease 1 0.9755067825317383
dystrophy I-Disease 1 0.9781940579414368
region O 0 0.12136060744524002
is O 0 0.017553873360157013
age O 0 0.04961887001991272
dependent O 0 0.04718361049890518
but O 0 0.0052523426711559296
not O 0 0.004532339051365852
correlated O 0 0.07271730899810791
to O 0 0.0040413388051092625
the O 0 0.00669150659814477
relative O 0 0.08448701351881027
intertissue O 1 0.5351419448852539
transcription O 1 0.682380735874176
levels O 0 0.24033814668655396
and O 0 0.03966710343956947
proliferative O 1 0.9080864787101746
capacities O 0 0.24405518174171448
. O 0 0.05945861339569092

A O 0 0.047024618834257126
( O 0 0.051590073853731155
CTG O 0 0.2916000187397003
) O 0 0.020368563011288643
nexpansion O 0 0.04985058680176735
in O 0 0.00692002335563302
the O 0 0.005913358181715012
3 O 0 0.02059260569512844
- O 0 0.1188964694738388
untranslated O 0 0.43967607617378235
region O 0 0.0722605511546135
( O 0 0.07932224124670029
UTR O 0 0.4818894863128662
) O 0 0.019529283046722412
of O 0 0.006784519180655479
the O 0 0.03478803113102913
DM O 1 0.9587841033935547
protein O 1 0.9170349836349487
kinase O 1 0.9458356499671936
gene O 1 0.9230332970619202
( O 0 0.19968965649604797
DMPK O 1 0.5165360569953918
) O 0 0.034170255064964294
is O 0 0.012240951880812645
responsible O 0 0.07691258192062378
for O 0 0.08510057628154755
causing O 1 0.931722104549408
myotonic B-Disease 1 0.9791622161865234
dystrophy I-Disease 1 0.9816587567329407
( O 1 0.7319059371948242
DM B-Disease 1 0.9361622333526611
) O 0 0.1659640669822693
. O 0 0.04974045976996422

Major O 0 0.05520834028720856
instability O 0 0.17415988445281982
, O 0 0.008553451858460903
with O 0 0.006023924332112074
very O 0 0.005247981753200293
large O 0 0.0066830250434577465
expansions O 0 0.026605186983942986
between O 0 0.008104739710688591
generations O 0 0.03237379714846611
and O 0 0.004197794944047928
high O 0 0.012528132647275925
levels O 0 0.058885544538497925
of O 0 0.01632290706038475
somatic O 1 0.8450736403465271
mosaicism O 1 0.8684115409851074
, O 0 0.02112334780395031
is O 0 0.01485664863139391
observed O 0 0.08407536894083023
in O 0 0.043193522840738297
patients O 1 0.855751097202301
. O 0 0.059268198907375336

There O 0 0.015087174251675606
is O 0 0.008926304057240486
a O 0 0.0076604136265814304
good O 0 0.008275858126580715
correlation O 0 0.061424192041158676
between O 0 0.011721311137080193
repeat O 0 0.09762056171894073
size O 0 0.019360097125172615
( O 0 0.016780376434326172
at O 0 0.005024963524192572
least O 0 0.009824483655393124
in O 0 0.011722493916749954
leucocytes O 0 0.3680984079837799
) O 0 0.052092138677835464
, O 0 0.029924187809228897
clinical O 1 0.7207533121109009
severity O 1 0.5612888932228088
and O 0 0.010690690949559212
age O 0 0.07154413312673569
of O 0 0.03557982295751572
onset O 1 0.9250735640525818
. O 0 0.09927559643983841

The O 0 0.05231412127614021
trinucleotide O 1 0.802387535572052
repeat O 0 0.49884653091430664
instability O 1 0.609809398651123
mechanisms O 0 0.38589486479759216
involved O 0 0.06146388500928879
in O 0 0.03381803259253502
DM B-Disease 1 0.8952752947807312
and O 0 0.019038712605834007
other O 0 0.046145182102918625
human O 1 0.7127879858016968
genetic B-Disease 1 0.9759997129440308
diseases I-Disease 1 0.9767007231712341
are O 0 0.04748285934329033
unknown O 0 0.18314553797245026
. O 0 0.05226615071296692

We O 0 0.02559209242463112
studied O 0 0.03725774958729744
somatic O 0 0.33779624104499817
instability O 0 0.1641039252281189
by O 0 0.010033292695879936
measuring O 0 0.016776105388998985
the O 0 0.007216514088213444
CTG O 0 0.24491816759109497
repeat O 0 0.08486400544643402
length O 0 0.01661967858672142
at O 0 0.004858320578932762
several O 0 0.004524098243564367
ages O 0 0.026400359347462654
in O 0 0.004435588140040636
various O 0 0.007025137543678284
tissues O 0 0.3025333285331726
of O 0 0.010766751132905483
transgenic O 1 0.5630102753639221
mice O 1 0.7438011169433594
carrying O 0 0.02046114020049572
a O 0 0.023839442059397697
( O 0 0.07701011747121811
CTG O 0 0.4419173300266266
) O 0 0.02602255344390869
55expansion O 0 0.0947386845946312
surrounded O 0 0.013146649114787579
by O 0 0.005965930875390768
45 O 0 0.007865780964493752
kb O 0 0.027896398678421974
of O 0 0.004894238896667957
the O 0 0.006915257778018713
human O 0 0.14775873720645905
DM B-Disease 1 0.8575395345687866
region O 0 0.03156078979372978
, O 0 0.007592176087200642
using O 0 0.011507014743983746
small O 0 0.016817349940538406
- O 0 0.09491105377674103
pool O 0 0.13214747607707977
PCR O 1 0.5419096350669861
. O 0 0.04691708832979202

These O 0 0.02736550383269787
mice O 0 0.28115516901016235
have O 0 0.00927828997373581
been O 0 0.0065274727530777454
shown O 0 0.007113776635378599
to O 0 0.004559454042464495
reproduce O 0 0.09136880189180374
the O 0 0.0058638956397771835
intergenerational O 0 0.26652923226356506
and O 0 0.008769064210355282
somatic O 0 0.4836117923259735
instability O 0 0.17658957839012146
of O 0 0.004599492531269789
the O 0 0.005131520330905914
55 O 0 0.026513535529375076
CTG O 0 0.37058964371681213
repeat O 0 0.1316559612751007
suggesting O 0 0.03693879023194313
that O 0 0.004461284261196852
surrounding O 0 0.016629179939627647
sequences O 0 0.041153717786073685
and O 0 0.004199782386422157
the O 0 0.005093420390039682
chromatin O 0 0.2049197554588318
environment O 0 0.02452467940747738
are O 0 0.005946199409663677
involved O 0 0.021813564002513885
in O 0 0.016491370275616646
instability O 1 0.522053062915802
mechanisms O 0 0.4273902177810669
. O 0 0.04733198508620262

As O 0 0.01642058789730072
observed O 0 0.016738463193178177
in O 0 0.005369001999497414
some O 0 0.003848743624985218
of O 0 0.003333186963573098
the O 0 0.006947626359760761
tissues O 1 0.6672802567481995
of O 0 0.062096308916807175
DM B-Disease 1 0.9660273790359497
patients O 1 0.8901787996292114
, O 0 0.008289364166557789
there O 0 0.0038612389471381903
is O 0 0.0035167864989489317
a O 0 0.004626133479177952
tendency O 0 0.04084272310137749
for O 0 0.005456285085529089
repeat O 0 0.08586058765649796
length O 0 0.0439240001142025
and O 0 0.010445017367601395
somatic O 1 0.5907743573188782
mosaicism O 1 0.5486049056053162
to O 0 0.005417037755250931
increase O 0 0.010008608922362328
with O 0 0.004558774642646313
the O 0 0.0037886416539549828
age O 0 0.014966650865972042
of O 0 0.00571279926225543
the O 0 0.013538790866732597
mouse O 1 0.5179852247238159
. O 0 0.05017026141285896

Furthermore O 0 0.04113907739520073
, O 0 0.011346647515892982
we O 0 0.006479751318693161
observed O 0 0.013571311719715595
no O 0 0.006265928503125906
correlation O 0 0.06394188106060028
between O 0 0.012311776168644428
the O 0 0.02478942647576332
somatic O 1 0.9023534655570984
mutation O 1 0.9520767331123352
rate O 0 0.28838223218917847
and O 0 0.04736853763461113
tissue O 1 0.8974797129631042
proliferation O 1 0.5265993475914001
capacity O 0 0.04312838613986969
. O 0 0.03437209501862526

The O 0 0.038606300950050354
somatic O 1 0.7008060812950134
mutation O 1 0.7538876533508301
rates O 0 0.04288619011640549
in O 0 0.007541560102254152
different O 0 0.007440751884132624
tissues O 0 0.13150840997695923
were O 0 0.0027406744193285704
also O 0 0.002512946492061019
not O 0 0.0025999867357313633
correlated O 0 0.033868368715047836
to O 0 0.002387572778388858
the O 0 0.00354903656989336
relative O 0 0.037208788096904755
inter O 0 0.12868395447731018
- O 0 0.22908875346183777
tissue O 1 0.640976071357727
difference O 0 0.04476480931043625
in O 0 0.010858957655727863
transcriptional O 0 0.1732681393623352
levels O 0 0.023363210260868073
of O 0 0.003997150342911482
the O 0 0.004526847507804632
three O 0 0.017677951604127884
genes O 1 0.787950873374939
( O 0 0.1331298053264618
DMAHP O 0 0.4002586603164673
, O 0 0.012648651376366615
DMPK O 0 0.15409807860851288
and O 0 0.0062429276295006275
59 O 0 0.022095054388046265
) O 0 0.011403363198041916
surrounding O 0 0.01185771357268095
the O 0 0.006753441412001848
repeat O 0 0.08905729651451111
. O 0 0.016376879066228867
. O 0 0.02453925460577011

A O 0 0.07575248181819916
novel O 0 0.37263211607933044
missense O 1 0.8887723088264465
mutation O 1 0.9113796353340149
in O 0 0.06233657896518707
patients O 1 0.8084375858306885
from O 0 0.02261403389275074
a O 0 0.03961668163537979
retinoblastoma B-Disease 1 0.8694846630096436
pedigree O 0 0.3980644643306732
showing O 0 0.05239713191986084
only O 0 0.015843292698264122
mild O 1 0.5242456793785095
expression O 0 0.12907004356384277
of O 0 0.017534922808408737
the O 0 0.08870479464530945
tumor B-Disease 1 0.9654144644737244
phenotype O 1 0.946307361125946
. O 0 0.16730009019374847

We O 0 0.014935442246496677
have O 0 0.008760679513216019
used O 0 0.007828372530639172
single O 0 0.01325360406190157
strand O 0 0.14009876549243927
conformation O 0 0.15075762569904327
polymorphism O 0 0.20425021648406982
analysis O 0 0.012265716679394245
to O 0 0.0045077186077833176
study O 0 0.00782200787216425
the O 0 0.004484137985855341
27 O 0 0.01219726912677288
exons O 0 0.1305413544178009
of O 0 0.006491928361356258
the O 0 0.01635720580816269
RB1 O 1 0.8883970379829407
gene O 1 0.6260020732879639
in O 0 0.01003715768456459
individuals O 0 0.0309457890689373
from O 0 0.008207426406443119
a O 0 0.011169006116688251
family O 0 0.04237672686576843
showing O 0 0.05652862787246704
mild O 1 0.5681070685386658
expression O 0 0.12651105225086212
of O 0 0.016595419496297836
the O 0 0.0576230026781559
retinoblastoma B-Disease 1 0.9489829540252686
phenotype O 1 0.942631185054779
. O 0 0.13031944632530212

In O 0 0.024498427286744118
this O 0 0.013757755979895592
family O 0 0.05688735842704773
affected O 0 0.156637042760849
individuals O 0 0.12417066842317581
developed O 0 0.21552088856697083
unilateral B-Disease 0 0.3101957142353058
tumors I-Disease 1 0.9070655107498169
and O 0 0.005695755127817392
, O 0 0.003378923749551177
as O 0 0.0027952163945883512
a O 0 0.004420826677232981
result O 0 0.015951141715049744
of O 0 0.006421180907636881
linkage O 0 0.3013296127319336
analysis O 0 0.10169553011655807
, O 0 0.029542092233896255
unaffected O 1 0.6241847276687622
mutation O 1 0.903733491897583
carriers O 0 0.13962459564208984
were O 0 0.004635575693100691
also O 0 0.005940601695328951
identified O 0 0.015638317912817
within O 0 0.009543295949697495
the O 0 0.01113789901137352
pedigree O 0 0.3124002516269684
. O 0 0.04216973856091499

A O 0 0.027509750798344612
single O 0 0.019546503201127052
band O 0 0.01741468906402588
shift O 0 0.01812257245182991
using O 0 0.011284401640295982
SSCP O 0 0.08280613273382187
was O 0 0.007413659244775772
identified O 0 0.010791786946356297
in O 0 0.005804557353258133
exon O 0 0.10983384400606155
21 O 0 0.011042043566703796
which O 0 0.005025914404541254
resulted O 0 0.021254628896713257
in O 0 0.00585608696565032
a O 0 0.019749224185943604
missense O 1 0.8016337156295776
mutation O 1 0.8687012791633606
converting O 0 0.09706222265958786
a O 0 0.05851767212152481
cys O 1 0.8615156412124634
- O 0 0.4239651560783386
- O 0 0.39468473196029663
> O 1 0.5150470733642578
arg O 0 0.4285963475704193
at O 0 0.01249088253825903
nucleotide O 0 0.1329222470521927
position O 0 0.008542824536561966
28 O 0 0.011035910807549953
in O 0 0.007354301866143942
the O 0 0.010196499526500702
exon O 0 0.244483083486557
. O 0 0.033497560769319534

The O 0 0.04121799394488335
mutation O 1 0.6645888686180115
destroyed O 0 0.04317191243171692
an O 0 0.021603617817163467
NdeI O 0 0.3212929964065552
restriction O 0 0.13989019393920898
enzyme O 0 0.4310324490070343
site O 0 0.035776179283857346
. O 0 0.03096325881779194

Analysis O 0 0.02864566072821617
of O 0 0.00814275536686182
all O 0 0.005503850523382425
family O 0 0.009983353316783905
members O 0 0.005306197330355644
demonstrated O 0 0.010935099795460701
that O 0 0.004639745224267244
the O 0 0.011427809484302998
missense O 1 0.8488739728927612
mutation O 1 0.9531474709510803
co O 0 0.4521978199481964
- O 0 0.3317077159881592
segregated O 0 0.4288029074668884
with O 0 0.15396016836166382
patients O 1 0.9441673755645752
with O 0 0.1205253005027771
tumors B-Disease 1 0.960039496421814
or O 0 0.02536335401237011
who O 0 0.005251602735370398
, O 0 0.002903406275436282
as O 0 0.00243091257289052
a O 0 0.004160821437835693
result O 0 0.008660669438540936
of O 0 0.004145533312112093
linkage O 0 0.12109052389860153
analysis O 0 0.012090922333300114
had O 0 0.003966683987528086
been O 0 0.003646093886345625
predicted O 0 0.010787987150251865
to O 0 0.004182653035968542
carry O 0 0.011511534452438354
the O 0 0.021387863904237747
predisposing O 1 0.8907552361488342
mutation O 1 0.9205579161643982
. O 0 0.08704683184623718

These O 0 0.016070639714598656
observations O 0 0.013294789008796215
point O 0 0.0061768111772835255
to O 0 0.003635228145867586
another O 0 0.004411907866597176
region O 0 0.005054808687418699
of O 0 0.004162795376032591
the O 0 0.01203556451946497
RB1 O 1 0.888892650604248
gene O 1 0.7190713286399841
where O 0 0.015991438180208206
mutations O 1 0.6877453923225403
only O 0 0.004580820444971323
modify O 0 0.025362065061926842
the O 0 0.003376063657924533
function O 0 0.015661045908927917
of O 0 0.0030529145151376724
the O 0 0.005738002248108387
gene O 0 0.4174741804599762
and O 0 0.004783748183399439
raise O 0 0.02022663503885269
important O 0 0.0071077123284339905
questions O 0 0.01626991294324398
for O 0 0.015166313387453556
genetic O 1 0.8151829242706299
counseling O 0 0.3789263665676117
in O 0 0.008465873077511787
families O 0 0.02934076450765133
with O 0 0.009079531766474247
these O 0 0.01395374070852995
distinctive O 0 0.30034205317497253
phenotypes O 1 0.816230058670044
. O 0 0.037718869745731354
. O 0 0.038714196532964706

Maternal B-Disease 1 0.8367135524749756
disomy I-Disease 1 0.6250922679901123
and O 0 0.17072783410549164
Prader B-Disease 1 0.9360607862472534
- I-Disease 1 0.8869727849960327
Willi I-Disease 1 0.9482787251472473
syndrome I-Disease 1 0.9688066244125366
consistent O 0 0.20466738939285278
with O 0 0.0665978193283081
gamete O 1 0.7069951891899109
complementation O 1 0.6528320908546448
in O 0 0.01404558215290308
a O 0 0.01474735140800476
case O 0 0.029393214732408524
of O 0 0.025726784020662308
familial O 1 0.9402275681495667
translocation O 1 0.8114548325538635
( O 0 0.09764450043439865
3 O 0 0.03156692907214165
; O 0 0.02085966430604458
15 O 0 0.020581942051649094
) O 0 0.032567646354436874
( O 0 0.05886031687259674
p25 O 1 0.5664904117584229
; O 0 0.03225152567028999
q11 O 0 0.15226806700229645
. O 0 0.010219037532806396
2 O 0 0.015803774818778038
) O 0 0.02152949757874012
. O 0 0.019588220864534378

Maternal B-Disease 1 0.8649725317955017
uniparental I-Disease 1 0.8818833231925964
disomy I-Disease 1 0.7493025064468384
( I-Disease 0 0.2691391408443451
UPD I-Disease 1 0.8080694675445557
) I-Disease 0 0.03038041666150093
for I-Disease 0 0.011691256426274776
chromosome I-Disease 0 0.43375229835510254
15 I-Disease 0 0.008049314841628075
is O 0 0.004297501873224974
responsible O 0 0.005846542306244373
for O 0 0.002744837896898389
an O 0 0.0031575392931699753
estimated O 0 0.009593844413757324
30 O 0 0.007227926980704069
% O 0 0.016928907483816147
of O 0 0.008929895237088203
cases O 0 0.2672375440597534
of O 0 0.11071334779262543
Prader B-Disease 1 0.9714261889457703
- I-Disease 1 0.9528003931045532
Willi I-Disease 1 0.9763972759246826
syndrome I-Disease 1 0.9858444929122925
( O 1 0.7520236968994141
PWS B-Disease 1 0.928265392780304
) O 0 0.1796990931034088
. O 0 0.050537098199129105

We O 0 0.013694719411432743
report O 0 0.010337017476558685
on O 0 0.005063915625214577
an O 0 0.005103148054331541
unusual O 0 0.015660179778933525
case O 0 0.01193736307322979
of O 0 0.006966245826333761
maternal B-Disease 1 0.5185084939002991
disomy I-Disease 0 0.2817646265029907
15 I-Disease 0 0.019901517778635025
in O 0 0.012701737694442272
PWS B-Disease 1 0.699939489364624
that O 0 0.004277377855032682
is O 0 0.003624286502599716
most O 0 0.0035648660268634558
consistent O 0 0.010445662774145603
with O 0 0.004536996595561504
adjacent O 0 0.01850273087620735
- O 0 0.04536391422152519
1 O 0 0.012068950571119785
segregation O 0 0.07552662491798401
of O 0 0.005184696055948734
a O 0 0.02084258198738098
paternal O 1 0.5227336883544922
t O 1 0.5963290929794312
( O 0 0.07383985072374344
3 O 0 0.021677155047655106
; O 0 0.019528375938534737
15 O 0 0.013113653287291527
) O 0 0.022685976698994637
( O 0 0.04834262281656265
p25 O 1 0.5117830038070679
; O 0 0.027765721082687378
q11 O 0 0.10187995433807373
. O 0 0.005919918417930603
2 O 0 0.008368771523237228
) O 0 0.010428840294480324
with O 0 0.007943403907120228
simultaneous O 0 0.08564107120037079
maternal O 1 0.7829015851020813
meiotic O 1 0.8482202291488647
nondisjunction O 1 0.5293246507644653
for O 0 0.042965784668922424
chromosome O 1 0.7715433239936829
15 O 0 0.05134675279259682
. O 0 0.031458932906389236

The O 0 0.04959016665816307
patient O 1 0.7083808183670044
( O 0 0.1202705129981041
J O 0 0.4713244140148163
. O 0 0.012688422575592995
B O 0 0.0706123635172844
. O 0 0.004962848033756018
) O 0 0.005608289036899805
, O 0 0.002975626615807414
a O 0 0.003859966527670622
17 O 0 0.012033257633447647
- O 0 0.05082155019044876
year O 0 0.019319385290145874
- O 0 0.07829553633928299
old O 0 0.03174763172864914
white O 0 0.07090382277965546
male O 0 0.15091606974601746
with O 0 0.03138314187526703
PWS B-Disease 1 0.8367446064949036
, O 0 0.006678430363535881
was O 0 0.0034485773649066687
found O 0 0.0039052183274179697
to O 0 0.0025580599904060364
have O 0 0.003291485132649541
47 O 0 0.014454548247158527
chromosomes O 0 0.18293358385562897
with O 0 0.006905766669660807
a O 0 0.013642736710608006
supernumerary O 0 0.3586356043815613
, O 0 0.013164110481739044
paternal O 0 0.3367936909198761
der O 0 0.16185057163238525
( O 0 0.0205109603703022
15 O 0 0.006208575330674648
) O 0 0.005802416708320379
consisting O 0 0.003904528683051467
of O 0 0.002363309497013688
the O 0 0.0032083780970424414
short O 0 0.016475290060043335
arm O 0 0.051217544823884964
and O 0 0.005084844306111336
the O 0 0.009620031341910362
proximal O 1 0.7195292115211487
long O 0 0.12611237168312073
arm O 0 0.20804733037948608
of O 0 0.02381042391061783
chromosome O 1 0.8003548383712769
15 O 0 0.03882095217704773
, O 0 0.017179833725094795
and O 0 0.02573426626622677
distal O 1 0.9111660122871399
chromosome O 1 0.9191777110099792
arm O 1 0.5165018439292908
3p O 1 0.6386603116989136
. O 0 0.06666599214076996

The O 0 0.027834957465529442
t O 0 0.2970237731933594
( O 0 0.030145516619086266
3 O 0 0.011759818531572819
; O 0 0.008979401551187038
15 O 0 0.0055378032848238945
) O 0 0.003988488111644983
was O 0 0.0019620361272245646
present O 0 0.0026504225097596645
in O 0 0.002279906300827861
the O 0 0.002201750874519348
balanced O 0 0.010548725724220276
state O 0 0.003947610966861248
in O 0 0.004500919487327337
the O 0 0.010032495483756065
patients O 1 0.7554457187652588
father O 0 0.038392119109630585
and O 0 0.009232777170836926
a O 0 0.022286927327513695
sister O 0 0.09874067455530167
. O 0 0.03269803151488304

Fluorescent O 0 0.19696193933486938
in O 0 0.027543243020772934
situ O 0 0.2108791470527649
hybridization O 0 0.09891164302825928
analysis O 0 0.01966465264558792
demonstrated O 0 0.01618294045329094
that O 0 0.005909231025725603
the O 0 0.007466185372322798
PWS B-Disease 1 0.6846647262573242
critical O 0 0.032438602298498154
region O 0 0.014051929116249084
resided O 0 0.017289601266384125
on O 0 0.0037712515331804752
the O 0 0.005048088263720274
derivative O 0 0.14868324995040894
chromosome O 0 0.4731532633304596
3 O 0 0.007096865214407444
and O 0 0.002554845530539751
that O 0 0.0020643381867557764
there O 0 0.002044239081442356
was O 0 0.0024503329768776894
no O 0 0.003924353513866663
deletion O 0 0.06980490684509277
of O 0 0.003500009421259165
the O 0 0.0065582818351686
PWS B-Disease 1 0.6793606281280518
region O 0 0.01033733319491148
on O 0 0.0035029458813369274
the O 0 0.0038167103193700314
normal O 0 0.03453986719250679
pair O 0 0.016343124210834503
of O 0 0.006596370600163937
15s O 0 0.23087260127067566
present O 0 0.02850349433720112
in O 0 0.021049996837973595
J O 1 0.5472028255462646
. O 0 0.05566887930035591

B O 0 0.2639842629432678
. O 0 0.08105572313070297

Methylation O 0 0.21111127734184265
analysis O 0 0.03201855719089508
at O 0 0.015033955685794353
exon O 0 0.06186823546886444
alpha O 0 0.017365626990795135
of O 0 0.006035238038748503
the O 0 0.005939898081123829
small O 0 0.012727579101920128
nuclear O 0 0.04531555622816086
ribonucleoprotein O 1 0.718515157699585
- O 0 0.31491848826408386
associated O 0 0.21482589840888977
polypeptide O 1 0.6400855779647827
N O 0 0.25550344586372375
( O 0 0.1062820553779602
SNRPN O 0 0.47828492522239685
) O 0 0.0500984825193882
gene O 0 0.3449338972568512
showed O 0 0.011853505857288837
a O 0 0.007501064799726009
pattern O 0 0.06526116281747818
characteristic O 0 0.048036858439445496
of O 0 0.004077055025845766
only O 0 0.004590465221554041
the O 0 0.013649705797433853
maternal O 1 0.8079546689987183
chromosome O 1 0.8378803133964539
15 O 0 0.05022905394434929
in O 0 0.03143293038010597
J O 1 0.5177683234214783
. O 0 0.044458843767642975

B O 0 0.241716206073761
. O 0 0.0732528492808342

Maternal B-Disease 1 0.6135588884353638
disomy I-Disease 0 0.2331254780292511
was O 0 0.020193643867969513
confirmed O 0 0.03714907169342041
by O 0 0.017802737653255463
polymerase O 0 0.35815027356147766
chain O 0 0.13997608423233032
reaction O 0 0.07607951015233994
analysis O 0 0.022124649956822395
of O 0 0.008731567300856113
microsatellite O 1 0.5737835168838501
repeats O 0 0.12376493215560913
at O 0 0.009520092979073524
the O 0 0.012198292650282383
gamma O 0 0.45569297671318054
- O 0 0.41663944721221924
aminobutyric O 1 0.7516965270042419
acid O 1 0.8954302072525024
receptor O 1 0.9146706461906433
beta3 O 1 0.7910770773887634
subunit O 1 0.7141857147216797
( O 0 0.21785946190357208
GABRB3 O 1 0.6150767803192139
) O 0 0.10134735703468323
locus O 1 0.5997271537780762
. O 0 0.05379914864897728

A O 0 0.04706209525465965
niece O 0 0.2527274489402771
( O 0 0.05736662074923515
B O 0 0.07995378971099854
. O 0 0.008655155077576637
B O 0 0.03513139486312866
. O 0 0.004259700886905193
) O 0 0.005543320439755917
with O 0 0.003610677784308791
45 O 0 0.0064139715395867825
chromosomes O 0 0.0657581239938736
and O 0 0.002663136925548315
the O 0 0.0026698107831180096
derivative O 0 0.037130825221538544
3 O 0 0.005383620038628578
but O 0 0.002638195175677538
without O 0 0.0035614813677966595
the O 0 0.003630476538091898
der O 0 0.09662572294473648
( O 0 0.0269719697535038
15 O 0 0.012244492769241333
) O 0 0.014639497734606266
demonstrated O 0 0.030233271420001984
a O 0 0.015091299079358578
phenotype O 1 0.7171847224235535
consistent O 0 0.02280421182513237
with O 0 0.005406307987868786
that O 0 0.003933007828891277
reported O 0 0.016602307558059692
for O 0 0.00800544023513794
haploinsufficiency O 0 0.22387690842151642
of O 0 0.018026145175099373
distal O 1 0.7922661304473877
3 O 0 0.09577304124832153
p O 0 0.2777792811393738
. O 0 0.04434390366077423

Uniparental B-Disease 1 0.843133270740509
disomy I-Disease 1 0.5166575312614441
associated O 0 0.08137856423854828
with O 0 0.01964069902896881
unbalanced O 0 0.14101175963878632
segregation O 0 0.08595284074544907
of O 0 0.009976060129702091
non O 0 0.08330456167459488
- O 0 0.16932812333106995
Robertsonian O 0 0.3941042721271515
translocations O 1 0.5206166505813599
has O 0 0.007788204587996006
been O 0 0.004941025283187628
reported O 0 0.01024203933775425
previously O 0 0.004048865754157305
but O 0 0.002153297420591116
has O 0 0.0018722990062087774
not O 0 0.0014862550888210535
, O 0 0.0015493880491703749
to O 0 0.0014361473731696606
our O 0 0.0020818975754082203
knowledge O 0 0.004050933290272951
, O 0 0.002693458227440715
been O 0 0.002542270580306649
observed O 0 0.008990389294922352
in O 0 0.004222439136356115
a O 0 0.00719005661085248
case O 0 0.02172286994755268
of O 0 0.016418736428022385
PWS B-Disease 1 0.8524041175842285
. O 0 0.05859360098838806

Furthermore O 0 0.03924185782670975
, O 0 0.010731506161391735
our O 0 0.007607831619679928
findings O 0 0.01023632287979126
are O 0 0.004272620193660259
best O 0 0.005975388456135988
interpreted O 0 0.00914221815764904
as O 0 0.006674628704786301
true O 0 0.05577975511550903
gamete O 1 0.7938912510871887
complementation O 1 0.9046112895011902
resulting O 1 0.5226640701293945
in O 0 0.08693336695432663
maternal B-Disease 1 0.8698571920394897
UPD I-Disease 1 0.8889591693878174
15 I-Disease 0 0.10494734346866608
and O 0 0.06799305975437164
PWS B-Disease 1 0.8736997246742249

Schwartz B-Disease 1 0.7883875966072083
- I-Disease 1 0.7730523943901062
Jampel I-Disease 1 0.9023470282554626
syndrome I-Disease 1 0.9656214118003845
type I-Disease 0 0.343365341424942
2 I-Disease 0 0.043756384402513504
and O 0 0.03201578930020332
Stuve B-Disease 1 0.7828227281570435
- I-Disease 1 0.8261954188346863
Wiedemann I-Disease 1 0.9566812515258789
syndrome I-Disease 1 0.978803813457489
: O 0 0.028343264013528824
a O 0 0.009833958931267262
case O 0 0.01190319936722517
for O 0 0.006056732498109341
" O 0 0.010329346172511578
lumping O 0 0.11145182698965073
" O 0 0.016166161745786667
. O 0 0.022163528949022293

Recent O 0 0.03955623880028725
studies O 0 0.02587088756263256
demonstrated O 0 0.015586947090923786
the O 0 0.006011380814015865
existence O 0 0.008915579877793789
of O 0 0.004761178977787495
a O 0 0.00950203463435173
genetically O 0 0.3273521959781647
distinct O 0 0.10341332852840424
, O 0 0.009717658162117004
usually O 0 0.023611975833773613
lethal O 0 0.2357856184244156
form O 0 0.03671134635806084
of O 0 0.00986902043223381
the O 0 0.05044087767601013
Schwartz B-Disease 1 0.8352064490318298
- I-Disease 1 0.8801578283309937
Jampel I-Disease 1 0.96995609998703
syndrome I-Disease 1 0.990502119064331
( O 1 0.685804009437561
SJS B-Disease 1 0.9551900625228882
) O 0 0.09307987242937088
of O 0 0.032546792179346085
myotonia B-Disease 1 0.9531868100166321
and O 0 0.10528586059808731
skeletal B-Disease 1 0.9511905908584595
dysplasia I-Disease 1 0.9707632660865784
, O 0 0.015255223959684372
which O 0 0.007985690608620644
we O 0 0.0074248649179935455
called O 0 0.06870276480913162
SJS B-Disease 1 0.8974762558937073
type I-Disease 0 0.22153030335903168
2 I-Disease 0 0.0383174903690815
. O 0 0.032048165798187256

This O 0 0.05533529445528984
disorder O 1 0.8973239660263062
is O 0 0.015335704199969769
reminiscent O 0 0.0428658090531826
of O 0 0.008241388946771622
another O 0 0.029823051765561104
rare O 0 0.3390873968601227
condition O 0 0.37465330958366394
, O 0 0.01700490526854992
the O 0 0.03000352904200554
Stuve B-Disease 1 0.8899770975112915
- I-Disease 1 0.9022682309150696
Wiedemann I-Disease 1 0.9745705127716064
syndrome I-Disease 1 0.9882610440254211
( O 0 0.44179248809814453
SWS B-Disease 1 0.8831186294555664
) O 0 0.03050938807427883
, O 0 0.005477643106132746
which O 0 0.004501214250922203
comprises O 0 0.01401143055409193
campomelia B-Disease 0 0.21742399036884308
at O 0 0.02128984034061432
birth O 1 0.5549866557121277
with O 0 0.1964862048625946
skeletal B-Disease 1 0.9679374694824219
dysplasia I-Disease 1 0.9820288419723511
, O 0 0.08324684202671051
contractures B-Disease 1 0.8476004004478455
, O 0 0.014610367827117443
and O 0 0.007996190339326859
early B-Disease 0 0.024017445743083954
death I-Disease 0 0.13821688294410706
. O 0 0.03867384046316147

To O 0 0.015864258632063866
test O 0 0.014585786499083042
for O 0 0.007627761922776699
possible O 0 0.018231509253382683
nosologic O 0 0.19931408762931824
identity O 0 0.05300753191113472
between O 0 0.014081504195928574
these O 0 0.023108772933483124
disorders O 1 0.9167644381523132
, O 0 0.004197216592729092
we O 0 0.0020759098697453737
reviewed O 0 0.003728447249159217
the O 0 0.002267660805955529
literature O 0 0.00440716790035367
and O 0 0.002143053337931633
obtained O 0 0.0031529644038528204
a O 0 0.0029904567636549473
follow O 0 0.004430375527590513
- O 0 0.00999653059989214
up O 0 0.0025395958218723536
of O 0 0.001968897646293044
the O 0 0.0024701934307813644
only O 0 0.0027021924033761024
two O 0 0.007624452468007803
surviving O 0 0.250087708234787
patients O 1 0.7739773988723755
, O 0 0.009601314552128315
one O 0 0.009419652633368969
with O 0 0.04237094148993492
SJS B-Disease 1 0.9174762964248657
type I-Disease 0 0.12169414758682251
2 I-Disease 0 0.008242947980761528
at O 0 0.004446264356374741
age O 0 0.011929767206311226
10 O 0 0.004418585915118456
years O 0 0.004157742019742727
and O 0 0.0031211136374622583
another O 0 0.007479940075427294
with O 0 0.01405513845384121
SWS B-Disease 1 0.6327323317527771
at O 0 0.011614564806222916
age O 0 0.03577780723571777
7 O 0 0.023888273164629936
years O 0 0.02852029539644718
. O 0 0.025763193145394325

Patients O 1 0.8277909755706787
reported O 0 0.05349693447351456
as O 0 0.01685505546629429
having O 0 0.04298000410199165
either O 0 0.16702595353126526
neonatal O 1 0.9627448916435242
SJS B-Disease 1 0.9446262717247009
or O 0 0.13179944455623627
SWS B-Disease 1 0.721036970615387
presented O 0 0.017554227262735367
a O 0 0.013781657442450523
combination O 0 0.15252526104450226
of O 0 0.014796677976846695
a O 0 0.12693063914775848
severe O 1 0.9457061290740967
, O 0 0.41834720969200134
prenatal O 1 0.9809203147888184
- O 1 0.9681688547134399
onset O 1 0.9896718263626099
neuromuscular B-Disease 1 0.9901430606842041
disorder I-Disease 1 0.9903185367584229
( O 1 0.8016169667243958
with O 1 0.6990344524383545
congenital B-Disease 1 0.9896621704101562
joint I-Disease 1 0.8878803253173828
contractures I-Disease 1 0.9727875590324402
, O 0 0.37683096528053284
respiratory O 1 0.9783242344856262
and O 0 0.04788739234209061
feeding O 1 0.5220789313316345
difficulties O 0 0.25991567969322205
, O 0 0.017550554126501083
tendency O 0 0.24425500631332397
to O 0 0.01680898107588291
hyperthermia B-Disease 1 0.8644853830337524
, O 0 0.010089963674545288
and O 0 0.006639168597757816
frequent O 0 0.13487526774406433
death O 0 0.1017691120505333
in O 0 0.02159557119011879
infancy O 1 0.5594608187675476
) O 0 0.020945392549037933
with O 0 0.009629658423364162
a O 0 0.023176036775112152
distinct O 0 0.3470187485218048
campomelic B-Disease 1 0.7935388684272766
- I-Disease 1 0.7441557049751282
metaphyseal I-Disease 1 0.9137267470359802
skeletal I-Disease 1 0.9582623839378357
dysplasia I-Disease 1 0.9592806696891785
. O 0 0.16120246052742004

The O 0 0.017049400135874748
similarity O 0 0.02538502775132656
of O 0 0.007274284027516842
the O 0 0.007688971236348152
clinical O 0 0.3245691955089569
and O 0 0.006907700095325708
radiographic O 0 0.3281380236148834
findings O 0 0.03572305291891098
is O 0 0.005273273680359125
so O 0 0.004718633834272623
extensive O 0 0.016136934980750084
that O 0 0.005198149010539055
these O 0 0.024787137284874916
disorders O 1 0.9434260129928589
appear O 0 0.02065904624760151
to O 0 0.0038230852223932743
be O 0 0.0037444564513862133
a O 0 0.00736444815993309
single O 0 0.02024128846824169
entity O 0 0.09567538648843765
. O 0 0.029469048604369164

The O 0 0.017780756577849388
follow O 0 0.017392996698617935
- O 0 0.01762697659432888
up O 0 0.005707790609449148
observation O 0 0.007586877793073654
of O 0 0.002938849851489067
an O 0 0.0035493862815201283
identical O 0 0.01553792878985405
and O 0 0.004062438849359751
unique O 0 0.022906173020601273
pattern O 0 0.1841447502374649
of O 0 0.027649296447634697
progressive O 1 0.8476100564002991
bone B-Disease 1 0.9794495105743408
dysplasia I-Disease 1 0.9749531149864197
in O 0 0.018868980929255486
the O 0 0.009428816847503185
two O 0 0.031797319650650024
patients O 1 0.910802960395813
( O 0 0.07073614001274109
one O 0 0.012785348109900951
with O 0 0.05840470269322395
SJS B-Disease 1 0.9402673244476318
type I-Disease 0 0.1610570102930069
2 I-Disease 0 0.010222780518233776
, O 0 0.004372687544673681
one O 0 0.0046186563558876514
with O 0 0.015717322006821632
SWS B-Disease 1 0.764090359210968
) O 0 0.041710346937179565
surviving O 0 0.07261594384908676
beyond O 0 0.022088412195444107
infancy O 0 0.2587611973285675
adds O 0 0.021683914586901665
to O 0 0.002782844239845872
the O 0 0.0028998784255236387
evidence O 0 0.00518328882753849
in O 0 0.0040132272988557816
favor O 0 0.00816011056303978
of O 0 0.007197132334113121
identity O 0 0.06820932775735855
. O 0 0.030733587220311165

The O 0 0.03135678172111511
hypothesis O 0 0.14746317267417908
that O 0 0.02181583270430565
SWS B-Disease 1 0.7590373158454895
and O 0 0.03621281683444977
SJS B-Disease 1 0.8887413144111633
type I-Disease 0 0.08206402510404587
2 I-Disease 0 0.007938242517411709
are O 0 0.0036541116423904896
the O 0 0.004524067509919405
same O 0 0.030911358073353767
disorder O 1 0.916351318359375
should O 0 0.007855260744690895
be O 0 0.004506479948759079
testable O 0 0.07145781815052032
by O 0 0.012202137149870396
molecular O 0 0.23039324581623077
methods O 0 0.04024280235171318
. O 0 0.015795549377799034
. O 0 0.019090628251433372

A O 0 0.07071506232023239
mouse O 1 0.5130325555801392
model O 0 0.1568928211927414
of O 0 0.15722766518592834
severe O 1 0.9594884514808655
von B-Disease 1 0.9629326462745667
Willebrand I-Disease 1 0.9832700490951538
disease I-Disease 1 0.9852795600891113
: O 1 0.5179491639137268
defects O 1 0.9547550678253174
in O 0 0.22336611151695251
hemostasis O 1 0.9397401213645935
and O 0 0.21827413141727448
thrombosis B-Disease 1 0.9479560256004333
. O 0 0.13506783545017242

von B-Disease 1 0.8341574668884277
Willebrand I-Disease 1 0.9211664795875549
factor I-Disease 1 0.8478001952171326
( I-Disease 1 0.6965252757072449
vWf I-Disease 1 0.936195433139801
) I-Disease 1 0.871835470199585
deficiency I-Disease 1 0.9836628437042236
causes O 1 0.9682184457778931
severe O 1 0.9700656533241272
von B-Disease 1 0.962936282157898
Willebrand I-Disease 1 0.9769020676612854
disease I-Disease 1 0.9779152870178223
in O 0 0.23234058916568756
humans O 1 0.7345714569091797
. O 0 0.10203980654478073

We O 0 0.016749735921621323
generated O 0 0.021723955869674683
a O 0 0.014005166478455067
mouse O 0 0.2597057819366455
model O 0 0.025694172829389572
for O 0 0.009854135103523731
this O 0 0.021993430331349373
disease O 1 0.9414146542549133
by O 0 0.01856238767504692
using O 0 0.05328729748725891
gene O 1 0.7311520576477051
targeting O 0 0.17843766510486603
. O 0 0.04205544292926788

vWf B-Disease 1 0.868883490562439
- I-Disease 1 0.6795374155044556
deficient I-Disease 1 0.8730274438858032
mice O 1 0.785690426826477
appeared O 0 0.035206615924835205
normal O 0 0.05882083997130394
at O 0 0.0119272256270051
birth O 0 0.16243474185466766
; O 0 0.009445601142942905
they O 0 0.003471332136541605
were O 0 0.004200059920549393
viable O 0 0.03974829241633415
and O 0 0.010354544967412949
fertile O 0 0.2172214686870575
. O 0 0.03385487198829651

Neither O 0 0.1775420904159546
vWf O 1 0.7914344072341919
nor O 0 0.29732832312583923
vWf O 1 0.848616898059845
propolypeptide O 1 0.743468165397644
( O 0 0.4698096811771393
von B-Disease 1 0.8678373694419861
Willebrand I-Disease 1 0.9626843333244324
antigen O 1 0.9347622394561768
II O 0 0.23567821085453033
) O 0 0.0263131782412529
were O 0 0.007112455554306507
detectable O 0 0.3318880796432495
in O 0 0.01916361041367054
plasma O 0 0.41665148735046387
, O 0 0.03719111904501915
platelets O 1 0.8248278498649597
, O 0 0.03165527433156967
or O 0 0.10291946679353714
endothelial O 1 0.9021362662315369
cells O 1 0.6476860046386719
of O 0 0.015462580136954784
the O 0 0.029626885429024696
homozygous O 1 0.8594076633453369
mutant O 1 0.8602896928787231
mice O 1 0.9149802923202515
. O 0 0.10939107835292816

The O 0 0.04835357889533043
mutant O 1 0.7648809552192688
mice O 1 0.9147009253501892
exhibited O 0 0.42852914333343506
defects O 1 0.900886058807373
in O 0 0.05045023187994957
hemostasis O 1 0.801138699054718
with O 0 0.02466936968266964
a O 0 0.033539630472660065
highly O 0 0.23804102838039398
prolonged O 1 0.840437650680542
bleeding O 1 0.9004719853401184
time O 0 0.01807139627635479
and O 0 0.018498433753848076
spontaneous O 1 0.5468418002128601
bleeding O 1 0.8089208602905273
events O 0 0.023573383688926697
in O 0 0.00992606207728386
approximately O 0 0.014494191855192184
10 O 0 0.011986986733973026
% O 0 0.022129962220788002
of O 0 0.014304929412901402
neonates O 1 0.7068026661872864
. O 0 0.054346222430467606

As O 0 0.01935829222202301
in O 0 0.012030825950205326
the O 0 0.012310377322137356
human O 0 0.2564237117767334
disease O 1 0.9513558745384216
, O 0 0.009198376908898354
the O 0 0.0062674907967448235
factor O 0 0.11302348971366882
VIII O 0 0.16856811940670013
level O 0 0.009789625182747841
in O 0 0.005963776260614395
these O 0 0.007534779142588377
mice O 0 0.47952237725257874
was O 0 0.0049148439429700375
reduced O 0 0.01439598947763443
strongly O 0 0.005190559662878513
as O 0 0.0023877599742263556
a O 0 0.003724733367562294
result O 0 0.00789936538785696
of O 0 0.0023152418434619904
the O 0 0.003149507800117135
lack O 0 0.011547792702913284
of O 0 0.004719517659395933
protection O 0 0.03401638939976692
provided O 0 0.014596836641430855
by O 0 0.022309333086013794
vWf O 1 0.6492001414299011
. O 0 0.04031400382518768

Defective O 1 0.8799884915351868
thrombosis B-Disease 1 0.9213609099388123
in O 0 0.05908611789345741
mutant O 1 0.6829431056976318
mice O 1 0.7186959981918335
was O 0 0.00998569093644619
also O 0 0.006561537738889456
evident O 0 0.01622173935174942
in O 0 0.005380556918680668
an O 0 0.005615029018372297
in O 0 0.011147734709084034
vivo O 0 0.45888322591781616
model O 0 0.12266462296247482
of O 0 0.08824916183948517
vascular B-Disease 1 0.9665626883506775
injury I-Disease 1 0.8795564770698547
. O 0 0.11344657838344574

In O 0 0.016208795830607414
this O 0 0.008663030341267586
model O 0 0.011131204664707184
, O 0 0.00634799525141716
the O 0 0.0067426287569105625
exteriorized O 0 0.18914124369621277
mesentery O 0 0.43324533104896545
was O 0 0.012201527133584023
superfused O 0 0.1733962595462799
with O 0 0.02043183520436287
ferric O 1 0.6438568234443665
chloride O 0 0.368344783782959
and O 0 0.007390620186924934
the O 0 0.008069190196692944
accumulation O 0 0.21080462634563446
of O 0 0.0158060435205698
fluorescently O 1 0.6489552855491638
labeled O 0 0.4061824083328247
platelets O 1 0.8224802017211914
was O 0 0.01724245399236679
observed O 0 0.07250446081161499
by O 0 0.02742423675954342
intravital O 0 0.36693644523620605
microscopy O 0 0.34265851974487305
. O 0 0.04714104160666466

We O 0 0.018300112336874008
conclude O 0 0.026044460013508797
that O 0 0.008070484735071659
these O 0 0.013524970039725304
mice O 1 0.7831878662109375
very O 0 0.08069802820682526
closely O 0 0.31866466999053955
mimic O 1 0.940981924533844
severe O 1 0.9679677486419678
human O 1 0.8974567651748657
von B-Disease 1 0.9682537913322449
Willebrand I-Disease 1 0.9846550226211548
disease I-Disease 1 0.9725844264030457
and O 0 0.008348534815013409
will O 0 0.0033744436223059893
be O 0 0.002276840852573514
very O 0 0.0032423201482743025
useful O 0 0.005249822046607733
for O 0 0.0025617426726967096
investigating O 0 0.006762736011296511
the O 0 0.002930163871496916
role O 0 0.011362040415406227
of O 0 0.00795229896903038
vWf O 1 0.6456083655357361
in O 0 0.0189823005348444
normal O 0 0.22535540163516998
physiology O 1 0.5833281874656677
and O 0 0.03002108447253704
in O 0 0.0948609709739685
disease O 1 0.9684599041938782
models O 0 0.12823741137981415
. O 0 0.03876902163028717
. O 0 0.03592950478196144

Oral O 0 0.46089398860931396
contraceptives O 0 0.39730772376060486
and O 0 0.024233320727944374
the O 0 0.02727501466870308
risk O 1 0.7627165913581848
of O 0 0.18686296045780182
hereditary B-Disease 1 0.9612176418304443
ovarian I-Disease 1 0.9823682904243469
cancer I-Disease 1 0.9697859883308411
. O 0 0.2414204627275467

Hereditary B-Disease 1 0.9426942467689514
Ovarian I-Disease 1 0.9682906866073608
Cancer I-Disease 1 0.9649606943130493
Clinical O 1 0.8978582620620728
Study O 0 0.2581383287906647
Group O 0 0.09297531843185425
. O 0 0.044282663613557816

BACKGROUND O 0 0.07001790404319763
Women O 0 0.05027315020561218
with O 0 0.026802046224474907
mutations O 1 0.6839171648025513
in O 0 0.010470260865986347
either O 0 0.014796881005167961
the O 0 0.014400266110897064
BRCA1 O 1 0.9270271062850952
or O 0 0.05078338831663132
the O 0 0.04315407946705818
BRCA2 O 1 0.9633888006210327
gene O 1 0.734261691570282
have O 0 0.011770246550440788
a O 0 0.02449537254869938
high O 0 0.12277358770370483
lifetime O 1 0.7136006355285645
risk O 1 0.9267392158508301
of O 0 0.41554373502731323
ovarian B-Disease 1 0.9851952195167542
cancer I-Disease 1 0.973914384841919
. O 0 0.29322537779808044

Oral O 1 0.7453217506408691
contraceptives O 1 0.8028975129127502
protect O 0 0.4007847011089325
against O 0 0.4447905719280243
ovarian B-Disease 1 0.9839773774147034
cancer I-Disease 1 0.9670999050140381
in O 0 0.017085647210478783
general O 0 0.007579701021313667
, O 0 0.003760546213015914
but O 0 0.0027367130387574434
it O 0 0.0020892105530947447
is O 0 0.0021953408140689135
not O 0 0.0020178277045488358
known O 0 0.003952032420784235
whether O 0 0.003284905571490526
they O 0 0.0024727266281843185
also O 0 0.0037700438406318426
protect O 0 0.03176422417163849
against O 0 0.0269782654941082
hereditary B-Disease 1 0.7899491786956787
forms I-Disease 0 0.38919326663017273
of I-Disease 0 0.3182035982608795
ovarian I-Disease 1 0.9863815307617188
cancer I-Disease 1 0.9752045273780823
. O 0 0.30126315355300903

METHODS O 0 0.04749493673443794
We O 0 0.016618672758340836
enrolled O 0 0.0909162238240242
207 O 0 0.28151053190231323
women O 0 0.25957900285720825
with O 0 0.35746046900749207
hereditary B-Disease 1 0.9768335819244385
ovarian I-Disease 1 0.989003598690033
cancer I-Disease 1 0.9710006713867188
and O 0 0.01175050251185894
161 O 0 0.02662949450314045
of O 0 0.004492179024964571
their O 0 0.00487062893807888
sisters O 0 0.026873432099819183
as O 0 0.0049487510696053505
controls O 0 0.014957662671804428
in O 0 0.006165032275021076
a O 0 0.009786251001060009
case O 0 0.03276177868247032
- O 0 0.09069450199604034
control O 0 0.0595838837325573
study O 0 0.0744699239730835
. O 0 0.032183095812797546

All O 0 0.019625788554549217
the O 0 0.01661437191069126
patients O 1 0.5609698295593262
carried O 0 0.02384338155388832
a O 0 0.0612298846244812
pathogenic O 1 0.931525707244873
mutation O 1 0.9346328377723694
in O 0 0.0558369904756546
either O 0 0.21273423731327057
BRCA1 O 1 0.9575116038322449
( O 0 0.1410028040409088
179 O 0 0.1446632593870163
women O 0 0.1251036375761032
) O 0 0.07835253328084946
or O 0 0.12732596695423126
BRCA2 O 1 0.944100558757782
( O 0 0.11077792197465897
28 O 0 0.04248299449682236
women O 0 0.08778959512710571
) O 0 0.053972210735082626
. O 0 0.030830632895231247

The O 0 0.019143546000123024
control O 0 0.021278219297528267
women O 0 0.011047950014472008
were O 0 0.0048563070595264435
enrolled O 0 0.012862706556916237
regardless O 0 0.007418377324938774
of O 0 0.0035082644317299128
whether O 0 0.004687131382524967
or O 0 0.00522196339443326
not O 0 0.0031689510215073824
they O 0 0.003917773719877005
had O 0 0.007891006767749786
either O 0 0.04035019502043724
mutation O 1 0.8349931836128235
. O 0 0.05631259083747864

Lifetime O 0 0.1835782825946808
histories O 0 0.12856526672840118
of O 0 0.014944992028176785
oral O 0 0.2692122161388397
- O 0 0.140793576836586
contraceptive O 0 0.4510608911514282
use O 0 0.007586648687720299
were O 0 0.00423322943970561
obtained O 0 0.005788796581327915
by O 0 0.003976218868046999
interview O 0 0.006710607558488846
or O 0 0.00454154796898365
by O 0 0.0036088991910219193
written O 0 0.004620224237442017
questionnaire O 0 0.016405893489718437
and O 0 0.0027580023743212223
were O 0 0.0025978274643421173
compared O 0 0.027271782979369164
between O 0 0.044129565358161926
patients O 1 0.7512663006782532
and O 0 0.0052517917938530445
control O 0 0.028535423800349236
women O 0 0.027723338454961777
, O 0 0.004848613403737545
after O 0 0.007296302821487188
adjustment O 0 0.030000114813447
for O 0 0.00400911457836628
year O 0 0.005552923306822777
of O 0 0.005343157332390547
birth O 0 0.1307167112827301
and O 0 0.012202979996800423
parity O 0 0.17336466908454895
. O 0 0.033746737986803055

RESULTS O 0 0.04707374796271324
The O 0 0.017968596890568733
adjusted O 0 0.09098310768604279
odds O 0 0.33458712697029114
ratio O 1 0.5388461351394653
for O 0 0.36012354493141174
ovarian B-Disease 1 0.9898421168327332
cancer I-Disease 1 0.9836465716362
associated O 0 0.1541067510843277
with O 0 0.008013305254280567
any O 0 0.005575318355113268
past O 0 0.006905450019985437
use O 0 0.0083849485963583
of O 0 0.007568650878965855
oral O 0 0.36234426498413086
contraceptives O 0 0.45468246936798096
was O 0 0.015726692974567413
0 O 0 0.06303456425666809
. O 0 0.031082995235919952

5 O 0 0.0370488204061985
( O 0 0.021446440368890762
95 O 0 0.012961860746145248
percent O 0 0.009731976315379143
confidence O 0 0.010737096890807152
interval O 0 0.016240829601883888
, O 0 0.004402341786772013
0 O 0 0.008230775594711304
. O 0 0.0038989337626844645
3 O 0 0.004869434051215649
to O 0 0.0032619547564536333
0 O 0 0.010127419605851173
. O 0 0.006146410945802927
8 O 0 0.011694865301251411
) O 0 0.017310230061411858
. O 0 0.015432092361152172

The O 0 0.02808394841849804
risk O 0 0.31676071882247925
decreased O 0 0.09888041764497757
with O 0 0.009976804256439209
increasing O 0 0.018179254606366158
duration O 0 0.024607406929135323
of O 0 0.0045983619056642056
use O 0 0.008417513221502304
( O 0 0.020930631086230278
P O 0 0.05654806271195412
for O 0 0.0049230968579649925
trend O 0 0.039771050214767456
, O 0 0.007186258677393198
< O 0 0.18042010068893433
0 O 0 0.017345136031508446
. O 0 0.00542211951687932
001 O 0 0.07181903719902039
) O 0 0.008289230056107044
; O 0 0.004214507527649403
use O 0 0.002586185233667493
for O 0 0.0018702885136008263
six O 0 0.0027823669370263815
or O 0 0.0034290889743715525
more O 0 0.0023904116824269295
years O 0 0.003895921865478158
was O 0 0.003106616670265794
associated O 0 0.008713862858712673
with O 0 0.0033480117563158274
a O 0 0.005708945915102959
60 O 0 0.01402010302990675
percent O 0 0.04385878145694733
reduction O 0 0.20588979125022888
in O 0 0.03430730849504471
risk O 1 0.6058375835418701
. O 0 0.04406164959073067

Oral O 1 0.6804641485214233
- O 0 0.435397744178772
contraceptive O 1 0.8063977956771851
use O 0 0.061893854290246964
protected O 0 0.23257888853549957
against O 0 0.34258583188056946
ovarian B-Disease 1 0.9858978986740112
cancer I-Disease 1 0.9711101651191711
both O 0 0.02347131259739399
for O 0 0.014549164101481438
carriers O 0 0.15450748801231384
of O 0 0.010074833407998085
the O 0 0.054161436855793
BRCA1 O 1 0.9747155904769897
mutation O 1 0.9489896297454834
( O 0 0.11401303112506866
odds O 0 0.12721171975135803
ratio O 0 0.07437341660261154
, O 0 0.00663726357743144
0 O 0 0.012494634836912155
. O 0 0.004063625354319811
5 O 0 0.006100146099925041
; O 0 0.005270733498036861
95 O 0 0.005744363181293011
percent O 0 0.007450191769748926
confidence O 0 0.009199585765600204
interval O 0 0.02347131259739399
, O 0 0.0037259384989738464
0 O 0 0.006419638637453318
. O 0 0.0027224216610193253
3 O 0 0.0033925871830433607
to O 0 0.0022578504867851734
0 O 0 0.005491640884429216
. O 0 0.0028679806273430586
9 O 0 0.004114559851586819
) O 0 0.003963566850870848
and O 0 0.0022239433601498604
for O 0 0.0027994143310934305
carriers O 0 0.04263872280716896
of O 0 0.005442267749458551
the O 0 0.03665054589509964
BRCA2 O 1 0.9732786417007446
mutation O 1 0.9477126002311707
( O 0 0.0974661111831665
odds O 0 0.13487817347049713
ratio O 0 0.08847048878669739
, O 0 0.0062274811789393425
0 O 0 0.011986144818365574
. O 0 0.004146101884543896
4 O 0 0.005572466645389795
; O 0 0.005259844474494457
95 O 0 0.0054388828575611115
percent O 0 0.007748648524284363
confidence O 0 0.0076602790504693985
interval O 0 0.023285405710339546
, O 0 0.0034378194250166416
0 O 0 0.006870473735034466
. O 0 0.003231094451621175
2 O 0 0.003825936932116747
to O 0 0.002976119052618742
1 O 0 0.005570999812334776
. O 0 0.0052280849777162075
1 O 0 0.009983193129301071
) O 0 0.01848536543548107
. O 0 0.016645561903715134

CONCLUSIONS O 0 0.14693361520767212
Oral O 0 0.427144318819046
- O 0 0.21504627168178558
contraceptive O 1 0.6496299505233765
use O 0 0.03188832476735115
may O 0 0.05842414125800133
reduce O 0 0.16561175882816315
the O 0 0.038715749979019165
risk O 1 0.8605794310569763
of O 0 0.3153027296066284
ovarian B-Disease 1 0.9907754063606262
cancer I-Disease 1 0.9847391843795776
in O 0 0.09482543915510178
women O 0 0.3034544289112091
with O 0 0.21730712056159973
pathogenic O 1 0.9600813388824463
mutations O 1 0.9531673789024353
in O 0 0.08108232170343399
the O 0 0.12513695657253265
BRCA1 O 1 0.962383508682251
or O 1 0.640127956867218
BRCA2 O 1 0.9536147117614746
gene O 1 0.9131772518157959

A O 0 0.03561444208025932
Japanese O 0 0.02555261179804802
family O 0 0.041417960077524185
with O 0 0.021621717140078545
adrenoleukodystrophy B-Disease 1 0.8926205039024353
with O 0 0.01417552400380373
a O 0 0.019662778824567795
codon O 0 0.37368184328079224
291 O 0 0.3523790240287781
deletion O 1 0.690937340259552
: O 0 0.03775307163596153
a O 0 0.027327295392751694
clinical O 1 0.5919569134712219
, O 0 0.02129119634628296
biochemical O 0 0.4549536406993866
, O 0 0.02295527420938015
pathological O 0 0.46902787685394287
, O 0 0.013891459442675114
and O 0 0.018927190452814102
genetic O 1 0.7025936245918274
report O 0 0.04791723191738129
. O 0 0.04007713869214058

We O 0 0.01742616295814514
report O 0 0.013184674084186554
a O 0 0.010877739638090134
Japanese O 0 0.014746533706784248
family O 0 0.07790736854076385
with O 0 0.06690461933612823
adrenoleukodystrophy B-Disease 1 0.9671012163162231
( O 0 0.3261358439922333
ALD B-Disease 1 0.9411192536354065
) O 0 0.01719478890299797
with O 0 0.005520713049918413
a O 0 0.005347875878214836
three O 0 0.006531444378197193
base O 0 0.011042814701795578
pair O 0 0.08271778374910355
deletion O 1 0.7788172364234924
( O 0 0.1367274969816208
delGAG O 0 0.4530586004257202
291 O 0 0.2573394477367401
) O 0 0.03715534880757332
in O 0 0.015210319310426712
the O 0 0.04076068848371506
ALD B-Disease 1 0.9496403336524963
gene O 1 0.8832731246948242
. O 0 0.07301785796880722

A O 0 0.02907504327595234
variety O 0 0.021677600219845772
of O 0 0.01089499145746231
phenotypes O 0 0.33623072504997253
were O 0 0.007306982763111591
observed O 0 0.02343287132680416
within O 0 0.010941863059997559
this O 0 0.0096316272392869
family O 0 0.03961382433772087
. O 0 0.024613477289676666

While O 0 0.029366156086325645
the O 0 0.020367121323943138
proband O 0 0.4215923845767975
( O 0 0.11875402182340622
patient O 0 0.42131906747817993
1 O 0 0.01216102484613657
) O 0 0.008506998419761658
was O 0 0.0033757139462977648
classified O 0 0.010878088884055614
as O 0 0.0031719922553747892
having O 0 0.0069010499864816666
a O 0 0.009980280883610249
rare O 0 0.14064592123031616
intermediate O 0 0.14948856830596924
type O 0 0.15208792686462402
of O 0 0.017959101125597954
adult O 1 0.5444644093513489
cerebral O 1 0.9423946142196655
and O 0 0.07386747002601624
cerebello O 1 0.870002806186676
- O 1 0.734291672706604
brain O 1 0.9583584070205688
stem O 1 0.8199644684791565
forms O 0 0.1628013551235199
, O 0 0.014510232955217361
his O 0 0.016310174018144608
younger O 0 0.3083959221839905
brother O 0 0.24191834032535553
( O 0 0.193582221865654
patient O 1 0.716121256351471
2 O 0 0.036329541355371475
) O 0 0.02573913335800171
and O 0 0.0092094661667943
nephew O 0 0.2868838310241699
( O 0 0.16040997207164764
patient O 1 0.6213515996932983
3 O 0 0.03142945468425751
) O 0 0.026020651683211327
had O 0 0.01469110045582056
a O 0 0.05418325588107109
childhood O 1 0.845582902431488
ALD B-Disease 1 0.9525429010391235
type O 1 0.5864468812942505
. O 0 0.09058308601379395

Another O 0 0.07919421792030334
nephew O 0 0.3371993899345398
( O 0 0.12608283758163452
patient O 1 0.5242664217948914
4 O 0 0.0243484266102314
) O 0 0.015113655477762222
of O 0 0.0063042896799743176
patient O 0 0.2623460292816162
1 O 0 0.009177198633551598
was O 0 0.004471408203244209
classified O 0 0.01883787102997303
as O 0 0.0049970755353569984
having O 0 0.009821802377700806
an O 0 0.01201675646007061
adolescent O 1 0.6298038959503174
form O 0 0.16086216270923615
. O 0 0.050159357488155365

The O 0 0.023026298731565475
tau O 0 0.0955529659986496
level O 0 0.014581453986465931
in O 0 0.010483212769031525
the O 0 0.018574299290776253
cerebrospinal O 1 0.9394113421440125
fluid O 1 0.8480653762817383
( O 0 0.33388417959213257
CSF O 1 0.8392308354377747
) O 0 0.03672198951244354
in O 0 0.01263264287263155
patient O 0 0.2665281593799591
1 O 0 0.006652862764894962
was O 0 0.0030856935773044825
as O 0 0.0027720530051738024
high O 0 0.005244194995611906
as O 0 0.0037370515055954456
that O 0 0.006998488213866949
of O 0 0.04810696840286255
patients O 1 0.9656963348388672
with O 1 0.6042789816856384
Alzheimers B-Disease 1 0.9861489534378052
disease I-Disease 1 0.9840706586837769
( O 0 0.3873497247695923
AD B-Disease 0 0.32609105110168457
) O 0 0.0789722129702568
. O 0 0.03583196550607681

His O 0 0.05432146415114403
brain O 1 0.774019181728363
magnetic O 0 0.11125741899013519
resonance O 0 0.33161699771881104
image O 0 0.19824041426181793
( O 0 0.14072775840759277
MRI O 0 0.49461373686790466
) O 0 0.05245046317577362
showed O 0 0.05990815535187721
abnormalities B-Disease 1 0.8516618013381958
in I-Disease 0 0.009121580980718136
the I-Disease 0 0.01125576812773943
bilateral I-Disease 0 0.16507580876350403
cerebellar I-Disease 1 0.9229960441589355
hemispheres I-Disease 1 0.5489665865898132
and O 0 0.05717838928103447
brain O 1 0.912865161895752
stem O 1 0.5437476634979248
, O 0 0.0071392967365682125
but O 0 0.0033475374802947044
not O 0 0.002600177191197872
in O 0 0.0035496302880346775
the O 0 0.00637948838993907
cerebral O 1 0.7892634868621826
white O 0 0.04407842457294464
matter O 0 0.007668450474739075
, O 0 0.0033707700204104185
where O 0 0.0032628076151013374
marked O 0 0.01058755349367857
reductions O 0 0.029196592047810555
of O 0 0.00602946849539876
the O 0 0.0206998810172081
cerebral O 1 0.9409455060958862
blood O 1 0.7288954257965088
flow O 0 0.15934602916240692
and O 0 0.017410781234502792
oxygen O 0 0.4580252766609192
metabolism O 1 0.5955085754394531
were O 0 0.0067355274222791195
clearly O 0 0.02149573527276516
demonstrated O 0 0.06794726103544235
by O 0 0.035487785935401917
positron O 1 0.8264749050140381
emission O 1 0.6632946729660034
tomography O 1 0.8207626342773438
( O 0 0.16759724915027618
PET O 0 0.4070882797241211
) O 0 0.07034216821193695
. O 0 0.03557438775897026

In O 0 0.03601279854774475
patients O 0 0.42295798659324646
2 O 0 0.014803282916545868
and O 0 0.006199350114911795
3 O 0 0.007358619477599859
, O 0 0.004048977512866259
the O 0 0.004612225107848644
autopsy O 0 0.10645066946744919
findings O 0 0.03463485836982727
showed O 0 0.02552890218794346
massive O 0 0.18058885633945465
demyelination B-Disease 1 0.8551564812660217
of I-Disease 0 0.012306354939937592
the I-Disease 0 0.02432173863053322
cerebral I-Disease 1 0.8879186511039734
white I-Disease 0 0.06370239704847336
matter I-Disease 0 0.011996393091976643
with O 0 0.007881036959588528
sparing O 0 0.09188533574342728
of O 0 0.004405779764056206
the O 0 0.005796654149889946
U O 0 0.10550675541162491
- O 0 0.15758053958415985
fibers O 0 0.40273919701576233
, O 0 0.010348238050937653
compatible O 0 0.02675020508468151
with O 0 0.005696725100278854
the O 0 0.005931074731051922
findings O 0 0.049529705196619034
of O 0 0.027936847880482674
childhood O 1 0.8394396901130676
ALD B-Disease 1 0.9487671256065369
. O 0 0.13944189250469208

Oleic O 0 0.41344043612480164
and O 0 0.03320765122771263
erucic O 1 0.6463402509689331
acids O 0 0.41547393798828125
( O 0 0.059112925082445145
Lorenzos O 0 0.1514270156621933
Oil O 0 0.015029655769467354
) O 0 0.010067782364785671
were O 0 0.004268805496394634
administered O 0 0.03586889058351517
to O 0 0.00598599249497056
patients O 0 0.4619361460208893
1 O 0 0.006766798440366983
and O 0 0.0032868890557438135
4 O 0 0.00561113003641367
, O 0 0.003029179759323597
but O 0 0.003062377218157053
sufficient O 0 0.010792138986289501
effectiveness O 0 0.04446710646152496
was O 0 0.004481033887714148
not O 0 0.005314820911735296
obtained O 0 0.014313653111457825
. O 0 0.018449705094099045

The O 0 0.017488913610577583
findings O 0 0.018826311454176903
in O 0 0.006924268323928118
this O 0 0.005877077579498291
family O 0 0.013734090141952038
suggest O 0 0.009837424382567406
that O 0 0.0037417321000248194
delGAG291 O 0 0.04552394896745682
is O 0 0.0033563997130841017
part O 0 0.003262600162997842
of O 0 0.0028594471514225006
the O 0 0.004976500291377306
cause O 0 0.18330666422843933
of O 0 0.008026445284485817
Japanese O 0 0.06900838017463684
ALD B-Disease 1 0.9458009004592896
with O 0 0.063613660633564
phenotypic O 1 0.6654953956604004
variations O 0 0.35055533051490784
. O 0 0.07237223535776138

Moreover O 0 0.03612718731164932
, O 0 0.00872715376317501
although O 0 0.006034912075847387
the O 0 0.0035849460400640965
scale O 0 0.006320123560726643
of O 0 0.002521652029827237
the O 0 0.002580879256129265
study O 0 0.007293081376701593
is O 0 0.0029302334878593683
limited O 0 0.004093003924936056
, O 0 0.001956542721018195
there O 0 0.0017087383894249797
is O 0 0.002060399856418371
a O 0 0.0032824522349983454
possibility O 0 0.016574794426560402
that O 0 0.0047309077344834805
PET O 0 0.2039634734392166
can O 0 0.02776709571480751
detect O 0 0.31909629702568054
an O 0 0.037040770053863525
insidious B-Disease 1 0.8252187967300415
lesion I-Disease 1 0.9351853728294373
which O 0 0.02091912180185318
is O 0 0.02490837313234806
undetectable O 1 0.6899770498275757
by O 0 0.03298988938331604
computed O 0 0.4828716814517975
tomogram O 1 0.7126806974411011
( O 0 0.24413467943668365
CT O 1 0.7997026443481445
) O 0 0.030507829040288925
or O 0 0.017930084839463234
MRI O 0 0.17591366171836853
analysis O 0 0.011127479374408722
, O 0 0.0024914108216762543
and O 0 0.001776293502189219
that O 0 0.0017419279320165515
the O 0 0.0019627907313406467
higher O 0 0.00436705956235528
level O 0 0.003934457898139954
of O 0 0.0035150921903550625
tau O 0 0.0768115222454071
reflects O 0 0.0136727225035429
the O 0 0.005205349065363407
process O 0 0.023671748116612434
of O 0 0.025529883801937103
neuronal B-Disease 1 0.9269101023674011
degeneration I-Disease 1 0.9688892364501953
in O 0 0.29603439569473267
ALD B-Disease 1 0.9466164112091064
. O 0 0.16295519471168518

Lorenzos O 0 0.09527786076068878
Oil O 0 0.02205914631485939
should O 0 0.008555939421057701
be O 0 0.004851290490478277
given O 0 0.004552291240543127
in O 0 0.0037064922507852316
the O 0 0.004095169715583324
early O 0 0.01026242971420288
stage O 0 0.04910927265882492
. O 0 0.016959229484200478
. O 0 0.024140501394867897

Nonsense O 0 0.2934889793395996
mutation O 1 0.7306506633758545
in O 0 0.020695149898529053
exon O 0 0.16247259080410004
4 O 0 0.01481305155903101
of O 0 0.007270124740898609
human O 0 0.10743765532970428
complement O 0 0.1685243844985962
C9 O 1 0.8522553443908691
gene O 1 0.6188927292823792
is O 0 0.008821780793368816
the O 0 0.006495920941233635
major O 0 0.028879782184958458
cause O 0 0.2150125503540039
of O 0 0.012016111984848976
Japanese O 0 0.06398256868124008
complement B-Disease 1 0.5254595279693604
C9 I-Disease 1 0.9364750981330872
deficiency I-Disease 1 0.9648333191871643
. O 0 0.16811798512935638

Deficiency B-Disease 1 0.8825783729553223
of I-Disease 0 0.015460888855159283
the I-Disease 0 0.010292870923876762
ninth I-Disease 0 0.0228339321911335
component I-Disease 0 0.02128525823354721
of I-Disease 0 0.006800535600632429
human I-Disease 0 0.07510921359062195
complement I-Disease 0 0.12443552166223526
( O 0 0.10125953704118729
C9 O 1 0.6347588896751404
) O 0 0.013171057216823101
is O 0 0.0036866036243736744
the O 0 0.0032765904907137156
most O 0 0.0075174905359745026
common O 0 0.1446089744567871
complement B-Disease 0 0.4909549951553345
deficiency I-Disease 1 0.9744754433631897
in O 0 0.007934615015983582
Japan O 0 0.007049414794892073
but O 0 0.00489647313952446
is O 0 0.006411729380488396
rare O 0 0.04045277088880539
in O 0 0.005451456177979708
other O 0 0.007380678318440914
countries O 0 0.015713339671492577
. O 0 0.02191399410367012

We O 0 0.01837955415248871
studied O 0 0.018386248499155045
the O 0 0.009455152787268162
molecular O 0 0.10799643397331238
basis O 0 0.014442957937717438
of O 0 0.020570896565914154
C9 B-Disease 1 0.9166861772537231
deficiency I-Disease 1 0.9693853259086609
in O 0 0.01926303654909134
four O 0 0.02810761332511902
Japanese O 0 0.1757553517818451
C9 B-Disease 1 0.9485341906547546
- I-Disease 1 0.8658389449119568
deficient I-Disease 1 0.9584265351295471
patients O 1 0.9503766894340515
who O 0 0.1005379781126976
had O 0 0.08854696154594421
suffered O 1 0.8577273488044739
from O 0 0.46888259053230286
meningococcal B-Disease 1 0.977277398109436
meningitis I-Disease 1 0.9707251787185669
. O 0 0.2632490396499634

Direct O 0 0.049051765352487564
sequencing O 0 0.06379217654466629
of O 0 0.018626438453793526
amplified O 0 0.15491800010204315
C9 O 1 0.540672779083252
cDNA O 0 0.1599651277065277
and O 0 0.01322542130947113
DNA O 0 0.13115565478801727
revealed O 0 0.024923279881477356
a O 0 0.012472720816731453
nonsense O 0 0.07008691132068634
substitution O 0 0.1543080359697342
( O 0 0.08241714537143707
CGA O 0 0.18636929988861084
- O 0 0.2739439308643341
- O 0 0.3605475425720215
> O 1 0.6282718181610107
TGA O 1 0.7316134572029114
) O 0 0.020211467519402504
at O 0 0.00688505545258522
codon O 0 0.07111851125955582
95 O 0 0.012005988508462906
in O 0 0.005903805140405893
exon O 0 0.0912095382809639
4 O 0 0.008157645352184772
in O 0 0.004664349835366011
the O 0 0.005816472694277763
four O 0 0.020130706951022148
C9 B-Disease 1 0.8446652293205261
- I-Disease 0 0.4672640860080719
deficient I-Disease 1 0.821792483329773
individuals O 0 0.1805734932422638
. O 0 0.05529390648007393

An O 0 0.0473611056804657
allele O 1 0.6546483039855957
- O 0 0.14908328652381897
specific O 0 0.059137701988220215
polymerase O 0 0.4049399495124817
chain O 0 0.1312163770198822
reaction O 0 0.05060655623674393
system O 0 0.012517864815890789
designed O 0 0.007792856078594923
to O 0 0.0034265443682670593
detect O 0 0.023780403658747673
exclusively O 0 0.00411554891616106
only O 0 0.00230998732149601
one O 0 0.0021518059074878693
of O 0 0.0022518837358802557
the O 0 0.0033665436785668135
normal O 0 0.04753383994102478
and O 0 0.0069881826639175415
mutant O 1 0.5112011432647705
alleles O 1 0.7265720367431641
indicated O 0 0.015864958986639977
that O 0 0.0028179085347801447
all O 0 0.0022000607568770647
the O 0 0.003036252688616514
four O 0 0.00974330585449934
patients O 1 0.5894969701766968
were O 0 0.005282821599394083
homozygous O 0 0.3433496356010437
for O 0 0.0066285571083426476
the O 0 0.00932527706027031
mutation O 1 0.7379920482635498
in O 0 0.01089557260274887
exon O 0 0.15847428143024445
4 O 0 0.008973482996225357
and O 0 0.0028788542840629816
that O 0 0.002906362060457468
the O 0 0.003540421836078167
parents O 0 0.020613206550478935
of O 0 0.008125404827296734
patient O 0 0.49328362941741943
2 O 0 0.019551385194063187
were O 0 0.011258119717240334
heterozygous O 1 0.5074196457862854
. O 0 0.04159564897418022

The O 0 0.02778993360698223
common O 0 0.08900739997625351
mutation O 1 0.5909746885299683
at O 0 0.014879840426146984
codon O 0 0.12963458895683289
95 O 0 0.01664717122912407
in O 0 0.00798921100795269
exon O 0 0.1115671843290329
4 O 0 0.009434734471142292
might O 0 0.007016172166913748
be O 0 0.0033502671867609024
responsible O 0 0.009261265397071838
for O 0 0.005400600377470255
most O 0 0.015391659922897816
Japanese O 0 0.13027223944664001
C9 B-Disease 1 0.952598512172699
deficiency I-Disease 1 0.977081835269928
. O 0 0.06440237909555435
. O 0 0.04418735206127167

BRCA1 O 1 0.8076606392860413
required O 0 0.038219600915908813
for O 0 0.0227417703717947
transcription O 1 0.5696837902069092
- O 0 0.25484931468963623
coupled O 0 0.3154655396938324
repair O 0 0.401771605014801
of O 0 0.04968321695923805
oxidative O 1 0.9119146466255188
DNA O 1 0.7810090184211731
damage O 1 0.5857983827590942
. O 0 0.06522347778081894

The O 0 0.35373571515083313
breast B-Disease 1 0.9644080996513367
and I-Disease 1 0.7409934401512146
ovarian I-Disease 1 0.986692488193512
cancer I-Disease 1 0.9879767298698425
susceptibility O 1 0.9751965999603271
gene O 1 0.9619126319885254
BRCA1 O 1 0.9633020758628845
encodes O 1 0.633150041103363
a O 0 0.07105490565299988
zinc O 1 0.6426085233688354
finger O 0 0.4300244450569153
protein O 0 0.297181099653244
of O 0 0.013552774675190449
unknown O 0 0.0975721925497055
function O 0 0.13644671440124512
. O 0 0.03619995340704918

Association O 0 0.03913481533527374
of O 0 0.01229233667254448
the O 0 0.01363652665168047
BRCA1 O 1 0.8807592391967773
protein O 0 0.25410139560699463
with O 0 0.010112496092915535
the O 0 0.009872167371213436
DNA O 0 0.3759565055370331
repair O 0 0.3597886264324188
protein O 0 0.36527955532073975
Rad51 O 0 0.4642315208911896
and O 0 0.00540892081335187
changes O 0 0.007120720576494932
in O 0 0.0032670069485902786
the O 0 0.003009610343724489
phosphorylation O 0 0.029434528201818466
and O 0 0.00437289709225297
cellular O 0 0.09490502625703812
localization O 0 0.043653856962919235
of O 0 0.004094405565410852
the O 0 0.007044726982712746
protein O 0 0.3071495294570923
after O 0 0.04728672280907631
exposure O 1 0.5528067350387573
to O 0 0.019990980625152588
DNA O 1 0.5208449363708496
- O 0 0.1841554343700409
damaging O 0 0.1753934621810913
agents O 0 0.020925696939229965
are O 0 0.003569187829270959
consistent O 0 0.010628998279571533
with O 0 0.0052733635529875755
a O 0 0.008186841383576393
role O 0 0.03418579325079918
for O 0 0.023391878232359886
BRCA1 O 1 0.9392728209495544
in O 0 0.07287140190601349
DNA O 1 0.6349831819534302
repair O 1 0.5019153952598572
. O 0 0.05054338276386261

Here O 0 0.01844821870326996
, O 0 0.010934723541140556
it O 0 0.006185470148921013
is O 0 0.006085557863116264
shown O 0 0.012701798230409622
that O 0 0.013233919627964497
mouse O 1 0.7947615385055542
embryonic O 1 0.9432007670402527
stem O 1 0.960676372051239
cells O 1 0.958111584186554
deficient B-Disease 1 0.9201543927192688
in I-Disease 0 0.08195965737104416
BRCA1 I-Disease 1 0.9300727844238281
are O 0 0.015255925245583057
defective O 0 0.26163768768310547
in O 0 0.00458376994356513
the O 0 0.00352726923301816
ability O 0 0.011218475177884102
to O 0 0.003110133344307542
carry O 0 0.00728202797472477
out O 0 0.00819291453808546
transcription O 1 0.5503906011581421
- O 0 0.2678801417350769
coupled O 0 0.357668936252594
repair O 0 0.41019999980926514
of O 0 0.042951732873916626
oxidative O 1 0.9159830808639526
DNA O 1 0.6347998380661011
damage O 0 0.24966824054718018
, O 0 0.00538067938759923
and O 0 0.004281697794795036
are O 0 0.00604693777859211
hypersensitive O 0 0.33916953206062317
to O 0 0.016765527427196503
ionizing O 1 0.7558996081352234
radiation O 1 0.707729697227478
and O 0 0.024108702316880226
hydrogen O 0 0.3584192395210266
peroxide O 1 0.6790268421173096
. O 0 0.06024548038840294

These O 0 0.02130950801074505
results O 0 0.028047561645507812
suggest O 0 0.030199242755770683
that O 0 0.015753893181681633
BRCA1 O 1 0.8877975344657898
participates O 0 0.09535575658082962
, O 0 0.00710989348590374
directly O 0 0.009096878580749035
or O 0 0.012742501683533192
indirectly O 0 0.05002983659505844
, O 0 0.006596723571419716
in O 0 0.011806471273303032
transcription O 1 0.6630998253822327
- O 0 0.3359292447566986
coupled O 0 0.43707671761512756
repair O 1 0.5299973487854004
of O 0 0.05784536153078079
oxidative O 1 0.944354772567749
DNA O 1 0.8253278732299805
damage O 1 0.5039125084877014
. O 0 0.0264421533793211
. O 0 0.030141020193696022

Truncation O 1 0.5676423907279968
mutations O 1 0.7115545868873596
in O 0 0.018408723175525665
the O 0 0.014516575261950493
transactivation O 0 0.4622539281845093
region O 0 0.03373342752456665
of O 0 0.013158059678971767
PAX6 O 1 0.7422969937324524
result O 0 0.10712583363056183
in O 0 0.02135067619383335
dominant O 0 0.287519246339798
- O 0 0.2863326072692871
negative O 0 0.27290311455726624
mutants O 1 0.5085596442222595
. O 0 0.05783774331212044

PAX6 O 0 0.47488927841186523
is O 0 0.02289978787302971
a O 0 0.02040625736117363
transcription O 0 0.2631349265575409
factor O 0 0.05784093588590622
with O 0 0.009244722314178944
two O 0 0.011148948222398758
DNA O 0 0.35186949372291565
- O 0 0.13453485071659088
binding O 0 0.169640451669693
domains O 0 0.22422680258750916
( O 0 0.06348830461502075
paired O 0 0.16158407926559448
box O 0 0.04444975405931473
and O 0 0.01170482486486435
homeobox O 1 0.8369121551513672
) O 0 0.017980903387069702
and O 0 0.006048244424164295
a O 0 0.0165642648935318
proline O 0 0.48618367314338684
- O 0 0.30463603138923645
serine O 1 0.5249727368354797
- O 0 0.36680686473846436
threonine O 1 0.5632606148719788
( O 0 0.20000548660755157
PST O 1 0.5718161463737488
) O 0 0.05265923589468002
- O 0 0.18896368145942688
rich O 0 0.15403763949871063
transactivation O 1 0.6831199526786804
domain O 0 0.1774502396583557
. O 0 0.040953196585178375

PAX6 O 1 0.8256480097770691
regulates O 0 0.45512425899505615
eye O 0 0.26959002017974854
development O 0 0.025050679221749306
in O 0 0.012160325422883034
animals O 0 0.05285489559173584
ranging O 0 0.03231223300099373
from O 0 0.012760796584188938
jellyfish O 0 0.2300102859735489
to O 0 0.012117360718548298
Drosophila O 0 0.286334753036499
to O 0 0.020088544115424156
humans O 0 0.41605114936828613
. O 0 0.049275368452072144

Heterozygous O 1 0.7926828861236572
mutations O 1 0.7807950973510742
in O 0 0.020718751475214958
the O 0 0.01765100285410881
human O 0 0.3174564838409424
PAX6 O 1 0.912619948387146
gene O 1 0.8098667860031128
result O 0 0.07117496430873871
in O 0 0.011137925088405609
various O 0 0.020056486129760742
phenotypes O 1 0.7677049040794373
, O 0 0.01756628230214119
including O 0 0.03188516944646835
aniridia B-Disease 1 0.6511831879615784
, O 0 0.07740606367588043
Peters B-Disease 1 0.7890578508377075
anomaly I-Disease 1 0.9243087768554688
, O 0 0.3340959846973419
autosomal B-Disease 1 0.9824735522270203
dominant I-Disease 1 0.8809480667114258
keratitis I-Disease 1 0.9594925045967102
, O 0 0.06968513876199722
and O 0 0.09396673738956451
familial B-Disease 1 0.955274760723114
foveal I-Disease 1 0.9185584187507629
dysplasia I-Disease 1 0.9582589268684387
. O 0 0.21107563376426697

It O 0 0.01599934697151184
is O 0 0.009937413036823273
believed O 0 0.009576164186000824
that O 0 0.0056676906533539295
the O 0 0.008215480484068394
mutated O 1 0.756575882434845
allele O 1 0.6895974278450012
of O 0 0.02508709393441677
PAX6 O 1 0.8404262065887451
produces O 0 0.22574974596500397
an O 0 0.01743307150900364
inactive O 0 0.2231013923883438
protein O 0 0.2407747209072113
and O 0 0.011505642905831337
aniridia B-Disease 0 0.3980441689491272
is O 0 0.02190479263663292
caused O 0 0.2461891621351242
due O 0 0.05519452318549156
to O 0 0.02159523405134678
genetic O 1 0.8145732283592224
haploinsufficiency O 1 0.5301075577735901
. O 0 0.06626816838979721

However O 0 0.02452641725540161
, O 0 0.011968150734901428
several O 0 0.011625885032117367
truncation O 0 0.28538230061531067
mutations O 1 0.5914308428764343
have O 0 0.0056720455177128315
been O 0 0.00376680213958025
found O 0 0.004214467480778694
to O 0 0.002942569088190794
occur O 0 0.03885013237595558
in O 0 0.003762318752706051
the O 0 0.005817250814288855
C O 0 0.12839996814727783
- O 0 0.10753922909498215
terminal O 0 0.08521351963281631
half O 0 0.015441826544702053
of O 0 0.013804852031171322
PAX6 O 1 0.8545352220535278
in O 0 0.04951246827840805
patients O 1 0.8491386771202087
with O 0 0.03601337969303131
Aniridia B-Disease 1 0.5640032291412354
resulting O 0 0.18372873961925507
in O 0 0.014238063246011734
mutant O 0 0.41495126485824585
proteins O 0 0.17186829447746277
that O 0 0.005627475678920746
retain O 0 0.020327622070908546
the O 0 0.007557430304586887
DNA O 0 0.34087780117988586
- O 0 0.10580863803625107
binding O 0 0.07597814500331879
domains O 0 0.049160197377204895
but O 0 0.0034864896442741156
have O 0 0.0031221136450767517
lost O 0 0.004482205491513014
most O 0 0.003671315498650074
of O 0 0.004169527906924486
the O 0 0.008587474003434181
transactivation O 1 0.5592637062072754
domain O 0 0.13211490213871002
. O 0 0.0335017591714859

It O 0 0.014862225390970707
is O 0 0.008529478684067726
not O 0 0.005064439028501511
clear O 0 0.0049377200193703175
whether O 0 0.005078996066004038
such O 0 0.005358366295695305
mutants O 0 0.07761161774396896
really O 0 0.010175159201025963
behave O 0 0.06306637078523636
as O 0 0.006881733890622854
loss O 0 0.07296857237815857
- O 0 0.06528743356466293
of O 0 0.009833727031946182
- O 0 0.16137437522411346
function O 0 0.12610670924186707
mutants O 0 0.23321910202503204
as O 0 0.016346674412488937
predicted O 0 0.0984504297375679
by O 0 0.02693920210003853
haploinsufficiency O 0 0.33787238597869873
. O 0 0.041716765612363815

Contrary O 0 0.027981789782643318
to O 0 0.009150229394435883
this O 0 0.00544821796938777
theory O 0 0.007683879695832729
, O 0 0.003026355756446719
our O 0 0.0027377763763070107
data O 0 0.0034261310938745737
showed O 0 0.004110483452677727
that O 0 0.0026319818571209908
these O 0 0.0038580673281103373
mutants O 0 0.07119547575712204
are O 0 0.006640149746090174
dominant O 0 0.1711130440235138
- O 0 0.12263937294483185
negative O 0 0.12720994651317596
in O 0 0.03226320073008537
transient O 1 0.747182309627533
transfection O 1 0.8135951161384583
assays O 0 0.23132961988449097
when O 0 0.007409387268126011
they O 0 0.004250538535416126
are O 0 0.00529892835766077
coexpressed O 0 0.16299796104431152
with O 0 0.02072780951857567
wild O 0 0.2416021227836609
- O 1 0.5144686102867126
type O 1 0.5960952043533325
PAX6 O 1 0.8756556510925293
. O 0 0.10541501641273499

We O 0 0.013305889442563057
found O 0 0.010844185948371887
that O 0 0.006183629389852285
the O 0 0.005986472591757774
dominant O 0 0.11397907882928848
- O 0 0.11324004083871841
negative O 0 0.1310499608516693
effects O 0 0.2865343689918518
result O 0 0.03374748304486275
from O 0 0.00656878761947155
the O 0 0.006716627161949873
enhanced O 0 0.13588550686836243
DNA O 0 0.2306903749704361
binding O 0 0.058981623500585556
ability O 0 0.023126602172851562
of O 0 0.00730149494484067
these O 0 0.013657168485224247
mutants O 0 0.29793447256088257
. O 0 0.04059214890003204

Kinetic O 0 0.05637364089488983
studies O 0 0.026424653828144073
of O 0 0.009122300893068314
binding O 0 0.02341340109705925
and O 0 0.006983958184719086
dissociation O 0 0.19168491661548615
revealed O 0 0.01866404339671135
that O 0 0.004641630221158266
various O 0 0.007905474863946438
truncation O 0 0.13592100143432617
mutants O 0 0.11438600718975067
have O 0 0.008088801987469196
3 O 0 0.014424757100641727
- O 0 0.05678121745586395
5 O 0 0.014056079089641571
- O 0 0.03526560589671135
fold O 0 0.03634759411215782
higher O 0 0.014465400017797947
affinity O 0 0.059529583901166916
to O 0 0.003861543256789446
various O 0 0.009576498530805111
DNA O 0 0.2143837958574295
- O 0 0.04947468638420105
binding O 0 0.034974630922079086
sites O 0 0.007985690608620644
when O 0 0.005266260355710983
compared O 0 0.015571924857795238
with O 0 0.006646289024502039
the O 0 0.008058471605181694
wild O 0 0.14804106950759888
- O 0 0.3906552791595459
type O 0 0.4656274914741516
PAX6 O 1 0.8187116384506226
. O 0 0.06513477116823196

These O 0 0.016837144270539284
results O 0 0.015493773855268955
provide O 0 0.009018080309033394
a O 0 0.007149927783757448
new O 0 0.005355601664632559
insight O 0 0.012447213754057884
into O 0 0.004796962719410658
the O 0 0.004616918042302132
role O 0 0.013384056277573109
of O 0 0.011590874753892422
mutant O 1 0.7085634469985962
PAX6 O 1 0.8841445446014404
in O 0 0.05813734978437424
causing O 1 0.6634711623191833
aniridia B-Disease 1 0.6155188083648682
. O 0 0.0327477864921093
. O 0 0.03378000855445862

Reversal O 0 0.49756500124931335
of O 0 0.14538230001926422
severe O 1 0.9417845606803894
hypertrophic B-Disease 1 0.9622731804847717
cardiomyopathy I-Disease 1 0.9553432464599609
and O 0 0.03281363099813461
excellent O 0 0.061399031430482864
neuropsychologic O 0 0.25969794392585754
outcome O 0 0.05260324105620384
in O 0 0.012307780794799328
very B-Disease 0 0.025037594139575958
- I-Disease 0 0.1884893774986267
long I-Disease 0 0.15497197210788727
- I-Disease 0 0.44960448145866394
chain I-Disease 1 0.6378806829452515
acyl I-Disease 1 0.9125582575798035
- I-Disease 1 0.7182310223579407
coenzyme I-Disease 1 0.8976276516914368
A I-Disease 0 0.4670352339744568
dehydrogenase I-Disease 1 0.9539797306060791
deficiency I-Disease 1 0.9607849717140198
. O 0 0.17591898143291473

Very B-Disease 0 0.049351051449775696
- I-Disease 0 0.16480672359466553
long I-Disease 0 0.10412842035293579
- I-Disease 0 0.3708658516407013
chain I-Disease 1 0.5231935977935791
acyl I-Disease 1 0.8866258263587952
- I-Disease 1 0.6000615954399109
coenzyme I-Disease 1 0.8514869213104248
A I-Disease 0 0.28072699904441833
dehydrogenase I-Disease 1 0.9576196074485779
( I-Disease 1 0.5019996762275696
VLCAD I-Disease 1 0.8842079639434814
) I-Disease 0 0.47779569029808044
deficiency I-Disease 1 0.9797144532203674
is O 0 0.04632163420319557
a O 0 0.09216730296611786
disorder O 1 0.9666289687156677
of O 0 0.04676862433552742
fatty O 1 0.8995492458343506
acid O 1 0.8186508417129517
beta O 0 0.47491660714149475
oxidation O 0 0.41070398688316345
that O 0 0.0076139746233820915
reportedly O 0 0.01932160183787346
has O 0 0.006954486016184092
high O 0 0.015098671428859234
rates O 0 0.07188615947961807
of O 0 0.018278786912560463
morbidity O 1 0.8661862015724182
and O 0 0.046460073441267014
mortality O 1 0.8408873677253723
. O 0 0.0859278216958046

We O 0 0.01588599570095539
describe O 0 0.01819102093577385
the O 0 0.006810914259403944
outcome O 0 0.007782929576933384
of O 0 0.004064895212650299
a O 0 0.00638625118881464
5 O 0 0.012345043942332268
- O 0 0.055217090994119644
year O 0 0.019660603255033493
- O 0 0.11021668463945389
old O 0 0.05472617596387863
girl O 0 0.20493242144584656
with O 0 0.08836474269628525
VLCAD B-Disease 1 0.9059152007102966
deficiency I-Disease 1 0.9736811518669128
who O 0 0.010453309863805771
was O 0 0.004350184462964535
first O 0 0.003995510283857584
seen O 0 0.007688742130994797
at O 0 0.005447478964924812
5 O 0 0.010762745514512062
months O 0 0.01936984248459339
of O 0 0.011490089818835258
age O 0 0.24936099350452423
with O 0 0.3625938892364502
severe O 1 0.9772562980651855
hypertrophic B-Disease 1 0.9826142191886902
cardiomyopathy I-Disease 1 0.9829855561256409
, O 1 0.5546712279319763
hepatomegaly B-Disease 1 0.962356448173523
, O 0 0.3438884913921356
encephalopathy B-Disease 1 0.9698268175125122
, O 0 0.058482665568590164
and O 0 0.03585805371403694
hypotonia B-Disease 1 0.8650158643722534
. O 0 0.06969358772039413

Biochemical O 1 0.7514718174934387
studies O 0 0.440864622592926
indicated O 1 0.5100743174552917
VLCAD B-Disease 1 0.9303689002990723
deficiency I-Disease 1 0.9742253422737122
caused O 0 0.4759581387042999
by O 0 0.02302904613316059
a O 0 0.022181188687682152
stable O 0 0.176060289144516
yet O 0 0.0405704528093338
inactive O 0 0.24172662198543549
enzyme O 1 0.6157709360122681
. O 0 0.04611079394817352

Molecular O 1 0.5774679780006409
genetic O 1 0.5605415105819702
analysis O 0 0.02998563088476658
of O 0 0.011360595002770424
her O 0 0.042606763541698456
VLCAD O 1 0.57274329662323
gene O 1 0.7182432413101196
revealed O 0 0.08847998082637787
a O 0 0.035028789192438126
T1372C O 0 0.44131726026535034
( O 0 0.12241772562265396
F458L O 1 0.5139923691749573
) O 0 0.16858279705047607
missense O 1 0.8628525733947754
mutation O 1 0.8546717762947083
and O 0 0.015266044065356255
a O 0 0.03235498443245888
1668 O 1 0.6556049585342407
ACAG O 1 0.6484422087669373
1669 O 1 0.6623523831367493
splice O 1 0.6802215576171875
site O 0 0.1449299156665802
mutation O 1 0.8748295307159424
. O 0 0.059547699987888336

After O 0 0.052407655864953995
initial O 0 0.09779635816812515
treatment O 0 0.44569969177246094
with O 0 0.0457199402153492
intravenous O 1 0.8589448928833008
glucose O 1 0.7188410758972168
and O 0 0.019341425970196724
carnitine O 1 0.6983884572982788
, O 0 0.009585891850292683
the O 0 0.00808790884912014
patient O 0 0.2869153618812561
has O 0 0.007706169970333576
thrived O 0 0.03968852385878563
on O 0 0.004132422152906656
a O 0 0.008746578358113766
low O 0 0.06614505499601364
- O 0 0.13211391866207123
fat O 0 0.3323044776916504
diet O 0 0.38552871346473694
supplemented O 0 0.08421072363853455
with O 0 0.018302034586668015
medium O 0 0.10961087048053741
- O 0 0.1506328135728836
chain O 0 0.19936151802539825
triglyceride O 0 0.46550384163856506
oil O 0 0.0218676570802927
and O 0 0.01463678851723671
carnitine O 1 0.6686633825302124
and O 0 0.016865329816937447
avoidance O 0 0.4398910105228424
of O 0 0.018547354266047478
fasting O 0 0.321137398481369
. O 0 0.05578971281647682

Her O 0 0.21773624420166016
ventricular O 1 0.9072366952896118
hypertrophy O 1 0.9029803276062012
resolved O 0 0.08197472989559174
significantly O 0 0.05635790526866913
over O 0 0.007988368161022663
1 O 0 0.007401115261018276
year O 0 0.006627071648836136
, O 0 0.004049560520797968
and O 0 0.003935232758522034
cognitively O 0 0.1425178050994873
, O 0 0.003479581093415618
she O 0 0.00279323011636734
is O 0 0.002323764842003584
in O 0 0.0026644000317901373
the O 0 0.0032654637470841408
superior O 0 0.014867182821035385
range O 0 0.00956274475902319
for O 0 0.009327537380158901
age O 0 0.05223037675023079
. O 0 0.029493380337953568

Clinical O 1 0.5879119038581848
recognition O 0 0.0815586969256401
of O 0 0.03050612285733223
VLCAD B-Disease 1 0.8758645057678223
deficiency I-Disease 1 0.9669085144996643
is O 0 0.01076151616871357
important O 0 0.0061079454608261585
because O 0 0.004439304117113352
it O 0 0.002381940372288227
is O 0 0.0020216733682900667
one O 0 0.0018538364674896002
of O 0 0.0020044632256031036
the O 0 0.0036306302063167095
few O 0 0.015647105872631073
directly O 0 0.11411645263433456
treatable O 1 0.9700825214385986
causes O 1 0.894751250743866
of O 0 0.14220258593559265
cardiomyopathy B-Disease 1 0.9746212363243103
in O 0 0.07382320612668991
children O 0 0.1769724041223526
. O 0 0.03104129433631897
. O 0 0.03823220357298851

Cloning O 0 0.0822272077202797
of O 0 0.013706124387681484
a O 0 0.01224153395742178
novel O 0 0.017062213271856308
member O 0 0.007128751836717129
of O 0 0.005084430333226919
the O 0 0.0078075653873384
low O 0 0.1352776139974594
- O 0 0.3706367611885071
density O 1 0.5885167121887207
lipoprotein O 1 0.9375552535057068
receptor O 1 0.8810708522796631
family O 0 0.26038023829460144
. O 0 0.05550886690616608

A O 0 0.05017158016562462
gene O 0 0.4240991473197937
encoding O 0 0.09518958628177643
a O 0 0.02054814249277115
novel O 0 0.08542200922966003
transmembrane O 0 0.3619413673877716
protein O 0 0.20822863280773163
was O 0 0.008197147399187088
identified O 0 0.025536127388477325
by O 0 0.009596526622772217
DNA O 0 0.15516433119773865
sequence O 0 0.058613136410713196
analysis O 0 0.039314012974500656
within O 0 0.021767327561974525
the O 0 0.05113721638917923
insulin B-Disease 1 0.9633691310882568
- I-Disease 1 0.9063331484794617
dependent I-Disease 1 0.9498167037963867
diabetes I-Disease 1 0.9904609322547913
mellitus I-Disease 1 0.9778202176094055
( O 1 0.5869666337966919
IDDM B-Disease 1 0.8060433864593506
) O 0 0.21430425345897675
locus O 1 0.7847849130630493
IDDM4 O 1 0.6254447102546692
on O 0 0.0378253310918808
chromosome O 1 0.8865320086479187
11q13 O 1 0.5344482064247131
. O 0 0.054900310933589935

Based O 0 0.021287452429533005
on O 0 0.010625944472849369
its O 0 0.009919881820678711
chromosomal O 0 0.3914511501789093
position O 0 0.008435094729065895
, O 0 0.005170859862118959
this O 0 0.0050791166722774506
gene O 0 0.2589767873287201
is O 0 0.005425142124295235
a O 0 0.006636995822191238
candidate O 0 0.017766205593943596
for O 0 0.016547564417123795
conferring O 0 0.4905436336994171
susceptibility O 1 0.9377094507217407
to O 0 0.16637147963047028
diabetes B-Disease 1 0.9724743962287903
. O 0 0.15587176382541656

The O 0 0.031902555376291275
gene O 1 0.5484808087348938
, O 0 0.01940583437681198
termed O 0 0.18797683715820312
low O 0 0.2054789513349533
- O 0 0.4331730902194977
density O 1 0.6276756525039673
lipoprotein O 1 0.9516858458518982
receptor O 1 0.8886220455169678
related O 0 0.35322263836860657
protein O 1 0.5443306565284729
5 O 0 0.05608072876930237
( O 0 0.06495339423418045
LRP5 O 0 0.219522163271904
) O 0 0.012661777436733246
, O 0 0.005224473774433136
encodes O 0 0.03322942554950714
a O 0 0.006406785454601049
protein O 0 0.07867040485143661
of O 0 0.006369503680616617
1615 O 0 0.193867489695549
amino O 0 0.1520993858575821
acids O 0 0.11469990760087967
that O 0 0.004393685609102249
contains O 0 0.008696556091308594
conserved O 0 0.03679516911506653
modules O 0 0.016215328127145767
which O 0 0.002961589489132166
are O 0 0.002533555030822754
characteristic O 0 0.023151006549596786
of O 0 0.004098190926015377
the O 0 0.00818654615432024
low O 0 0.1796763390302658
- O 0 0.4733259379863739
density O 1 0.6294060349464417
lipoprotein O 1 0.9591116309165955
( O 1 0.6368492841720581
LDL O 1 0.9584413170814514
) O 0 0.29851266741752625
receptor O 1 0.8000084161758423
family O 0 0.19544513523578644
. O 0 0.04696369171142578

These O 0 0.02144617587327957
modules O 0 0.024750521406531334
include O 0 0.014082403853535652
a O 0 0.010735121555626392
putative O 0 0.18246051669120789
signal O 0 0.03665647655725479
peptide O 0 0.20139004290103912
for O 0 0.007994973100721836
protein O 0 0.1523497849702835
export O 0 0.014556714333593845
, O 0 0.008314158767461777
four O 0 0.020073119550943375
epidermal O 1 0.9147207736968994
growth O 0 0.4478670060634613
factor O 1 0.5062167048454285
( O 0 0.23137854039669037
EGF O 1 0.8675709962844849
) O 0 0.058954499661922455
repeats O 0 0.1559566855430603
with O 0 0.018535993993282318
associated O 0 0.10213785618543625
spacer O 1 0.5243101119995117
domains O 0 0.2137823849916458
, O 0 0.012458045035600662
three O 0 0.03262244537472725
LDL O 1 0.9535560607910156
- O 1 0.6219192147254944
receptor O 1 0.8532079458236694
( O 0 0.13724252581596375
LDLR O 0 0.4752863049507141
) O 0 0.028310805559158325
repeats O 0 0.05810008943080902
, O 0 0.003996683284640312
a O 0 0.004680876154452562
single O 0 0.01089613325893879
transmembrane O 0 0.15178146958351135
spanning O 0 0.056871216744184494
domain O 0 0.0362640917301178
, O 0 0.004792407620698214
and O 0 0.004813618492335081
a O 0 0.010148515924811363
cytoplasmic O 0 0.3389689326286316
domain O 0 0.11073809862136841
. O 0 0.03474370762705803

The O 0 0.024016138166189194
encoded O 0 0.04146988317370415
protein O 0 0.08442195504903793
has O 0 0.0068664951249957085
a O 0 0.005979267414659262
unique O 0 0.009191409684717655
organization O 0 0.01048904750496149
of O 0 0.007029312662780285
EGF O 1 0.6407510042190552
and O 0 0.011908870190382004
LDLR O 0 0.4243541359901428
repeats O 0 0.20299753546714783
; O 0 0.017096107825636864
therefore O 0 0.007498093880712986
, O 0 0.0045679667964577675
LRP5 O 0 0.09258468449115753
likely O 0 0.010885356925427914
represents O 0 0.007441251538693905
a O 0 0.004615647718310356
new O 0 0.004381783306598663
category O 0 0.010223577730357647
of O 0 0.004926604218780994
the O 0 0.011084634810686111
LDLR O 0 0.3561277985572815
family O 0 0.10945167392492294
. O 0 0.03569711372256279

Both O 0 0.02558482624590397
human O 0 0.04304097592830658
and O 0 0.012975357472896576
mouse O 0 0.42348718643188477
LRP5 O 0 0.3527514934539795
cDNAs O 0 0.14199088513851166
have O 0 0.006329473108053207
been O 0 0.004667707718908787
isolated O 0 0.028806762769818306
and O 0 0.0033710969146341085
the O 0 0.0036161320749670267
encoded O 0 0.04969126358628273
mature O 0 0.24493639171123505
proteins O 0 0.11196862161159515
are O 0 0.003984286915510893
95 O 0 0.008336815051734447
% O 0 0.012310250662267208
identical O 0 0.02486281655728817
, O 0 0.004025353584438562
indicating O 0 0.013308131136000156
a O 0 0.005457819905132055
high O 0 0.007295014336705208
degree O 0 0.010210832580924034
of O 0 0.005913515575230122
evolutionary O 0 0.12454825639724731
conservation O 0 0.050215426832437515
. O 0 0.01683621294796467
. O 0 0.024135524407029152

The O 0 0.03506820276379585
APC B-Disease 0 0.4170328974723816
variants O 0 0.3750230073928833
I1307K O 0 0.2608504593372345
and O 0 0.01604255475103855
E1317Q O 0 0.2633078396320343
are O 0 0.020000264048576355
associated O 0 0.18616704642772675
with O 0 0.17833992838859558
colorectal B-Disease 1 0.9870890974998474
tumors I-Disease 1 0.9717939496040344
, O 0 0.012718802317976952
but O 0 0.005273598711937666
not O 0 0.0035494668409228325
always O 0 0.004542023874819279
with O 0 0.005261491052806377
a O 0 0.009345460683107376
family O 0 0.038161132484674454
history O 0 0.021506819874048233
. O 0 0.027799127623438835

Classical O 1 0.742010235786438
familial B-Disease 1 0.9560565948486328
adenomatous I-Disease 1 0.9677664041519165
polyposis I-Disease 1 0.9640877842903137
( O 1 0.5392019748687744
FAP B-Disease 1 0.8687313199043274
) O 0 0.0440857969224453
is O 0 0.012206739746034145
a O 0 0.01919948123395443
high O 0 0.13201704621315002
- O 1 0.7390303611755371
penetrance O 1 0.972994863986969
autosomal B-Disease 1 0.9885106086730957
dominant I-Disease 1 0.9258458614349365
disease I-Disease 1 0.9785254597663879
that O 0 0.04235800355672836
predisposes O 1 0.7450135946273804
to O 0 0.010170742869377136
hundreds O 0 0.028639817610383034
or O 0 0.03749735653400421
thousands O 0 0.08039123564958572
of O 0 0.18807117640972137
colorectal B-Disease 1 0.9893391728401184
adenomas I-Disease 1 0.9774382710456848
and I-Disease 0 0.14195454120635986
carcinoma I-Disease 1 0.975695788860321
and O 0 0.011914942413568497
that O 0 0.007952953688800335
results O 0 0.043947260826826096
from O 0 0.02931870147585869
truncating O 1 0.7462453246116638
mutations O 1 0.9070553779602051
in O 0 0.030832355841994286
the O 0 0.035146333277225494
APC B-Disease 1 0.8205295205116272
gene O 1 0.871038556098938
. O 0 0.06400204449892044

A O 0 0.06831852346658707
variant O 1 0.5469939112663269
of O 0 0.05941705405712128
FAP B-Disease 1 0.909838855266571
is O 0 0.44839394092559814
attenuated B-Disease 1 0.9617675542831421
adenomatous I-Disease 1 0.9785184860229492
polyposis I-Disease 1 0.9744006991386414
coli I-Disease 1 0.9448183178901672
, O 0 0.022097405046224594
which O 0 0.009176604449748993
results O 0 0.03905836492776871
from O 0 0.021310361102223396
germ O 1 0.6350449323654175
- O 0 0.12985478341579437
line O 0 0.04223596677184105
mutations O 1 0.7389315962791443
in O 0 0.005385164637118578
the O 0 0.0033179777674376965
5 O 0 0.005137666128575802
and O 0 0.00300352624617517
3 O 0 0.006658978760242462
regions O 0 0.015780702233314514
of O 0 0.00618412159383297
the O 0 0.016996776685118675
APC B-Disease 1 0.7184938192367554
gene O 1 0.8411194682121277
. O 0 0.07176216691732407

Attenuated B-Disease 1 0.9195839166641235
adenomatous I-Disease 1 0.958784282207489
polyposis I-Disease 1 0.9653674960136414
coli I-Disease 1 0.9573398232460022
patients O 1 0.8983488082885742
have O 0 0.02664462849497795
" O 0 0.02654031664133072
multiple O 0 0.27797338366508484
" O 0 0.16523092985153198
colorectal B-Disease 1 0.9815109372138977
adenomas I-Disease 1 0.9569709300994873
( O 0 0.10265742242336273
typically O 0 0.02640032023191452
fewer O 0 0.014979034662246704
than O 0 0.005543236620724201
100 O 0 0.006238243076950312
) O 0 0.008552243001759052
without O 0 0.007451725658029318
the O 0 0.009757284075021744
florid O 1 0.6296234726905823
phenotype O 1 0.8640070557594299
of O 0 0.02176523022353649
classical O 0 0.15041479468345642
FAP B-Disease 1 0.8506408929824829
. O 0 0.0699840635061264

Another O 0 0.029483849182724953
group O 0 0.024176720529794693
of O 0 0.01422277931123972
patients O 1 0.7176142930984497
with O 0 0.02501378394663334
multiple O 0 0.33205634355545044
adenomas B-Disease 1 0.9001771807670593
has O 0 0.020569391548633575
no O 0 0.023059917613863945
mutations O 1 0.7804247736930847
in O 0 0.011433899402618408
the O 0 0.014090019278228283
APC B-Disease 1 0.721009373664856
gene O 1 0.5934061408042908
, O 0 0.005412261933088303
and O 0 0.0036871330812573433
their O 0 0.0067297969944775105
phenotype O 1 0.754167377948761
probably O 0 0.01815815083682537
results O 0 0.01942584663629532
from O 0 0.006340105086565018
variation O 0 0.06511938571929932
at O 0 0.006725323386490345
a O 0 0.012521390803158283
locus O 0 0.45477086305618286
, O 0 0.010623708367347717
or O 0 0.024818353354930878
loci O 0 0.4327273666858673
, O 0 0.0077714198268949986
elsewhere O 0 0.010429011657834053
in O 0 0.006482088007032871
the O 0 0.01179149653762579
genome O 0 0.4464474022388458
. O 0 0.04671941697597504

Recently O 0 0.03667188808321953
, O 0 0.012665320187807083
however O 0 0.008764034137129784
, O 0 0.006954011972993612
a O 0 0.010790592059493065
missense O 1 0.582051694393158
variant O 1 0.5337318778038025
of O 0 0.015772400423884392
APC B-Disease 1 0.6344951391220093
( O 0 0.08305393904447556
I1307K O 0 0.22391557693481445
) O 0 0.015849435701966286
was O 0 0.004329240415245295
described O 0 0.014448747970163822
that O 0 0.006732274312525988
confers O 0 0.25332924723625183
an O 0 0.02007918804883957
increased O 0 0.2324185073375702
risk O 1 0.8358590006828308
of O 0 0.25104254484176636
colorectal B-Disease 1 0.990044355392456
tumors I-Disease 1 0.9809273481369019
, O 0 0.051203202456235886
including O 0 0.06819836050271988
multiple O 1 0.5145552158355713
adenomas B-Disease 1 0.913198709487915
, O 0 0.024578148499131203
in O 0 0.03341576084494591
Ashkenazim O 1 0.6513565182685852
. O 0 0.06576083600521088

We O 0 0.01365343015640974
have O 0 0.007846109569072723
studied O 0 0.00991652999073267
a O 0 0.006703764200210571
set O 0 0.00634072395041585
of O 0 0.008655251003801823
164 O 0 0.2978551685810089
patients O 1 0.9449809193611145
with O 0 0.2002749741077423
multiple O 1 0.9119173288345337
colorectal B-Disease 1 0.9908416271209717
adenomas I-Disease 1 0.9779139161109924
and I-Disease 0 0.15053248405456543
/ I-Disease 1 0.7836818695068359
or I-Disease 0 0.30044978857040405
carcinoma I-Disease 1 0.9755082130432129
and O 0 0.034398388117551804
analyzed O 0 0.29750946164131165
codons O 1 0.7750836610794067
1263 O 1 0.83512943983078
- O 0 0.4999440014362335
1377 O 1 0.7578362226486206
( O 0 0.15366129577159882
exon O 1 0.5543895959854126
15G O 0 0.4419855773448944
) O 0 0.015998033806681633
of O 0 0.0071237352676689625
the O 0 0.011929502710700035
APC B-Disease 1 0.6358495354652405
gene O 1 0.7197586297988892
for O 0 0.029465463012456894
germ O 1 0.7487326860427856
- O 0 0.23330096900463104
line O 0 0.0603739395737648
variants O 0 0.3541249632835388
. O 0 0.04874953627586365

Three O 0 0.04088066145777702
patients O 1 0.5821994543075562
with O 0 0.013037597760558128
the O 0 0.010462922975420952
I1307K O 0 0.3207344710826874
allele O 1 0.5076016187667847
were O 0 0.00814060214906931
detected O 0 0.0974317267537117
, O 0 0.006509337108582258
each O 0 0.006472615525126457
of O 0 0.010222000069916248
Ashkenazi O 0 0.3517696261405945
descent O 0 0.15263615548610687
. O 0 0.04601312428712845

Four O 0 0.04722864180803299
patients O 1 0.6138518452644348
had O 0 0.017255865037441254
a O 0 0.024809276685118675
germ O 1 0.5654811263084412
- O 0 0.16354122757911682
line O 0 0.04523741453886032
E1317Q O 1 0.5283509492874146
missense O 1 0.7849025130271912
variant O 0 0.4844954013824463
of O 0 0.00900932215154171
APC O 0 0.19423392415046692
that O 0 0.0037454438861459494
was O 0 0.002622368512675166
not O 0 0.0018879977287724614
present O 0 0.0033777323551476
in O 0 0.0030792229808866978
controls O 0 0.01037951372563839
; O 0 0.0032077895011752844
one O 0 0.001755959470756352
of O 0 0.001921357586979866
these O 0 0.0023653970565646887
individuals O 0 0.009777120314538479
had O 0 0.003198078367859125
an O 0 0.0032757758162915707
unusually O 0 0.03194978088140488
large O 0 0.0068229790776968
number O 0 0.005440902896225452
of O 0 0.01020855363458395
metaplastic B-Disease 0 0.49917665123939514
polyps I-Disease 1 0.8617950677871704
of I-Disease 0 0.01336741168051958
the I-Disease 0 0.02186608873307705
colorectum I-Disease 0 0.4420878291130066
. O 0 0.05870942398905754

There O 0 0.017451247200369835
is O 0 0.009454978629946709
increasing O 0 0.011775757186114788
evidence O 0 0.007141368929296732
that O 0 0.004218284972012043
there O 0 0.004563513677567244
exist O 0 0.023347925394773483
germ O 0 0.35463204979896545
- O 0 0.05596031993627548
line O 0 0.012361536733806133
variants O 0 0.0690993219614029
of O 0 0.004543039947748184
the O 0 0.009378354996442795
APC B-Disease 1 0.6248425245285034
gene O 1 0.6169210076332092
that O 0 0.010122448205947876
predispose O 0 0.45759937167167664
to O 0 0.005150198470801115
the O 0 0.005638330243527889
development O 0 0.04038967192173004
of O 0 0.04053337499499321
multiple O 1 0.8643292188644409
colorectal B-Disease 1 0.990675151348114
adenomas I-Disease 1 0.9783445596694946
and I-Disease 0 0.17812275886535645
carcinoma I-Disease 1 0.9786806106567383
, O 0 0.011350765824317932
but O 0 0.005377605091780424
without O 0 0.007136744447052479
the O 0 0.008107656612992287
florid O 1 0.5647318959236145
phenotype O 1 0.8747197389602661
of O 0 0.01187276653945446
classical O 0 0.13388730585575104
FAP B-Disease 1 0.8325420618057251
, O 0 0.009404124692082405
and O 0 0.004804781638085842
possibly O 0 0.03414951264858246
with O 0 0.013049148954451084
importance O 0 0.07991921901702881
for O 0 0.3581649661064148
colorectal B-Disease 1 0.9931005239486694
cancer I-Disease 1 0.9889391660690308
risk O 1 0.7491912841796875
in O 0 0.0150450449436903
the O 0 0.00847842637449503
general O 0 0.01322364341467619
population O 0 0.046685636043548584
. O 0 0.019001778215169907
. O 0 0.026761818677186966

Genomic O 1 0.5196399688720703
structure O 0 0.050455279648303986
of O 0 0.018167223781347275
the O 0 0.05015262961387634
human O 1 0.8236929178237915
congenital B-Disease 1 0.9850794076919556
chloride I-Disease 1 0.9698567390441895
diarrhea I-Disease 1 0.9812387228012085
( O 1 0.7964645028114319
CLD B-Disease 1 0.9413146376609802
) O 0 0.3472660183906555
gene O 1 0.8147117495536804
. O 0 0.06288076192140579

Congenital B-Disease 1 0.9640418291091919
chloride I-Disease 1 0.9415535926818848
diarrhea I-Disease 1 0.9673823714256287
( O 1 0.6015411615371704
CLD B-Disease 1 0.9189508557319641
) O 0 0.07363253086805344
is O 0 0.015575462952256203
caused O 0 0.18270842730998993
by O 0 0.02433975599706173
mutations O 1 0.8326887488365173
in O 0 0.016502493992447853
a O 0 0.044190458953380585
gene O 1 0.7670096158981323
which O 0 0.03862851858139038
encodes O 1 0.5425670742988586
an O 0 0.129033625125885
intestinal O 1 0.9624380469322205
anion O 1 0.874755322933197
transporter O 1 0.7942371964454651
. O 0 0.08048053085803986

We O 0 0.01592661812901497
report O 0 0.011971884407103062
here O 0 0.005936010740697384
the O 0 0.005214087199419737
complete O 0 0.009501626715064049
genomic O 0 0.17478995025157928
organization O 0 0.010430955328047276
of O 0 0.004452973138540983
the O 0 0.008098459802567959
human O 0 0.21164730191230774
CLD B-Disease 1 0.9121617674827576
gene O 1 0.6636227965354919
which O 0 0.01069648191332817
spans O 0 0.06165224313735962
approximately O 0 0.016706880182027817
39kb O 0 0.1154460459947586
, O 0 0.006897302344441414
and O 0 0.0061297290958464146
comprises O 0 0.013511070981621742
21 O 0 0.02384829893708229
exons O 0 0.3070627748966217
. O 0 0.035594336688518524

All O 0 0.03803868591785431
exon O 0 0.3394041955471039
/ O 0 0.2198384553194046
intron O 0 0.2751854658126831
boundaries O 0 0.01929043047130108
conform O 0 0.021581463515758514
to O 0 0.009396393783390522
the O 0 0.011806681752204895
GT O 0 0.47596311569213867
/ O 1 0.5542822480201721
AG O 1 0.5651030540466309
rule O 0 0.08050165325403214
. O 0 0.036033887416124344

An O 0 0.018953824415802956
analysis O 0 0.017393266782164574
of O 0 0.007233133539557457
the O 0 0.007516803685575724
putative O 0 0.24526159465312958
promoter O 0 0.1394830048084259
region O 0 0.018232088536024094
sequence O 0 0.0256939847022295
shows O 0 0.010907795280218124
a O 0 0.010415011085569859
putative O 0 0.2844955623149872
TATA O 0 0.19372551143169403
box O 0 0.047567106783390045
and O 0 0.011570326052606106
predicts O 0 0.23322997987270355
multiple O 0 0.2864929735660553
transcription O 1 0.6203097701072693
factor O 0 0.2188083529472351
binding O 0 0.10560404509305954
sites O 0 0.03236958757042885
. O 0 0.028374284505844116

The O 0 0.027924178168177605
genomic O 0 0.19464826583862305
structure O 0 0.02196664735674858
was O 0 0.007798551116138697
determined O 0 0.009372039698064327
using O 0 0.00891917385160923
DNA O 0 0.04654376953840256
from O 0 0.004506621044129133
several O 0 0.0044603776186704636
sources O 0 0.006862851325422525
including O 0 0.0057965596206486225
multiple O 0 0.06258607655763626
large O 0 0.024383096024394035
- O 0 0.17707188427448273
insert O 0 0.3740203082561493
libaries O 0 0.4277452826499939
and O 0 0.024096885696053505
genomic O 1 0.7495378255844116
DNA O 0 0.4900891184806824
from O 0 0.04485370218753815
Finnish O 0 0.44603395462036133
CLD B-Disease 1 0.9529516100883484
patients O 1 0.930248498916626
and O 0 0.03022238053381443
controls O 0 0.12977606058120728
. O 0 0.03827575594186783

Exon O 0 0.38392797112464905
- O 0 0.1020367443561554
specific O 0 0.03496800363063812
primers O 0 0.14012682437896729
developed O 0 0.03097970224916935
in O 0 0.006120561622083187
this O 0 0.004796084016561508
study O 0 0.020614514127373695
will O 0 0.008065001107752323
facilitate O 0 0.1563866138458252
mutation O 1 0.9265446066856384
screening O 0 0.41331130266189575
studies O 0 0.17367899417877197
of O 0 0.033298417925834656
patients O 1 0.9069235324859619
with O 0 0.057722561061382294
the O 0 0.09846354275941849
disease O 1 0.9660437703132629
. O 0 0.11186615377664566

Genomic O 0 0.3623102307319641
sequencing O 0 0.07713022083044052
of O 0 0.0194171704351902
a O 0 0.030539996922016144
BAC O 1 0.6976075768470764
clone O 1 0.6532023549079895
H O 0 0.32285356521606445
_ O 0 0.03920763358473778
RG364P16 O 0 0.11523165553808212
revealed O 0 0.01291554793715477
the O 0 0.003989729098975658
presence O 0 0.007719935849308968
of O 0 0.003431749064475298
another O 0 0.006526947021484375
, O 0 0.006955842487514019
highly O 0 0.08295131474733353
homologous O 1 0.7277818322181702
gene O 1 0.5999786257743835
3 O 0 0.012715277262032032
of O 0 0.004189856816083193
the O 0 0.010966845788061619
CLD B-Disease 1 0.868109405040741
gene O 1 0.6011625528335571
, O 0 0.005850931163877249
with O 0 0.0042457678355276585
a O 0 0.005979094188660383
similar O 0 0.03131958469748497
genomic O 0 0.4089568853378296
structure O 0 0.03825877606868744
, O 0 0.007066892925649881
recently O 0 0.019913366064429283
identified O 0 0.04099932685494423
as O 0 0.014658109284937382
the O 0 0.08977632969617844
Pendred B-Disease 1 0.9638827443122864
syndrome I-Disease 1 0.9909074306488037
gene O 1 0.9548945426940918
( O 0 0.3781149089336395
PDS B-Disease 1 0.7855560779571533
) O 0 0.07541035860776901
. O 0 0.01908395253121853
. O 0 0.023992905393242836

The O 0 0.04923659563064575
APCI1307K O 1 0.770473837852478
allele O 1 0.8790557384490967
and O 0 0.10172183811664581
cancer B-Disease 1 0.964070200920105
risk O 0 0.470466673374176
in O 0 0.008487473241984844
a O 0 0.01118487399071455
community O 0 0.019717054441571236
- O 0 0.05171619728207588
based O 0 0.011298232711851597
study O 0 0.023631591349840164
of O 0 0.010511782951653004
Ashkenazi O 0 0.3066594898700714
Jews O 0 0.05434029549360275
. O 0 0.0355057567358017

Mutations O 1 0.8477709293365479
in O 0 0.047029316425323486
APC O 0 0.4927956163883209
are O 0 0.03770889714360237
classically O 1 0.7722461223602295
associated O 1 0.5288175940513611
with O 0 0.4813289940357208
familial B-Disease 1 0.9791921377182007
adenomatous I-Disease 1 0.9833822846412659
polyposis I-Disease 1 0.9785163998603821
( O 1 0.6446691751480103
FAP B-Disease 1 0.9245321154594421
) O 0 0.08097952604293823
, O 0 0.020386524498462677
a O 0 0.06652336567640305
highly O 1 0.7012996077537537
penetrant O 1 0.9768145680427551
autosomal B-Disease 1 0.99049311876297
dominant I-Disease 1 0.9680029153823853
disorder I-Disease 1 0.9897724986076355
characterized O 1 0.9379028677940369
by O 0 0.36900171637535095
multiple O 1 0.919299304485321
intestinal O 1 0.98655104637146
polyps B-Disease 1 0.9645472764968872
and O 0 0.025453777983784676
, O 0 0.01724819839000702
without O 0 0.03639959543943405
surgical O 1 0.5745049715042114
intervention O 0 0.1311713308095932
, O 0 0.008819183334708214
the O 0 0.008826927281916142
development O 0 0.15861015021800995
of O 0 0.2636452913284302
colorectal B-Disease 1 0.9893227219581604
cancer I-Disease 1 0.9853301048278809
( O 1 0.59343022108078
CRC B-Disease 1 0.8436510562896729
) O 0 0.10571134090423584
. O 0 0.043457161635160446

APC B-Disease 0 0.43387648463249207
is O 0 0.04237896576523781
a O 0 0.13082554936408997
tumour O 1 0.9568648934364319
- O 1 0.7399137616157532
suppressor O 1 0.9366546869277954
gene O 1 0.8551416993141174
, O 0 0.02411777526140213
and O 0 0.021407756954431534
somatic O 1 0.779628574848175
loss O 1 0.5168620347976685
occurs O 1 0.6391038298606873
in O 0 0.10908904671669006
tumours B-Disease 1 0.9369213581085205
. O 0 0.11547600477933884

The O 0 0.0467156246304512
germline O 1 0.8823487758636475
T O 1 0.5534290075302124
- O 0 0.0754493996500969
to O 0 0.009912879206240177
- O 0 0.0476098358631134
A O 0 0.014831138774752617
transversion O 0 0.1631726771593094
responsible O 0 0.018853552639484406
for O 0 0.005716462153941393
the O 0 0.007261078804731369
APC O 0 0.3613855540752411
I1307K O 0 0.3808998167514801
allele O 1 0.554368793964386
converts O 0 0.04470786079764366
the O 0 0.00797072984278202
wild O 0 0.0765591487288475
- O 0 0.11252283304929733
type O 0 0.09915551543235779
sequence O 0 0.04619946703314781
to O 0 0.00642992090433836
a O 0 0.03318450227379799
homopolymer O 1 0.7196676731109619
tract O 1 0.9229229092597961
( O 0 0.12882500886917114
A8 O 1 0.545623242855072
) O 0 0.028430262580513954
that O 0 0.006724132224917412
is O 0 0.015864860266447067
genetically O 1 0.6261126399040222
unstable O 1 0.6013072729110718
and O 0 0.023662148043513298
prone O 0 0.49877050518989563
to O 0 0.03878709673881531
somatic O 1 0.8816187977790833
mutation O 1 0.9252278804779053
. O 0 0.08004366606473923

The O 0 0.036215029656887054
I1307K O 0 0.25625503063201904
allele O 0 0.3779869079589844
was O 0 0.01567760854959488
found O 0 0.016242681071162224
in O 0 0.01251645851880312
6 O 0 0.0252979788929224
. O 0 0.02325103059411049

1 O 0 0.02994033694267273
% O 0 0.02217777445912361
of O 0 0.011482561938464642
unselected O 0 0.161723792552948
Ashkenazi O 0 0.18518133461475372
Jews O 0 0.013743050396442413
and O 0 0.005502926651388407
higher O 0 0.012015697546303272
proportions O 0 0.10698758810758591
of O 0 0.007460114546120167
Ashkenazim O 0 0.39025503396987915
with O 0 0.01775897480547428
family O 0 0.04633033648133278
or O 0 0.018000703305006027
personal O 0 0.03386061638593674
histories O 0 0.21920688450336456
of O 0 0.019806763157248497
CRC B-Disease 1 0.7098730802536011
( O 0 0.0910564661026001
ref O 0 0.2557193338871002
. O 0 0.01153058372437954
2 O 0 0.01637144386768341
) O 0 0.022389812394976616
. O 0 0.018520986661314964

To O 0 0.017203228548169136
evaluate O 0 0.02445458061993122
the O 0 0.008961181156337261
role O 0 0.01399126648902893
of O 0 0.008016308769583702
I1307K O 0 0.3424307107925415
in O 0 0.03945775702595711
cancer B-Disease 1 0.9395480155944824
, O 0 0.008364525623619556
we O 0 0.004799804650247097
genotyped O 0 0.1166783943772316
5 O 0 0.014060202054679394
, O 0 0.009964773431420326
081 O 0 0.42229393124580383
Ashkenazi O 0 0.2732473611831665
volunteers O 0 0.02337338589131832
in O 0 0.008199852891266346
a O 0 0.009902074001729488
community O 0 0.02046855352818966
survey O 0 0.028648726642131805
. O 0 0.021824536845088005

Risk O 1 0.6067194938659668
of O 0 0.05175062641501427
developing O 1 0.7796207070350647
colorectal B-Disease 1 0.9728642702102661
, I-Disease 0 0.09984047710895538
breast I-Disease 1 0.9310154914855957
and I-Disease 0 0.01281337533146143
other I-Disease 0 0.024871530011296272
cancers I-Disease 1 0.9145189523696899
were O 0 0.007133843377232552
compared O 0 0.055031824856996536
between O 0 0.03939862549304962
genotyped O 1 0.5311728119850159
I1307K O 1 0.5077880620956421
carriers O 0 0.2997582256793976
and O 0 0.010818642564117908
non O 0 0.06295507401227951
- O 0 0.10580762475728989
carriers O 0 0.07963912189006805
and O 0 0.004298971500247717
their O 0 0.004805067088454962
first O 0 0.009166127070784569
- O 0 0.09209714829921722
degree O 0 0.04713226109743118
relatives O 0 0.09976170212030411
. O 0 0.03660964593291283

Sperm O 1 0.6080337762832642
DNA O 0 0.3061789572238922
analysis O 0 0.04415455460548401
in O 0 0.020199906080961227
a O 0 0.06928221881389618
Friedreich B-Disease 1 0.9321475028991699
ataxia I-Disease 1 0.9591338634490967
premutation O 1 0.7249422073364258
carrier O 0 0.22725212574005127
suggests O 0 0.09556430578231812
both O 0 0.017302177846431732
meiotic O 1 0.5117567181587219
and O 0 0.0110239889472723
mitotic O 0 0.25475460290908813
expansion O 0 0.025735117495059967
in O 0 0.012214073911309242
the O 0 0.019707871600985527
FRDA B-Disease 1 0.6176437139511108
gene O 1 0.8249405026435852
. O 0 0.06659242510795593

Friedreich B-Disease 1 0.8792775869369507
ataxia I-Disease 1 0.9013930559158325
is O 0 0.027761310338974
usually O 0 0.025463951751589775
caused O 0 0.0798460990190506
by O 0 0.007197988219559193
an O 0 0.004503948148339987
expansion O 0 0.008932077325880527
of O 0 0.005178125575184822
a O 0 0.013651152141392231
GAA O 0 0.13160200417041779
trinucleotide O 1 0.6871590614318848
repeat O 0 0.19590631127357483
in O 0 0.019954804331064224
intron O 0 0.49573442339897156
1 O 0 0.013247582130134106
of O 0 0.008762620389461517
the O 0 0.016457805410027504
FRDA B-Disease 1 0.6064426302909851
gene O 1 0.8071614503860474
. O 0 0.07635430246591568

Occasionally O 0 0.030712148174643517
, O 0 0.011724725365638733
a O 0 0.009225103072822094
fully O 0 0.010092425160109997
expanded O 0 0.011483228765428066
allele O 0 0.18357014656066895
has O 0 0.005521053448319435
been O 0 0.0033660829067230225
found O 0 0.004191910848021507
to O 0 0.0030794483609497547
arise O 0 0.03838113322854042
from O 0 0.004670705180615187
a O 0 0.006257712375372648
premutation O 0 0.0657496452331543
of O 0 0.004775322042405605
100 O 0 0.007826775312423706
or O 0 0.015613426454365253
less O 0 0.04201618209481239
triplet O 1 0.6754406690597534
repeats O 0 0.3676574230194092
. O 0 0.055024102330207825

We O 0 0.017085622996091843
have O 0 0.011491844430565834
examined O 0 0.023117847740650177
the O 0 0.010561615228652954
sperm O 0 0.3029070496559143
DNA O 0 0.13542266190052032
of O 0 0.011619843542575836
a O 0 0.02600087597966194
premutation O 0 0.42697465419769287
carrier O 0 0.21299250423908234
. O 0 0.03945211321115494

This O 0 0.027494993060827255
mans O 0 0.09827398508787155
leucocyte O 0 0.3028694987297058
DNA O 0 0.22355075180530548
showed O 0 0.0205537062138319
one O 0 0.010743318125605583
normal O 0 0.1006208285689354
allele O 0 0.4359153211116791
and O 0 0.006980179343372583
one O 0 0.0065042017959058285
allele O 0 0.21797508001327515
of O 0 0.00729634752497077
approximately O 0 0.014129227958619595
100 O 0 0.016703419387340546
repeats O 0 0.15641114115715027
. O 0 0.029978597536683083

His O 0 0.029820922762155533
sperm O 0 0.09531022608280182
showed O 0 0.020084379240870476
an O 0 0.010006851516664028
expanded O 0 0.015475411899387836
allele O 0 0.19311533868312836
in O 0 0.0054430351592600346
a O 0 0.006427944637835026
tight O 0 0.010495566762983799
range O 0 0.006722969934344292
centering O 0 0.01265003252774477
on O 0 0.0034356454852968454
a O 0 0.00472774263471365
size O 0 0.007916387170553207
of O 0 0.006367180496454239
approximately O 0 0.02453710325062275
320 O 0 0.16498392820358276
trinucleotide O 1 0.7666831016540527
repeats O 0 0.36793339252471924
. O 0 0.04696732014417648

His O 0 0.037940263748168945
affected O 0 0.1264553666114807
son O 0 0.04639119654893875
has O 0 0.013229019939899445
repeat O 0 0.06295938044786453
sizes O 0 0.0299530029296875
of O 0 0.013887526467442513
1040 O 0 0.36925801634788513
and O 0 0.01909054070711136
540 O 0 0.15304668247699738
. O 0 0.0390801876783371

These O 0 0.01653209887444973
data O 0 0.011510389856994152
suggest O 0 0.011719180271029472
that O 0 0.004436430521309376
expansion O 0 0.009703963063657284
occurs O 0 0.03563237190246582
in O 0 0.003676807275041938
two O 0 0.0035297120921313763
stages O 0 0.024408159777522087
, O 0 0.003129111835733056
the O 0 0.002845924347639084
first O 0 0.004430553875863552
during O 0 0.012248114682734013
meiosis O 0 0.25300243496894836
followed O 0 0.01373500656336546
by O 0 0.007792612072080374
a O 0 0.009998342953622341
second O 0 0.0170244462788105
mitotic O 0 0.30126482248306274
expansion O 0 0.07319878041744232
. O 0 0.033881500363349915

We O 0 0.010900136083364487
also O 0 0.006000697147101164
show O 0 0.0052326153963804245
that O 0 0.003186608199030161
in O 0 0.003064366290345788
all O 0 0.002856949809938669
informative O 0 0.017483947798609734
carrier O 0 0.040291424840688705
father O 0 0.010955464094877243
to O 0 0.004977050703018904
affected O 0 0.10001149028539658
child O 0 0.08690174669027328
transmissions O 0 0.06578857451677322
, O 0 0.003424145048484206
with O 0 0.0027438823599368334
the O 0 0.0024488274939358234
notable O 0 0.006415528245270252
exception O 0 0.006933698430657387
of O 0 0.0033121174201369286
the O 0 0.004794379696249962
premutation O 0 0.14561296999454498
carrier O 0 0.05046271160244942
, O 0 0.005393172148615122
the O 0 0.005298325326293707
expansion O 0 0.02244642563164234
size O 0 0.03280038759112358
decreases O 0 0.1778595745563507
. O 0 0.017476333305239677
. O 0 0.02492522820830345

The O 0 0.03754178062081337
R496H O 0 0.360329806804657
mutation O 1 0.6053711771965027
of O 0 0.015259895473718643
arylsulfatase O 0 0.2134082168340683
A O 0 0.02104586735367775
does O 0 0.029022028669714928
not O 0 0.021338744089007378
cause O 1 0.5863640308380127
metachromatic B-Disease 1 0.8126793503761292
leukodystrophy I-Disease 1 0.9177240133285522
. O 0 0.10738188773393631

Deficiency B-Disease 1 0.9152406454086304
of I-Disease 0 0.03429820016026497
arylsulfatase I-Disease 0 0.3591652512550354
A I-Disease 0 0.06309418380260468
( O 0 0.213723286986351
ARSA O 1 0.8755855560302734
) O 0 0.23334503173828125
enzyme O 1 0.8479331731796265
activity O 1 0.5487858653068542
causes O 1 0.9280447959899902
metachromatic B-Disease 1 0.9278796315193176
leukodystrophy I-Disease 1 0.957923412322998
( O 1 0.5148416757583618
MLD B-Disease 1 0.8786858916282654
) O 0 0.12086170166730881
. O 0 0.04168492555618286

A O 0 0.03316565230488777
number O 0 0.021512586623430252
of O 0 0.02566218003630638
ARSA O 1 0.907026469707489
gene O 1 0.9174417853355408
mutations O 1 0.9287477731704712
responsible O 0 0.09620143473148346
for O 0 0.02005731128156185
MLD B-Disease 1 0.6356063485145569
have O 0 0.014290407299995422
been O 0 0.01489422656595707
identified O 0 0.045589957386255264
. O 0 0.02609112672507763

Recently O 0 0.042032673954963684
, O 0 0.01459897868335247
the O 0 0.011624081060290337
R496H O 0 0.18303704261779785
mutation O 1 0.6320890188217163
of O 0 0.012012996710836887
ARSA O 0 0.38453659415245056
was O 0 0.006654634140431881
proposed O 0 0.008412874303758144
to O 0 0.003896428970620036
be O 0 0.003486756468191743
a O 0 0.008037303574383259
cause O 0 0.2292517125606537
of O 0 0.02260703779757023
MLD B-Disease 1 0.8989031314849854
( O 0 0.1549133062362671
Draghia O 0 0.485958456993103
et O 0 0.24964743852615356
al O 0 0.04536992311477661
. O 0 0.010299284011125565
, O 0 0.00999001506716013
1997 O 0 0.032747745513916016
) O 0 0.027400493621826172
. O 0 0.025956476107239723

We O 0 0.01707901619374752
have O 0 0.011625615879893303
investigated O 0 0.01926085725426674
the O 0 0.010440843179821968
R496H O 0 0.3669290840625763
mutation O 1 0.7559021711349487
and O 0 0.007093374617397785
found O 0 0.010184403508901596
this O 0 0.006280235480517149
mutation O 1 0.5562921166419983
at O 0 0.005222674459218979
a O 0 0.006966964807361364
relatively O 0 0.021038929000496864
high O 0 0.010101361200213432
frequency O 0 0.02066740393638611
in O 0 0.003604830941185355
an O 0 0.004590622149407864
African O 0 0.023920593783259392
American O 0 0.01559202466160059
population O 0 0.04322955012321472
( O 0 0.04227384552359581
f O 0 0.06457605957984924
= O 0 0.08405445516109467
0 O 0 0.02103620208799839
. O 0 0.006574004422873259
09 O 0 0.034895215183496475
, O 0 0.007782788947224617
n O 0 0.03475995361804962
= O 0 0.09010922163724899
61 O 0 0.03580392524600029
subjects O 0 0.057870518416166306
) O 0 0.031154954805970192
. O 0 0.02368343435227871

The O 0 0.04035882279276848
ARSA O 1 0.752507209777832
enzyme O 0 0.35786953568458557
activity O 0 0.02214219979941845
in O 0 0.0068289428018033504
subjects O 0 0.010543463751673698
with O 0 0.004768096376210451
and O 0 0.003328294027596712
without O 0 0.0055525884963572025
the O 0 0.0060036503709852695
R496H O 0 0.3022608160972595
mutation O 1 0.7153875827789307
was O 0 0.005591971334069967
determined O 0 0.010335617698729038
and O 0 0.003719127969816327
found O 0 0.005854477174580097
to O 0 0.004741409327834845
be O 0 0.007437467109411955
normal O 0 0.07143192738294601
. O 0 0.021276060491800308

It O 0 0.014582152478396893
is O 0 0.009264051914215088
therefore O 0 0.007445869967341423
concluded O 0 0.00952591747045517
that O 0 0.004077537450939417
the O 0 0.006134916562587023
R496H O 0 0.29314643144607544
mutation O 1 0.7555785179138184
of O 0 0.015233369544148445
ARSA O 1 0.6439536809921265
does O 0 0.01239747367799282
not O 0 0.004745611920952797
negatively O 0 0.025575144216418266
influence O 0 0.008963978849351406
the O 0 0.004324258770793676
activity O 0 0.01679619401693344
of O 0 0.005436824634671211
ARSA O 0 0.4619874656200409
and O 0 0.004973613657057285
is O 0 0.004894301760941744
not O 0 0.00488180760294199
a O 0 0.014531542547047138
cause O 0 0.27660277485847473
of O 0 0.03013034164905548
MLD B-Disease 1 0.8451135158538818

Down O 0 0.05056365951895714
- O 0 0.1064593568444252
regulation O 0 0.08826903998851776
of O 0 0.025651374831795692
transmembrane O 1 0.7577866911888123
carbonic O 1 0.9128153920173645
anhydrases O 1 0.856499195098877
in O 0 0.4781058430671692
renal B-Disease 1 0.9851408004760742
cell I-Disease 1 0.9658927917480469
carcinoma I-Disease 1 0.9867932200431824
cell O 1 0.8435298800468445
lines O 0 0.1716427206993103
by O 0 0.04758261889219284
wild O 0 0.3144170939922333
- O 1 0.5884421467781067
type O 1 0.7434984445571899
von B-Disease 1 0.8863277435302734
Hippel I-Disease 1 0.9358517527580261
- I-Disease 1 0.769192636013031
Lindau I-Disease 1 0.9144819378852844
transgenes O 1 0.7891544103622437
. O 0 0.08673784881830215

To O 0 0.03190068155527115
discover O 0 0.1581316590309143
genes O 0 0.49048325419425964
involved O 0 0.0543070062994957
in O 0 0.04166141897439957
von B-Disease 1 0.7091137766838074
Hippel I-Disease 1 0.9315183758735657
- I-Disease 1 0.8055895566940308
Lindau I-Disease 1 0.9435847401618958
( O 1 0.5923402905464172
VHL B-Disease 1 0.9547315835952759
) O 0 0.309124231338501
- O 1 0.5651898384094238
mediated O 1 0.8488080501556396
carcinogenesis O 1 0.8827697038650513
, O 0 0.022065039724111557
we O 0 0.017096973955631256
used O 0 0.2547021508216858
renal B-Disease 1 0.9860848188400269
cell I-Disease 1 0.9663577079772949
carcinoma I-Disease 1 0.9868090152740479
cell O 1 0.8634169697761536
lines O 0 0.375529408454895
stably O 1 0.766719400882721
transfected O 1 0.8668129444122314
with O 0 0.060951706022024155
wild O 0 0.3360491693019867
- O 1 0.5749096870422363
type O 1 0.7177298665046692
VHL O 1 0.9305770993232727
- O 0 0.4425504207611084
expressing O 0 0.2583695948123932
transgenes O 1 0.6609258055686951
. O 0 0.054272521287202835

Large O 0 0.04302259162068367
- O 0 0.07548917084932327
scale O 0 0.05998026579618454
RNA O 0 0.19690966606140137
differential O 0 0.04440696910023689
display O 0 0.008657828904688358
technology O 0 0.010052748024463654
applied O 0 0.006768785882741213
to O 0 0.0032055063638836145
these O 0 0.004942713305354118
cell O 0 0.12669239938259125
lines O 0 0.02795962058007717
identified O 0 0.03327781334519386
several O 0 0.009247863665223122
differentially O 0 0.31954604387283325
expressed O 0 0.03285675495862961
genes O 0 0.46606889367103577
, O 0 0.006895473692566156
including O 0 0.010131128132343292
an O 0 0.014573263004422188
alpha O 0 0.2637968957424164
carbonic O 1 0.9112439155578613
anhydrase O 1 0.9043776988983154
gene O 1 0.8227729797363281
, O 0 0.02948148176074028
termed O 0 0.25568726658821106
CA12 O 0 0.4778117537498474
. O 0 0.05276425927877426

The O 0 0.02262609452009201
deduced O 0 0.04747701808810234
protein O 0 0.11773879081010818
sequence O 0 0.026837032288312912
was O 0 0.00608182093128562
classified O 0 0.011649698950350285
as O 0 0.0034359428100287914
a O 0 0.004303272347897291
one O 0 0.004762530792504549
- O 0 0.04498927667737007
pass O 0 0.020236123353242874
transmembrane O 0 0.27178412675857544
CA O 0 0.044624414294958115
possessing O 0 0.035457778722047806
an O 0 0.00810304842889309
apparently O 0 0.02445073239505291
intact O 0 0.07596826553344727
catalytic O 0 0.21478819847106934
domain O 0 0.036459386348724365
in O 0 0.007369284518063068
the O 0 0.00943711493164301
extracellular O 0 0.29550713300704956
CA O 0 0.10274204611778259
module O 0 0.11008330434560776
. O 0 0.030581146478652954

Reintroduced O 0 0.22591820359230042
wild O 0 0.19233393669128418
- O 0 0.35314998030662537
type O 0 0.38833510875701904
VHL B-Disease 1 0.8542312979698181
strongly O 0 0.0495135635137558
inhibited O 0 0.2746369242668152
the O 0 0.009608101099729538
overexpression O 0 0.40695199370384216
of O 0 0.008601613342761993
the O 0 0.0140896150842309
CA12 O 1 0.6331515908241272
gene O 1 0.7664241194725037
in O 0 0.03743937984108925
the O 0 0.11044953018426895
parental O 1 0.9487228989601135
renal B-Disease 1 0.985363245010376
cell I-Disease 1 0.9680869579315186
carcinoma I-Disease 1 0.9832752346992493
cell O 1 0.8838636875152588
lines O 0 0.2906961739063263
. O 0 0.0655413568019867

Similar O 0 0.03530523553490639
results O 0 0.02059147134423256
were O 0 0.008454672992229462
obtained O 0 0.013097846880555153
with O 0 0.01100170984864235
CA9 O 1 0.5408571362495422
, O 0 0.010038181208074093
encoding O 0 0.10015427321195602
another O 0 0.016599340364336967
transmembrane O 0 0.29373177886009216
CA O 0 0.02681184746325016
with O 0 0.007097805850207806
an O 0 0.00873858667910099
intact O 0 0.0702253058552742
catalytic O 0 0.28594258427619934
domain O 0 0.11510372161865234
. O 0 0.03266533091664314

Although O 0 0.024169305339455605
both O 0 0.012137091718614101
domains O 0 0.03376239538192749
of O 0 0.0067799706012010574
the O 0 0.011522553861141205
VHL B-Disease 1 0.8751850724220276
protein O 0 0.32221925258636475
contribute O 0 0.03724024444818497
to O 0 0.005629280116409063
regulation O 0 0.027932243421673775
of O 0 0.0057089971378445625
CA12 O 0 0.2179051786661148
expression O 0 0.05162203684449196
, O 0 0.005110625177621841
the O 0 0.0055276681669056416
elongin O 0 0.1468064934015274
binding O 0 0.0759345069527626
domain O 0 0.05668340623378754
alone O 0 0.02185957320034504
could O 0 0.018114162608981133
effectively O 0 0.10380009561777115
regulate O 0 0.4488659203052521
CA9 O 1 0.8538638949394226
expression O 0 0.26910096406936646
. O 0 0.04260428994894028

We O 0 0.0345228910446167
mapped O 0 0.06637147068977356
CA12 O 0 0.24308298528194427
and O 0 0.031492482870817184
CA9 O 1 0.8185693025588989
loci O 1 0.7152156233787537
to O 0 0.030509088188409805
chromosome O 1 0.7508506774902344
bands O 0 0.06933696568012238
15q22 O 0 0.26654380559921265
and O 0 0.020395096391439438
17q21 O 0 0.2658713757991791
. O 0 0.04311778023838997

2 O 0 0.031993333250284195
respectively O 0 0.023085080087184906
, O 0 0.011321960017085075
regions O 0 0.05591917783021927
prone O 0 0.20280613005161285
to O 0 0.008776959963142872
amplification O 0 0.2395068109035492
in O 0 0.012664907611906528
some O 0 0.02070550248026848
human O 0 0.4442879557609558
cancers B-Disease 1 0.9613139033317566
. O 0 0.12227827310562134

Additional O 0 0.030817825347185135
experiments O 0 0.022961284965276718
are O 0 0.006838214583694935
needed O 0 0.006191238760948181
to O 0 0.0030972238164395094
define O 0 0.006528208963572979
the O 0 0.003068293444812298
role O 0 0.007724912371486425
of O 0 0.004632133990526199
CA O 0 0.04683028534054756
IX O 0 0.19359226524829865
and O 0 0.007843527011573315
CA O 0 0.05898008868098259
XII O 0 0.2043815702199936
enzymes O 0 0.15443308651447296
in O 0 0.004301678389310837
the O 0 0.0037405944894999266
regulation O 0 0.026956044137477875
of O 0 0.006391014903783798
pH O 0 0.37355491518974304
in O 0 0.006402252707630396
the O 0 0.007119433023035526
extracellular O 0 0.3317481577396393
microenvironment O 0 0.47737574577331543
and O 0 0.004938725382089615
its O 0 0.0057590315118432045
potential O 0 0.07316736876964569
impact O 0 0.12329623103141785
on O 0 0.05744154378771782
cancer B-Disease 1 0.977161169052124
cell O 1 0.8044489026069641
growth O 0 0.4029761850833893
. O 0 0.07440746575593948

A O 0 0.06835120916366577
gene O 1 0.6404250860214233
encoding O 0 0.22905825078487396
a O 0 0.04882624372839928
transmembrane O 1 0.6807411909103394
protein O 1 0.7359121441841125
is O 0 0.1253286749124527
mutated O 1 0.9443279504776001
in O 0 0.3990839719772339
patients O 1 0.9778680801391602
with O 1 0.858544111251831
diabetes B-Disease 1 0.991957426071167
mellitus I-Disease 1 0.9838539958000183
and O 1 0.7135221362113953
optic B-Disease 1 0.9782654643058777
atrophy I-Disease 1 0.9790999293327332
( O 1 0.9033498764038086
Wolfram B-Disease 1 0.9627253413200378
syndrome I-Disease 1 0.9825628995895386
) O 0 0.3728901743888855
. O 0 0.08789040148258209

Wolfram B-Disease 1 0.8927388191223145
syndrome I-Disease 1 0.9598391056060791
( O 1 0.5882554650306702
WFS B-Disease 1 0.8931016325950623
; O 0 0.403144508600235
OMIM O 1 0.9098137021064758
222300 O 1 0.6770316362380981
) O 0 0.14119595289230347
is O 0 0.10020649433135986
an O 0 0.469347208738327
autosomal B-Disease 1 0.9892297387123108
recessive I-Disease 1 0.9897485375404358
neurodegenerative I-Disease 1 0.9877782464027405
disorder I-Disease 1 0.9817938804626465
defined O 0 0.4940531849861145
by O 0 0.18578042089939117
young O 1 0.6790823340415955
- O 1 0.9016007781028748
onset O 1 0.9812465310096741
non O 1 0.8935019969940186
- O 1 0.9590480327606201
immune O 1 0.9872181415557861
insulin B-Disease 1 0.9779826402664185
- I-Disease 1 0.951955258846283
dependent I-Disease 1 0.9530707001686096
diabetes I-Disease 1 0.9878786206245422
mellitus I-Disease 1 0.9668399691581726
and O 0 0.3438142240047455
progressive O 1 0.9008814692497253
optic B-Disease 1 0.9435396194458008
atrophy I-Disease 1 0.9373754858970642
. O 0 0.16585202515125275

Linkage O 0 0.13650473952293396
to O 0 0.02017977274954319
markers O 0 0.0873994380235672
on O 0 0.016612954437732697
chromosome O 1 0.6640505790710449
4p O 0 0.2664394974708557
was O 0 0.012077732011675835
confirmed O 0 0.016255546361207962
in O 0 0.009123258292675018
five O 0 0.012978898361325264
families O 0 0.05302178114652634
. O 0 0.02637632004916668

On O 0 0.01762174814939499
the O 0 0.01121869683265686
basis O 0 0.011884224601089954
of O 0 0.011432724073529243
meiotic O 1 0.8291073441505432
recombinants O 1 0.7767837643623352
and O 0 0.1744118481874466
disease O 1 0.982229471206665
- O 1 0.598362147808075
associated O 0 0.4644603133201599
haplotypes O 1 0.8450016975402832
, O 0 0.016317961737513542
the O 0 0.019687248393893242
WFS B-Disease 1 0.842553973197937
gene O 1 0.6921770572662354
was O 0 0.012348143383860588
localized O 0 0.3235929012298584
to O 0 0.007952592335641384
a O 0 0.027564849704504013
BAC O 1 0.7789831757545471
/ O 0 0.39608606696128845
P1 O 0 0.3226239085197449
contig O 0 0.11235620081424713
of O 0 0.0065208738669753075
less O 0 0.011341983452439308
than O 0 0.011912064626812935
250 O 0 0.03293951228260994
kb O 0 0.22185485064983368
. O 0 0.0373973622918129

Mutations O 1 0.7980953454971313
in O 0 0.024834519252181053
a O 0 0.027407415211200714
novel O 0 0.226518452167511
gene O 1 0.7622107267379761
( O 0 0.08790273219347
WFS1 O 0 0.3659802973270416
) O 0 0.02948354184627533
encoding O 0 0.10176989436149597
a O 0 0.0125865014269948
putative O 0 0.3287075459957123
transmembrane O 0 0.36760979890823364
protein O 0 0.11174847930669785
were O 0 0.0034603639505803585
found O 0 0.004774877801537514
in O 0 0.0028383859898895025
all O 0 0.0030603280756622553
affected O 0 0.08037254214286804
individuals O 0 0.03574957326054573
in O 0 0.008512892760336399
six O 0 0.028156248852610588
WFS B-Disease 1 0.7717713117599487
families O 0 0.039869312196969986
, O 0 0.005365333985537291
and O 0 0.004246679600328207
these O 0 0.009896586649119854
mutations O 1 0.7493590116500854
were O 0 0.009473088197410107
associated O 0 0.106996551156044
with O 0 0.0375203937292099
the O 0 0.12508134543895721
disease O 1 0.9772619009017944
phenotype O 1 0.9485095739364624
. O 0 0.17147573828697205

WFS1 O 0 0.21461939811706543
appears O 0 0.04202861711382866
to O 0 0.013695312663912773
function O 0 0.03441264107823372
in O 0 0.012185542844235897
survival O 0 0.20531564950942993
of O 0 0.01660480722784996
islet O 1 0.6834102272987366
beta O 1 0.6830905675888062
- O 1 0.5743045210838318
cells O 1 0.8025306463241577
and O 0 0.027088800445199013
neurons O 1 0.5365537405014038
. O 0 0.02780233882367611
. O 0 0.03006782941520214

Stable O 0 0.12861572206020355
interaction O 0 0.037821441888809204
between O 0 0.010608527809381485
the O 0 0.005966122727841139
products O 0 0.013442912138998508
of O 0 0.007551549468189478
the O 0 0.02860768884420395
BRCA1 O 1 0.9616861939430237
and O 0 0.28966835141181946
BRCA2 O 1 0.9802349805831909
tumor B-Disease 1 0.9794951677322388
suppressor O 1 0.9539316892623901
genes O 1 0.8772745728492737
in O 0 0.06977637857198715
mitotic O 1 0.6957055926322937
and O 0 0.06700967252254486
meiotic O 1 0.8654682636260986
cells O 1 0.8342629075050354
. O 0 0.08977662026882172

BRCA1 O 1 0.8739027976989746
and O 0 0.038323819637298584
BRCA2 O 1 0.8384042978286743
account O 0 0.018221747130155563
for O 0 0.007207958493381739
most O 0 0.010271301493048668
cases O 0 0.11094079166650772
of O 0 0.029741449281573296
familial O 1 0.955051600933075
, O 0 0.1182854026556015
early O 0 0.4779890477657318
onset O 1 0.9843429327011108
breast B-Disease 1 0.9842391014099121
and I-Disease 0 0.2587479054927826
/ I-Disease 1 0.9004904627799988
or I-Disease 1 0.7161667346954346
ovarian I-Disease 1 0.9904068112373352
cancer I-Disease 1 0.9790665507316589
and O 0 0.021989958360791206
encode O 0 0.14887556433677673
products O 0 0.050728689879179
that O 0 0.006878192070871592
each O 0 0.010303908959031105
interact O 0 0.08746916055679321
with O 0 0.022427909076213837
hRAD51 O 0 0.29735007882118225
. O 0 0.04360412433743477

Results O 0 0.0372915081679821
presented O 0 0.019425442442297935
here O 0 0.009595893323421478
show O 0 0.012012657709419727
that O 0 0.012975770980119705
BRCA1 O 1 0.8957570195198059
and O 0 0.025111036375164986
BRCA2 O 1 0.9262609481811523
coexist O 0 0.22575600445270538
in O 0 0.008957333862781525
a O 0 0.010654481127858162
biochemical O 0 0.19488166272640228
complex O 0 0.025755595415830612
and O 0 0.006717495154589415
colocalize O 0 0.18195085227489471
in O 0 0.01943216472864151
subnuclear O 0 0.46856409311294556
foci O 1 0.6627623438835144
in O 0 0.03766445815563202
somatic O 1 0.7405490875244141
cells O 0 0.45059704780578613
and O 0 0.004858909174799919
on O 0 0.0035157641395926476
the O 0 0.004655512049794197
axial O 0 0.1195264458656311
elements O 0 0.01654977723956108
of O 0 0.012235274538397789
developing O 0 0.26276108622550964
synaptonemal O 1 0.5231781005859375
complexes O 0 0.4158325493335724
. O 0 0.05763745680451393

Like O 0 0.10458536446094513
BRCA1 O 1 0.8668451905250549
and O 0 0.03935203701257706
RAD51 O 1 0.7971606254577637
, O 0 0.062339283525943756
BRCA2 O 1 0.923862636089325
relocates O 0 0.4059394896030426
to O 0 0.031122850254178047
PCNA O 1 0.8235807418823242
+ O 1 0.5059298872947693
replication O 1 0.570956826210022
sites O 0 0.023446470499038696
following O 0 0.027439303696155548
exposure O 0 0.3928264081478119
of O 0 0.010601568035781384
S O 0 0.23514406383037567
phase O 0 0.3546087443828583
cells O 1 0.8283026218414307
to O 0 0.04980701953172684
hydroxyurea O 1 0.8871266841888428
or O 0 0.20445199310779572
UV O 1 0.8733879923820496
irradiation O 1 0.5873775482177734
. O 0 0.06612143665552139

Thus O 0 0.05597655475139618
, O 0 0.03164131939411163
BRCA1 O 1 0.8489238023757935
and O 0 0.015514357015490532
BRCA2 O 1 0.7751486897468567
participate O 0 0.01033015176653862
, O 0 0.0048502725549042225
together O 0 0.004611646756529808
, O 0 0.0031970778945833445
in O 0 0.0033205649815499783
a O 0 0.00792072806507349
pathway O 0 0.36345338821411133
( O 0 0.06050306186079979
s O 0 0.11316857486963272
) O 0 0.020484237000346184
associated O 0 0.015151774510741234
with O 0 0.003721966641023755
the O 0 0.0040559787303209305
activation O 0 0.1386032998561859
of O 0 0.005990156903862953
double O 0 0.10177001357078552
- O 0 0.24261663854122162
strand O 0 0.41135329008102417
break O 0 0.14346373081207275
repair O 0 0.45129629969596863
and O 0 0.02411942556500435
/ O 0 0.4637593626976013
or O 0 0.09899847954511642
homologous O 1 0.8323796391487122
recombination O 1 0.8090056777000427
. O 0 0.0750136747956276

Dysfunction O 1 0.825370192527771
of O 0 0.014436721801757812
this O 0 0.010552381165325642
pathway O 0 0.2319212406873703
may O 0 0.015968868508934975
be O 0 0.0034705307334661484
a O 0 0.0038793617859482765
general O 0 0.003867083229124546
phenomenon O 0 0.049306780099868774
in O 0 0.003599385032430291
the O 0 0.003682472510263324
majority O 0 0.018753904849290848
of O 0 0.009408713318407536
cases O 0 0.2632935345172882
of O 0 0.07222548872232437
hereditary B-Disease 1 0.9713808298110962
breast I-Disease 1 0.9837808609008789
and I-Disease 0 0.34442105889320374
/ I-Disease 1 0.9359033107757568
or I-Disease 1 0.8371650576591492
ovarian I-Disease 1 0.9896798729896545
cancer I-Disease 1 0.9824817776679993
. O 0 0.1404537856578827
. O 0 0.08340322226285934

A O 0 0.053316012024879456
novel O 0 0.1338164210319519
Arg362Ser O 0 0.4163045883178711
mutation O 1 0.645524799823761
in O 0 0.01578916236758232
the O 0 0.015792695805430412
sterol O 1 0.6658989191055298
27 O 0 0.12268760055303574
- O 0 0.49532222747802734
hydroxylase O 1 0.8725484013557434
gene O 1 0.8379064798355103
( O 0 0.08622810989618301
CYP27 O 0 0.259909063577652
) O 0 0.014270191080868244
: O 0 0.006348407361656427
its O 0 0.004641711711883545
effects O 0 0.0874880775809288
on O 0 0.005935558117926121
pre O 0 0.09084652364253998
- O 0 0.15336036682128906
mRNA O 0 0.336047887802124
splicing O 1 0.5968158841133118
and O 0 0.03174901381134987
enzyme O 1 0.643349826335907
activity O 0 0.12118031084537506
. O 0 0.03669646009802818

A O 0 0.037638477981090546
novel O 0 0.06486902385950089
C O 0 0.043546583503484726
to O 0 0.007526656612753868
A O 0 0.011741235852241516
mutation O 0 0.49412772059440613
in O 0 0.00786477979272604
the O 0 0.010479775257408619
sterol O 1 0.6702042818069458
27 O 0 0.13611054420471191
- O 1 0.5103416442871094
hydroxylase O 1 0.891560971736908
gene O 1 0.8707312941551208
( O 0 0.13574351370334625
CYP27 O 0 0.36452925205230713
) O 0 0.01462443545460701
was O 0 0.004705850034952164
identified O 0 0.018349962309002876
by O 0 0.010664728470146656
sequencing O 0 0.2674684524536133
amplified O 0 0.4115743041038513
CYP27 O 1 0.721665620803833
gene O 1 0.8077579140663147
products O 0 0.10394516587257385
from O 0 0.01805132068693638
a O 0 0.04318619146943092
patient O 1 0.7421363592147827
with O 0 0.06512060761451721
cerebrotendinous B-Disease 1 0.834360659122467
xanthomatosis I-Disease 1 0.8448894023895264
( O 0 0.29462680220603943
CTX B-Disease 1 0.8683604598045349
) O 0 0.09366150945425034
. O 0 0.03494444489479065

The O 0 0.03286951407790184
mutation O 0 0.46145302057266235
changed O 0 0.022749517112970352
the O 0 0.013207667507231236
adrenodoxin O 0 0.2053145468235016
cofactor O 0 0.23510998487472534
binding O 0 0.12404055148363113
residue O 0 0.17809203267097473
362Arg O 0 0.21802909672260284
to O 0 0.011332004331052303
362Ser O 0 0.3244307339191437
( O 0 0.08472249656915665
CGT O 0 0.4022919237613678
362Arg O 0 0.385786771774292
to O 0 0.02206435240805149
AGT O 1 0.8330162167549133
362Ser O 0 0.351139098405838
) O 0 0.016439221799373627
, O 0 0.003926481120288372
and O 0 0.0028811341617256403
was O 0 0.0035573276691138744
responsible O 0 0.020402297377586365
for O 0 0.014767399989068508
deficiency O 1 0.9461009502410889
in O 0 0.007823857478797436
the O 0 0.009511194191873074
sterol O 1 0.5834737420082092
27 O 0 0.06454302370548248
- O 0 0.22711679339408875
hydroxylase O 1 0.5365874171257019
activity O 0 0.030639592558145523
, O 0 0.005166309420019388
as O 0 0.00458046467974782
confirmed O 0 0.009662254713475704
by O 0 0.005826474633067846
expression O 0 0.03195186331868172
of O 0 0.008386530913412571
mutant O 0 0.34759554266929626
cDNA O 0 0.3276712894439697
into O 0 0.04288466274738312
COS O 1 0.6278170943260193
- O 0 0.35578784346580505
1 O 0 0.09676095843315125
cells O 1 0.7263966798782349
. O 0 0.05916431546211243

Quantitative O 0 0.07125401496887207
analysis O 0 0.023976001888513565
showed O 0 0.012938322499394417
that O 0 0.0053847492672502995
the O 0 0.005230932496488094
expression O 0 0.02661455050110817
of O 0 0.009713038802146912
CYP27 O 1 0.5091050863265991
gene O 1 0.7086406350135803
mRNA O 0 0.1975032538175583
in O 0 0.010744432918727398
the O 0 0.010623332113027573
patient O 0 0.4321262240409851
represented O 0 0.02325618453323841
52 O 0 0.050763532519340515
. O 0 0.03161732479929924

5 O 0 0.03300190716981888
% O 0 0.019363833591341972
of O 0 0.008913123980164528
the O 0 0.009541492909193039
normal O 0 0.04523205757141113
level O 0 0.023727238178253174
. O 0 0.02546958066523075

As O 0 0.021910520270466805
the O 0 0.014877173118293285
mutation O 1 0.5141244530677795
occurred O 0 0.019947268068790436
at O 0 0.0071194968186318874
the O 0 0.005179054103791714
penultimate O 0 0.08564084768295288
nucleotide O 0 0.15396329760551453
of O 0 0.008552405051887035
exon O 0 0.20868852734565735
6 O 0 0.03128885477781296
( O 0 0.021476414054632187
- O 0 0.02464696206152439
2 O 0 0.0063871280290186405
position O 0 0.004602435976266861
of O 0 0.004498119466006756
exon O 0 0.20928186178207397
6 O 0 0.03282754123210907
- O 0 0.16271120309829712
intron O 1 0.6133043766021729
6 O 0 0.03795527666807175
splice O 0 0.33263450860977173
site O 0 0.011808567680418491
) O 0 0.006839840207248926
of O 0 0.0028187872376292944
the O 0 0.0041070785373449326
gene O 0 0.2889276146888733
, O 0 0.004372855648398399
we O 0 0.003228389658033848
hypothesized O 0 0.07285046577453613
that O 0 0.004401237238198519
the O 0 0.007976425811648369
mutation O 1 0.7842873930931091
may O 0 0.055014677345752716
partially O 0 0.11126670241355896
affect O 0 0.052959997206926346
the O 0 0.0065683117136359215
normal O 0 0.08715925365686417
splicing O 0 0.34460777044296265
efficiency O 0 0.049439091235399246
in O 0 0.01142056193202734
exon O 0 0.240724578499794
6 O 0 0.023235829547047615
and O 0 0.007654626853764057
cause O 0 0.19932490587234497
alternative O 0 0.056852810084819794
splicing O 0 0.32901984453201294
elsewhere O 0 0.017670219764113426
, O 0 0.004921756684780121
which O 0 0.004498140886425972
resulted O 0 0.03373365104198456
in O 0 0.008322473615407944
decreased O 0 0.1973063051700592
transcript O 0 0.12287392467260361
in O 0 0.012957976199686527
the O 0 0.020726189017295837
patient O 1 0.6890112161636353
. O 0 0.05325240269303322

Transfection O 0 0.27268698811531067
of O 0 0.017235474660992622
constructed O 0 0.02024230919778347
minigenes O 0 0.06206561625003815
, O 0 0.006994296796619892
with O 0 0.005425133742392063
or O 0 0.007675006054341793
without O 0 0.006960383150726557
the O 0 0.0061054411344230175
mutation O 1 0.632346510887146
, O 0 0.006771578919142485
into O 0 0.013066036626696587
COS O 1 0.5196828842163086
- O 0 0.18141357600688934
1 O 0 0.03714940324425697
cells O 1 0.5233827829360962
confirmed O 0 0.019197922199964523
that O 0 0.003126872470602393
the O 0 0.004104205407202244
mutant O 0 0.21192464232444763
minigene O 0 0.1276765912771225
was O 0 0.004740421660244465
responsible O 0 0.008516212925314903
for O 0 0.004069623537361622
a O 0 0.009702256880700588
mRNA O 0 0.18798527121543884
species O 0 0.09512637555599213
alternatively O 0 0.15340350568294525
spliced O 0 0.3068430721759796
at O 0 0.00901759136468172
an O 0 0.011644966900348663
activated O 0 0.18475191295146942
cryptic O 0 0.16429097950458527
5 O 0 0.017281273379921913
splice O 0 0.22505606710910797
site O 0 0.01060626469552517
88 O 0 0.014693130739033222
bp O 0 0.01969730295240879
upstream O 0 0.013597879558801651
from O 0 0.00498590711504221
the O 0 0.004255843348801136
3 O 0 0.007245669141411781
end O 0 0.008501039817929268
of O 0 0.007077956572175026
exon O 0 0.1712239533662796
6 O 0 0.030874032527208328
. O 0 0.027465978637337685

Our O 0 0.022275380790233612
data O 0 0.014461180195212364
suggest O 0 0.013063018210232258
that O 0 0.004749224055558443
the O 0 0.00431025680154562
C O 0 0.016173891723155975
to O 0 0.003570838365703821
A O 0 0.0075167822651565075
mutation O 0 0.3574293255805969
at O 0 0.005213209427893162
the O 0 0.00448760949075222
penultimate O 0 0.08599827438592911
nucleotide O 0 0.1264166682958603
of O 0 0.0058759357780218124
exon O 0 0.07775145024061203
6 O 0 0.00805016327649355
of O 0 0.003955344669520855
the O 0 0.00747572910040617
CYP27 O 0 0.482456773519516
gene O 1 0.6198384761810303
not O 0 0.006802162621170282
only O 0 0.008435418829321861
causes O 1 0.5493325591087341
the O 0 0.03616085276007652
deficiency B-Disease 1 0.9693618416786194
in I-Disease 0 0.01376862358301878
the I-Disease 0 0.015424110926687717
sterol I-Disease 1 0.7084366083145142
27 I-Disease 0 0.09754837304353714
- I-Disease 0 0.30244946479797363
hydroxylase I-Disease 1 0.6239562034606934
activity I-Disease 0 0.0492677204310894
, O 0 0.0046981628984212875
but O 0 0.003251457354053855
also O 0 0.0030774539336562157
partially O 0 0.016721811145544052
leads O 0 0.012026112526655197
to O 0 0.004155275411903858
alternative O 0 0.025330454111099243
pre O 0 0.09738645702600479
- O 0 0.13414713740348816
mRNA O 0 0.21635058522224426
splicing O 0 0.2850804328918457
of O 0 0.01378649938851595
the O 0 0.0234262365847826
gene O 1 0.7167417407035828
. O 0 0.058593980967998505

To O 0 0.013282970525324345
our O 0 0.00881196279078722
knowledge O 0 0.007738368585705757
, O 0 0.003652359591796994
this O 0 0.002502397634088993
is O 0 0.0024258531630039215
the O 0 0.002194792265072465
first O 0 0.0024354010820388794
report O 0 0.004227912053465843
regarding O 0 0.006280889734625816
effects O 0 0.07721124589443207
on O 0 0.004548403900116682
pre O 0 0.07592432200908661
- O 0 0.10336322337388992
mRNA O 0 0.1836433708667755
splicing O 0 0.31554967164993286
of O 0 0.006992187350988388
a O 0 0.014832966029644012
mutation O 1 0.6114640235900879
at O 0 0.005942945368587971
the O 0 0.003947599790990353
- O 0 0.019431710243225098
2 O 0 0.005128242075443268
position O 0 0.0038860375061631203
of O 0 0.003637070069089532
a O 0 0.008079543709754944
5 O 0 0.016261739656329155
splice O 0 0.25565147399902344
site O 0 0.028537819162011147
. O 0 0.02699781209230423

ATM O 1 0.7044884562492371
germline O 1 0.8914574980735779
mutations O 1 0.9049351811408997
in O 0 0.0894991084933281
classical O 1 0.5221148133277893
ataxia B-Disease 1 0.9727562069892883
- I-Disease 1 0.9037194848060608
telangiectasia I-Disease 1 0.9658501148223877
patients O 1 0.9162120223045349
in O 0 0.018473081290721893
the O 0 0.013500116765499115
Dutch O 0 0.08179059624671936
population O 0 0.08004987984895706
. O 0 0.04063001647591591

Germline O 1 0.8744102120399475
mutations O 1 0.7538868188858032
in O 0 0.021153923124074936
the O 0 0.01733510196208954
ATM O 0 0.25102725625038147
gene O 1 0.5324105620384216
are O 0 0.012686510570347309
responsible O 0 0.06814245134592056
for O 0 0.057340167462825775
the O 1 0.5547558069229126
autosomal B-Disease 1 0.9915321469306946
recessive I-Disease 1 0.9924390316009521
disorder I-Disease 1 0.9927577972412109
ataxia B-Disease 1 0.9866423606872559
- I-Disease 1 0.9536725878715515
telangiectasia I-Disease 1 0.975629985332489
( O 0 0.4355461001396179
A B-Disease 0 0.23499219119548798
- I-Disease 1 0.599963366985321
T I-Disease 1 0.8082121014595032
) O 0 0.09555280208587646
. O 0 0.039971787482500076

In O 0 0.018173640593886375
our O 0 0.011903239414095879
study O 0 0.01338235568255186
, O 0 0.004921487532556057
we O 0 0.0030810050666332245
have O 0 0.0033629729878157377
determined O 0 0.006138848606497049
the O 0 0.005288013722747564
ATM O 0 0.16694018244743347
mutation O 1 0.6737848520278931
spectrum O 0 0.06504552066326141
in O 0 0.007009783759713173
19 O 0 0.017811620607972145
classical O 0 0.050539467483758926
A B-Disease 0 0.0963943600654602
- I-Disease 0 0.49455615878105164
T I-Disease 1 0.8448691964149475
patients O 1 0.8074706196784973
, O 0 0.006055550184100866
including O 0 0.005459566600620747
some O 0 0.0038387784734368324
immigrant O 0 0.05036558210849762
populations O 0 0.06864280998706818
, O 0 0.003228843677788973
as O 0 0.002284993650391698
well O 0 0.002543270355090499
as O 0 0.0025420174933969975
12 O 0 0.004256915301084518
of O 0 0.004411619156599045
Dutch O 0 0.026014097034931183
ethnic O 0 0.03708977624773979
origin O 0 0.059331465512514114
. O 0 0.03163362666964531

Both O 0 0.023409008979797363
the O 0 0.016335835680365562
protein O 0 0.2642958462238312
truncation O 0 0.23169955611228943
test O 0 0.029005108401179314
( O 0 0.02199600636959076
PTT O 0 0.03647645190358162
) O 0 0.010546506382524967
and O 0 0.0043368893675506115
the O 0 0.005032420624047518
restriction O 0 0.10241691768169403
endonuclease O 1 0.5452721118927002
fingerprinting O 0 0.1956375241279602
( O 0 0.04406263306736946
REF O 0 0.1521163433790207
) O 0 0.007012592162936926
method O 0 0.0052047413773834705
were O 0 0.0020808614790439606
used O 0 0.002417692681774497
and O 0 0.00204655434936285
compared O 0 0.004451286513358355
for O 0 0.002416384406387806
their O 0 0.003551148809492588
detection O 0 0.07543625682592392
efficiency O 0 0.02554169110953808
, O 0 0.004962412640452385
identifying O 0 0.031117763370275497
76 O 0 0.01966853253543377
% O 0 0.011602513492107391
and O 0 0.0033518485724925995
60 O 0 0.006368403322994709
% O 0 0.009668052196502686
of O 0 0.004113963805139065
the O 0 0.011226247996091843
mutations O 1 0.823674738407135
, O 0 0.014204800128936768
respectively O 0 0.034866686910390854
. O 0 0.028729764744639397

Most O 0 0.040570978075265884
patients O 0 0.4244273602962494
were O 0 0.007468394003808498
found O 0 0.008108224719762802
to O 0 0.006796333938837051
be O 0 0.008713600225746632
compound O 0 0.09347480535507202
heterozygote O 1 0.6049671769142151
. O 0 0.04524226486682892

Seventeen O 0 0.05989670008420944
mutations O 0 0.46358510851860046
were O 0 0.010152196511626244
distinct O 0 0.018860194832086563
, O 0 0.00493905832991004
of O 0 0.0033381714019924402
which O 0 0.0033735311590135098
10 O 0 0.004041368141770363
were O 0 0.00295732612721622
not O 0 0.004975803662091494
reported O 0 0.016367727890610695
previously O 0 0.016904545947909355
. O 0 0.02230517566204071

Mutations O 1 0.7124309539794922
are O 0 0.02093931846320629
small O 0 0.026742395013570786
deletions O 0 0.2639766335487366
or O 0 0.027161123231053352
point O 0 0.025035785511136055
mutations O 1 0.8571182489395142
frequently O 0 0.11094993352890015
affecting O 0 0.4311171770095825
splice O 1 0.5820547938346863
sites O 0 0.07841266691684723
. O 0 0.04819474741816521

Moreover O 0 0.06306300312280655
, O 0 0.024536138400435448
a O 0 0.02339242398738861
16 O 0 0.03086700104176998
. O 0 0.03182392194867134

7 O 0 0.058216843754053116
- O 0 0.11530172824859619
kb O 0 0.1813870370388031
genomic O 0 0.42715051770210266
deletion O 0 0.19317813217639923
of O 0 0.006438425742089748
the O 0 0.004718429408967495
3 O 0 0.005934832151979208
end O 0 0.0042952680960297585
of O 0 0.0030918840784579515
the O 0 0.0047118281945586205
gene O 0 0.25315162539482117
, O 0 0.003278493881225586
most O 0 0.003058398375287652
likely O 0 0.0058989571407437325
a O 0 0.003915485460311174
result O 0 0.011933786794543266
of O 0 0.003969459794461727
recombination O 0 0.13873283565044403
between O 0 0.005704387091100216
two O 0 0.003957583103328943
LINE O 0 0.00804138369858265
elements O 0 0.009011026471853256
, O 0 0.006029060110449791
was O 0 0.006790427025407553
identified O 0 0.03171737864613533
. O 0 0.020412100479006767

The O 0 0.017567383125424385
most O 0 0.012290879152715206
frequently O 0 0.021569032222032547
found O 0 0.03457022085785866
mutation O 1 0.702881395816803
, O 0 0.007091779727488756
identified O 0 0.012986842542886734
in O 0 0.004763072822242975
three O 0 0.007129312958568335
unrelated O 0 0.19016946852207184
Turkish O 0 0.039085641503334045
A B-Disease 0 0.052006397396326065
- I-Disease 0 0.24186977744102478
T I-Disease 1 0.6274358034133911
individuals O 0 0.03664785623550415
, O 0 0.003946351353079081
was O 0 0.0028369410429149866
previously O 0 0.0036380409728735685
described O 0 0.0052972096018493176
to O 0 0.002387627260759473
be O 0 0.0027633982244879007
a O 0 0.005312250927090645
Turkish O 0 0.0205677542835474
A B-Disease 0 0.04913314804434776
- I-Disease 0 0.3413841724395752
T I-Disease 1 0.7806276679039001
founder O 0 0.3329794108867645
mutation O 1 0.8909751176834106
. O 0 0.08444622159004211

The O 0 0.01787842996418476
presence O 0 0.01681581512093544
of O 0 0.007476131897419691
a O 0 0.009920088574290276
founder O 0 0.07925283163785934
mutation O 1 0.6631104350090027
among O 0 0.014093663543462753
relatively O 0 0.022130999714136124
small O 0 0.008145582862198353
ethnic O 0 0.014762994833290577
population O 0 0.012039477936923504
groups O 0 0.006096966564655304
in O 0 0.0032362197525799274
Western O 0 0.0057295458391308784
Europe O 0 0.006954512093216181
could O 0 0.004463410936295986
indicate O 0 0.012112167663872242
a O 0 0.006656701676547527
high O 0 0.014611288905143738
carrier O 0 0.07447917014360428
frequency O 0 0.03147374093532562
in O 0 0.006849071942269802
such O 0 0.01276437845081091
communities O 0 0.056684594601392746
. O 0 0.02514900080859661

In O 0 0.033349547535181046
patients O 0 0.388458788394928
of O 0 0.00934691447764635
Dutch O 0 0.017689930275082588
ethnic O 0 0.017966629937291145
origin O 0 0.0186289232224226
, O 0 0.004599606152623892
however O 0 0.004551647696644068
, O 0 0.0033460285048931837
no O 0 0.0040831780061125755
significant O 0 0.013536719605326653
founder O 0 0.03305281326174736
effect O 0 0.0321800671517849
could O 0 0.008387652225792408
be O 0 0.006868664640933275
identified O 0 0.029459716752171516
. O 0 0.023499520495533943

The O 0 0.027541441842913628
observed O 0 0.09277822822332382
genetic O 1 0.5004920959472656
heterogeneity O 0 0.12941785156726837
including O 0 0.008704748935997486
the O 0 0.005080870818346739
relative O 0 0.010745772160589695
high O 0 0.007336840033531189
percentage O 0 0.013556694611907005
of O 0 0.0072088222950696945
splice O 1 0.5876795649528503
- O 0 0.2044171541929245
site O 0 0.05267715081572533
mutations O 1 0.7672854661941528
had O 0 0.01028919406235218
no O 0 0.006799733731895685
reflection O 0 0.02225550264120102
on O 0 0.006647979840636253
the O 0 0.01704050973057747
phenotype O 1 0.8984212875366211
. O 0 0.0589635856449604

All O 0 0.04261164739727974
patients O 1 0.742815375328064
manifested O 0 0.264455109834671
classical O 0 0.046783123165369034
A B-Disease 0 0.05953735113143921
- I-Disease 0 0.27558228373527527
T I-Disease 1 0.5492213368415833
and O 0 0.014387913979589939
increased O 0 0.0848500058054924
cellular O 1 0.511577308177948
radioresistant O 1 0.6019728779792786
DNA O 1 0.6086719632148743
synthesis O 0 0.41702285408973694
. O 0 0.048044849187135696

Determination O 0 0.029954301193356514
of O 0 0.010876462794840336
the O 0 0.010039900429546833
genomic O 0 0.19542968273162842
structure O 0 0.016355767846107483
of O 0 0.006416840944439173
the O 0 0.012067243456840515
COL4A4 O 1 0.6141260266304016
gene O 1 0.743510901927948
and O 0 0.017791535705327988
of O 0 0.04474304988980293
novel O 1 0.7735434174537659
mutations O 1 0.9803490042686462
causing O 1 0.9760489463806152
autosomal B-Disease 1 0.9884795546531677
recessive I-Disease 1 0.9860568046569824
Alport I-Disease 1 0.9715065956115723
syndrome I-Disease 1 0.9734795689582825
. O 0 0.32217440009117126

Autosomal B-Disease 1 0.9609625339508057
recessive I-Disease 1 0.9639785885810852
Alport I-Disease 1 0.9464746713638306
syndrome I-Disease 1 0.9619449377059937
is O 0 0.08989016711711884
a O 0 0.09979106485843658
progressive O 1 0.7311267256736755
hematuric B-Disease 1 0.8830916881561279
glomerulonephritis I-Disease 1 0.9561406373977661
characterized O 1 0.834813117980957
by O 0 0.2230963110923767
glomerular B-Disease 1 0.9501758813858032
basement I-Disease 1 0.5650349259376526
membrane I-Disease 1 0.7905210852622986
abnormalities I-Disease 1 0.9351087212562561
and O 0 0.01658177562057972
associated O 0 0.07564398646354675
with O 0 0.019349880516529083
mutations O 1 0.7410264611244202
in O 0 0.006205723155289888
either O 0 0.006852933205664158
the O 0 0.0056327935308218
COL4A3 O 0 0.21170632541179657
or O 0 0.013950579799711704
the O 0 0.007983092218637466
COL4A4 O 0 0.412092387676239
gene O 0 0.4720051884651184
, O 0 0.006274963729083538
which O 0 0.004622507840394974
encode O 0 0.026685481891036034
the O 0 0.00741618312895298
alpha3 O 0 0.27215564250946045
and O 0 0.019190385937690735
alpha4 O 1 0.6216614842414856
type O 1 0.6207191348075867
IV O 1 0.7573187947273254
collagen O 1 0.8926482796669006
chains O 0 0.2411102056503296
, O 0 0.01975206285715103
respectively O 0 0.0353427417576313
. O 0 0.02896384336054325

To O 0 0.02046063169836998
date O 0 0.019779840484261513
, O 0 0.013294639065861702
mutation O 1 0.6144177317619324
screening O 0 0.0630517229437828
in O 0 0.005160244647413492
the O 0 0.004277252126485109
two O 0 0.006724829785525799
genes O 0 0.3186720013618469
has O 0 0.006230815779417753
been O 0 0.005437108688056469
hampered O 0 0.06709817796945572
by O 0 0.004559190012514591
the O 0 0.003983758855611086
lack O 0 0.02017473615705967
of O 0 0.0092240609228611
genomic O 0 0.4852254092693329
structure O 0 0.07353439182043076
information O 0 0.02392764203250408
. O 0 0.025151045992970467

We O 0 0.01262732781469822
report O 0 0.009892906062304974
here O 0 0.004760158248245716
the O 0 0.003580639138817787
complete O 0 0.0048329816199839115
characterization O 0 0.008966604247689247
of O 0 0.002834307961165905
the O 0 0.00296383467502892
48 O 0 0.008699427358806133
exons O 0 0.07574175298213959
of O 0 0.004222054500132799
the O 0 0.007589822635054588
COL4A4 O 0 0.34748339653015137
gene O 1 0.5033652186393738
, O 0 0.006035487167537212
a O 0 0.00752386124804616
comprehensive O 0 0.04638398438692093
gene O 0 0.3818286955356598
screen O 0 0.019851045683026314
, O 0 0.0033779414370656013
and O 0 0.0025301938876509666
the O 0 0.0034577911719679832
subsequent O 0 0.033031392842531204
detection O 0 0.09047245234251022
of O 0 0.006338344421237707
10 O 0 0.03586839139461517
novel O 0 0.3980938196182251
mutations O 1 0.9569171071052551
in O 0 0.1930447518825531
eight O 1 0.5957793593406677
patients O 1 0.9857719540596008
diagnosed O 1 0.9881424307823181
with O 1 0.9308473467826843
autosomal B-Disease 1 0.9890134334564209
recessive I-Disease 1 0.9842357635498047
Alport I-Disease 1 0.9731554985046387
syndrome I-Disease 1 0.9762292504310608
. O 0 0.3587789535522461

Furthermore O 0 0.036487359553575516
, O 0 0.009970664978027344
we O 0 0.00551946647465229
identified O 0 0.008103222586214542
a O 0 0.006640999112278223
glycine O 0 0.03563191369175911
to O 0 0.005253767594695091
alanine O 0 0.10364500433206558
substitution O 0 0.03217078372836113
in O 0 0.005160394124686718
the O 0 0.00606578728184104
collagenous O 1 0.5457229614257812
domain O 0 0.03292440250515938
that O 0 0.00461991922929883
is O 0 0.004845698829740286
apparently O 0 0.011260434053838253
silent O 0 0.027490418404340744
in O 0 0.0053604659624397755
the O 0 0.0076589640229940414
heterozygous O 1 0.5481369495391846
carriers O 0 0.1640784740447998
, O 0 0.008452961221337318
in O 0 0.009625343605875969
11 O 0 0.024266069754958153
. O 0 0.02337772026658058

5 O 0 0.0253143273293972
% O 0 0.014616075903177261
of O 0 0.005558418575674295
all O 0 0.003920524846762419
control O 0 0.010970747098326683
individuals O 0 0.010294390842318535
, O 0 0.0030237543396651745
and O 0 0.002264217706397176
in O 0 0.0025815509725362062
one O 0 0.0031783035956323147
control O 0 0.014411111362278461
individual O 0 0.019488690420985222
homozygous O 0 0.27076712250709534
for O 0 0.00673172902315855
this O 0 0.00886170007288456
glycine O 0 0.14845708012580872
substitution O 0 0.17517498135566711
. O 0 0.03556138277053833

There O 0 0.014803950674831867
has O 0 0.007531074341386557
been O 0 0.003951238933950663
no O 0 0.0031297882087528706
previous O 0 0.0039974539540708065
finding O 0 0.00424146605655551
of O 0 0.0026367350947111845
a O 0 0.00510728033259511
glycine O 0 0.06677468121051788
substitution O 0 0.04512955620884895
that O 0 0.0037804078310728073
is O 0 0.004191453102976084
not O 0 0.0034239827655255795
associated O 0 0.01579899713397026
with O 0 0.005844095256179571
any O 0 0.008915401995182037
obvious O 0 0.18308283388614655
phenotype O 1 0.9270887970924377
in O 0 0.08036600053310394
homozygous O 1 0.8561924695968628
individuals O 0 0.3042382001876831
. O 0 0.06920430809259415

Founder O 0 0.49360427260398865
BRCA1 O 1 0.905116617679596
and O 0 0.14116249978542328
BRCA2 O 1 0.9482445120811462
mutations O 1 0.929729163646698
in O 0 0.07455580681562424
French O 0 0.3332643210887909
Canadian O 1 0.6119180917739868
breast B-Disease 1 0.9745283126831055
and I-Disease 1 0.5955291390419006
ovarian I-Disease 1 0.9841958284378052
cancer I-Disease 1 0.9767639636993408
families O 0 0.45672956109046936
. O 0 0.11794111877679825

We O 0 0.016094643622636795
have O 0 0.008956389501690865
identified O 0 0.013831226155161858
four O 0 0.008742040954530239
mutations O 1 0.6302211284637451
in O 0 0.006290169898420572
each O 0 0.006816558074206114
of O 0 0.025119325146079063
the O 0 0.2359950840473175
breast B-Disease 1 0.9903997778892517
cancer I-Disease 1 0.9907875657081604
- O 1 0.9368827939033508
susceptibility O 1 0.9792764186859131
genes O 1 0.9576015472412109
, O 0 0.2414017766714096
BRCA1 O 1 0.9678745865821838
and O 0 0.11969161778688431
BRCA2 O 1 0.9617919325828552
, O 0 0.03493986278772354
in O 0 0.05562656745314598
French O 0 0.43081462383270264
Canadian O 1 0.8130553364753723
breast B-Disease 1 0.9891096353530884
cancer I-Disease 1 0.989345133304596
and O 1 0.8038504123687744
breast B-Disease 1 0.9898239970207214
/ I-Disease 1 0.9783613085746765
ovarian I-Disease 1 0.9900075197219849
cancer I-Disease 1 0.9827295541763306
families O 0 0.4530807435512543
from O 0 0.08750324696302414
Quebec O 0 0.22949708998203278
. O 0 0.06080898642539978

To O 0 0.022911764681339264
identify O 0 0.048436783254146576
founder O 0 0.05267715081572533
effects O 0 0.15317809581756592
, O 0 0.007199388928711414
we O 0 0.004926837980747223
examined O 0 0.039659321308135986
independently O 0 0.024238677695393562
ascertained O 0 0.11752629280090332
French O 0 0.050985585898160934
Canadian O 0 0.12530860304832458
cancer B-Disease 1 0.9148338437080383
families O 0 0.021819621324539185
for O 0 0.004253170918673277
the O 0 0.0035179227124899626
distribution O 0 0.008814986795186996
of O 0 0.0049490067176520824
these O 0 0.00997643731534481
eight O 0 0.04055503383278847
mutations O 1 0.8967567682266235
. O 0 0.06797956675291061

Mutations O 1 0.5457230806350708
were O 0 0.015863411128520966
found O 0 0.01318863220512867
in O 0 0.00945912767201662
41 O 0 0.01413531880825758
of O 0 0.009124460630118847
97 O 0 0.03827551752328873
families O 0 0.04886820912361145
. O 0 0.025459397584199905

Six O 0 0.02300358936190605
of O 0 0.013333350419998169
eight O 0 0.016732608899474144
mutations O 1 0.5809478759765625
were O 0 0.008509045466780663
observed O 0 0.02396901696920395
at O 0 0.00996590219438076
least O 0 0.015042253769934177
twice O 0 0.030043791979551315
. O 0 0.02550293505191803

The O 0 0.06614986062049866
BRCA1 O 1 0.9161887764930725
C4446T O 1 0.5955014824867249
mutation O 1 0.6975584626197815
was O 0 0.010418614372611046
the O 0 0.007255019154399633
most O 0 0.01126598846167326
common O 0 0.12514029443264008
mutation O 1 0.7622888684272766
found O 0 0.016245316714048386
, O 0 0.007219764403998852
followed O 0 0.015093425288796425
by O 0 0.014931338839232922
the O 0 0.05431763082742691
BRCA2 O 1 0.9558905959129333
8765delAG O 1 0.8783669471740723
mutation O 1 0.9247437715530396
. O 0 0.11196620762348175

Together O 0 0.023938247933983803
, O 0 0.010199827142059803
these O 0 0.007802389096468687
mutations O 0 0.35019785165786743
were O 0 0.003579970682039857
found O 0 0.004213911015540361
in O 0 0.0028767199255526066
28 O 0 0.004779126029461622
of O 0 0.003106232499703765
41 O 0 0.013161007314920425
families O 0 0.015535243786871433
identified O 0 0.010862927883863449
to O 0 0.004732474684715271
have O 0 0.007090410217642784
a O 0 0.022578012198209763
mutation O 1 0.805120587348938
. O 0 0.04159969463944435

The O 0 0.019960064440965652
odds O 0 0.030919931828975677
of O 0 0.007228032685816288
detection O 0 0.029429107904434204
of O 0 0.00387226277962327
any O 0 0.003637963440269232
of O 0 0.003975633066147566
the O 0 0.006265400443226099
four O 0 0.039546675980091095
BRCA1 O 1 0.9599669575691223
mutations O 1 0.9141244292259216
was O 0 0.02034134976565838
18 O 0 0.03952015936374664
. O 0 0.03176228702068329

7x O 0 0.2791471779346466
greater O 0 0.024324191734194756
if O 0 0.010553794912993908
one O 0 0.006549386773258448
or O 0 0.009598902426660061
more O 0 0.01432446762919426
cases O 0 0.2576468586921692
of O 0 0.11809508502483368
ovarian B-Disease 1 0.9888894557952881
cancer I-Disease 1 0.9710224866867065
were O 0 0.006848215591162443
also O 0 0.005345564801245928
present O 0 0.008960259146988392
in O 0 0.00588104035705328
the O 0 0.008500071242451668
family O 0 0.06720530241727829
. O 0 0.02865728735923767

The O 0 0.018055876716971397
odds O 0 0.02589728683233261
of O 0 0.0071721808053553104
detection O 0 0.02445860765874386
of O 0 0.004427948966622353
any O 0 0.004093972034752369
of O 0 0.003869017818942666
the O 0 0.006902746390551329
four O 0 0.047115910798311234
BRCA2 O 1 0.9644625782966614
mutations O 1 0.9231984615325928
was O 0 0.028220083564519882
5 O 0 0.03903179243206978
. O 0 0.030330907553434372

3x O 0 0.091115802526474
greater O 0 0.018421528860926628
if O 0 0.007097993977367878
there O 0 0.003897879971191287
were O 0 0.002843386959284544
at O 0 0.0036915182135999203
least O 0 0.007155474275350571
five O 0 0.017022354528307915
cases O 0 0.282429963350296
of O 0 0.11692295223474503
breast B-Disease 1 0.984380841255188
cancer I-Disease 1 0.9709092974662781
in O 0 0.029858876019716263
the O 0 0.022595340386033058
family O 0 0.15224991738796234
. O 0 0.0443994365632534

Interestingly O 0 0.06405111402273178
, O 0 0.012748266570270061
the O 0 0.009340742602944374
presence O 0 0.025151636451482773
of O 0 0.011472058482468128
a O 0 0.15264970064163208
breast B-Disease 1 0.9825563430786133
cancer I-Disease 1 0.9772999286651611
case O 0 0.13917046785354614
< O 0 0.2721817195415497
36 O 0 0.013051226735115051
years O 0 0.005759872030466795
of O 0 0.003777573350816965
age O 0 0.01188020408153534
was O 0 0.003266323357820511
strongly O 0 0.006561746820807457
predictive O 0 0.04812195897102356
of O 0 0.0025070381816476583
the O 0 0.0024253500159829855
presence O 0 0.005353169050067663
of O 0 0.0023161883000284433
any O 0 0.002617939841002226
of O 0 0.0029850120190531015
the O 0 0.005692558828741312
eight O 0 0.041775062680244446
mutations O 1 0.9098540544509888
screened O 0 0.2902318835258484
. O 0 0.04701078683137894

Carriers O 0 0.05982181429862976
of O 0 0.009344314225018024
the O 0 0.007151552475988865
same O 0 0.010988206602633
mutation O 0 0.483006089925766
, O 0 0.00529886269941926
from O 0 0.004218695685267448
different O 0 0.005240330472588539
families O 0 0.013962220400571823
, O 0 0.004428472835570574
shared O 0 0.011635883711278439
similar O 0 0.03903422877192497
haplotypes O 1 0.5726296901702881
, O 0 0.006218315567821264
indicating O 0 0.01979697123169899
that O 0 0.0034941979683935642
the O 0 0.004669191315770149
mutant O 0 0.38029277324676514
alleles O 1 0.5543593764305115
were O 0 0.00442880904302001
likely O 0 0.009019589982926846
to O 0 0.0026862157974392176
be O 0 0.0026072105392813683
identical O 0 0.018863879144191742
by O 0 0.004788978956639767
descent O 0 0.030465301126241684
for O 0 0.006350765936076641
a O 0 0.017120901495218277
mutation O 1 0.7203300595283508
in O 0 0.009603699669241905
the O 0 0.008876991458237171
founder O 0 0.07802018523216248
population O 0 0.07357984781265259
. O 0 0.0357263907790184

The O 0 0.025259073823690414
identification O 0 0.03349260613322258
of O 0 0.014816599898040295
common O 0 0.2621932625770569
BRCA1 O 1 0.9374499917030334
and O 0 0.09624852985143661
BRCA2 O 1 0.9636485576629639
mutations O 1 0.9124205112457275
will O 0 0.020521016791462898
facilitate O 0 0.14097577333450317
carrier O 0 0.26248306035995483
detection O 0 0.37891650199890137
in O 0 0.04638579860329628
French O 0 0.414562463760376
Canadian O 1 0.8083890080451965
breast B-Disease 1 0.9882864356040955
cancer I-Disease 1 0.988584041595459
and O 1 0.829764187335968
breast B-Disease 1 0.9885899424552917
/ I-Disease 1 0.9727948904037476
ovarian I-Disease 1 0.9881161451339722
cancer I-Disease 1 0.979350745677948
families O 1 0.5851006507873535
. O 0 0.1405511200428009

Are O 0 0.04412226378917694
Dp71 O 0 0.3368523120880127
and O 0 0.04745085537433624
Dp140 O 1 0.7790295481681824
brain O 1 0.9529929757118225
dystrophin O 1 0.9329872727394104
isoforms O 1 0.7980830669403076
related O 0 0.4489505887031555
to O 0 0.07522770762443542
cognitive B-Disease 1 0.9086288809776306
impairment I-Disease 1 0.9498722553253174
in O 1 0.5801503658294678
Duchenne B-Disease 1 0.9679205417633057
muscular I-Disease 1 0.9639841318130493
dystrophy I-Disease 1 0.9614335894584656
? O 1 0.6497176885604858

Molecular O 0 0.18511047959327698
study O 0 0.03564918041229248
and O 0 0.011653060093522072
neuropsychological O 0 0.16160832345485687
analysis O 0 0.014192386530339718
were O 0 0.005387548357248306
performed O 0 0.010400169529020786
concurrently O 0 0.013030213303864002
on O 0 0.009388288483023643
49 O 0 0.2700563371181488
patients O 1 0.9600651860237122
with O 1 0.5545079112052917
Duchenne B-Disease 1 0.9854134321212769
muscular I-Disease 1 0.9858241081237793
dystrophy I-Disease 1 0.9885987043380737
( O 1 0.7581068277359009
DMD B-Disease 1 0.9646154046058655
) O 0 0.03310544788837433
in O 0 0.005668429657816887
order O 0 0.0041673798114061356
to O 0 0.0027570168022066355
find O 0 0.005110469646751881
a O 0 0.005650657694786787
molecular O 0 0.13909979164600372
explanation O 0 0.021217694506049156
for O 0 0.006574674509465694
the O 0 0.017750950530171394
cognitive B-Disease 1 0.7849204540252686
impairment I-Disease 1 0.9050049185752869
observed O 0 0.30765625834465027
in O 0 0.07274001091718674
most O 0 0.26668497920036316
DMD B-Disease 1 0.9694435000419617
patients O 1 0.9494805932044983
. O 0 0.15099817514419556

Complete O 0 0.03424258902668953
analysis O 0 0.02324613370001316
of O 0 0.009661124087870121
the O 0 0.010583152994513512
dystrophin O 1 0.6766898036003113
gene O 0 0.315643310546875
was O 0 0.0056783659383654594
performed O 0 0.00638554897159338
to O 0 0.003192402422428131
define O 0 0.008004963397979736
the O 0 0.003958598244935274
localization O 0 0.036454979330301285
of O 0 0.0053960713557899
deletions O 0 0.15887561440467834
and O 0 0.006223984062671661
duplications O 0 0.15359482169151306
in O 0 0.007006541360169649
relation O 0 0.02001134306192398
to O 0 0.005337399430572987
the O 0 0.008484882302582264
different O 0 0.05593380331993103
DMD B-Disease 1 0.9358267784118652
promoters O 0 0.46409785747528076
. O 0 0.06725379824638367

Qualitative O 0 0.050120167434215546
analysis O 0 0.019531693309545517
of O 0 0.00786421075463295
the O 0 0.006858867593109608
Dp71 O 0 0.1048152968287468
transcript O 0 0.02622070163488388
and O 0 0.003990719560533762
testing O 0 0.008879484608769417
for O 0 0.00314941443502903
the O 0 0.0027644799556583166
specific O 0 0.006444623693823814
first O 0 0.004282352048903704
exon O 0 0.06496161222457886
of O 0 0.004900582600384951
Dp140 O 0 0.05937555059790611
were O 0 0.004477977752685547
also O 0 0.005092589650303125
carried O 0 0.008835829794406891
out O 0 0.011848727241158485
. O 0 0.022909827530384064

Neuropsychological O 1 0.5729214549064636
analysis O 0 0.06246614828705788
assessed O 0 0.05271272361278534
verbal O 0 0.05614833906292915
and O 0 0.014567142352461815
visuospatial O 0 0.41680195927619934
intelligence O 0 0.025790877640247345
, O 0 0.00940011441707611
verbal O 0 0.03503663092851639
memory O 0 0.04596039280295372
, O 0 0.007156504318118095
and O 0 0.006194182205945253
reading O 0 0.014899244531989098
skills O 0 0.038566652685403824
. O 0 0.026707638055086136

Comparison O 0 0.03835022822022438
of O 0 0.014128223992884159
molecular O 0 0.106234610080719
and O 0 0.008721833117306232
psychometric O 0 0.16728414595127106
findings O 0 0.029056904837489128
demonstrated O 0 0.018197612836956978
that O 0 0.005746172275394201
deletions O 0 0.13289843499660492
and O 0 0.005141562316566706
duplications O 0 0.11000963300466537
that O 0 0.004282042849808931
were O 0 0.0037112636491656303
localized O 0 0.18339236080646515
in O 0 0.004818442743271589
the O 0 0.004819901660084724
distal O 0 0.39544862508773804
part O 0 0.0068103596568107605
of O 0 0.003888034960255027
the O 0 0.006796656176447868
gene O 0 0.4133186638355255
seemed O 0 0.01433637086302042
to O 0 0.005283483769744635
be O 0 0.007419714704155922
preferentially O 0 0.2728097438812256
associated O 0 0.11380898952484131
with O 0 0.04851940646767616
cognitive B-Disease 1 0.8028267025947571
impairment I-Disease 1 0.8997718691825867
. O 0 0.1014641746878624

Two O 0 0.026020847260951996
altered O 0 0.07661765068769455
Dp71 O 0 0.10805739462375641
transcripts O 0 0.02092229574918747
and O 0 0.006139578763395548
two O 0 0.00693141994997859
deleted O 0 0.06226836517453194
Dp140 O 0 0.236387699842453
DNA O 0 0.2320137321949005
sequences O 0 0.05611552298069
were O 0 0.005216494202613831
found O 0 0.015047814697027206
in O 0 0.01505451649427414
four O 0 0.08238387852907181
patients O 1 0.95412677526474
with O 0 0.44135546684265137
severe O 1 0.9702292680740356
cerebral B-Disease 1 0.9730315208435059
dysfunction I-Disease 1 0.9661301970481873
. O 0 0.25085654854774475

These O 0 0.018044551834464073
findings O 0 0.019186370074748993
suggest O 0 0.010874354280531406
that O 0 0.004175051115453243
some O 0 0.0035809436812996864
sequences O 0 0.014585155062377453
located O 0 0.0038297316059470177
in O 0 0.0031058723106980324
the O 0 0.003684306750074029
distal O 0 0.2635937035083771
part O 0 0.004992515780031681
of O 0 0.0033325357362627983
the O 0 0.0062164305709302425
gene O 0 0.38695088028907776
and O 0 0.0040226345881819725
, O 0 0.003643164411187172
in O 0 0.004298422485589981
particular O 0 0.014948115684092045
, O 0 0.005836080759763718
some O 0 0.014463994652032852
DMD B-Disease 1 0.9296414852142334
isoforms O 0 0.2907767593860626
expressed O 0 0.019733309745788574
in O 0 0.008423835039138794
the O 0 0.014598826877772808
brain O 1 0.836121678352356
may O 0 0.055101536214351654
be O 0 0.005698102060705423
related O 0 0.05119381844997406
to O 0 0.0064277951605618
the O 0 0.022930068895220757
cognitive B-Disease 1 0.8632851243019104
impairment I-Disease 1 0.9383629560470581
associated O 0 0.36781105399131775
with O 0 0.13092723488807678
DMD B-Disease 1 0.942299485206604
. O 0 0.04559553787112236
. O 0 0.043405044823884964

I1307K O 0 0.46435126662254333
APC O 0 0.4645926356315613
and O 0 0.02818734385073185
hMLH1 O 0 0.4173922836780548
mutations O 1 0.7403496503829956
in O 0 0.010936611331999302
a O 0 0.012603756971657276
non O 0 0.05571487173438072
- O 0 0.11997386813163757
Jewish O 0 0.08371615409851074
family O 0 0.14269642531871796
with O 0 0.09533421695232391
hereditary B-Disease 1 0.9418694972991943
non I-Disease 1 0.8391513228416443
- I-Disease 1 0.951200008392334
polyposis I-Disease 1 0.9821857810020447
colorectal I-Disease 1 0.9863560199737549
cancer I-Disease 1 0.9737941026687622
. O 0 0.3521381616592407

We O 0 0.02163451910018921
describe O 0 0.031039012596011162
a O 0 0.020305925980210304
French O 0 0.08777280896902084
Canadian O 0 0.2778787910938263
hereditary B-Disease 1 0.9472728371620178
non I-Disease 1 0.877287745475769
- I-Disease 1 0.9601731896400452
polyposis I-Disease 1 0.988442599773407
colorectal I-Disease 1 0.9912806153297424
cancer I-Disease 1 0.9887176752090454
( O 1 0.8082905411720276
HNPCC B-Disease 1 0.961384654045105
) O 0 0.14219924807548523
kindred O 0 0.3955967128276825
which O 0 0.010388274677097797
carries O 0 0.02656574547290802
a O 0 0.017737453803420067
novel O 0 0.18281243741512299
truncating O 1 0.8081334829330444
mutation O 1 0.9253296256065369
in O 0 0.06959415972232819
hMLH1 O 1 0.5242952704429626
. O 0 0.0441502146422863

Interestingly O 0 0.07283549010753632
, O 0 0.017834752798080444
the O 0 0.014818619005382061
I1307K O 0 0.3210497796535492
APC O 1 0.5318308472633362
polymorphism O 0 0.42230555415153503
, O 0 0.011519763618707657
associated O 0 0.030991951003670692
with O 0 0.008316148072481155
an O 0 0.01859641820192337
increased O 0 0.2173478901386261
risk O 1 0.8505632877349854
of O 0 0.27712196111679077
colorectal B-Disease 1 0.9918745160102844
cancer I-Disease 1 0.9778294563293457
, O 0 0.013450470753014088
is O 0 0.0057021239772439
also O 0 0.004143572878092527
present O 0 0.0067365230061113834
in O 0 0.005910031963139772
this O 0 0.007457698695361614
family O 0 0.04196285456418991
. O 0 0.02599911577999592

The O 0 0.029088791459798813
I1307K O 0 0.19938869774341583
polymorphism O 0 0.17744949460029602
has O 0 0.008709350600838661
previously O 0 0.006836469750851393
only O 0 0.0036681778728961945
been O 0 0.0034880104940384626
identified O 0 0.007877704687416553
in O 0 0.0042954073287546635
individuals O 0 0.01725943014025688
of O 0 0.006790552753955126
self O 0 0.08577658236026764
- O 0 0.1890917420387268
reported O 0 0.103695809841156
Ashkenazi O 0 0.38062140345573425
Jewish O 0 0.07211016118526459
origins O 0 0.17414748668670654
. O 0 0.04461207613348961

In O 0 0.015407855622470379
addition O 0 0.010743632912635803
, O 0 0.005761606618762016
in O 0 0.003981672693043947
this O 0 0.003120965091511607
family O 0 0.007674832362681627
, O 0 0.0026272295508533716
there O 0 0.0023666033521294594
appears O 0 0.004648067057132721
to O 0 0.0019763759337365627
be O 0 0.0019139725482091308
no O 0 0.0031574158929288387
relationship O 0 0.014387357980012894
between O 0 0.005205847788602114
the O 0 0.005221894010901451
I1307K O 0 0.2411705106496811
polymorphism O 0 0.20935982465744019
and O 0 0.004769653081893921
the O 0 0.004586042370647192
presence O 0 0.039365630596876144
or O 0 0.0279088132083416
absence O 0 0.1588703691959381
of O 0 0.05584234744310379
cancer B-Disease 1 0.9569357633590698
. O 0 0.041964735835790634
. O 0 0.0384969599545002

Identification O 0 0.032279323786497116
of O 0 0.011381366290152073
a O 0 0.012592611834406853
novel O 0 0.07220938801765442
mutation O 0 0.483885794878006
of O 0 0.0068228719756007195
the O 0 0.009028973989188671
CPO O 0 0.2091149240732193
gene O 1 0.5800507664680481
in O 0 0.010541245341300964
a O 0 0.015458869747817516
Japanese O 0 0.04167136922478676
hereditary B-Disease 1 0.820037841796875
coproporphyria I-Disease 1 0.5807733535766602
family O 0 0.17889511585235596
. O 0 0.05539537966251373

Hereditary B-Disease 1 0.8687936067581177
coproporphyria I-Disease 1 0.6770807504653931
( O 0 0.2475317418575287
HCP B-Disease 1 0.8197058439254761
) O 0 0.07426048070192337
is O 0 0.03759888559579849
an O 0 0.1330851912498474
autosomal B-Disease 1 0.9823085069656372
dominant I-Disease 1 0.9260607957839966
disease I-Disease 1 0.9852225184440613
characterized O 1 0.7887164950370789
by O 0 0.0763784870505333
a O 0 0.14797551929950714
deficiency B-Disease 1 0.9749327301979065
of I-Disease 0 0.05434540659189224
coproporphyrinogen I-Disease 1 0.7940359711647034
oxidase I-Disease 1 0.925589382648468
( O 0 0.1940474659204483
CPO O 0 0.2934684157371521
) O 0 0.04659381881356239
caused O 0 0.14239995181560516
by O 0 0.010648516938090324
a O 0 0.021149640902876854
mutation O 1 0.712032675743103
in O 0 0.011800915002822876
the O 0 0.018167801201343536
CPO O 0 0.3823976516723633
gene O 1 0.7957032322883606
. O 0 0.06122284382581711

Only O 0 0.023050209507346153
11 O 0 0.02804669551551342
mutations O 1 0.500910222530365
of O 0 0.00785569567233324
the O 0 0.00894194282591343
gene O 0 0.4182600677013397
have O 0 0.008822434581816196
been O 0 0.012602737173438072
reported O 0 0.06763437390327454
in O 0 0.06129908189177513
HCP B-Disease 1 0.9058083891868591
patients O 1 0.9128231406211853
. O 0 0.07770707458257675

We O 0 0.02080935798585415
report O 0 0.01968277059495449
another O 0 0.017529385164380074
mutation O 0 0.42812150716781616
in O 0 0.011199090629816055
a O 0 0.012868501245975494
Japanese O 0 0.018952736631035805
family O 0 0.049193449318408966
. O 0 0.02899855002760887

Polymerase O 1 0.5263779163360596
chain O 0 0.1944226175546646
reaction O 0 0.15874028205871582
- O 0 0.1243741363286972
single O 0 0.04672111198306084
strand O 0 0.3913830518722534
conformational O 0 0.4677705764770508
polymorphism O 0 0.27721866965293884
and O 0 0.0063646468333899975
direct O 0 0.012304500676691532
sequence O 0 0.026978159323334694
analyses O 0 0.024572601541876793
demonstrated O 0 0.018273325636982918
a O 0 0.008568236604332924
C O 0 0.05551833659410477
to O 0 0.005462172441184521
T O 0 0.1821158528327942
substitution O 0 0.03922175243496895
in O 0 0.006854425650089979
exon O 0 0.08525268733501434
1 O 0 0.006014783401042223
of O 0 0.003720001084730029
the O 0 0.006379343569278717
CPO O 0 0.15039075911045074
gene O 0 0.48676902055740356
at O 0 0.008093933574855328
nucleotide O 0 0.09149016439914703
position O 0 0.005278716329485178
85 O 0 0.00889868289232254
, O 0 0.0033924102317541838
which O 0 0.002816243562847376
lies O 0 0.0046295952051877975
in O 0 0.0031459375750273466
the O 0 0.0040754410438239574
putative O 0 0.19800743460655212
presequence O 0 0.13503484427928925
for O 0 0.008079960942268372
targeting O 0 0.03813055902719498
to O 0 0.012590602971613407
mitochondria O 0 0.49148377776145935
. O 0 0.04703395813703537

This O 0 0.029662828892469406
mutation O 0 0.46197980642318726
changes O 0 0.018471552059054375
the O 0 0.008133243769407272
codon O 0 0.06223874166607857
for O 0 0.007550774607807398
glutamine O 0 0.06456299871206284
to O 0 0.006033359561115503
a O 0 0.011471164412796497
termination O 0 0.25650566816329956
codon O 0 0.2388675957918167
at O 0 0.019334668293595314
amino O 0 0.26360440254211426
acid O 0 0.4064275026321411
position O 0 0.020144546404480934
29 O 0 0.03400277718901634
. O 0 0.02594231441617012

MaeI O 0 0.21004383265972137
restriction O 0 0.0448981374502182
analysis O 0 0.023452116176486015
showed O 0 0.012800397351384163
two O 0 0.007576499599963427
other O 0 0.006883011199533939
carriers O 0 0.05652305483818054
in O 0 0.007800716441124678
the O 0 0.01059440802782774
family O 0 0.06129636615514755
. O 0 0.02712257392704487

The O 0 0.03899849206209183
C O 0 0.3246500790119171
- O 0 0.3333311378955841
T O 1 0.6240878105163574
mutation O 1 0.6687910556793213
is O 0 0.007724832743406296
located O 0 0.006138697732239962
within O 0 0.004651051014661789
a O 0 0.004892627242952585
recently O 0 0.008002479560673237
proposed O 0 0.012373781763017178
putative O 0 0.1633286327123642
alternative O 0 0.057102132588624954
translation O 0 0.09036964178085327
initiation O 1 0.506716787815094
codon O 1 0.6012439727783203
( O 0 0.2371242195367813
TIC O 1 0.7112456560134888
- O 0 0.1228240430355072
1 O 0 0.015114819630980492
) O 0 0.009949194267392159
, O 0 0.004042798187583685
supporting O 0 0.009171229787170887
that O 0 0.005719183944165707
TIC O 0 0.3110567629337311
- O 0 0.03590533137321472
1 O 0 0.006698619574308395
is O 0 0.0038494784384965897
the O 0 0.004060129635035992
real O 0 0.021134017035365105
TIC O 0 0.4079066812992096
rather O 0 0.02040579915046692
than O 0 0.026922689750790596
TIC O 1 0.7251583337783813
- O 0 0.15101012587547302
2 O 0 0.023873483762145042
. O 0 0.014299464412033558
. O 0 0.021791862323880196

Human B-Disease 0 0.3928510844707489
complement I-Disease 0 0.4430397152900696
factor I-Disease 1 0.7803827524185181
H I-Disease 1 0.9134318232536316
deficiency I-Disease 1 0.9697684049606323
associated O 1 0.8550859093666077
with O 1 0.7656409740447998
hemolytic B-Disease 1 0.9768307209014893
uremic I-Disease 1 0.9741463661193848
syndrome I-Disease 1 0.967912495136261
. O 0 0.3478178083896637

This O 0 0.017114752903580666
study O 0 0.01907648704946041
reports O 0 0.010267181321978569
on O 0 0.005050349980592728
six O 0 0.010254369117319584
cases O 0 0.10736322402954102
of O 0 0.022741016000509262
deficiency B-Disease 1 0.9625236392021179
in I-Disease 0 0.007507998030632734
the I-Disease 0 0.007655036635696888
human I-Disease 0 0.11637284606695175
complement I-Disease 0 0.23267985880374908
regulatory I-Disease 1 0.5021848082542419
protein I-Disease 1 0.7174906134605408
Factor I-Disease 1 0.5983594059944153
H I-Disease 1 0.6873912215232849
( O 0 0.16273054480552673
FH O 1 0.7384227514266968
) O 0 0.01619788631796837
in O 0 0.0051237489096820354
the O 0 0.004896290134638548
context O 0 0.03524402156472206
of O 0 0.03690028935670853
an O 0 0.35966745018959045
acute B-Disease 1 0.9818430542945862
renal I-Disease 1 0.9875747561454773
disease I-Disease 1 0.9817925095558167
. O 0 0.3478933870792389

Five O 0 0.01878666877746582
of O 0 0.009348247200250626
the O 0 0.00789997074753046
cases O 0 0.026378028094768524
were O 0 0.0057170940563082695
observed O 0 0.0374072790145874
in O 0 0.019558103755116463
children O 0 0.3133683204650879
presenting O 1 0.6087676882743835
with O 1 0.8054876923561096
idiopathic O 1 0.9876517057418823
hemolytic B-Disease 1 0.9911044836044312
uremic I-Disease 1 0.9909486174583435
syndrome I-Disease 1 0.9874247908592224
( O 1 0.8471301198005676
HUS B-Disease 1 0.9428808093070984
) O 0 0.22331196069717407
. O 0 0.05832904577255249

Two O 0 0.015262768603861332
of O 0 0.008113507181406021
the O 0 0.007543052546679974
children O 0 0.05235603451728821
exhibited O 0 0.11296740174293518
a O 0 0.09876560419797897
homozygous O 1 0.9530670046806335
deficiency O 1 0.9834895133972168
characterized O 0 0.4560004770755768
by O 0 0.007900254800915718
the O 0 0.0044779060408473015
absence O 0 0.011900332756340504
of O 0 0.0032505225390195847
the O 0 0.003909000661224127
150 O 0 0.014277772977948189
- O 0 0.09396468847990036
kD O 0 0.27227991819381714
form O 0 0.02445998415350914
of O 0 0.005866120103746653
Factor O 0 0.11958304047584534
H O 0 0.15079739689826965
and O 0 0.0038712110836058855
the O 0 0.0029671224765479565
presence O 0 0.008725362829864025
, O 0 0.0026521955151110888
upon O 0 0.0035883986856788397
immunoblotting O 0 0.05064167082309723
, O 0 0.003066983772441745
of O 0 0.0028870292007923126
the O 0 0.004732740111649036
42 O 0 0.052855294197797775
- O 0 0.32469263672828674
kD O 1 0.6709907054901123
Factor O 0 0.3892918825149536
H O 1 0.5351450443267822
- O 0 0.145235076546669
like O 0 0.028438284993171692
protein O 0 0.39482423663139343
1 O 0 0.042981673032045364
( O 0 0.10280153900384903
FHL O 1 0.7295486927032471
- O 0 0.13492389023303986
1 O 0 0.017171066254377365
) O 0 0.015401669777929783
and O 0 0.006010870449244976
other O 0 0.014706127345561981
FH O 1 0.8635866045951843
- O 0 0.44970741868019104
related O 0 0.43485167622566223
protein O 1 0.627530038356781
( O 0 0.1477193534374237
FHR O 0 0.49254822731018066
) O 0 0.0564672127366066
bands O 0 0.047940444201231
. O 0 0.02565731666982174

Southern O 0 0.04567854106426239
blot O 0 0.09407912194728851
and O 0 0.015871228650212288
PCR O 0 0.17161808907985687
analysis O 0 0.01706957258284092
of O 0 0.006319255568087101
DNA O 0 0.09223152697086334
of O 0 0.006942844949662685
one O 0 0.02269432321190834
patient O 1 0.7299734354019165
with O 0 0.10389801114797592
homozygous O 1 0.9429233074188232
deficiency O 1 0.9757054448127747
ruled O 0 0.05984725430607796
out O 0 0.004838466178625822
the O 0 0.0034389158245176077
presence O 0 0.006526443175971508
of O 0 0.002807525685057044
a O 0 0.004402016289532185
large O 0 0.008199830539524555
deletion O 0 0.23503346741199493
of O 0 0.005600396543741226
the O 0 0.01848154328763485
FH O 1 0.8938460946083069
gene O 1 0.6510519981384277
as O 0 0.008173981681466103
the O 0 0.010778089053928852
underlying O 0 0.3367559313774109
defect O 1 0.7197928428649902
for O 0 0.03361710160970688
the O 0 0.07189060747623444
deficiency O 1 0.962493360042572
. O 0 0.11580079793930054

The O 0 0.017068205401301384
other O 0 0.00895206443965435
four O 0 0.00858331099152565
children O 0 0.025003481656312943
presented O 0 0.018789485096931458
with O 0 0.05610219016671181
heterozygous O 1 0.9189477562904358
deficiency O 1 0.9738215804100037
and O 0 0.010429867543280125
exhibited O 0 0.049090828746557236
a O 0 0.015399378724396229
normal O 0 0.1144358366727829
immunoblotting O 0 0.28928619623184204
pattern O 0 0.11849920451641083
of O 0 0.008349387906491756
proteins O 0 0.13339917361736298
of O 0 0.009654118679463863
the O 0 0.019189845770597458
FH O 1 0.8135159015655518
family O 0 0.15114977955818176
. O 0 0.03880090266466141

Factor B-Disease 1 0.756422221660614
H I-Disease 1 0.840587854385376
deficiency I-Disease 1 0.9479183554649353
is O 0 0.01661689579486847
the O 0 0.010906643234193325
only O 0 0.023420948535203934
complement B-Disease 1 0.6262345910072327
deficiency I-Disease 1 0.9762603640556335
associated O 0 0.3610081672668457
with O 0 0.10298299044370651
HUS B-Disease 1 0.8973428606987
. O 0 0.09593711048364639

These O 0 0.02135426364839077
observations O 0 0.01870710402727127
suggest O 0 0.015629056841135025
a O 0 0.009291586466133595
role O 0 0.017909426242113113
for O 0 0.011446814984083176
FH O 1 0.797295093536377
and O 0 0.02383916638791561
/ O 0 0.4603578448295593
or O 0 0.10154003649950027
FH O 1 0.8961163759231567
receptors O 1 0.6243296265602112
in O 0 0.019603190943598747
the O 0 0.03734932094812393
pathogenesis O 1 0.9334458112716675
of O 0 0.17541395127773285
idiopathic O 1 0.97066330909729
HUS B-Disease 1 0.9333567023277283
. O 0 0.08670676499605179
. O 0 0.05131726339459419

Further O 0 0.02197383902966976
evidence O 0 0.015187208540737629
for O 0 0.008666247129440308
a O 0 0.010318750515580177
major O 0 0.03592514991760254
ancient O 0 0.17313149571418762
mutation O 1 0.9674569964408875
underlying O 1 0.9300717115402222
myotonic B-Disease 1 0.9776556491851807
dystrophy I-Disease 1 0.9774726629257202
from O 0 0.20389986038208008
linkage O 1 0.8344418406486511
disequilibrium O 1 0.8111779689788818
studies O 0 0.09358290582895279
in O 0 0.009252448566257954
the O 0 0.008475764654576778
Japanese O 0 0.024655502289533615
population O 0 0.060107387602329254
. O 0 0.0365191251039505

The O 0 0.3305743634700775
myotonic B-Disease 1 0.9348493814468384
dystrophy I-Disease 1 0.9631215929985046
( O 1 0.6738024950027466
DM B-Disease 1 0.9404087662696838
) O 0 0.2696024775505066
mutation O 1 0.862932026386261
is O 0 0.017352020367980003
an O 0 0.016616512089967728
unstable O 1 0.5967881083488464
( O 0 0.10098173469305038
CTG O 1 0.5521975159645081
) O 0 0.02484367974102497
n O 0 0.032620832324028015
repeat O 0 0.054758694022893906
, O 0 0.0037327734753489494
present O 0 0.003597415518015623
at O 0 0.002631696406751871
a O 0 0.0027992278337478638
copy O 0 0.005239669233560562
number O 0 0.0027264226227998734
of O 0 0.0032098207157105207
5 O 0 0.008768152445554733
- O 0 0.035198066383600235
37 O 0 0.017924243584275246
repeats O 0 0.06684059649705887
on O 0 0.005548788700252771
normal O 0 0.07517573237419128
chromosomes O 0 0.22007042169570923
but O 0 0.006328088231384754
amplified O 0 0.050209566950798035
to O 0 0.005224539898335934
50 O 0 0.015321166254580021
- O 0 0.09301450848579407
3000 O 0 0.17324654757976532
copies O 0 0.04264935851097107
on O 0 0.022107411175966263
DM B-Disease 1 0.908487856388092
chromosomes O 1 0.718486487865448
. O 0 0.06463220715522766

Previous O 0 0.040677499026060104
findings O 0 0.04295717179775238
in O 0 0.01727675460278988
Caucasian O 0 0.35344570875167847
populations O 0 0.17172853648662567
of O 0 0.011407459154725075
a O 0 0.040640685707330704
DM B-Disease 1 0.9312695860862732
founder O 0 0.2650970220565796
chromosome O 1 0.7114517688751221
raise O 0 0.022224199026823044
a O 0 0.006142919883131981
question O 0 0.005093971733003855
about O 0 0.0033075599931180477
the O 0 0.003494510194286704
molecular O 0 0.07416455447673798
events O 0 0.013439781963825226
involved O 0 0.013788237236440182
in O 0 0.007300562225282192
the O 0 0.01106148399412632
expansion O 0 0.13224495947360992
mutation O 1 0.8786123991012573
. O 0 0.05364977568387985

To O 0 0.01860210858285427
investigate O 0 0.021787643432617188
whether O 0 0.012217186391353607
a O 0 0.010586459189653397
founder O 0 0.06896243244409561
chromosome O 1 0.5220760107040405
for O 0 0.010262753814458847
the O 0 0.02413705363869667
DM B-Disease 1 0.9514560103416443
mutation O 1 0.896555483341217
exists O 0 0.0413435734808445
in O 0 0.0038975283969193697
the O 0 0.002995459595695138
Japanese O 0 0.0060700783506035805
population O 0 0.010312060825526714
, O 0 0.003909375984221697
we O 0 0.0038312533870339394
genotyped O 0 0.1055271103978157
families O 0 0.02562871016561985
using O 0 0.01656358875334263
polymorphic O 1 0.5475673675537109
markers O 0 0.10928383469581604
near O 0 0.01539059728384018
the O 0 0.008362691849470139
( O 0 0.07223032414913177
CTG O 0 0.49070125818252563
) O 0 0.03403677046298981
n O 0 0.052400074899196625
repeat O 0 0.13645729422569275
region O 0 0.026020243763923645
and O 0 0.010021700523793697
constructed O 0 0.042623840272426605
haplotypes O 1 0.7648102641105652
. O 0 0.05069337412714958

Six O 0 0.030630800873041153
different O 0 0.019605189561843872
haplotypes O 0 0.3804948627948761
were O 0 0.008973081596195698
found O 0 0.022978655993938446
and O 0 0.019851846620440483
DM B-Disease 1 0.9018794298171997
alleles O 1 0.7714946866035461
were O 0 0.013287058100104332
always O 0 0.029012581333518028
haplotype O 1 0.6897569298744202
A O 0 0.03534264490008354
. O 0 0.029719317331910133

To O 0 0.014270633459091187
find O 0 0.011247429065406322
an O 0 0.005504944361746311
origin O 0 0.007626268081367016
of O 0 0.0041273850947618484
the O 0 0.005212917923927307
( O 0 0.042261261492967606
CTG O 0 0.43975815176963806
) O 0 0.03158975765109062
n O 0 0.06836485862731934
repeat O 0 0.21360903978347778
mutation O 1 0.572905957698822
and O 0 0.003796954173594713
to O 0 0.00304886675439775
investigate O 0 0.006429317872971296
the O 0 0.0030908407643437386
mechanism O 0 0.026100363582372665
of O 0 0.0025567717384546995
the O 0 0.003539715427905321
expansion O 0 0.02348913997411728
mutation O 0 0.4813680946826935
in O 0 0.0035847555845975876
the O 0 0.002514089224860072
Japanese O 0 0.00439519202336669
population O 0 0.0060627637431025505
we O 0 0.0023785436060279608
have O 0 0.0026951839681714773
studied O 0 0.007871040143072605
90 O 0 0.011892514303326607
Japanese O 0 0.02460300736129284
DM B-Disease 1 0.8476391434669495
families O 0 0.05943752080202103
comprising O 0 0.026341237127780914
190 O 0 0.030168883502483368
affected O 0 0.07400181889533997
and O 0 0.008824704214930534
130 O 0 0.03492393344640732
unaffected O 0 0.24722792208194733
members O 0 0.02234986238181591
. O 0 0.02718666009604931

The O 0 0.017804473638534546
results O 0 0.018068308010697365
suggest O 0 0.011874646879732609
that O 0 0.0048754108138382435
a O 0 0.005487335380166769
few O 0 0.007176063489168882
common O 0 0.05857336148619652
ancestral O 0 0.21949394047260284
mutations O 1 0.754771888256073
in O 0 0.007053303997963667
both O 0 0.007387948222458363
Caucasian O 0 0.2134137600660324
and O 0 0.0047666640020906925
Japanese O 0 0.011135757900774479
populations O 0 0.10259706526994705
have O 0 0.005399889312684536
originated O 0 0.021512271836400032
by O 0 0.004107203334569931
expansion O 0 0.007034607231616974
of O 0 0.0030114096589386463
an O 0 0.0055158198811113834
ancestral O 0 0.07670223712921143
n O 0 0.07524442672729492
= O 0 0.1157248243689537
5 O 0 0.016367966309189796
repeat O 0 0.07362224161624908
to O 0 0.007195265498012304
n O 0 0.049893155694007874
= O 0 0.10040980577468872
19 O 0 0.022199245169758797
- O 0 0.07009126991033554
37 O 0 0.02991523966193199
copies O 0 0.03126794844865799
. O 0 0.024394622072577477

These O 0 0.0193487536162138
data O 0 0.014261320233345032
support O 0 0.011336851865053177
multistep O 0 0.08842270076274872
models O 0 0.015323757193982601
of O 0 0.0071699474938213825
triplet O 0 0.33154046535491943
repeat O 0 0.05703532695770264
expansion O 0 0.012222533114254475
that O 0 0.003074358217418194
have O 0 0.0029123860877007246
been O 0 0.00310342269949615
proposed O 0 0.006389437709003687
for O 0 0.005224926862865686
both O 0 0.02197227068245411
DM B-Disease 1 0.9084234833717346
and O 0 0.06195937842130661
Friedreichs B-Disease 1 0.8166806697845459
ataxia I-Disease 1 0.9461109042167664
. O 0 0.0590318962931633
. O 0 0.046137768775224686

The O 0 0.02713879384100437
molecular O 0 0.18446935713291168
basis O 0 0.022439075633883476
of O 0 0.038424838334321976
C6 B-Disease 1 0.9282363057136536
deficiency I-Disease 1 0.9644909501075745
in O 0 0.011883116327226162
the O 0 0.007024282589554787
western O 0 0.012546515092253685
Cape O 0 0.03206496313214302
, O 0 0.008127391338348389
South O 0 0.013523335568606853
Africa O 0 0.035313427448272705
. O 0 0.02500663325190544

Deficiency B-Disease 1 0.8708330988883972
of I-Disease 0 0.01380955334752798
the I-Disease 0 0.009117078967392445
sixth I-Disease 0 0.017467336729168892
component I-Disease 0 0.023784425109624863
of I-Disease 0 0.006355691235512495
human I-Disease 0 0.08034532517194748
complement I-Disease 0 0.10754338651895523
( O 0 0.06449092924594879
C6 O 0 0.49566352367401123
) O 0 0.012851232662796974
has O 0 0.0035698493011295795
been O 0 0.0029728689696639776
reported O 0 0.005020116455852985
in O 0 0.0023424839600920677
a O 0 0.002714768284931779
number O 0 0.0023916352074593306
of O 0 0.002613999880850315
families O 0 0.006167486310005188
from O 0 0.003759965533390641
the O 0 0.0036298849154263735
western O 0 0.007611608132719994
Cape O 0 0.03198091685771942
, O 0 0.008091751486063004
South O 0 0.015017244964838028
Africa O 0 0.052833426743745804
. O 0 0.0294936653226614

Meningococcal B-Disease 1 0.9559931755065918
disease I-Disease 1 0.9585701823234558
is O 0 0.03541155904531479
endemic O 0 0.17096693813800812
in O 0 0.0071660857647657394
the O 0 0.004475007299333811
Cape O 0 0.011748806573450565
and O 0 0.0035254480317234993
almost O 0 0.004844124428927898
all O 0 0.0037655120249837637
pedigrees O 0 0.1635519415140152
of O 0 0.013808110728859901
total O 0 0.1704828143119812
C6 B-Disease 1 0.9722288250923157
deficiency I-Disease 1 0.9875126481056213
( O 0 0.2690665125846863
C6Q0 O 1 0.539141833782196
) O 0 0.02143971063196659
have O 0 0.0054964711889624596
been O 0 0.007573570124804974
ascertained O 0 0.13608288764953613
because O 0 0.03891899064183235
of O 0 0.04864509031176567
recurrent O 1 0.9560006856918335
disease O 1 0.9716845154762268
. O 0 0.17640240490436554

We O 0 0.015344520099461079
have O 0 0.009649651125073433
sequenced O 0 0.026339182630181313
the O 0 0.0062451171688735485
expressed O 0 0.00877896323800087
exons O 0 0.07529716193675995
of O 0 0.005719178356230259
the O 0 0.009876609779894352
C6 O 1 0.7156858444213867
gene O 0 0.47751256823539734
from O 0 0.006789305247366428
selected O 0 0.005891791544854641
cases O 0 0.027382083237171173
and O 0 0.0026780383195728064
have O 0 0.002993655623868108
found O 0 0.009079809300601482
three O 0 0.015398358926177025
molecular O 1 0.6357303261756897
defects O 1 0.8827572464942932
leading O 0 0.055323321372270584
to O 0 0.009087152779102325
total O 0 0.07572881877422333
deficiency O 1 0.9796456694602966
879delG O 0 0.3328096270561218
, O 0 0.005725882016122341
which O 0 0.0032201632857322693
is O 0 0.0031050220131874084
the O 0 0.003656210843473673
common O 0 0.06265448778867722
defect O 0 0.42488840222358704
in O 0 0.004966275300830603
the O 0 0.003500122344121337
Cape O 0 0.020967872813344002
and O 0 0.004641839303076267
hitherto O 0 0.05856175720691681
unreported O 0 0.11749198287725449
, O 0 0.005612782668322325
and O 0 0.00453599588945508
1195delC O 0 0.10848841071128845
and O 0 0.004620982334017754
1936delG O 0 0.08767926692962646
, O 0 0.0035681670997291803
which O 0 0.0027704795356839895
have O 0 0.002521841786801815
been O 0 0.0033791325986385345
previously O 0 0.006163860205560923
reported O 0 0.014313532039523125
in O 0 0.007896114140748978
African O 0 0.07925301045179367
- O 0 0.16474251449108124
Americans O 0 0.08180945366621017
. O 0 0.03537309169769287

We O 0 0.012324891984462738
also O 0 0.007215049583464861
show O 0 0.007288531865924597
that O 0 0.004416417330503464
the O 0 0.006113934330642223
879delG O 0 0.14018110930919647
and O 0 0.012844524346292019
1195delC O 1 0.5183300375938416
defects O 1 0.8574426770210266
are O 0 0.014218943193554878
associated O 0 0.08787433803081512
with O 0 0.02609059400856495
characteristic O 1 0.5045055150985718
C6 O 1 0.896374523639679
/ O 1 0.7504003643989563
C7 O 1 0.8636595010757446
region O 0 0.14442844688892365
DNA O 1 0.5092229247093201
marker O 0 0.2734355628490448
haplotypes O 1 0.7226723432540894
, O 0 0.010317839682102203
although O 0 0.008374297991394997
small O 0 0.009049249812960625
variations O 0 0.04068804159760475
were O 0 0.008725659921765327
observed O 0 0.06155737489461899
. O 0 0.029018884524703026

The O 0 0.03145656734704971
1936delG O 0 0.35129594802856445
defect O 0 0.3543862998485565
was O 0 0.009311758913099766
observed O 0 0.01144892442971468
only O 0 0.0036757574416697025
once O 0 0.004268774762749672
in O 0 0.0033373855985701084
the O 0 0.003117465879768133
Cape O 0 0.01564267836511135
, O 0 0.00399770075455308
but O 0 0.003733626799657941
its O 0 0.005892331246286631
associated O 0 0.08747800439596176
haplotype O 1 0.5964614748954773
could O 0 0.011731191538274288
be O 0 0.008997133933007717
deduced O 0 0.06382816284894943
. O 0 0.02867194637656212

The O 0 0.01563684269785881
data O 0 0.0124590415507555
from O 0 0.007893686182796955
the O 0 0.006222304422408342
haplotypes O 0 0.31776800751686096
indicate O 0 0.012460309080779552
that O 0 0.0037207365967333317
these O 0 0.004198561888188124
three O 0 0.007294351235032082
molecular O 0 0.4207499325275421
defects O 1 0.7214370965957642
account O 0 0.009780124761164188
for O 0 0.004302279092371464
the O 0 0.0058278837241232395
defects O 0 0.49556872248649597
in O 0 0.004079418256878853
all O 0 0.002715819515287876
the O 0 0.004184919875115156
38 O 0 0.03513380140066147
unrelated O 0 0.2792899012565613
C6Q0 O 0 0.26951098442077637
individuals O 0 0.02187935821712017
we O 0 0.0034583844244480133
have O 0 0.0037474334239959717
studied O 0 0.007866227068006992
from O 0 0.005615111440420151
the O 0 0.007665424607694149
Cape O 0 0.06494492292404175
. O 0 0.02881203219294548

We O 0 0.016058672219514847
have O 0 0.009511877782642841
also O 0 0.006749261636286974
observed O 0 0.012095853686332703
the O 0 0.007059277500957251
879delG O 0 0.26451465487480164
defect O 0 0.45745378732681274
in O 0 0.009227121248841286
two O 0 0.013770035468041897
Dutch O 0 0.22246825695037842
C6 B-Disease 1 0.9039493799209595
- I-Disease 1 0.5844954252243042
deficient I-Disease 1 0.8947856426239014
kindreds O 1 0.6387920379638672
, O 0 0.010732751339673996
but O 0 0.006316545885056257
the O 0 0.007153828628361225
879delG O 0 0.2935590147972107
defect O 0 0.36689990758895874
in O 0 0.007160903420299292
the O 0 0.004951482638716698
Cape O 0 0.01947675831615925
probably O 0 0.006782983895391226
did O 0 0.003658053930848837
not O 0 0.0026673271786421537
come O 0 0.0036969829816371202
from O 0 0.004461830481886864
The O 0 0.005835089832544327
Netherlands O 0 0.02455664612352848
. O 0 0.012449202127754688
. O 0 0.0204379390925169

Complement B-Disease 1 0.6005011796951294
C7 I-Disease 1 0.9073200821876526
deficiency I-Disease 1 0.9536126255989075
: O 0 0.03208525851368904
seven O 0 0.018933000043034554
further O 0 0.03645433112978935
molecular O 1 0.554273784160614
defects O 1 0.7914671301841736
and O 0 0.011024488136172295
their O 0 0.015577058307826519
associated O 0 0.18104930222034454
marker O 0 0.3313932418823242
haplotypes O 1 0.83551424741745
. O 0 0.06366489082574844

Seven O 0 0.03666763752698898
further O 0 0.027516048401594162
molecular O 0 0.14227177202701569
bases O 0 0.03247399628162384
of O 0 0.04355377331376076
C7 B-Disease 1 0.9380207657814026
deficiency I-Disease 1 0.970570981502533
are O 0 0.03607629984617233
described O 0 0.08706066012382507
. O 0 0.04167667403817177

All O 0 0.01538678165525198
these O 0 0.010637084022164345
new O 0 0.01600782386958599
molecular O 0 0.4199075698852539
defects O 1 0.8037357926368713
involve O 0 0.08916077017784119
single O 0 0.034186944365501404
- O 0 0.097572922706604
nucleotide O 0 0.17322541773319244
events O 0 0.015281199477612972
, O 0 0.006207645870745182
deletions O 0 0.06590600311756134
and O 0 0.003494889009743929
substitutions O 0 0.008280383422970772
, O 0 0.0030385556165128946
some O 0 0.0023921974934637547
of O 0 0.0027395018842071295
which O 0 0.004302508197724819
alter O 0 0.10614290088415146
splice O 0 0.2833712697029114
sites O 0 0.012517565861344337
, O 0 0.007756659295409918
and O 0 0.0075587616302073
others O 0 0.022804930806159973
codons O 0 0.3295519948005676
. O 0 0.04039404168725014

They O 0 0.015431659296154976
are O 0 0.008833199739456177
distributed O 0 0.011367087252438068
along O 0 0.007272141519933939
the O 0 0.009503013454377651
C7 O 1 0.6790590882301331
gene O 0 0.4839709997177124
, O 0 0.005681134294718504
but O 0 0.004361351020634174
predominantly O 0 0.008021618239581585
towards O 0 0.007213221862912178
the O 0 0.006216969341039658
3 O 0 0.01436138991266489
end O 0 0.019659951329231262
. O 0 0.022612549364566803

All O 0 0.015123793855309486
were O 0 0.009175069630146027
found O 0 0.01131343375891447
in O 0 0.010544050484895706
compound O 0 0.09070685505867004
heterozygous O 1 0.5891313552856445
individuals O 0 0.1603616327047348
. O 0 0.04340493306517601

The O 0 0.0666702389717102
C6 O 1 0.8374857306480408
/ O 1 0.7084985375404358
C7 O 1 0.8462778925895691
marker O 0 0.4699569642543793
haplotypes O 1 0.8394094109535217
associated O 0 0.10110990703105927
with O 0 0.01737300306558609
most O 0 0.023728400468826294
C7 B-Disease 1 0.8141983151435852
defects I-Disease 1 0.8457323908805847
are O 0 0.010887554846704006
tabulated O 0 0.031912583857774734
. O 0 0.018090959638357162
. O 0 0.023220468312501907

A O 0 0.055900152772665024
genome O 0 0.2983509302139282
- O 0 0.06968218833208084
wide O 0 0.02597917430102825
search O 0 0.02351645939052105
for O 0 0.028396667912602425
chromosomal O 1 0.936335563659668
loci O 1 0.8910905718803406
linked O 1 0.5839822292327881
to O 0 0.05391036719083786
mental O 1 0.8884212970733643
health O 1 0.7082712650299072
wellness O 1 0.5875549912452698
in O 0 0.02340765669941902
relatives O 0 0.10359278321266174
at O 0 0.03494582697749138
high O 0 0.2531593441963196
risk O 1 0.9134408831596375
for O 0 0.3506118655204773
bipolar B-Disease 1 0.9879871010780334
affective I-Disease 1 0.9781383275985718
disorder I-Disease 1 0.9779160618782043
among O 0 0.06812424212694168
the O 0 0.013444195501506329
Old O 0 0.053316228091716766
Order O 0 0.038859639316797256
Amish O 0 0.19253087043762207
. O 0 0.039135850965976715

Bipolar B-Disease 1 0.9535403251647949
affective I-Disease 1 0.9525226354598999
disorder I-Disease 1 0.9695079922676086
( O 1 0.8043348789215088
BPAD B-Disease 1 0.9309247136116028
; O 1 0.7478110790252686
manic B-Disease 1 0.9702128767967224
- I-Disease 1 0.9495255351066589
depressive I-Disease 1 0.9800178408622742
illness I-Disease 1 0.9724714756011963
) O 0 0.16055700182914734
is O 0 0.02471066080033779
characterized O 0 0.2770616114139557
by O 0 0.012234645895659924
episodes O 0 0.05652419850230217
of O 0 0.01706966944038868
mania B-Disease 1 0.8325773477554321
and O 0 0.02490255795419216
/ O 0 0.3863355815410614
or O 0 0.09096549451351166
hypomania B-Disease 1 0.9037884473800659
interspersed O 0 0.23108038306236267
with O 0 0.02658424712717533
periods O 0 0.14620019495487213
of O 0 0.03737335279583931
depression B-Disease 1 0.8892008662223816
. O 0 0.09032518416643143

Compelling O 0 0.04711269214749336
evidence O 0 0.022801905870437622
supports O 0 0.023152848705649376
a O 0 0.014067674055695534
significant O 0 0.04719941318035126
genetic O 1 0.5909091830253601
component O 0 0.05660102143883705
in O 0 0.009188322350382805
the O 0 0.013278872705996037
susceptibility O 1 0.8101924061775208
to O 0 0.024995965883135796
develop O 0 0.3700766861438751
BPAD B-Disease 1 0.6682708263397217
. O 0 0.06618064641952515

To O 0 0.016030095517635345
date O 0 0.013558493927121162
, O 0 0.007029506843537092
however O 0 0.006495478097349405
, O 0 0.005518294405192137
linkage O 0 0.08731579035520554
studies O 0 0.012918666936457157
have O 0 0.00346345454454422
attempted O 0 0.006510752718895674
only O 0 0.0035299689043313265
to O 0 0.0062837060540914536
identify O 0 0.21477249264717102
chromosomal O 1 0.926802396774292
loci O 1 0.8136379718780518
that O 0 0.020485224202275276
cause O 0 0.4066024422645569
or O 0 0.026107678189873695
increase O 0 0.0313715897500515
the O 0 0.010905284434556961
risk O 0 0.43372830748558044
of O 0 0.017771996557712555
developing O 0 0.35853198170661926
BPAD B-Disease 1 0.6838105916976929
. O 0 0.06974013149738312

To O 0 0.01569586805999279
determine O 0 0.014025677926838398
whether O 0 0.00839686393737793
there O 0 0.005228358320891857
could O 0 0.005273603834211826
be O 0 0.0048925853334367275
protective O 0 0.17716872692108154
alleles O 1 0.6196698546409607
that O 0 0.00894873682409525
prevent O 0 0.1653427630662918
or O 0 0.022091718390583992
reduce O 0 0.0808902382850647
the O 0 0.008307764306664467
risk O 0 0.2964997887611389
of O 0 0.007288901135325432
developing O 0 0.17239989340305328
BPAD B-Disease 0 0.3967480957508087
, O 0 0.005533382296562195
similar O 0 0.008500810712575912
to O 0 0.0029100854881107807
what O 0 0.003735627979040146
is O 0 0.004329885821789503
observed O 0 0.03238429129123688
in O 0 0.016155585646629333
other O 0 0.08907248079776764
genetic B-Disease 1 0.9758053421974182
disorders I-Disease 1 0.9829330444335938
, O 0 0.01722024753689766
we O 0 0.007267458364367485
used O 0 0.05193544179201126
mental O 1 0.8730847835540771
health O 1 0.7764371633529663
wellness O 1 0.778578519821167
( O 0 0.13137474656105042
absence O 0 0.12055846303701401
of O 0 0.017312154173851013
any O 0 0.11374407261610031
psychiatric B-Disease 1 0.9622464776039124
disorder I-Disease 1 0.975397527217865
) O 0 0.04426923021674156
as O 0 0.0059031834825873375
the O 0 0.00941454153507948
phenotype O 1 0.8259994983673096
in O 0 0.009304300881922245
our O 0 0.009059902280569077
genome O 0 0.37672752141952515
- O 0 0.058705348521471024
wide O 0 0.02387566864490509
linkage O 0 0.17033617198467255
scan O 0 0.04958419129252434
of O 0 0.0045286123640835285
several O 0 0.005151033867150545
large O 0 0.010746541433036327
multigeneration O 0 0.13507197797298431
Old O 0 0.022453201934695244
Order O 0 0.015858149155974388
Amish O 0 0.15705515444278717
pedigrees O 0 0.35793590545654297
exhibiting O 0 0.2565022110939026
an O 0 0.02075846679508686
extremely O 0 0.09690716862678528
high O 0 0.07263272255659103
incidence O 1 0.8592580556869507
of O 0 0.04008575156331062
BPAD B-Disease 1 0.670117974281311
. O 0 0.08010562509298325

We O 0 0.014072727411985397
have O 0 0.007633662316948175
found O 0 0.007636123336851597
strong O 0 0.006860170513391495
evidence O 0 0.005133027210831642
for O 0 0.004413698799908161
a O 0 0.008110031485557556
locus O 0 0.32795625925064087
on O 0 0.015869053080677986
chromosome O 1 0.8249078392982483
4p O 1 0.5062563419342041
at O 0 0.018208933994174004
D4S2949 O 0 0.2944501042366028
( O 0 0.037855684757232666
maximum O 0 0.022732235491275787
GENEHUNTER O 0 0.27695852518081665
- O 0 0.09032797813415527
PLUS O 0 0.03742962330579758
nonparametric O 0 0.2147548943758011
linkage O 0 0.21994495391845703
score O 0 0.012297095730900764
= O 0 0.0813429206609726
4 O 0 0.009330539032816887
. O 0 0.005258217919617891
05 O 0 0.025510495528578758
, O 0 0.007355408277362585
P O 0 0.08331418037414551
= O 0 0.056376583874225616
5 O 0 0.008456719107925892
. O 0 0.004601798951625824
22 O 0 0.008527616038918495
x O 0 0.023831013590097427
10 O 0 0.009287592023611069
( O 0 0.026353854686021805
- O 0 0.04688708856701851
4 O 0 0.01596926338970661
) O 0 0.01927996426820755
; O 0 0.01917596533894539
SIBPAL O 0 0.19284863770008087
Pempirical O 0 0.17278605699539185
value O 0 0.015306282788515091
< O 0 0.24098066985607147
3 O 0 0.02009822055697441
x O 0 0.046307872980833054
10 O 0 0.01006406731903553
( O 0 0.02100963145494461
- O 0 0.03607574850320816
5 O 0 0.01229685265570879
) O 0 0.010669187642633915
) O 0 0.006714256945997477
and O 0 0.0029920078814029694
suggestive O 0 0.08353891968727112
evidence O 0 0.006415868178009987
for O 0 0.00386429182253778
a O 0 0.009326391853392124
locus O 0 0.3511415123939514
on O 0 0.014394431374967098
chromosome O 1 0.8667808771133423
4q O 1 0.6877291202545166
at O 0 0.019203482195734978
D4S397 O 0 0.26971015334129333
( O 0 0.040745943784713745
maximum O 0 0.031217169016599655
GENEHUNTER O 0 0.3043994605541229
- O 0 0.09046828001737595
PLUS O 0 0.04045511782169342
nonparametric O 0 0.22021780908107758
linkage O 0 0.197368785738945
score O 0 0.012202567420899868
= O 0 0.07745449244976044
3 O 0 0.009854140691459179
. O 0 0.005123041570186615
29 O 0 0.008701268583536148
, O 0 0.005673977080732584
P O 0 0.07014849781990051
= O 0 0.059228818863630295
2 O 0 0.00825957115739584
. O 0 0.004434771370142698
57 O 0 0.011302237398922443
x O 0 0.032378412783145905
10 O 0 0.009308794513344765
( O 0 0.023852230980992317
- O 0 0.05485589802265167
3 O 0 0.02226860076189041
) O 0 0.024489978328347206
; O 0 0.0235039871186018
SIBPAL O 0 0.25208327174186707
Pempirical O 0 0.20964758098125458
value O 0 0.015273215249180794
< O 0 0.23169440031051636
1 O 0 0.01408989168703556
x O 0 0.04915229231119156
10 O 0 0.01113873440772295
( O 0 0.03241191431879997
- O 0 0.05589214339852333
3 O 0 0.015199386514723301
) O 0 0.014512128196656704
) O 0 0.0077124773524701595
that O 0 0.0032006038818508387
are O 0 0.004968160763382912
linked O 0 0.1594412922859192
to O 0 0.018830066546797752
mental O 1 0.7792578339576721
health O 1 0.7173406481742859
wellness O 1 0.7745688557624817
. O 0 0.10196659713983536

These O 0 0.01833743043243885
findings O 0 0.018190715461969376
are O 0 0.006485165096819401
consistent O 0 0.008537378162145615
with O 0 0.004312033765017986
the O 0 0.003657993394881487
hypothesis O 0 0.05788775905966759
that O 0 0.005823255050927401
certain O 0 0.03517035394906998
alleles O 1 0.7470206022262573
could O 0 0.0270397812128067
prevent O 0 0.20278926193714142
or O 0 0.03280767425894737
modify O 0 0.1568845808506012
the O 0 0.014180202968418598
clinical O 1 0.6801033020019531
manifestations O 0 0.34875234961509705
of O 0 0.02245735190808773
BPAD B-Disease 1 0.5272898077964783
and O 0 0.016898784786462784
perhaps O 0 0.08574093133211136
other O 0 0.05574342608451843
related O 1 0.6464597582817078
affective B-Disease 1 0.9608609080314636
disorders I-Disease 1 0.970657467842102
. O 0 0.20589381456375122

Segregation O 1 0.5533024668693542
distortion O 1 0.6262234449386597
in O 0 0.2340029776096344
myotonic B-Disease 1 0.9262855052947998
dystrophy I-Disease 1 0.9371169209480286
. O 0 0.1773175746202469

Myotonic B-Disease 1 0.9288439750671387
dystrophy I-Disease 1 0.9498550891876221
( O 1 0.5897214412689209
DM B-Disease 1 0.9210030436515808
) O 0 0.12280090153217316
is O 0 0.04421423375606537
an O 0 0.1429501473903656
autosomal B-Disease 1 0.9807440638542175
dominant I-Disease 1 0.8024558424949646
disease I-Disease 1 0.9653804898262024
which O 0 0.011186160147190094
, O 0 0.0052442392334342
in O 0 0.004367075860500336
the O 0 0.004319685511291027
typical O 0 0.041971076279878616
pedigree O 0 0.12342045456171036
, O 0 0.005789241753518581
shows O 0 0.006911014672368765
a O 0 0.006952925119549036
three O 0 0.008377580903470516
generation O 0 0.06043832004070282
anticipation O 0 0.09124702960252762
cascade O 0 0.4419964551925659
. O 0 0.043025415390729904

This O 0 0.034503273665905
results O 0 0.19598764181137085
in O 0 0.2551158666610718
infertility B-Disease 1 0.9717459082603455
and O 1 0.6662011742591858
congenital B-Disease 1 0.9883540868759155
myotonic I-Disease 1 0.9813866019248962
dystrophy I-Disease 1 0.9822725057601929
( O 1 0.5226860046386719
CDM B-Disease 1 0.7220042943954468
) O 0 0.022152351215481758
with O 0 0.006785412319004536
the O 0 0.006776927039027214
disappearance O 0 0.08120055496692657
of O 0 0.015610375441610813
DM B-Disease 1 0.8505836129188538
in O 0 0.021127697080373764
that O 0 0.017822343856096268
pedigree O 0 0.33057597279548645
. O 0 0.03367697820067406

The O 0 0.015259609557688236
concept O 0 0.014658529311418533
of O 0 0.0074430485256016254
segregation O 0 0.04952647536993027
distortion O 0 0.05643114820122719
, O 0 0.00435629952698946
where O 0 0.0032808894757181406
there O 0 0.002895466983318329
is O 0 0.0033400326501578093
preferential O 0 0.024392681196331978
transmission O 0 0.060771580785512924
of O 0 0.0029838173650205135
the O 0 0.0036649007815867662
larger O 0 0.024667738005518913
allele O 0 0.46659067273139954
at O 0 0.011314937844872475
the O 0 0.018958022817969322
DM B-Disease 1 0.9065937995910645
locus O 0 0.4874487519264221
, O 0 0.006273726932704449
has O 0 0.003304900135844946
been O 0 0.0028042772319167852
put O 0 0.0037293650675565004
forward O 0 0.0036646833177655935
to O 0 0.003045617137104273
explain O 0 0.012632893398404121
partially O 0 0.0323101170361042
the O 0 0.005200790241360664
maintenance O 0 0.034367743879556656
of O 0 0.009775139391422272
DM B-Disease 1 0.7774731516838074
in O 0 0.011140893213450909
the O 0 0.009732096455991268
population O 0 0.051441892981529236
. O 0 0.0239463709294796

In O 0 0.021826855838298798
a O 0 0.013262400403618813
survey O 0 0.015726987272500992
of O 0 0.009848847053945065
DM B-Disease 1 0.620894730091095
in O 0 0.009830523282289505
Northern O 0 0.012970240786671638
Ireland O 0 0.014102921821177006
, O 0 0.008843129500746727
59 O 0 0.025641195476055145
pedigrees O 0 0.13132666051387787
were O 0 0.012224831618368626
ascertained O 0 0.15842166543006897
. O 0 0.03245773911476135

Sibships O 0 0.09944163262844086
where O 0 0.01006287895143032
the O 0 0.005139265209436417
status O 0 0.0049498663283884525
of O 0 0.0022041292395442724
all O 0 0.0018846832681447268
the O 0 0.001753689255565405
members O 0 0.0023091535549610853
had O 0 0.002191171981394291
been O 0 0.0025449502281844616
identified O 0 0.00538628688082099
were O 0 0.0019564602989703417
examined O 0 0.009734665043652058
to O 0 0.002107384381815791
determine O 0 0.004178341012448072
the O 0 0.002910107607021928
transmission O 0 0.08167438954114914
of O 0 0.003988335840404034
the O 0 0.008678331971168518
DM B-Disease 1 0.8138511776924133
expansion O 0 0.030288496986031532
from O 0 0.012835150584578514
affected O 0 0.14238664507865906
parents O 0 0.030722202733159065
to O 0 0.0065250215120613575
their O 0 0.011878520250320435
offspring O 0 0.4196018576622009
. O 0 0.04381205514073372

Where O 0 0.02700567990541458
the O 0 0.019496167078614235
transmitting O 0 0.20120464265346527
parent O 0 0.14837031066417694
was O 0 0.013587139546871185
male O 0 0.10688197612762451
, O 0 0.015685927122831345
58 O 0 0.03927997872233391
. O 0 0.02733519859611988

3 O 0 0.02433599717915058
% O 0 0.013806384988129139
of O 0 0.0059443083591759205
the O 0 0.004870180506259203
offspring O 0 0.09021588414907455
were O 0 0.003389992518350482
affected O 0 0.02590024098753929
, O 0 0.002755257301032543
and O 0 0.0020338944159448147
in O 0 0.0021586110815405846
the O 0 0.0021356428042054176
case O 0 0.004838098771870136
of O 0 0.003654241794720292
a O 0 0.009867949411273003
female O 0 0.11747267842292786
transmitting O 0 0.43531090021133423
parent O 0 0.2948915660381317
, O 0 0.015126721002161503
68 O 0 0.05766526609659195
. O 0 0.03238664194941521

7 O 0 0.04823671281337738
% O 0 0.03508324176073074
were O 0 0.01858389377593994
affected O 0 0.10869358479976654
. O 0 0.03304673731327057

Studies O 0 0.052142832428216934
on O 0 0.018056971952319145
meiotic O 0 0.33869192004203796
drive O 0 0.029964027926325798
in O 0 0.01824101433157921
DM B-Disease 1 0.6489077210426331
have O 0 0.007469292264431715
shown O 0 0.013330966234207153
increased O 0 0.02215053327381611
transmission O 0 0.1256343126296997
of O 0 0.0040189363062381744
the O 0 0.004603878129273653
larger O 0 0.035991884768009186
allele O 1 0.5354011654853821
at O 0 0.014584866352379322
the O 0 0.026891205459833145
DM B-Disease 1 0.9407943487167358
locus O 1 0.8111501932144165
in O 0 0.047922711819410324
non O 0 0.29609593749046326
- O 1 0.6008908152580261
DM O 1 0.9422143697738647
heterozygotes O 1 0.84189373254776
for O 0 0.05760545656085014
CTGn O 1 0.5379757881164551
. O 0 0.06204869598150253

This O 0 0.019951539114117622
study O 0 0.021522868424654007
provides O 0 0.014189056120812893
further O 0 0.007702943403273821
evidence O 0 0.007081173826009035
that O 0 0.004585015121847391
the O 0 0.00727670406922698
DM B-Disease 1 0.7473176121711731
expansion O 0 0.03840935230255127
tends O 0 0.06194400042295456
to O 0 0.008700869977474213
be O 0 0.011410907842218876
transmitted O 0 0.41231226921081543
preferentially O 0 0.27770718932151794
. O 0 0.03628729283809662

Diagnosis O 1 0.8458974957466125
of O 0 0.09733493626117706
hemochromatosis B-Disease 1 0.8906248211860657
. O 0 0.08899280428886414

If O 0 0.140846386551857
untreated O 1 0.8912801146507263
, O 0 0.15233682096004486
hemochromatosis B-Disease 1 0.9651968479156494
can O 0 0.30425119400024414
cause O 1 0.8394445776939392
serious O 1 0.686371922492981
illness O 1 0.9271488189697266
and O 0 0.015799064189195633
early B-Disease 0 0.032523106783628464
death I-Disease 0 0.08398564159870148
, O 0 0.0068502649664878845
but O 0 0.007286394014954567
the O 0 0.025479380041360855
disease O 1 0.962242603302002
is O 0 0.023128122091293335
still O 0 0.02386532351374626
substantially O 0 0.22571422159671783
under O 0 0.06936689466238022
- O 1 0.6965436339378357
diagnosed O 1 0.9616254568099976
. O 0 0.11746254563331604

The O 0 0.019577955827116966
cornerstone O 0 0.02969101071357727
of O 0 0.009616252966225147
screening O 0 0.0620775930583477
and O 0 0.006214303430169821
case O 0 0.012146838009357452
detection O 0 0.048182349652051926
is O 0 0.0037769919726997614
the O 0 0.003932221792638302
measurement O 0 0.026234377175569534
of O 0 0.007988879457116127
serum O 1 0.5474172830581665
transferrin O 1 0.5043591856956482
saturation O 0 0.18188433349132538
and O 0 0.009584520012140274
the O 0 0.015227749943733215
serum O 1 0.7112192511558533
ferritin O 1 0.6152037978172302
level O 0 0.07484139502048492
. O 0 0.04266098514199257

Once O 0 0.04052824154496193
the O 0 0.02659236639738083
diagnosis O 1 0.8305362462997437
is O 0 0.015480062924325466
suspected O 0 0.06400466710329056
, O 0 0.010771125555038452
physicians O 0 0.139527827501297
must O 0 0.009183553047478199
use O 0 0.01682019792497158
serum O 1 0.538408637046814
ferritin O 1 0.5773059129714966
levels O 0 0.21214450895786285
and O 0 0.03722647950053215
hepatic O 1 0.9555498957633972
iron O 0 0.255801260471344
stores O 0 0.0928095355629921
on O 0 0.06489227712154388
liver O 1 0.978449285030365
biopsy O 1 0.9139623641967773
specimens O 0 0.28571265935897827
to O 0 0.016562197357416153
assess O 0 0.1894475668668747
patients O 1 0.5715047121047974
for O 0 0.005978501867502928
the O 0 0.006099726539105177
presence O 0 0.029741110280156136
of O 0 0.01484100241214037
iron B-Disease 0 0.3099369704723358
overload I-Disease 1 0.8059641718864441
. O 0 0.08179455250501633

Liver O 1 0.9184554219245911
biopsy O 0 0.3336394429206848
is O 0 0.011147312819957733
also O 0 0.005739294458180666
used O 0 0.004281988367438316
to O 0 0.0030657975003123283
establish O 0 0.005836124997586012
the O 0 0.003482644446194172
presence O 0 0.017456939443945885
or O 0 0.010603128932416439
absence O 0 0.04274499788880348
of O 0 0.01742682419717312
cirrhosis B-Disease 1 0.9503577351570129
, O 0 0.01197735033929348
which O 0 0.009427393786609173
can O 0 0.02893461287021637
affect O 0 0.30521026253700256
prognosis O 1 0.852421224117279
and O 0 0.027290761470794678
management O 0 0.13843874633312225
. O 0 0.034615010023117065

A O 0 0.043571893125772476
DNA O 0 0.16791489720344543
- O 0 0.03954610228538513
based O 0 0.010395788587629795
test O 0 0.010823220945894718
for O 0 0.005369870457798243
the O 0 0.00933129619807005
HFE O 1 0.7504410147666931
gene O 0 0.45802491903305054
is O 0 0.006176934111863375
commercially O 0 0.009703745134174824
available O 0 0.003292292123660445
, O 0 0.002129019470885396
but O 0 0.0017768093384802341
its O 0 0.001925669377669692
place O 0 0.002606295747682452
in O 0 0.0035062748938798904
the O 0 0.008283806964755058
diagnosis O 1 0.8183864951133728
of O 0 0.02007540874183178
hemochromatosis B-Disease 1 0.9451776146888733
is O 0 0.016393864527344704
still O 0 0.01297708973288536
being O 0 0.013193474151194096
evaluated O 0 0.10590720921754837
. O 0 0.03038625791668892

Currently O 0 0.019462265074253082
, O 0 0.008377054706215858
the O 0 0.004667403642088175
most O 0 0.004286840092390776
useful O 0 0.00622207997366786
role O 0 0.005425514653325081
for O 0 0.002551059005782008
this O 0 0.0022720484994351864
test O 0 0.005154427140951157
is O 0 0.0024961885064840317
in O 0 0.0027065621688961983
the O 0 0.003247438929975033
detection O 0 0.11053302884101868
of O 0 0.009418223984539509
hemochromatosis B-Disease 1 0.9246546030044556
in O 0 0.007322171702980995
the O 0 0.004775729496032
family O 0 0.02134079486131668
members O 0 0.005716391839087009
of O 0 0.007123280316591263
patients O 1 0.6742267608642578
with O 0 0.009852935560047626
a O 0 0.013778921216726303
proven O 0 0.08404392004013062
case O 0 0.02187316305935383
of O 0 0.010588906705379486
the O 0 0.0696323812007904
disease O 1 0.9662323594093323
. O 0 0.12212828546762466

It O 0 0.022334419190883636
is O 0 0.017385020852088928
crucial O 0 0.03365662321448326
to O 0 0.05739689990878105
diagnose O 1 0.9630000591278076
hemochromatosis B-Disease 1 0.9723740816116333
before O 1 0.7513377666473389
hepatic B-Disease 1 0.9854018688201904
cirrhosis I-Disease 1 0.984831690788269
develops O 1 0.9497659206390381
because O 1 0.609195351600647
phlebotomy O 1 0.953841507434845
therapy O 1 0.9591086506843567
can O 0 0.42796358466148376
avert O 1 0.9374678730964661
serious O 1 0.9530012011528015
chronic O 1 0.9881194233894348
disease O 1 0.9794586896896362
and O 0 0.016547588631510735
can O 0 0.01179590541869402
even O 0 0.00933112483471632
lead O 0 0.029528839513659477
to O 0 0.007068220991641283
normal O 0 0.09416759014129639
life O 0 0.061718352138996124
expectancy O 0 0.41445019841194153
. O 0 0.030753279104828835
. O 0 0.03191349655389786

Prevalence O 0 0.4971159100532532
of O 0 0.02171504870057106
the O 0 0.021981826052069664
I1307K O 1 0.6396443247795105
APC B-Disease 1 0.8208469152450562
gene O 1 0.8091641664505005
variant O 0 0.4330916106700897
in O 0 0.008828174322843552
Israeli O 0 0.009168293327093124
Jews O 0 0.008477584458887577
of O 0 0.004638276528567076
differing O 0 0.04492270201444626
ethnic O 0 0.05605713278055191
origin O 0 0.10551716387271881
and O 0 0.05449540168046951
risk O 1 0.8910054564476013
for O 0 0.3898622989654541
colorectal B-Disease 1 0.9854848980903625
cancer I-Disease 1 0.978060781955719
. O 0 0.2892969250679016

BACKGROUND O 0 0.05476640909910202
& O 0 0.03969674929976463
AIMS O 0 0.021934563294053078
Israeli O 0 0.011358425952494144
Jews O 0 0.007457491010427475
of O 0 0.005324933677911758
European O 0 0.009891130961477757
birth O 0 0.08677898347377777
, O 0 0.005006181076169014
i O 0 0.004239376168698072
. O 0 0.004506535362452269
e O 0 0.022642619907855988
. O 0 0.004032026045024395
, O 0 0.0037758206017315388
Ashkenazim O 0 0.11412812769412994
, O 0 0.004724298138171434
have O 0 0.004545705858618021
the O 0 0.019228367134928703
highest O 0 0.48491454124450684
colorectal B-Disease 1 0.9916480779647827
cancer I-Disease 1 0.9892473816871643
incidence O 1 0.9156594276428223
of O 0 0.011738945730030537
any O 0 0.010557848028838634
Israeli O 0 0.018075386062264442
ethnic O 0 0.04168911650776863
group O 0 0.041314929723739624
. O 0 0.03193233534693718

The O 0 0.05305853113532066
I1307K O 1 0.5753549337387085
APC B-Disease 1 0.7700717449188232
gene O 1 0.7560031414031982
variant O 0 0.4590582847595215
was O 0 0.013355210423469543
found O 0 0.014862384647130966
in O 0 0.012012289837002754
6 O 0 0.031160369515419006
. O 0 0.02606051042675972

1 O 0 0.021552616730332375
% O 0 0.013870356604456902
of O 0 0.005362357944250107
American O 0 0.006984999869018793
Jews O 0 0.00766131654381752
, O 0 0.00439844373613596
28 O 0 0.008772140368819237
% O 0 0.02387111820280552
of O 0 0.014372450299561024
their O 0 0.16364718973636627
familial O 1 0.9879240393638611
colorectal B-Disease 1 0.9933134913444519
cancer I-Disease 1 0.989431619644165
cases O 1 0.5139809846878052
, O 0 0.012996918521821499
but O 0 0.005118280183523893
not O 0 0.004113379400223494
in O 0 0.00766234565526247
non O 0 0.05069265142083168
- O 0 0.1276485025882721
Jews O 0 0.04583872854709625
. O 0 0.03326749801635742

We O 0 0.02206398732960224
assessed O 0 0.030779661610722542
the O 0 0.012281330302357674
I1307K O 0 0.22545258700847626
prevalence O 0 0.4354121685028076
in O 0 0.007394556887447834
Israeli O 0 0.00965704582631588
Jews O 0 0.009164724498987198
of O 0 0.005046354606747627
differing O 0 0.04164937883615494
ethnic O 0 0.062026552855968475
origin O 0 0.1111363023519516
and O 0 0.06406161189079285
risk O 1 0.9026010632514954
for O 0 0.47752442955970764
colorectal B-Disease 1 0.9870707392692566
cancer I-Disease 1 0.9780159592628479
. O 0 0.25068333745002747

METHODS O 0 0.05976066365838051
DNA O 0 0.11567562818527222
samples O 0 0.029427392408251762
from O 0 0.011552060954272747
500 O 0 0.013948900625109673
unrelated O 0 0.05398648977279663
Jews O 0 0.007862496189773083
of O 0 0.00449305260553956
European O 0 0.009607885964214802
or O 0 0.01000987458974123
non O 0 0.02108711376786232
- O 0 0.04296339303255081
European O 0 0.010990249924361706
origin O 0 0.01406834740191698
, O 0 0.0032424340024590492
with O 0 0.002953081391751766
or O 0 0.004453408531844616
without O 0 0.003993770107626915
a O 0 0.0042174081318080425
personal O 0 0.01195074524730444
and O 0 0.005293000489473343
/ O 0 0.12230133265256882
or O 0 0.011042439378798008
family O 0 0.01603400707244873
history O 0 0.008063795045018196
of O 0 0.007867962121963501
neoplasia B-Disease 1 0.781620442867279
, O 0 0.005051042418926954
were O 0 0.002790190279483795
examined O 0 0.01516545657068491
for O 0 0.0035853260196745396
the O 0 0.005610107909888029
I1307K O 0 0.25111818313598633
variant O 0 0.45532381534576416
by O 0 0.011818554252386093
the O 0 0.019500888884067535
allele O 1 0.8321184515953064
- O 0 0.24710750579833984
specific O 0 0.12325391173362732
oligonucleotide O 1 0.6861556768417358
( O 0 0.14971962571144104
ASO O 0 0.4163912832736969
) O 0 0.05000393092632294
method O 0 0.07363652437925339
. O 0 0.027317151427268982

RESULTS O 0 0.0584261380136013
In O 0 0.0224293302744627
persons O 0 0.05735136568546295
at O 0 0.026126781478524208
average O 0 0.21102240681648254
risk O 1 0.8729689121246338
for O 0 0.38469234108924866
colorectal B-Disease 1 0.9905142784118652
cancer I-Disease 1 0.9805787205696106
, O 0 0.03822045400738716
I1307K O 0 0.2384190559387207
was O 0 0.009030292741954327
found O 0 0.01403775904327631
in O 0 0.011554782278835773
5 O 0 0.023906337097287178
. O 0 0.02817247062921524

0 O 0 0.04112664982676506
% O 0 0.02009781263768673
of O 0 0.00978056900203228
120 O 0 0.012510118074715137
European O 0 0.012204832397401333
and O 0 0.009372862987220287
1 O 0 0.017141614109277725
. O 0 0.021632634103298187

6 O 0 0.031796716153621674
% O 0 0.02064455673098564
of O 0 0.010245448909699917
188 O 0 0.023824002593755722
non O 0 0.02299632504582405
- O 0 0.041230686008930206
European O 0 0.014826731756329536
Jews O 0 0.034400638192892075
( O 0 0.05764848366379738
P O 0 0.2175358235836029
= O 0 0.1242932602763176
0 O 0 0.0293861273676157
. O 0 0.010580641217529774
08 O 0 0.058389972895383835
) O 0 0.024229325354099274
. O 0 0.02149081788957119

It O 0 0.027351753786206245
occurred O 0 0.03793828934431076
in O 0 0.01813727430999279
15 O 0 0.026079680770635605
. O 0 0.026934482157230377

4 O 0 0.037488553673028946
% O 0 0.022036604583263397
of O 0 0.011851719580590725
52 O 0 0.046974409371614456
Ashkenazi O 0 0.4797358214855194
Israelis O 0 0.1641649752855301
with O 0 0.22890573740005493
familial O 1 0.9762731790542603
cancer B-Disease 1 0.9800292253494263
( O 0 0.2887336313724518
P O 0 0.42922019958496094
= O 0 0.18053874373435974
0 O 0 0.03412126004695892
. O 0 0.009357795119285583
02 O 0 0.1523471623659134
) O 0 0.007718788459897041
and O 0 0.002293643541634083
was O 0 0.002394129289314151
not O 0 0.002838559215888381
detected O 0 0.05370224267244339
in O 0 0.005436685401946306
51 O 0 0.02452034503221512
non O 0 0.04077676311135292
- O 0 0.07343944907188416
European O 0 0.025088483467698097
Jews O 0 0.04578816518187523
at O 0 0.06155623495578766
increased O 1 0.511212944984436
cancer B-Disease 1 0.9720557928085327
risk O 1 0.8470908999443054
. O 0 0.10490179806947708

Colorectal B-Disease 1 0.9410776495933533
neoplasia I-Disease 1 0.8915987014770508
occurred O 0 0.07106760144233704
personally O 0 0.02172422595322132
or O 0 0.008866718970239162
in O 0 0.004763538483530283
the O 0 0.003521538805216551
families O 0 0.006105409935116768
of O 0 0.0031423624604940414
13 O 0 0.006424522493034601
of O 0 0.004659416154026985
20 O 0 0.015592251904308796
Ashkenazi O 0 0.3521900773048401
I1307K O 0 0.32869282364845276
carriers O 0 0.14366023242473602
, O 0 0.004650502931326628
8 O 0 0.005021760240197182
of O 0 0.002641890197992325
whom O 0 0.005691139027476311
also O 0 0.002541842171922326
had O 0 0.0030080315191298723
a O 0 0.004308023024350405
personal O 0 0.009376865811645985
or O 0 0.010755807161331177
family O 0 0.02568184584379196
history O 0 0.015240703709423542
of O 0 0.025983251631259918
noncolonic O 1 0.6765792965888977
neoplasia B-Disease 1 0.9156261682510376
. O 0 0.09980287402868271

CONCLUSIONS O 0 0.05367407202720642
The O 0 0.023434706032276154
I1307K O 0 0.41548529267311096
APC O 1 0.657548725605011
variant O 1 0.6161686182022095
may O 0 0.04967687651515007
represent O 0 0.03219889476895332
a O 0 0.10430841892957687
susceptibility O 1 0.9576064944267273
gene O 1 0.9294003844261169
for O 0 0.1300923079252243
colorectal B-Disease 1 0.9756014943122864
, I-Disease 0 0.020011775195598602
or I-Disease 0 0.020879389718174934
other I-Disease 0 0.010664991103112698
, I-Disease 0 0.02528262883424759
cancers I-Disease 1 0.9375260472297668
in O 0 0.021349012851715088
Ashkenazi O 0 0.255528062582016
Jews O 0 0.0170391034334898
, O 0 0.005470514763146639
and O 0 0.004670428577810526
partially O 0 0.06994146853685379
explains O 0 0.05757177248597145
the O 0 0.014577720314264297
higher O 0 0.21948489546775818
incidence O 1 0.9600504636764526
of O 0 0.37369304895401
colorectal B-Disease 1 0.989518940448761
cancer I-Disease 1 0.9791504144668579
in O 0 0.055039502680301666
European O 0 0.07975341379642487
Israelis O 0 0.14970120787620544
. O 0 0.06224016472697258

Systematic O 0 0.17354068160057068
analysis O 0 0.058314383029937744
of O 0 0.03266635164618492
coproporphyrinogen O 1 0.7839755415916443
oxidase O 1 0.9362912774085999
gene O 1 0.9435869455337524
defects O 1 0.9436957836151123
in O 0 0.1299300491809845
hereditary B-Disease 1 0.9207994341850281
coproporphyria I-Disease 1 0.7431334257125854
and O 0 0.08666901290416718
mutation O 1 0.9254118800163269
update O 0 0.4108017683029175
. O 0 0.06528544425964355

Hereditary B-Disease 1 0.8400134444236755
coproporphyria I-Disease 1 0.6594613790512085
( O 0 0.21467545628547668
HC B-Disease 1 0.5820576548576355
) O 0 0.11101170629262924
is O 0 0.06085068732500076
an O 0 0.22658830881118774
acute O 1 0.9779761433601379
hepatic B-Disease 1 0.9828574657440186
porphyria I-Disease 1 0.9795663952827454
with O 1 0.6724496483802795
autosomal O 1 0.9856467843055725
dominant O 1 0.8708468079566956
inheritance O 1 0.9124671816825867
caused O 1 0.6846780180931091
by O 0 0.07662802189588547
deficient B-Disease 1 0.7948794960975647
activity I-Disease 0 0.10515652596950531
of I-Disease 0 0.023027339950203896
coproporphyrinogen I-Disease 1 0.7244485020637512
III I-Disease 1 0.7160733938217163
oxidase I-Disease 1 0.9041975736618042
( O 0 0.15309756994247437
CPO O 0 0.24169045686721802
) O 0 0.06279952079057693
. O 0 0.030284594744443893

Clinical O 1 0.7055489420890808
manifestations O 0 0.2739886939525604
of O 0 0.022616567090153694
the O 0 0.07332371175289154
disease O 1 0.9715541005134583
are O 0 0.059895534068346024
characterized O 1 0.7228399515151978
by O 0 0.1877865195274353
acute O 1 0.9698347449302673
attacks O 1 0.5511301755905151
of O 0 0.23410312831401825
neurological B-Disease 1 0.9862467050552368
dysfunction I-Disease 1 0.9779245853424072
often O 0 0.27594390511512756
precipitated O 1 0.7902422547340393
by O 0 0.10389183461666107
drugs O 1 0.7088444232940674
, O 0 0.06246321648359299
fasting O 1 0.5951510071754456
, O 0 0.08822981268167496
cyclical O 1 0.8914889693260193
hormonal O 1 0.9527360200881958
changes O 0 0.4246251881122589
, O 0 0.1403990238904953
or O 0 0.48263317346572876
infectious B-Disease 1 0.9698290228843689
diseases I-Disease 1 0.9687871932983398
. O 0 0.2011643797159195

Skin O 1 0.905243456363678
photosensitivity O 1 0.7993031144142151
may O 0 0.03882259875535965
also O 0 0.014304223470389843
be O 0 0.011502780020236969
present O 0 0.020465409383177757
. O 0 0.023153865709900856

The O 0 0.021449724212288857
seven O 0 0.019815167412161827
exons O 0 0.10828380286693573
, O 0 0.010334153659641743
the O 0 0.008667122572660446
exon O 0 0.3250449597835541
/ O 0 0.20216211676597595
intron O 0 0.27119556069374084
boundaries O 0 0.008378492668271065
and O 0 0.0035391487181186676
part O 0 0.004014601465314627
of O 0 0.0031258855015039444
3 O 0 0.008818033151328564
noncoding O 0 0.23965045809745789
sequence O 0 0.01530778594315052
of O 0 0.0036262685898691416
the O 0 0.005161468870937824
CPO O 0 0.10807638615369797
gene O 0 0.3417298197746277
were O 0 0.004707806743681431
systematically O 0 0.03727411851286888
analyzed O 0 0.028482671827077866
by O 0 0.00789378397166729
an O 0 0.009946689009666443
exon O 0 0.38814061880111694
- O 0 0.16066592931747437
by O 0 0.026768410578370094
- O 0 0.29666364192962646
exon O 1 0.7334411144256592
denaturing O 1 0.8763180375099182
gradient O 1 0.7450312376022339
gel O 1 0.8914543986320496
electrophoresis O 1 0.8156429529190063
( O 0 0.12540869414806366
DGGE O 0 0.3112448751926422
) O 0 0.015170001424849033
strategy O 0 0.01572214439511299
followed O 0 0.008768737316131592
by O 0 0.005593234207481146
direct O 0 0.013780645094811916
sequencing O 0 0.07305842638015747
in O 0 0.0077530089765787125
seven O 0 0.02839544415473938
unrelated O 1 0.6071960926055908
heterozygous O 1 0.8956133127212524
HC B-Disease 1 0.8123265504837036
patients O 1 0.8753862977027893
from O 0 0.022210050374269485
France O 0 0.036158401519060135
, O 0 0.009196775034070015
Holland O 0 0.043819837272167206
, O 0 0.005880572367459536
and O 0 0.005837953649461269
Czech O 0 0.030915196985006332
Republic O 0 0.021415263414382935
. O 0 0.025791272521018982

Seven O 0 0.04369973763823509
novel O 0 0.14610148966312408
mutations O 1 0.6254088878631592
and O 0 0.011300724931061268
two O 0 0.009429107420146465
new O 0 0.016171138733625412
polymorphisms O 1 0.6089487671852112
were O 0 0.015939371660351753
detected O 0 0.29786670207977295
. O 0 0.034425344318151474

Among O 0 0.034181106835603714
these O 0 0.019266216084361076
mutations O 1 0.5418753027915955
two O 0 0.010055264458060265
are O 0 0.012636027298867702
missense O 1 0.6492016911506653
( O 0 0.06808781623840332
G197W O 0 0.2407493144273758
, O 0 0.01199023425579071
W427R O 0 0.16421493887901306
) O 0 0.009330559521913528
, O 0 0.0031743631698191166
two O 0 0.003225324908271432
are O 0 0.004046074580401182
nonsense O 0 0.0461147204041481
( O 0 0.029909804463386536
Q306X O 0 0.13634710013866425
, O 0 0.007043412420898676
Q385X O 0 0.09400518983602524
) O 0 0.00805030856281519
, O 0 0.0026766161900013685
two O 0 0.002658883575350046
are O 0 0.003273780457675457
small O 0 0.01122581958770752
deletions O 0 0.32655757665634155
( O 0 0.05752246826887131
662de14bp O 0 0.23808462917804718
; O 0 0.021817762404680252
1168del3bp O 0 0.1489700824022293
removing O 0 0.03432638943195343
a O 0 0.007385396398603916
glycine O 0 0.04318967089056969
at O 0 0.004844209179282188
position O 0 0.005235207732766867
390 O 0 0.03220890089869499
) O 0 0.008058076724410057
, O 0 0.0028062486089766026
and O 0 0.0023488844744861126
one O 0 0.002988577587530017
is O 0 0.005245045758783817
a O 0 0.02035670168697834
splicing O 1 0.8090395331382751
mutation O 1 0.9554546475410461
( O 0 0.28662821650505066
IVS1 O 1 0.6939244270324707
- O 0 0.43104979395866394
15c O 1 0.789924681186676
- O 0 0.4243117868900299
- O 0 0.4227038323879242
> O 1 0.5835476517677307
g O 0 0.21597695350646973
) O 0 0.014762843027710915
which O 0 0.005213577300310135
creates O 0 0.036545224487781525
a O 0 0.00860540010035038
new O 0 0.01429867185652256
acceptor O 0 0.3775717616081238
splice O 1 0.5347278714179993
site O 0 0.04257247969508171
. O 0 0.03263739123940468

The O 0 0.021106865257024765
pathological O 0 0.11750519275665283
significance O 0 0.015978986397385597
of O 0 0.005998759996145964
the O 0 0.006022234447300434
point O 0 0.01421296875923872
mutations O 1 0.8420678973197937
G197W O 0 0.21267154812812805
, O 0 0.008423843421041965
W427R O 0 0.08486633747816086
, O 0 0.004067119676619768
and O 0 0.0027501031290739775
the O 0 0.0030540511943399906
in O 0 0.005095511209219694
- O 0 0.051280733197927475
frame O 0 0.051057152450084686
deletion O 0 0.4617915749549866
390delGly O 0 0.15157462656497955
were O 0 0.004272788297384977
assessed O 0 0.010957871563732624
by O 0 0.0037666980642825365
their O 0 0.0034764129668474197
respective O 0 0.008141194470226765
expression O 0 0.03156749904155731
in O 0 0.005015412345528603
a O 0 0.0074172536842525005
prokaryotic O 0 0.15444141626358032
system O 0 0.018059605732560158
using O 0 0.011812468990683556
site O 0 0.014146946370601654
- O 0 0.07437674701213837
directed O 0 0.05216749384999275
mutagenesis O 0 0.43302130699157715
. O 0 0.04177267849445343

These O 0 0.03642402961850166
mutations O 1 0.6703667640686035
resulted O 0 0.03821021690964699
in O 0 0.00781303085386753
the O 0 0.0057737198658287525
absence O 0 0.022131433710455894
or O 0 0.009365038946270943
a O 0 0.0070769647136330605
dramatic O 0 0.04138687252998352
decrease O 0 0.11769229918718338
of O 0 0.0138366324827075
CPO O 0 0.1919635832309723
activity O 0 0.1038847342133522
. O 0 0.03258558735251427

The O 0 0.02156371809542179
two O 0 0.016378846019506454
polymorphisms O 0 0.41855746507644653
were O 0 0.00967132207006216
localized O 0 0.33560216426849365
in O 0 0.010080794803798199
noncoding O 0 0.21177004277706146
part O 0 0.006818533409386873
of O 0 0.0045576258562505245
the O 0 0.0076848287135362625
gene O 0 0.4811323881149292
1 O 0 0.01693183369934559
) O 0 0.01725839637219906
a O 0 0.014622317627072334
C O 0 0.21891702711582184
/ O 0 0.31946811079978943
G O 0 0.2203657329082489
polymorphism O 0 0.26911261677742004
in O 0 0.006561588030308485
the O 0 0.006290119607001543
promotor O 0 0.317041277885437
region O 0 0.015136441215872765
, O 0 0.005451778881251812
142 O 0 0.017482394352555275
bp O 0 0.02141987718641758
upstream O 0 0.019352218136191368
from O 0 0.0064794630743563175
the O 0 0.007129538804292679
transcriptional O 0 0.39624089002609253
initiation O 0 0.34984201192855835
site O 0 0.0418904684484005
( O 0 0.09609239548444748
- O 0 0.2674373984336853
142C O 1 0.6491414308547974
/ O 1 0.5510331392288208
G O 0 0.2940371036529541
) O 0 0.016154471784830093
, O 0 0.0033828795421868563
and O 0 0.00274671264924109
2 O 0 0.005521918181329966
) O 0 0.0054064225405454636
a O 0 0.00477558933198452
6 O 0 0.011408830992877483
bp O 0 0.039379894733428955
deletion O 0 0.2785611152648926
polymorphism O 0 0.15180854499340057
in O 0 0.005184240639209747
the O 0 0.004043773747980595
3 O 0 0.008764071390032768
noncoding O 0 0.20608413219451904
part O 0 0.0051055289804935455
of O 0 0.0036780578084290028
the O 0 0.005822713486850262
CPO O 0 0.17016322910785675
gene O 1 0.5224860906600952
, O 0 0.00798917654901743
574 O 0 0.08797570317983627
bp O 0 0.025143131613731384
downstream O 0 0.018226373940706253
of O 0 0.0034373735543340445
the O 0 0.0027469058986753225
last O 0 0.0035593213979154825
base O 0 0.0038117787335067987
of O 0 0.003385530086234212
the O 0 0.007178818341344595
normal O 0 0.19481082260608673
termination O 1 0.5855304598808289
codon O 1 0.6036867499351501
( O 0 0.20197194814682007
+ O 1 0.5303322076797485
574 O 1 0.5731557011604309
delATTCTT O 1 0.5231029987335205
) O 0 0.06792188435792923
. O 0 0.03238053247332573

Five O 0 0.03173504024744034
intragenic O 0 0.15324553847312927
dimorphisms O 0 0.06765575706958771
are O 0 0.006650915835052729
now O 0 0.005610574036836624
well O 0 0.004253831226378679
characterized O 0 0.03135456517338753
and O 0 0.0027621868066489697
the O 0 0.0027183417696505785
high O 0 0.006478085182607174
degree O 0 0.01586882956326008
of O 0 0.007738067768514156
allelic O 1 0.6161407828330994
heterogeneity O 0 0.463409423828125
in O 0 0.012966211885213852
HC B-Disease 0 0.19870656728744507
is O 0 0.005488652735948563
demonstrated O 0 0.011232553981244564
with O 0 0.003993100952357054
seven O 0 0.004532799590379
new O 0 0.005389886908233166
different O 0 0.008948951959609985
mutations O 0 0.4546031951904297
making O 0 0.0055368500761687756
a O 0 0.004595732782036066
total O 0 0.005201794672757387
of O 0 0.006589497439563274
nineteen O 0 0.09743492305278778
CPO O 1 0.6094753742218018
gene B-Disease 1 0.943395733833313
defects I-Disease 1 0.9396759271621704
reported O 0 0.0839923545718193
so O 0 0.011307215318083763
far O 0 0.013890440575778484
. O 0 0.014270580373704433
. O 0 0.022781062871217728

Coincidence O 0 0.05072609335184097
of O 0 0.013243655674159527
two O 0 0.0118726110085845
novel O 0 0.08422034978866577
arylsulfatase O 0 0.2979651093482971
A O 0 0.0473419688642025
alleles O 1 0.8640778660774231
and O 0 0.05636148154735565
mutation O 1 0.9223141670227051
459 O 1 0.6138584017753601
+ O 1 0.5195973515510559
1G O 1 0.5824405550956726
> O 0 0.2834811508655548
A O 0 0.012217865325510502
within O 0 0.00810207985341549
a O 0 0.010323216207325459
family O 0 0.043994657695293427
with O 0 0.024629084393382072
metachromatic B-Disease 1 0.705769956111908
leukodystrophy I-Disease 1 0.9354520440101624
: O 0 0.035231634974479675
molecular O 0 0.2196800708770752
basis O 0 0.016235359013080597
of O 0 0.015794800594449043
phenotypic O 1 0.6536861658096313
heterogeneity O 1 0.6661943793296814
. O 0 0.06274283677339554

In O 0 0.021510735154151917
a O 0 0.013682532124221325
family O 0 0.01514800451695919
with O 0 0.006322795525193214
three O 0 0.006508992053568363
siblings O 0 0.08599777519702911
, O 0 0.00625964067876339
one O 0 0.006753243040293455
developed O 0 0.07227590680122375
classical O 0 0.07768698036670685
late O 0 0.23891784250736237
infantile O 1 0.9756106734275818
metachromatic B-Disease 1 0.9638302326202393
leukodystrophy I-Disease 1 0.9781529307365417
( O 1 0.5720567107200623
MLD B-Disease 1 0.9285071492195129
) O 0 0.08712203800678253
, O 0 0.014602209441363811
fatal O 1 0.5901903510093689
at O 0 0.008270646445453167
age O 0 0.01882423274219036
5 O 0 0.009303036145865917
years O 0 0.007852250710129738
, O 0 0.00565449520945549
with O 0 0.01531926542520523
deficient O 1 0.6721380352973938
arylsulfatase O 0 0.4129659831523895
A O 0 0.04901133477687836
( O 0 0.11908487975597382
ARSA O 1 0.7762115001678467
) O 0 0.036835551261901855
activity O 0 0.033303018659353256
and O 0 0.007976780645549297
increased O 0 0.06031171977519989
galactosylsulfatide O 0 0.4693063199520111
( O 0 0.1735077202320099
GS O 1 0.7906352877616882
) O 0 0.1460459679365158
excretion O 1 0.7280583381652832
. O 0 0.05932766944169998

The O 0 0.015245270915329456
two O 0 0.010014025494456291
other O 0 0.008212284184992313
siblings O 0 0.11540874093770981
, O 0 0.007741700392216444
apparently O 0 0.02314961515367031
healthy O 0 0.10163862258195877
at O 0 0.0061265453696250916
12 O 0 0.01148996502161026
( O 0 0.019918596372008324
1 O 0 0.010895902290940285
/ O 0 0.08691569417715073
2 O 0 0.007646043784916401
) O 0 0.005824557971209288
and O 0 0.002047566697001457
15 O 0 0.0034164381213486195
years O 0 0.003239404410123825
, O 0 0.002433552872389555
respectively O 0 0.0037354608066380024
, O 0 0.002056722529232502
and O 0 0.0016435134457424283
their O 0 0.002463161712512374
father O 0 0.010024220682680607
, O 0 0.004061860032379627
apparently O 0 0.012071252800524235
healthy O 0 0.07603354007005692
as O 0 0.0036727148108184338
well O 0 0.0039969151839613914
, O 0 0.004282795358449221
presented O 0 0.010155565105378628
ARSA O 0 0.40000128746032715
and O 0 0.0072280606254935265
GS O 0 0.2867041230201721
values O 0 0.009628026746213436
within O 0 0.007426857482641935
the O 0 0.005971959792077541
range O 0 0.02514481544494629
of O 0 0.041860487312078476
MLD B-Disease 1 0.9254795908927917
patients O 1 0.9326582551002502
. O 0 0.09693743288516998

Mutation O 1 0.8107288479804993
screening O 0 0.09328809380531311
and O 0 0.01159235741943121
sequence O 0 0.02567467838525772
analysis O 0 0.016436902806162834
disclosed O 0 0.015204113908112049
the O 0 0.004006887786090374
involvement O 0 0.009748878888785839
of O 0 0.0037863675970584154
three O 0 0.005642106290906668
different O 0 0.018948540091514587
ARSA O 1 0.7721920609474182
mutations O 1 0.7392452955245972
being O 0 0.007668896112591028
the O 0 0.006205475423485041
molecular O 0 0.13478204607963562
basis O 0 0.011464927345514297
of O 0 0.016250697895884514
intrafamilial O 1 0.5720117092132568
phenotypic O 1 0.8054782152175903
heterogeneity O 1 0.7171579003334045
. O 0 0.06766827404499054

The O 0 0.04268347844481468
late O 0 0.2622104585170746
infantile O 1 0.9567607045173645
patient O 1 0.8769981861114502
inherited O 1 0.5983555912971497
from O 0 0.015314722433686256
his O 0 0.0099498825147748
mother O 0 0.05286668986082077
the O 0 0.010331641882658005
frequent O 0 0.22627903521060944
0 O 0 0.17095468938350677
- O 0 0.43897387385368347
type O 1 0.625139594078064
mutation O 1 0.9449365139007568
459 O 1 0.7131273150444031
+ O 1 0.6168028712272644
1G O 1 0.6227547526359558
> O 0 0.26643890142440796
A O 0 0.008012637495994568
, O 0 0.003508007386699319
and O 0 0.00254655908793211
from O 0 0.0031502305064350367
his O 0 0.0033654607832431793
father O 0 0.010499865747988224
a O 0 0.005495793651789427
novel O 0 0.028430327773094177
, O 0 0.005911348853260279
single O 0 0.01228857971727848
basepair O 0 0.2095281481742859
microdeletion O 0 0.1682962328195572
of O 0 0.009001169353723526
guanine O 0 0.1557907909154892
at O 0 0.009424218907952309
nucleotide O 0 0.14325574040412903
7 O 0 0.017614353448152542
in O 0 0.012847444973886013
exon O 0 0.2940942049026489
1 O 0 0.032373275607824326
( O 0 0.06807248294353485
7delG O 0 0.3190378248691559
) O 0 0.05054857209324837
. O 0 0.02707713469862938

The O 0 0.025149350985884666
two O 0 0.021615583449602127
clinically O 1 0.5456909537315369
unaffected O 0 0.4090760350227356
siblings O 0 0.28308039903640747
carried O 0 0.02686731144785881
the O 0 0.028168823570013046
maternal O 1 0.8916377425193787
mutation O 1 0.9495386481285095
459 O 1 0.7321705222129822
+ O 1 0.6653271317481995
1G O 1 0.6054292321205139
> O 0 0.21726109087467194
A O 0 0.00753422686830163
and O 0 0.003605406265705824
, O 0 0.0028191106393933296
on O 0 0.002554507227614522
their O 0 0.004394044168293476
paternal O 0 0.28329360485076904
allele O 1 0.5587894320487976
, O 0 0.0085135567933321
a O 0 0.009146180003881454
novel O 0 0.05530701205134392
cytosine O 0 0.16104088723659515
to O 0 0.007260354235768318
thymidine O 0 0.30118119716644287
transition O 0 0.05269438773393631
at O 0 0.01755206659436226
nucleotide O 0 0.3627741038799286
2435 O 0 0.4990618824958801
in O 0 0.013455989770591259
exon O 0 0.1838734894990921
8 O 0 0.013150942511856556
, O 0 0.006363989785313606
resulting O 0 0.041850388050079346
in O 0 0.006690945476293564
substitution O 0 0.04590509459376335
of O 0 0.009161918424069881
alanine O 0 0.334786057472229
464 O 0 0.29715779423713684
by O 0 0.03565414249897003
valine O 1 0.6078266501426697
( O 0 0.16143178939819336
A464V O 0 0.4042048454284668
) O 0 0.05775924399495125
. O 0 0.0311368927359581

The O 0 0.04535367339849472
fathers O 0 0.1475255787372589
genotype O 1 0.5991792678833008
thus O 0 0.049816638231277466
was O 0 0.02779553271830082
7delG O 0 0.4517107903957367
/ O 0 0.4278474748134613
A464V O 0 0.3651528060436249
. O 0 0.043587058782577515

Mutation O 1 0.7683418393135071
A464V O 0 0.12652438879013062
was O 0 0.015448976308107376
not O 0 0.008813733235001564
found O 0 0.011800441890954971
in O 0 0.010149029083549976
18 O 0 0.06095781549811363
unrelated O 1 0.6962774395942688
MLD B-Disease 1 0.9330414533615112
patients O 1 0.8615548610687256
and O 0 0.015018577687442303
50 O 0 0.025997014716267586
controls O 0 0.07745841890573502
. O 0 0.02989567443728447

A464V O 0 0.1607760488986969
, O 0 0.019610518589615822
although O 0 0.018188901245594025
clearly O 0 0.023095786571502686
modifying O 0 0.2853968143463135
ARSA O 1 0.7198349833488464
and O 0 0.017772480845451355
GS O 1 0.5897997617721558
levels O 0 0.07617656141519547
, O 0 0.007075781933963299
apparently O 0 0.012791921384632587
bears O 0 0.012766385450959206
little O 0 0.008425385691225529
significance O 0 0.011412597261369228
for O 0 0.009154057130217552
clinical O 0 0.4660658538341522
manifestation O 0 0.2468949407339096
of O 0 0.027276603505015373
MLD B-Disease 1 0.8487039804458618
, O 0 0.02640766277909279
mimicking O 0 0.3727889955043793
the O 0 0.032738469541072845
frequent O 0 0.4638015329837799
ARSA O 1 0.8919475674629211
pseudodeficiency O 1 0.7893943786621094
allele O 1 0.8611896634101868
. O 0 0.09562128782272339

Our O 0 0.02348535880446434
results O 0 0.019431328400969505
demonstrate O 0 0.01586957648396492
that O 0 0.006339125335216522
in O 0 0.008077453821897507
certain O 0 0.04949193820357323
genetic O 1 0.8588821291923523
conditions O 0 0.4002763330936432
MLD B-Disease 1 0.9033465385437012
- O 0 0.22272224724292755
like O 0 0.05014597624540329
ARSA O 1 0.6420853734016418
and O 0 0.011789397336542606
GS O 0 0.3194301724433899
values O 0 0.012679369188845158
need O 0 0.0071255299262702465
not O 0 0.004105140920728445
be O 0 0.004831518977880478
paralleled O 0 0.24841798841953278
by O 0 0.09713609516620636
clinical O 1 0.9458693861961365
disease O 1 0.9743006825447083
, O 0 0.015791401267051697
a O 0 0.012034823186695576
finding O 0 0.04866368696093559
with O 0 0.03153039515018463
serious O 0 0.3910159170627594
diagnostic O 1 0.6826463937759399
and O 0 0.042878635227680206
prognostic O 1 0.8293071985244751
implications O 0 0.47429147362709045
. O 0 0.0729011818766594

Moreover O 0 0.06705325096845627
, O 0 0.02249467559158802
further O 0 0.03353011608123779
ARSA O 1 0.7777262926101685
alleles O 1 0.786706268787384
functionally O 0 0.2826668620109558
similar O 0 0.01739291474223137
to O 0 0.006150522269308567
A464V O 0 0.09604262560606003
might O 0 0.009553595446050167
exist O 0 0.007928648963570595
which O 0 0.003250823589041829
, O 0 0.003484173910692334
together O 0 0.005334540270268917
with O 0 0.009921634569764137
0 O 0 0.1322789192199707
- O 0 0.4653208255767822
type O 1 0.6054957509040833
mutations O 1 0.9539035558700562
, O 0 0.052664536982774734
may O 0 0.17068922519683838
cause O 1 0.7167630195617676
pathological O 1 0.846290111541748
ARSA O 1 0.863193690776825
and O 0 0.03439582139253616
GS O 1 0.745896577835083
levels O 0 0.1514463573694229
, O 0 0.00973249226808548
but O 0 0.007863800972700119
not O 0 0.01602877303957939
clinical O 1 0.7442281246185303
outbreak O 1 0.8407523036003113
of O 0 0.021811185404658318
the O 0 0.08134286105632782
disease O 1 0.9697273373603821
. O 0 0.05409911274909973
. O 0 0.05000525340437889

Human O 1 0.7614299654960632
MLH1 O 1 0.8914052844047546
deficiency O 1 0.9564637541770935
predisposes O 1 0.8832640647888184
to O 0 0.16006088256835938
hematological B-Disease 1 0.9390197396278381
malignancy I-Disease 1 0.9416506290435791
and O 0 0.16621920466423035
neurofibromatosis B-Disease 1 0.9266061186790466
type I-Disease 0 0.3646495044231415
1 I-Disease 0 0.0502791702747345
. O 0 0.040905293077230453

Heterozygous O 1 0.8095064759254456
germ O 1 0.7072607278823853
- O 0 0.2209615409374237
line O 0 0.0592474639415741
mutations O 1 0.7636727690696716
in O 0 0.01452752947807312
the O 0 0.01993798278272152
DNA O 1 0.671373724937439
mismatch O 1 0.8341315388679504
repair O 1 0.7681158185005188
genes O 1 0.8688444495201111
lead O 0 0.329855740070343
to O 0 0.12543924152851105
hereditary B-Disease 1 0.9591910243034363
nonpolyposis I-Disease 1 0.9483058452606201
colorectal I-Disease 1 0.9828324913978577
cancer I-Disease 1 0.9689465165138245
. O 0 0.29860013723373413

The O 0 0.1916200965642929
disease O 1 0.9613945484161377
susceptibility O 1 0.8376514911651611
of O 0 0.01587146706879139
individuals O 0 0.046817269176244736
who O 0 0.010610745288431644
constitutionally O 0 0.05800642818212509
lack O 0 0.03027605637907982
both O 0 0.01341266743838787
wild O 0 0.2072555422782898
- O 0 0.3985358774662018
type O 1 0.5019925236701965
alleles O 1 0.889829158782959
is O 0 0.038925182074308395
unknown O 0 0.12696366012096405
. O 0 0.043355897068977356

We O 0 0.014876157976686954
have O 0 0.009687218815088272
identified O 0 0.0156567245721817
three O 0 0.009676323272287846
offspring O 0 0.3778585195541382
in O 0 0.026592884212732315
a O 0 0.17731666564941406
hereditary B-Disease 1 0.9734600782394409
nonpolyposis I-Disease 1 0.9743168354034424
colorectal I-Disease 1 0.9917961359024048
cancer I-Disease 1 0.9881267547607422
family O 0 0.4584976136684418
who O 0 0.1044522300362587
developed O 1 0.5917069315910339
hematological B-Disease 1 0.9504190683364868
malignancy I-Disease 1 0.9050748348236084
at O 0 0.010196028277277946
a O 0 0.008134436793625355
very O 0 0.007028388325124979
early O 0 0.007831249386072159
age O 0 0.013241861946880817
, O 0 0.00283315172418952
and O 0 0.0022097486071288586
at O 0 0.002146876649931073
least O 0 0.002660508966073394
two O 0 0.0021600474137812853
of O 0 0.0022316742688417435
them O 0 0.003150255884975195
displayed O 0 0.007803776767104864
signs O 0 0.05418115481734276
of O 0 0.028528908267617226
neurofibromatosis B-Disease 1 0.9529196619987488
type I-Disease 0 0.42227277159690857
1 I-Disease 0 0.09005484730005264
( O 0 0.20033279061317444
NF1 B-Disease 1 0.8567187786102295
) O 0 0.06226538121700287
. O 0 0.033455170691013336

DNA O 0 0.2702156603336334
sequence O 0 0.07857363671064377
analysis O 0 0.037762247025966644
and O 0 0.014460010454058647
allele O 1 0.6196232438087463
- O 0 0.11810358613729477
specific O 0 0.04409646987915039
amplification O 0 0.1818391978740692
in O 0 0.00788302905857563
two O 0 0.010457828640937805
siblings O 0 0.3532933294773102
revealed O 0 0.1324155628681183
a O 0 0.07927896827459335
homozygous O 1 0.9285451769828796
MLH1 O 1 0.9543660283088684
mutation O 1 0.9606776833534241
( O 0 0.38231420516967773
C676T O 1 0.7737143039703369
- O 1 0.5250696539878845
- O 1 0.526367723941803
> O 1 0.7170906066894531
Arg226Stop O 1 0.5414558053016663
) O 0 0.06929092109203339
. O 0 0.031847141683101654

Thus O 0 0.04402481019496918
, O 0 0.022941676899790764
a O 0 0.027445770800113678
homozygous O 1 0.7544036507606506
germ O 1 0.7708618640899658
- O 0 0.33187466859817505
line O 0 0.1748269945383072
MLH1 O 1 0.9296059608459473
mutation O 1 0.9386094808578491
and O 0 0.08748488873243332
consequent O 1 0.8896442651748657
mismatch O 1 0.9443869590759277
repair O 1 0.9383034110069275
deficiency O 1 0.9789819121360779
results O 0 0.2687165439128876
in O 0 0.06371814757585526
a O 0 0.18519452214241028
mutator O 1 0.9641563892364502
phenotype O 1 0.9773678183555603
characterized O 1 0.9392933249473572
by O 1 0.605444073677063
leukemia B-Disease 1 0.9874148964881897
and O 0 0.23457983136177063
/ O 1 0.9030194282531738
or O 1 0.6226831674575806
lymphoma B-Disease 1 0.9865586757659912
associated O 1 0.5773080587387085
with O 0 0.18395847082138062
neurofibromatosis B-Disease 1 0.9586127996444702
type I-Disease 0 0.33732128143310547
1 I-Disease 0 0.0357317253947258
. O 0 0.018247881904244423
. O 0 0.024182235822081566

Missense O 1 0.7083205580711365
mutations O 1 0.5584734678268433
in O 0 0.012210484594106674
the O 0 0.007553719449788332
most O 0 0.006486911326646805
ancient O 0 0.009717011824250221
residues O 0 0.03765426576137543
of O 0 0.006740394048392773
the O 0 0.014888931065797806
PAX6 O 1 0.8059256076812744
paired O 0 0.34410104155540466
domain O 0 0.1624385565519333
underlie O 1 0.5383936166763306
a O 0 0.03181510046124458
spectrum O 0 0.31574973464012146
of O 0 0.08059589564800262
human O 1 0.8476805686950684
congenital B-Disease 1 0.9848281741142273
eye I-Disease 1 0.9409698843955994
malformations I-Disease 1 0.9525505900382996
. O 0 0.20033907890319824

Mutations O 1 0.7424202561378479
of O 0 0.021065400913357735
the O 0 0.02285832352936268
human O 0 0.4611078202724457
PAX6 O 1 0.9426566362380981
gene O 1 0.9473802447319031
underlie O 1 0.9334641098976135
aniridia B-Disease 1 0.9295313954353333
( O 1 0.5334009528160095
congenital B-Disease 1 0.9753433465957642
absence I-Disease 0 0.1029529720544815
of I-Disease 0 0.008299943059682846
the I-Disease 0 0.011967896483838558
iris I-Disease 1 0.5156650543212891
) O 0 0.025306513532996178
, O 0 0.008820301853120327
a O 0 0.01488472055643797
rare O 0 0.22677326202392578
dominant O 0 0.4679003953933716
malformation B-Disease 1 0.904731035232544
of I-Disease 0 0.013966330327093601
the I-Disease 0 0.024229224771261215
eye I-Disease 1 0.5803778767585754
. O 0 0.047240570187568665

The O 0 0.02872888185083866
spectrum O 0 0.09479241073131561
of O 0 0.029979920014739037
PAX6 O 1 0.9154466986656189
mutations O 1 0.9261735081672668
in O 0 0.07846155017614365
aniridia B-Disease 1 0.8006759881973267
patients O 1 0.8272232413291931
is O 0 0.012658815830945969
highly O 0 0.026909641921520233
biased O 0 0.024772826582193375
, O 0 0.004392939154058695
with O 0 0.004007662180811167
92 O 0 0.011412574909627438
% O 0 0.006798085290938616
of O 0 0.0026736122090369463
all O 0 0.0038815531879663467
reported O 0 0.05340077728033066
mutations O 1 0.7146708965301514
leading O 0 0.0242545735090971
to O 0 0.007274927571415901
premature O 0 0.446452796459198
truncation O 0 0.140080064535141
of O 0 0.005038101226091385
the O 0 0.006232183426618576
protein O 0 0.26086974143981934
( O 0 0.03168991953134537
nonsense O 0 0.041990119963884354
, O 0 0.007929785177111626
splicing O 0 0.2528200149536133
, O 0 0.00869428738951683
insertions O 0 0.15612001717090607
and O 0 0.00592490378767252
deletions O 0 0.1753644049167633
) O 0 0.007388357538729906
and O 0 0.0025127409026026726
just O 0 0.002913162810727954
2 O 0 0.003964709583669901
% O 0 0.004815816879272461
leading O 0 0.004092072602361441
to O 0 0.0025949724949896336
substitution O 0 0.013590693473815918
of O 0 0.003219208214432001
one O 0 0.006563471630215645
amino O 0 0.23971307277679443
acid O 0 0.48116999864578247
by O 0 0.018217908218503
another O 0 0.03705606609582901
( O 0 0.105840764939785
missense O 1 0.7435175180435181
) O 0 0.062460169196128845
. O 0 0.030845817178487778

The O 0 0.019738955423235893
extraordinary O 0 0.020474320277571678
conservation O 0 0.01617966778576374
of O 0 0.007173953577876091
the O 0 0.00836101919412613
PAX6 O 1 0.5695924758911133
protein O 0 0.13763481378555298
at O 0 0.007087308913469315
the O 0 0.006175289396196604
amino O 0 0.1283053457736969
acid O 0 0.3485948443412781
level O 0 0.03367432951927185
amongst O 0 0.08399991691112518
vertebrates O 0 0.46800145506858826
predicts O 0 0.3509185016155243
that O 0 0.0322127602994442
pathological O 1 0.8007667064666748
missense O 1 0.8883463144302368
mutations O 1 0.8309289813041687
should O 0 0.007322886027395725
in O 0 0.00402433518320322
fact O 0 0.004847382660955191
be O 0 0.002310920739546418
common O 0 0.008600138127803802
even O 0 0.003379727015271783
though O 0 0.003752143355086446
they O 0 0.0022161821834743023
are O 0 0.002723854035139084
hardly O 0 0.011691896244883537
ever O 0 0.008230452425777912
seen O 0 0.022544462233781815
in O 0 0.03896430507302284
aniridia B-Disease 1 0.7947072386741638
patients O 1 0.9166494011878967
. O 0 0.08818183839321136

This O 0 0.01431252434849739
indicates O 0 0.015101849101483822
that O 0 0.0046979282051324844
there O 0 0.0034383046440780163
is O 0 0.0032807025127112865
a O 0 0.004282254260033369
heavy O 0 0.014226672239601612
ascertainment O 0 0.22769580781459808
bias O 0 0.07073712348937988
in O 0 0.004427286796271801
the O 0 0.0036207304801791906
selection O 0 0.012276137247681618
of O 0 0.01635933108627796
patients O 1 0.8841384053230286
for O 0 0.06062757223844528
PAX6 O 1 0.9335387945175171
mutation O 1 0.9053958058357239
analysis O 0 0.04081754386425018
and O 0 0.004895455669611692
that O 0 0.004914764314889908
the O 0 0.008771801367402077
missing O 0 0.17759138345718384
PAX6 O 1 0.9434432983398438
missense O 1 0.9533560872077942
mutations O 1 0.9633603096008301
frequently O 0 0.2987300753593445
may O 0 0.259165495634079
underlie O 1 0.8431453108787537
phenotypes O 1 0.9016804099082947
distinct O 0 0.3186534643173218
from O 0 0.04429665207862854
textbook O 0 0.27738630771636963
aniridia B-Disease 1 0.6350765228271484
. O 0 0.07264387607574463

Here O 0 0.01925363391637802
we O 0 0.009573766961693764
present O 0 0.013041162863373756
four O 0 0.01411968469619751
novel O 0 0.2683275043964386
PAX6 O 1 0.9232387542724609
missense O 1 0.9254859089851379
mutations O 1 0.9109984636306763
, O 0 0.010584674775600433
two O 0 0.006560350768268108
in O 0 0.011268984526395798
association O 0 0.07215070724487305
with O 0 0.08391812443733215
atypical O 1 0.9498568177223206
phenotypes O 1 0.9521735310554504
ectopia B-Disease 1 0.8504562377929688
pupillae I-Disease 1 0.8074464201927185
( O 0 0.20721915364265442
displaced B-Disease 0 0.3531875014305115
pupils I-Disease 0 0.20063607394695282
) O 0 0.09754747152328491
and O 0 0.09244829416275024
congenital B-Disease 1 0.9865905046463013
nystagmus I-Disease 1 0.9411957859992981
( O 0 0.09708015620708466
searching B-Disease 0 0.03898424282670021
gaze I-Disease 0 0.07031138986349106
) O 0 0.01265448983758688
, O 0 0.003026943886652589
and O 0 0.0024674299638718367
two O 0 0.0030044827144593
in O 0 0.0040946039371192455
association O 0 0.013240252621471882
with O 0 0.007120724301785231
more O 0 0.016232579946517944
recognizable O 0 0.38415980339050293
aniridia B-Disease 1 0.7828076481819153
phenotypes O 1 0.8922831416130066
. O 0 0.10374665260314941

Strikingly O 0 0.05743543803691864
, O 0 0.01167008001357317
all O 0 0.006127986125648022
four O 0 0.007177645806223154
mutations O 0 0.415078729391098
are O 0 0.003985291812568903
located O 0 0.0050713298842310905
within O 0 0.005355814937502146
the O 0 0.005569991189986467
PAX6 O 1 0.5539135932922363
paired O 0 0.09676025062799454
domain O 0 0.034053631126880646
and O 0 0.005916265305131674
affect O 0 0.06616432219743729
amino O 0 0.16871780157089233
acids O 0 0.14187784492969513
which O 0 0.003841416211798787
are O 0 0.0028290445916354656
highly O 0 0.012308708392083645
conserved O 0 0.024811169132590294
in O 0 0.004087256267666817
all O 0 0.0037424308247864246
known O 0 0.022001493722200394
paired O 0 0.16481736302375793
domain O 0 0.17580197751522064
proteins O 0 0.4513217806816101
. O 0 0.049469832330942154

Our O 0 0.01963992789387703
results O 0 0.01568388007581234
support O 0 0.0076656099408864975
the O 0 0.004527589306235313
hypothesis O 0 0.013993893750011921
that O 0 0.0027870156336575747
the O 0 0.002841563429683447
under O 0 0.004013872239738703
- O 0 0.025986075401306152
representation O 0 0.014870247803628445
of O 0 0.01887628249824047
missense O 1 0.9012270569801331
mutations O 1 0.9431166648864746
is O 0 0.03465251252055168
caused O 0 0.26905563473701477
by O 0 0.019909372553229332
ascertainment O 0 0.40329068899154663
bias O 0 0.09331826865673065
and O 0 0.004746479447931051
suggest O 0 0.013026219792664051
that O 0 0.0037182006053626537
a O 0 0.006308434531092644
substantial O 0 0.04088875278830528
burden O 0 0.20502622425556183
of O 0 0.03546009957790375
PAX6 B-Disease 1 0.9438652396202087
- I-Disease 1 0.7297669053077698
related I-Disease 1 0.7327568531036377
disease I-Disease 1 0.9673568606376648
remains O 0 0.03864011913537979
to O 0 0.007217351347208023
be O 0 0.008276625536382198
uncovered O 0 0.05026090890169144
. O 0 0.014733437448740005
. O 0 0.02187904715538025

The O 0 0.02990701235830784
chromosomal O 1 0.5528225302696228
order O 0 0.01695588417351246
of O 0 0.01141407061368227
genes O 0 0.4734078645706177
controlling O 0 0.1450059562921524
the O 0 0.01006359700113535
major O 0 0.05670526251196861
histocompatibility O 1 0.8448846340179443
complex O 0 0.14347878098487854
, O 0 0.028041379526257515
properdin O 1 0.5001726746559143
factor O 0 0.345138818025589
B O 0 0.22057676315307617
, O 0 0.010048089548945427
and O 0 0.009382501244544983
deficiency B-Disease 1 0.9027450680732727
of I-Disease 0 0.004579408094286919
the I-Disease 0 0.004428123589605093
second I-Disease 0 0.007778555620461702
component I-Disease 0 0.035691939294338226
of I-Disease 0 0.00983605906367302
complement I-Disease 0 0.08748717606067657
. O 0 0.026829199865460396

The O 0 0.01905423402786255
relationship O 0 0.0266891960054636
of O 0 0.007117356639355421
the O 0 0.008462939411401749
genes O 1 0.552915632724762
coding O 0 0.39511364698410034
for O 0 0.012548519298434258
HLA O 1 0.5624934434890747
to O 0 0.0061285290867090225
those O 0 0.010469767265021801
coding O 0 0.30519911646842957
for O 0 0.01353954616934061
properdin O 0 0.44996508955955505
Factor O 0 0.4020756781101227
B O 0 0.30886805057525635
allotypes O 0 0.3100137710571289
and O 0 0.007740993518382311
for O 0 0.01244186982512474
deficiency B-Disease 1 0.9046537280082703
of I-Disease 0 0.0032572171185165644
the I-Disease 0 0.002926485612988472
second I-Disease 0 0.004330293275415897
component I-Disease 0 0.020062603056430817
of I-Disease 0 0.005206776317209005
complement I-Disease 0 0.07349395751953125
( O 0 0.08246999979019165
C2 O 1 0.6227954626083374
) O 0 0.015085672959685326
was O 0 0.0043730465695261955
studied O 0 0.01350291259586811
in O 0 0.009654136374592781
families O 0 0.07421982288360596
of O 0 0.05928477644920349
patients O 1 0.9585040807723999
with O 1 0.5093236565589905
connective O 1 0.9806818962097168
tissue O 1 0.976707398891449
disorders O 1 0.9754496812820435
. O 0 0.28811490535736084

Patients O 0 0.4278382658958435
were O 0 0.013403670862317085
selected O 0 0.011332491412758827
because O 0 0.00878811627626419
they O 0 0.005733831319957972
were O 0 0.007649105507880449
heterozygous O 0 0.47007662057876587
or O 0 0.09378061443567276
homozygous O 1 0.8372681736946106
for O 0 0.17373794317245483
C2 B-Disease 1 0.9515779614448547
deficiency I-Disease 1 0.9739406108856201
. O 0 0.19987758994102478

12 O 0 0.040174953639507294
families O 0 0.03152526542544365
with O 0 0.017593657597899437
15 O 0 0.02362799271941185
matings O 0 0.4832514524459839
informative O 0 0.1372358500957489
for O 0 0.06322531402111053
C2 B-Disease 1 0.9375653266906738
deficiency I-Disease 1 0.9623511433601379
were O 0 0.020645560696721077
found O 0 0.05172443762421608
. O 0 0.036672767251729965

Of O 0 0.02153821662068367
57 O 0 0.02672729827463627
informative O 0 0.028629746288061142
meioses O 0 0.06165798753499985
, O 0 0.0065240757539868355
two O 0 0.0045640659518539906
crossovers O 0 0.016990510746836662
were O 0 0.0040695928037166595
noted O 0 0.011013035662472248
between O 0 0.017998790368437767
the O 0 0.07653100043535233
C2 B-Disease 1 0.9786844849586487
deficiency I-Disease 1 0.990825355052948
gene O 1 0.9083526730537415
and O 0 0.026393530890345573
the O 0 0.042896371334791183
HLA O 1 0.9333062767982483
- O 1 0.5650234222412109
B O 1 0.5488923192024231
gene O 1 0.6465945243835449
, O 0 0.008220646530389786
with O 0 0.007465673144906759
a O 0 0.012029159814119339
recombinant O 0 0.34407728910446167
fraction O 0 0.04607577621936798
of O 0 0.01216528657823801
0 O 0 0.04707993194460869
. O 0 0.028442591428756714

035 O 1 0.5908287763595581
. O 0 0.12245629727840424

A O 0 0.03554552420973778
lod O 0 0.05179959163069725
score O 0 0.011476421728730202
of O 0 0.006467021536082029
13 O 0 0.008365420624613762
was O 0 0.0046304273419082165
calculated O 0 0.009717172011733055
for O 0 0.009770297445356846
linkage O 0 0.47940048575401306
between O 0 0.294705331325531
C2 B-Disease 1 0.9738587737083435
deficiency I-Disease 1 0.9882414937019348
and O 0 0.1199105829000473
HLA O 1 0.9225109815597534
- O 0 0.25418177247047424
B O 0 0.10704078525304794
at O 0 0.0052930451929569244
a O 0 0.00452674925327301
maximum O 0 0.006407678592950106
likelihood O 0 0.019592972472310066
value O 0 0.004340920131653547
of O 0 0.0032809756230562925
the O 0 0.005467741750180721
recombinant O 0 0.31406164169311523
fraction O 0 0.03685465455055237
of O 0 0.010529269464313984
0 O 0 0.053639307618141174
. O 0 0.03146996349096298

04 O 0 0.24159714579582214
. O 0 0.09710261970758438

18 O 0 0.03238930553197861
families O 0 0.021341999992728233
with O 0 0.010094201192259789
21 O 0 0.014747848734259605
informative O 0 0.044662442058324814
matings O 0 0.22530324757099152
for O 0 0.0074430485256016254
both O 0 0.013927824795246124
properdin O 0 0.4666298031806946
Factor O 0 0.4413725733757019
B O 0 0.42348960041999817
allotype O 1 0.5617614388465881
and O 0 0.05846704915165901
HLA O 1 0.9224458336830139
- O 0 0.28300970792770386
B O 0 0.13553516566753387
were O 0 0.009362814016640186
found O 0 0.02854437753558159
. O 0 0.02643488720059395

Of O 0 0.020318573340773582
72 O 0 0.0326942540705204
informative O 0 0.037986304610967636
meioses O 0 0.07536433637142181
, O 0 0.00865808967500925
three O 0 0.006107401568442583
recombinants O 0 0.042239900678396225
were O 0 0.0042895847000181675
found O 0 0.005820572376251221
, O 0 0.004410517401993275
giving O 0 0.008930845186114311
a O 0 0.008957617916166782
recombinant O 0 0.2924638092517853
fraction O 0 0.03788347169756889
of O 0 0.01029503345489502
0 O 0 0.04913182929158211
. O 0 0.027160964906215668

042 O 0 0.339375376701355
. O 0 0.10193575918674469

A O 0 0.03277652710676193
lod O 0 0.055130526423454285
score O 0 0.013751926831901073
of O 0 0.008211635053157806
16 O 0 0.016803883016109467
between O 0 0.04710199683904648
HLA O 1 0.8945443034172058
- O 0 0.2904367744922638
B O 0 0.2093227058649063
and O 0 0.010518280789256096
Factor O 0 0.1791263073682785
B O 0 0.1532689779996872
allotypes O 0 0.10605072230100632
was O 0 0.00457941647619009
calculated O 0 0.006868742406368256
at O 0 0.0035623107105493546
a O 0 0.003810448106378317
maximum O 0 0.005349722690880299
likelihood O 0 0.01823093183338642
value O 0 0.003952383529394865
of O 0 0.0033257154282182455
the O 0 0.00548296794295311
recombinant O 0 0.26095470786094666
fraction O 0 0.04051787406206131
of O 0 0.012179385870695114
0 O 0 0.050105538219213486
. O 0 0.028787370771169662

04 O 0 0.2417089194059372
. O 0 0.09265321493148804

A O 0 0.0229177288711071
crossover O 0 0.02449101209640503
was O 0 0.007850799709558487
shown O 0 0.00769260386005044
to O 0 0.0036058176774531603
have O 0 0.004205535631626844
occurred O 0 0.01973850280046463
between O 0 0.016838382929563522
genes O 1 0.5739884972572327
for O 0 0.020095020532608032
Factor O 0 0.3673292100429535
B O 0 0.41375282406806946
and O 0 0.035437025129795074
HLA O 1 0.9259552955627441
- O 0 0.3946160078048706
D O 0 0.3343130648136139
, O 0 0.010026227682828903
in O 0 0.011195416562259197
which O 0 0.030945852398872375
HLA O 1 0.9010758399963379
- O 0 0.44361257553100586
D O 1 0.5796105265617371
segregared O 1 0.5513840913772583
with O 0 0.07959716022014618
HLA O 1 0.8808139562606812
- O 0 0.15771974623203278
A O 0 0.02097473479807377
and O 0 0.014890140853822231
B O 0 0.18416181206703186
. O 0 0.029931481927633286

These O 0 0.020268889144062996
studies O 0 0.02560535818338394
suggest O 0 0.01372559741139412
that O 0 0.00503807608038187
the O 0 0.005634674336761236
genes O 0 0.3482174277305603
for O 0 0.010656435042619705
Factor O 0 0.3179630637168884
B O 0 0.3507622480392456
and O 0 0.049619898200035095
C2 B-Disease 1 0.9587330222129822
deficiency I-Disease 1 0.9758224487304688
are O 0 0.00690939137712121
located O 0 0.0058791618794202805
outside O 0 0.003641973715275526
those O 0 0.0038083489052951336
for O 0 0.00569103704765439
HLA O 0 0.4542071223258972
, O 0 0.0029348288662731647
that O 0 0.0023503219708800316
the O 0 0.002369128866121173
order O 0 0.003767025424167514
of O 0 0.004874614533036947
genese O 0 0.33888399600982666
is O 0 0.03854464367032051
HLA O 1 0.8399628400802612
- O 0 0.1468244045972824
A O 0 0.021814128383994102
, O 0 0.016603032127022743
- O 0 0.20513466000556946
B O 0 0.23223309218883514
, O 0 0.02279846742749214
- O 0 0.21734905242919922
D O 0 0.37533220648765564
, O 0 0.02731405198574066
Factor O 0 0.4023006558418274
B O 0 0.491879940032959
allotype O 1 0.6971154808998108
, O 0 0.12647247314453125
C2 B-Disease 1 0.9623656272888184
deficiency I-Disease 1 0.9817488193511963
, O 0 0.014985103160142899
that O 0 0.006303124595433474
the O 0 0.013157899491488934
genes O 1 0.8283163905143738
coding O 1 0.7873099446296692
for O 0 0.12628354132175446
C2 B-Disease 1 0.9741232991218567
deficiency I-Disease 1 0.9866185784339905
and O 0 0.04235955327749252
Factor O 0 0.368732750415802
B O 0 0.28729093074798584
allotypes O 0 0.1642172634601593
are O 0 0.0059262048453092575
approximately O 0 0.012384239584207535
3 O 0 0.016469789668917656
- O 0 0.0718531459569931
- O 0 0.06897382438182831
5 O 0 0.02407190203666687
centimorgans O 0 0.15999531745910645
from O 0 0.00996351707726717
the O 0 0.017045700922608376
HLA O 1 0.8715705871582031
- O 0 0.17883892357349396
A O 0 0.03889356553554535
and O 0 0.03338401019573212
HLA O 1 0.9187355041503906
- O 0 0.4122615158557892
B O 0 0.34636881947517395
loci O 1 0.5516676902770996
, O 0 0.006470569409430027
and O 0 0.0028293151408433914
that O 0 0.002340972889214754
the O 0 0.002822512062266469
apparent O 0 0.03817123547196388
lack O 0 0.01892353780567646
of O 0 0.00586423184722662
recombinants O 0 0.18770572543144226
between O 0 0.020267924293875694
the O 0 0.015337187796831131
Factor O 1 0.5637623071670532
B O 1 0.722293496131897
gene O 1 0.9374098777770996
and O 0 0.1875489503145218
C2 B-Disease 1 0.975019097328186
deficiency I-Disease 1 0.9886285066604614
gene O 1 0.8912057876586914
suggests O 0 0.09482233226299286
that O 0 0.005215982906520367
these O 0 0.004687243141233921
two O 0 0.00514753395691514
genes O 0 0.30080273747444153
lie O 0 0.013075491413474083
in O 0 0.00475225830450654
close O 0 0.007709660567343235
proximity O 0 0.01815766654908657
to O 0 0.004458011128008366
one O 0 0.0065110307186841965
another O 0 0.016809634864330292
. O 0 0.02272414043545723

Distribution O 0 0.04501006007194519
of O 0 0.017153846099972725
emerin O 0 0.1039162203669548
and O 0 0.01058157067745924
lamins O 0 0.22992365062236786
in O 0 0.008932304568588734
the O 0 0.00898775178939104
heart O 0 0.4558716118335724
and O 0 0.020113257691264153
implications O 0 0.3561689555644989
for O 0 0.0805094763636589
Emery B-Disease 1 0.7924507856369019
- I-Disease 1 0.8311096429824829
Dreifuss I-Disease 1 0.9469207525253296
muscular I-Disease 1 0.9631099700927734
dystrophy I-Disease 1 0.9616169929504395
. O 0 0.2721068561077118

Emerin O 0 0.11490286141633987
is O 0 0.017272479832172394
a O 0 0.013059747405350208
nuclear O 0 0.018969200551509857
membrane O 0 0.0890113040804863
protein O 0 0.07719948887825012
which O 0 0.006285343784838915
is O 0 0.006930842529982328
missing O 0 0.03550170734524727
or O 0 0.04464364051818848
defective O 1 0.7038010954856873
in O 0 0.08743148297071457
Emery B-Disease 1 0.854513943195343
- I-Disease 1 0.8701262474060059
Dreifuss I-Disease 1 0.9641856551170349
muscular I-Disease 1 0.9781222343444824
dystrophy I-Disease 1 0.9791331887245178
( O 1 0.6465151906013489
EDMD B-Disease 1 0.8322251439094543
) O 0 0.11977845430374146
. O 0 0.044476188719272614

It O 0 0.012111591175198555
is O 0 0.0067639220505952835
one O 0 0.004559410270303488
member O 0 0.004143375903367996
of O 0 0.0030099970754235983
a O 0 0.005131245125085115
family O 0 0.021756496280431747
of O 0 0.011432153172791004
lamina O 1 0.7588351368904114
- O 0 0.3119454085826874
associated O 0 0.15184901654720306
proteins O 0 0.20801977813243866
which O 0 0.007595863193273544
includes O 0 0.019348902627825737
LAP1 O 0 0.376383513212204
, O 0 0.02100057527422905
LAP2 O 0 0.4604843854904175
and O 0 0.046130407601594925
lamin O 1 0.8907710909843445
B O 1 0.697202205657959
receptor O 1 0.8916037082672119
( O 0 0.32697561383247375
LBR O 1 0.8617766499519348
) O 0 0.09441546350717545
. O 0 0.03537213057279587

A O 0 0.031247202306985855
panel O 0 0.026119794696569443
of O 0 0.01329746562987566
16 O 0 0.0564710907638073
monoclonal O 1 0.8295676708221436
antibodies O 1 0.8503634929656982
( O 0 0.12586456537246704
mAbs O 1 0.522577166557312
) O 0 0.011531002819538116
has O 0 0.004200887866318226
been O 0 0.002997001865878701
mapped O 0 0.005434973631054163
to O 0 0.002298269420862198
six O 0 0.0032794431317597628
specific O 0 0.005072638392448425
sites O 0 0.004790456499904394
throughout O 0 0.004891223274171352
the O 0 0.005058541428297758
emerin O 0 0.20414094626903534
molecule O 0 0.25702235102653503
using O 0 0.0348636768758297
phage O 1 0.6521713733673096
- O 0 0.08366326987743378
displayed O 0 0.023274976760149002
peptide O 0 0.32452577352523804
libraries O 0 0.012710051611065865
and O 0 0.002939825411885977
has O 0 0.002598204417154193
been O 0 0.002767127240076661
used O 0 0.0036618709564208984
to O 0 0.004746213089674711
localize O 0 0.34145790338516235
emerin O 0 0.34312278032302856
in O 0 0.017841968685388565
human O 0 0.12120232731103897
and O 0 0.03201926127076149
rabbit O 1 0.7881845235824585
heart O 1 0.8027597069740295
. O 0 0.10068639367818832

Several O 0 0.03938232362270355
mAbs O 0 0.28041547536849976
against O 0 0.018290290609002113
different O 0 0.015657398849725723
emerin O 0 0.18315957486629486
epitopes O 0 0.22397692501544952
did O 0 0.008543485775589943
not O 0 0.006061292253434658
recognize O 0 0.030907349660992622
intercalated O 0 0.1684911847114563
discs O 0 0.02563338540494442
in O 0 0.00491409283131361
the O 0 0.00462412228807807
heart O 0 0.23188677430152893
, O 0 0.003971720580011606
though O 0 0.004120710771530867
they O 0 0.002891943324357271
recognized O 0 0.017146700993180275
cardiomyocyte O 0 0.14245177805423737
nuclei O 0 0.08428299427032471
strongly O 0 0.009675752371549606
, O 0 0.00313225737772882
both O 0 0.0027883797883987427
at O 0 0.003048807382583618
the O 0 0.0035179397091269493
rim O 0 0.030909379944205284
and O 0 0.00549050560221076
in O 0 0.009033340960741043
intranuclear O 0 0.21308808028697968
spots O 0 0.0590636320412159
or O 0 0.028054317459464073
channels O 0 0.06237595155835152
. O 0 0.028995096683502197

A O 0 0.07519178837537766
polyclonal O 1 0.7170822620391846
rabbit O 1 0.6056031584739685
antiserum O 0 0.4883112609386444
against O 0 0.02421327494084835
emerin O 0 0.10557330399751663
did O 0 0.009306496009230614
recognize O 0 0.015109708532691002
both O 0 0.005515485070645809
nuclear O 0 0.0120581965893507
membrane O 0 0.060749493539333344
and O 0 0.0053284806199371815
intercalated O 0 0.11826018244028091
discs O 0 0.020281560719013214
but O 0 0.0039624907076358795
, O 0 0.0036175306886434555
after O 0 0.005965964403003454
affinity O 0 0.052923351526260376
purification O 0 0.04172756150364876
against O 0 0.005778320133686066
a O 0 0.006363269407302141
pure O 0 0.026934901252388954
- O 0 0.06673973053693771
emerin O 0 0.10599271953105927
band O 0 0.00856171827763319
on O 0 0.003258130745962262
a O 0 0.004638414829969406
western O 0 0.007550702430307865
blot O 0 0.05883505195379257
, O 0 0.004649278707802296
it O 0 0.0038167941384017467
stained O 0 0.06243819370865822
only O 0 0.004222386982291937
the O 0 0.005945785902440548
nuclear O 0 0.026286398991942406
membrane O 0 0.1697443425655365
. O 0 0.02661001682281494

These O 0 0.013575104996562004
results O 0 0.01205343846231699
would O 0 0.0047760955058038235
not O 0 0.003156587714329362
be O 0 0.002573970705270767
expected O 0 0.003885474754497409
if O 0 0.004085808526724577
immunostaining O 0 0.05350814014673233
at O 0 0.005203611217439175
intercalated O 0 0.09834347665309906
discs O 0 0.012827842496335506
were O 0 0.0026042750105261803
due O 0 0.004464821889996529
to O 0 0.0021528913639485836
a O 0 0.002954083029180765
product O 0 0.005367624573409557
of O 0 0.002626264002174139
the O 0 0.004572991281747818
emerin O 0 0.23845911026000977
gene O 0 0.36997082829475403
and O 0 0.003769315080717206
, O 0 0.003258313750848174
therefore O 0 0.0037219314835965633
, O 0 0.002268571872264147
cast O 0 0.0035861916840076447
some O 0 0.002346721012145281
doubt O 0 0.005522092804312706
upon O 0 0.003573732217773795
the O 0 0.005811379756778479
hypothesis O 0 0.34160056710243225
that O 0 0.06766659021377563
cardiac B-Disease 1 0.9783514142036438
defects I-Disease 1 0.9569728970527649
in O 0 0.054455436766147614
EDMD B-Disease 1 0.5871632099151611
are O 0 0.014351661317050457
caused O 0 0.21349729597568512
by O 0 0.009893205016851425
absence O 0 0.041482605040073395
of O 0 0.009046385996043682
emerin O 0 0.25225403904914856
from O 0 0.02517370879650116
intercalated O 0 0.4521154463291168
discs O 0 0.16476233303546906
. O 0 0.04548734053969383

Although O 0 0.034663792699575424
emerin O 0 0.08247455209493637
was O 0 0.009852893650531769
abundant O 0 0.012494552880525589
in O 0 0.005392031744122505
the O 0 0.005153378006070852
membranes O 0 0.19165794551372528
of O 0 0.006424379535019398
cardiomyocyte O 0 0.20900221168994904
nuclei O 0 0.0989881083369255
, O 0 0.0046275826171040535
it O 0 0.0028683815617114305
was O 0 0.003024642588570714
absent O 0 0.019488099962472916
from O 0 0.004866405855864286
many O 0 0.008764059282839298
non O 0 0.16762703657150269
- O 1 0.5136240720748901
myocyte O 1 0.9139302968978882
cells O 1 0.794261634349823
in O 0 0.026262560859322548
the O 0 0.027023816481232643
heart O 1 0.7070075273513794
. O 0 0.06858337670564651

This O 0 0.016377311199903488
distribution O 0 0.017341673374176025
of O 0 0.007042852696031332
emerin O 0 0.04464224725961685
was O 0 0.005155816208571196
similar O 0 0.006197134964168072
to O 0 0.0026122897397726774
that O 0 0.0025979832280427217
of O 0 0.0033935129176825285
lamin O 0 0.15369026362895966
A O 0 0.007065089885145426
, O 0 0.004041200503706932
a O 0 0.006404036656022072
candidate O 0 0.03249390795826912
gene O 1 0.54228276014328
for O 0 0.014100966043770313
an O 0 0.04411559924483299
autosomal O 1 0.9632570743560791
form O 0 0.16331747174263
of O 0 0.03465404361486435
EDMD B-Disease 1 0.688045859336853
. O 0 0.05877811461687088

In O 0 0.030325697734951973
contrast O 0 0.04938464239239693
, O 0 0.02416994981467724
lamin O 1 0.6083409190177917
B1 O 1 0.5747810006141663
was O 0 0.011809759773314
absent O 0 0.05610846355557442
from O 0 0.013148491270840168
cardiomyocyte O 0 0.20665033161640167
nuclei O 0 0.13037386536598206
, O 0 0.007202569395303726
showing O 0 0.016130836680531502
that O 0 0.010113116353750229
lamin O 1 0.5785769820213318
B1 O 0 0.4841141402721405
is O 0 0.0053434125147759914
not O 0 0.003161404747515917
essential O 0 0.005968510173261166
for O 0 0.0037448673974722624
localization O 0 0.03572563827037811
of O 0 0.005731246434152126
emerin O 0 0.0828612744808197
to O 0 0.00597239239141345
the O 0 0.010026857256889343
nuclear O 0 0.053879667073488235
lamina O 1 0.5432009100914001
. O 0 0.037184856832027435

Lamin O 1 0.7181607484817505
B1 O 0 0.3850015699863434
is O 0 0.019044063985347748
also O 0 0.010159121826291084
almost O 0 0.01196262426674366
completely O 0 0.023139266297221184
absent O 0 0.138853058218956
from O 0 0.06302431225776672
skeletal O 1 0.9120993614196777
muscle O 1 0.9207623600959778
nuclei O 1 0.6102506518363953
. O 0 0.08124696463346481

In O 0 0.027633005753159523
EDMD B-Disease 0 0.12383268773555756
, O 0 0.010563887655735016
the O 0 0.007023651618510485
additional O 0 0.010605914518237114
absence O 0 0.03136219456791878
of O 0 0.01324506476521492
lamin O 1 0.8372094631195068
B1 O 1 0.8685277700424194
from O 0 0.08256105333566666
heart O 1 0.8219085335731506
and O 0 0.0677972361445427
skeletal O 1 0.9265594482421875
muscle O 1 0.9002780318260193
nuclei O 0 0.31847113370895386
which O 0 0.011211004108190536
already O 0 0.017538486048579216
lack O 0 0.03609267622232437
emerin O 0 0.1457965224981308
may O 0 0.016371043398976326
offer O 0 0.006505156867206097
an O 0 0.004163653589785099
alternative O 0 0.01369809452444315
explanation O 0 0.010008387267589569
of O 0 0.003830079222097993
why O 0 0.013337121345102787
these O 0 0.010492976754903793
tissues O 0 0.49238497018814087
are O 0 0.010737862437963486
particularly O 0 0.05185961723327637
affected O 0 0.2082875818014145
. O 0 0.02123832143843174
. O 0 0.02388986572623253

Genetic O 0 0.4916810989379883
mapping O 0 0.04547115042805672
of O 0 0.01307262945920229
the O 0 0.013057732954621315
copper B-Disease 0 0.11946160346269608
toxicosis I-Disease 1 0.8299187421798706
locus O 1 0.599059522151947
in O 0 0.044426802545785904
Bedlington O 1 0.7046456933021545
terriers O 0 0.4794292747974396
to O 0 0.018531441688537598
dog O 0 0.3442167043685913
chromosome O 1 0.7185426354408264
10 O 0 0.011105363257229328
, O 0 0.004983489867299795
in O 0 0.00439739553257823
a O 0 0.007204956375062466
region O 0 0.019553229212760925
syntenic O 0 0.18739637732505798
to O 0 0.0121360057964921
human O 0 0.26372790336608887
chromosome O 1 0.8724012970924377
region O 0 0.17722827196121216
2p13 O 1 0.662111759185791
- O 0 0.49507731199264526
p16 O 1 0.8389942049980164
. O 0 0.07379437237977982

Abnormal O 1 0.9048793315887451
hepatic B-Disease 1 0.927215039730072
copper I-Disease 0 0.2666931450366974
accumulation I-Disease 0 0.40522661805152893
is O 0 0.016614090651273727
recognized O 0 0.030162079259753227
as O 0 0.01303926669061184
an O 0 0.08586188405752182
inherited B-Disease 1 0.9612113833427429
disorder I-Disease 1 0.9786347150802612
in O 0 0.03168519213795662
man O 0 0.06557008624076843
, O 0 0.03210621327161789
mouse O 1 0.5899244546890259
, O 0 0.025938156992197037
rat O 1 0.5099375247955322
and O 0 0.02226175181567669
dog O 0 0.2503059506416321
. O 0 0.05256224051117897

The O 0 0.025548938661813736
major O 0 0.04831186309456825
cause O 0 0.3653203845024109
of O 0 0.0353245735168457
hepatic B-Disease 1 0.9530103802680969
copper I-Disease 0 0.28023964166641235
accumulation I-Disease 0 0.46622234582901
in O 0 0.01515149138867855
man O 0 0.023342210799455643
is O 0 0.014572536572813988
a O 0 0.051026251167058945
dysfunctional O 1 0.887622058391571
ATP7B O 1 0.9170330166816711
gene O 1 0.9418272972106934
, O 0 0.22064027190208435
causing O 1 0.9231404662132263
Wilson B-Disease 1 0.9177294373512268
disease I-Disease 1 0.9828322529792786
( O 1 0.576276957988739
WD B-Disease 1 0.9289647936820984
) O 0 0.12156064063310623
. O 0 0.03852482885122299

Mutations O 1 0.698693037033081
in O 0 0.017085062339901924
the O 0 0.014053707011044025
ATP7B O 0 0.34542420506477356
genes O 0 0.3310716152191162
have O 0 0.007176742423325777
also O 0 0.005079207941889763
been O 0 0.005720211658626795
demonstrated O 0 0.026228919625282288
in O 0 0.01256190799176693
mouse O 0 0.4325665235519409
and O 0 0.0253393966704607
rat O 1 0.6472998857498169
. O 0 0.06872904300689697

The O 0 0.03801655024290085
ATP7B O 0 0.4309644401073456
gene O 0 0.2847755253314972
has O 0 0.009217518381774426
been O 0 0.007044389843940735
excluded O 0 0.014543941244482994
in O 0 0.00548535818234086
the O 0 0.005544587504118681
much O 0 0.023662235587835312
rarer O 1 0.7353309988975525
human O 1 0.541409432888031
copper B-Disease 1 0.778581976890564
overload I-Disease 1 0.9673096537590027
disease O 1 0.9828737378120422
non B-Disease 1 0.5306832194328308
- I-Disease 1 0.6180129051208496
Indian I-Disease 0 0.28293728828430176
childhood I-Disease 1 0.9245054125785828
cirrhosis I-Disease 1 0.9708905816078186
, O 0 0.10579120367765427
indicating O 1 0.5227319598197937
genetic O 1 0.9118713140487671
heterogeneity O 1 0.7299677729606628
. O 0 0.0685189738869667

By O 0 0.04327823966741562
investigating O 0 0.07542768865823746
the O 0 0.04825004190206528
common O 1 0.8036466240882874
autosomal O 1 0.9836097955703735
recessive O 1 0.9781569242477417
copper B-Disease 1 0.8274206519126892
toxicosis I-Disease 1 0.9520196914672852
( O 0 0.41268184781074524
CT B-Disease 1 0.8098137378692627
) O 0 0.05297594517469406
in O 0 0.0158709604293108
Bedlington O 0 0.46387574076652527
terriers O 0 0.18945138156414032
, O 0 0.005795296281576157
we O 0 0.0034577238839119673
have O 0 0.003934106789529324
identified O 0 0.010014894418418407
a O 0 0.007066420745104551
new O 0 0.014598483219742775
locus O 1 0.6287145018577576
involved O 0 0.14754685759544373
in O 0 0.16571113467216492
progressive O 1 0.9372919201850891
liver B-Disease 1 0.9848757386207581
disease I-Disease 1 0.9806150794029236
. O 0 0.29208090901374817

We O 0 0.02005545236170292
examined O 0 0.0350659117102623
whether O 0 0.014756511896848679
the O 0 0.018325049430131912
WD B-Disease 1 0.9022868871688843
gene O 1 0.7756627202033997
ATP7B O 0 0.3080265522003174
was O 0 0.010737957432866096
also O 0 0.011021099984645844
causative O 0 0.4823819398880005
for O 0 0.016304045915603638
CT B-Disease 0 0.4952820837497711
by O 0 0.013771667145192623
investigating O 0 0.03779441490769386
the O 0 0.015544611029326916
chromosomal O 1 0.8628837466239929
co O 0 0.20127218961715698
- O 0 0.09105149656534195
localization O 0 0.10658024996519089
of O 0 0.007766630034893751
ATP7B O 0 0.19193534553050995
and O 0 0.00845654308795929
C04107 O 0 0.12129789590835571
, O 0 0.007354311179369688
using O 0 0.012987177819013596
fluorescence O 0 0.23301969468593597
in O 0 0.020292509347200394
situ O 1 0.5123746991157532
hybridization O 0 0.46763283014297485
( O 0 0.0839887484908104
FISH O 0 0.07000638544559479
) O 0 0.0355776809155941
. O 0 0.024810409173369408

C04107 O 0 0.1629326492547989
is O 0 0.024098718538880348
an O 0 0.01902846433222294
anonymous O 0 0.11565442383289337
microsatellite O 1 0.6597763895988464
marker O 0 0.23610690236091614
closely O 0 0.0641230121254921
linked O 0 0.2616926431655884
to O 0 0.027304261922836304
CT B-Disease 1 0.6965087652206421
. O 0 0.0508941225707531

However O 0 0.035811446607112885
, O 0 0.02384907752275467
BAC O 0 0.47949591279029846
clones O 0 0.2971990704536438
containing O 0 0.03263275325298309
ATP7B O 0 0.15105360746383667
and O 0 0.008080713450908661
C04107 O 0 0.06656824797391891
mapped O 0 0.016705691814422607
to O 0 0.005867307540029287
the O 0 0.013396693393588066
canine O 1 0.8037047982215881
chromosome O 1 0.8709338307380676
regions O 0 0.1712036281824112
CFA22q11 O 0 0.35498082637786865
and O 0 0.010360018350183964
CFA10q26 O 0 0.18328091502189636
, O 0 0.006177903618663549
respectively O 0 0.008828600868582726
, O 0 0.004811942111700773
demonstrating O 0 0.015615710988640785
that O 0 0.009151906706392765
WD B-Disease 1 0.7153639197349548
cannot O 0 0.016237972304224968
be O 0 0.0081818588078022
homologous O 0 0.4458456039428711
to O 0 0.018979094922542572
CT B-Disease 1 0.579100489616394
. O 0 0.0389162078499794

The O 0 0.0275941863656044
copper O 0 0.08295757323503494
transport O 0 0.06574758887290955
genes O 1 0.5906366109848022
CTR1 O 0 0.2671123445034027
and O 0 0.007672333624213934
CTR2 O 0 0.06608770787715912
were O 0 0.003971196245402098
also O 0 0.003900066949427128
excluded O 0 0.013240515254437923
as O 0 0.004759751260280609
candidate O 0 0.021529672667384148
genes O 0 0.48246750235557556
for O 0 0.012929214164614677
CT B-Disease 0 0.40085771679878235
since O 0 0.010040739551186562
they O 0 0.004272250924259424
both O 0 0.0064262207597494125
mapped O 0 0.02991572581231594
to O 0 0.019937558099627495
canine O 1 0.8797800540924072
chromosome O 1 0.9068920016288757
region O 0 0.17441123723983765
CFA11q22 O 1 0.526508629322052
. O 0 0.044925156980752945

2 O 0 0.06711062043905258
- O 0 0.09670056402683258
22 O 0 0.04942724108695984
. O 0 0.03695608302950859

5 O 0 0.10700763761997223
. O 0 0.07291694730520248

A O 0 0.0341995432972908
transcribed O 0 0.0619073249399662
sequence O 0 0.02925230748951435
identified O 0 0.01607285626232624
from O 0 0.006672959309071302
the O 0 0.006329221185296774
C04107 O 0 0.19437484443187714
- O 0 0.08282768726348877
containing O 0 0.033123135566711426
BAC O 0 0.24423432350158691
was O 0 0.004391286056488752
found O 0 0.004635716322809458
to O 0 0.0028137483168393373
be O 0 0.0032755734864622355
homologous O 0 0.18145504593849182
to O 0 0.0046792770735919476
a O 0 0.014962286688387394
gene O 1 0.5681947469711304
expressed O 0 0.030427351593971252
from O 0 0.030104387551546097
human O 0 0.3564610481262207
chromosome O 1 0.9107483625411987
2p13 O 1 0.657267689704895
- O 0 0.2964968979358673
p16 O 1 0.6575504541397095
, O 0 0.007961343042552471
a O 0 0.007232938893139362
region O 0 0.012529972940683365
devoid O 0 0.021239111199975014
of O 0 0.006188460160046816
any O 0 0.009650390595197678
positional O 0 0.10364449769258499
candidate O 0 0.06407875567674637
genes O 1 0.6231928467750549
. O 0 0.05653193220496178

Molecular O 0 0.1751893013715744
analysis O 0 0.025404831394553185
of O 0 0.010172436013817787
the O 0 0.011240235529839993
APC B-Disease 0 0.4977477192878723
gene O 1 0.5352891683578491
in O 0 0.01290168333798647
205 O 0 0.10668843239545822
families O 0 0.06180567294359207
: O 0 0.039526619017124176
extended O 0 0.1334894299507141
genotype O 1 0.9340927600860596
- O 1 0.6712514162063599
phenotype O 1 0.9500516057014465
correlations O 0 0.48119020462036133
in O 0 0.032156456261873245
FAP B-Disease 1 0.6618948578834534
and O 0 0.005363390315324068
evidence O 0 0.005716725252568722
for O 0 0.003069958183914423
the O 0 0.00400344654917717
role O 0 0.01871977001428604
of O 0 0.013372223824262619
APC B-Disease 1 0.7290940880775452
amino O 1 0.758004367351532
acid O 1 0.9258017539978027
changes O 1 0.6610968112945557
in O 1 0.6701773405075073
colorectal B-Disease 1 0.9881564378738403
cancer I-Disease 1 0.981844425201416
predisposition O 1 0.9437570571899414
. O 0 0.25259438157081604

BACKGROUND O 0 0.11320850253105164
/ O 0 0.1585076004266739
AIMS O 0 0.034730181097984314
The O 0 0.011313394643366337
development O 0 0.06820281594991684
of O 0 0.12294925004243851
colorectal B-Disease 1 0.9881383776664734
cancer I-Disease 1 0.9770243763923645
and O 0 0.0172172449529171
a O 0 0.024545865133404732
variable O 0 0.2012416124343872
range O 0 0.031495992094278336
of O 0 0.02072140760719776
extracolonic O 1 0.7540914416313171
manifestations O 1 0.8660521507263184
in O 1 0.5465970039367676
familial B-Disease 1 0.984683096408844
adenomatous I-Disease 1 0.9847536087036133
polyposis I-Disease 1 0.9809399247169495
( O 1 0.5563839077949524
FAP B-Disease 1 0.8674705028533936
) O 0 0.02673940733075142
is O 0 0.00553160160779953
the O 0 0.004390329122543335
result O 0 0.010695002973079681
of O 0 0.004757036920636892
the O 0 0.012101035565137863
dominant O 1 0.5270076990127563
inheritance O 1 0.8671332597732544
of O 1 0.501703679561615
adenomatous B-Disease 1 0.9848765134811401
polyposis I-Disease 1 0.9850601553916931
coli I-Disease 1 0.97756028175354
( O 1 0.7140507698059082
APC B-Disease 1 0.9206901788711548
) O 0 0.48704805970191956
gene O 1 0.9288786053657532
mutations O 1 0.9311888217926025
. O 0 0.0935591533780098

In O 0 0.017732877284288406
this O 0 0.009082895703613758
study O 0 0.015307007357478142
, O 0 0.00610707700252533
direct O 0 0.018514050170779228
mutation O 1 0.5266125798225403
analysis O 0 0.012804386205971241
of O 0 0.0044056144542992115
the O 0 0.006205057259649038
APC B-Disease 0 0.4164245128631592
gene O 0 0.4684063494205475
was O 0 0.005708859767764807
performed O 0 0.015112066641449928
to O 0 0.0063457791693508625
determine O 0 0.09903113543987274
genotype O 1 0.9187473654747009
- O 1 0.5749713778495789
phenotype O 1 0.9368780255317688
correlations O 0 0.33304446935653687
for O 0 0.008375422097742558
nine O 0 0.019627131521701813
extracolonic O 0 0.2853739261627197
manifestations O 0 0.16097483038902283
and O 0 0.004552205093204975
to O 0 0.004657368175685406
investigate O 0 0.030129577964544296
the O 0 0.014289016835391521
incidence O 1 0.8680465817451477
of O 0 0.0710429772734642
APC B-Disease 1 0.9214074611663818
mutations O 1 0.961892306804657
in O 0 0.19294755160808563
non O 1 0.7377746105194092
- O 1 0.9282386898994446
FAP O 1 0.9743061065673828
colorectal B-Disease 1 0.9861370325088501
cancer I-Disease 1 0.9736026525497437
. O 0 0.3612618148326874

METHODS O 0 0.060894984751939774
The O 0 0.03104325756430626
APC B-Disease 1 0.500181257724762
gene O 0 0.4555801451206207
was O 0 0.013207984156906605
analysed O 0 0.038428183645009995
in O 0 0.013286233879625797
190 O 0 0.07214195281267166
unrelated O 1 0.53971266746521
FAP B-Disease 1 0.845880925655365
and O 0 0.021102676168084145
15 O 0 0.1115296259522438
non O 1 0.5890375971794128
- O 1 0.9392043352127075
FAP O 1 0.9811949133872986
colorectal B-Disease 1 0.9912419319152832
cancer I-Disease 1 0.9878681898117065
patients O 1 0.9598075747489929
using O 0 0.22512249648571014
denaturing O 1 0.8813986778259277
gradient O 1 0.7052534818649292
gel O 1 0.8357625603675842
electrophoresis O 1 0.5798189043998718
, O 0 0.0106117008253932
the O 0 0.00830816850066185
protein O 0 0.3020719587802887
truncation O 0 0.26114216446876526
test O 0 0.02805854193866253
, O 0 0.007373862434178591
and O 0 0.006851148325949907
direct O 0 0.026937276124954224
sequencing O 0 0.1885865181684494
. O 0 0.032381847500801086

RESULTS O 0 0.07192414999008179
Chain O 0 0.12689869105815887
terminating O 0 0.10191033780574799
signals O 0 0.02122044563293457
were O 0 0.0053503564558923244
only O 0 0.005161101929843426
identified O 0 0.02404511719942093
in O 0 0.012489587999880314
patients O 1 0.6335694789886475
belonging O 0 0.01980774477124214
to O 0 0.0062471055425703526
the O 0 0.013958832249045372
FAP B-Disease 1 0.8431752324104309
group O 0 0.11491062492132187
( O 0 0.14889240264892578
105 O 0 0.1965721845626831
patients O 1 0.9092974066734314
) O 0 0.09026413410902023
. O 0 0.03743037208914757

Amino O 0 0.2780248522758484
acid O 0 0.2577997148036957
changes O 0 0.019959772005677223
were O 0 0.006142314523458481
identified O 0 0.011140861548483372
in O 0 0.004619265906512737
four O 0 0.007264740765094757
patients O 0 0.40343964099884033
, O 0 0.0034509196411818266
three O 0 0.0034171263687312603
of O 0 0.0032727071084082127
whom O 0 0.00992451049387455
belonged O 0 0.009274547919631004
to O 0 0.004250421654433012
the O 0 0.00789276510477066
non O 0 0.18742148578166962
- O 1 0.5810894966125488
FAP O 1 0.9465876817703247
group O 0 0.44516655802726746
of O 1 0.5902614593505859
colorectal B-Disease 1 0.9888328313827515
cancer I-Disease 1 0.9867537617683411
patients O 1 0.9601832032203674
. O 0 0.25161799788475037

Genotype O 1 0.8789262175559998
- O 1 0.6151466369628906
phenotype O 1 0.9073479771614075
correlations O 0 0.34016719460487366
identified O 0 0.04410780966281891
significant O 0 0.013957357034087181
differences O 0 0.013506952673196793
in O 0 0.004729528911411762
the O 0 0.003698355285450816
nature O 0 0.012454954907298088
of O 0 0.005632435902953148
certain O 0 0.04410865157842636
extracolonic O 1 0.522855818271637
manifestations O 1 0.6236441135406494
in O 0 0.15557551383972168
FAP B-Disease 1 0.9549118876457214
patients O 1 0.9199076294898987
belonging O 0 0.06430479139089584
to O 0 0.012011220678687096
three O 0 0.03591219708323479
mutation O 1 0.9009513854980469
subgroups O 0 0.48223358392715454
. O 0 0.07065634429454803

CONCLUSIONS O 0 0.08356413245201111
Extended O 0 0.10391929745674133
genotype O 1 0.8174303770065308
- O 0 0.387649804353714
phenotype O 1 0.8479047417640686
correlations O 0 0.14425884187221527
made O 0 0.00634707510471344
in O 0 0.0044630845077335835
this O 0 0.0032446924597024918
study O 0 0.009398416616022587
may O 0 0.0060720667243003845
have O 0 0.0023074049968272448
the O 0 0.0023246107157319784
potential O 0 0.008234930224716663
to O 0 0.002348218346014619
determine O 0 0.004821134731173515
the O 0 0.0027793017216026783
most O 0 0.00462515652179718
appropriate O 0 0.027150817215442657
surveillance O 0 0.08696933090686798
and O 0 0.02486838959157467
prophylactic O 1 0.891995370388031
treatment O 1 0.9033167958259583
regimens O 1 0.9028867483139038
for O 0 0.05237141251564026
those O 0 0.13806715607643127
patients O 1 0.9534106850624084
with O 0 0.17338745296001434
mutations O 1 0.9530689716339111
associated O 0 0.24982856214046478
with O 0 0.03284308686852455
life O 0 0.12459424883127213
threatening O 1 0.6266757845878601
conditions O 0 0.29964619874954224
. O 0 0.07047608494758606

This O 0 0.015094595029950142
study O 0 0.013995910994708538
also O 0 0.005261950194835663
provided O 0 0.005799903068691492
evidence O 0 0.004425072576850653
for O 0 0.0035175136290490627
the O 0 0.004251160193234682
pathological O 0 0.1987193375825882
nature O 0 0.028397103771567345
of O 0 0.008024816401302814
amino O 0 0.32149726152420044
acid O 0 0.4862269163131714
changes O 0 0.06404488533735275
in O 0 0.027949707582592964
APC O 1 0.5533063411712646
associated O 0 0.09592194855213165
with O 0 0.017609041184186935
both O 0 0.03855324909090996
FAP B-Disease 1 0.9188687205314636
and O 0 0.08923085778951645
non O 1 0.7389682531356812
- O 1 0.9471677541732788
FAP O 1 0.9824278950691223
colorectal B-Disease 1 0.9906796813011169
cancer I-Disease 1 0.9870816469192505
patients O 1 0.9609636068344116
. O 0 0.11164877563714981
. O 0 0.06006508320569992

Inherited B-Disease 1 0.9205859899520874
colorectal I-Disease 1 0.9661011695861816
polyposis I-Disease 1 0.9545159935951233
and O 0 0.3462482690811157
cancer B-Disease 1 0.9547449946403503
risk O 1 0.5622041821479797
of O 0 0.018336409702897072
the O 0 0.027854595333337784
APC O 1 0.6838048100471497
I1307K O 1 0.6755852103233337
polymorphism O 1 0.7059199810028076
. O 0 0.06314362585544586

Germ O 1 0.6014562249183655
- O 0 0.10587456822395325
line O 0 0.03119887039065361
and O 0 0.019950751215219498
somatic O 1 0.6708570122718811
truncating O 1 0.6914833188056946
mutations O 1 0.8176380395889282
of O 0 0.01408245600759983
the O 0 0.021161392331123352
APC B-Disease 1 0.6561547517776489
gene O 1 0.7054494023323059
are O 0 0.013473459519445896
thought O 0 0.04221826046705246
to O 0 0.056822799146175385
initiate O 1 0.8978920578956604
colorectal B-Disease 1 0.9877201914787292
tumor I-Disease 1 0.9825406670570374
formation O 1 0.9323498606681824
in O 1 0.8213760256767273
familial B-Disease 1 0.986047625541687
adenomatous I-Disease 1 0.9853752851486206
polyposis I-Disease 1 0.9873450398445129
syndrome I-Disease 1 0.9828437566757202
and O 0 0.42036476731300354
sporadic O 1 0.9191517233848572
colorectal O 1 0.9731176495552063
carcinogenesis O 1 0.9187526702880859
, O 0 0.05606542155146599
respectively O 0 0.0705987885594368
. O 0 0.04644028842449188

Recently O 0 0.050892967730760574
, O 0 0.019507238641381264
an O 0 0.016405802220106125
isoleucine O 0 0.3804541528224945
- O 0 0.3283812403678894
- O 0 0.3726811408996582
> O 1 0.6765551567077637
lysine O 1 0.6152597069740295
polymorphism O 1 0.5388005375862122
at O 0 0.024464838206768036
codon O 1 0.5437865853309631
1307 O 1 0.7085334658622742
( O 0 0.08374644070863724
I1307K O 0 0.1763700544834137
) O 0 0.0098376190289855
of O 0 0.0035686008632183075
the O 0 0.006702688056975603
APC B-Disease 0 0.4433435797691345
gene O 0 0.4038832187652588
has O 0 0.004728261381387711
been O 0 0.004148344974964857
identified O 0 0.010217726230621338
in O 0 0.003769318573176861
6 O 0 0.00904044508934021
% O 0 0.02039552479982376
- O 0 0.03471066430211067
7 O 0 0.007946650497615337
% O 0 0.008759834803640842
of O 0 0.003903484670445323
the O 0 0.007592775858938694
Ashkenazi O 0 0.324625700712204
Jewish O 0 0.058268290013074875
population O 0 0.06486092507839203
. O 0 0.03427731990814209

To O 0 0.019686589017510414
assess O 0 0.03391256928443909
the O 0 0.010960223153233528
risk O 0 0.12256857007741928
of O 0 0.006768036168068647
this O 0 0.010811066254973412
common O 0 0.26567137241363525
APC B-Disease 1 0.8593509793281555
allelic O 1 0.936566948890686
variant O 1 0.9386117458343506
in O 0 0.2272859364748001
colorectal O 1 0.9815014004707336
carcinogenesis O 1 0.8405351638793945
, O 0 0.008368898183107376
we O 0 0.0038867152761667967
have O 0 0.003594587789848447
analyzed O 0 0.012189430184662342
a O 0 0.006453535985201597
large O 0 0.012366033159196377
cohort O 0 0.15266236662864685
of O 0 0.009985866956412792
unselected O 0 0.49770110845565796
Ashkenazi O 1 0.5982270836830139
Jewish O 0 0.126154825091362
subjects O 0 0.25969061255455017
with O 0 0.2866910398006439
adenomatous B-Disease 1 0.9827845692634583
polyps I-Disease 1 0.9740257859230042
and O 0 0.09289506822824478
. O 0 0.1562139093875885
or O 1 0.6069404482841492
colorectal B-Disease 1 0.9906486868858337
cancer I-Disease 1 0.9836855530738831
, I-Disease 0 0.03007727675139904
for O 0 0.013495191000401974
the O 0 0.025388507172465324
APC O 1 0.7298203110694885
I1307K O 1 0.6956437230110168
polymorphism O 1 0.7691622972488403
. O 0 0.06775418668985367

The O 0 0.03663841634988785
APC O 1 0.5364720225334167
I1307K O 0 0.45802831649780273
allele O 0 0.4915434718132019
was O 0 0.010903535410761833
identified O 0 0.014780296944081783
in O 0 0.005940019153058529
48 O 0 0.012607069686055183
( O 0 0.012360839173197746
10 O 0 0.005590070970356464
. O 0 0.004287833347916603
1 O 0 0.006471679545938969
% O 0 0.018240295350551605
) O 0 0.01299553643912077
of O 0 0.011599033139646053
476 O 1 0.5012246966362
patients O 1 0.8944915533065796
. O 0 0.06669431179761887

Compared O 0 0.02997451089322567
with O 0 0.010017967782914639
the O 0 0.006090191658586264
frequency O 0 0.01224244013428688
in O 0 0.0040404293686151505
two O 0 0.003901734948158264
separate O 0 0.00892062857747078
population O 0 0.015481763519346714
control O 0 0.016249950975179672
groups O 0 0.008566204458475113
, O 0 0.005233384668827057
the O 0 0.008151775225996971
APC O 1 0.5418655872344971
I1307K O 1 0.6079052090644836
allele O 1 0.730344831943512
is O 0 0.012699883431196213
associated O 0 0.02459055185317993
with O 0 0.005300675518810749
an O 0 0.006040387321263552
estimated O 0 0.02681039832532406
relative O 0 0.06173150613903999
risk O 0 0.23773153126239777
of O 0 0.00919631402939558
1 O 0 0.030849596485495567
. O 0 0.030069762840867043

5 O 0 0.07589127868413925
- O 0 0.11931896954774857
1 O 0 0.04431147128343582
. O 0 0.037847358733415604

7 O 0 0.09853646159172058
for O 0 0.12260833382606506
colorectal B-Disease 1 0.9620366096496582
neoplasia I-Disease 1 0.9170105457305908
( O 0 0.11950258910655975
both O 0 0.026998477056622505
P O 0 0.32862138748168945
= O 0 0.23608233034610748
. O 0 0.02137145958840847
01 O 0 0.3383360505104065
) O 0 0.044788721948862076
. O 0 0.02707142010331154

Furthermore O 0 0.05458325147628784
, O 0 0.019283005967736244
compared O 0 0.026170693337917328
with O 0 0.015798494219779968
noncarriers O 0 0.2502598464488983
, O 0 0.018493492156267166
APC O 0 0.4657931327819824
I1307K O 0 0.35590845346450806
carriers O 0 0.12908469140529633
had O 0 0.008716496638953686
increased O 0 0.026343120262026787
numbers O 0 0.02248615212738514
of O 0 0.03998004272580147
adenomas B-Disease 1 0.9619330167770386
and O 0 0.3705911636352539
colorectal B-Disease 1 0.9885573387145996
cancers I-Disease 1 0.9837846755981445
per O 0 0.33863377571105957
patient O 1 0.893154501914978
( O 0 0.18905140459537506
P O 0 0.3751260042190552
= O 0 0.17905855178833008
. O 0 0.009321740828454494
03 O 0 0.10562928020954132
) O 0 0.008284245617687702
, O 0 0.0032302988693118095
as O 0 0.002674587769433856
well O 0 0.0027211273554712534
as O 0 0.0034739377442747355
a O 0 0.008838177658617496
younger O 0 0.13429270684719086
age O 0 0.14418932795524597
at O 0 0.07293828576803207
diagnosis O 1 0.922981321811676
. O 0 0.06588013470172882

We O 0 0.01890009641647339
conclude O 0 0.024019882082939148
that O 0 0.00884294044226408
the O 0 0.010610389523208141
APC O 1 0.5070688128471375
I1307K O 0 0.4170311987400055
variant O 1 0.6103943586349487
leads O 0 0.07698707282543182
to O 0 0.011686178855597973
increased O 0 0.11591621488332748
adenoma B-Disease 1 0.9121171236038208
formation O 0 0.10049626231193542
and O 0 0.006437879987061024
directly O 0 0.009846894070506096
contributes O 0 0.042606648057699203
to O 0 0.00431964872404933
3 O 0 0.0112381586804986
% O 0 0.024068782106041908
- O 0 0.03906555473804474
4 O 0 0.01037164218723774
% O 0 0.017114778980612755
of O 0 0.006697407457977533
all O 0 0.014964479021728039
Ashkenazi O 1 0.7702480554580688
Jewish O 1 0.77525395154953
colorectal B-Disease 1 0.9836049675941467
cancer I-Disease 1 0.9779219627380371
. O 0 0.2437003254890442

The O 0 0.022217217832803726
estimated O 0 0.035164725035429
relative O 0 0.07691796123981476
risk O 0 0.3875238001346588
for O 0 0.012772612273693085
carriers O 0 0.23417086899280548
may O 0 0.04205906018614769
justify O 0 0.06525589525699615
specific O 0 0.05707966163754463
clinical O 0 0.3941147029399872
screening O 0 0.06538822501897812
for O 0 0.004324482753872871
the O 0 0.003975131083279848
360 O 0 0.012043493799865246
, O 0 0.00427287956699729
000 O 0 0.012206891551613808
Americans O 0 0.005933470092713833
expected O 0 0.003675526939332485
to O 0 0.002624612068757415
harbor O 0 0.011818109080195427
this O 0 0.004612211603671312
allele O 0 0.35526567697525024
, O 0 0.005383865442126989
and O 0 0.004631990101188421
genetic O 0 0.4114600718021393
testing O 0 0.023285774514079094
in O 0 0.0031229464802891016
the O 0 0.0026259254664182663
setting O 0 0.0076820338144898415
of O 0 0.004986308980733156
long O 0 0.04945213720202446
- O 0 0.13124042749404907
term O 0 0.07932015508413315
- O 0 0.1512371003627777
outcome O 0 0.11308573931455612
studies O 0 0.1919662207365036
may O 0 0.1124059334397316
impact O 0 0.3026163876056671
significantly O 1 0.731856107711792
on O 0 0.3161051869392395
colorectal B-Disease 1 0.9927021265029907
cancer I-Disease 1 0.9893231987953186
prevention O 1 0.9147484302520752
in O 0 0.030493823811411858
this O 0 0.02346336655318737
population O 0 0.10403066873550415
. O 0 0.03910193219780922

Localization O 0 0.09479396790266037
of O 0 0.016953149810433388
human O 0 0.1059146299958229
BRCA1 O 1 0.7449086308479309
and O 0 0.008390513248741627
its O 0 0.007266832049936056
loss O 0 0.04316246509552002
in O 0 0.008921783417463303
high O 0 0.04496914520859718
- O 0 0.2061462551355362
grade O 0 0.18813738226890564
, O 0 0.035134971141815186
non B-Disease 0 0.3330552279949188
- I-Disease 1 0.8059720396995544
inherited I-Disease 1 0.9625501036643982
breast I-Disease 1 0.9779784083366394
carcinomas I-Disease 1 0.958672285079956
. O 0 0.23681142926216125

Although O 0 0.028957746922969818
the O 0 0.017435148358345032
link O 0 0.11666279286146164
between O 0 0.058544646948575974
the O 0 0.16027554869651794
BRCA1 O 1 0.9794480204582214
tumour B-Disease 1 0.9801605343818665
- O 1 0.9282013773918152
suppressor O 1 0.972439706325531
gene O 1 0.964508593082428
and O 0 0.40521907806396484
hereditary B-Disease 1 0.9807159900665283
breast I-Disease 1 0.9889380931854248
and I-Disease 1 0.6477339863777161
ovarian I-Disease 1 0.9928567409515381
cancer I-Disease 1 0.9827430248260498
is O 0 0.022533878684043884
established O 0 0.01375468261539936
, O 0 0.0033725567627698183
the O 0 0.002807559445500374
role O 0 0.009161503054201603
, O 0 0.002979530720040202
if O 0 0.0028117916081100702
any O 0 0.0032243840396404266
, O 0 0.003863660851493478
of O 0 0.007928687147796154
BRCA1 O 1 0.9233573079109192
in O 0 0.058876022696495056
non B-Disease 0 0.49641430377960205
- I-Disease 1 0.8533562421798706
familial I-Disease 1 0.9770109057426453
cancers I-Disease 1 0.9740399122238159
is O 0 0.07967472076416016
unclear O 0 0.11704739928245544
. O 0 0.03973834216594696

BRCA1 O 1 0.9201626181602478
mutations O 1 0.8700928688049316
are O 0 0.027261216193437576
rare O 0 0.17092368006706238
in O 0 0.029645754024386406
sporadic B-Disease 1 0.6130098104476929
cancers I-Disease 1 0.9547691941261292
, O 0 0.011110496707260609
but O 0 0.006776028778403997
loss O 0 0.06554248183965683
of O 0 0.01724192127585411
BRCA1 O 1 0.9352907538414001
resulting O 0 0.2660371661186218
from O 0 0.018633373081684113
reduced O 0 0.08324858546257019
expression O 0 0.11640811711549759
or O 0 0.03491693362593651
incorrect O 0 0.1202239990234375
subcellular O 0 0.24745865166187286
localization O 0 0.14244364202022552
is O 0 0.008861023001372814
postulated O 0 0.05430816859006882
to O 0 0.003590752137824893
be O 0 0.0037068354431539774
important O 0 0.00898670218884945
in O 0 0.021464956924319267
non B-Disease 0 0.4394463896751404
- I-Disease 1 0.8837013840675354
familial I-Disease 1 0.9814759492874146
breast I-Disease 1 0.985249936580658
and I-Disease 1 0.7412068247795105
ovarian I-Disease 1 0.9857726693153381
cancers I-Disease 1 0.9773766994476318
. O 0 0.34785571694374084

Epigenetic O 1 0.6458274722099304
loss O 0 0.06426846235990524
, O 0 0.00966830737888813
however O 0 0.006029508542269468
, O 0 0.0038551711477339268
has O 0 0.0030260293278843164
not O 0 0.002445060992613435
received O 0 0.0036661687772721052
general O 0 0.0035571944899857044
acceptance O 0 0.01490660198032856
due O 0 0.00835474394261837
to O 0 0.003501195227727294
controversy O 0 0.012804856523871422
regarding O 0 0.006597692146897316
the O 0 0.004996385890990496
subcellular O 0 0.1477096527814865
localization O 0 0.1382259726524353
of O 0 0.017277183011174202
BRCA1 O 1 0.9373157024383545
proteins O 0 0.2670021057128906
, O 0 0.004764447920024395
reports O 0 0.003762474050745368
of O 0 0.00242228782735765
which O 0 0.002525530057027936
have O 0 0.00238431291654706
ranged O 0 0.006350175943225622
from O 0 0.003323950571939349
exclusively O 0 0.005921389441937208
nuclear O 0 0.0068199485540390015
, O 0 0.002953905612230301
to O 0 0.002575429156422615
conditionally O 0 0.015600738115608692
nuclear O 0 0.007246328517794609
, O 0 0.0034415365662425756
to O 0 0.0035725419875234365
the O 0 0.008427238091826439
ER O 1 0.5713974833488464
/ O 0 0.36614763736724854
golgi O 0 0.404516339302063
, O 0 0.0092248460277915
to O 0 0.007541721686720848
cytoplasmic O 0 0.23175863921642303
invaginations O 0 0.1290895938873291
into O 0 0.010400066152215004
the O 0 0.014150451868772507
nucleus O 0 0.19459772109985352
. O 0 0.038058724254369736

In O 0 0.017929473891854286
an O 0 0.008475475944578648
attempt O 0 0.008395545184612274
to O 0 0.004452146589756012
resolve O 0 0.010941966436803341
this O 0 0.003273159731179476
issue O 0 0.004482152871787548
, O 0 0.0030097293201833963
we O 0 0.002748984843492508
have O 0 0.004258978646248579
comprehensively O 0 0.07046204060316086
characterized O 0 0.2857595682144165
19 O 0 0.08793660998344421
anti O 0 0.3404909670352936
- O 1 0.7289171814918518
BRCA1 O 1 0.9657054543495178
antibodies O 1 0.9295350909233093
. O 0 0.13142330944538116

These O 0 0.03367070108652115
reagents O 0 0.2115495651960373
detect O 0 0.11336098611354828
a O 0 0.01762140914797783
220 O 0 0.04925920441746712
- O 0 0.21359017491340637
kD O 1 0.5677359700202942
protein O 1 0.5057349801063538
localized O 0 0.4837598204612732
in O 0 0.013066835701465607
discrete O 0 0.08568543940782547
nuclear O 0 0.02800547517836094
foci O 0 0.2721869647502899
in O 0 0.007892529480159283
all O 0 0.008831121027469635
epithelial O 1 0.8384549021720886
cell O 0 0.45818573236465454
lines O 0 0.04468328878283501
, O 0 0.006320072803646326
including O 0 0.00758326007053256
those O 0 0.012864685617387295
derived O 0 0.20281986892223358
from O 0 0.18954280018806458
breast B-Disease 1 0.9728235602378845
malignancies I-Disease 1 0.9437989592552185
. O 0 0.166683629155159

Immunohistochemical O 1 0.7670671343803406
staining O 1 0.5911634564399719
of O 0 0.041481513530015945
human O 1 0.504422664642334
breast O 1 0.9610050320625305
specimens O 0 0.4566495418548584
also O 0 0.049887508153915405
revealed O 0 0.3629261553287506
BRCA1 O 1 0.9643049240112305
nuclear O 0 0.3921767473220825
foci O 1 0.9207767844200134
in O 0 0.45712581276893616
benign O 1 0.9766921997070312
breast O 1 0.9841063618659973
, O 1 0.6599630117416382
invasive B-Disease 1 0.9800691604614258
lobular I-Disease 1 0.9803024530410767
cancers I-Disease 1 0.9787959456443787
and O 0 0.11233483999967575
low B-Disease 1 0.5144560933113098
- I-Disease 1 0.6705255508422852
grade I-Disease 1 0.7595076560974121
ductal I-Disease 1 0.9607604742050171
carcinomas I-Disease 1 0.9577498435974121
. O 0 0.19967176020145416

Conversely O 0 0.2468704730272293
, O 0 0.036039434373378754
BRCA1 O 1 0.8670920133590698
expression O 0 0.08323724567890167
was O 0 0.007861094549298286
reduced O 0 0.0310167595744133
or O 0 0.012469408102333546
undetectable O 0 0.2378668338060379
in O 0 0.003954170737415552
the O 0 0.0032381508499383926
majority O 0 0.009259702637791634
of O 0 0.0048489817418158054
high O 0 0.03058401495218277
- O 0 0.21937419474124908
grade O 0 0.25386881828308105
, O 0 0.09780944883823395
ductal B-Disease 1 0.9697825312614441
carcinomas I-Disease 1 0.9535536766052246
, O 0 0.01984225958585739
suggesting O 0 0.07194162905216217
that O 0 0.006604675203561783
absence O 0 0.056172654032707214
of O 0 0.01338447816669941
BRCA1 O 1 0.9290828108787537
may O 0 0.06213369220495224
contribute O 0 0.0497933067381382
to O 0 0.003957947716116905
the O 0 0.006410451140254736
pathogenesis O 1 0.5763280391693115
of O 0 0.005206593777984381
a O 0 0.010638879612088203
significant O 0 0.03338342159986496
percentage O 0 0.08242231607437134
of O 0 0.049995675683021545
sporadic B-Disease 1 0.879491925239563
breast I-Disease 1 0.9833201766014099
cancers I-Disease 1 0.9760196805000305
. O 0 0.09754288196563721
. O 0 0.048801302909851074

